data_2mui_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mui _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.1 mt . . . . . 0 N--CA 1.468 0.475 0 CA-C-O 120.746 0.308 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -90.19 20.0 4.67 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.928 0.394 . . . . 0.0 111.214 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 175.33 55.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.124 0.97 . . . . 0.0 110.116 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -134.25 159.47 40.86 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.654 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 16.5 m-30 -97.75 135.17 39.91 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.532 ' O ' HG12 ' A' ' 29' ' ' VAL . 6.0 mt -107.64 138.99 42.87 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.968 177.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.3 mm -117.26 134.11 61.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.14 128.54 33.41 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.749 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 43.2 mtt -113.75 157.4 41.79 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.268 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.56 32.74 0.52 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.655 2.237 . . . . 0.0 113.143 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -86.0 -18.3 32.94 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.71 -163.46 0.86 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.096 0.248 . . . . 0.0 110.451 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.514 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -99.24 31.73 2.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 7.9 m-20 -112.42 80.78 3.68 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.0 Cg_exo -75.44 -21.17 15.32 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 123.11 2.54 . . . . 0.0 113.276 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -85.53 -38.5 18.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.515 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -93.27 2.67 56.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.69 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 22' ' ' ASP . . . -68.23 8.24 0.47 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -141.87 39.42 1.65 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.152 0.501 . . . . 0.0 112.186 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.2 p -123.16 156.12 35.68 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.426 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 14' ' ' LEU . 59.5 t -130.25 132.7 64.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.902 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -113.41 152.91 29.42 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.415 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.529 ' OH ' HD22 ' A' ' 105' ' ' LEU . 43.6 t80 -107.23 120.07 41.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.04 108.57 17.06 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 123.515 0.509 . . . . 0.0 111.402 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.477 ' O ' HD21 ' A' ' 102' ' ' LEU . 31.2 t -67.45 -59.24 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.713 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -143.65 115.61 8.32 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.1 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -98.01 128.32 44.49 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.912 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -138.92 152.21 47.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.358 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.02 -17.91 64.85 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.881 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -102.31 3.29 37.91 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.52 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.54 166.89 15.16 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.285 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.409 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -145.92 141.07 27.44 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.91 133.92 55.45 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.125 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.542 ' O ' ' HB1' ' A' ' 133' ' ' ALA . . . -159.24 156.84 27.95 Favored Glycine 0 N--CA 1.449 -0.461 0 O-C-N 124.268 0.98 . . . . 0.0 112.492 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 mt -113.31 135.24 54.06 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.226 0.513 . . . . 0.0 111.638 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 78' ' ' GLY . 11.6 t -68.77 124.06 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -127.41 55.83 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.688 0.756 . . . . 0.0 111.961 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.847 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.0 t-20 -146.87 -4.16 0.57 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.23 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.437 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 2.5 ttt180 -129.72 87.89 51.09 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.482 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.1 Cg_exo -58.87 141.75 98.37 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 121.635 1.557 . . . . 0.0 112.176 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.425 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.9 m -90.29 158.02 17.37 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.41 0.444 . . . . 0.0 111.649 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.12 49.39 1.38 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.585 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.424 ' C ' HG12 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -133.22 155.36 49.5 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.337 -0.432 . . . . 0.0 109.99 -179.281 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -112.39 161.08 17.08 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.578 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 tp -58.36 -27.03 63.83 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.663 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . . . -61.86 -42.79 99.48 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.45 -47.42 79.11 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.052 0.22 . . . . 0.0 111.423 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.859 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.8 m -61.76 -44.49 98.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.6 mt -55.54 -36.04 66.32 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.748 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.05 -28.14 48.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.409 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.405 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -78.07 -30.04 49.5 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.269 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.859 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.94 -46.22 21.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.759 -1.564 . . . . 0.0 111.372 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -132.7 118.68 15.72 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.003 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.4 -32.36 3.01 Favored 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.628 2.885 . . . . 0.0 112.556 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -82.18 -15.29 53.74 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.294 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.21 149.27 26.92 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 123.283 0.365 . . . . 0.0 111.42 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.94 121.45 31.55 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.64 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.709 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 47.2 Cg_endo -71.4 138.07 32.03 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.555 2.17 . . . . 0.0 112.339 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -90.07 -156.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.705 2.27 . . . . 0.0 112.532 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.09 -24.88 51.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.264 0.626 . . . . 0.0 111.824 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.515 ' O ' HG13 ' A' ' 73' ' ' ILE . 10.0 ptp180 -67.86 -45.42 74.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.709 ' SG ' ' HB2' ' A' ' 66' ' ' PRO . 19.5 p -65.59 -32.66 74.36 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -66.97 -26.84 67.02 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.664 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -97.49 8.28 44.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.734 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 69' ' ' ARG . 64.2 mt -113.58 137.73 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.179 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.516 ' O ' HD13 ' A' ' 128' ' ' ILE . 1.8 m-20 -106.75 163.31 13.03 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.873 0.733 . . . . 0.0 112.937 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.424 HG12 ' C ' ' A' ' 51' ' ' LEU . 14.0 mm -111.81 152.95 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.598 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.707 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -119.5 153.72 34.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.21 118.76 24.36 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.533 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -99.53 -23.93 10.59 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 120.185 -1.007 . . . . 0.0 113.797 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.41 -167.74 35.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.218 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -88.62 -10.53 4.4 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.702 2.935 . . . . 0.0 114.227 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.96 130.39 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 123.023 0.202 . . . . 0.0 111.098 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 45.94 85.02 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.431 1.092 . . . . 0.0 113.194 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 68.6 p -85.91 -5.81 59.17 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.953 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.87 -2.43 58.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.766 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.627 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.66 152.13 51.77 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.47 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.627 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.6 132.21 10.98 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.56 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -86.19 144.85 27.25 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.047 0.939 . . . . 0.0 110.756 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.29 104.49 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 123.474 0.484 . . . . 0.0 110.514 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 126' ' ' SER . 13.0 tp -108.32 129.53 55.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.213 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.422 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 4.3 p80 -127.04 169.07 12.89 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-O 118.874 -0.584 . . . . 0.0 111.769 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.68 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.5 Cg_endo -98.06 13.83 0.74 Allowed 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.856 2.37 . . . . 0.0 113.802 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.422 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 9.2 t -101.26 160.94 13.98 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.881 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.38 22.03 42.24 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.537 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 tp -86.8 154.05 21.2 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.613 0.365 . . . . 0.0 110.642 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.6 p -127.66 156.3 42.55 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.563 ' CE2' HG23 ' A' ' 113' ' ' VAL . 54.9 m-85 -129.96 -152.31 0.51 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.811 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -57.64 -46.58 83.98 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.76 0.424 . . . . 0.0 111.615 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 64.4 m -135.92 83.56 2.02 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.259 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.3 m -130.63 130.37 43.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.835 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.99 123.34 48.97 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.626 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.19 129.14 34.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.071 0.462 . . . . 0.0 110.747 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -125.12 46.27 2.39 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.419 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.12 -106.12 1.41 Allowed Glycine 0 C--N 1.336 0.575 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.162 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.6 -10.64 3.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.529 HD22 ' OH ' ' A' ' 31' ' ' TYR . 2.3 pp -156.12 153.29 29.09 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.237 0.335 . . . . 0.0 111.508 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.43 156.12 28.49 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.545 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.58 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 17.5 ttm -121.48 126.14 48.55 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 m -122.29 128.05 50.61 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.192 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.5 p -118.05 13.04 13.82 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.44 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.2 p -87.91 127.06 35.36 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.644 0.735 . . . . 0.0 111.952 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.491 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 21.1 pt20 -59.32 -29.11 67.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.358 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.97 -43.07 96.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.541 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 117' ' ' ILE . 4.7 p -67.76 -37.62 78.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.528 HD22 ' NH2' ' A' ' 85' ' ' ARG . 5.0 tp -58.4 -47.86 82.53 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 123.552 0.532 . . . . 0.0 110.266 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.491 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 26.4 m-85 -67.66 -39.91 84.51 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.813 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -52.45 64.74 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.351 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.71 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.93 -43.65 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.546 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.65 -32.32 65.25 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.774 0.671 . . . . 0.0 109.642 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.55 -20.03 32.18 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.238 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.44 14.41 32.77 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 114.693 -1.14 . . . . 0.0 114.785 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.8 p -104.58 7.55 35.14 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.23 -138.1 9.68 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 119.207 -0.774 . . . . 0.0 112.625 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.9 173.88 11.55 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 123.292 2.661 . . . . 0.0 113.536 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.21 -54.75 43.24 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.716 0.806 . . . . 0.0 111.962 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.68 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.9 mmtt -141.58 139.96 33.26 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.873 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 34.6 p -137.45 166.33 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.0 tp -126.97 116.06 20.2 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.577 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.703 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 11.5 pt -98.47 102.7 13.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.779 0.799 . . . . 0.0 109.647 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.4 t -123.01 123.98 42.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.818 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.36 115.79 7.4 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.493 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.415 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 66.75 172.47 5.09 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.633 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -128.41 -177.51 4.2 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.313 0.578 . . . . 0.0 110.864 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 42' ' ' GLY . . . -118.48 127.9 54.08 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.093 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.23 143.06 14.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.474 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.409 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 27.9 m-90 -119.28 137.37 53.72 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.773 0.337 . . . . 0.0 110.404 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -81.75 158.15 24.27 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.878 0.737 . . . . 0.0 110.539 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.56 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.81 -25.2 7.27 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.072 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -57.95 -44.58 87.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.93 0.492 . . . . 0.0 112.275 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.564 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.6 -47.76 65.87 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.146 0.279 . . . . 0.0 110.605 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.1 -29.53 68.65 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.958 0.408 . . . . 0.0 110.619 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.14 -50.36 41.31 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.872 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.0 pt-20 -70.17 -26.68 64.03 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.787 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tp -74.77 -38.94 62.04 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.645 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.3 m -77.84 -28.34 50.15 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.352 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.8 t70 -82.64 -0.28 46.45 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.472 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 60.07 29.01 18.62 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.865 0.866 . . . . 0.0 111.787 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.13 -42.8 18.62 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.942 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -125.58 115.25 19.87 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.0 tp -86.45 143.14 27.92 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.506 0.194 . . . . 0.0 111.465 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.9 p -103.7 135.91 44.39 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.058 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 76.9 m -151.23 155.06 34.55 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.626 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.88 159.19 26.02 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.253 1.969 . . . . 0.0 111.244 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -131.94 166.59 21.31 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -135.69 135.12 21.4 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.963 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.19 -26.41 14.81 Favored 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.597 2.198 . . . . 0.0 113.682 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.81 -40.57 63.38 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.847 0.717 . . . . 0.0 112.135 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.557 HD11 HH12 ' A' ' 167' ' ' ARG . 4.5 mt -71.43 -35.5 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.366 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.71 -37.79 65.04 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.482 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -84.86 -34.71 22.57 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -84.71 -72.52 0.47 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.924 0.329 . . . . 0.0 111.637 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.89 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.64 99.42 6.28 Favored Pre-proline 0 C--N 1.349 0.563 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.847 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.4 Cg_endo -91.86 -0.45 4.36 Favored 'Trans proline' 0 CA--C 1.57 2.284 0 C-N-CA 121.716 1.611 . . . . 0.0 114.262 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.626 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 77.6 Cg_endo -73.96 -52.34 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 122.589 2.193 . . . . 0.0 114.437 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.544 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.7 mt-10 -122.45 -30.02 4.01 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.714 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.89 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.1 tt0 -70.23 -10.85 60.14 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.391 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.557 HH12 HD11 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -77.06 -40.52 45.92 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -71.36 -49.88 37.79 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.207 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.1 t -58.41 -49.03 78.76 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.504 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.654 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.7 -40.25 95.05 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.249 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.21 78.52 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 123.516 0.51 . . . . 0.0 110.534 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.16 90.07 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.495 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.3 -27.69 68.8 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.538 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.73 -40.15 42.11 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 122.92 0.488 . . . . 0.0 110.264 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.37 -32.0 69.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.38 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.789 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.933 179.539 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 120.775 0.321 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -90.58 19.14 5.57 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.908 0.385 . . . . 0.0 111.072 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 175.88 55.96 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.087 0.955 . . . . 0.0 110.17 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -134.94 159.35 41.74 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.618 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.512 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.6 m-30 -98.08 135.12 40.21 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.09 0.471 . . . . 0.0 112.153 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.552 ' O ' HG11 ' A' ' 29' ' ' VAL . 6.1 mt -108.7 137.6 46.37 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.785 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 mp -120.51 132.69 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.82 127.57 33.17 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.722 0.639 . . . . 0.0 112.003 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.8 mmt -110.26 158.19 35.94 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.179 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -80.55 21.4 0.86 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.693 2.262 . . . . 0.0 113.549 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -83.07 -19.38 36.94 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.569 ' SD ' ' HB3' ' A' ' 148' ' ' ALA . 15.9 ptt? -102.31 -164.75 1.12 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.272 0.357 . . . . 0.0 110.38 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.525 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -106.74 30.9 5.68 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.5 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 7.9 m-20 -110.44 84.84 4.15 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.712 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.3 Cg_exo -75.31 -23.8 12.96 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.059 2.506 . . . . 0.0 113.48 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -85.11 -37.01 20.75 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.794 0.438 . . . . 0.0 111.557 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.85 3.06 55.97 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.499 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.5 ' HB1' ' O ' ' A' ' 22' ' ' ASP . . . -66.78 5.82 0.58 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -140.83 38.84 1.81 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.116 0.484 . . . . 0.0 112.156 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 p -123.14 155.02 37.84 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.417 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 14' ' ' LEU . 50.1 t -130.5 131.95 64.85 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.856 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -113.6 153.58 28.6 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.365 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.498 ' OH ' HD22 ' A' ' 105' ' ' LEU . 42.9 t80 -106.99 119.63 39.89 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.84 109.24 17.4 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.3 0.571 . . . . 0.0 111.25 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.544 ' O ' HD22 ' A' ' 102' ' ' LEU . 31.6 t -69.03 -59.65 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.674 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -141.96 114.34 8.3 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.337 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -97.45 128.29 44.11 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.754 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -139.4 152.64 47.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.34 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -65.11 -18.13 65.04 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.797 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -100.56 1.56 41.01 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.432 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.32 167.3 15.57 Favored Glycine 0 C--N 1.345 1.055 0 C-N-CA 121.541 -0.361 . . . . 0.0 112.205 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.02 142.49 29.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -120.62 135.51 55.08 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.57 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 133' ' ' ALA . . . -158.75 156.95 27.97 Favored Glycine 0 N--CA 1.449 -0.448 0 O-C-N 124.364 1.04 . . . . 0.0 112.817 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mt -111.93 131.63 55.26 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.9 0.35 . . . . 0.0 110.974 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 78' ' ' GLY . 18.1 t -66.89 125.35 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -128.22 55.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.715 0.769 . . . . 0.0 112.22 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.845 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.0 t-20 -147.19 -4.61 0.53 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.308 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.68 87.89 51.21 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.481 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.1 Cg_exo -59.3 141.11 97.32 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.631 1.554 . . . . 0.0 112.004 175.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.406 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 46.0 m -89.32 159.12 17.53 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.253 0.346 . . . . 0.0 111.638 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.28 45.55 1.46 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.363 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.439 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.7 154.37 51.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 16.6 p-10 -104.17 161.09 14.32 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.294 0.371 . . . . 0.0 110.783 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.469 HD21 ' SG ' ' A' ' 70' ' ' CYS . 15.3 tp -58.19 -35.78 72.11 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.25 61.14 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.525 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.65 -43.22 97.42 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.841 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -62.28 -48.31 88.96 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.435 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 4.5 mp -52.89 -36.63 59.6 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.977 0.798 . . . . 0.0 111.024 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -78.06 -28.62 48.94 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.466 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.29 -30.27 48.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.368 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.841 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.0 mt -77.89 -44.98 25.45 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.86 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -132.48 116.79 15.24 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.441 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.72 -32.66 2.64 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.619 2.879 . . . . 0.0 112.835 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -82.38 -13.99 55.96 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.429 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.3 148.63 25.53 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 123.329 0.393 . . . . 0.0 111.734 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.6 123.03 31.91 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.149 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.17 144.46 29.71 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.244 1.963 . . . . 0.0 112.553 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.406 ' C ' HE21 ' A' ' 71' ' ' GLN . 5.8 Cg_endo -92.8 -169.73 0.25 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.657 2.238 . . . . 0.0 112.248 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.48 -24.61 67.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.303 0.641 . . . . 0.0 112.202 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.569 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 9.1 ptp180 -66.76 -55.58 14.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.469 ' SG ' HD21 ' A' ' 53' ' ' LEU . 69.1 m -70.89 -25.56 62.84 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.406 HE21 ' C ' ' A' ' 67' ' ' PRO . 42.6 mt-30 -68.77 -32.76 72.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.772 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -91.77 19.56 6.38 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.614 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 69' ' ' ARG . 52.0 mt -122.28 140.92 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.858 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.587 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.6 m-20 -109.02 152.37 25.09 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.814 0.696 . . . . 0.0 112.44 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 51' ' ' LEU . 14.6 mm -99.6 153.48 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.237 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -120.24 152.48 37.68 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.7 119.42 24.28 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.76 0.254 . . . . 0.0 110.823 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -100.58 -23.76 9.9 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.732 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.04 -167.75 34.93 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.182 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -88.49 -8.28 5.4 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.614 2.876 . . . . 0.0 114.235 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.29 128.83 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 123.07 0.231 . . . . 0.0 111.087 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 45.01 86.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.532 1.133 . . . . 0.0 113.326 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 78.3 p -86.68 -2.45 58.53 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.995 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -88.68 -4.46 58.54 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.895 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.599 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.2 153.01 51.93 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.134 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.599 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.51 131.12 10.41 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.07 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.719 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.6 OUTLIER -85.59 151.13 24.15 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.253 1.021 . . . . 0.0 110.428 -179.647 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.626 ' HB ' ' OG ' ' A' ' 108' ' ' SER . 3.4 t -128.37 106.39 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 O-C-N 123.312 0.383 . . . . 0.0 111.159 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.592 ' HB2' ' SD ' ' A' ' 107' ' ' MET . 14.6 tp -108.45 127.79 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.041 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.491 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 4.2 p80 -128.42 168.27 16.25 Favored Pre-proline 0 CA--C 1.554 1.11 0 O-C-N 123.669 0.606 . . . . 0.0 111.411 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.649 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 14.8 Cg_endo -95.39 14.21 1.19 Allowed 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 122.526 2.151 . . . . 0.0 113.39 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.491 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 8.6 t -101.17 159.7 15.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.861 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.3 18.9 55.84 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.714 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.99 154.83 24.29 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.499 0.32 . . . . 0.0 110.922 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.4 p -126.37 157.64 37.97 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.663 ' H ' ' HG1' ' A' ' 99' ' ' THR . 50.3 m-85 -129.9 -149.54 0.4 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.433 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -61.15 -45.73 93.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.55 0.34 . . . . 0.0 111.18 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.3 m -137.54 83.06 1.96 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.234 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.663 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 8.0 m -128.22 122.35 31.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.718 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -99.89 120.77 40.3 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.987 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -83.54 127.26 33.59 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.167 0.508 . . . . 0.0 110.331 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.544 HD22 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.43 46.91 2.1 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.44 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.28 -107.72 2.09 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.103 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.41 -10.03 4.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.498 HD22 ' OH ' ' A' ' 31' ' ' TYR . 2.0 pp -155.14 153.63 31.08 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.256 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -121.47 158.57 28.12 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.783 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.592 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 25.8 tpp -125.28 140.12 53.11 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.626 ' OG ' ' HB ' ' A' ' 88' ' ' VAL . 21.4 p -134.06 133.16 40.85 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.933 0.396 . . . . 0.0 110.351 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.4 p -117.14 16.51 14.95 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.049 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.0 m -89.66 127.78 35.97 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.636 0.731 . . . . 0.0 112.023 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.479 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 10.1 pt20 -61.43 -28.81 69.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.973 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -65.81 -42.17 90.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.669 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.722 ' O ' HG23 ' A' ' 117' ' ' ILE . 3.8 p -67.38 -39.9 83.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.571 ' N ' HG11 ' A' ' 113' ' ' VAL . 6.4 tp -58.97 -47.36 85.41 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 123.592 0.557 . . . . 0.0 110.469 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.479 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 24.1 m-85 -69.36 -38.47 78.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.914 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.81 66.76 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.043 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.75 -43.47 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.348 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.25 -31.56 65.67 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.74 0.65 . . . . 0.0 109.588 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.569 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.63 -20.15 31.81 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.238 176.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.15 14.85 32.23 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.648 -1.16 . . . . 0.0 114.602 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.1 p -105.14 7.3 33.71 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.19 -138.74 10.01 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.715 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.8 168.06 17.94 Favored 'Trans proline' 0 C--N 1.367 1.526 0 C-N-CA 123.255 2.637 . . . . 0.0 113.956 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.492 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -51.11 -59.2 4.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.511 1.125 . . . . 0.0 111.897 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.649 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -140.19 139.88 35.78 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.783 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 32.6 p -137.93 168.38 19.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.66 118.25 23.5 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.685 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.0 pt -98.12 102.24 13.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 121.782 0.801 . . . . 0.0 109.738 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 5.6 t -119.35 122.36 41.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.847 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.5 tp -66.85 114.62 5.84 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.195 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.43 176.02 5.69 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.737 -1.119 . . . . 0.0 114.385 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -128.58 -178.55 4.63 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.437 0.636 . . . . 0.0 110.957 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -118.49 128.77 54.91 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.977 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.7 147.27 17.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.532 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 -125.46 136.86 53.82 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.93 0.429 . . . . 0.0 110.303 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.43 158.27 27.37 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.94 0.775 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.0 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.21 -25.6 7.75 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.182 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -57.84 -44.15 86.32 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.886 0.474 . . . . 0.0 112.257 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.571 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.72 -47.13 67.12 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.575 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -60.49 -29.4 69.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.025 0.44 . . . . 0.0 110.38 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.14 -50.09 43.98 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.802 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.35 -26.65 63.84 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.766 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.7 tp -75.0 -38.38 61.62 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.623 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.6 t -77.87 -28.65 50.05 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.12 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -82.46 0.02 44.19 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.429 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.44 29.82 19.43 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.839 0.856 . . . . 0.0 111.869 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.569 ' HB3' ' SD ' ' A' ' 20' ' ' MET . . . -83.16 -42.44 17.31 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.942 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -124.03 113.6 18.62 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.5 tp -84.36 141.9 30.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.643 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.0 p -103.27 134.85 45.98 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.651 0.595 . . . . 0.0 111.057 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.449 ' SG ' ' HD2' ' A' ' 153' ' ' PRO . 48.8 t -150.02 144.53 17.71 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.414 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.449 ' HD2' ' SG ' ' A' ' 152' ' ' CYS . 57.1 Cg_exo -53.0 157.45 8.12 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.467 2.111 . . . . 0.0 111.595 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.512 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.02 167.39 18.34 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -135.21 135.4 22.63 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 114.173 -1.376 . . . . 0.0 107.919 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.46 -26.4 14.25 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.601 2.2 . . . . 0.0 113.727 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.71 -40.66 63.2 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.832 0.708 . . . . 0.0 112.199 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.55 HD13 HH12 ' A' ' 167' ' ' ARG . 4.8 mt -71.25 -35.35 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.4 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -74.06 -37.55 64.23 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.438 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -84.87 -33.88 22.73 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -85.89 -72.63 0.48 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.016 0.371 . . . . 0.0 111.654 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.898 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.36 99.49 6.43 Favored Pre-proline 0 C--N 1.348 0.531 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.845 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 67.9 Cg_endo -92.01 -0.22 4.26 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 C-N-CA 121.678 1.585 . . . . 0.0 114.317 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.626 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 81.7 Cg_endo -73.98 -52.62 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.894 0 C-N-CA 122.61 2.206 . . . . 0.0 114.361 -178.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.544 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.15 -30.09 4.09 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.691 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.898 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 4.9 tp10 -70.0 -11.12 60.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.388 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.55 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.93 -41.61 42.71 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.259 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -70.36 -50.24 41.03 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.4 m -58.39 -49.57 76.8 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.656 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.653 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -63.99 -39.58 94.43 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.037 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.95 -45.48 78.82 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.583 0.552 . . . . 0.0 110.508 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.03 93.12 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.441 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.58 -28.06 69.38 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.663 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.653 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.96 -40.18 40.25 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 122.865 0.466 . . . . 0.0 110.43 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.83 -33.77 75.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.407 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.78 0 C-N-CA 121.06 -0.591 . . . . 0.0 113.175 179.378 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.779 0.323 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -89.44 20.8 3.67 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.846 0.355 . . . . 0.0 111.355 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 174.66 54.62 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.024 0.929 . . . . 0.0 110.172 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -133.42 160.64 36.8 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.721 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 16.2 m-30 -97.97 137.68 36.42 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 2.8 mt -110.49 140.56 44.64 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.913 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mp -125.43 135.53 63.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.77 122.86 21.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.075 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -105.53 156.07 37.01 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -80.92 31.94 0.51 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.67 2.247 . . . . 0.0 113.197 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -87.36 -17.63 31.93 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.53 -169.6 1.65 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 123.076 0.235 . . . . 0.0 110.783 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.534 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -105.62 42.94 1.17 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.141 0.496 . . . . 0.0 111.561 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.48 81.83 2.54 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.934 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.2 Cg_exo -75.45 -22.16 14.32 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 123.083 2.522 . . . . 0.0 113.431 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -84.49 -36.49 22.2 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.871 0.468 . . . . 0.0 111.791 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.62 3.98 52.63 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.948 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.7 163.6 21.18 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 48.6 31.88 3.18 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.8 p -115.57 153.95 30.29 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 120.564 0.221 . . . . 0.0 110.735 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.6 t -127.58 132.1 69.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.805 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 m -114.84 152.59 31.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.889 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.509 ' OH ' HD21 ' A' ' 105' ' ' LEU . 38.0 t80 -106.59 118.43 36.64 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.426 HD11 ' O ' ' A' ' 41' ' ' MET . 0.2 OUTLIER -82.4 107.95 15.45 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 111.122 -178.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG11 ' SD ' ' A' ' 107' ' ' MET . 54.0 t -63.66 -61.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.811 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -145.49 116.41 7.79 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.09 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -98.06 127.74 44.18 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.559 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -139.09 152.9 47.89 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.545 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.83 -19.2 65.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.804 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.38 7.48 42.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.393 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.81 166.22 12.49 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.394 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.92 145.27 30.63 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.426 ' O ' HD11 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -124.72 137.41 54.35 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.474 178.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 133' ' ' ALA . . . -157.93 156.53 27.42 Favored Glycine 0 N--CA 1.447 -0.617 0 O-C-N 124.403 1.065 . . . . 0.0 112.566 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mt -111.16 133.32 53.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 117.108 0.454 . . . . 0.0 111.042 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 78' ' ' GLY . 15.0 t -69.09 123.68 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.706 ' O ' ' HG3' ' A' ' 167' ' ' ARG . 1.5 pt -127.68 52.52 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.232 0.539 . . . . 0.0 112.335 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.929 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 24.1 t-20 -144.56 -1.36 0.9 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.133 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -129.53 87.08 54.03 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.487 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 31.4 Cg_exo -59.2 144.58 99.33 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.805 1.67 . . . . 0.0 112.65 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.417 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 51.5 m -94.33 158.65 15.48 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.503 0.502 . . . . 0.0 111.371 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.75 50.69 1.22 Allowed Glycine 0 C--N 1.339 0.696 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.742 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mt -133.77 157.74 45.1 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 122.851 0.461 . . . . 0.0 110.151 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.63 ' ND2' ' HB1' ' A' ' 54' ' ' ALA . 10.1 p-10 -112.25 157.37 21.01 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.198 0.311 . . . . 0.0 110.172 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.734 ' O ' HG23 ' A' ' 56' ' ' VAL . 14.0 tp -56.81 -36.47 69.96 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.63 ' HB1' ' ND2' ' A' ' 52' ' ' ASN . . . -55.53 -35.32 65.53 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -64.67 -45.27 87.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.286 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.875 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 31.6 m -63.24 -43.48 98.76 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.453 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 4.0 mp -54.98 -36.75 65.72 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.83 0.706 . . . . 0.0 110.205 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -77.84 -27.78 49.98 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.499 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -78.16 -30.46 49.2 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.286 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.875 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.3 mt -77.87 -44.96 25.63 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.923 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -132.04 116.1 15.54 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.459 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.72 -32.88 2.52 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 123.611 2.874 . . . . 0.0 112.841 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.09 -14.09 56.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.414 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.35 149.26 24.62 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 123.33 0.394 . . . . 0.0 111.814 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -116.55 122.78 31.34 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.949 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.43 151.05 37.18 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.297 1.998 . . . . 0.0 112.506 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.514 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.2 Cg_endo -92.36 -162.59 0.1 Allowed 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.617 2.211 . . . . 0.0 111.706 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.45 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -73.25 -24.95 60.53 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.75 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -64.81 -50.78 65.41 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.471 ' SG ' HD22 ' A' ' 53' ' ' LEU . 61.2 m -72.61 -24.97 61.14 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 42.1 mt-30 -68.69 -34.84 76.35 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.45 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 23.5 p80 -90.73 22.57 3.48 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.193 0.52 . . . . 0.0 111.74 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 60.5 mt -121.8 139.52 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.188 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.55 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.7 m-20 -105.81 154.73 20.11 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.0 mm -102.09 151.62 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.739 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.692 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -119.44 154.66 33.37 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -85.18 121.27 27.69 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 117.789 0.268 . . . . 0.0 110.806 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -104.07 -23.7 8.0 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 120.209 -0.996 . . . . 0.0 114.207 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.01 -167.98 33.89 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.907 -0.664 . . . . 0.0 113.353 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -88.72 -16.17 2.48 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.404 2.736 . . . . 0.0 114.439 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.66 129.19 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.725 0.298 . . . . 0.0 111.518 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 47.72 82.97 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.527 1.131 . . . . 0.0 113.2 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.4 p -80.9 -14.83 57.64 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.918 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -76.94 -18.02 58.53 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.211 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.604 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.08 146.84 52.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.939 0.4 . . . . 0.0 111.825 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.604 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -112.18 150.42 18.19 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.782 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.516 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 1.3 m-85 -86.51 152.59 22.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.346 1.058 . . . . 0.0 111.321 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 3.4 t -126.3 103.76 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.627 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 126' ' ' SER . 1.1 mt -98.85 126.72 44.58 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.181 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.415 ' CE1' ' HB2' ' A' ' 106' ' ' ALA . 4.7 p80 -129.44 164.06 42.25 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.76 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 23.2 Cg_endo -99.27 23.74 0.21 Allowed 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 122.888 2.392 . . . . 0.0 113.92 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.403 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 13.5 t -107.6 160.82 15.39 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.756 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.25 18.98 56.51 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.685 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -91.78 153.78 19.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.553 0.341 . . . . 0.0 110.528 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.9 m -126.97 155.58 42.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.108 0.48 . . . . 0.0 112.112 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.528 ' CE2' HG23 ' A' ' 113' ' ' VAL . 51.2 m-85 -126.09 -150.89 0.46 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.837 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -58.82 -47.08 86.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.605 0.362 . . . . 0.0 111.372 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 m -132.19 81.26 1.95 Allowed 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.912 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 107' ' ' MET . 42.5 m -129.38 121.69 27.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.327 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 124.7 49.99 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.794 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -82.72 127.99 33.94 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.133 0.492 . . . . 0.0 111.141 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.441 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -120.28 46.47 1.97 Allowed 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.574 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.62 -107.07 1.76 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.281 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.69 -10.44 3.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.509 HD21 ' OH ' ' A' ' 31' ' ' TYR . 2.9 pp -154.86 158.76 39.85 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.335 0.397 . . . . 0.0 110.99 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.415 ' HB2' ' CE1' ' A' ' 90' ' ' HIS . . . -118.92 161.51 20.07 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.472 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.563 ' O ' ' HA ' ' A' ' 99' ' ' THR . 24.6 ttm -125.22 134.34 52.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.7 m -136.08 133.03 36.92 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 75.6 p -124.53 21.23 8.58 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.717 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.4 p -93.71 134.15 36.33 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 121.648 0.737 . . . . 0.0 112.345 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.476 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 4.9 mt-30 -62.51 -26.62 68.65 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.403 178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.41 -40.43 93.37 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.169 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.759 ' O ' HG22 ' A' ' 117' ' ' ILE . 3.4 p -71.68 -39.03 68.62 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.596 HD12 ' NH1' ' A' ' 85' ' ' ARG . 6.6 mt -57.25 -49.04 77.31 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 123.507 0.504 . . . . 0.0 110.874 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.476 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 35.5 m-85 -69.69 -38.55 77.03 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.216 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.64 -52.68 63.37 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.212 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.84 -43.74 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.432 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.93 -31.57 65.09 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 123.754 0.658 . . . . 0.0 109.615 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.09 -20.23 30.68 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.273 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.82 17.67 25.02 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.704 -1.134 . . . . 0.0 114.634 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.9 p -108.33 7.48 27.21 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.6 -137.76 9.32 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.793 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.45 175.21 9.81 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 123.216 2.611 . . . . 0.0 113.347 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -58.33 -53.08 62.32 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.509 0.723 . . . . 0.0 111.584 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.544 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.8 mmtt -139.24 153.76 47.89 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.71 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.4 m -150.05 163.33 38.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.1 tp -129.05 117.56 21.08 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.14 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.55 HD11 ' O ' ' A' ' 74' ' ' ASP . 12.3 pt -98.94 103.16 14.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.579 0.704 . . . . 0.0 109.475 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.1 t -121.21 120.46 35.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.846 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.45 115.34 6.96 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.335 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.42 167.9 10.76 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.226 -0.897 . . . . 0.0 114.091 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -128.45 178.0 6.6 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.167 0.508 . . . . 0.0 110.703 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -116.33 131.48 56.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.916 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.08 149.89 18.66 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.315 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.402 ' HZ2' ' CZ3' ' A' ' 149' ' ' TRP . 25.7 m-90 -130.15 136.9 49.78 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.833 0.372 . . . . 0.0 110.602 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.06 158.34 27.87 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.941 0.776 . . . . 0.0 111.064 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.88 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.12 -28.09 6.19 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.826 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -56.38 -46.4 80.09 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.006 0.522 . . . . 0.0 112.135 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.552 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.4 tp -67.33 -47.54 70.2 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -57.36 -30.27 64.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.473 0.483 . . . . 0.0 110.602 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.65 -49.97 41.75 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.887 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -72.12 -26.66 62.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.899 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 4.8 tp -75.78 -38.41 58.3 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.85 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -78.18 -30.9 49.31 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.315 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.43 0.77 31.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.641 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.74 29.88 19.45 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.813 0.845 . . . . 0.0 111.682 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.65 -42.92 19.27 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.78 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.402 ' CZ3' ' HZ2' ' A' ' 135' ' ' TRP . 11.3 m95 -122.42 112.04 17.6 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 123.388 0.43 . . . . 0.0 109.966 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -80.19 141.55 35.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.326 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.0 p -110.56 138.47 46.91 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.312 0.383 . . . . 0.0 111.212 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.5 m -152.89 155.6 32.31 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.527 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.02 155.96 36.43 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.226 1.951 . . . . 0.0 111.098 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.73 169.33 14.64 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -138.08 137.55 21.35 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 114.295 -1.321 . . . . 0.0 107.906 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.41 -26.46 12.14 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.491 2.128 . . . . 0.0 113.959 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.22 -36.31 60.88 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.824 0.703 . . . . 0.0 112.571 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.556 HD11 HH21 ' A' ' 167' ' ' ARG . 4.6 mt -75.68 -38.35 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.41 0.624 . . . . 0.0 110.254 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.1 tt -69.44 -36.65 76.86 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.906 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -86.38 -42.78 13.37 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -77.91 -71.24 0.43 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.778 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.42 96.35 6.36 Favored Pre-proline 0 C--N 1.346 0.445 0 CA-C-O 121.18 0.514 . . . . 0.0 111.966 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.929 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 63.7 Cg_endo -91.78 3.31 4.11 Favored 'Trans proline' 0 CA--C 1.567 2.156 0 C-N-CA 121.626 1.551 . . . . 0.0 114.407 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.645 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 60.9 Cg_endo -76.93 -52.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 122.435 2.09 . . . . 0.0 114.168 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.541 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 4.3 mt-10 -126.42 -24.36 3.64 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.468 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.778 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 27.6 tt0 -76.53 -12.97 60.11 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.762 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.706 ' HG3' ' O ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -77.19 -36.66 54.77 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.651 177.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.1 tp -73.47 -48.74 31.1 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 52.4 m -58.87 -45.31 90.49 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.527 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -67.22 -42.81 83.44 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.445 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.499 ' HB3' ' NH1' ' A' ' 167' ' ' ARG . . . -55.97 -45.86 78.78 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.494 0.496 . . . . 0.0 110.499 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.05 93.33 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.357 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.96 -26.95 68.52 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.663 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.76 -40.3 41.38 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 122.929 0.491 . . . . 0.0 110.175 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -71.87 -30.79 65.78 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.466 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.724 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.933 179.59 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.512 ' H ' ' HD1' ' A' ' 35' ' ' HIS . 19.2 mt . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 121.125 0.488 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -92.41 17.7 9.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.1 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.618 ' CE1' ' HH ' ' A' ' 31' ' ' TYR . 5.7 t-80 175.51 55.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.841 0.856 . . . . 0.0 109.79 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.429 ' CD2' ' HA ' ' A' ' 153' ' ' PRO . 30.0 m80 -138.57 160.8 38.69 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 18.6 m-30 -99.2 137.37 37.81 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.01 0.433 . . . . 0.0 111.867 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 3.7 mt -107.43 141.4 38.89 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.118 177.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 150' ' ' LEU . 2.8 mp -121.24 136.76 57.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 O-C-N 123.419 0.449 . . . . 0.0 110.006 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.23 124.83 28.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.027 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.4 ' HB3' ' HD1' ' A' ' 19' ' ' HIS . 35.3 mtt -109.78 157.54 37.35 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.211 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.78 30.93 0.52 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.686 2.257 . . . . 0.0 113.185 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.4 ' HD1' ' HB3' ' A' ' 17' ' ' MET . 42.8 m80 -86.06 -18.89 31.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.65 -167.13 1.15 Allowed 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.068 0.23 . . . . 0.0 110.617 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.33 40.4 1.48 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.993 0.425 . . . . 0.0 111.737 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -111.98 80.88 3.32 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.883 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.8 Cg_exo -75.55 -22.99 13.34 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.045 2.497 . . . . 0.0 113.187 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -84.56 -34.97 23.12 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.933 0.493 . . . . 0.0 111.753 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.56 3.85 52.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.992 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 164.34 19.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.82 0.343 . . . . 0.0 111.82 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 49.04 31.1 3.16 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.5 p -116.87 154.7 30.32 Favored 'General case' 0 C--O 1.24 0.59 0 O-C-N 122.347 -0.221 . . . . 0.0 110.553 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 85.2 t -129.16 133.64 65.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-O 121.429 0.633 . . . . 0.0 110.832 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -113.85 153.78 28.6 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.755 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.618 ' HH ' ' CE1' ' A' ' 11' ' ' HIS . 32.4 t80 -107.66 118.77 37.62 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.73 109.97 17.93 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-O 121.465 0.65 . . . . 0.0 110.935 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.441 ' O ' HD13 ' A' ' 102' ' ' LEU . 33.5 t -72.03 -63.2 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.639 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.518 ' OE2' HD11 ' A' ' 100' ' ' LEU . 7.7 tt0 -134.11 118.49 17.78 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.592 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.512 ' HD1' ' H ' ' A' ' 9' ' ' LEU . 15.3 t-80 -103.67 127.49 51.11 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.737 0.303 . . . . 0.0 110.754 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -138.88 151.51 47.02 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.246 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.57 -12.64 54.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -108.2 1.91 22.45 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.416 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.7 166.2 16.01 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 121.608 -0.329 . . . . 0.0 112.335 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.32 146.27 29.64 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.85 136.95 54.27 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.078 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 133' ' ' ALA . . . -158.97 161.71 32.13 Favored Glycine 0 C--O 1.228 -0.277 0 O-C-N 124.785 1.303 . . . . 0.0 112.573 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.442 HD22 ' C ' ' A' ' 42' ' ' GLY . 2.9 mt -117.35 133.77 55.59 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.943 0.371 . . . . 0.0 111.267 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 78' ' ' GLY . 10.7 t -66.13 122.88 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.538 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.12 54.44 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.607 0.718 . . . . 0.0 112.104 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.848 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.6 t-20 -147.49 -3.93 0.53 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.145 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -129.56 87.82 51.78 Favored Pre-proline 0 CA--C 1.556 1.181 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.487 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 40.4 Cg_exo -58.74 143.15 99.11 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 121.716 1.611 . . . . 0.0 112.415 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.426 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 66.5 m -93.28 158.67 15.63 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.485 0.491 . . . . 0.0 111.497 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.14 51.04 1.06 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.658 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.41 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -133.17 156.1 48.09 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.961 0.448 . . . . 0.0 110.054 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.476 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 15.6 p-10 -112.23 158.25 19.93 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.552 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.452 ' HG ' ' CD1' ' A' ' 57' ' ' LEU . 15.5 tp -57.4 -37.09 72.15 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.46 -37.27 62.49 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.476 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 36.8 mt-10 -64.97 -42.48 94.53 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.006 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.855 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -62.63 -46.32 96.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.452 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 4.1 mp -54.37 -36.8 64.25 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 123.81 0.694 . . . . 0.0 110.674 177.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.76 -27.86 50.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.486 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.417 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -78.41 -30.41 47.72 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.309 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.855 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.2 mt -77.64 -44.95 26.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.848 -1.523 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -132.38 116.54 15.28 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.496 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -77.49 -33.13 2.56 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.619 2.879 . . . . 0.0 112.823 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.08 -13.87 56.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.398 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.46 149.72 24.24 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 123.382 0.426 . . . . 0.0 111.752 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.16 123.88 29.64 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.021 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.16 145.68 35.32 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.204 1.936 . . . . 0.0 112.444 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.499 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.8 Cg_endo -92.2 -169.78 0.28 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.652 2.235 . . . . 0.0 111.932 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.499 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -64.44 -24.95 67.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.04 0.536 . . . . 0.0 112.135 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -66.11 -53.17 41.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.442 ' SG ' HD23 ' A' ' 53' ' ' LEU . 61.6 m -71.79 -25.05 61.85 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 48.3 mt-30 -67.88 -35.81 79.15 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.499 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 21.4 p80 -90.52 23.78 2.87 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.164 0.507 . . . . 0.0 111.689 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 53.5 mt -121.52 138.46 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.487 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.554 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.7 m-20 -106.27 163.11 13.08 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 51' ' ' LEU . 17.1 mm -112.25 153.41 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.141 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.701 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -117.36 155.62 29.27 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -85.67 118.57 25.25 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.825 0.284 . . . . 0.0 110.551 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.564 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.52 -23.72 8.22 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 120.05 -1.071 . . . . 0.0 114.135 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.46 -167.84 34.11 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.511 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.44 -14.44 3.16 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 123.526 2.817 . . . . 0.0 114.412 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.9 124.07 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 123.103 0.252 . . . . 0.0 111.036 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.611 HE21 ' HH ' ' A' ' 132' ' ' TYR . 43.6 mt-30 50.84 77.0 0.14 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.196 0.999 . . . . 0.0 112.512 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.8 m -79.37 -12.86 59.91 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.561 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.7 0.51 52.56 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.587 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.16 153.73 51.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.587 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.47 132.38 11.08 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.137 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.791 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.76 145.7 27.13 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.486 1.114 . . . . 0.0 110.69 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.16 103.89 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.401 0.438 . . . . 0.0 110.771 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 126' ' ' SER . 13.7 tp -107.2 129.1 54.91 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.876 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.422 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 3.9 p80 -127.03 168.5 14.51 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-O 118.921 -0.561 . . . . 0.0 111.705 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.651 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.4 Cg_endo -97.03 12.2 1.05 Allowed 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 122.829 2.353 . . . . 0.0 113.793 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.422 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 8.9 t -99.76 160.67 14.12 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.791 -178.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.96 21.12 47.88 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.532 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -86.73 154.2 21.14 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.625 0.37 . . . . 0.0 110.568 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.8 p -127.34 156.85 41.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.556 ' CE2' HG21 ' A' ' 113' ' ' VAL . 52.3 m-85 -129.19 -151.57 0.48 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.668 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -59.14 -46.5 88.19 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.547 0.339 . . . . 0.0 111.413 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 57.9 m -134.37 83.22 2.02 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.495 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.6 m -130.98 128.97 41.5 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.847 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.518 HD11 ' OE2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.57 124.23 50.16 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.506 178.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.38 128.17 34.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.089 0.471 . . . . 0.0 110.972 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.28 48.08 1.89 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.378 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.72 -109.86 3.14 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 114.724 -1.126 . . . . 0.0 113.056 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.09 -8.41 5.38 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.498 HD22 ' OH ' ' A' ' 31' ' ' TYR . 2.8 pp -152.84 152.77 31.94 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.29 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.74 157.16 28.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.839 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.568 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.8 ttm -121.13 126.63 50.23 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.9 m -122.7 128.78 51.0 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.834 0.349 . . . . 0.0 110.176 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.4 p -119.39 16.54 13.03 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.318 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.6 t -88.9 127.61 35.65 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.515 0.674 . . . . 0.0 111.445 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.49 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 10.1 pt20 -59.98 -30.49 69.15 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.235 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -64.58 -42.15 95.81 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.732 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.721 ' O ' HG23 ' A' ' 117' ' ' ILE . 4.5 p -67.78 -37.98 79.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.545 HD21 ' NH2' ' A' ' 85' ' ' ARG . 3.9 tp -59.27 -48.64 80.87 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 123.449 0.468 . . . . 0.0 110.19 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.49 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 36.8 m-85 -68.52 -38.25 80.71 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.959 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.68 -51.76 67.11 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.21 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.69 -43.43 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.304 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.3 -31.3 65.5 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.759 0.662 . . . . 0.0 109.6 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.23 -19.95 30.88 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.129 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.79 16.4 28.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 114.705 -1.134 . . . . 0.0 114.623 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.1 p -106.86 7.46 30.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.16 -138.18 9.71 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-O 119.23 -0.761 . . . . 0.0 112.625 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.85 173.68 11.8 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.205 2.603 . . . . 0.0 113.554 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.06 -54.57 45.3 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.735 0.814 . . . . 0.0 111.988 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.651 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.2 mmtt -140.98 143.7 34.63 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.82 -178.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.0 m -141.09 165.01 28.72 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.0 tp -127.61 117.02 21.23 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.466 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.791 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.5 pt -98.33 102.46 13.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-O 121.934 0.873 . . . . 0.0 109.82 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.493 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 9.0 t -119.34 124.05 45.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.784 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.4 tp -67.09 113.73 5.29 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.385 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.82 175.16 8.49 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 114.665 -1.152 . . . . 0.0 114.576 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.611 ' HH ' HE21 ' A' ' 82' ' ' GLN . 0.2 OUTLIER -128.49 176.3 7.85 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.342 0.591 . . . . 0.0 110.474 178.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -115.92 130.68 56.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.062 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.04 145.9 16.61 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.476 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -121.24 136.47 54.97 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.242 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.05 158.08 25.21 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.824 0.703 . . . . 0.0 110.746 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.78 90.71 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.24 -25.19 7.5 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.164 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -57.57 -44.24 85.16 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.558 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.9 -47.96 64.51 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.16 0.287 . . . . 0.0 110.634 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.52 -28.79 68.67 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.002 0.43 . . . . 0.0 110.665 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.82 -50.74 32.23 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.797 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.0 pt-20 -69.67 -26.62 64.47 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.845 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.91 -38.37 57.82 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.722 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -77.82 -28.42 50.26 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -83.2 0.75 44.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.426 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 59.41 29.11 18.63 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.796 0.838 . . . . 0.0 111.818 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.76 -43.18 18.74 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.956 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -124.38 114.29 19.33 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.9 tp -85.59 139.88 31.06 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.629 0.252 . . . . 0.0 111.418 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -104.46 137.31 42.52 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.038 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.0 m -150.94 154.88 34.9 Favored Pre-proline 0 N--CA 1.469 0.51 0 O-C-N 123.515 0.509 . . . . 0.0 110.909 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.429 ' HA ' ' CD2' ' A' ' 12' ' ' HIS . 31.7 Cg_exo -59.28 152.58 59.34 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.32 2.013 . . . . 0.0 111.055 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.76 167.84 16.71 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.76 135.62 23.74 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.105 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.3 -26.47 14.51 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 122.605 2.203 . . . . 0.0 113.66 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.39 -40.72 62.44 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 123.909 0.756 . . . . 0.0 112.19 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.589 HD12 HH12 ' A' ' 167' ' ' ARG . 4.9 mt -71.36 -34.96 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.304 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.32 -36.99 63.72 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.335 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -84.66 -35.47 22.6 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -84.71 -72.5 0.47 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.963 0.347 . . . . 0.0 111.726 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.655 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -141.82 99.02 6.24 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.848 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 70.9 Cg_endo -91.95 -0.29 4.31 Favored 'Trans proline' 0 CA--C 1.57 2.29 0 C-N-CA 121.773 1.649 . . . . 0.0 114.351 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.628 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 69.0 Cg_endo -74.87 -50.03 0.14 Allowed 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 122.738 2.292 . . . . 0.0 114.519 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.527 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.3 mt-10 -122.39 -33.98 3.36 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.713 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 8.4 mt-10 -68.86 -10.9 59.5 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.077 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.589 HH12 HD12 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.86 -41.8 42.54 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.091 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.9 tp -70.41 -50.07 42.33 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 44.3 m -58.49 -49.12 78.51 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.633 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.658 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.17 -39.82 94.82 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.129 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.15 78.53 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.608 0.568 . . . . 0.0 110.6 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.44 91.09 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.499 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.96 -27.85 69.12 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.611 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.84 -40.05 41.55 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 122.831 0.452 . . . . 0.0 110.355 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -68.58 -33.37 73.95 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.346 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.759 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.155 179.405 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.811 0.339 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -89.81 20.34 4.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.934 0.397 . . . . 0.0 111.242 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 174.53 55.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.126 0.971 . . . . 0.0 110.1 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -133.62 159.38 40.67 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.643 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 15.4 m-30 -97.3 135.72 38.81 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.534 ' O ' HG13 ' A' ' 29' ' ' VAL . 2.8 mt -107.99 137.04 46.67 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.848 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.3 mm -117.01 133.88 62.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 O-C-N 123.493 0.495 . . . . 0.0 109.721 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.05 120.33 18.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.488 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 150' ' ' LEU . 91.4 mtp -110.18 154.88 42.61 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.22 77.71 3.89 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.59 2.193 . . . . 0.0 112.932 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -135.68 -19.41 1.6 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.025 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.98 -164.19 0.91 Allowed 'General case' 0 CA--C 1.541 0.631 0 O-C-N 123.191 0.307 . . . . 0.0 110.495 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.534 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.92 37.84 2.06 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.052 0.453 . . . . 0.0 111.856 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 7.9 m-20 -110.51 83.79 3.55 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.827 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.1 Cg_exo -75.26 -24.62 12.25 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.03 2.486 . . . . 0.0 113.442 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -85.09 -37.84 19.81 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.931 0.492 . . . . 0.0 111.573 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.53 -3.4 57.63 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.84 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 22' ' ' ASP . . . -59.85 0.25 0.16 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -141.19 41.56 1.78 Allowed 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.234 0.54 . . . . 0.0 112.052 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.1 p -124.28 157.27 35.31 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.686 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 14' ' ' LEU . 59.3 t -131.27 132.8 62.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.617 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -114.48 153.54 29.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.615 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.428 ' OH ' HD22 ' A' ' 105' ' ' LEU . 44.4 t80 -107.14 118.71 37.42 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.88 109.1 16.71 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.095 0.474 . . . . 0.0 111.232 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.56 ' O ' HD21 ' A' ' 102' ' ' LEU . 38.9 t -67.28 -62.53 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 113.853 -1.522 . . . . 0.0 110.515 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -140.54 115.68 9.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.163 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -98.22 127.46 44.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.604 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -139.29 152.93 47.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.48 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.542 ' HB3' ' NE2' ' A' ' 38' ' ' GLN . 17.9 tt0 -64.73 -21.02 66.66 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.405 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.542 ' NE2' ' HB3' ' A' ' 37' ' ' GLU . 1.7 mp0 -96.65 0.89 50.49 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.487 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.38 168.35 16.44 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 112.209 -0.356 . . . . 0.0 112.209 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.83 144.33 30.19 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -122.82 136.14 54.77 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.564 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 133' ' ' ALA . . . -157.78 158.83 29.41 Favored Glycine 0 N--CA 1.447 -0.581 0 O-C-N 124.454 1.097 . . . . 0.0 112.529 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mt -113.35 132.92 55.4 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.025 0.412 . . . . 0.0 111.129 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 78' ' ' GLY . 12.4 t -67.98 124.54 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.532 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -127.53 55.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.606 0.717 . . . . 0.0 112.196 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.853 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.0 t-20 -146.43 -3.3 0.64 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.072 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.454 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 2.8 ttt180 -130.11 89.82 44.09 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.455 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 52.6 Cg_exo -57.82 140.65 94.44 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 121.55 1.5 . . . . 0.0 111.763 174.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.406 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 56.4 m -71.23 -44.63 64.97 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.03 -15.94 56.17 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.226 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.66 162.06 16.52 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.506 0.323 . . . . 0.0 110.168 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.596 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.2 p-10 -100.92 160.63 14.21 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 tt -58.48 -28.65 65.55 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.076 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.588 ' HB1' ' ND2' ' A' ' 52' ' ' ASN . . . -62.07 -39.76 93.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.599 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.67 -46.98 85.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.637 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.85 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 17.1 m -62.32 -43.45 98.09 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.6 mt -56.94 -34.95 68.53 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.544 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -78.15 -27.34 48.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.262 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.81 -30.65 51.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.129 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.85 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.8 mt -77.79 -45.48 24.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.789 -1.551 . . . . 0.0 111.12 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -131.7 116.16 15.96 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.631 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -77.71 -32.62 2.66 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.659 2.906 . . . . 0.0 112.755 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.1 -14.55 55.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.35 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.7 149.9 24.56 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.35 0.407 . . . . 0.0 111.685 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.5 mp -118.34 122.52 30.13 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.178 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.98 153.02 41.58 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.307 2.005 . . . . 0.0 112.26 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 7.1 Cg_endo -94.21 -165.31 0.12 Allowed 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.596 2.198 . . . . 0.0 112.263 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.448 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -71.38 -24.84 62.15 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.196 0.598 . . . . 0.0 111.964 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 12.0 ptp180 -67.1 -46.99 72.54 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 16.6 m -72.84 -25.57 61.16 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 48.8 mt-30 -70.54 -26.99 63.82 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.448 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 25.3 p80 -99.21 16.51 22.6 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 123.439 0.462 . . . . 0.0 111.722 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 70.0 mt -114.35 138.63 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.313 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.589 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.9 m-20 -106.16 151.46 24.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.3 mm -102.61 151.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.613 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.738 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.9 t80 -118.27 155.23 30.94 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.625 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.94 121.34 28.43 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.535 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -103.35 -23.53 8.4 Favored Glycine 0 C--N 1.345 1.042 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.195 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.67 -167.77 35.31 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.313 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -88.59 -12.21 3.8 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.588 2.859 . . . . 0.0 114.358 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -86.37 128.75 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 123.07 0.231 . . . . 0.0 111.171 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 45.35 82.15 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.564 1.145 . . . . 0.0 113.132 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.0 p -84.04 -8.25 59.18 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.206 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.62 -3.87 59.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.631 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.72 152.98 51.6 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.631 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.58 135.39 12.82 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.073 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.708 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -86.16 146.16 26.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.304 1.042 . . . . 0.0 110.573 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.9 103.58 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 123.47 0.481 . . . . 0.0 110.533 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 126' ' ' SER . 11.4 tp -107.18 128.59 54.54 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.981 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.44 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 4.0 p80 -128.29 167.44 18.92 Favored Pre-proline 0 CA--C 1.554 1.122 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.799 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.669 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 17.9 Cg_endo -97.42 19.91 0.43 Allowed 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.67 2.247 . . . . 0.0 113.563 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.44 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 9.1 t -107.69 160.56 15.61 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.835 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.27 22.08 41.84 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.587 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -84.98 152.88 23.15 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 122.618 0.367 . . . . 0.0 110.487 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.7 p -128.0 156.81 42.13 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.563 ' CE2' HG23 ' A' ' 113' ' ' VAL . 56.4 m-85 -130.44 -150.97 0.45 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.726 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -58.91 -46.16 88.57 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.655 0.382 . . . . 0.0 111.511 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.8 m -137.41 82.64 1.94 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.285 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 107' ' ' MET . 12.8 m -127.77 123.42 35.25 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.425 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -102.71 120.92 41.42 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.744 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.53 125.01 29.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.172 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.56 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -119.51 43.59 2.59 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.722 -179.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.81 -100.59 0.29 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.264 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -56.08 -14.53 2.71 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.428 HD22 ' OH ' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -160.91 160.23 30.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.842 0.457 . . . . 0.0 110.951 -179.283 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.77 156.97 27.38 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.625 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.575 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.4 ttm -123.3 129.7 51.7 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.3 m -125.99 129.22 48.79 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.9 p -119.98 14.56 12.39 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.658 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.3 m -87.14 130.15 34.65 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.425 0.631 . . . . 0.0 112.042 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.498 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 21.0 pt20 -61.45 -28.67 69.45 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.101 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.37 -44.14 92.3 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.452 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.722 ' O ' HG23 ' A' ' 117' ' ' ILE . 4.4 p -67.9 -34.83 69.58 Favored 'Isoleucine or valine' 0 C--N 1.354 0.792 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.472 ' N ' HG13 ' A' ' 113' ' ' VAL . 2.5 tm? -59.13 -49.61 77.22 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 123.693 0.62 . . . . 0.0 109.81 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.498 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 31.5 m-85 -67.19 -39.63 86.42 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.955 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -52.97 62.59 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.456 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.0 -43.86 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.524 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.93 -32.03 65.55 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.72 0.637 . . . . 0.0 109.594 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.44 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.69 -19.7 32.38 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.232 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.69 14.93 33.17 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.718 -1.128 . . . . 0.0 114.633 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.5 p -105.58 7.9 33.02 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.18 -138.35 9.14 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.283 -0.732 . . . . 0.0 112.731 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.64 168.02 18.25 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.141 2.561 . . . . 0.0 113.968 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.485 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -49.39 -59.67 3.52 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.537 1.135 . . . . 0.0 111.837 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.669 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.5 mmtt -141.43 139.81 33.48 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 69.5 m -138.02 169.07 18.43 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 tp -126.41 118.14 24.37 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.296 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 10.1 pt -96.95 102.14 13.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 121.465 0.65 . . . . 0.0 109.711 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 7.2 t -118.9 119.13 33.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.099 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.19 112.93 4.74 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.136 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 169.81 11.26 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.005 -0.998 . . . . 0.0 114.186 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.6 177.54 6.95 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.196 0.522 . . . . 0.0 110.83 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -117.72 131.93 56.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.51 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.47 149.67 18.72 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.363 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 24.4 m-90 -129.09 135.55 49.05 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 123.855 0.385 . . . . 0.0 110.465 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.05 158.17 29.3 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.784 0.678 . . . . 0.0 111.129 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.23 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.54 -26.75 6.83 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.935 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -55.93 -45.59 78.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.076 0.55 . . . . 0.0 112.06 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.557 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.2 tp -67.37 -47.16 71.21 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.58 -30.51 65.32 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.426 0.454 . . . . 0.0 110.747 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.5 -50.19 40.52 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.91 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -71.61 -26.64 62.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.945 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.3 tp -75.11 -39.21 60.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.937 0.895 . . . . 0.0 110.806 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 m -78.15 -30.21 49.09 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.553 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -80.38 0.19 34.24 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.701 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 60.42 29.47 19.04 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.757 0.823 . . . . 0.0 111.723 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.92 -42.46 19.46 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.813 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -123.97 112.07 16.77 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 123.383 0.427 . . . . 0.0 109.865 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.536 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 7.0 tp -83.57 138.65 33.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.275 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.5 p -103.6 137.66 41.35 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.578 0.549 . . . . 0.0 111.307 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 73.0 m -152.86 155.6 32.36 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.544 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.51 159.81 22.43 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.2 1.933 . . . . 0.0 111.366 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -131.74 167.24 19.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -134.85 135.14 22.68 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.941 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.45 -26.42 14.23 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 122.613 2.208 . . . . 0.0 113.81 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.89 -40.64 63.67 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.857 0.723 . . . . 0.0 112.147 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.553 HD13 HH12 ' A' ' 167' ' ' ARG . 4.5 mt -71.08 -35.52 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.348 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.74 -38.7 64.68 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.417 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.38 -32.36 22.44 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -87.01 -72.68 0.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.145 0.429 . . . . 0.0 111.656 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.914 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.79 98.81 6.29 Favored Pre-proline 0 C--N 1.35 0.608 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.853 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 62.4 Cg_endo -92.71 0.37 3.81 Favored 'Trans proline' 0 CA--C 1.57 2.306 0 C-N-CA 121.715 1.61 . . . . 0.0 114.288 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.632 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 98.0 Cg_endo -73.25 -52.41 0.15 Allowed 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.583 2.189 . . . . 0.0 114.245 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.54 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -122.82 -29.85 3.92 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.7 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.914 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.05 -11.14 60.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.437 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.553 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -77.02 -40.39 46.71 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -71.07 -50.21 36.33 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.6 m -58.49 -48.49 80.62 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.611 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.646 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.86 -40.16 94.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.298 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.43 -46.78 80.11 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 123.498 0.499 . . . . 0.0 110.368 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.83 88.81 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.406 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.27 -27.83 68.91 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.59 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.53 -39.79 44.89 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 122.841 0.456 . . . . 0.0 110.3 178.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.2 -31.47 67.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.455 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.734 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.963 179.404 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.414 ' H ' ' HD1' ' A' ' 35' ' ' HIS . 12.6 mt . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.808 0.337 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -92.66 21.3 5.6 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.897 0.38 . . . . 0.0 110.686 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.602 ' CE1' ' HH ' ' A' ' 31' ' ' TYR . 4.3 t60 178.01 54.64 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.586 0.754 . . . . 0.0 110.268 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -139.17 160.14 40.5 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 30' ' ' THR . 11.5 m-30 -100.57 138.09 38.1 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.089 0.471 . . . . 0.0 112.021 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 4.3 mt -107.47 141.09 39.43 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.341 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.406 HD11 ' O ' ' A' ' 150' ' ' LEU . 2.8 mp -120.73 134.32 64.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 O-C-N 123.522 0.514 . . . . 0.0 109.759 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.73 126.18 30.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.085 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.2 mtt -110.32 157.15 38.92 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.222 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.52 29.84 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.611 2.207 . . . . 0.0 113.188 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -86.14 -16.29 38.37 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.15 -167.45 1.22 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.009 0.193 . . . . 0.0 110.641 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.503 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.28 40.39 1.48 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.995 0.426 . . . . 0.0 111.694 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.32 80.5 3.45 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.781 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.2 Cg_exo -75.41 -21.92 14.64 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.008 2.472 . . . . 0.0 113.327 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -84.44 -36.07 22.61 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.966 0.507 . . . . 0.0 111.852 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.29 4.01 51.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.098 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.35 163.47 20.63 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.896 0.379 . . . . 0.0 111.849 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 49.4 32.04 4.33 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.2 p -117.55 153.66 32.83 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 120.469 0.176 . . . . 0.0 110.556 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.549 HG11 HH11 ' A' ' 167' ' ' ARG . 77.4 t -128.49 133.71 66.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.583 0.706 . . . . 0.0 110.596 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 6.2 m -114.76 152.98 31.15 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.87 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.602 ' HH ' ' CE1' ' A' ' 11' ' ' HIS . 13.2 t80 -106.29 118.63 37.13 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.474 HD11 ' O ' ' A' ' 41' ' ' MET . 0.2 OUTLIER -82.84 108.55 16.27 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.432 0.634 . . . . 0.0 110.927 -179.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.513 ' O ' HD21 ' A' ' 102' ' ' LEU . 35.8 t -68.89 -60.36 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 113.228 -1.805 . . . . 0.0 110.576 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -142.26 113.48 7.65 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.62 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.414 ' HD1' ' H ' ' A' ' 9' ' ' LEU . 16.6 t-80 -97.34 128.74 44.43 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.672 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -139.71 153.27 47.19 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.604 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.25 -18.82 65.62 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.701 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.44 0.88 43.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.414 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.88 166.99 15.44 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.37 143.4 30.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.474 ' O ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -124.62 137.95 54.34 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.341 178.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' O ' ' HB1' ' A' ' 133' ' ' ALA . . . -160.23 158.65 30.03 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.531 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 mt -112.83 131.54 55.66 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.935 0.367 . . . . 0.0 110.939 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 78' ' ' GLY . 41.2 t -67.93 124.68 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.554 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.1 pt -129.85 55.35 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.524 0.678 . . . . 0.0 112.347 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.863 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 24.7 t-20 -144.27 -7.76 0.7 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.286 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -130.39 92.26 35.97 Favored Pre-proline 0 CA--C 1.555 1.145 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.49 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.5 Cg_exo -61.09 146.4 97.68 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 121.747 1.631 . . . . 0.0 112.602 175.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.411 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 44.9 t -89.14 162.96 15.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.557 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.69 -5.78 62.78 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-O 119.75 -0.472 . . . . 0.0 114.242 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.424 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -88.89 151.45 22.33 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.104 0.452 . . . . 0.0 111.566 -179.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.49 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 41.2 p-10 -98.55 165.74 11.68 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.655 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 57' ' ' LEU . 13.9 tp -59.03 -26.88 64.96 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.601 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . . . -61.95 -42.5 99.18 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.49 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 41.4 mt-10 -62.39 -47.35 84.52 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.072 0.233 . . . . 0.0 111.492 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.869 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.7 m -61.68 -45.34 98.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 53' ' ' LEU . 6.9 mt -54.48 -35.97 63.64 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.972 0.795 . . . . 0.0 110.742 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -78.13 -28.0 48.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.467 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.418 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.98 -30.38 50.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.375 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.869 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.1 mt -77.93 -46.62 20.7 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.749 -1.569 . . . . 0.0 111.376 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -131.89 118.18 16.42 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.003 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.33 -32.33 3.07 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.665 2.91 . . . . 0.0 112.56 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -82.22 -15.07 54.41 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.296 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.42 149.15 26.86 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.368 0.418 . . . . 0.0 111.425 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.57 121.78 31.59 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.743 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.66 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 46.4 Cg_endo -71.26 138.16 32.6 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.575 2.183 . . . . 0.0 112.423 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.454 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 2.7 Cg_endo -90.38 -157.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.733 2.289 . . . . 0.0 112.403 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.04 -25.07 52.1 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.249 0.62 . . . . 0.0 111.824 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.466 ' HA ' ' NE2' ' A' ' 72' ' ' HIS . 6.4 ptp180 -66.54 -46.14 77.12 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' A' ' 66' ' ' PRO . 18.5 p -67.49 -29.57 69.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 71.4 mt-30 -65.75 -32.85 74.63 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.466 ' NE2' ' HA ' ' A' ' 69' ' ' ARG . 32.9 p80 -95.37 9.94 38.11 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.432 0.458 . . . . 0.0 112.021 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 69' ' ' ARG . 71.0 mt -108.64 137.68 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.519 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.7 m-20 -109.55 153.07 24.65 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.822 0.702 . . . . 0.0 112.711 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 51' ' ' LEU . 25.6 mm -101.21 153.58 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.125 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.698 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -117.13 156.03 28.31 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 32.4 m-20 -89.26 117.4 28.19 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 117.832 0.287 . . . . 0.0 110.465 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.525 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -102.53 -23.24 9.0 Favored Glycine 0 C--N 1.35 1.358 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.817 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.53 -167.86 35.25 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.727 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -88.59 -14.74 2.97 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.501 2.801 . . . . 0.0 114.383 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -82.11 125.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 123.126 0.266 . . . . 0.0 111.166 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.471 HE21 ' HH ' ' A' ' 132' ' ' TYR . 47.9 mt-30 45.36 89.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.582 1.153 . . . . 0.0 113.216 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.2 p -85.65 -10.17 56.17 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.931 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.26 -9.94 59.68 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.8 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.597 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.09 151.5 52.01 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.597 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.28 142.31 16.55 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.153 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.5 m-85 -86.77 149.37 24.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.077 -1.062 . . . . 0.0 110.528 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.594 ' HB ' ' OG ' ' A' ' 108' ' ' SER . 5.1 t -126.83 103.96 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 123.627 0.579 . . . . 0.0 110.194 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 126' ' ' SER . 16.0 tp -106.28 127.55 53.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.309 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.428 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 4.5 p80 -128.57 168.9 14.17 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.444 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.624 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.6 Cg_endo -97.31 17.75 0.56 Allowed 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.682 2.255 . . . . 0.0 113.555 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.428 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 8.5 t -105.32 158.86 16.33 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.895 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.34 22.23 41.98 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.483 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -84.62 155.09 22.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.661 0.384 . . . . 0.0 110.491 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.8 p -125.74 156.49 39.32 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.572 ' CE2' HG22 ' A' ' 113' ' ' VAL . 58.1 m-85 -131.5 -151.24 0.45 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.494 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -60.3 -46.55 89.47 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.44 0.296 . . . . 0.0 111.291 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.1 m -136.68 83.5 2.01 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.21 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 107' ' ' MET . 7.4 m -128.03 121.08 28.86 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.909 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -99.58 120.68 40.05 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.913 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.96 126.89 33.01 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.403 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.513 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -123.98 50.52 1.63 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.578 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.83 -111.94 4.28 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.151 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.77 -6.68 6.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 pp -151.36 151.89 32.38 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.17 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -121.09 158.13 28.56 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.851 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.56 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 25.3 tpp -125.73 140.03 53.04 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.594 ' OG ' ' HB ' ' A' ' 88' ' ' VAL . 25.2 p -134.98 133.23 39.27 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.813 0.339 . . . . 0.0 110.435 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.4 p -118.76 15.44 13.54 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.0 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.2 p -90.27 130.08 36.43 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.661 0.743 . . . . 0.0 112.424 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.486 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 20.3 pt20 -61.75 -27.01 68.42 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.401 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.28 -42.26 93.34 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.495 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 117' ' ' ILE . 4.1 p -69.77 -38.3 75.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.532 ' N ' HG11 ' A' ' 113' ' ' VAL . 6.4 tp -57.93 -48.46 79.87 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 123.68 0.613 . . . . 0.0 110.573 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.486 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 26.1 m-85 -68.77 -39.17 80.36 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.806 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.39 -53.0 62.28 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.306 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.35 -43.86 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.718 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.6 -32.1 64.93 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.782 0.676 . . . . 0.0 109.599 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.02 -20.01 31.11 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.291 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.67 13.82 33.83 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.668 -1.151 . . . . 0.0 114.799 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 p -103.83 6.48 36.61 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.38 -137.57 9.16 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.419 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.74 171.81 14.0 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.069 2.513 . . . . 0.0 113.493 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.19 -55.24 37.29 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.642 0.777 . . . . 0.0 111.998 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.624 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.0 mmtt -141.23 139.69 33.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.691 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 34.5 p -139.01 168.58 19.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.3 tp -126.97 117.38 22.4 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.804 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.642 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.4 pt -98.64 102.45 13.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-O 121.532 0.682 . . . . 0.0 109.536 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.0 t -121.24 122.32 39.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.025 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 tp -66.58 112.97 4.41 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.544 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 173.71 18.5 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 114.545 -1.207 . . . . 0.0 114.764 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.471 ' HH ' HE21 ' A' ' 82' ' ' GLN . 0.1 OUTLIER -127.82 175.06 8.62 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.25 178.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 42' ' ' GLY . . . -115.54 129.01 56.38 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.154 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.73 150.23 18.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.375 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -128.37 138.23 52.26 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.858 0.387 . . . . 0.0 110.344 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.71 157.65 27.13 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.885 0.741 . . . . 0.0 110.622 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.74 91.67 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.54 -23.51 8.95 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.322 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -57.44 -44.55 84.8 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.938 0.495 . . . . 0.0 112.14 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.571 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.9 tm? -67.87 -47.7 68.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.5 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.35 -30.0 68.08 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.05 -49.96 45.92 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.941 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -70.71 -26.76 63.55 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.694 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.4 tp -74.18 -38.98 63.51 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.602 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.9 m -77.84 -28.4 50.16 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.211 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 3.0 t70 -82.25 -1.42 49.29 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.395 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.2 m120 61.03 28.5 18.26 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.857 0.863 . . . . 0.0 111.903 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.96 -43.54 17.91 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.856 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -124.77 113.38 17.86 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.0 tp -86.21 138.49 31.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.5 p -101.66 136.33 41.68 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.502 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 80.6 m -150.78 150.92 29.25 Favored Pre-proline 0 C--O 1.238 0.487 0 O-C-N 123.412 0.445 . . . . 0.0 110.983 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.05 151.06 83.97 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.233 1.956 . . . . 0.0 110.997 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -134.29 176.85 8.23 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -134.56 140.26 35.04 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 113.725 -1.58 . . . . 0.0 108.693 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.83 -26.71 13.14 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.735 2.29 . . . . 0.0 113.646 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.65 -41.79 55.78 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.857 0.723 . . . . 0.0 112.46 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.5 mt -68.83 -33.83 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.526 0.679 . . . . 0.0 110.276 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.66 -37.23 56.58 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.538 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -84.83 -31.21 23.96 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -88.7 -73.24 0.51 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 117.97 0.35 . . . . 0.0 111.628 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.854 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.82 99.8 6.12 Favored Pre-proline 0 C--N 1.35 0.589 0 CA-C-O 121.183 0.516 . . . . 0.0 112.228 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.863 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 72.4 Cg_endo -91.18 -0.11 4.79 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 121.711 1.608 . . . . 0.0 114.381 175.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.634 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 89.3 Cg_endo -74.92 -56.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.395 2.976 0 C-N-CA 122.653 2.235 . . . . 0.0 114.579 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.581 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 4.7 mt-10 -118.43 -30.67 5.15 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.542 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.854 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 28.5 tt0 -69.7 -12.18 61.43 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.235 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.549 HH11 HG11 ' A' ' 29' ' ' VAL . 3.7 tpm_? -77.1 -43.88 32.57 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.59 -49.2 64.25 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.4 m -58.21 -48.66 79.67 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.789 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.558 ' O ' ' HG3' ' A' ' 174' ' ' ARG . . . -63.25 -41.92 99.12 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.494 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.01 87.88 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.577 0.548 . . . . 0.0 110.82 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.51 -37.14 85.89 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.53 -28.19 69.48 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.152 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 170' ' ' ALA . 9.1 mtm105 -77.28 -40.78 43.31 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 123.291 0.636 . . . . 0.0 110.757 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 tp -69.61 -31.24 69.25 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.449 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.798 0 C-N-CA 121.129 -0.557 . . . . 0.0 113.046 179.475 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.405 ' O ' HD13 ' A' ' 32' ' ' LEU . 15.8 mt . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 121.112 0.482 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -88.82 16.09 7.37 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.378 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.424 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 17.3 p80 172.83 58.87 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.43 1.092 . . . . 0.0 109.698 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -135.22 159.36 41.78 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.659 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.518 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.7 m-30 -97.1 136.17 38.01 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.533 ' O ' HG13 ' A' ' 29' ' ' VAL . 3.2 mt -108.42 137.12 46.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.793 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.3 mm -117.04 133.23 64.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.545 0.528 . . . . 0.0 109.635 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.54 121.94 21.42 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 123.461 0.475 . . . . 0.0 111.666 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.6 mmt -110.47 152.91 43.63 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.338 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -80.45 73.96 5.77 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.594 2.196 . . . . 0.0 112.622 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -131.46 -19.22 2.75 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.716 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.58 -162.97 0.83 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.3 0.375 . . . . 0.0 110.481 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.516 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.73 36.66 2.24 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.869 0.366 . . . . 0.0 111.968 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.37 82.71 3.66 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.809 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.32 -24.87 11.93 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 123.019 2.48 . . . . 0.0 113.349 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -85.16 -37.11 20.57 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.887 0.475 . . . . 0.0 111.595 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.11 -3.04 57.46 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.8 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -60.51 1.62 0.13 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -141.46 41.48 1.75 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.213 0.53 . . . . 0.0 112.076 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.9 p -124.52 157.68 34.73 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.642 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 14' ' ' LEU . 57.6 t -131.0 133.51 62.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.806 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -115.04 152.37 32.59 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.381 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.546 ' OH ' HD22 ' A' ' 105' ' ' LEU . 43.4 t80 -106.95 120.99 43.54 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 11' ' ' HIS . 0.1 OUTLIER -83.73 108.62 16.9 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 123.481 0.488 . . . . 0.0 111.419 -178.273 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.471 ' O ' HD21 ' A' ' 102' ' ' LEU . 36.9 t -67.76 -59.97 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.623 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -141.93 120.8 12.75 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.433 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -102.35 127.94 49.13 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.988 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.84 151.85 47.35 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.418 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.3 -19.59 65.52 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.893 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -98.4 -1.63 41.07 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.681 0.613 . . . . 0.0 111.533 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.03 169.73 20.56 Favored Glycine 0 C--N 1.344 1.012 0 C-N-CA 121.529 -0.367 . . . . 0.0 112.304 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.32 146.97 30.88 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.81 135.74 53.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.363 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.54 ' O ' ' HB1' ' A' ' 133' ' ' ALA . . . -158.21 158.36 29.13 Favored Glycine 0 N--CA 1.447 -0.619 0 O-C-N 124.472 1.107 . . . . 0.0 112.486 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 mt -112.9 134.59 54.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 117.253 0.526 . . . . 0.0 111.469 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 78' ' ' GLY . 12.0 t -68.35 122.94 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.38 56.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.618 0.723 . . . . 0.0 111.98 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.846 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.8 t-20 -147.04 -3.43 0.58 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.256 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -129.92 88.08 49.91 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.481 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 41.4 Cg_exo -58.44 144.62 96.42 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 121.689 1.593 . . . . 0.0 112.43 175.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.441 ' HG ' ' N ' ' A' ' 77' ' ' ASN . 73.9 m -94.82 160.45 14.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.509 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.72 51.04 0.94 Allowed Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.687 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.475 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.6 OUTLIER -133.19 154.05 50.98 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.871 0.395 . . . . 0.0 110.042 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.596 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 10.3 p-10 -112.43 157.6 20.86 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.25 0.343 . . . . 0.0 110.918 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 tt -57.54 -26.66 61.71 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.596 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -67.94 -40.39 83.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.383 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.42 -45.57 86.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.092 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.849 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.6 m -61.88 -45.06 99.53 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.6 mt -55.74 -35.26 65.97 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.546 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.99 -27.25 49.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.429 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.426 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.82 -30.54 51.19 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.768 0.794 . . . . 0.0 109.318 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.849 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.2 mt -77.86 -46.01 22.64 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.038 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -130.99 116.63 16.91 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.626 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.56 -33.08 2.54 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.687 2.925 . . . . 0.0 112.785 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.63 -14.92 56.1 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.4 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.19 149.69 24.45 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 123.338 0.399 . . . . 0.0 111.689 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.06 123.13 29.09 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.304 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.52 154.15 39.86 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.296 1.997 . . . . 0.0 112.301 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.476 ' HD2' ' HG ' ' A' ' 70' ' ' CYS . 6.8 Cg_endo -94.14 -163.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.67 2.247 . . . . 0.0 112.064 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.44 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -74.05 -24.76 59.57 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.782 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.512 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 7.9 ptp180 -67.11 -46.49 74.04 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.476 ' HG ' ' HD2' ' A' ' 67' ' ' PRO . 20.8 m -73.31 -25.58 60.71 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 46.3 mt-30 -70.45 -29.09 65.57 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.44 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 25.7 p80 -96.09 21.31 8.96 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.16 0.505 . . . . 0.0 111.582 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 57.0 mt -119.53 137.12 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.204 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.584 ' O ' HD13 ' A' ' 128' ' ' ILE . 2.1 m-20 -106.06 163.12 13.02 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 51' ' ' LEU . 14.2 mm -113.63 154.18 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.996 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.719 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -118.11 155.83 29.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.594 0.358 . . . . 0.0 110.33 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.441 ' N ' ' HG ' ' A' ' 49' ' ' SER . 2.4 t-20 -85.76 119.99 26.7 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.531 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -101.85 -23.64 9.15 Favored Glycine 0 C--N 1.346 1.109 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.158 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.86 -167.91 34.87 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.272 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -88.73 -13.03 3.39 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 123.618 2.878 . . . . 0.0 114.413 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.55 130.52 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 123.075 0.235 . . . . 0.0 111.518 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 46.66 82.85 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.551 1.141 . . . . 0.0 113.301 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 77.2 p -82.85 -12.02 57.76 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.197 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.76 -13.46 59.42 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.62 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.81 149.73 52.23 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.62 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.29 144.42 17.02 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.46 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.574 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.2 m-85 -86.85 149.4 24.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.021 -1.09 . . . . 0.0 110.94 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 17.4 t -127.32 105.93 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 O-C-N 123.587 0.554 . . . . 0.0 110.351 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 126' ' ' SER . 14.6 tp -106.74 127.63 53.55 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.281 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -128.08 168.41 15.53 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.548 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.3 Cg_endo -97.7 21.78 0.34 Allowed 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 122.677 2.251 . . . . 0.0 113.748 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.2 t -109.83 158.88 17.71 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.686 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.06 22.42 38.51 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.609 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.02 151.79 22.07 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.539 0.335 . . . . 0.0 110.514 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 m -128.82 157.12 42.39 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.555 ' CE2' HG22 ' A' ' 113' ' ' VAL . 55.0 m-85 -126.95 -150.97 0.46 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.757 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -58.85 -46.32 88.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.655 0.382 . . . . 0.0 111.415 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.9 m -133.12 81.03 1.91 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.848 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 107' ' ' MET . 42.4 m -129.49 122.62 29.64 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.381 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.33 123.48 46.89 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.879 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.88 130.13 34.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.979 0.419 . . . . 0.0 110.878 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.471 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -125.43 46.35 2.4 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.667 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.16 -106.85 1.65 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 114.863 -1.062 . . . . 0.0 113.381 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.28 -10.63 3.14 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.546 HD22 ' OH ' ' A' ' 31' ' ' TYR . 1.7 pp -155.22 152.15 28.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.609 0.364 . . . . 0.0 111.25 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.06 157.5 26.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.863 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.524 ' O ' HG23 ' A' ' 99' ' ' THR . 17.3 ttm -123.9 134.2 53.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.0 m -136.44 133.8 37.02 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.7 p -127.49 19.07 6.84 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.144 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.758 ' O ' HG11 ' A' ' 113' ' ' VAL . 46.8 p -90.16 131.19 36.14 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.393 0.616 . . . . 0.0 112.037 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.482 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 5.3 mt-30 -58.16 -26.96 63.36 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.759 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -64.12 -40.44 96.2 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.902 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.758 HG11 ' O ' ' A' ' 110' ' ' SER . 2.6 p -71.1 -38.43 71.28 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.423 HD11 HH12 ' A' ' 85' ' ' ARG . 4.4 mm? -55.51 -50.1 70.85 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.533 0.521 . . . . 0.0 110.495 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.482 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 39.9 m-85 -67.8 -40.6 83.86 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.222 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.69 -54.17 48.48 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.753 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.755 HG21 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.11 -43.73 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.45 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.6 -32.27 65.08 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 123.674 0.609 . . . . 0.0 109.59 178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.512 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.66 -20.2 31.68 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.363 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.05 17.0 26.4 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.841 -1.072 . . . . 0.0 114.64 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.6 p -107.08 7.08 29.49 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.57 -137.29 8.74 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.113 -0.826 . . . . 0.0 112.47 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.51 169.3 13.94 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.942 2.428 . . . . 0.0 113.652 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.61 -56.46 21.04 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.776 0.831 . . . . 0.0 112.106 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.646 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.5 mmtt -139.63 139.76 36.79 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.502 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 35.8 p -141.04 168.97 18.5 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.3 tp -125.63 115.18 19.72 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.695 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.584 HD13 ' O ' ' A' ' 74' ' ' ASP . 7.9 pt -99.29 104.43 16.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 O-C-N 123.751 0.657 . . . . 0.0 109.229 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -124.55 122.08 36.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.21 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.34 113.64 5.39 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.346 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.432 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 73.87 167.92 16.04 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 115.093 -0.958 . . . . 0.0 114.461 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -128.64 179.95 5.4 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.115 0.483 . . . . 0.0 110.655 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 42' ' ' GLY . . . -118.2 130.37 56.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.368 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.57 146.04 16.58 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.539 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 31.4 m-90 -122.31 135.71 54.77 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 122.655 0.382 . . . . 0.0 110.35 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.36 158.11 26.13 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.935 0.772 . . . . 0.0 110.663 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.1 90.86 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.14 -25.01 7.61 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.172 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -57.59 -44.17 85.2 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.938 0.495 . . . . 0.0 112.252 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.563 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.98 -47.57 65.25 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.118 0.261 . . . . 0.0 110.527 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.33 -29.22 68.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.088 0.47 . . . . 0.0 110.643 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.63 -50.66 34.63 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.788 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.1 pt-20 -69.57 -26.64 64.58 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.816 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.7 tp -75.2 -39.16 60.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.637 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.2 m -77.82 -27.83 50.13 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.492 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -82.96 0.1 46.14 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.518 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.5 m120 60.09 29.39 18.96 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.811 0.844 . . . . 0.0 111.761 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.61 -43.28 17.2 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.917 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -124.17 113.61 18.54 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.6 tp -83.92 139.22 32.73 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.205 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.3 p -104.66 138.1 41.48 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.32 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 24.7 p -152.88 155.5 32.27 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.595 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.08 158.24 26.41 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.259 1.972 . . . . 0.0 111.214 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.518 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.97 166.24 21.4 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.11 134.89 23.37 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 114.317 -1.311 . . . . 0.0 107.983 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.13 -26.47 14.86 Favored 'Trans proline' 0 C--N 1.364 1.354 0 C-N-CA 122.594 2.196 . . . . 0.0 113.616 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.67 -40.04 62.48 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 123.787 0.68 . . . . 0.0 112.211 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.55 HD12 HH12 ' A' ' 167' ' ' ARG . 4.6 mt -72.07 -35.1 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 121.411 0.624 . . . . 0.0 110.351 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.26 -37.22 63.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.343 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -85.45 -34.9 21.54 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -84.85 -72.16 0.49 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 117.98 0.354 . . . . 0.0 111.657 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.888 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.85 99.04 6.21 Favored Pre-proline 0 C--N 1.348 0.539 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.846 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.7 Cg_endo -91.99 -0.15 4.28 Favored 'Trans proline' 0 CA--C 1.569 2.259 0 C-N-CA 121.64 1.56 . . . . 0.0 114.253 175.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.626 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 81.3 Cg_endo -73.89 -52.34 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 122.539 2.159 . . . . 0.0 114.43 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.541 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.5 mt-10 -122.54 -30.19 3.95 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.672 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.888 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.8 tt0 -70.02 -10.84 60.01 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.338 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.55 HH12 HD12 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.91 -41.52 43.21 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.9 tp -70.62 -50.33 38.1 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.7 m -58.07 -49.61 76.32 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.666 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.649 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -63.66 -40.0 95.75 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.069 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.76 -45.32 78.11 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.54 0.525 . . . . 0.0 110.485 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 -38.35 90.77 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.497 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.95 -27.63 68.3 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.65 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.649 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -78.05 -40.29 39.18 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.963 0.505 . . . . 0.0 110.378 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.66 -32.76 71.6 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.353 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.757 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.944 179.47 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.4 mt . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.842 0.353 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -90.06 18.68 5.59 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 120.893 0.377 . . . . 0.0 111.058 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.1 p80 176.82 55.49 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.04 0.936 . . . . 0.0 110.265 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -134.32 159.78 39.94 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.625 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.542 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 18.9 m-30 -98.6 136.59 38.47 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.035 0.445 . . . . 0.0 112.02 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 4.3 mt -108.34 141.86 39.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.919 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.669 HD12 ' SG ' ' A' ' 152' ' ' CYS . 2.3 mp -124.87 137.36 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 O-C-N 123.274 0.358 . . . . 0.0 110.351 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.05 120.13 19.22 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.748 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.5 mmt -97.86 159.0 31.95 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.565 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.04 6.81 4.36 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.678 2.252 . . . . 0.0 113.727 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.489 ' ND1' HD22 ' A' ' 147' ' ' ASN . 4.2 t60 -79.82 -12.94 59.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.303 0.241 . . . . 0.0 111.549 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.722 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -105.82 153.13 22.34 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.175 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.91 42.95 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.376 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.722 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.1 m-20 -116.55 87.6 21.47 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.526 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.51 -20.0 18.54 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.926 2.417 . . . . 0.0 113.331 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -84.52 -34.67 23.26 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.828 0.451 . . . . 0.0 111.708 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -94.02 3.83 54.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.024 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.72 163.65 21.12 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 48.87 32.07 3.54 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.9 p -116.29 154.22 30.55 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 120.568 0.223 . . . . 0.0 110.738 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 47.2 t -129.33 132.2 66.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.781 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 6.1 m -113.34 153.39 28.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.755 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.504 ' OH ' HD22 ' A' ' 105' ' ' LEU . 45.2 t80 -107.18 120.5 42.27 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.451 HD11 ' O ' ' A' ' 41' ' ' MET . 0.2 OUTLIER -85.26 109.75 18.57 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.639 0.587 . . . . 0.0 111.128 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.466 ' O ' HD22 ' A' ' 102' ' ' LEU . 34.9 t -69.13 -60.22 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 113.569 -1.651 . . . . 0.0 110.841 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -141.32 115.81 9.54 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.407 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -99.07 128.13 45.15 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.802 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -139.28 152.64 47.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.398 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.87 -18.98 65.64 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.787 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.45 2.35 42.09 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.536 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.46 166.79 15.01 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 121.517 -0.373 . . . . 0.0 112.375 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.91 145.82 31.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.451 ' O ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -125.56 136.82 53.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.966 178.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 133' ' ' ALA . . . -160.93 159.78 31.37 Favored Glycine 0 N--CA 1.452 -0.284 0 O-C-N 124.575 1.172 . . . . 0.0 112.59 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.405 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.2 mt -115.12 135.08 54.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.08 0.44 . . . . 0.0 111.228 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 78' ' ' GLY . 11.0 t -66.83 124.11 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.65 54.08 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.538 0.685 . . . . 0.0 112.015 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.825 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.6 t-20 -147.32 -3.42 0.56 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.996 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.422 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 2.8 ttt180 -129.7 87.61 51.98 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.503 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 35.2 Cg_exo -59.73 142.45 98.74 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 121.658 1.572 . . . . 0.0 112.273 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.414 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.2 m -89.44 159.39 17.3 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.465 0.478 . . . . 0.0 111.589 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.84 48.54 1.47 Allowed Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.513 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mt -133.48 157.02 46.67 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 124.002 0.471 . . . . 0.0 110.141 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 18.4 p-10 -112.22 158.74 19.34 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.245 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.53 -29.23 64.2 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.38 96.0 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.33 -47.02 77.96 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.854 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.3 m -62.06 -43.92 98.32 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.7 mt -57.34 -34.57 68.92 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.587 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -78.18 -27.72 48.0 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.325 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.67 -30.29 51.97 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.263 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.854 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 14.7 mt -77.87 -45.55 23.9 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 113.667 -1.606 . . . . 0.0 111.056 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -130.94 116.01 16.81 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.609 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.43 -32.91 2.7 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 123.604 2.869 . . . . 0.0 112.744 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.36 -15.38 55.46 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.315 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.3 150.49 23.83 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.611 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.78 122.79 28.29 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.167 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.7 149.74 49.22 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.357 2.038 . . . . 0.0 112.189 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.458 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 8.7 Cg_endo -94.69 -171.5 0.23 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.639 2.226 . . . . 0.0 112.477 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.475 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -64.72 -24.79 67.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.113 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.512 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 7.4 ptp180 -68.73 -46.73 68.15 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 15.4 m -75.49 -25.44 57.31 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 52.3 mt-30 -68.63 -26.92 65.58 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.475 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 23.6 p80 -99.46 21.68 11.81 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.138 0.494 . . . . 0.0 111.318 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 63.4 mt -117.79 139.1 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.268 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.505 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.7 m-20 -107.18 154.62 20.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.5 mm -101.28 152.59 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.235 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.699 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.9 t80 -118.81 154.87 32.15 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -85.94 119.2 25.99 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.613 0.188 . . . . 0.0 110.555 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.567 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -103.29 -23.72 8.31 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.022 -1.085 . . . . 0.0 114.047 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.15 -168.24 35.11 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.359 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -88.66 -13.26 3.37 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.47 2.78 . . . . 0.0 114.37 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.3 t -82.39 125.19 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 123.082 0.239 . . . . 0.0 111.233 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 47.23 85.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.488 1.115 . . . . 0.0 113.027 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -86.8 1.45 52.27 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.288 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -94.63 -4.23 48.08 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.636 ' NH2' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -133.05 152.85 51.92 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.625 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.63 137.4 14.12 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.413 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.719 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.6 OUTLIER -86.49 144.55 27.2 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.029 0.932 . . . . 0.0 110.635 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -125.28 103.67 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 123.636 0.585 . . . . 0.0 110.046 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 126' ' ' SER . 15.5 tp -107.51 128.38 54.46 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.138 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.411 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 4.1 p80 -127.55 169.09 13.12 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.612 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.644 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.4 Cg_endo -97.25 15.2 0.75 Allowed 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.756 2.304 . . . . 0.0 113.818 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.411 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 9.4 t -102.77 159.91 15.06 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.668 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.76 22.47 37.7 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.636 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -89.4 153.01 21.19 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.56 0.344 . . . . 0.0 110.622 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.6 m -130.31 156.65 44.32 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 112.196 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.695 ' H ' ' HG1' ' A' ' 99' ' ' THR . 46.4 m-85 -126.27 -150.59 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.844 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -56.78 -46.86 81.25 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.975 0.51 . . . . 0.0 111.633 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 m -134.5 82.25 1.96 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.86 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.695 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 30.4 m -130.1 124.51 32.92 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.229 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.71 123.54 47.22 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.844 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.21 129.22 34.9 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.081 0.467 . . . . 0.0 110.787 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.55 45.88 2.43 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.411 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.06 -105.87 1.33 Allowed Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.155 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.55 -10.67 3.65 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.504 HD22 ' OH ' ' A' ' 31' ' ' TYR . 2.2 pp -155.46 153.19 29.94 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 123.26 0.35 . . . . 0.0 111.392 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.39 156.2 29.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.716 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.557 ' O ' ' HA ' ' A' ' 99' ' ' THR . 18.6 ttm -122.52 130.58 53.19 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 m -131.52 130.86 42.9 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.8 p -120.36 18.63 12.17 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.549 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.746 ' O ' HG13 ' A' ' 113' ' ' VAL . 68.3 m -88.09 133.99 33.86 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.963 0.887 . . . . 0.0 112.694 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.631 ' HA ' ' NH2' ' A' ' 85' ' ' ARG . 3.9 mt-30 -62.7 -30.81 71.68 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.96 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.79 -40.31 95.02 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.735 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 110' ' ' SER . 3.5 p -70.46 -39.41 76.29 Favored 'Isoleucine or valine' 0 C--N 1.353 0.745 0 O-C-N 123.142 0.276 . . . . 0.0 110.502 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.636 HD23 ' NH2' ' A' ' 85' ' ' ARG . 4.2 tp -59.36 -46.54 88.36 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 123.471 0.482 . . . . 0.0 110.164 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.495 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 24.1 m-85 -67.22 -40.96 86.45 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 178.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -53.21 59.78 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.599 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.91 -43.57 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.527 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.466 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.33 -32.72 64.94 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.815 0.697 . . . . 0.0 109.59 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.512 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.89 -19.64 32.0 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.376 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.06 15.21 31.43 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.689 -1.141 . . . . 0.0 114.755 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 p -105.1 6.77 33.49 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.2 -137.35 8.99 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.481 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -81.62 172.6 12.2 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.046 2.497 . . . . 0.0 113.526 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.64 -55.16 37.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.695 0.798 . . . . 0.0 111.962 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.644 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.8 mmtt -141.76 139.74 32.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.656 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 36.6 p -139.02 167.82 21.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.0 tp -126.88 118.49 24.7 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.574 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.5 pt -98.46 102.18 13.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.575 0.703 . . . . 0.0 109.725 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.7 t -121.02 122.05 39.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.713 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 tp -67.33 118.03 10.14 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.464 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.86 173.24 5.63 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 114.763 -1.108 . . . . 0.0 114.524 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.41 175.5 8.46 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.179 0.514 . . . . 0.0 110.659 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -115.86 129.68 56.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.271 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.47 146.75 17.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.631 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -121.86 136.83 54.94 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.149 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.32 157.81 26.28 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.848 0.718 . . . . 0.0 110.786 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.23 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.51 -25.82 7.55 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.119 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -58.54 -44.22 89.52 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.885 0.474 . . . . 0.0 112.272 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.562 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.89 -47.58 65.5 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.16 0.287 . . . . 0.0 110.481 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.29 -29.55 68.9 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.014 0.435 . . . . 0.0 110.555 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.56 -49.91 49.79 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.84 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.32 -26.81 63.0 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.696 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.5 tp -74.55 -37.31 63.03 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.492 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.0 t -77.88 -29.83 50.51 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.712 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.0 t70 -84.11 1.15 45.54 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.072 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.489 HD22 ' ND1' ' A' ' 19' ' ' HIS . 3.6 p-10 52.63 33.98 14.85 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.841 1.256 . . . . 0.0 112.201 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.53 -41.61 21.4 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.372 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -122.14 113.02 18.92 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.0 tp -83.92 136.18 34.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.5 p -101.13 136.91 40.22 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.967 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.669 ' SG ' HD12 ' A' ' 15' ' ' ILE . 26.2 p -150.79 154.98 35.42 Favored Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 123.458 0.474 . . . . 0.0 110.738 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.63 152.6 61.37 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.189 1.926 . . . . 0.0 110.989 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.542 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.93 167.45 17.41 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.74 134.22 21.9 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.943 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.87 -26.48 15.55 Favored 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 122.493 2.129 . . . . 0.0 113.434 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.14 -48.49 53.72 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 124.032 0.832 . . . . 0.0 111.441 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.554 HD11 HH12 ' A' ' 167' ' ' ARG . 4.7 mt -64.06 -34.87 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.371 0.668 . . . . 0.0 110.839 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -73.55 -35.62 65.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.281 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -83.66 -34.89 24.91 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.484 ' O ' HD11 ' A' ' 162' ' ' LEU . 2.2 p30 -86.81 -67.22 0.83 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.744 0.702 . . . . 0.0 112.729 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.657 ' C ' ' HD2' ' A' ' 164' ' ' PRO . 1.1 tp -145.73 98.98 4.44 Favored Pre-proline 0 C--N 1.344 0.333 0 CA-C-O 121.042 0.448 . . . . 0.0 111.786 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.825 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 65.7 Cg_endo -91.54 -0.14 4.56 Favored 'Trans proline' 0 CA--C 1.57 2.282 0 C-N-CA 121.795 1.663 . . . . 0.0 114.488 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.657 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 79.4 Cg_endo -74.67 -50.41 0.14 Allowed 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.76 2.307 . . . . 0.0 114.438 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.539 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 10.8 mt-10 -121.61 -33.98 3.51 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.705 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 6.0 mt-10 -68.6 -11.28 59.81 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.045 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.554 HH12 HD11 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -77.06 -41.7 41.32 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -69.82 -49.78 49.33 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.8 m -58.33 -49.05 78.58 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.682 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.653 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.39 -40.21 95.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.265 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.82 79.46 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 123.538 0.524 . . . . 0.0 110.489 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.69 88.27 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.466 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.25 -27.76 68.87 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.507 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.653 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.6 mmp_? -77.52 -40.03 44.12 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.899 0.479 . . . . 0.0 110.192 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -71.3 -31.29 67.26 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.461 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.806 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.911 179.603 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.724 ' HB3' ' ND1' ' A' ' 12' ' ' HIS . 14.2 mt . . . . . 0 C--O 1.239 0.504 0 CA-C-O 120.948 0.404 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -89.53 26.77 1.63 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.95 0.405 . . . . 0.0 110.63 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 178.37 53.9 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.668 0.787 . . . . 0.0 109.979 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.724 ' ND1' ' HB3' ' A' ' 9' ' ' LEU . 6.9 p-80 -131.11 156.29 45.5 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 11.0 m-30 -98.68 133.72 42.61 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.843 0.354 . . . . 0.0 111.205 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 8.6 mt -106.58 140.98 38.59 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.299 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.21 131.19 73.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.25 132.84 38.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.885 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 55.5 mtt -121.46 156.6 57.93 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.191 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.85 75.83 4.61 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.629 2.219 . . . . 0.0 112.885 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -134.02 -21.99 1.84 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.787 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.57 -162.91 0.86 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.25 0.344 . . . . 0.0 110.382 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.518 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -101.79 32.94 3.19 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 8.1 m-20 -111.47 82.49 3.66 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.41 -24.17 12.45 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 123.034 2.489 . . . . 0.0 113.361 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -85.01 -37.81 19.96 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.953 0.501 . . . . 0.0 111.612 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.61 -3.4 57.57 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.791 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 22' ' ' ASP . . . -60.83 1.93 0.13 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -141.33 39.37 1.74 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.191 0.519 . . . . 0.0 111.981 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.7 p -123.22 158.52 30.67 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.788 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.518 HG12 ' HE ' ' A' ' 167' ' ' ARG . 97.0 t -130.85 132.3 64.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.955 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -113.25 153.75 27.89 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.343 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.507 ' OH ' HD21 ' A' ' 105' ' ' LEU . 34.9 t80 -108.61 119.6 40.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.581 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.51 107.8 15.43 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 123.491 0.494 . . . . 0.0 111.295 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.485 ' O ' HD21 ' A' ' 102' ' ' LEU . 39.0 t -68.12 -60.65 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.203 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.504 ' OE1' HD13 ' A' ' 100' ' ' LEU . 12.8 tt0 -142.16 114.76 8.49 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.426 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.489 ' CE1' HD11 ' A' ' 9' ' ' LEU . 15.7 t-80 -96.75 129.78 44.11 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.9 151.54 47.03 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.068 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.39 -17.82 64.12 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -104.79 6.32 33.91 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.664 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.61 164.39 12.62 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 121.511 -0.376 . . . . 0.0 112.295 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -146.02 141.13 27.36 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.94 134.9 54.51 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.584 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 133' ' ' ALA . . . -159.04 160.56 31.29 Favored Glycine 0 N--CA 1.449 -0.444 0 O-C-N 124.5 1.125 . . . . 0.0 112.573 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.5 mt -115.95 135.26 54.14 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.148 0.474 . . . . 0.0 111.503 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 78' ' ' GLY . 12.0 t -68.64 123.55 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.3 pt -126.83 56.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.679 0.752 . . . . 0.0 111.798 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.85 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.9 t-20 -147.45 -4.17 0.53 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.42 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.436 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 2.4 ttm180 -129.7 88.21 50.21 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.48 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.2 Cg_exo -59.58 142.26 98.57 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.655 1.57 . . . . 0.0 112.151 175.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.407 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 43.7 m -91.43 159.48 15.94 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.346 0.404 . . . . 0.0 111.574 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.53 46.76 1.24 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.362 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.466 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.69 155.1 51.12 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.48 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 14.7 p-10 -105.79 161.08 14.73 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.889 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.445 HD22 ' SG ' ' A' ' 70' ' ' CYS . 13.5 tp -58.77 -37.85 77.21 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.59 -36.58 56.44 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.48 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 37.4 mt-10 -64.37 -43.04 95.75 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.171 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.854 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -62.77 -46.48 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.432 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 4.5 mp -54.01 -36.77 63.35 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.858 0.724 . . . . 0.0 110.788 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.93 -28.22 49.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.525 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -30.05 48.82 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.358 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.854 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.1 mt -77.75 -45.03 25.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.945 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -132.3 116.48 15.35 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.543 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.5 -32.75 2.74 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.566 2.844 . . . . 0.0 112.803 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.29 -14.17 55.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.426 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.89 149.93 24.46 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 123.38 0.425 . . . . 0.0 111.716 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.3 123.65 29.79 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.046 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.17 145.42 34.92 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 122.271 1.981 . . . . 0.0 112.371 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.483 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.7 Cg_endo -92.58 -171.34 0.33 Allowed 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.561 2.174 . . . . 0.0 111.978 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.504 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -63.15 -24.79 68.05 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.215 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.556 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.3 ptp180 -66.22 -53.27 39.16 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.445 ' SG ' HD22 ' A' ' 53' ' ' LEU . 60.7 m -72.38 -25.0 61.34 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 49.5 mt-30 -67.11 -35.69 80.3 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.504 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 20.2 p80 -91.62 23.99 3.28 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.256 0.551 . . . . 0.0 111.689 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 55.8 mt -120.42 138.97 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.573 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.589 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.5 m-20 -107.62 154.79 20.92 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.768 0.668 . . . . 0.0 112.639 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 51' ' ' LEU . 16.6 mm -102.74 152.57 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.207 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.5 t80 -119.27 152.75 36.14 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -83.45 120.59 26.09 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.899 0.318 . . . . 0.0 110.796 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.535 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -103.6 -23.66 8.22 Favored Glycine 0 C--N 1.348 1.206 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.984 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.6 -167.86 35.29 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.333 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -88.66 -11.51 4.0 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.511 2.807 . . . . 0.0 114.378 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -86.06 127.34 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 123.054 0.221 . . . . 0.0 111.266 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 46.04 84.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.528 1.131 . . . . 0.0 113.289 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 p -85.69 -4.41 59.16 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.072 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.91 -5.64 59.2 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.729 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.615 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.43 154.27 50.92 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.615 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.28 133.69 11.8 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.986 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.741 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.61 145.07 27.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.377 1.071 . . . . 0.0 110.426 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.28 103.94 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 123.414 0.446 . . . . 0.0 110.726 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 126' ' ' SER . 14.1 tp -106.75 128.29 54.09 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.727 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.452 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 3.6 p80 -125.51 166.42 21.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-O 118.937 -0.554 . . . . 0.0 112.048 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.5 Cg_endo -96.16 14.84 0.97 Allowed 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.663 2.242 . . . . 0.0 113.59 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.452 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 8.8 t -101.93 160.84 14.14 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.808 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.65 19.42 54.77 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.794 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mp -85.62 154.1 21.93 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.481 0.312 . . . . 0.0 111.057 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 p -127.07 156.86 41.02 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.596 ' H ' ' HG1' ' A' ' 99' ' ' THR . 51.4 m-85 -129.8 -152.57 0.52 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.821 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -57.27 -46.43 83.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.847 0.459 . . . . 0.0 111.721 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.7 m -136.27 81.67 1.9 Allowed 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.209 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.596 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 11.3 m -129.33 126.84 39.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.691 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.504 HD13 ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -105.68 123.26 47.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.743 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -82.89 128.81 34.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.53 . . . . 0.0 110.763 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.485 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.54 46.69 2.25 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.337 -179.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.47 -107.95 2.2 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.04 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -61.22 -9.24 4.59 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.507 HD21 ' OH ' ' A' ' 31' ' ' TYR . 2.6 pp -154.29 152.39 30.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.41 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.14 156.74 28.17 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.706 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.571 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.8 ttm -121.45 127.21 50.88 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.2 m -123.84 129.47 51.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.182 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 58.7 p -119.57 15.12 12.81 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.71 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.8 m -87.76 129.71 35.08 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.358 0.599 . . . . 0.0 111.872 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.485 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.6 pt20 -61.55 -29.4 69.99 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.158 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -64.98 -42.86 94.17 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.627 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.72 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.2 p -67.75 -38.17 79.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 O-C-N 123.171 0.294 . . . . 0.0 110.291 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.578 HD23 ' NH2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -59.13 -48.99 79.58 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 123.572 0.545 . . . . 0.0 110.323 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.485 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 32.0 m-85 -69.12 -37.52 78.39 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.995 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.04 -51.7 66.93 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.085 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.81 -43.44 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.257 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.1 -31.68 65.52 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 123.734 0.646 . . . . 0.0 109.544 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.556 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.74 -20.08 31.65 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.233 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.05 15.1 31.76 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.689 -1.141 . . . . 0.0 114.67 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.5 p -105.8 8.16 32.68 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.3 -138.49 9.91 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.203 -0.776 . . . . 0.0 112.774 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.9 172.11 13.49 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.283 2.656 . . . . 0.0 113.87 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.478 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -52.05 -57.23 10.16 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.417 1.087 . . . . 0.0 111.624 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.525 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -139.6 152.91 47.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.811 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.5 m -147.34 164.21 33.98 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.79 117.81 22.57 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.449 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.741 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.7 pt -98.44 102.35 13.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 121.842 0.83 . . . . 0.0 109.833 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 7.2 t -118.94 122.27 41.87 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.727 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -66.95 115.21 6.43 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.109 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.01 174.15 5.25 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.694 -1.139 . . . . 0.0 114.355 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -128.64 179.9 5.43 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.251 0.548 . . . . 0.0 110.842 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -117.43 130.49 56.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.215 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.86 139.56 11.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.757 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.403 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 32.6 m-90 -113.88 135.01 54.44 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.934 0.432 . . . . 0.0 110.151 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.62 158.03 25.8 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.887 0.742 . . . . 0.0 110.501 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.91 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 122.26 -26.11 6.48 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.015 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.71 -45.07 86.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.558 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.32 -47.93 66.22 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.156 0.285 . . . . 0.0 110.502 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.62 -28.54 68.62 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.411 0.445 . . . . 0.0 110.729 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.53 -51.13 30.83 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.74 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -69.47 -26.49 64.59 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.7 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.2 tp -75.37 -39.34 59.32 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.873 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.6 m -77.75 -28.46 50.72 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.532 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -82.93 0.55 43.92 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.438 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 59.31 28.89 18.35 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.777 0.831 . . . . 0.0 111.7 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.93 -43.4 19.82 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.304 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -125.69 118.07 24.83 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 4.8 tp -87.97 150.88 23.19 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.484 0.183 . . . . 0.0 111.357 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.575 HG21 ' NE2' ' A' ' 12' ' ' HIS . 80.8 p -111.25 137.11 49.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.792 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 78.6 m -149.86 154.5 37.36 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 123.315 0.384 . . . . 0.0 111.357 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.37 148.37 86.91 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.555 2.17 . . . . 0.0 110.993 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -123.21 166.92 14.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -135.53 134.53 21.09 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.929 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.46 -26.38 17.02 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.604 2.202 . . . . 0.0 113.542 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.91 -40.12 63.29 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.862 0.726 . . . . 0.0 112.116 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.566 HD12 HH12 ' A' ' 167' ' ' ARG . 4.8 mt -71.75 -35.66 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 121.382 0.611 . . . . 0.0 110.277 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.5 tt -73.65 -37.72 65.21 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.455 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -85.3 -34.71 21.82 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -84.92 -72.58 0.47 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 117.967 0.349 . . . . 0.0 111.627 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.888 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.28 98.97 6.56 Favored Pre-proline 0 C--N 1.348 0.529 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.85 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 66.3 Cg_endo -92.19 -0.05 4.15 Favored 'Trans proline' 0 CA--C 1.569 2.269 0 C-N-CA 121.702 1.601 . . . . 0.0 114.226 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.619 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 77.4 Cg_endo -74.03 -52.5 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.899 0 C-N-CA 122.605 2.204 . . . . 0.0 114.389 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.542 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.3 mt-10 -122.43 -29.92 4.03 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.707 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.888 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.9 tt0 -70.09 -10.89 60.21 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.37 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.566 HH12 HD12 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.83 -39.62 50.64 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.9 tt -72.64 -49.98 28.21 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.1 m -58.0 -47.96 81.47 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.508 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.656 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.96 -39.9 90.82 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.17 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.32 79.94 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 123.393 0.433 . . . . 0.0 110.594 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.23 -38.49 90.55 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.523 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.29 -28.55 69.79 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.601 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.656 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.86 -40.45 40.05 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 122.905 0.482 . . . . 0.0 110.35 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.98 -33.24 74.26 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.533 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.789 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.108 179.429 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.6 mt . . . . . 0 N--CA 1.47 0.538 0 CA-C-O 121.046 0.451 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -89.92 16.03 8.9 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.441 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 173.94 54.86 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.967 0.907 . . . . 0.0 110.518 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -133.14 163.58 28.96 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.303 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -100.69 140.73 34.55 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.242 0.544 . . . . 0.0 112.258 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.6 mp -111.75 137.49 49.59 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.185 -1.371 . . . . 0.0 109.807 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 150' ' ' LEU . 2.9 mp -119.98 136.2 57.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.81 127.21 32.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.117 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.406 ' HB3' ' HD1' ' A' ' 19' ' ' HIS . 33.1 mtt -110.79 157.88 37.26 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.196 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.12 29.36 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.577 2.184 . . . . 0.0 113.127 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.406 ' HD1' ' HB3' ' A' ' 17' ' ' MET . 43.3 m80 -85.81 -17.62 35.2 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -167.76 1.26 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.088 0.242 . . . . 0.0 110.598 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.514 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.42 40.9 1.39 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.036 0.446 . . . . 0.0 111.732 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -111.92 80.69 3.18 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.844 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.5 Cg_exo -75.55 -23.06 13.27 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.036 2.491 . . . . 0.0 113.28 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -84.53 -34.96 23.18 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.916 0.487 . . . . 0.0 111.708 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.63 3.82 53.09 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.077 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.12 163.18 20.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.767 0.318 . . . . 0.0 111.807 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 49.69 32.32 5.05 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.9 p -118.22 154.82 31.59 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 122.395 -0.191 . . . . 0.0 110.508 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 68.7 t -128.54 134.7 64.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-O 121.416 0.627 . . . . 0.0 110.789 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.8 m -116.11 151.95 34.61 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.658 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.475 ' OH ' HD23 ' A' ' 105' ' ' LEU . 12.8 t80 -105.32 118.88 37.69 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.72 107.84 15.65 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.365 0.602 . . . . 0.0 110.065 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.477 HG22 ' HA2' ' A' ' 42' ' ' GLY . 23.5 t -71.87 -59.6 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.76 -178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -137.25 119.23 15.33 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.51 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -103.94 126.2 50.89 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -139.94 153.2 46.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.577 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.23 -18.34 65.23 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.522 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -98.31 -3.55 36.94 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.391 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.0 171.48 21.75 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 121.564 -0.35 . . . . 0.0 112.29 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.67 144.43 29.47 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.42 137.2 54.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.747 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.477 ' HA2' HG22 ' A' ' 33' ' ' VAL . . . -159.82 158.44 29.69 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.858 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.437 HD21 ' C ' ' A' ' 42' ' ' GLY . 2.4 mt -115.6 134.67 54.82 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.952 0.376 . . . . 0.0 111.287 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.544 HG21 ' O ' ' A' ' 78' ' ' GLY . 6.1 t -68.75 121.73 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.27 54.71 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.586 0.707 . . . . 0.0 112.221 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.849 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 21.9 t-20 -148.7 -1.55 0.51 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.104 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -129.75 85.51 57.97 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.51 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.2 Cg_exo -60.55 144.79 99.56 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 121.74 1.627 . . . . 0.0 112.582 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.421 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.6 m -94.41 153.77 17.79 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.075 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.82 51.9 1.97 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.851 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mt -134.07 160.27 38.27 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.903 0.413 . . . . 0.0 110.28 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.3 p-10 -112.1 157.37 20.89 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.459 HD22 ' SG ' ' A' ' 70' ' ' CYS . 12.4 tp -58.02 -36.13 72.26 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.04 -39.27 66.06 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -63.48 -41.08 98.58 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.678 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.841 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.8 t -61.53 -50.29 80.94 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.409 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 5.0 mp -52.44 -36.39 54.38 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 123.975 0.797 . . . . 0.0 110.995 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.13 -28.53 48.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.489 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -78.44 -31.8 48.2 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.457 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.841 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.1 mt -77.5 -45.04 26.77 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.0 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -132.11 116.88 15.69 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.412 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.5 -33.11 2.56 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 123.65 2.9 . . . . 0.0 112.807 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.16 -14.02 56.28 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.462 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.3 149.81 24.29 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.33 0.394 . . . . 0.0 111.737 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.77 123.43 29.7 Favored Pre-proline 0 C--O 1.235 0.333 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.038 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.88 145.34 31.81 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.217 1.944 . . . . 0.0 112.462 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.513 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.8 Cg_endo -92.15 -169.34 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.612 2.208 . . . . 0.0 111.895 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.501 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -64.89 -24.89 67.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.12 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -66.63 -51.56 54.92 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.459 ' SG ' HD22 ' A' ' 53' ' ' LEU . 59.6 m -72.74 -25.05 61.06 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 47.0 mt-30 -68.16 -35.3 77.85 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.501 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 21.6 p80 -90.92 22.98 3.35 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.099 0.476 . . . . 0.0 111.718 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 61.2 mt -119.84 139.02 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.464 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.608 ' O ' HD13 ' A' ' 128' ' ' ILE . 1.9 m-20 -104.65 156.71 17.74 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.854 0.721 . . . . 0.0 112.564 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.8 mm -102.84 155.38 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.432 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.69 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.8 t80 -124.84 155.83 38.81 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -88.37 122.69 32.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 119.691 -0.195 . . . . 0.0 110.512 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.544 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -101.87 -23.68 9.12 Favored Glycine 0 C--N 1.351 1.413 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.793 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.77 -167.31 35.25 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.086 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -87.11 -10.56 5.71 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 123.266 2.644 . . . . 0.0 113.84 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.64 ' O ' ' HA3' ' A' ' 131' ' ' GLY . 4.1 t -86.19 126.74 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.178 0.299 . . . . 0.0 110.383 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 43.78 87.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.292 1.037 . . . . 0.0 113.099 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.573 ' O ' HD21 ' A' ' 130' ' ' LEU . 76.9 p -86.04 -12.44 50.2 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.306 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -84.94 0.26 51.86 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -132.7 153.57 51.02 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.96 126.0 7.97 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.35 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.645 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 0.2 OUTLIER -85.77 145.74 27.1 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.86 1.264 . . . . 0.0 109.92 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 t -121.57 103.53 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.741 0.305 . . . . 0.0 110.824 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 126' ' ' SER . 2.2 tt -99.43 126.76 45.39 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.484 ' CE1' ' HB1' ' A' ' 106' ' ' ALA . 3.9 p80 -131.86 164.11 45.27 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-O 118.93 -0.557 . . . . 0.0 112.193 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.2 Cg_endo -96.9 9.84 1.31 Allowed 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 122.733 2.289 . . . . 0.0 113.945 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.471 ' OG ' HD21 ' A' ' 94' ' ' LEU . 8.7 t -94.35 158.98 15.32 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.976 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.12 19.06 56.03 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.789 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.471 HD21 ' OG ' ' A' ' 92' ' ' SER . 4.6 mm? -86.8 154.24 21.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.431 0.292 . . . . 0.0 110.77 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 p -123.02 155.36 37.0 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.696 ' H ' ' HG1' ' A' ' 99' ' ' THR . 62.2 m-85 -130.57 -152.79 0.53 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.344 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -58.6 -47.24 84.97 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.896 0.316 . . . . 0.0 111.446 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 56.2 m -134.3 85.19 2.17 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.488 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.696 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 8.1 m -130.78 128.75 41.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.922 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.41 124.38 50.3 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.427 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.63 128.19 34.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.237 0.541 . . . . 0.0 111.172 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -121.48 47.2 1.9 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.214 -179.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.88 -106.81 1.69 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-N 114.706 -1.134 . . . . 0.0 113.081 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.38 -9.93 4.18 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.475 HD23 ' OH ' ' A' ' 31' ' ' TYR . 3.5 pp -156.27 160.44 39.76 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.53 0.332 . . . . 0.0 111.252 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.484 ' HB1' ' CE1' ' A' ' 90' ' ' HIS . . . -123.38 162.59 22.47 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 123.625 0.578 . . . . 0.0 110.526 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.645 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 22.4 ttm -123.6 130.18 52.27 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.6 m -124.7 127.94 48.04 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 120.844 0.354 . . . . 0.0 110.21 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.4 p -117.21 20.15 13.84 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.466 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.1 p -98.18 127.75 44.29 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 122.011 0.91 . . . . 0.0 112.03 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.497 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 2.3 mt-30 -61.59 -25.96 67.67 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.314 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -64.54 -42.41 95.73 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.104 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.718 ' O ' HG22 ' A' ' 117' ' ' ILE . 5.2 p -69.02 -38.18 78.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.521 ' N ' HG13 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -56.98 -47.67 80.23 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 123.732 0.645 . . . . 0.0 110.303 178.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.497 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 28.2 m-85 -69.61 -39.8 77.02 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.068 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.3 -51.37 69.18 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.146 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.44 -43.31 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.123 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.49 -30.89 65.46 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.792 0.682 . . . . 0.0 109.731 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.56 -19.73 30.66 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.16 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.15 17.77 26.32 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.682 -1.145 . . . . 0.0 114.558 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.5 p -109.49 9.93 25.32 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.88 -138.5 9.5 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-O 119.374 -0.681 . . . . 0.0 113.038 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.26 173.08 12.92 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.338 2.692 . . . . 0.0 113.793 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.482 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -52.13 -56.64 13.19 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.258 1.023 . . . . 0.0 111.27 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.505 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -139.34 154.38 47.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.509 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.5 m -150.03 162.81 39.67 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.4 tp -129.93 115.79 17.7 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.872 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 74' ' ' ASP . 16.4 pt -95.67 102.5 13.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-O 121.807 0.813 . . . . 0.0 109.242 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 59.7 p -125.07 130.65 52.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.263 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.573 HD21 ' O ' ' A' ' 83' ' ' THR . 16.2 mt -67.03 118.22 10.17 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.031 0.444 . . . . 0.0 111.372 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 81' ' ' VAL . . . 55.93 -172.86 1.53 Allowed Glycine 0 C--N 1.343 0.934 0 CA-C-N 114.232 -1.349 . . . . 0.0 115.012 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -128.53 -176.0 3.69 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.641 0.734 . . . . 0.0 111.358 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -119.39 130.38 55.28 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 113.866 -1.516 . . . . 0.0 108.367 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.37 152.3 19.12 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.667 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -129.88 136.92 50.08 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 124.011 0.477 . . . . 0.0 110.169 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.15 158.44 27.72 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.93 0.769 . . . . 0.0 110.631 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.47 89.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.96 -22.28 9.18 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.356 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -56.99 -47.44 80.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.985 0.514 . . . . 0.0 112.162 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.6 tp -66.89 -47.89 70.44 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.18 -29.95 64.1 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.43 0.456 . . . . 0.0 110.895 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.92 -49.32 47.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.042 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.6 pt-20 -72.45 -26.71 61.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.681 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 4.6 tp -75.43 -38.44 59.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.822 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.2 t -78.23 -30.44 48.78 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.286 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.5 t70 -80.3 0.92 30.8 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.604 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 60.79 28.33 18.08 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.981 0.912 . . . . 0.0 111.813 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.81 -42.53 19.56 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.639 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -123.55 111.14 15.91 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.938 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.552 ' O ' HD12 ' A' ' 15' ' ' ILE . 6.0 tp -85.31 130.82 34.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.67 0.272 . . . . 0.0 111.484 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.2 p -104.64 141.98 35.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.862 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.9 m -154.91 157.11 31.91 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.83 146.77 96.97 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.242 1.962 . . . . 0.0 111.188 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -131.66 175.86 8.82 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -133.18 139.93 35.78 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.278 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.73 -26.62 11.31 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 122.771 2.314 . . . . 0.0 114.015 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -49.98 -43.13 50.18 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.809 0.693 . . . . 0.0 112.355 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.616 HD11 HH12 ' A' ' 167' ' ' ARG . 4.7 mt -67.71 -32.88 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 121.504 0.669 . . . . 0.0 110.318 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.1 tt -75.29 -41.23 57.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.673 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.68 -24.39 25.25 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -90.18 -72.02 0.59 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.313 0.506 . . . . 0.0 110.944 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.874 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.09 98.58 6.15 Favored Pre-proline 0 C--N 1.348 0.538 0 CA-C-O 121.078 0.466 . . . . 0.0 112.171 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.849 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 64.8 Cg_endo -91.39 -0.17 4.66 Favored 'Trans proline' 0 CA--C 1.57 2.321 0 C-N-CA 121.691 1.594 . . . . 0.0 114.266 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.643 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 83.6 Cg_endo -74.14 -54.14 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.627 2.218 . . . . 0.0 114.554 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.574 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -121.74 -29.39 4.35 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.783 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.874 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.07 -12.24 61.46 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.321 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.616 HH12 HD11 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.1 -44.12 40.21 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -68.97 -50.37 49.67 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -57.61 -50.55 72.76 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.773 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.512 ' O ' ' HG3' ' A' ' 174' ' ' ARG . . . -61.68 -40.39 94.8 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.154 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.11 -46.38 82.66 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.625 0.578 . . . . 0.0 110.489 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.53 87.72 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.477 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.55 69.71 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.31 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 170' ' ' ALA . 7.9 mtm105 -77.16 -41.09 43.1 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.196 0.598 . . . . 0.0 110.893 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.7 tp -71.28 -29.86 65.57 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.542 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.789 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.797 179.597 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.7 mt . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 120.772 0.32 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -90.8 19.5 5.46 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 120.772 0.32 . . . . 0.0 111.349 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 15.8 p80 174.51 57.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.025 0.93 . . . . 0.0 110.174 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -135.13 159.57 41.11 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.859 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.519 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.8 m-30 -96.96 138.0 35.17 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.147 0.499 . . . . 0.0 112.29 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.564 ' O ' HG12 ' A' ' 29' ' ' VAL . 1.7 mp -111.97 133.36 54.2 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.198 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 150' ' ' LEU . 2.6 mp -119.02 133.12 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.56 122.8 19.77 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.036 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.9 mmt -103.83 160.46 26.01 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.262 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.31 20.6 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.713 2.276 . . . . 0.0 113.659 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -81.24 -14.94 56.93 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.578 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -113.53 160.8 18.12 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.606 0.363 . . . . 0.0 110.238 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.45 52.84 2.54 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.419 0.628 . . . . 0.0 112.084 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.578 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.2 m-20 -128.12 87.47 55.39 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.528 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.03 -13.92 21.21 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.924 2.416 . . . . 0.0 113.558 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -85.08 -38.27 19.32 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.388 0.43 . . . . 0.0 111.534 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -98.26 -1.36 42.07 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.606 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 22' ' ' ASP . . . -63.65 2.52 0.44 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -139.57 42.3 2.02 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.276 0.56 . . . . 0.0 112.071 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.4 p -125.39 154.06 42.48 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.588 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 14' ' ' LEU . 25.2 t -130.56 133.65 63.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.742 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -115.85 152.43 33.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.585 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.505 ' OH ' HD23 ' A' ' 105' ' ' LEU . 41.8 t80 -106.58 120.79 42.87 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -84.24 108.98 17.42 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.079 0.466 . . . . 0.0 111.043 -178.356 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' O ' HD21 ' A' ' 102' ' ' LEU . 35.3 t -66.8 -60.18 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.732 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -144.66 115.54 7.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.304 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -97.78 128.22 44.27 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.45 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -139.58 153.3 47.36 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.69 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.55 -18.62 65.46 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.601 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.66 4.4 43.21 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.392 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.17 165.37 12.81 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.229 -0.349 . . . . 0.0 112.229 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.61 139.4 29.63 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.471 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -121.1 136.98 54.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.959 178.714 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.559 ' O ' ' HB1' ' A' ' 133' ' ' ALA . . . -159.05 157.52 28.57 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 124.372 1.045 . . . . 0.0 112.465 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 mt -112.26 134.9 53.53 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.206 0.503 . . . . 0.0 110.957 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 78' ' ' GLY . 11.9 t -69.83 123.41 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.72 56.28 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.666 0.746 . . . . 0.0 112.117 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.856 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.0 t-20 -147.41 -2.45 0.59 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.115 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -130.27 88.52 47.57 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.473 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 47.5 Cg_exo -58.29 141.87 97.1 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 121.533 1.489 . . . . 0.0 111.86 174.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.416 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 8.9 t -77.79 -39.51 43.71 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.62 -8.7 74.28 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.873 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 5.7 mt -81.43 170.27 16.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.706 0.402 . . . . 0.0 110.161 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.627 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.9 p-10 -112.79 156.28 23.14 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.477 ' O ' HG21 ' A' ' 56' ' ' VAL . 1.6 tt -57.69 -26.69 62.08 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 123.478 0.486 . . . . 0.0 111.992 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.08 99.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.959 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.528 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 34.1 mt-10 -63.01 -46.79 85.96 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.139 0.275 . . . . 0.0 111.586 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.859 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 20.5 m -62.0 -44.06 98.43 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.6 mt -56.66 -34.89 67.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.639 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.01 -27.64 48.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.327 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.93 -30.9 50.71 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.308 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.859 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.0 mt -77.83 -45.47 24.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.243 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -131.32 116.23 16.42 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.643 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -77.76 -32.73 2.57 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.637 2.891 . . . . 0.0 112.791 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.95 -14.52 55.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.374 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.98 149.5 24.73 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.382 0.426 . . . . 0.0 111.667 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.74 122.91 30.19 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.239 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.5 149.55 34.89 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.277 1.985 . . . . 0.0 112.374 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -94.59 -167.53 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.631 2.22 . . . . 0.0 112.56 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.94 -24.57 64.29 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.288 0.635 . . . . 0.0 112.095 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.421 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 11.6 ptp180 -67.9 -48.21 66.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 24.5 m -72.58 -26.13 61.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.169 0.587 . . . . 0.0 112.338 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -70.86 -27.54 63.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.674 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -95.39 16.72 16.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.61 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 53.9 mt -120.07 139.41 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.666 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.621 ' O ' HD13 ' A' ' 128' ' ' ILE . 1.8 m-20 -104.92 155.64 18.76 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.9 mm -107.17 150.45 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.206 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.722 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -119.2 157.08 28.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.588 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -87.98 122.2 31.3 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.526 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -102.0 -23.6 9.09 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 120.263 -0.97 . . . . 0.0 114.257 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.91 -167.81 34.87 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.289 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -88.75 -11.67 3.86 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.635 2.89 . . . . 0.0 114.421 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.09 131.85 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.569 0.223 . . . . 0.0 111.375 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.477 HE21 ' HH ' ' A' ' 132' ' ' TYR . 47.4 mt-30 45.18 89.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.632 1.173 . . . . 0.0 113.503 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -87.02 1.04 54.15 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.378 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -92.7 -18.31 23.14 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.594 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.17 147.44 52.06 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.373 0.421 . . . . 0.0 111.441 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.594 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -113.34 151.01 18.44 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.149 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.404 ' CE2' ' SD ' ' A' ' 107' ' ' MET . 1.2 m-85 -86.66 151.33 23.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.951 -1.124 . . . . 0.0 110.829 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 3.6 t -127.76 107.99 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.087 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 126' ' ' SER . 13.8 tp -104.93 127.74 52.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.619 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.407 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 3.4 p80 -124.37 162.18 43.59 Favored Pre-proline 0 CA--C 1.552 1.022 0 O-C-N 123.653 0.596 . . . . 0.0 111.59 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.0 Cg_endo -97.42 28.89 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.802 2.334 . . . . 0.0 113.579 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.407 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 18.0 t -115.69 156.73 25.39 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.63 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.74 23.18 35.31 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.817 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.01 153.17 21.49 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.472 0.309 . . . . 0.0 110.523 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.7 p -121.55 153.25 38.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.508 ' CG ' HG11 ' A' ' 113' ' ' VAL . 28.5 m-85 -132.89 -151.13 0.44 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.834 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -61.02 -48.69 80.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.791 0.436 . . . . 0.0 111.267 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.529 ' H ' ' HG ' ' A' ' 110' ' ' SER . 38.3 m -134.01 79.05 1.79 Allowed 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.243 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.3 m -126.72 115.95 20.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.956 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.49 122.18 42.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.859 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.97 128.45 34.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.095 0.474 . . . . 0.0 111.15 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.483 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.63 46.76 2.15 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.482 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.93 -107.6 2.02 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 114.819 -1.082 . . . . 0.0 113.25 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.88 -10.28 3.83 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.505 HD23 ' OH ' ' A' ' 31' ' ' TYR . 1.8 pp -155.06 153.15 30.46 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.335 0.397 . . . . 0.0 111.167 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.17 158.05 24.92 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.884 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.585 ' O ' ' HA ' ' A' ' 99' ' ' THR . 16.0 ttm -122.52 135.17 54.58 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 98' ' ' SER . 15.9 m -136.18 134.35 38.11 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 81.1 p -125.42 21.36 7.89 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.64 0.587 . . . . 0.0 111.836 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.849 ' O ' HG21 ' A' ' 113' ' ' VAL . 51.6 m -91.12 131.63 36.56 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.944 0.878 . . . . 0.0 112.885 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.471 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 5.2 mt-30 -61.91 -26.16 68.0 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.419 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.39 -45.45 90.99 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.493 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.849 HG21 ' O ' ' A' ' 110' ' ' SER . 18.6 m -62.28 -43.46 98.04 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.522 HD11 ' NH1' ' A' ' 85' ' ' ARG . 29.3 mt -54.82 -51.48 65.7 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.864 0.727 . . . . 0.0 112.177 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.471 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 43.2 m-85 -65.63 -45.64 82.28 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.4 -52.7 64.49 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.865 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.833 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.4 tp -64.22 -43.91 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.45 -31.18 65.67 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.793 0.683 . . . . 0.0 109.683 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.421 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -85.3 -20.43 30.03 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.156 176.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.26 18.01 22.96 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.731 -1.122 . . . . 0.0 114.581 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.2 p -109.42 7.83 25.11 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.25 -137.51 9.37 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.583 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.82 168.11 19.63 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.251 2.634 . . . . 0.0 113.519 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.475 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -50.94 -57.79 7.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.31 1.044 . . . . 0.0 111.789 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 124' ' ' GLU . 13.7 mmtt -138.48 157.27 46.52 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.619 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 40.8 m -149.99 162.89 39.48 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.9 tp -126.41 113.96 17.57 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.744 177.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 74' ' ' ASP . 10.1 pt -98.81 104.59 16.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.492 0.663 . . . . 0.0 109.507 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.3 t -125.0 124.88 42.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.508 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.59 ' O ' HD12 ' A' ' 130' ' ' LEU . 2.1 pp -67.12 117.2 8.82 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.095 0.474 . . . . 0.0 111.738 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.99 174.69 4.4 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.259 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.477 ' HH ' HE21 ' A' ' 82' ' ' GLN . 10.7 p90 -128.47 -179.87 5.28 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.334 0.588 . . . . 0.0 111.027 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 42' ' ' GLY . . . -116.31 130.63 56.87 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.227 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.55 153.01 19.75 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.488 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -134.17 137.87 44.76 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.84 0.377 . . . . 0.0 110.666 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -78.1 158.36 29.16 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.904 0.753 . . . . 0.0 110.822 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.79 92.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.28 7.72 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.134 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -56.01 -47.38 77.89 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.082 0.553 . . . . 0.0 112.125 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.561 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 16.3 tp -67.51 -46.45 72.85 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.31 -30.54 64.85 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.443 0.465 . . . . 0.0 110.693 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -71.06 -49.33 45.91 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.013 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -72.1 -26.76 62.26 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.749 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.1 tp -75.3 -38.73 60.16 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.84 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.6 m -78.03 -29.91 49.65 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.355 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.17 0.17 33.48 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.533 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 61.29 29.37 18.6 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.89 0.876 . . . . 0.0 111.712 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.94 -41.91 16.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.516 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -122.9 109.62 14.38 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.328 0.393 . . . . 0.0 110.113 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.01 128.46 34.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.387 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.1 p -102.33 141.81 34.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.039 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 80.2 m -155.37 158.6 31.97 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.315 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -57.44 153.93 38.45 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.215 1.943 . . . . 0.0 111.429 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.519 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.33 169.2 14.51 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -177.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -134.93 135.06 22.39 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 114.264 -1.334 . . . . 0.0 107.934 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.77 -26.59 13.37 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.64 2.226 . . . . 0.0 113.907 -177.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -51.95 -40.64 61.16 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.874 0.734 . . . . 0.0 112.284 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.551 HD12 HH12 ' A' ' 167' ' ' ARG . 4.6 mt -71.42 -34.49 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 121.378 0.609 . . . . 0.0 110.328 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.22 -38.47 63.54 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.253 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -84.25 -33.86 23.97 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -85.63 -72.67 0.48 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.026 0.375 . . . . 0.0 111.69 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.887 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.35 99.22 6.48 Favored Pre-proline 0 C--N 1.348 0.54 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.856 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.3 Cg_endo -92.02 -0.03 4.26 Favored 'Trans proline' 0 CA--C 1.57 2.301 0 C-N-CA 121.677 1.585 . . . . 0.0 114.26 175.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.63 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 88.0 Cg_endo -73.85 -52.55 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 122.63 2.22 . . . . 0.0 114.388 -178.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.54 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.61 -30.37 3.91 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.694 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.887 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -69.73 -11.14 60.62 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.303 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.551 HH12 HD12 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.54 -42.95 41.22 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -69.18 -50.68 45.37 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.2 m -57.76 -50.7 72.35 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.734 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.631 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -62.85 -38.57 91.36 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.07 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.27 -45.43 80.11 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.664 0.602 . . . . 0.0 110.441 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.45 91.04 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.552 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.36 -29.12 70.2 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.667 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.631 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.99 -40.19 39.95 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 122.865 0.466 . . . . 0.0 110.423 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.14 -34.02 76.67 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.485 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.771 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.272 179.477 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.656 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 7.0 mp . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -41.98 9.45 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.618 ' H ' ' C ' ' A' ' 9' ' ' LEU . 13.0 p-80 177.02 52.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.144 0.978 . . . . 0.0 110.513 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -141.82 166.08 25.7 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.759 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 30' ' ' THR . 14.2 m-30 -104.54 138.54 40.74 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.495 ' O ' HG12 ' A' ' 29' ' ' VAL . 6.4 mt -107.19 143.38 35.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.405 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 mp -123.47 137.71 55.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.462 0.476 . . . . 0.0 110.128 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.47 123.48 26.61 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.837 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 mmt -106.32 157.09 35.75 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.202 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.6 30.58 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.678 2.252 . . . . 0.0 113.248 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -87.32 -15.56 37.65 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.93 -168.35 1.41 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 123.075 0.234 . . . . 0.0 110.703 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.518 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.82 41.87 1.28 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.082 0.468 . . . . 0.0 111.628 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -111.32 81.05 2.78 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.916 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.3 Cg_exo -75.49 -22.24 14.18 Favored 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 123.017 2.478 . . . . 0.0 113.312 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -84.62 -36.3 22.11 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.875 0.47 . . . . 0.0 111.867 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.8 3.72 53.64 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.021 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.42 163.77 20.16 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 48.75 32.15 3.47 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.2 p -116.68 154.27 30.87 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 122.367 -0.208 . . . . 0.0 110.573 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.501 HG11 ' HE ' ' A' ' 167' ' ' ARG . 60.3 t -129.05 132.69 67.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-O 121.515 0.674 . . . . 0.0 110.857 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.2 m -114.48 154.39 28.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.691 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.406 ' OH ' HD21 ' A' ' 105' ' ' LEU . 13.2 t80 -110.22 115.7 30.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.656 ' HB3' ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -81.08 110.63 16.79 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.684 0.754 . . . . 0.0 110.566 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.432 ' CG2' ' HA2' ' A' ' 42' ' ' GLY . 32.2 t -71.18 -63.93 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 112.819 -1.991 . . . . 0.0 110.614 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' OE1' HD13 ' A' ' 100' ' ' LEU . 12.3 tt0 -132.51 117.63 18.24 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.96 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.593 ' ND1' ' H ' ' A' ' 9' ' ' LEU . 12.9 t-80 -106.92 127.91 53.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.733 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -138.9 153.45 48.27 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.22 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -64.82 -15.63 62.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -104.88 5.41 32.93 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.687 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.6 164.72 12.64 Favored Glycine 0 C--N 1.344 1.015 0 C-N-CA 121.486 -0.388 . . . . 0.0 112.35 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.402 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -144.73 146.46 32.19 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.529 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -125.97 137.58 53.69 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.954 178.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.432 ' HA2' ' CG2' ' A' ' 33' ' ' VAL . . . -158.72 159.95 30.66 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.83 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.431 HD21 ' C ' ' A' ' 42' ' ' GLY . 3.4 mt -114.62 130.66 56.81 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.703 0.252 . . . . 0.0 110.837 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 78' ' ' GLY . 20.7 t -65.96 125.39 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.537 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -128.44 55.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.542 0.686 . . . . 0.0 112.408 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.845 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.8 t-20 -147.63 -3.61 0.53 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.265 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.419 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 3.0 ttm180 -129.78 87.84 51.05 Favored Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.483 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 35.3 Cg_exo -59.09 141.91 98.73 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 121.578 1.518 . . . . 0.0 112.277 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.447 ' HG ' ' C ' ' A' ' 76' ' ' TYR . 59.9 m -88.64 161.96 16.59 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.364 0.415 . . . . 0.0 111.561 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.96 44.69 1.43 Allowed Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.37 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.446 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.97 150.95 50.44 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.1 p-10 -100.52 161.4 13.62 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.268 0.355 . . . . 0.0 110.939 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.454 HD22 ' SG ' ' A' ' 70' ' ' CYS . 12.3 tp -58.7 -37.58 76.4 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.16 -37.14 53.64 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.96 -43.68 95.05 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.206 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.845 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 1.3 t -62.8 -45.77 98.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.406 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 4.5 mp -54.55 -36.51 64.4 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.702 0.626 . . . . 0.0 110.618 177.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.9 -27.86 49.65 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.466 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -78.16 -30.14 49.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.283 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.845 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.9 mt -77.75 -45.12 25.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.945 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -132.26 116.24 15.32 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.524 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.62 -32.64 2.71 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.604 2.869 . . . . 0.0 112.769 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.3 -14.15 55.84 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.361 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.86 149.68 24.65 Favored 'General case' 0 C--N 1.345 0.389 0 O-C-N 123.323 0.389 . . . . 0.0 111.754 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.65 123.88 29.98 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.02 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.82 144.68 35.25 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.226 1.951 . . . . 0.0 112.408 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.6 Cg_endo -92.52 -170.98 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.566 2.177 . . . . 0.0 111.974 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.502 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -63.37 -24.89 68.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.297 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -66.15 -54.17 28.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.454 ' SG ' HD22 ' A' ' 53' ' ' LEU . 61.3 m -71.58 -25.05 62.03 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 50.4 mt-30 -66.91 -36.02 81.32 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.502 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 19.9 p80 -91.55 23.18 3.6 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.147 0.498 . . . . 0.0 111.65 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 56.8 mt -119.47 140.04 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.517 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.611 ' O ' HD13 ' A' ' 128' ' ' ILE . 1.6 m-20 -109.56 154.91 22.08 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.692 0.62 . . . . 0.0 112.498 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 51' ' ' LEU . 24.4 mm -103.53 153.66 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.093 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.692 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -117.31 155.95 28.65 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.57 118.92 26.3 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.844 0.293 . . . . 0.0 110.698 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -103.08 -23.62 8.46 Favored Glycine 0 C--N 1.348 1.242 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.976 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.76 -167.9 35.4 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.293 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -88.35 -11.38 4.31 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 123.313 2.675 . . . . 0.0 114.263 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.61 126.91 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 123.12 0.263 . . . . 0.0 110.893 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 48.81 82.16 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.309 1.043 . . . . 0.0 112.91 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.454 ' O ' HD23 ' A' ' 130' ' ' LEU . 9.1 t -84.75 1.55 46.14 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -99.13 -0.66 41.22 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.586 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.09 153.27 51.66 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.198 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.586 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.83 133.34 11.6 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.434 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.754 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.8 OUTLIER -85.75 150.87 24.27 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.321 1.048 . . . . 0.0 110.288 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.1 t -127.11 104.81 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 123.429 0.455 . . . . 0.0 111.039 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.598 ' HB2' ' SD ' ' A' ' 107' ' ' MET . 15.2 tp -106.67 127.66 53.54 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.821 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.454 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 4.4 p80 -129.14 169.44 13.1 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.38 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.632 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.6 Cg_endo -97.13 18.06 0.55 Allowed 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.65 2.233 . . . . 0.0 113.52 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.454 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 8.4 t -105.85 159.73 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.951 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.2 20.62 49.31 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.501 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -84.21 154.44 23.04 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.645 0.378 . . . . 0.0 110.438 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.0 p -126.78 157.22 39.75 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.569 ' CE2' HG22 ' A' ' 113' ' ' VAL . 53.0 m-85 -129.51 -150.9 0.45 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.418 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -60.2 -46.84 88.36 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.418 0.287 . . . . 0.0 111.25 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.8 m -135.63 83.05 1.99 Allowed 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.338 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 107' ' ' MET . 7.8 m -129.34 124.39 34.17 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.868 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.416 HD13 ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.93 123.94 46.7 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.902 178.627 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -88.74 130.56 35.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.103 0.478 . . . . 0.0 110.748 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.14 48.67 2.18 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.314 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.47 -106.76 1.64 Allowed Glycine 0 C--N 1.334 0.433 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.279 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.06 -10.18 4.0 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.406 HD21 ' OH ' ' A' ' 31' ' ' TYR . 2.5 pp -155.44 155.19 33.09 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.206 0.317 . . . . 0.0 111.561 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -125.14 157.73 35.66 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.875 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.598 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 27.0 tpp -125.33 141.25 52.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -134.15 133.53 41.12 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.916 0.388 . . . . 0.0 110.275 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.0 p -118.3 16.41 13.95 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.985 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.477 ' O ' HG13 ' A' ' 113' ' ' VAL . 32.9 p -91.51 126.93 36.76 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 121.681 0.753 . . . . 0.0 111.686 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.499 ' HA ' ' NH2' ' A' ' 85' ' ' ARG . 20.3 pt20 -60.87 -26.91 67.73 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.602 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -66.11 -41.06 91.08 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.585 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.735 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.2 p -69.85 -39.74 78.09 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.582 HD23 ' NH2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -58.03 -47.64 82.48 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 123.672 0.608 . . . . 0.0 110.457 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.479 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 25.9 m-85 -69.72 -38.39 76.89 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.924 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.94 -52.1 65.42 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.0 tp -64.66 -42.99 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.173 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.38 -31.04 65.39 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.83 0.706 . . . . 0.0 109.627 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.35 -20.26 30.2 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.167 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.59 15.17 30.22 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 114.626 -1.17 . . . . 0.0 114.735 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.2 p -105.34 7.66 33.43 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.58 -137.52 9.47 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-O 119.093 -0.837 . . . . 0.0 112.598 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.41 171.56 14.67 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.167 2.578 . . . . 0.0 113.615 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.82 -55.64 31.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.776 0.83 . . . . 0.0 112.159 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.632 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.2 mmtt -140.72 139.82 34.77 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.728 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.8 m -140.26 168.35 20.01 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 tp -127.9 119.3 25.3 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.794 -1.093 . . . . 0.0 108.734 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 15.8 pt -98.26 102.0 12.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.852 0.834 . . . . 0.0 109.814 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.1 t -117.88 122.75 44.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.37 -1.287 . . . . 0.0 110.925 -178.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 83' ' ' THR . 6.1 tp -66.64 114.94 5.95 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.327 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.29 178.16 6.95 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 114.442 -1.254 . . . . 0.0 114.562 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.6 176.81 7.48 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.367 0.603 . . . . 0.0 110.8 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -117.39 130.11 56.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.927 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.44 149.73 18.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.601 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.402 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 20.1 m-90 -126.46 135.96 52.02 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 124.022 0.483 . . . . 0.0 110.235 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.39 158.09 27.46 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.844 0.715 . . . . 0.0 110.766 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.57 90.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.92 -25.06 6.9 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.997 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -56.07 -45.63 79.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.984 0.514 . . . . 0.0 112.058 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.542 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 10.5 tp -66.97 -48.28 69.0 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.22 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.47 -30.26 64.91 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 123.451 0.469 . . . . 0.0 110.861 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.4 -50.7 35.88 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.903 178.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -71.65 -26.61 62.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.026 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 6.1 tp -76.05 -38.48 57.07 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.898 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.0 m -77.98 -30.85 50.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -80.9 0.5 35.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.571 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.45 29.16 18.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.853 0.861 . . . . 0.0 111.735 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.82 -42.52 24.2 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.051 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -123.02 113.0 18.47 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.46 0.475 . . . . 0.0 109.752 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.3 tp -82.76 142.14 31.82 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.408 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 25.3 p -105.0 135.77 45.72 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.088 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 79.5 m -149.22 148.68 27.42 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.24 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.55 153.7 64.83 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.325 2.016 . . . . 0.0 110.772 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -134.75 174.58 10.42 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -135.02 138.89 30.48 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.322 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.58 -26.66 16.33 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 122.686 2.257 . . . . 0.0 113.561 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.84 -41.02 57.37 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.967 0.792 . . . . 0.0 112.451 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.691 HD11 HH12 ' A' ' 167' ' ' ARG . 4.3 mt -69.94 -34.38 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.569 0.7 . . . . 0.0 110.395 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.5 tt -75.71 -36.82 59.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.462 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -84.8 -32.15 23.51 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -88.83 -72.88 0.52 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.982 0.356 . . . . 0.0 111.714 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -141.27 99.26 6.52 Favored Pre-proline 0 C--N 1.349 0.584 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.845 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 73.1 Cg_endo -91.74 -0.43 4.44 Favored 'Trans proline' 0 CA--C 1.571 2.331 0 C-N-CA 121.831 1.687 . . . . 0.0 114.421 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.634 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 69.2 Cg_endo -75.09 -50.01 0.14 Allowed 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.73 2.287 . . . . 0.0 114.532 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.527 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.5 mt-10 -122.22 -34.02 3.39 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.792 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.648 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 8.6 mt-10 -69.01 -10.99 60.31 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.219 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.691 HH12 HD11 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -77.03 -41.55 42.12 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.176 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -70.85 -49.58 44.56 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 t -58.29 -48.03 81.78 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.644 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.57 -40.37 92.7 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.578 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.62 82.77 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.409 0.443 . . . . 0.0 110.582 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.91 -37.29 85.7 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.795 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.56 71.67 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.497 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 3.4 mmp_? -77.67 -40.33 41.93 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.802 0.441 . . . . 0.0 110.372 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.36 -33.94 76.85 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.526 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.759 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.133 179.454 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.542 HD11 ' CE1' ' A' ' 35' ' ' HIS . 11.2 mt . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 120.671 0.272 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -92.68 23.01 4.31 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.964 0.412 . . . . 0.0 110.841 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.576 ' CE1' ' HH ' ' A' ' 31' ' ' TYR . 14.4 t-80 177.08 51.99 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.775 0.83 . . . . 0.0 110.0 -177.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -136.87 160.22 39.52 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 15.1 m-30 -98.17 137.46 36.9 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.267 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.565 ' O ' HG13 ' A' ' 29' ' ' VAL . 3.6 mt -108.63 137.03 47.25 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.033 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mm -117.38 133.79 63.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 123.519 0.512 . . . . 0.0 109.713 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.09 123.03 23.63 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.598 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.9 mmt -114.46 155.12 46.32 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 123.463 0.477 . . . . 0.0 111.341 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -80.68 79.28 3.36 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.652 2.235 . . . . 0.0 112.935 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -136.38 -20.65 1.39 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.994 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -163.29 0.87 Allowed 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.182 0.301 . . . . 0.0 110.431 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.522 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.61 35.84 2.48 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.01 0.433 . . . . 0.0 111.9 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.483 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.32 82.87 3.69 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.36 -24.6 12.11 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.006 2.471 . . . . 0.0 113.316 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -85.2 -37.38 20.19 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.469 0.481 . . . . 0.0 111.619 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.58 -0.53 57.6 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.794 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 22' ' ' ASP . . . -63.5 2.81 0.38 Allowed 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -141.22 40.12 1.76 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.172 0.51 . . . . 0.0 112.237 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 p -123.28 158.04 31.83 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.562 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 14' ' ' LEU . 60.6 t -131.32 132.88 62.79 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.005 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -114.9 152.01 33.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.266 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.576 ' HH ' ' CE1' ' A' ' 11' ' ' HIS . 36.0 t80 -105.95 120.48 41.87 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -84.76 108.32 17.39 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.447 0.642 . . . . 0.0 111.304 -178.387 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.464 ' O ' HD22 ' A' ' 102' ' ' LEU . 24.0 t -67.42 -59.92 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.786 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -144.68 112.64 6.35 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.31 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.542 ' CE1' HD11 ' A' ' 9' ' ' LEU . 15.6 t-80 -95.84 128.74 42.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.606 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -139.85 153.37 47.03 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.624 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.53 -18.39 65.28 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.725 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.33 2.22 42.3 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.418 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.88 167.2 15.21 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.456 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -144.82 136.43 25.49 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.45 ' HE2' ' O ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -114.97 134.37 55.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.399 178.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 133' ' ' ALA . . . -157.9 155.01 26.05 Favored Glycine 0 N--CA 1.45 -0.425 0 O-C-N 124.195 0.935 . . . . 0.0 112.5 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 mt -110.95 133.32 53.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.022 0.411 . . . . 0.0 111.194 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.527 HG21 ' O ' ' A' ' 78' ' ' GLY . 20.5 t -69.34 124.61 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -128.24 56.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.47 0.653 . . . . 0.0 112.276 -177.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.854 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.7 t-20 -147.9 -3.5 0.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.491 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.73 87.75 51.48 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.486 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -59.63 142.51 98.93 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 121.695 1.596 . . . . 0.0 112.177 175.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.427 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 50.2 m -92.73 158.67 15.79 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.504 0.502 . . . . 0.0 111.572 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.44 50.15 1.29 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.67 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mt -133.34 159.14 41.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.226 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.609 ' ND2' ' HB2' ' A' ' 54' ' ' ALA . 7.4 p-10 -112.48 157.71 20.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.621 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.446 ' O ' HG21 ' A' ' 56' ' ' VAL . 1.9 tt -58.5 -26.95 64.01 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.956 0.408 . . . . 0.0 111.765 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.609 ' HB2' ' ND2' ' A' ' 52' ' ' ASN . . . -65.12 -39.97 93.82 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.645 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.71 -46.66 84.45 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.289 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.852 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 19.2 m -62.12 -43.81 98.25 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.8 mt -56.13 -35.13 66.77 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.487 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.05 -27.75 48.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.425 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.427 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.89 -30.57 50.79 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.339 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.852 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.94 -45.58 23.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -131.12 116.31 16.68 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.58 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.63 -32.97 2.54 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 123.677 2.918 . . . . 0.0 112.732 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.86 -14.62 56.0 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.334 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.36 149.94 24.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.445 0.466 . . . . 0.0 111.722 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.3 122.42 29.46 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.184 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.87 153.92 38.12 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.25 1.966 . . . . 0.0 112.299 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.451 ' HD2' ' HG ' ' A' ' 70' ' ' CYS . 8.4 Cg_endo -95.07 -166.0 0.12 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.67 2.247 . . . . 0.0 112.387 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.26 -24.58 62.2 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.311 0.644 . . . . 0.0 111.921 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 73' ' ' ILE . 10.5 ptp180 -67.39 -47.7 69.56 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.451 ' HG ' ' HD2' ' A' ' 67' ' ' PRO . 29.4 m -71.59 -26.02 62.43 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -72.83 -26.89 61.65 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.402 0.62 . . . . 0.0 111.511 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -92.87 15.84 13.88 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.057 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 44.6 mt -122.08 139.55 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.582 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.7 m-20 -108.01 153.55 22.94 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.0 mm -99.78 153.07 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.88 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.687 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.4 t80 -119.98 155.67 32.38 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.16 120.36 27.45 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 117.733 0.242 . . . . 0.0 110.572 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.527 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -102.16 -23.74 8.91 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.949 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.24 -168.48 34.65 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.291 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -88.73 -11.52 3.93 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.546 2.831 . . . . 0.0 114.366 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.56 131.29 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.709 0.29 . . . . 0.0 111.418 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 48.2 86.25 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.532 1.133 . . . . 0.0 113.232 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.9 p -81.74 -18.87 42.77 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.151 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -76.92 -18.1 58.5 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.58 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.97 147.83 52.28 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.0 0.428 . . . . 0.0 111.558 179.526 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.58 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -112.41 141.33 16.73 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.776 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.23 134.44 33.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.65 -1.275 . . . . 0.0 109.493 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 4.8 t -116.31 128.52 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 123.067 0.23 . . . . 0.0 111.376 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.551 HD12 ' SD ' ' A' ' 107' ' ' MET . 13.4 tp -114.23 127.64 55.98 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.608 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.479 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 4.9 p80 -122.01 162.84 35.08 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.18 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -97.52 31.15 0.14 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.588 2.192 . . . . 0.0 113.403 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.479 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 19.5 t -118.33 156.74 28.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.651 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.49 22.13 42.48 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.71 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tp -87.71 153.5 21.31 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.526 0.33 . . . . 0.0 110.479 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.8 p -122.84 153.17 39.94 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.538 ' CD2' HG13 ' A' ' 113' ' ' VAL . 25.6 m-85 -132.99 -149.05 0.36 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.862 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -60.33 -48.91 79.71 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 122.834 0.453 . . . . 0.0 111.395 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 108' ' ' SER . 57.9 m -135.38 80.29 1.83 Allowed 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.434 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.688 ' HG1' ' HG ' ' A' ' 108' ' ' SER . 7.9 m -126.6 116.85 21.67 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.867 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.96 122.16 40.75 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.098 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.35 130.36 34.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.128 0.489 . . . . 0.0 111.135 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.464 HD22 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -127.4 48.64 2.2 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.354 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.42 -109.82 3.12 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.169 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.44 -8.9 4.58 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.507 HD23 ' OH ' ' A' ' 31' ' ' TYR . 2.2 pp -153.34 150.23 28.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.285 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -120.81 160.61 23.04 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.812 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.568 ' O ' ' HA ' ' A' ' 99' ' ' THR . 17.1 tpp -126.46 142.22 51.61 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.688 ' HG ' ' HG1' ' A' ' 99' ' ' THR . 54.3 m -137.32 136.62 38.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.73 0.3 . . . . 0.0 110.478 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.7 p -123.03 18.72 10.05 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.383 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 113' ' ' VAL . 14.5 t -92.31 130.11 38.08 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 122.044 0.926 . . . . 0.0 112.564 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.465 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 4.8 mt-30 -61.48 -26.27 67.79 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.725 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -62.54 -47.14 85.2 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.527 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.841 ' O ' HG22 ' A' ' 117' ' ' ILE . 21.0 m -62.2 -43.12 97.52 Favored 'Isoleucine or valine' 0 C--N 1.36 1.043 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 177.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.527 HD11 ' NH1' ' A' ' 85' ' ' ARG . 22.0 mt -54.57 -50.58 67.63 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.718 0.636 . . . . 0.0 111.984 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.465 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 37.2 m-85 -65.6 -47.2 76.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.771 0.319 . . . . 0.0 111.23 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.08 -52.99 63.23 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.138 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.841 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.02 -43.3 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.75 -30.48 65.63 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 123.618 0.574 . . . . 0.0 109.662 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.21 -19.64 29.72 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.174 176.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.75 17.19 26.57 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 114.652 -1.158 . . . . 0.0 114.904 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.7 p -107.88 8.14 28.45 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -98.17 -136.51 9.26 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-O 119.195 -0.78 . . . . 0.0 112.527 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.78 169.9 19.94 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.333 2.688 . . . . 0.0 113.161 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -51.5 -58.36 6.51 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.695 0.798 . . . . 0.0 110.863 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -133.66 168.41 18.73 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.452 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.6 p -152.52 156.9 40.28 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.8 tp -125.68 106.09 9.47 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.582 HD11 ' O ' ' A' ' 74' ' ' ASP . 15.7 pt -92.82 102.62 13.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.812 0.815 . . . . 0.0 110.044 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.401 ' HG ' ' N ' ' A' ' 78' ' ' GLY . 4.0 t -122.45 122.64 39.43 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.255 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.12 117.07 8.65 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.198 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.435 ' H ' ' HA2' ' A' ' 86' ' ' GLY . . . 66.38 172.94 4.95 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.366 -0.833 . . . . 0.0 114.307 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -128.11 -179.06 4.79 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.231 0.538 . . . . 0.0 110.824 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -116.81 128.98 55.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.246 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.25 148.83 18.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.379 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.456 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 22.3 m-90 -127.14 137.86 53.05 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.803 0.354 . . . . 0.0 110.435 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.85 158.02 26.86 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.818 0.699 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.14 92.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.32 -24.72 8.05 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.177 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -57.57 -44.38 85.27 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.87 0.468 . . . . 0.0 112.15 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.573 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.9 tm? -68.07 -47.64 67.73 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.502 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.21 -30.12 67.99 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.013 0.435 . . . . 0.0 110.644 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.17 -49.91 45.66 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.887 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.55 -26.63 63.64 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.84 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.6 tp -74.71 -38.91 62.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.593 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.0 m -77.88 -28.44 49.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.296 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -81.93 -0.92 46.07 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.553 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 61.19 29.55 18.83 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.801 0.841 . . . . 0.0 111.744 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.53 -43.6 15.55 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.829 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -124.62 113.4 17.99 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.5 tp -84.67 140.43 31.32 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.442 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.4 p -104.61 137.42 42.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.17 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 73.2 m -152.46 155.87 33.12 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.629 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.21 157.66 29.33 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.319 2.013 . . . . 0.0 111.191 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.36 168.32 17.12 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -136.31 135.03 20.33 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 114.405 -1.27 . . . . 0.0 107.84 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.27 -26.57 14.45 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.582 2.188 . . . . 0.0 113.695 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.68 -40.5 62.97 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.768 0.667 . . . . 0.0 112.329 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.55 HD13 HH12 ' A' ' 167' ' ' ARG . 4.8 mt -71.06 -35.37 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-O 121.375 0.607 . . . . 0.0 110.354 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -73.88 -38.58 64.37 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.051 -1.431 . . . . 0.0 111.392 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -84.77 -33.44 23.02 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.35 -72.34 0.49 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.047 0.385 . . . . 0.0 111.532 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.879 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.3 99.52 6.46 Favored Pre-proline 0 C--N 1.348 0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 112.349 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.854 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 73.0 Cg_endo -91.45 -0.68 4.63 Favored 'Trans proline' 0 CA--C 1.569 2.254 0 C-N-CA 121.721 1.614 . . . . 0.0 114.304 175.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.629 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 73.9 Cg_endo -74.37 -52.62 0.12 Allowed 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.643 2.229 . . . . 0.0 114.48 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.547 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.6 mt-10 -122.29 -30.33 4.01 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.75 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.879 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.0 tt0 -69.78 -11.59 60.97 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.367 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.55 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.63 -41.7 44.95 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.272 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.36 -50.28 40.54 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.349 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.8 m -58.09 -49.45 76.91 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.651 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.65 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.26 -39.95 94.99 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.209 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.09 -46.58 79.0 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 123.545 0.528 . . . . 0.0 110.587 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.67 88.33 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.51 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.24 -28.26 69.24 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.492 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.65 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.75 -40.14 42.0 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 122.835 0.454 . . . . 0.0 110.303 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.98 -32.03 70.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.489 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.755 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.94 179.505 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 mt . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 120.924 0.392 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -91.23 20.21 5.28 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.846 0.355 . . . . 0.0 111.276 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.2 p80 176.71 52.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.99 0.916 . . . . 0.0 110.257 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -133.2 160.43 37.27 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.716 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 14.4 m-30 -95.59 135.01 37.81 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.531 ' O ' HG13 ' A' ' 29' ' ' VAL . 1.6 mm? -108.04 139.92 41.97 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.525 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.58 134.43 66.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 O-C-N 123.545 0.528 . . . . 0.0 109.936 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.33 133.21 35.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.479 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 24.5 mmt -123.2 157.36 61.28 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.03 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.22 78.01 3.61 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.563 2.175 . . . . 0.0 112.879 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -135.53 -21.79 1.52 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.875 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.53 -162.89 0.86 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 123.209 0.318 . . . . 0.0 110.493 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.53 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.39 30.89 4.64 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.1 m-20 -110.85 83.29 3.49 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.1 Cg_exo -75.37 -20.7 15.9 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.069 2.513 . . . . 0.0 113.417 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -84.93 -39.04 18.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 122.833 0.453 . . . . 0.0 111.649 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.27 -2.72 56.28 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.76 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -61.0 2.29 0.12 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -142.28 38.95 1.57 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.167 0.508 . . . . 0.0 112.03 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 p -123.22 158.45 30.83 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.625 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 14' ' ' LEU . 99.4 t -130.57 131.45 64.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.896 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 2.3 m -113.15 154.55 26.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.363 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.414 ' OH ' HD21 ' A' ' 105' ' ' LEU . 43.3 t80 -106.66 119.93 40.62 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.34 106.86 14.56 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 123.595 0.559 . . . . 0.0 111.391 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.523 ' O ' HD22 ' A' ' 102' ' ' LEU . 34.3 t -67.69 -57.98 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.597 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -144.56 118.84 9.55 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.187 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -99.05 128.12 45.13 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.875 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -139.25 152.44 47.3 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.586 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -62.58 -24.19 67.42 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.644 0.378 . . . . 0.0 111.781 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -93.17 -3.72 53.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 123.492 0.495 . . . . 0.0 111.498 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.3 173.72 24.35 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 121.518 -0.373 . . . . 0.0 112.274 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.85 141.53 26.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -114.55 134.7 54.84 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.09 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.589 ' O ' ' HB2' ' A' ' 133' ' ' ALA . . . -157.26 157.64 28.25 Favored Glycine 0 N--CA 1.443 -0.844 0 O-C-N 124.215 0.947 . . . . 0.0 112.618 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 mt -112.32 128.72 56.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.925 0.363 . . . . 0.0 110.511 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.441 HG11 ' C ' ' A' ' 78' ' ' GLY . 11.1 p -68.29 125.97 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.536 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.05 57.76 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.725 0.774 . . . . 0.0 112.059 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.829 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.6 t-20 -146.28 -1.7 0.72 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.032 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -130.2 88.26 48.56 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.485 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 40.9 Cg_exo -58.67 145.94 93.76 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 121.711 1.607 . . . . 0.0 112.48 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.43 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 73.1 m -96.38 160.23 14.52 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.554 0.534 . . . . 0.0 111.489 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.94 51.53 0.9 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.636 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.479 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -133.35 154.02 51.09 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.929 0.429 . . . . 0.0 110.03 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.592 ' ND2' ' HB2' ' A' ' 54' ' ' ALA . 10.4 p-10 -112.45 157.7 20.76 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.822 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.407 ' O ' HG21 ' A' ' 56' ' ' VAL . 2.4 tt -57.53 -26.74 61.82 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.592 ' HB2' ' ND2' ' A' ' 52' ' ' ASN . . . -67.54 -40.87 84.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.419 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.1 -45.51 88.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.17 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.849 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.1 m -62.04 -44.96 99.66 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.8 mt -56.16 -35.15 66.86 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.494 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.05 -27.25 48.68 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.313 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.423 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.77 -30.46 51.42 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.334 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.849 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.79 -45.91 23.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.099 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -131.22 116.75 16.68 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.52 -33.05 2.58 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.674 2.916 . . . . 0.0 112.78 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.71 -14.99 55.83 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.376 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.99 149.47 24.75 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 123.327 0.392 . . . . 0.0 111.636 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.71 123.21 29.26 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.303 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.61 153.48 38.99 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.298 1.999 . . . . 0.0 112.264 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.42 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 6.6 Cg_endo -94.01 -165.07 0.12 Allowed 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.596 2.198 . . . . 0.0 112.119 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.452 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -71.83 -24.74 61.76 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.134 0.574 . . . . 0.0 111.888 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.457 ' HD3' ' O ' ' A' ' 118' ' ' ALA . 12.0 ptp180 -67.33 -46.06 74.57 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 17.5 m -73.82 -25.54 60.15 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 46.8 mt-30 -70.63 -27.62 64.2 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.452 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 25.0 p80 -97.9 20.42 12.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.089 0.471 . . . . 0.0 111.606 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 62.8 mt -118.72 136.76 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.255 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.577 ' O ' HD12 ' A' ' 128' ' ' ILE . 2.2 m-20 -104.83 163.94 12.14 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 51' ' ' LEU . 14.3 mm -115.23 152.69 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.022 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.735 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.5 t80 -116.49 155.1 29.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.895 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.72 125.03 31.48 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 131' ' ' GLY . . . -104.14 -23.53 8.06 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.741 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.86 -167.95 33.3 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.186 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -88.55 -10.38 4.52 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.434 2.756 . . . . 0.0 114.262 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.84 131.34 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 123.08 0.237 . . . . 0.0 111.206 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 45.06 82.98 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.537 1.135 . . . . 0.0 113.385 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.2 p -81.66 -14.6 56.44 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.198 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.91 -17.13 59.13 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.748 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.626 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.61 148.2 52.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.927 0.394 . . . . 0.0 111.882 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.626 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.71 148.48 17.68 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.404 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.5 m-85 -86.84 150.76 23.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.913 -1.144 . . . . 0.0 111.115 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 21.6 t -128.22 105.69 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.163 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 126' ' ' SER . 13.6 tp -106.26 127.95 53.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.456 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.416 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 3.7 p80 -128.43 166.34 25.04 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.421 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.665 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.34 25.22 0.25 Allowed 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.691 2.261 . . . . 0.0 113.691 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.416 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 13.0 t -112.98 158.83 19.77 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.624 -178.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.27 22.94 34.13 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.653 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.27 150.51 22.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.502 0.321 . . . . 0.0 110.534 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.7 m -128.47 157.09 42.1 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.146 0.498 . . . . 0.0 112.189 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.688 ' H ' ' HG1' ' A' ' 99' ' ' THR . 57.6 m-85 -126.81 -150.88 0.46 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.8 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -59.07 -46.87 87.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.595 0.358 . . . . 0.0 111.338 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.8 m -132.58 80.3 1.89 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.943 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.688 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 47.2 m -128.7 121.15 27.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.153 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.5 123.57 46.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.861 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.58 127.82 34.04 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.764 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -120.58 43.11 2.83 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.798 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.61 -100.57 0.28 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.424 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -55.61 -14.83 2.36 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.414 HD21 ' OH ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -160.0 159.87 32.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.907 0.483 . . . . 0.0 110.687 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.73 156.98 28.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.846 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.531 ' O ' HG21 ' A' ' 99' ' ' THR . 16.1 ttm -123.91 134.64 53.49 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 m -136.68 133.72 36.47 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.7 p -127.97 19.7 6.52 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.007 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.762 ' O ' HG12 ' A' ' 113' ' ' VAL . 42.2 p -90.61 130.9 36.58 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.306 0.574 . . . . 0.0 112.021 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.49 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 7.9 mt-30 -57.95 -26.9 62.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.777 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -64.53 -40.02 94.84 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.119 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.762 HG12 ' O ' ' A' ' 110' ' ' SER . 2.7 p -71.49 -38.5 68.39 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.409 HD11 HH12 ' A' ' 85' ' ' ARG . 4.5 mm? -55.77 -49.84 72.07 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.578 0.549 . . . . 0.0 110.495 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.49 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 39.2 m-85 -68.01 -40.79 82.93 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.405 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.64 -53.95 51.23 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.679 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.3 tp -64.56 -43.96 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.457 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.56 -32.31 65.05 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.665 0.603 . . . . 0.0 109.703 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.43 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.38 -20.55 31.75 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.365 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.35 17.23 25.02 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.8 -1.091 . . . . 0.0 114.472 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 p -108.26 8.39 27.79 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -93.84 -138.01 8.83 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 119.204 -0.776 . . . . 0.0 112.863 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.37 165.76 16.34 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.146 2.564 . . . . 0.0 113.998 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.496 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -49.94 -60.14 3.2 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.482 1.113 . . . . 0.0 111.76 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.665 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -140.1 139.72 35.9 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 37.2 p -139.25 169.41 17.82 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.2 tp -125.61 115.81 20.73 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.45 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.577 HD12 ' O ' ' A' ' 74' ' ' ASP . 8.6 pt -99.25 104.98 16.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.3 t -124.16 121.99 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.035 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.0 tp -67.21 113.06 4.84 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.379 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.502 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 72.75 170.51 17.06 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.158 -0.928 . . . . 0.0 114.283 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -128.66 177.77 6.8 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.206 0.526 . . . . 0.0 110.809 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -114.94 131.73 56.79 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.937 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.33 144.05 15.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.598 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -122.15 131.68 54.08 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.046 0.498 . . . . 0.0 110.597 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -78.94 159.19 27.83 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.53 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.16 124.05 10.77 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.671 0.388 . . . . 0.0 111.497 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.27 -28.02 8.64 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.017 -0.611 . . . . 0.0 114.128 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -56.71 -48.88 76.75 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.526 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.0 tp -67.8 -47.77 68.16 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.673 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.83 -31.57 64.88 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.456 0.472 . . . . 0.0 110.814 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.88 -50.35 43.29 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.044 178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -72.29 -26.64 62.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.4 tp -75.65 -38.49 58.81 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.738 0.815 . . . . 0.0 110.784 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.7 m -78.12 -31.09 49.75 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.444 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -80.8 0.4 35.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.649 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 60.13 28.68 18.27 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.908 0.883 . . . . 0.0 111.749 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.99 -43.16 22.49 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.831 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -126.29 116.48 21.31 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -84.72 150.34 25.17 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.8 p -110.78 136.29 50.07 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.363 0.414 . . . . 0.0 110.915 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 74.9 m -151.83 154.87 33.42 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.54 159.04 25.12 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.284 1.989 . . . . 0.0 111.104 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.89 166.09 21.65 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -134.95 134.16 21.57 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 114.368 -1.287 . . . . 0.0 107.863 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.51 -26.43 16.79 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.596 2.198 . . . . 0.0 113.663 -177.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.8 -39.97 62.82 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 123.871 0.732 . . . . 0.0 112.056 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.547 HD13 HH12 ' A' ' 167' ' ' ARG . 4.2 mt -72.27 -35.66 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.363 0.602 . . . . 0.0 110.392 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.61 -37.41 65.43 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.412 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -86.67 -33.75 19.99 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -85.78 -72.33 0.49 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.052 0.387 . . . . 0.0 111.666 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.906 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.75 98.11 6.44 Favored Pre-proline 0 C--N 1.349 0.584 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.829 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 59.5 Cg_endo -92.76 1.2 3.77 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 C-N-CA 121.719 1.613 . . . . 0.0 114.258 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.623 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 80.4 Cg_endo -74.1 -52.14 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.561 2.174 . . . . 0.0 114.224 -178.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.533 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.97 -29.79 3.88 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.658 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.906 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.5 tt0 -70.36 -10.13 58.18 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.247 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.547 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -77.01 -38.2 53.52 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.135 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.7 tt -74.01 -49.58 23.7 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.3 m -58.41 -46.72 85.89 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.487 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.651 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -67.14 -40.66 86.78 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.397 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.15 -45.98 79.43 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 123.362 0.414 . . . . 0.0 110.446 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.99 -38.65 91.87 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.487 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.87 69.25 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.595 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.651 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.69 -40.23 42.14 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 122.931 0.492 . . . . 0.0 110.26 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.0 -31.19 67.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.529 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.776 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.884 179.524 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 C--O 1.236 0.373 0 CA-C-O 120.585 0.231 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.516 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 14.2 ptmt -95.16 27.65 3.15 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.494 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 176.44 51.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.563 0.745 . . . . 0.0 110.91 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -134.04 159.39 40.95 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.452 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 30' ' ' THR . 12.3 m-30 -98.58 138.33 35.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.168 0.509 . . . . 0.0 112.15 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.9 mp -109.89 135.41 50.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.565 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 mp -120.04 130.72 73.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.53 127.63 33.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.012 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.6 mmt -112.28 154.62 44.37 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.171 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -79.96 72.57 6.45 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.561 2.174 . . . . 0.0 112.611 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -130.79 -16.4 3.32 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.54 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -164.69 0.94 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.303 0.377 . . . . 0.0 110.604 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.519 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.55 37.77 2.05 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 111.85 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 8.0 m-20 -110.99 82.95 3.36 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.832 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.33 -21.88 14.8 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.973 2.449 . . . . 0.0 113.384 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -85.19 -38.52 18.89 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.909 0.484 . . . . 0.0 111.527 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.08 -5.53 55.06 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.842 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 22' ' ' ASP . . . -57.3 -0.67 0.06 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -178.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -142.3 43.86 1.65 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.179 0.514 . . . . 0.0 111.839 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p -127.38 155.58 43.39 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.616 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 48.0 t -129.22 133.54 65.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.676 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 3.9 m -115.15 154.68 28.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.471 -178.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -109.14 116.26 31.59 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.61 108.47 12.03 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-O 121.04 0.448 . . . . 0.0 110.466 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.78 -57.92 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 114.033 -1.439 . . . . 0.0 110.115 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.516 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 32.7 tt0 -151.11 119.67 6.48 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.793 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -95.8 129.24 43.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.629 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -139.48 152.89 47.35 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.475 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.8 -18.98 65.58 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.623 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -95.68 -5.83 41.35 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.346 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.81 172.37 22.51 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.2 143.24 30.19 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.5 136.6 54.26 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.638 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 133' ' ' ALA . . . -159.29 158.53 29.61 Favored Glycine 0 N--CA 1.452 -0.292 0 O-C-N 124.364 1.04 . . . . 0.0 112.529 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mt -115.6 134.86 54.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.099 0.449 . . . . 0.0 111.438 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.549 HG21 ' O ' ' A' ' 78' ' ' GLY . 11.1 t -68.55 122.48 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.91 55.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.638 0.732 . . . . 0.0 112.074 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.859 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.6 t-20 -148.32 -2.75 0.51 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.157 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -130.19 87.23 51.71 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.505 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -59.7 143.15 99.7 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 121.559 1.506 . . . . 0.0 112.14 175.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.0 m -92.54 158.5 15.97 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 123.39 0.431 . . . . 0.0 111.368 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.89 50.29 1.37 Allowed Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.837 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 mt -133.57 158.96 41.85 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.979 0.458 . . . . 0.0 110.229 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.1 p-10 -112.23 157.54 20.77 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.102 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.433 HD21 ' SG ' ' A' ' 70' ' ' CYS . 13.4 tp -57.79 -37.07 73.08 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.07 -37.91 62.06 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -63.66 -43.03 97.93 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.21 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.849 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -62.63 -46.82 95.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.428 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 4.4 mp -53.56 -36.72 62.17 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.87 0.731 . . . . 0.0 110.784 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.93 -28.34 49.63 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.564 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -29.97 47.9 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.381 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.849 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.9 mt -77.83 -45.14 25.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.884 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -132.02 116.57 15.7 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.535 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -77.59 -32.73 2.69 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 123.615 2.876 . . . . 0.0 112.747 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.22 -14.38 55.63 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.364 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 149.7 24.52 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 123.321 0.388 . . . . 0.0 111.792 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.32 123.75 29.68 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.99 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.45 146.04 34.55 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.185 1.923 . . . . 0.0 112.351 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.504 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.4 Cg_endo -92.43 -170.62 0.3 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.491 2.127 . . . . 0.0 111.83 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.488 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -63.82 -24.89 67.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.142 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.494 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.6 ptp180 -66.18 -53.38 38.14 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -177.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.433 ' SG ' HD21 ' A' ' 53' ' ' LEU . 60.1 m -71.74 -25.02 61.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 47.7 mt-30 -68.12 -35.63 78.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.488 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 20.5 p80 -90.37 22.12 3.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.228 0.537 . . . . 0.0 111.667 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 55.1 mt -119.39 139.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.383 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.555 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.5 m-20 -107.11 153.78 22.14 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.802 0.689 . . . . 0.0 112.728 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.9 mm -100.02 150.3 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.093 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.7 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -116.51 154.98 29.44 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.52 118.94 26.27 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.636 0.198 . . . . 0.0 110.552 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.549 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -101.46 -23.66 9.37 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.826 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.82 -167.77 35.4 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.123 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -88.39 -9.66 4.95 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 123.492 2.794 . . . . 0.0 114.264 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 t -87.07 131.18 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.003 0.19 . . . . 0.0 111.035 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 44.13 87.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.533 1.133 . . . . 0.0 113.316 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.415 ' O ' HD23 ' A' ' 130' ' ' LEU . 9.0 t -88.09 1.51 54.11 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.428 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.87 -5.47 47.91 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.604 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.26 154.45 50.66 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.11 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.604 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.5 134.2 12.1 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.175 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.734 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.54 145.58 27.31 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.366 1.067 . . . . 0.0 110.231 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -123.97 103.42 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 123.366 0.416 . . . . 0.0 110.874 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 126' ' ' SER . 6.2 tp -105.71 129.21 53.97 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.429 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 3.7 p80 -125.6 168.23 14.37 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 118.985 -0.531 . . . . 0.0 112.146 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 16.5 Cg_endo -96.61 13.99 0.96 Allowed 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.862 2.375 . . . . 0.0 113.644 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.429 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 8.6 t -101.89 161.06 13.95 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.874 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.84 19.21 55.5 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.512 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -85.47 153.86 22.19 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.604 0.362 . . . . 0.0 110.403 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.0 p -127.03 157.89 38.39 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.559 ' CE2' HG21 ' A' ' 113' ' ' VAL . 52.0 m-85 -129.34 -151.94 0.5 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.671 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -57.44 -46.26 83.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.776 0.431 . . . . 0.0 111.723 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 m -138.32 78.94 1.71 Allowed 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.642 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 107' ' ' MET . 25.1 m -126.29 120.96 31.3 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tp -77.36 162.02 27.59 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.051 176.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -135.2 125.5 26.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.896 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -135.84 43.99 2.52 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.279 -179.383 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.13 -99.16 0.19 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.815 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -57.4 -12.99 2.91 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 pp -158.44 148.11 19.55 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.265 0.555 . . . . 0.0 112.493 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -120.83 158.6 27.24 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.324 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.59 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 8.9 ttm -119.68 134.08 55.37 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.7 m -128.76 127.36 41.86 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.8 p -119.92 11.78 11.88 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.782 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.2 m -85.59 130.38 34.59 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.617 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.496 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.7 pt20 -61.58 -29.52 70.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.382 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.45 -43.16 95.15 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.603 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.731 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.0 p -68.14 -39.77 81.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 123.189 0.306 . . . . 0.0 110.38 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.559 ' N ' HG13 ' A' ' 113' ' ' VAL . 1.5 tt -58.12 -48.34 80.51 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 123.571 0.544 . . . . 0.0 110.47 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.496 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 35.3 m-85 -69.98 -37.57 75.8 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.865 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.25 -51.94 65.72 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.0 tp -64.56 -43.14 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.156 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.02 -31.59 65.28 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 123.826 0.704 . . . . 0.0 109.546 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.494 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.71 -20.8 30.6 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.255 176.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.61 13.1 33.39 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.729 -1.123 . . . . 0.0 114.692 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.1 p -103.39 7.8 38.09 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.68 -137.7 9.6 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.239 -0.756 . . . . 0.0 112.635 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.72 173.72 12.59 Favored 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 123.228 2.619 . . . . 0.0 113.601 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.01 -54.37 47.53 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.757 0.823 . . . . 0.0 111.916 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.572 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.9 mmtt -139.05 151.14 46.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.775 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.0 m -148.05 165.38 30.97 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.7 tp -127.5 118.05 23.26 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.361 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.734 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 18.5 pt -98.63 102.7 13.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.989 0.9 . . . . 0.0 109.819 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 6.8 t -119.75 121.6 39.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.76 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 83' ' ' THR . 6.9 tp -66.84 115.06 6.2 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.01 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.71 174.61 4.11 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.352 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -128.44 -179.49 5.06 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.408 0.623 . . . . 0.0 111.092 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -117.34 130.47 56.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.179 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.46 152.24 19.48 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.354 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 27.4 m-90 -132.69 139.02 47.48 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.898 0.41 . . . . 0.0 110.537 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.25 158.17 27.63 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.851 0.719 . . . . 0.0 110.794 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.92 91.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.82 -22.05 10.11 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.339 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -57.22 -46.35 83.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.866 0.466 . . . . 0.0 111.978 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.573 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.5 tp -66.73 -47.18 73.09 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -56.69 -30.84 63.86 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.453 0.471 . . . . 0.0 110.793 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.43 -49.08 52.57 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.04 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.4 pt-20 -72.69 -26.75 61.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.0 tp -75.48 -38.23 59.68 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.744 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -78.19 -30.31 48.92 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.272 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.06 0.5 31.61 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.605 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 61.38 28.98 18.3 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.871 0.868 . . . . 0.0 111.797 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.45 -42.71 16.63 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.528 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -124.14 111.39 15.86 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 123.495 0.497 . . . . 0.0 109.856 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.3 tp -86.93 128.36 35.06 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.614 0.245 . . . . 0.0 111.506 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.5 p -100.33 142.3 31.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.758 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 78.2 m -154.95 155.83 30.66 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 123.446 0.466 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.51 148.46 92.94 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.325 2.016 . . . . 0.0 110.999 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.522 ' HA ' ' CZ ' ' A' ' 174' ' ' ARG . . . -135.06 177.42 7.82 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -134.29 141.11 38.02 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 113.88 -1.509 . . . . 0.0 108.584 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -74.85 -26.54 11.14 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 122.766 2.311 . . . . 0.0 114.007 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -48.89 -41.71 34.4 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.915 0.759 . . . . 0.0 112.631 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.6 HD11 HH12 ' A' ' 167' ' ' ARG . 4.9 mt -70.26 -32.63 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.467 0.651 . . . . 0.0 110.421 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.6 tt -76.65 -37.12 56.81 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.37 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.61 -33.45 25.32 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -86.84 -72.93 0.48 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.939 0.336 . . . . 0.0 111.657 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.886 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.47 99.93 6.3 Favored Pre-proline 0 C--N 1.349 0.578 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.859 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 70.3 Cg_endo -90.94 -0.91 4.97 Favored 'Trans proline' 0 CA--C 1.57 2.275 0 C-N-CA 121.742 1.628 . . . . 0.0 114.261 175.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.634 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 87.8 Cg_endo -74.28 -54.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 122.636 2.224 . . . . 0.0 114.502 -178.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.566 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.1 mt-10 -120.58 -29.84 4.64 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.729 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.886 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.0 tt0 -70.38 -11.38 60.88 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.422 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.6 HH12 HD11 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.28 -45.5 32.29 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.397 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.5 tp -68.06 -50.19 56.72 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.1 m -57.57 -51.16 70.6 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.922 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.402 ' HB3' HH12 ' A' ' 167' ' ' ARG . . . -61.22 -39.09 88.98 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.158 0.286 . . . . 0.0 110.987 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.28 83.92 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 123.657 0.598 . . . . 0.0 110.457 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.11 84.54 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.646 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.76 -32.28 73.39 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.532 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.522 ' CZ ' ' HA ' ' A' ' 154' ' ' ALA . 10.9 mtm-85 -77.7 -41.57 37.47 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 122.682 0.393 . . . . 0.0 110.702 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.77 -35.47 79.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.634 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.681 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.2 179.441 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.4 mt . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 121.102 0.477 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -93.0 19.36 7.89 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.068 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 175.55 55.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.268 1.027 . . . . 0.0 109.209 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -137.96 156.88 47.4 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 154' ' ' ALA . 15.5 m-30 -96.46 135.43 38.34 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.928 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.514 ' O ' HG12 ' A' ' 29' ' ' VAL . 6.2 mt -107.62 138.2 44.27 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.182 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 mm -116.69 132.63 65.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 O-C-N 123.623 0.577 . . . . 0.0 109.617 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.58 128.15 33.67 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.724 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.5 mtt -117.79 154.32 51.06 Favored Pre-proline 0 CA--C 1.538 0.509 0 O-C-N 123.383 0.427 . . . . 0.0 111.336 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.41 74.0 5.76 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.673 2.249 . . . . 0.0 112.661 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -131.63 -17.64 2.86 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.741 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.32 -163.26 0.84 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.272 0.357 . . . . 0.0 110.403 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.514 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -101.96 34.4 2.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.906 0.384 . . . . 0.0 111.979 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.6 82.4 3.75 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.37 -22.3 14.32 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.033 2.488 . . . . 0.0 113.333 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -85.13 -39.13 18.25 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.93 0.492 . . . . 0.0 111.498 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -4.63 56.94 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.889 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 22' ' ' ASP . . . -57.69 0.71 0.05 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -143.13 43.34 1.55 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.212 0.529 . . . . 0.0 111.866 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.6 p -126.49 158.28 36.5 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.674 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 14' ' ' LEU . 58.4 t -130.72 133.07 63.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.641 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.8 m -114.33 155.18 26.71 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.647 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.499 ' OH ' HD21 ' A' ' 105' ' ' LEU . 34.1 t80 -107.71 115.58 30.4 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.08 108.21 13.48 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-O 121.393 0.616 . . . . 0.0 111.236 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.486 ' O ' HD13 ' A' ' 102' ' ' LEU . 43.4 t -68.42 -63.32 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.267 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -136.82 122.65 19.99 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.492 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -104.66 128.79 52.82 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.9 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -139.81 153.14 47.02 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.627 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.61 -21.56 66.43 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.005 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -94.99 -4.66 46.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.398 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.54 176.23 27.48 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.405 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.99 148.95 30.36 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.21 136.17 54.62 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.289 177.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 133' ' ' ALA . . . -157.11 160.39 30.4 Favored Glycine 0 N--CA 1.447 -0.624 0 O-C-N 124.603 1.189 . . . . 0.0 112.509 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mt -112.69 131.19 55.77 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.939 0.37 . . . . 0.0 111.223 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 78' ' ' GLY . 15.7 t -67.05 122.12 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.498 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.49 56.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.648 0.737 . . . . 0.0 112.038 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.858 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.1 t-20 -147.15 -3.25 0.58 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.158 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.45 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 2.5 ttm180 -130.08 88.57 47.99 Favored Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.495 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.3 Cg_exo -59.6 143.68 99.61 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.712 1.608 . . . . 0.0 112.157 175.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.423 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.2 m -93.29 159.71 15.15 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 123.386 0.429 . . . . 0.0 111.639 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.06 50.69 1.18 Allowed Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.588 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mt -133.6 158.44 43.19 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 122.848 0.459 . . . . 0.0 110.143 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.515 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 24.7 p-10 -112.61 157.61 20.99 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 tt -58.1 -26.51 62.68 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 120.947 0.403 . . . . 0.0 111.847 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.68 95.47 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.173 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.56 -45.78 88.92 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.095 0.247 . . . . 0.0 111.457 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.855 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 7.8 m -62.12 -44.51 99.12 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.4 mt -55.99 -35.14 66.43 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.853 0.721 . . . . 0.0 110.618 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.08 -27.41 48.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.391 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.431 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.84 -30.97 51.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.284 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.855 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.2 mt -77.69 -45.76 23.92 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.162 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -131.12 116.52 16.73 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.581 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.7 -32.94 2.51 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.554 2.836 . . . . 0.0 112.75 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.74 -14.77 56.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.313 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.18 149.66 24.48 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.42 0.45 . . . . 0.0 111.672 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.24 123.45 29.39 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.304 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.42 149.48 35.11 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.275 1.983 . . . . 0.0 112.279 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.467 ' CD ' ' HG ' ' A' ' 70' ' ' CYS . 7.6 Cg_endo -94.33 -167.86 0.16 Allowed 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.653 2.235 . . . . 0.0 112.432 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.43 -24.64 64.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.373 0.669 . . . . 0.0 112.095 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.495 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 9.1 ptp180 -67.91 -48.08 67.0 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.467 ' HG ' ' CD ' ' A' ' 67' ' ' PRO . 21.2 m -73.15 -26.19 61.11 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.087 0.555 . . . . 0.0 112.343 -178.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -70.34 -26.96 63.99 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.668 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -96.71 17.66 16.05 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.58 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 52.1 mt -120.97 139.63 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.818 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.59 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.9 m-20 -106.45 154.53 20.7 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.2 mm -102.02 153.12 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.805 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.7 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -117.97 155.21 30.64 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.64 121.23 28.87 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 117.684 0.22 . . . . 0.0 110.59 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.53 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -104.04 -23.6 8.07 Favored Glycine 0 C--N 1.346 1.137 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.888 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.7 -168.36 33.81 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.043 -0.598 . . . . 0.0 113.315 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -88.58 -13.09 3.48 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 123.545 2.83 . . . . 0.0 114.394 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 t -83.41 129.8 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.099 0.249 . . . . 0.0 111.162 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 44.25 86.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.635 1.174 . . . . 0.0 113.392 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.6 p -82.72 -13.88 55.56 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.085 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.05 -17.59 58.66 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.641 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.58 148.87 52.38 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.089 0.471 . . . . 0.0 111.908 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.641 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.71 159.75 13.66 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.429 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.3 m-85 -96.14 151.71 19.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.721 -1.24 . . . . 0.0 110.854 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 t -128.35 102.91 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.654 ' O ' ' HA ' ' A' ' 126' ' ' SER . 0.3 OUTLIER -102.37 127.69 49.27 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.869 -179.216 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' A' ' 106' ' ' ALA . 3.3 p80 -130.07 164.42 40.78 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.499 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.66 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.5 Cg_endo -97.08 19.78 0.46 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.647 2.231 . . . . 0.0 113.78 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.8 t -106.4 158.52 16.83 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.59 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.85 22.82 33.92 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.717 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 95' ' ' SER . 2.8 tt -90.73 149.58 21.97 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.521 0.329 . . . . 0.0 110.435 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.447 ' N ' HD23 ' A' ' 94' ' ' LEU . 27.5 m -126.22 155.51 41.71 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.054 0.454 . . . . 0.0 112.093 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.529 ' CE2' HG22 ' A' ' 113' ' ' VAL . 53.6 m-85 -126.55 -150.4 0.44 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.846 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -58.4 -47.29 84.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.61 0.364 . . . . 0.0 111.491 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 63.2 m -133.05 81.05 1.92 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.964 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 107' ' ' MET . 44.7 m -127.98 120.06 26.78 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.04 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -103.06 122.42 44.62 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.911 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.24 125.47 30.35 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.773 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -121.47 55.29 1.09 Allowed 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.232 1.015 . . . . 0.0 110.626 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.87 -114.35 5.53 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.259 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.5 -3.44 6.25 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.499 HD21 ' OH ' ' A' ' 31' ' ' TYR . 3.5 pp -147.78 157.02 43.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.19 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.401 ' HB2' ' CE1' ' A' ' 90' ' ' HIS . . . -120.44 158.59 26.87 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.368 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.602 ' O ' ' HA ' ' A' ' 99' ' ' THR . 25.6 ttm -124.56 132.14 53.46 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.2 m -133.95 130.99 38.49 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.9 p -124.37 18.82 8.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.433 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.0 t -90.66 133.97 34.74 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.92 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.468 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 5.7 mt-30 -62.35 -26.37 68.41 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.473 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.28 -41.96 93.66 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.496 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.734 ' O ' HG21 ' A' ' 117' ' ' ILE . 4.5 p -71.49 -37.58 64.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.486 ' N ' HG11 ' A' ' 113' ' ' VAL . 5.1 tp -58.89 -47.12 86.09 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 123.511 0.507 . . . . 0.0 110.198 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.468 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 18.4 m-85 -68.5 -40.91 80.67 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.837 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.68 -52.6 64.44 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.385 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.734 HG21 ' O ' ' A' ' 113' ' ' VAL . 4.4 tp -64.82 -44.23 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.718 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.433 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.54 -32.33 65.03 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 123.745 0.653 . . . . 0.0 109.679 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.495 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.56 -20.17 31.94 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.396 176.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.08 16.2 28.59 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.698 -1.137 . . . . 0.0 114.544 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.9 p -107.55 7.96 29.02 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.01 -138.28 9.04 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 119.213 -0.77 . . . . 0.0 112.747 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.75 168.46 15.87 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.191 2.594 . . . . 0.0 113.754 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.479 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -50.76 -58.83 4.96 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.363 1.065 . . . . 0.0 111.748 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.66 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.4 mmtt -141.3 139.93 33.74 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.797 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 36.7 p -137.02 168.05 20.33 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 tp -128.27 117.07 20.84 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.81 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.59 HD11 ' O ' ' A' ' 74' ' ' ASP . 11.5 pt -98.18 103.88 15.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-O 121.415 0.626 . . . . 0.0 109.639 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.0 t -121.37 120.09 34.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.014 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 tp -67.1 115.6 6.98 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.601 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 169.82 11.28 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.405 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -128.42 171.97 11.55 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.278 0.561 . . . . 0.0 110.803 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -108.86 130.89 55.42 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.05 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.5 142.67 13.83 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.387 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 17.4 m-90 -120.53 133.6 55.38 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.967 0.451 . . . . 0.0 110.391 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -82.12 158.86 23.52 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.181 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.77 124.37 9.63 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.364 0.415 . . . . 0.0 111.705 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.57 -26.76 8.72 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.036 -0.602 . . . . 0.0 114.35 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -58.27 -49.03 78.58 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.562 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.7 tm? -66.23 -48.96 68.85 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.983 0.177 . . . . 0.0 110.772 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.86 -31.12 66.37 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 120.927 0.394 . . . . 0.0 110.827 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.18 -50.09 50.69 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.086 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.45 -26.62 62.8 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.966 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.1 tp -75.22 -38.48 60.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.427 0.691 . . . . 0.0 110.668 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.0 m -77.93 -29.65 50.09 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.34 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.8 t70 -81.43 -1.13 44.58 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.615 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 t30 60.5 30.31 19.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.879 0.872 . . . . 0.0 111.402 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.73 -42.17 18.35 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.984 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -126.71 115.86 20.06 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.7 tp -86.78 145.3 26.69 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.514 0.197 . . . . 0.0 111.225 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.4 p -105.31 137.0 43.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.964 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 71.1 m -152.12 149.76 24.03 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.598 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.5 158.47 19.27 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.39 2.06 . . . . 0.0 111.247 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.67 167.22 19.14 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -177.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -133.39 135.64 25.7 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 114.132 -1.395 . . . . 0.0 107.85 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.82 -26.76 13.09 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.61 2.207 . . . . 0.0 114.013 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.77 -40.55 63.25 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.759 0.662 . . . . 0.0 112.104 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.564 HD11 HH12 ' A' ' 167' ' ' ARG . 4.5 mt -70.95 -34.71 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.24 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.3 tt -74.0 -38.62 64.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.654 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.413 ' HE1' ' O ' ' A' ' 89' ' ' LEU . 44.7 m-85 -88.0 -31.1 19.51 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -85.57 -71.73 0.52 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.215 0.461 . . . . 0.0 111.451 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.886 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.43 98.59 5.94 Favored Pre-proline 0 C--N 1.35 0.609 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.858 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 59.3 Cg_endo -91.99 0.35 4.27 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 121.602 1.535 . . . . 0.0 114.206 175.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.628 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 78.7 Cg_endo -74.19 -53.78 0.11 Allowed 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 122.546 2.164 . . . . 0.0 114.461 -178.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.565 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -121.09 -29.66 4.51 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.61 -178.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.886 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.8 tt0 -70.27 -11.49 60.94 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.382 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.564 HH12 HD11 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -77.04 -40.2 47.25 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.325 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -72.02 -49.9 32.98 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.8 m -58.92 -47.36 85.31 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.55 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.659 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.79 -40.69 92.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.158 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.82 -46.28 78.12 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 123.488 0.492 . . . . 0.0 110.472 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.21 90.28 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.428 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.82 -27.29 68.14 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.66 177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.76 -40.21 41.64 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 122.832 0.453 . . . . 0.0 110.306 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.84 -30.28 63.89 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.408 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.745 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.817 179.58 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.481 HD13 ' CE1' ' A' ' 35' ' ' HIS . 19.4 mt . . . . . 0 N--CA 1.469 0.514 0 CA-C-O 120.996 0.427 . . . . 0.0 110.655 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -89.22 17.3 6.14 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.529 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 19.0 p80 172.2 58.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.351 1.06 . . . . 0.0 110.108 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -137.19 161.61 35.71 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.465 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 154' ' ' ALA . 18.9 m-30 -97.76 136.95 37.37 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 3.7 mt -108.28 140.18 41.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.949 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.435 HD12 ' O ' ' A' ' 150' ' ' LEU . 2.9 mp -120.62 135.73 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 123.462 0.476 . . . . 0.0 110.02 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.14 125.61 29.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.048 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.9 mtt -110.34 157.44 38.12 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.206 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.21 30.16 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.63 2.22 . . . . 0.0 113.213 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -86.72 -17.02 34.69 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.29 -167.13 1.15 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.094 0.246 . . . . 0.0 110.597 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.509 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.09 40.33 1.47 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.102 0.477 . . . . 0.0 111.764 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -112.19 80.33 3.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.915 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.4 Cg_exo -75.45 -23.12 13.38 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 123.036 2.491 . . . . 0.0 113.315 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -84.54 -34.93 23.15 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.825 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.94 3.92 53.34 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.048 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.16 163.87 19.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.815 0.341 . . . . 0.0 111.761 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 49.23 31.79 3.88 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.0 p -117.53 154.25 31.8 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 96.4 t -128.93 134.2 64.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.487 0.661 . . . . 0.0 110.857 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.2 m -114.66 153.67 29.79 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.914 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.501 ' OH ' HD21 ' A' ' 105' ' ' LEU . 43.3 t80 -106.82 118.54 36.94 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' HIS . 0.2 OUTLIER -82.44 109.97 17.15 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.255 0.55 . . . . 0.0 111.139 -178.601 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.537 ' O ' HD22 ' A' ' 102' ' ' LEU . 38.1 t -71.35 -64.73 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.397 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -133.8 117.25 16.66 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.583 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.481 ' CE1' HD13 ' A' ' 9' ' ' LEU . 12.1 t-80 -102.46 126.8 49.62 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.466 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -139.25 152.01 46.96 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.08 -13.14 59.54 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.042 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -107.77 3.13 24.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.306 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.07 166.27 15.16 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.425 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -148.5 145.29 27.85 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.406 ' O ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -125.86 138.0 53.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.17 178.376 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.488 ' O ' ' HB1' ' A' ' 133' ' ' ALA . . . -158.43 158.94 29.72 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.451 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 mt -112.77 131.89 55.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.042 0.421 . . . . 0.0 111.196 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 78' ' ' GLY . 15.9 t -66.04 123.43 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.69 55.07 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.598 0.713 . . . . 0.0 112.224 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.845 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.4 t-20 -147.55 -3.24 0.55 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.116 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.72 87.03 53.64 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.512 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -60.27 147.29 94.19 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 121.695 1.597 . . . . 0.0 112.721 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.408 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 66.1 m -92.39 160.13 15.24 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.85 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.02 -2.19 64.64 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 116.144 -0.48 . . . . 0.0 113.711 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.457 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -90.16 152.78 20.95 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.731 0.3 . . . . 0.0 111.28 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -101.33 164.85 11.58 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.155 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 tp -60.26 -28.19 67.85 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 120.802 0.334 . . . . 0.0 111.739 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.55 98.79 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -63.99 -46.52 84.19 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.082 0.239 . . . . 0.0 111.625 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.856 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.5 m -61.91 -44.96 99.61 Favored 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.6 mt -56.58 -34.5 67.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.598 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.18 -27.5 48.01 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.317 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.425 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.85 -30.7 51.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.248 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.856 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.8 mt -77.87 -46.1 22.33 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.81 -1.541 . . . . 0.0 110.987 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -130.26 115.9 17.54 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -77.6 -32.9 2.59 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.589 2.859 . . . . 0.0 112.757 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.63 -14.91 56.12 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.291 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.43 150.38 23.82 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.355 0.409 . . . . 0.0 111.709 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.79 122.82 28.87 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.175 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.67 149.0 42.71 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.409 2.073 . . . . 0.0 112.25 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -94.86 -171.79 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.57 2.18 . . . . 0.0 112.6 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -24.5 67.58 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.116 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 7.8 ptp180 -68.55 -49.15 61.71 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 19.0 m -74.17 -26.03 60.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.083 0.553 . . . . 0.0 112.425 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -68.53 -27.54 66.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.949 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -97.51 18.85 14.45 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.439 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 69' ' ' ARG . 65.0 mt -119.64 140.07 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.941 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.535 ' O ' HD13 ' A' ' 128' ' ' ILE . 2.0 m-20 -107.18 154.34 21.34 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.819 0.7 . . . . 0.0 112.851 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 51' ' ' LEU . 20.7 mm -102.98 156.74 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.168 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.699 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -121.58 155.23 35.5 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.63 121.06 27.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 117.763 0.256 . . . . 0.0 110.471 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.97 -23.67 8.06 Favored Glycine 0 C--N 1.348 1.213 0 C-N-CA 120.206 -0.997 . . . . 0.0 114.211 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.52 -167.88 34.15 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.431 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -88.46 -13.55 3.43 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.468 2.778 . . . . 0.0 114.376 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.61 127.03 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 123.086 0.241 . . . . 0.0 111.148 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 46.99 84.18 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.406 1.082 . . . . 0.0 113.203 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -85.86 1.23 50.66 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.415 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -92.86 -10.76 35.51 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.611 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.03 150.82 52.11 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.008 0.432 . . . . 0.0 112.108 -179.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.611 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.24 144.88 17.07 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.172 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.8 OUTLIER -86.75 146.12 26.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.923 -1.139 . . . . 0.0 110.525 179.248 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.46 103.71 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 123.601 0.563 . . . . 0.0 109.949 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 126' ' ' SER . 11.4 tp -107.65 127.98 54.14 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.127 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' A' ' 106' ' ' ALA . 4.4 p80 -126.67 168.72 13.66 Favored Pre-proline 0 CA--C 1.556 1.196 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.663 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.665 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.11 17.44 0.6 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.75 2.3 . . . . 0.0 113.691 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.416 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 8.6 t -105.31 159.49 15.85 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.808 -178.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.84 19.58 54.19 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.752 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mp -85.24 154.59 21.85 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.585 0.354 . . . . 0.0 110.912 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.2 p -125.49 156.95 38.15 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.634 ' H ' ' HG1' ' A' ' 99' ' ' THR . 56.7 m-85 -130.0 -149.3 0.4 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.495 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -60.41 -45.69 92.68 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.406 0.283 . . . . 0.0 111.323 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.3 m -137.09 85.24 2.12 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.492 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.634 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 13.8 m -129.89 129.16 43.55 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.712 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -112.42 123.21 49.79 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.871 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.93 125.12 29.33 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.537 HD22 ' O ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -135.09 76.96 1.65 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.973 0.892 . . . . 0.0 112.041 -177.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.574 ' O ' ' HG2' ' A' ' 104' ' ' GLU . . . 43.25 104.88 0.01 OUTLIER Glycine 0 N--CA 1.475 1.279 0 CA-C-N 113.677 -1.601 . . . . 0.0 114.823 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 103' ' ' GLY . 10.4 pt-20 61.36 -15.86 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.777 1.231 . . . . 0.0 113.25 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.504 ' H ' ' C ' ' A' ' 103' ' ' GLY . 2.7 pp -132.88 145.56 51.04 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 120.806 0.336 . . . . 0.0 110.451 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.423 ' HB3' ' NE2' ' A' ' 90' ' ' HIS . . . -114.84 155.46 26.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.986 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' A' ' 99' ' ' THR . 16.9 ttm -121.66 128.96 52.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.9 m -128.57 129.64 46.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 p -119.65 16.39 12.8 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.311 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.0 p -91.17 131.0 36.99 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 121.737 0.78 . . . . 0.0 112.439 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.491 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.7 pt20 -61.43 -27.74 68.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.3 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.17 -43.42 95.19 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.484 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.722 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.6 p -69.56 -36.4 70.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.49 ' N ' HG13 ' A' ' 113' ' ' VAL . 5.4 tp -58.64 -49.43 77.56 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 123.472 0.482 . . . . 0.0 110.372 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.491 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 31.8 m-85 -68.19 -38.74 82.31 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.907 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.1 -52.74 63.64 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.269 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.48 -43.83 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.672 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.435 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.6 -32.59 65.4 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.714 0.634 . . . . 0.0 109.579 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.457 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.71 -19.53 32.61 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.316 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.62 14.99 33.13 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.748 -1.114 . . . . 0.0 114.739 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.9 p -104.88 6.53 33.84 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.52 -138.29 9.59 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.169 -0.795 . . . . 0.0 112.515 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.25 172.99 12.16 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 123.128 2.552 . . . . 0.0 113.611 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.61 -55.0 40.46 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.966 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.665 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.9 mmtt -141.63 139.93 33.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.843 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 67.3 m -137.67 166.83 22.99 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tp -125.38 116.46 21.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.601 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 9.8 pt -99.15 102.57 13.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 O-C-N 123.82 0.7 . . . . 0.0 109.45 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -120.26 120.78 37.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.031 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.08 112.86 4.63 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.488 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.66 171.54 19.13 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.88 -1.055 . . . . 0.0 114.405 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.38 176.12 7.96 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.099 -0.55 . . . . 0.0 110.397 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 42' ' ' GLY . . . -115.36 131.01 57.06 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.161 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.94 150.26 18.72 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.549 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.425 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 26.4 m-90 -127.78 136.12 51.05 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 123.902 0.413 . . . . 0.0 110.408 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.08 158.07 26.52 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.922 0.764 . . . . 0.0 110.725 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.27 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.43 -24.84 7.15 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 115.408 -0.815 . . . . 0.0 113.042 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.71 -45.46 85.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.968 0.507 . . . . 0.0 112.28 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.563 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.04 -48.25 66.15 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.187 0.304 . . . . 0.0 110.594 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.63 -29.39 67.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.98 0.419 . . . . 0.0 110.715 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.4 -50.42 38.87 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.84 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.35 -26.67 63.85 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.847 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.1 tp -76.02 -37.87 57.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.745 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.5 t -77.78 -29.03 50.7 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.202 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -82.64 0.21 44.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.395 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 59.64 29.51 19.08 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.944 0.897 . . . . 0.0 111.507 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.76 -42.76 19.31 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.949 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -124.52 113.65 18.38 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.2 tp -85.04 139.49 31.71 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.634 0.254 . . . . 0.0 111.371 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.5 p -104.46 137.85 41.72 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.047 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 74.3 m -151.69 154.95 33.74 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.816 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.76 153.26 51.16 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.314 2.009 . . . . 0.0 111.074 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.42 166.37 18.85 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -133.66 135.9 25.78 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.207 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.409 ' HG3' ' OE1' ' A' ' 104' ' ' GLU . 72.6 Cg_endo -73.51 -26.44 14.08 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.553 2.168 . . . . 0.0 113.684 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.11 62.17 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.9 0.75 . . . . 0.0 112.157 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.567 HD13 HH12 ' A' ' 167' ' ' ARG . 4.7 mt -72.31 -34.87 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.328 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.35 -36.16 63.59 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.277 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -85.28 -36.87 20.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.65 -71.96 0.48 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 117.927 0.331 . . . . 0.0 111.786 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.664 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -142.29 98.97 5.97 Favored Pre-proline 0 C--N 1.349 0.544 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.845 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.2 Cg_endo -91.8 0.21 4.39 Favored 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 121.652 1.568 . . . . 0.0 114.319 175.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.629 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 66.2 Cg_endo -75.46 -50.67 0.12 Allowed 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.609 2.206 . . . . 0.0 114.607 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.54 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.4 mt-10 -121.44 -34.06 3.52 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.731 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.664 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 9.0 mt-10 -69.04 -10.77 59.23 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.135 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.567 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -77.06 -41.57 41.86 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.217 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.8 tp -70.65 -49.98 41.6 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.8 m -58.5 -48.76 79.74 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.637 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.662 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.31 -40.19 95.41 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.148 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.46 78.25 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.568 0.542 . . . . 0.0 110.435 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.45 91.22 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.423 177.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.25 68.3 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.676 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.82 -39.93 42.09 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 122.823 0.449 . . . . 0.0 110.327 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.83 -31.85 68.71 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.376 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.743 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.834 179.482 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -91.89 17.21 9.5 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.765 0.317 . . . . 0.0 111.396 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 175.99 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.845 0.858 . . . . 0.0 110.474 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -136.95 158.97 43.25 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.305 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 30' ' ' THR . 13.7 m-30 -98.42 136.15 38.97 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 6.2 mt -105.39 139.2 40.38 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.936 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -120.15 132.53 69.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 123.572 0.545 . . . . 0.0 109.636 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.23 120.57 18.01 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.926 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.8 mmt -103.22 155.24 36.96 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.166 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -82.9 32.92 0.52 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.669 2.246 . . . . 0.0 112.965 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -87.01 -13.28 44.91 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.254 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -169.52 1.83 Allowed 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.984 0.178 . . . . 0.0 110.876 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.526 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -105.09 42.19 1.25 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.079 0.466 . . . . 0.0 111.583 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -111.58 80.72 2.88 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.88 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.1 Cg_exo -75.49 -16.99 18.87 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.081 2.521 . . . . 0.0 113.404 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -84.56 -38.41 20.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.845 0.458 . . . . 0.0 111.875 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.23 3.88 53.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.175 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.97 162.77 21.25 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.803 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 49.39 33.36 5.38 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.9 p -119.96 154.0 35.12 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 120.562 0.22 . . . . 0.0 110.445 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 99.8 t -129.41 134.95 62.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.503 0.668 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.3 m -116.91 155.26 29.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.875 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.435 ' OH ' HD23 ' A' ' 105' ' ' LEU . 22.6 t80 -109.67 117.34 33.65 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.46 108.14 10.4 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 123.499 0.5 . . . . 0.0 110.943 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.486 ' O ' HD21 ' A' ' 102' ' ' LEU . 51.8 t -66.29 -58.74 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.409 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -144.39 122.5 12.15 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.235 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -100.52 129.12 46.43 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.987 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -139.6 152.07 46.53 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.591 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.03 -22.63 66.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.657 0.383 . . . . 0.0 112.0 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -94.12 -5.35 47.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.346 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.94 176.16 27.76 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 121.579 -0.343 . . . . 0.0 112.333 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.57 148.29 30.0 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.1 tpp -121.67 136.45 54.94 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.105 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 133' ' ' ALA . . . -156.4 159.56 29.54 Favored Glycine 0 N--CA 1.447 -0.614 0 O-C-N 124.409 1.068 . . . . 0.0 112.446 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.419 ' C ' HG22 ' A' ' 30' ' ' THR . 3.2 mt -113.71 131.34 56.21 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.118 0.459 . . . . 0.0 111.365 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 78' ' ' GLY . 7.9 t -66.62 121.77 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.87 54.82 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.561 0.696 . . . . 0.0 112.377 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.858 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.6 t-20 -147.96 -2.31 0.55 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.09 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -130.21 88.03 49.23 Favored Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.504 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 42.9 Cg_exo -59.08 145.04 99.02 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 121.648 1.565 . . . . 0.0 112.412 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.411 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 71.5 m -94.57 161.06 14.36 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.41 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.89 51.34 0.97 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.806 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.451 ' C ' HG12 ' A' ' 75' ' ' ILE . 1.1 mt -133.48 156.33 47.94 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 123.86 0.388 . . . . 0.0 110.044 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 20.3 p-10 -112.7 159.67 18.68 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.836 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 56' ' ' VAL . 14.3 tp -59.15 -28.28 66.44 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.08 96.77 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.39 -45.47 87.54 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.068 0.23 . . . . 0.0 111.559 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.858 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 16.7 m -62.45 -44.5 99.33 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.3 mt -57.48 -33.85 68.43 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.552 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -78.25 -27.92 47.64 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.27 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.431 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.87 -30.96 51.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.297 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.858 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.1 mt -77.85 -45.62 23.8 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.851 -1.522 . . . . 0.0 111.113 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -130.34 115.83 17.44 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.623 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.7 -32.91 2.53 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.664 2.91 . . . . 0.0 112.759 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.66 -14.91 56.05 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.423 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.63 149.91 23.99 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.401 0.438 . . . . 0.0 111.679 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.14 123.0 29.13 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.232 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.03 149.7 36.94 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.318 2.012 . . . . 0.0 112.389 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -95.1 -171.61 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.576 2.184 . . . . 0.0 112.532 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.29 -24.52 67.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.294 0.638 . . . . 0.0 112.007 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.417 ' O ' HG13 ' A' ' 73' ' ' ILE . 9.8 ptp180 -68.72 -47.93 65.11 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.5 m -74.51 -25.91 59.65 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.555 0.535 . . . . 0.0 112.38 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -69.5 -26.97 64.8 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.797 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -97.36 20.46 11.54 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.497 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 59.4 mt -122.16 138.97 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.737 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.496 ' O ' HD11 ' A' ' 128' ' ' ILE . 2.0 m-20 -104.34 164.17 11.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.451 HG12 ' C ' ' A' ' 51' ' ' LEU . 13.6 mm -114.17 152.45 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.822 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.716 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -115.81 156.09 26.69 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.482 0.313 . . . . 0.0 110.429 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.36 119.92 27.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.615 0.189 . . . . 0.0 110.623 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.556 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -102.78 -23.45 8.72 Favored Glycine 0 C--N 1.346 1.1 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.884 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.99 -168.29 32.92 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.371 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -88.42 -13.9 3.35 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.513 2.809 . . . . 0.0 114.356 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.73 131.04 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 123.119 0.262 . . . . 0.0 111.29 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 47.79 83.14 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.366 1.066 . . . . 0.0 113.09 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -84.07 1.03 45.95 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.348 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -93.77 -18.4 22.11 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.587 ' CZ ' ' H ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.2 147.37 52.02 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.968 0.413 . . . . 0.0 111.562 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.587 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -112.65 152.69 17.82 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.646 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.45 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 1.2 m-85 -86.33 153.86 21.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.352 1.061 . . . . 0.0 111.174 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 3.7 t -127.85 103.65 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.666 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.637 ' O ' ' HA ' ' A' ' 126' ' ' SER . 0.3 OUTLIER -98.28 127.39 44.19 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.652 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -129.1 160.76 62.08 Favored Pre-proline 0 CA--C 1.552 1.03 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.614 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 27.2 Cg_endo -99.58 33.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.916 2.41 . . . . 0.0 113.468 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.3 t -118.13 159.08 23.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.749 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.58 21.15 47.65 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.646 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.28 153.62 21.07 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.556 0.342 . . . . 0.0 110.58 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.0 p -122.94 153.58 39.52 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.526 ' H ' ' HG1' ' A' ' 99' ' ' THR . 27.8 m-85 -131.93 -150.98 0.44 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.733 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -62.4 -48.62 78.89 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 122.507 0.323 . . . . 0.0 111.103 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.7 m -132.68 78.41 1.8 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.324 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.526 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 11.1 m -126.49 115.44 19.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.616 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.01 123.45 44.26 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.803 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -83.47 127.48 33.74 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.318 0.58 . . . . 0.0 110.859 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.486 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -120.33 50.01 1.36 Allowed 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.567 -179.422 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.29 -109.62 3.01 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 114.579 -1.191 . . . . 0.0 113.41 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -63.1 -6.85 4.56 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.435 HD23 ' OH ' ' A' ' 31' ' ' TYR . 3.3 pp -152.08 160.01 43.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -122.58 158.84 29.04 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 99' ' ' THR . 19.1 ttm -124.48 134.76 52.94 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.7 m -135.65 133.24 37.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.1 p -126.37 21.83 7.19 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.316 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.813 ' O ' HG22 ' A' ' 113' ' ' VAL . 10.7 t -89.26 130.31 35.68 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.13 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.461 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 21.2 pt20 -60.33 -28.3 68.03 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.554 0.692 . . . . 0.0 109.608 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -63.63 -44.7 93.12 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.925 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.83 ' O ' HG23 ' A' ' 117' ' ' ILE . 18.7 m -62.01 -42.64 95.65 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.557 HD13 ' NH1' ' A' ' 85' ' ' ARG . 31.4 mt -54.66 -52.19 63.09 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.795 0.685 . . . . 0.0 111.992 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.461 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 50.2 m-85 -64.86 -46.05 83.47 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.329 0.393 . . . . 0.0 111.585 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.83 63.89 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.83 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.5 tp -63.84 -43.92 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.92 -30.68 66.12 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.797 0.685 . . . . 0.0 109.762 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.63 -19.99 30.16 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.023 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.63 19.04 21.47 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.68 -1.145 . . . . 0.0 114.636 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.8 p -111.03 9.09 22.11 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.91 -137.78 9.42 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-O 119.256 -0.747 . . . . 0.0 112.756 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.72 167.65 22.13 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.284 2.656 . . . . 0.0 113.509 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.477 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -49.65 -58.19 5.74 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.378 1.071 . . . . 0.0 111.754 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.491 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -138.76 154.61 48.53 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 66.3 m -149.63 163.96 36.47 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 2.3 tp -130.31 115.08 16.43 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.883 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.496 HD11 ' O ' ' A' ' 74' ' ' ASP . 11.1 pt -98.03 107.86 20.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.399 0.618 . . . . 0.0 109.508 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 60.1 p -125.4 122.13 35.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.762 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.1 tp -67.5 117.51 9.55 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.604 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.443 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 70.05 167.69 6.43 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.183 -0.917 . . . . 0.0 114.271 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -128.5 174.16 9.6 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.157 0.503 . . . . 0.0 110.958 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -109.98 132.23 54.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.497 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.58 144.34 15.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.496 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -122.49 133.63 54.59 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.961 0.448 . . . . 0.0 110.585 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.77 158.95 23.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.321 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.57 125.42 11.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.746 0.418 . . . . 0.0 111.81 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.01 -26.45 7.64 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.119 -0.562 . . . . 0.0 114.475 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -58.3 -49.1 78.38 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.555 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.6 tm? -66.34 -49.36 67.2 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.0 0.188 . . . . 0.0 110.807 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.45 -31.59 66.07 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.472 0.482 . . . . 0.0 110.567 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -68.83 -50.12 52.69 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.157 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.86 -26.73 62.47 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.059 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.8 tp -75.34 -38.19 60.29 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.673 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.5 m -77.95 -29.99 50.16 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.291 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -81.46 -1.02 44.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.577 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 60.29 30.1 19.55 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.779 0.832 . . . . 0.0 111.658 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.22 -43.04 18.15 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.93 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -125.36 114.76 19.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.7 tp -86.24 138.53 31.79 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.0 p -101.75 137.52 39.94 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.488 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.6 m -149.95 146.19 20.01 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-O 119.192 -0.433 . . . . 0.0 111.4 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.27 148.18 91.0 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 122.286 1.991 . . . . 0.0 110.584 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.528 ' HA ' ' CZ ' ' A' ' 174' ' ' ARG . . . -134.11 176.32 8.69 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 -176.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -132.26 142.17 44.04 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 113.549 -1.66 . . . . 0.0 108.671 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.11 -26.51 9.14 Favored 'Trans proline' 0 C--N 1.364 1.392 0 C-N-CA 122.692 2.262 . . . . 0.0 114.177 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -49.77 -42.11 45.75 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.774 0.671 . . . . 0.0 112.448 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.645 HD13 HH12 ' A' ' 167' ' ' ARG . 4.6 mt -69.52 -32.65 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-O 121.492 0.663 . . . . 0.0 110.229 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.0 tt -75.81 -38.87 57.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.687 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.424 ' HE1' ' O ' ' A' ' 89' ' ' LEU . 42.8 m-85 -86.51 -29.7 22.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -87.02 -72.56 0.5 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.106 0.412 . . . . 0.0 111.378 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.891 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.18 98.73 6.07 Favored Pre-proline 0 C--N 1.348 0.514 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.858 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.4 Cg_endo -91.55 0.08 4.55 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 C-N-CA 121.657 1.571 . . . . 0.0 114.28 175.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.632 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 87.5 Cg_endo -74.11 -54.16 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.655 2.237 . . . . 0.0 114.445 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.57 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.1 mt-10 -121.05 -29.55 4.54 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.7 -177.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.891 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.6 tt0 -70.56 -11.24 60.8 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.417 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.645 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.66 -43.99 35.73 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.42 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -69.37 -50.21 48.28 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 m -57.65 -49.57 76.01 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.769 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.403 ' HB3' HH12 ' A' ' 167' ' ' ARG . . . -62.69 -40.33 96.77 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.096 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.54 -46.61 80.56 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 123.637 0.586 . . . . 0.0 110.729 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.12 82.47 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.7 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.45 -31.44 72.61 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.446 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.528 ' CZ ' ' HA ' ' A' ' 154' ' ' ALA . 11.3 mtm-85 -77.55 -41.5 38.81 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.793 0.437 . . . . 0.0 110.548 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.48 -34.1 77.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.676 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.747 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.017 179.425 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.568 ' H ' ' HD1' ' A' ' 35' ' ' HIS . 17.5 mt . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 121.158 0.504 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.408 ' NZ ' ' HG3' ' A' ' 34' ' ' GLU . 27.6 tttm -92.88 19.29 7.84 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.113 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.6 t60 173.79 56.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.039 0.936 . . . . 0.0 109.641 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.426 ' CD2' ' HA ' ' A' ' 153' ' ' PRO . 30.2 m80 -139.28 160.96 38.59 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 17.1 m-30 -99.09 137.44 37.6 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.057 0.456 . . . . 0.0 111.914 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 2.0 mt -108.16 140.97 40.59 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.202 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.55 137.21 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 123.352 0.407 . . . . 0.0 110.139 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.77 119.22 17.69 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.699 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 14.6 mmt -99.44 159.82 29.07 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.617 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.91 5.24 5.07 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.716 2.277 . . . . 0.0 113.652 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -77.34 -14.22 59.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.506 0.322 . . . . 0.0 111.856 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.713 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -104.4 154.98 19.18 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.264 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.44 48.67 1.41 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.253 0.549 . . . . 0.0 112.021 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.713 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.2 m-20 -125.05 89.66 52.27 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.626 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.54 -16.83 21.25 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.905 2.404 . . . . 0.0 113.388 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -84.47 -35.23 23.12 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 122.826 0.45 . . . . 0.0 111.772 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -93.41 3.96 54.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.045 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.49 163.21 21.52 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.847 0.356 . . . . 0.0 111.835 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 49.1 32.41 4.03 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.3 p -118.0 154.51 31.87 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 120.541 0.21 . . . . 0.0 110.694 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 60.7 t -129.76 133.15 65.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.773 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.2 m -113.74 153.57 28.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.759 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.496 ' OH ' HD21 ' A' ' 105' ' ' LEU . 33.4 t80 -107.66 116.82 32.63 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.38 109.52 16.7 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 121.457 0.646 . . . . 0.0 111.03 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.535 ' O ' HD22 ' A' ' 102' ' ' LEU . 29.6 t -70.22 -66.21 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.132 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.408 ' HG3' ' NZ ' ' A' ' 10' ' ' LYS . 6.6 tt0 -132.55 119.83 21.05 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.726 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.568 ' HD1' ' H ' ' A' ' 9' ' ' LEU . 12.5 t-80 -102.97 126.59 50.21 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.428 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -139.51 152.11 46.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.504 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.2 -19.56 65.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.832 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -97.73 -3.73 38.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.428 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.26 171.14 22.24 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 112.277 -0.329 . . . . 0.0 112.277 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.416 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -148.26 146.9 28.82 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -122.81 136.34 54.84 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.615 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 133' ' ' ALA . . . -158.12 158.79 29.48 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.334 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mt -114.75 133.72 55.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.055 0.427 . . . . 0.0 111.367 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.561 HG21 ' O ' ' A' ' 78' ' ' GLY . 14.9 t -67.69 123.21 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.6 54.55 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.57 0.7 . . . . 0.0 112.126 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.855 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.4 t-20 -147.66 -3.21 0.54 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.156 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -129.67 87.24 53.17 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.49 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.6 Cg_exo -59.39 142.77 99.52 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 121.702 1.602 . . . . 0.0 112.252 175.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 62.4 m -91.72 158.27 16.47 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.479 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.29 50.52 1.3 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.842 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mt -133.55 158.04 44.15 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.743 0.417 . . . . 0.0 110.046 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.7 p-10 -112.07 158.98 18.93 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.204 0.315 . . . . 0.0 110.423 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.428 ' HG ' ' CD1' ' A' ' 57' ' ' LEU . 12.7 tp -59.21 -36.16 74.9 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.08 -38.4 65.28 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -64.76 -40.2 94.88 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.36 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.84 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.0 t -61.8 -50.82 78.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.428 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 4.8 mp -52.31 -36.38 53.01 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.978 0.799 . . . . 0.0 111.099 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.94 -29.18 49.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.451 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.42 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -78.72 -31.72 46.55 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.713 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.84 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 11.5 mt -77.56 -44.63 27.9 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.833 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -131.93 116.8 15.87 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.479 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.49 -33.11 2.57 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.585 2.857 . . . . 0.0 112.844 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.2 -13.79 56.58 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.388 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.42 149.62 24.33 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.291 0.37 . . . . 0.0 111.721 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.68 123.72 29.5 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.972 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.97 143.84 29.66 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.271 1.981 . . . . 0.0 112.414 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.512 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.1 Cg_endo -91.93 -169.65 0.28 Allowed 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.576 2.184 . . . . 0.0 111.85 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.491 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -64.23 -24.92 67.84 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.224 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.511 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.8 ptp180 -66.91 -51.61 53.29 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.427 ' SG ' HD21 ' A' ' 53' ' ' LEU . 58.2 m -72.46 -25.07 61.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 47.4 mt-30 -68.21 -34.84 77.01 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.491 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 21.8 p80 -91.12 22.53 3.7 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.115 0.484 . . . . 0.0 111.649 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 58.9 mt -119.22 139.44 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.312 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.56 ' O ' HD13 ' A' ' 128' ' ' ILE . 1.7 m-20 -106.59 157.05 17.97 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.5 mm -103.7 152.69 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.853 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.7 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -118.68 154.71 32.27 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -85.82 120.48 27.28 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.623 0.192 . . . . 0.0 110.649 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.561 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -103.33 -23.64 8.35 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 120.082 -1.056 . . . . 0.0 114.006 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.98 -167.62 34.34 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.324 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -88.16 -12.17 4.16 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 123.364 2.71 . . . . 0.0 114.136 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.47 126.35 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 123.094 0.246 . . . . 0.0 110.596 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 50.26 79.02 0.09 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.099 0.96 . . . . 0.0 112.46 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.451 ' O ' HD23 ' A' ' 130' ' ' LEU . 9.5 t -83.01 1.57 39.3 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.554 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -102.63 2.74 36.39 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.492 HH21 ' HB3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -133.07 154.62 50.38 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -179.386 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.47 128.58 9.02 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.778 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.64 144.82 27.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.436 1.095 . . . . 0.0 109.936 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.87 105.86 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.142 0.276 . . . . 0.0 110.963 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 126' ' ' SER . 10.9 tp -107.57 127.82 53.98 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.406 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 2.9 p80 -123.35 164.35 28.55 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.762 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 12.4 Cg_endo -94.86 14.62 1.25 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.659 2.239 . . . . 0.0 113.615 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.406 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 11.1 t -101.81 157.52 16.79 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.73 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.12 20.98 48.38 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.631 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -85.66 154.7 21.49 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.611 0.364 . . . . 0.0 110.321 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.6 p -118.89 151.89 37.3 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.646 ' CD2' HG12 ' A' ' 113' ' ' VAL . 18.2 m-85 -130.68 -150.59 0.43 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.469 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -62.05 -47.6 83.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.775 0.321 . . . . 0.0 111.065 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.535 ' H ' ' HG ' ' A' ' 110' ' ' SER . 66.7 m -135.12 81.22 1.88 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.136 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.645 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 19.2 m -127.48 119.45 26.1 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.412 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -105.0 122.11 45.18 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.96 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -79.3 124.24 28.21 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -136.43 77.85 1.67 Allowed 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.862 0.839 . . . . 0.0 111.829 -177.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.563 ' O ' ' HG2' ' A' ' 104' ' ' GLU . . . 44.33 103.0 0.01 OUTLIER Glycine 0 N--CA 1.474 1.223 0 CA-C-N 113.679 -1.6 . . . . 0.0 114.676 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 103' ' ' GLY . 10.7 pt-20 60.75 -14.72 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.85 1.26 . . . . 0.0 113.426 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.497 ' H ' ' C ' ' A' ' 103' ' ' GLY . 2.8 pp -132.68 145.51 51.11 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-O 120.705 0.288 . . . . 0.0 110.486 178.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.8 155.61 26.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.056 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.574 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 15.2 ttm -120.33 122.15 40.2 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' SER . 51.0 m -121.25 129.59 53.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.209 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.1 p -119.43 22.12 11.86 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.886 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.535 ' HG ' ' H ' ' A' ' 98' ' ' SER . 61.7 m -92.29 126.19 37.27 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.215 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.502 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 10.8 pt20 -59.9 -28.08 67.27 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.394 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.29 -49.15 76.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.872 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.835 ' O ' HG23 ' A' ' 117' ' ' ILE . 16.6 m -59.43 -40.44 81.71 Favored 'Isoleucine or valine' 0 C--N 1.361 1.068 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.472 ' N ' HG22 ' A' ' 113' ' ' VAL . 6.6 tp -56.86 -54.06 50.8 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.684 0.615 . . . . 0.0 111.534 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.502 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 61.4 m-85 -67.02 -42.5 84.8 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.341 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.38 -51.7 68.79 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.542 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.835 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.15 -43.3 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.378 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -57.88 -30.26 65.7 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.893 0.745 . . . . 0.0 109.79 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.511 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -86.16 -19.92 29.37 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.09 176.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.15 15.65 29.96 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.696 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.4 p -107.22 8.42 29.95 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.95 -138.02 9.84 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.261 -0.744 . . . . 0.0 112.641 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.56 171.19 16.14 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 123.332 2.688 . . . . 0.0 113.557 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.47 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -51.11 -57.16 9.43 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.211 1.004 . . . . 0.0 111.604 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.5 mmtt -140.03 156.59 46.54 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.533 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 73.5 m -149.26 161.83 41.24 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.6 tp -126.61 115.7 19.88 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.326 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 13.3 pt -97.4 102.12 13.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.781 0.801 . . . . 0.0 109.685 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.5 t -119.36 121.86 40.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.606 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 83' ' ' THR . 8.9 tp -67.32 113.7 5.43 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.111 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.24 173.17 6.08 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-N 114.714 -1.13 . . . . 0.0 114.314 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -128.49 178.23 6.44 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.314 0.578 . . . . 0.0 110.73 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -114.23 129.54 56.63 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.151 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.61 147.56 17.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.37 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.416 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 29.6 m-90 -125.33 136.31 53.34 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 123.886 0.403 . . . . 0.0 110.35 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -80.19 158.27 26.32 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.901 0.751 . . . . 0.0 110.66 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.76 89.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.16 -23.79 7.57 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.161 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -56.58 -46.31 80.85 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.949 0.5 . . . . 0.0 112.231 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.555 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.4 tp -67.22 -47.88 69.51 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -57.35 -30.55 64.93 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.467 0.479 . . . . 0.0 110.77 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.19 -50.3 41.56 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.914 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.6 pt-20 -71.85 -26.7 62.47 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.924 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.0 tp -75.06 -39.23 61.02 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.833 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.5 m -78.14 -30.37 49.27 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.507 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.5 t70 -80.24 0.49 32.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.674 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 59.72 29.85 19.43 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.826 0.85 . . . . 0.0 111.645 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.32 -41.75 19.66 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.794 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -123.47 112.21 17.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.9 tp -84.13 138.37 33.06 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.533 0.206 . . . . 0.0 111.148 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.9 p -105.19 138.89 40.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.311 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.2 m -152.57 155.47 32.7 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.725 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' A' ' 12' ' ' HIS . 31.7 Cg_exo -59.06 153.52 51.35 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.332 2.021 . . . . 0.0 111.12 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -129.09 168.36 16.21 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.75 135.76 24.01 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.138 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.48 -26.48 14.12 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 122.591 2.194 . . . . 0.0 113.687 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.43 -40.44 62.2 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.885 0.74 . . . . 0.0 112.132 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.584 HD13 HH12 ' A' ' 167' ' ' ARG . 4.8 mt -71.68 -34.8 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.385 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.33 -36.96 63.69 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.279 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -84.92 -35.32 22.18 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -84.13 -72.45 0.46 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.006 0.367 . . . . 0.0 111.624 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.881 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.67 99.61 6.23 Favored Pre-proline 0 C--N 1.348 0.539 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.855 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 64.7 Cg_endo -91.24 -0.84 4.78 Favored 'Trans proline' 0 CA--C 1.569 2.266 0 C-N-CA 121.637 1.558 . . . . 0.0 114.271 175.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.63 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 74.6 Cg_endo -74.18 -52.95 0.12 Allowed 'Trans proline' 0 C--N 1.392 2.861 0 C-N-CA 122.656 2.238 . . . . 0.0 114.519 -178.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.553 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.5 mt-10 -122.17 -30.35 4.04 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.746 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.881 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 5.0 tp10 -69.8 -11.42 60.84 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.364 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.584 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.96 -41.71 41.99 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.296 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.38 -50.04 42.92 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -58.29 -49.0 78.68 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.717 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.655 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.34 -39.96 94.94 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.122 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.13 -46.72 79.1 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.626 0.579 . . . . 0.0 110.461 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.45 91.24 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.398 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.6 -27.81 68.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.705 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.7 -40.01 42.77 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 122.876 0.47 . . . . 0.0 110.4 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -72.82 -30.37 64.0 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.44 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.744 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.841 179.68 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.468 ' H ' ' HD1' ' A' ' 35' ' ' HIS . 20.7 mt . . . . . 0 N--CA 1.466 0.37 0 CA-C-O 121.063 0.458 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -89.79 16.37 8.15 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.642 -177.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 173.06 56.75 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.141 0.976 . . . . 0.0 110.161 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -135.82 161.67 34.96 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.654 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 16.4 m-30 -97.68 136.29 38.25 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.553 ' O ' HG11 ' A' ' 29' ' ' VAL . 2.8 mt -108.49 136.6 47.83 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.703 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 mp -120.85 131.4 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.44 126.61 30.26 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.588 0.555 . . . . 0.0 111.92 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.2 mmt -114.29 155.26 45.94 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.22 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -79.47 75.82 4.86 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.662 2.241 . . . . 0.0 112.593 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -132.32 -20.35 2.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.779 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.34 -163.54 0.86 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.324 0.39 . . . . 0.0 110.46 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.521 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.51 36.31 2.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.925 0.393 . . . . 0.0 111.861 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.1 m-20 -111.1 82.97 3.49 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.798 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.38 -22.78 13.82 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.969 2.446 . . . . 0.0 113.417 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -85.13 -37.78 19.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.94 0.496 . . . . 0.0 111.713 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.6 -3.22 56.66 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.823 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -61.17 1.99 0.15 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -141.77 40.33 1.68 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.187 0.518 . . . . 0.0 112.005 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 p -123.71 156.09 36.6 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.535 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.553 HG11 ' O ' ' A' ' 14' ' ' LEU . 48.9 t -130.41 132.03 64.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.89 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -114.59 154.01 29.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.341 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.427 ' OH ' HD21 ' A' ' 105' ' ' LEU . 42.9 t80 -107.21 119.24 38.86 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.52 109.95 17.81 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.32 0.581 . . . . 0.0 111.098 -178.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.532 ' O ' HD21 ' A' ' 102' ' ' LEU . 30.3 t -71.85 -63.73 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 113.461 -1.699 . . . . 0.0 110.685 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -133.91 117.96 17.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.537 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.468 ' HD1' ' H ' ' A' ' 9' ' ' LEU . 13.6 t-80 -103.0 126.61 50.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.491 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -139.46 152.1 46.74 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.514 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -65.63 -14.86 62.04 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.046 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -103.79 -0.36 29.38 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.302 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.01 169.2 19.32 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 112.064 -0.414 . . . . 0.0 112.064 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.49 149.22 30.41 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.82 137.85 53.25 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.047 178.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 133' ' ' ALA . . . -157.41 159.46 29.79 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.461 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.3 mt -114.58 131.44 56.68 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.794 0.297 . . . . 0.0 111.111 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 78' ' ' GLY . 14.0 t -66.19 123.74 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.528 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.8 55.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.773 0.797 . . . . 0.0 112.064 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.86 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.1 t-20 -146.82 -4.0 0.58 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.131 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -130.17 89.5 44.89 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.454 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 41.0 Cg_exo -59.39 139.38 89.4 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 121.483 1.456 . . . . 0.0 111.19 174.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.5 m -76.63 -53.32 8.18 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.1 -9.14 20.87 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.173 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 3.1 mp -82.43 169.64 16.18 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.0 p-10 -112.47 156.94 21.72 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.689 0.281 . . . . 0.0 111.7 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.41 -31.71 67.96 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.347 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.46 74.55 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 39.4 mt-10 -65.28 -42.56 93.02 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.735 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.835 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.9 t -61.42 -50.09 81.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 22.1 mt -53.5 -35.23 60.4 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.062 0.851 . . . . 0.0 111.568 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -78.34 -29.46 47.58 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.254 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.4 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -78.46 -31.29 47.85 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.66 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.835 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.3 mt -77.6 -44.93 26.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.83 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -131.35 116.47 16.45 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.583 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.24 -32.82 2.88 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.725 2.95 . . . . 0.0 112.812 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.79 -15.03 55.53 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.293 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.75 149.28 25.39 Favored 'General case' 0 C--N 1.345 0.38 0 O-C-N 123.402 0.439 . . . . 0.0 111.609 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -118.21 123.04 29.73 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.114 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.94 147.77 34.63 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.231 1.954 . . . . 0.0 112.246 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.492 ' HD2' ' HG ' ' A' ' 70' ' ' CYS . 8.2 Cg_endo -94.45 -169.83 0.2 Allowed 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 122.608 2.206 . . . . 0.0 112.172 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.476 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -66.75 -24.84 66.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.089 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HG3' ' HG ' ' A' ' 70' ' ' CYS . 6.5 ptp180 -67.88 -47.02 70.02 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.492 ' HG ' ' HD2' ' A' ' 67' ' ' PRO . 13.1 m -75.24 -25.34 58.01 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 51.1 mt-30 -69.57 -30.4 68.17 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.476 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 22.9 p80 -94.9 22.33 6.6 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.144 0.497 . . . . 0.0 111.461 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 62.8 mt -118.3 136.17 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.318 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.611 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.7 m-20 -103.49 158.39 16.39 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 mm -108.23 149.1 11.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.991 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.725 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -115.54 156.62 25.4 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.82 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -86.4 120.32 27.62 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.55 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -102.0 -23.42 9.21 Favored Glycine 0 C--N 1.345 1.044 0 C-N-CA 120.322 -0.942 . . . . 0.0 114.134 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.23 -167.59 35.01 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.261 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -88.15 -11.39 4.47 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.521 2.814 . . . . 0.0 114.173 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 t -86.84 127.16 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.088 0.242 . . . . 0.0 110.563 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 49.68 76.88 0.12 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.127 0.971 . . . . 0.0 112.518 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.446 ' O ' HD23 ' A' ' 130' ' ' LEU . 9.8 t -80.87 1.96 28.54 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.687 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -103.78 3.95 34.61 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.491 HH21 ' HB3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -132.91 155.18 49.53 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.211 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.42 127.4 8.47 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.982 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.707 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -85.91 144.24 27.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.482 1.113 . . . . 0.0 110.383 179.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.6 t -121.82 104.71 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 123.231 0.332 . . . . 0.0 110.852 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 126' ' ' SER . 9.9 tp -106.98 129.03 54.84 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.946 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -127.8 168.77 14.17 Favored Pre-proline 0 CA--C 1.555 1.136 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.54 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.659 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.03 13.77 0.89 Allowed 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.784 2.322 . . . . 0.0 113.857 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.0 t -101.82 160.38 14.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.726 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.14 21.35 44.59 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.617 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -88.81 152.7 21.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.616 0.366 . . . . 0.0 110.511 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.0 m -131.02 156.9 44.35 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.559 ' CE2' HG23 ' A' ' 113' ' ' VAL . 40.1 m-85 -123.87 -150.86 0.46 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.753 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -58.27 -46.68 85.58 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.604 0.362 . . . . 0.0 111.488 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.9 m -132.77 80.81 1.91 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.097 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.543 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 31.7 m -130.45 130.04 43.75 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.756 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -110.16 123.6 50.04 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.791 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.36 125.41 30.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.271 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.532 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -119.39 44.63 2.31 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.609 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.41 -101.6 0.4 Allowed Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.354 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -56.29 -14.27 2.75 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.427 HD21 ' OH ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -160.81 160.95 31.8 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.844 0.458 . . . . 0.0 110.821 -179.31 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -119.49 158.23 26.69 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.76 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.526 ' O ' HG22 ' A' ' 99' ' ' THR . 15.8 ttm -123.23 130.07 52.25 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.2 m -124.83 129.27 50.09 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.871 0.367 . . . . 0.0 110.257 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.7 p -120.87 21.0 11.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.335 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.5 p -93.48 127.81 39.3 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.518 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 20.8 pt20 -60.99 -28.67 69.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.926 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.31 -39.68 94.39 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.497 -1.228 . . . . 0.0 110.198 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.739 ' O ' HG23 ' A' ' 117' ' ' ILE . 2.9 p -70.11 -37.7 72.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.486 ' N ' HG11 ' A' ' 113' ' ' VAL . 6.4 mt -56.82 -47.96 79.09 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.532 0.52 . . . . 0.0 110.239 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.518 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 32.1 m-85 -66.54 -42.61 86.91 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.017 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.72 -53.88 52.07 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.888 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.69 -43.2 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.549 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.34 -31.73 66.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.716 0.635 . . . . 0.0 109.602 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.98 -19.44 32.08 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.331 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.97 17.06 28.78 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.697 -1.138 . . . . 0.0 114.575 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.8 p -107.39 7.7 29.21 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.08 -137.34 8.58 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-O 119.168 -0.795 . . . . 0.0 112.628 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -80.78 172.1 13.62 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 123.13 2.554 . . . . 0.0 113.545 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.01 -55.34 33.99 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.86 0.864 . . . . 0.0 111.994 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.659 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.0 mmtt -141.16 139.82 33.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.667 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 73.1 m -139.51 166.39 24.7 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 tp -127.19 117.79 23.02 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.273 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.707 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 10.9 pt -97.49 102.31 13.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-O 121.724 0.774 . . . . 0.0 109.778 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.2 t -118.98 121.08 39.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.907 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 10.9 tp -67.51 112.73 4.84 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.355 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.65 172.44 11.82 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 115.012 -0.994 . . . . 0.0 114.376 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -128.68 176.36 7.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.333 0.587 . . . . 0.0 110.908 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -115.82 130.71 56.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.029 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.52 149.11 18.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.447 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 21.1 m-90 -127.26 135.89 51.23 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 122.579 0.351 . . . . 0.0 110.381 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.34 158.15 27.52 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.863 0.727 . . . . 0.0 110.876 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.95 91.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.8 -24.47 7.51 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.11 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.88 -45.35 86.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.573 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -67.97 -48.05 66.9 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.136 0.273 . . . . 0.0 110.516 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.01 -29.11 68.26 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.008 0.432 . . . . 0.0 110.667 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.38 -50.48 38.29 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.938 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -70.09 -26.5 64.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.773 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.8 tp -75.79 -38.91 57.79 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.804 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.0 m -77.8 -28.37 50.38 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.572 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -82.66 0.96 40.78 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.496 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.88 29.54 19.1 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.874 0.87 . . . . 0.0 111.622 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.66 -43.11 17.32 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.94 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -123.52 113.4 18.68 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.348 0.405 . . . . 0.0 110.043 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.4 tp -83.61 139.81 32.6 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.245 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.4 p -105.81 138.09 42.58 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.513 0.508 . . . . 0.0 111.335 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.6 m -152.73 155.35 32.39 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.713 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.75 157.24 28.89 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.298 1.998 . . . . 0.0 111.182 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.69 166.97 19.58 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -177.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.22 135.35 23.98 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.997 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.39 -26.46 14.33 Favored 'Trans proline' 0 C--N 1.364 1.363 0 C-N-CA 122.54 2.16 . . . . 0.0 113.785 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.85 -40.6 63.51 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.818 0.699 . . . . 0.0 112.158 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.55 HD13 HH12 ' A' ' 167' ' ' ARG . 4.6 mt -71.18 -35.24 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.408 0.623 . . . . 0.0 110.388 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.5 tt -73.98 -38.2 64.23 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.437 -177.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -85.57 -32.76 21.94 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -86.69 -72.58 0.5 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.054 0.388 . . . . 0.0 111.636 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.911 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.72 98.84 6.32 Favored Pre-proline 0 C--N 1.349 0.56 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.86 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.5 Cg_endo -92.68 0.2 3.83 Favored 'Trans proline' 0 CA--C 1.57 2.281 0 C-N-CA 121.737 1.625 . . . . 0.0 114.256 175.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.629 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 94.8 Cg_endo -73.28 -52.39 0.15 Allowed 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 122.656 2.237 . . . . 0.0 114.195 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.54 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -122.79 -29.93 3.92 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.664 -178.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.911 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.07 -10.91 60.28 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.407 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.55 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -77.03 -41.21 43.54 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.151 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -70.47 -50.21 40.47 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.5 m -58.38 -49.25 77.93 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.689 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.655 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.05 -39.81 94.91 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.228 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.42 79.63 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 123.536 0.523 . . . . 0.0 110.424 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.4 90.99 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.448 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.29 -27.87 68.93 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.673 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.66 -40.01 43.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 122.908 0.483 . . . . 0.0 110.412 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.53 -31.96 69.24 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.413 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.784 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.81 179.471 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.495 0.188 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.1 mttp -100.58 141.91 32.8 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.091 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -98.67 -42.02 7.43 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.986 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.535 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 54.5 m -100.69 154.47 18.57 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.456 0.473 . . . . 0.0 110.731 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m -98.51 96.63 3.92 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.089 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.3 Cg_endo -87.6 8.48 4.22 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 122.924 2.416 . . . . 0.0 112.083 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.49 HG21 ' N ' ' A' ' 8' ' ' TYR . 13.3 t -90.02 -46.14 8.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.342 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.49 ' N ' HG21 ' A' ' 7' ' ' THR . 3.8 m-85 -101.84 157.02 17.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.465 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.1 mt -94.05 45.91 1.15 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.211 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -90.19 20.0 4.67 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.928 0.394 . . . . 0.0 111.214 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 175.33 55.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.124 0.97 . . . . 0.0 110.116 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -134.25 159.47 40.86 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.654 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 16.5 m-30 -97.75 135.17 39.91 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.532 ' O ' HG12 ' A' ' 29' ' ' VAL . 6.0 mt -107.64 138.99 42.87 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.968 177.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.3 mm -117.26 134.11 61.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.14 128.54 33.41 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.749 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 43.2 mtt -113.75 157.4 41.79 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.268 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.56 32.74 0.52 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.655 2.237 . . . . 0.0 113.143 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -86.0 -18.3 32.94 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.71 -163.46 0.86 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.096 0.248 . . . . 0.0 110.451 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.514 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -99.24 31.73 2.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 7.9 m-20 -112.42 80.78 3.68 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.0 Cg_exo -75.44 -21.17 15.32 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 123.11 2.54 . . . . 0.0 113.276 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -85.53 -38.5 18.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.515 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -93.27 2.67 56.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.69 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 22' ' ' ASP . . . -68.23 8.24 0.47 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -141.87 39.42 1.65 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.152 0.501 . . . . 0.0 112.186 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.2 p -123.16 156.12 35.68 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.426 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 14' ' ' LEU . 59.5 t -130.25 132.7 64.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.902 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -113.41 152.91 29.42 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.415 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.529 ' OH ' HD22 ' A' ' 105' ' ' LEU . 43.6 t80 -107.23 120.07 41.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.04 108.57 17.06 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 123.515 0.509 . . . . 0.0 111.402 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.477 ' O ' HD21 ' A' ' 102' ' ' LEU . 31.2 t -67.45 -59.24 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.713 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -143.65 115.61 8.32 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.1 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -98.01 128.32 44.49 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.912 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -138.92 152.21 47.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.358 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.02 -17.91 64.85 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.881 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -102.31 3.29 37.91 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.52 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.54 166.89 15.16 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.285 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.409 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -145.92 141.07 27.44 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.91 133.92 55.45 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.125 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.542 ' O ' ' HB1' ' A' ' 133' ' ' ALA . . . -159.24 156.84 27.95 Favored Glycine 0 N--CA 1.449 -0.461 0 O-C-N 124.268 0.98 . . . . 0.0 112.492 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 mt -113.31 135.24 54.06 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.226 0.513 . . . . 0.0 111.638 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 78' ' ' GLY . 11.6 t -68.77 124.06 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -127.41 55.83 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.688 0.756 . . . . 0.0 111.961 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.847 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.0 t-20 -146.87 -4.16 0.57 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.23 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.437 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 2.5 ttt180 -129.72 87.89 51.09 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.482 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.1 Cg_exo -58.87 141.75 98.37 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 121.635 1.557 . . . . 0.0 112.176 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.425 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.9 m -90.29 158.02 17.37 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.41 0.444 . . . . 0.0 111.649 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.12 49.39 1.38 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.585 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.424 ' C ' HG12 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -133.22 155.36 49.5 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.337 -0.432 . . . . 0.0 109.99 -179.281 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 44.8 p-10 -112.39 161.08 17.08 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.578 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.6 tp -58.36 -27.03 63.83 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.663 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . . . -61.86 -42.79 99.48 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.45 -47.42 79.11 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.052 0.22 . . . . 0.0 111.423 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.859 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.8 m -61.76 -44.49 98.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.6 mt -55.54 -36.04 66.32 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.748 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.05 -28.14 48.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.409 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.405 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -78.07 -30.04 49.5 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.269 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.859 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.94 -46.22 21.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.759 -1.564 . . . . 0.0 111.372 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -132.7 118.68 15.72 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.003 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.4 -32.36 3.01 Favored 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.628 2.885 . . . . 0.0 112.556 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -82.18 -15.29 53.74 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.294 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.21 149.27 26.92 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 123.283 0.365 . . . . 0.0 111.42 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.94 121.45 31.55 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.64 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.709 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 47.2 Cg_endo -71.4 138.07 32.03 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.555 2.17 . . . . 0.0 112.339 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -90.07 -156.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.705 2.27 . . . . 0.0 112.532 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.09 -24.88 51.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.264 0.626 . . . . 0.0 111.824 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.515 ' O ' HG13 ' A' ' 73' ' ' ILE . 10.0 ptp180 -67.86 -45.42 74.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.709 ' SG ' ' HB2' ' A' ' 66' ' ' PRO . 19.5 p -65.59 -32.66 74.36 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -66.97 -26.84 67.02 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.664 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -97.49 8.28 44.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.734 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 69' ' ' ARG . 64.2 mt -113.58 137.73 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.179 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.516 ' O ' HD13 ' A' ' 128' ' ' ILE . 1.8 m-20 -106.75 163.31 13.03 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.873 0.733 . . . . 0.0 112.937 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.424 HG12 ' C ' ' A' ' 51' ' ' LEU . 14.0 mm -111.81 152.95 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.598 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.707 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -119.5 153.72 34.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.21 118.76 24.36 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.533 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -99.53 -23.93 10.59 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 120.185 -1.007 . . . . 0.0 113.797 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.41 -167.74 35.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.218 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -88.62 -10.53 4.4 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.702 2.935 . . . . 0.0 114.227 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.96 130.39 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 123.023 0.202 . . . . 0.0 111.098 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 45.94 85.02 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.431 1.092 . . . . 0.0 113.194 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 68.6 p -85.91 -5.81 59.17 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.953 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.87 -2.43 58.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.766 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.627 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.66 152.13 51.77 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.47 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.627 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.6 132.21 10.98 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.56 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -86.19 144.85 27.25 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.047 0.939 . . . . 0.0 110.756 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.29 104.49 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 123.474 0.484 . . . . 0.0 110.514 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 126' ' ' SER . 13.0 tp -108.32 129.53 55.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.213 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.422 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 4.3 p80 -127.04 169.07 12.89 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-O 118.874 -0.584 . . . . 0.0 111.769 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.68 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.5 Cg_endo -98.06 13.83 0.74 Allowed 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.856 2.37 . . . . 0.0 113.802 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.422 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 9.2 t -101.26 160.94 13.98 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.881 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.38 22.03 42.24 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.537 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 tp -86.8 154.05 21.2 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.613 0.365 . . . . 0.0 110.642 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.6 p -127.66 156.3 42.55 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.563 ' CE2' HG23 ' A' ' 113' ' ' VAL . 54.9 m-85 -129.96 -152.31 0.51 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.811 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -57.64 -46.58 83.98 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.76 0.424 . . . . 0.0 111.615 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 64.4 m -135.92 83.56 2.02 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.259 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.3 m -130.63 130.37 43.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.835 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.99 123.34 48.97 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.626 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.19 129.14 34.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.071 0.462 . . . . 0.0 110.747 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.477 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -125.12 46.27 2.39 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.419 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.12 -106.12 1.41 Allowed Glycine 0 C--N 1.336 0.575 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.162 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.6 -10.64 3.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.529 HD22 ' OH ' ' A' ' 31' ' ' TYR . 2.3 pp -156.12 153.29 29.09 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.237 0.335 . . . . 0.0 111.508 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.43 156.12 28.49 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.545 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.58 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 17.5 ttm -121.48 126.14 48.55 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 m -122.29 128.05 50.61 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.192 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.5 p -118.05 13.04 13.82 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.44 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.2 p -87.91 127.06 35.36 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.644 0.735 . . . . 0.0 111.952 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.491 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 21.1 pt20 -59.32 -29.11 67.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.358 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.97 -43.07 96.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.541 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 117' ' ' ILE . 4.7 p -67.76 -37.62 78.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.528 HD22 ' NH2' ' A' ' 85' ' ' ARG . 5.0 tp -58.4 -47.86 82.53 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 123.552 0.532 . . . . 0.0 110.266 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.491 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 26.4 m-85 -67.66 -39.91 84.51 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.813 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -52.45 64.74 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.351 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.71 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.93 -43.65 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.546 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.65 -32.32 65.25 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.774 0.671 . . . . 0.0 109.642 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.55 -20.03 32.18 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.238 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.44 14.41 32.77 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 114.693 -1.14 . . . . 0.0 114.785 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.8 p -104.58 7.55 35.14 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.23 -138.1 9.68 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 119.207 -0.774 . . . . 0.0 112.625 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.9 173.88 11.55 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 123.292 2.661 . . . . 0.0 113.536 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.21 -54.75 43.24 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.716 0.806 . . . . 0.0 111.962 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.68 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.9 mmtt -141.58 139.96 33.26 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.873 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 34.6 p -137.45 166.33 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.0 tp -126.97 116.06 20.2 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.577 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.703 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 11.5 pt -98.47 102.7 13.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.779 0.799 . . . . 0.0 109.647 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.4 t -123.01 123.98 42.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.818 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.36 115.79 7.4 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.493 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.415 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 66.75 172.47 5.09 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.633 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -128.41 -177.51 4.2 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.313 0.578 . . . . 0.0 110.864 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 42' ' ' GLY . . . -118.48 127.9 54.08 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.093 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.23 143.06 14.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.474 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.409 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 27.9 m-90 -119.28 137.37 53.72 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.773 0.337 . . . . 0.0 110.404 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -81.75 158.15 24.27 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.878 0.737 . . . . 0.0 110.539 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.56 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.81 -25.2 7.27 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.072 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -57.95 -44.58 87.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.93 0.492 . . . . 0.0 112.275 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.564 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.6 -47.76 65.87 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.146 0.279 . . . . 0.0 110.605 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.1 -29.53 68.65 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.958 0.408 . . . . 0.0 110.619 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.14 -50.36 41.31 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.872 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.0 pt-20 -70.17 -26.68 64.03 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.787 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tp -74.77 -38.94 62.04 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.645 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.3 m -77.84 -28.34 50.15 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.352 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.8 t70 -82.64 -0.28 46.45 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.472 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 60.07 29.01 18.62 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.865 0.866 . . . . 0.0 111.787 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.13 -42.8 18.62 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.942 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -125.58 115.25 19.87 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.0 tp -86.45 143.14 27.92 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.506 0.194 . . . . 0.0 111.465 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.9 p -103.7 135.91 44.39 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.058 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 76.9 m -151.23 155.06 34.55 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.626 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.88 159.19 26.02 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.253 1.969 . . . . 0.0 111.244 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -131.94 166.59 21.31 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -135.69 135.12 21.4 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.963 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.19 -26.41 14.81 Favored 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.597 2.198 . . . . 0.0 113.682 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.81 -40.57 63.38 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.847 0.717 . . . . 0.0 112.135 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.557 HD11 HH12 ' A' ' 167' ' ' ARG . 4.5 mt -71.43 -35.5 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.366 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.71 -37.79 65.04 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.482 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -84.86 -34.71 22.57 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -84.71 -72.52 0.47 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.924 0.329 . . . . 0.0 111.637 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.89 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.64 99.42 6.28 Favored Pre-proline 0 C--N 1.349 0.563 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.847 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.4 Cg_endo -91.86 -0.45 4.36 Favored 'Trans proline' 0 CA--C 1.57 2.284 0 C-N-CA 121.716 1.611 . . . . 0.0 114.262 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.626 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 77.6 Cg_endo -73.96 -52.34 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 122.589 2.193 . . . . 0.0 114.437 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.544 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.7 mt-10 -122.45 -30.02 4.01 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.714 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.89 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.1 tt0 -70.23 -10.85 60.14 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.391 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.557 HH12 HD11 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -77.06 -40.52 45.92 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -71.36 -49.88 37.79 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.207 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.1 t -58.41 -49.03 78.76 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.504 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.654 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.7 -40.25 95.05 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.249 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.21 78.52 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 123.516 0.51 . . . . 0.0 110.534 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.16 90.07 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.495 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.3 -27.69 68.8 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.538 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.73 -40.15 42.11 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 122.92 0.488 . . . . 0.0 110.264 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.37 -32.0 69.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.38 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.93 53.52 0.48 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.933 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.94 147.11 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -89.4 78.47 7.17 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.653 0.74 . . . . 0.0 110.654 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.71 -26.15 49.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.801 -1.09 . . . . 0.0 112.149 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.8 m -58.67 -42.65 88.93 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.55 -26.68 51.15 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.7 mt -77.08 -36.2 56.01 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.249 0.343 . . . . 0.0 111.87 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.0 p -92.71 -48.0 6.8 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.319 0.387 . . . . 0.0 111.198 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 59.03 125.32 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.241 1.017 . . . . 0.0 112.849 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -98.98 151.0 21.4 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.962 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -96.91 131.04 44.09 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.262 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -179.43 -112.68 0.35 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.429 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -101.85 144.04 30.99 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.658 0.269 . . . . 0.0 110.811 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.12 -0.943 . . . . 0.0 111.184 -179.969 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.495 0.188 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -100.34 107.91 19.81 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -140.06 -45.65 0.43 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.156 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.566 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 44.4 p -129.76 -40.0 1.4 Allowed 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.32 0.388 . . . . 0.0 111.504 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.0 m -106.31 88.27 3.12 Favored Pre-proline 0 CA--C 1.545 0.759 0 O-C-N 123.434 0.458 . . . . 0.0 110.978 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.3 Cg_endo -87.73 9.13 3.93 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.011 2.474 . . . . 0.0 112.378 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.588 ' HG1' ' H ' ' A' ' 8' ' ' TYR . 15.2 t -86.53 168.33 13.8 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.367 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.588 ' H ' ' HG1' ' A' ' 7' ' ' THR . 9.5 m-85 65.26 149.76 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.264 1.025 . . . . 0.0 112.6 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.0 mt -102.87 48.22 0.87 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.961 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -90.58 19.14 5.57 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.908 0.385 . . . . 0.0 111.072 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 175.88 55.96 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.087 0.955 . . . . 0.0 110.17 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -134.94 159.35 41.74 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.618 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.512 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.6 m-30 -98.08 135.12 40.21 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.09 0.471 . . . . 0.0 112.153 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.552 ' O ' HG11 ' A' ' 29' ' ' VAL . 6.1 mt -108.7 137.6 46.37 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.785 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 mp -120.51 132.69 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.82 127.57 33.17 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.722 0.639 . . . . 0.0 112.003 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.8 mmt -110.26 158.19 35.94 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.179 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -80.55 21.4 0.86 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.693 2.262 . . . . 0.0 113.549 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -83.07 -19.38 36.94 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.569 ' SD ' ' HB3' ' A' ' 148' ' ' ALA . 15.9 ptt? -102.31 -164.75 1.12 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.272 0.357 . . . . 0.0 110.38 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.525 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -106.74 30.9 5.68 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.5 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 7.9 m-20 -110.44 84.84 4.15 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.712 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.3 Cg_exo -75.31 -23.8 12.96 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.059 2.506 . . . . 0.0 113.48 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -85.11 -37.01 20.75 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.794 0.438 . . . . 0.0 111.557 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.85 3.06 55.97 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.499 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.5 ' HB1' ' O ' ' A' ' 22' ' ' ASP . . . -66.78 5.82 0.58 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -140.83 38.84 1.81 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.116 0.484 . . . . 0.0 112.156 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 p -123.14 155.02 37.84 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.417 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 14' ' ' LEU . 50.1 t -130.5 131.95 64.85 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.856 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -113.6 153.58 28.6 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.365 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.498 ' OH ' HD22 ' A' ' 105' ' ' LEU . 42.9 t80 -106.99 119.63 39.89 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.84 109.24 17.4 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.3 0.571 . . . . 0.0 111.25 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.544 ' O ' HD22 ' A' ' 102' ' ' LEU . 31.6 t -69.03 -59.65 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.674 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -141.96 114.34 8.3 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.337 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -97.45 128.29 44.11 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.754 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -139.4 152.64 47.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.34 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -65.11 -18.13 65.04 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.797 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -100.56 1.56 41.01 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.432 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.32 167.3 15.57 Favored Glycine 0 C--N 1.345 1.055 0 C-N-CA 121.541 -0.361 . . . . 0.0 112.205 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.02 142.49 29.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -120.62 135.51 55.08 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.57 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 133' ' ' ALA . . . -158.75 156.95 27.97 Favored Glycine 0 N--CA 1.449 -0.448 0 O-C-N 124.364 1.04 . . . . 0.0 112.817 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mt -111.93 131.63 55.26 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.9 0.35 . . . . 0.0 110.974 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 78' ' ' GLY . 18.1 t -66.89 125.35 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -128.22 55.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.715 0.769 . . . . 0.0 112.22 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.845 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.0 t-20 -147.19 -4.61 0.53 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.308 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.68 87.89 51.21 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.481 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.1 Cg_exo -59.3 141.11 97.32 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.631 1.554 . . . . 0.0 112.004 175.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.406 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 46.0 m -89.32 159.12 17.53 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.253 0.346 . . . . 0.0 111.638 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.28 45.55 1.46 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.363 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.439 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.7 154.37 51.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 16.6 p-10 -104.17 161.09 14.32 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.294 0.371 . . . . 0.0 110.783 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.469 HD21 ' SG ' ' A' ' 70' ' ' CYS . 15.3 tp -58.19 -35.78 72.11 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.25 61.14 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.525 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.65 -43.22 97.42 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.841 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -62.28 -48.31 88.96 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.435 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 4.5 mp -52.89 -36.63 59.6 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.977 0.798 . . . . 0.0 111.024 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -78.06 -28.62 48.94 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.466 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.29 -30.27 48.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.368 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.841 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.0 mt -77.89 -44.98 25.45 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.86 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -132.48 116.79 15.24 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.441 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.72 -32.66 2.64 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.619 2.879 . . . . 0.0 112.835 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -82.38 -13.99 55.96 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.429 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.3 148.63 25.53 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 123.329 0.393 . . . . 0.0 111.734 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.6 123.03 31.91 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.149 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.17 144.46 29.71 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.244 1.963 . . . . 0.0 112.553 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.406 ' C ' HE21 ' A' ' 71' ' ' GLN . 5.8 Cg_endo -92.8 -169.73 0.25 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.657 2.238 . . . . 0.0 112.248 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.48 -24.61 67.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.303 0.641 . . . . 0.0 112.202 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.569 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 9.1 ptp180 -66.76 -55.58 14.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.469 ' SG ' HD21 ' A' ' 53' ' ' LEU . 69.1 m -70.89 -25.56 62.84 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.406 HE21 ' C ' ' A' ' 67' ' ' PRO . 42.6 mt-30 -68.77 -32.76 72.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.772 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -91.77 19.56 6.38 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.614 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 69' ' ' ARG . 52.0 mt -122.28 140.92 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.858 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.587 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.6 m-20 -109.02 152.37 25.09 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.814 0.696 . . . . 0.0 112.44 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 51' ' ' LEU . 14.6 mm -99.6 153.48 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.237 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -120.24 152.48 37.68 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.7 119.42 24.28 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.76 0.254 . . . . 0.0 110.823 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -100.58 -23.76 9.9 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.732 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.04 -167.75 34.93 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.182 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -88.49 -8.28 5.4 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.614 2.876 . . . . 0.0 114.235 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.29 128.83 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 123.07 0.231 . . . . 0.0 111.087 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 45.01 86.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.532 1.133 . . . . 0.0 113.326 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 78.3 p -86.68 -2.45 58.53 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.995 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -88.68 -4.46 58.54 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.895 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.599 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.2 153.01 51.93 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.134 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.599 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.51 131.12 10.41 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.07 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.719 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.6 OUTLIER -85.59 151.13 24.15 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.253 1.021 . . . . 0.0 110.428 -179.647 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.626 ' HB ' ' OG ' ' A' ' 108' ' ' SER . 3.4 t -128.37 106.39 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 O-C-N 123.312 0.383 . . . . 0.0 111.159 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.592 ' HB2' ' SD ' ' A' ' 107' ' ' MET . 14.6 tp -108.45 127.79 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.041 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.491 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 4.2 p80 -128.42 168.27 16.25 Favored Pre-proline 0 CA--C 1.554 1.11 0 O-C-N 123.669 0.606 . . . . 0.0 111.411 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.649 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 14.8 Cg_endo -95.39 14.21 1.19 Allowed 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 122.526 2.151 . . . . 0.0 113.39 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.491 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 8.6 t -101.17 159.7 15.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.861 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.3 18.9 55.84 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.714 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.99 154.83 24.29 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.499 0.32 . . . . 0.0 110.922 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.4 p -126.37 157.64 37.97 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.663 ' H ' ' HG1' ' A' ' 99' ' ' THR . 50.3 m-85 -129.9 -149.54 0.4 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.433 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -61.15 -45.73 93.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.55 0.34 . . . . 0.0 111.18 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.3 m -137.54 83.06 1.96 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.234 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.663 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 8.0 m -128.22 122.35 31.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.718 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -99.89 120.77 40.3 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.987 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -83.54 127.26 33.59 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.167 0.508 . . . . 0.0 110.331 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.544 HD22 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.43 46.91 2.1 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.44 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.28 -107.72 2.09 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.103 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.41 -10.03 4.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.498 HD22 ' OH ' ' A' ' 31' ' ' TYR . 2.0 pp -155.14 153.63 31.08 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.256 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -121.47 158.57 28.12 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.783 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.592 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 25.8 tpp -125.28 140.12 53.11 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.626 ' OG ' ' HB ' ' A' ' 88' ' ' VAL . 21.4 p -134.06 133.16 40.85 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.933 0.396 . . . . 0.0 110.351 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.4 p -117.14 16.51 14.95 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.049 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.0 m -89.66 127.78 35.97 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.636 0.731 . . . . 0.0 112.023 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.479 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 10.1 pt20 -61.43 -28.81 69.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.973 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -65.81 -42.17 90.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.669 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.722 ' O ' HG23 ' A' ' 117' ' ' ILE . 3.8 p -67.38 -39.9 83.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.571 ' N ' HG11 ' A' ' 113' ' ' VAL . 6.4 tp -58.97 -47.36 85.41 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 123.592 0.557 . . . . 0.0 110.469 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.479 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 24.1 m-85 -69.36 -38.47 78.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.914 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.81 66.76 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.043 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.75 -43.47 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.348 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.25 -31.56 65.67 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.74 0.65 . . . . 0.0 109.588 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.569 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.63 -20.15 31.81 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.238 176.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.15 14.85 32.23 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.648 -1.16 . . . . 0.0 114.602 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.1 p -105.14 7.3 33.71 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.19 -138.74 10.01 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.715 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.8 168.06 17.94 Favored 'Trans proline' 0 C--N 1.367 1.526 0 C-N-CA 123.255 2.637 . . . . 0.0 113.956 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.492 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -51.11 -59.2 4.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.511 1.125 . . . . 0.0 111.897 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.649 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -140.19 139.88 35.78 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.783 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 32.6 p -137.93 168.38 19.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.66 118.25 23.5 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.685 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.0 pt -98.12 102.24 13.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 121.782 0.801 . . . . 0.0 109.738 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 5.6 t -119.35 122.36 41.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.847 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.5 tp -66.85 114.62 5.84 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.195 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.43 176.02 5.69 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.737 -1.119 . . . . 0.0 114.385 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -128.58 -178.55 4.63 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.437 0.636 . . . . 0.0 110.957 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -118.49 128.77 54.91 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.977 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.7 147.27 17.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.532 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 -125.46 136.86 53.82 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.93 0.429 . . . . 0.0 110.303 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.43 158.27 27.37 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.94 0.775 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.0 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.21 -25.6 7.75 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.182 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -57.84 -44.15 86.32 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.886 0.474 . . . . 0.0 112.257 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.571 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.72 -47.13 67.12 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.575 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -60.49 -29.4 69.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.025 0.44 . . . . 0.0 110.38 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.14 -50.09 43.98 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.802 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.35 -26.65 63.84 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.766 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.7 tp -75.0 -38.38 61.62 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.623 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.6 t -77.87 -28.65 50.05 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.12 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -82.46 0.02 44.19 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.429 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.44 29.82 19.43 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.839 0.856 . . . . 0.0 111.869 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.569 ' HB3' ' SD ' ' A' ' 20' ' ' MET . . . -83.16 -42.44 17.31 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.942 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -124.03 113.6 18.62 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.5 tp -84.36 141.9 30.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.643 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.0 p -103.27 134.85 45.98 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.651 0.595 . . . . 0.0 111.057 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.449 ' SG ' ' HD2' ' A' ' 153' ' ' PRO . 48.8 t -150.02 144.53 17.71 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.414 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.449 ' HD2' ' SG ' ' A' ' 152' ' ' CYS . 57.1 Cg_exo -53.0 157.45 8.12 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.467 2.111 . . . . 0.0 111.595 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.512 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.02 167.39 18.34 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -135.21 135.4 22.63 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 114.173 -1.376 . . . . 0.0 107.919 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.46 -26.4 14.25 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.601 2.2 . . . . 0.0 113.727 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.71 -40.66 63.2 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.832 0.708 . . . . 0.0 112.199 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.55 HD13 HH12 ' A' ' 167' ' ' ARG . 4.8 mt -71.25 -35.35 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.4 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -74.06 -37.55 64.23 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.438 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -84.87 -33.88 22.73 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -85.89 -72.63 0.48 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.016 0.371 . . . . 0.0 111.654 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.898 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.36 99.49 6.43 Favored Pre-proline 0 C--N 1.348 0.531 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.845 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 67.9 Cg_endo -92.01 -0.22 4.26 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 C-N-CA 121.678 1.585 . . . . 0.0 114.317 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.626 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 81.7 Cg_endo -73.98 -52.62 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.894 0 C-N-CA 122.61 2.206 . . . . 0.0 114.361 -178.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.544 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.15 -30.09 4.09 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.691 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.898 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 4.9 tp10 -70.0 -11.12 60.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.388 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.55 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.93 -41.61 42.71 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.259 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -70.36 -50.24 41.03 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.4 m -58.39 -49.57 76.8 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.656 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.653 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -63.99 -39.58 94.43 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.037 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.95 -45.48 78.82 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.583 0.552 . . . . 0.0 110.508 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.03 93.12 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.441 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 177' ' ' VAL . . . -64.58 -28.06 69.38 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.663 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.653 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.96 -40.18 40.25 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 122.865 0.466 . . . . 0.0 110.43 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.83 -33.77 75.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.407 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 129.46 40.86 0.26 Allowed Glycine 0 C--N 1.34 0.78 0 C-N-CA 121.06 -0.591 . . . . 0.0 113.175 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 173' ' ' ALA . 4.3 t -129.2 133.64 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -88.84 83.56 6.66 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.588 0.709 . . . . 0.0 111.033 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.97 -26.29 48.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.803 -1.089 . . . . 0.0 112.421 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.3 m -58.17 -44.85 88.19 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 pp -77.3 -26.98 52.78 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.15 -29.94 54.81 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.579 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.7 p -90.93 -48.03 7.24 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.454 0.471 . . . . 0.0 111.36 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.67 119.19 22.04 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.443 0.464 . . . . 0.0 111.004 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -100.67 137.54 38.93 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.77 136.15 52.02 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.145 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 153.65 -127.13 2.09 Favored Glycine 0 C--N 1.337 0.607 0 O-C-N 123.632 0.583 . . . . 0.0 112.537 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -99.19 -40.67 7.86 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.311 0.245 . . . . 0.0 111.302 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.126 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.572 0.225 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.1 mttp -100.53 137.56 38.78 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.068 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -99.23 -41.85 7.29 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.09 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.527 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.9 m -100.28 153.98 18.85 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.6 m -96.91 97.93 4.06 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.965 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.2 Cg_endo -87.2 8.83 4.16 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.879 2.386 . . . . 0.0 112.212 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 8' ' ' TYR . 15.1 t -89.2 -47.32 8.15 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.313 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.529 ' CD1' ' HE3' ' A' ' 10' ' ' LYS . 3.8 m-85 -117.31 153.39 33.05 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.513 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.9 mt -97.86 43.39 1.07 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.829 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.529 ' HE3' ' CD1' ' A' ' 8' ' ' TYR . 87.8 mttt -89.44 20.8 3.67 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.846 0.355 . . . . 0.0 111.355 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 174.66 54.62 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.024 0.929 . . . . 0.0 110.172 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -133.42 160.64 36.8 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.721 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 16.2 m-30 -97.97 137.68 36.42 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.567 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 2.8 mt -110.49 140.56 44.64 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.913 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mp -125.43 135.53 63.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.77 122.86 21.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.075 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -105.53 156.07 37.01 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -80.92 31.94 0.51 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.67 2.247 . . . . 0.0 113.197 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -87.36 -17.63 31.93 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.53 -169.6 1.65 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 123.076 0.235 . . . . 0.0 110.783 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.534 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -105.62 42.94 1.17 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.141 0.496 . . . . 0.0 111.561 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.48 81.83 2.54 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.934 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.2 Cg_exo -75.45 -22.16 14.32 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 123.083 2.522 . . . . 0.0 113.431 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -84.49 -36.49 22.2 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.871 0.468 . . . . 0.0 111.791 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.62 3.98 52.63 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.948 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.7 163.6 21.18 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 48.6 31.88 3.18 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.8 p -115.57 153.95 30.29 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 120.564 0.221 . . . . 0.0 110.735 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.6 t -127.58 132.1 69.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.805 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 m -114.84 152.59 31.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.889 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.509 ' OH ' HD21 ' A' ' 105' ' ' LEU . 38.0 t80 -106.59 118.43 36.64 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.426 HD11 ' O ' ' A' ' 41' ' ' MET . 0.2 OUTLIER -82.4 107.95 15.45 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 111.122 -178.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG11 ' SD ' ' A' ' 107' ' ' MET . 54.0 t -63.66 -61.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.811 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -145.49 116.41 7.79 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.09 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -98.06 127.74 44.18 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.559 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -139.09 152.9 47.89 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.545 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.83 -19.2 65.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.804 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.38 7.48 42.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.393 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.81 166.22 12.49 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.394 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.92 145.27 30.63 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.426 ' O ' HD11 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -124.72 137.41 54.35 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.474 178.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 133' ' ' ALA . . . -157.93 156.53 27.42 Favored Glycine 0 N--CA 1.447 -0.617 0 O-C-N 124.403 1.065 . . . . 0.0 112.566 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mt -111.16 133.32 53.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 117.108 0.454 . . . . 0.0 111.042 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 78' ' ' GLY . 15.0 t -69.09 123.68 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.706 ' O ' ' HG3' ' A' ' 167' ' ' ARG . 1.5 pt -127.68 52.52 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.232 0.539 . . . . 0.0 112.335 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.929 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 24.1 t-20 -144.56 -1.36 0.9 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.133 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -129.53 87.08 54.03 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.487 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 31.4 Cg_exo -59.2 144.58 99.33 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.805 1.67 . . . . 0.0 112.65 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.417 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 51.5 m -94.33 158.65 15.48 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.503 0.502 . . . . 0.0 111.371 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.75 50.69 1.22 Allowed Glycine 0 C--N 1.339 0.696 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.742 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mt -133.77 157.74 45.1 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 122.851 0.461 . . . . 0.0 110.151 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.63 ' ND2' ' HB1' ' A' ' 54' ' ' ALA . 10.1 p-10 -112.25 157.37 21.01 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.198 0.311 . . . . 0.0 110.172 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.734 ' O ' HG23 ' A' ' 56' ' ' VAL . 14.0 tp -56.81 -36.47 69.96 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.63 ' HB1' ' ND2' ' A' ' 52' ' ' ASN . . . -55.53 -35.32 65.53 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -64.67 -45.27 87.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.286 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.875 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 31.6 m -63.24 -43.48 98.76 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.453 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 4.0 mp -54.98 -36.75 65.72 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.83 0.706 . . . . 0.0 110.205 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -77.84 -27.78 49.98 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.499 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -78.16 -30.46 49.2 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.286 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.875 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.3 mt -77.87 -44.96 25.63 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.923 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -132.04 116.1 15.54 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.459 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.72 -32.88 2.52 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 123.611 2.874 . . . . 0.0 112.841 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.09 -14.09 56.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.414 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.35 149.26 24.62 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 123.33 0.394 . . . . 0.0 111.814 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -116.55 122.78 31.34 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.949 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.43 151.05 37.18 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.297 1.998 . . . . 0.0 112.506 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.514 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.2 Cg_endo -92.36 -162.59 0.1 Allowed 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.617 2.211 . . . . 0.0 111.706 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.45 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -73.25 -24.95 60.53 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.75 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -64.81 -50.78 65.41 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.471 ' SG ' HD22 ' A' ' 53' ' ' LEU . 61.2 m -72.61 -24.97 61.14 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 42.1 mt-30 -68.69 -34.84 76.35 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.45 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 23.5 p80 -90.73 22.57 3.48 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.193 0.52 . . . . 0.0 111.74 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 60.5 mt -121.8 139.52 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.188 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.55 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.7 m-20 -105.81 154.73 20.11 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.0 mm -102.09 151.62 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.739 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.692 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -119.44 154.66 33.37 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -85.18 121.27 27.69 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 117.789 0.268 . . . . 0.0 110.806 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -104.07 -23.7 8.0 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 120.209 -0.996 . . . . 0.0 114.207 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.01 -167.98 33.89 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.907 -0.664 . . . . 0.0 113.353 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -88.72 -16.17 2.48 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.404 2.736 . . . . 0.0 114.439 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.66 129.19 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.725 0.298 . . . . 0.0 111.518 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 47.72 82.97 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.527 1.131 . . . . 0.0 113.2 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.4 p -80.9 -14.83 57.64 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.918 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -76.94 -18.02 58.53 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.211 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.604 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.08 146.84 52.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.939 0.4 . . . . 0.0 111.825 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.604 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -112.18 150.42 18.19 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.782 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.516 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 1.3 m-85 -86.51 152.59 22.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.346 1.058 . . . . 0.0 111.321 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 3.4 t -126.3 103.76 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.627 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 126' ' ' SER . 1.1 mt -98.85 126.72 44.58 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.181 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.415 ' CE1' ' HB2' ' A' ' 106' ' ' ALA . 4.7 p80 -129.44 164.06 42.25 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.76 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 23.2 Cg_endo -99.27 23.74 0.21 Allowed 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 122.888 2.392 . . . . 0.0 113.92 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.403 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 13.5 t -107.6 160.82 15.39 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.756 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.25 18.98 56.51 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.685 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -91.78 153.78 19.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.553 0.341 . . . . 0.0 110.528 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.9 m -126.97 155.58 42.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.108 0.48 . . . . 0.0 112.112 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.528 ' CE2' HG23 ' A' ' 113' ' ' VAL . 51.2 m-85 -126.09 -150.89 0.46 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.837 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -58.82 -47.08 86.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.605 0.362 . . . . 0.0 111.372 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 m -132.19 81.26 1.95 Allowed 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.912 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 107' ' ' MET . 42.5 m -129.38 121.69 27.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.327 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 124.7 49.99 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.794 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -82.72 127.99 33.94 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.133 0.492 . . . . 0.0 111.141 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.441 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -120.28 46.47 1.97 Allowed 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.574 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.62 -107.07 1.76 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.281 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.69 -10.44 3.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.509 HD21 ' OH ' ' A' ' 31' ' ' TYR . 2.9 pp -154.86 158.76 39.85 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.335 0.397 . . . . 0.0 110.99 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.415 ' HB2' ' CE1' ' A' ' 90' ' ' HIS . . . -118.92 161.51 20.07 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.472 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.563 ' O ' ' HA ' ' A' ' 99' ' ' THR . 24.6 ttm -125.22 134.34 52.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.7 m -136.08 133.03 36.92 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 75.6 p -124.53 21.23 8.58 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.717 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.4 p -93.71 134.15 36.33 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 121.648 0.737 . . . . 0.0 112.345 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.476 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 4.9 mt-30 -62.51 -26.62 68.65 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.403 178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.41 -40.43 93.37 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.169 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.759 ' O ' HG22 ' A' ' 117' ' ' ILE . 3.4 p -71.68 -39.03 68.62 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.596 HD12 ' NH1' ' A' ' 85' ' ' ARG . 6.6 mt -57.25 -49.04 77.31 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 123.507 0.504 . . . . 0.0 110.874 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.476 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 35.5 m-85 -69.69 -38.55 77.03 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.216 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.64 -52.68 63.37 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.212 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.84 -43.74 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.432 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.93 -31.57 65.09 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 123.754 0.658 . . . . 0.0 109.615 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.09 -20.23 30.68 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.273 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.82 17.67 25.02 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.704 -1.134 . . . . 0.0 114.634 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.9 p -108.33 7.48 27.21 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.6 -137.76 9.32 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.793 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.45 175.21 9.81 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 123.216 2.611 . . . . 0.0 113.347 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -58.33 -53.08 62.32 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.509 0.723 . . . . 0.0 111.584 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.544 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.8 mmtt -139.24 153.76 47.89 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.71 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.4 m -150.05 163.33 38.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.1 tp -129.05 117.56 21.08 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.14 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.55 HD11 ' O ' ' A' ' 74' ' ' ASP . 12.3 pt -98.94 103.16 14.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.579 0.704 . . . . 0.0 109.475 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.1 t -121.21 120.46 35.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.846 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.45 115.34 6.96 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.335 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.42 167.9 10.76 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.226 -0.897 . . . . 0.0 114.091 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -128.45 178.0 6.6 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.167 0.508 . . . . 0.0 110.703 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -116.33 131.48 56.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.916 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.08 149.89 18.66 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.315 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.402 ' HZ2' ' CZ3' ' A' ' 149' ' ' TRP . 25.7 m-90 -130.15 136.9 49.78 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.833 0.372 . . . . 0.0 110.602 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.06 158.34 27.87 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.941 0.776 . . . . 0.0 111.064 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.88 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.12 -28.09 6.19 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.826 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -56.38 -46.4 80.09 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.006 0.522 . . . . 0.0 112.135 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.552 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.4 tp -67.33 -47.54 70.2 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -57.36 -30.27 64.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.473 0.483 . . . . 0.0 110.602 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.65 -49.97 41.75 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.887 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -72.12 -26.66 62.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.899 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 4.8 tp -75.78 -38.41 58.3 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.85 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -78.18 -30.9 49.31 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.315 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.43 0.77 31.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.641 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.74 29.88 19.45 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.813 0.845 . . . . 0.0 111.682 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.65 -42.92 19.27 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.78 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.402 ' CZ3' ' HZ2' ' A' ' 135' ' ' TRP . 11.3 m95 -122.42 112.04 17.6 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 123.388 0.43 . . . . 0.0 109.966 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -80.19 141.55 35.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.326 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.0 p -110.56 138.47 46.91 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.312 0.383 . . . . 0.0 111.212 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.5 m -152.89 155.6 32.31 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.527 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.02 155.96 36.43 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.226 1.951 . . . . 0.0 111.098 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.73 169.33 14.64 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -138.08 137.55 21.35 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 114.295 -1.321 . . . . 0.0 107.906 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.41 -26.46 12.14 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.491 2.128 . . . . 0.0 113.959 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.22 -36.31 60.88 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.824 0.703 . . . . 0.0 112.571 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.556 HD11 HH21 ' A' ' 167' ' ' ARG . 4.6 mt -75.68 -38.35 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.41 0.624 . . . . 0.0 110.254 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.1 tt -69.44 -36.65 76.86 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.906 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -86.38 -42.78 13.37 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -77.91 -71.24 0.43 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.778 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.42 96.35 6.36 Favored Pre-proline 0 C--N 1.346 0.445 0 CA-C-O 121.18 0.514 . . . . 0.0 111.966 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.929 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 63.7 Cg_endo -91.78 3.31 4.11 Favored 'Trans proline' 0 CA--C 1.567 2.156 0 C-N-CA 121.626 1.551 . . . . 0.0 114.407 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.645 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 60.9 Cg_endo -76.93 -52.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 122.435 2.09 . . . . 0.0 114.168 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.541 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 4.3 mt-10 -126.42 -24.36 3.64 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.468 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.778 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 27.6 tt0 -76.53 -12.97 60.11 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.762 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.706 ' HG3' ' O ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -77.19 -36.66 54.77 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.651 177.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.1 tp -73.47 -48.74 31.1 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 52.4 m -58.87 -45.31 90.49 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.527 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -67.22 -42.81 83.44 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.445 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.499 ' HB3' ' NH1' ' A' ' 167' ' ' ARG . . . -55.97 -45.86 78.78 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.494 0.496 . . . . 0.0 110.499 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.05 93.33 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.357 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.96 -26.95 68.52 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.663 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.76 -40.3 41.38 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 122.929 0.491 . . . . 0.0 110.175 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -71.87 -30.79 65.78 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.466 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 102.74 52.52 0.96 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.933 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.4 t -127.46 150.56 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -85.77 77.98 9.65 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.735 0.779 . . . . 0.0 110.697 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.66 -26.3 50.27 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.924 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.5 t -56.22 -38.66 71.35 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.364 0.666 . . . . 0.0 112.773 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.08 -26.54 53.57 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 10.8 mt -76.72 -34.69 58.11 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.34 0.4 . . . . 0.0 111.482 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 11.0 p -85.94 -48.25 8.88 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.452 0.47 . . . . 0.0 111.658 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -128.98 118.07 21.99 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 123.53 0.519 . . . . 0.0 111.244 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -99.55 146.04 26.85 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.8 146.48 26.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.136 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 157.25 88.03 0.06 OUTLIER Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.447 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -128.19 143.81 51.07 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.648 0.263 . . . . 0.0 110.867 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.501 -0.761 . . . . 0.0 111.036 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.322 0.106 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -100.7 143.72 30.52 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.418 0.449 . . . . 0.0 110.559 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -108.99 -41.29 4.76 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.977 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.5 m -97.22 151.34 19.94 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 123.441 0.463 . . . . 0.0 111.109 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.4 m -95.35 99.73 4.96 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.966 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.0 OUTLIER -85.9 7.45 5.03 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.774 2.316 . . . . 0.0 112.281 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.1 m -113.12 -53.76 2.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.716 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -112.58 151.44 30.06 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.39 0.431 . . . . 0.0 111.667 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.512 ' H ' ' HD1' ' A' ' 35' ' ' HIS . 19.2 mt -98.28 50.84 1.01 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.076 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -92.41 17.7 9.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.1 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.618 ' CE1' ' HH ' ' A' ' 31' ' ' TYR . 5.7 t-80 175.51 55.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.841 0.856 . . . . 0.0 109.79 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.429 ' CD2' ' HA ' ' A' ' 153' ' ' PRO . 30.0 m80 -138.57 160.8 38.69 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 18.6 m-30 -99.2 137.37 37.81 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.01 0.433 . . . . 0.0 111.867 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 3.7 mt -107.43 141.4 38.89 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.118 177.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 150' ' ' LEU . 2.8 mp -121.24 136.76 57.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 O-C-N 123.419 0.449 . . . . 0.0 110.006 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.23 124.83 28.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.027 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.4 ' HB3' ' HD1' ' A' ' 19' ' ' HIS . 35.3 mtt -109.78 157.54 37.35 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.211 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.78 30.93 0.52 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.686 2.257 . . . . 0.0 113.185 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.4 ' HD1' ' HB3' ' A' ' 17' ' ' MET . 42.8 m80 -86.06 -18.89 31.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.65 -167.13 1.15 Allowed 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.068 0.23 . . . . 0.0 110.617 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.33 40.4 1.48 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.993 0.425 . . . . 0.0 111.737 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -111.98 80.88 3.32 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.883 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.8 Cg_exo -75.55 -22.99 13.34 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.045 2.497 . . . . 0.0 113.187 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -84.56 -34.97 23.12 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.933 0.493 . . . . 0.0 111.753 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.56 3.85 52.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.992 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 164.34 19.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.82 0.343 . . . . 0.0 111.82 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 49.04 31.1 3.16 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.5 p -116.87 154.7 30.32 Favored 'General case' 0 C--O 1.24 0.59 0 O-C-N 122.347 -0.221 . . . . 0.0 110.553 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 85.2 t -129.16 133.64 65.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-O 121.429 0.633 . . . . 0.0 110.832 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -113.85 153.78 28.6 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.755 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.618 ' HH ' ' CE1' ' A' ' 11' ' ' HIS . 32.4 t80 -107.66 118.77 37.62 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.73 109.97 17.93 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-O 121.465 0.65 . . . . 0.0 110.935 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.441 ' O ' HD13 ' A' ' 102' ' ' LEU . 33.5 t -72.03 -63.2 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.639 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.518 ' OE2' HD11 ' A' ' 100' ' ' LEU . 7.7 tt0 -134.11 118.49 17.78 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.592 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.512 ' HD1' ' H ' ' A' ' 9' ' ' LEU . 15.3 t-80 -103.67 127.49 51.11 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.737 0.303 . . . . 0.0 110.754 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -138.88 151.51 47.02 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.246 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.57 -12.64 54.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -108.2 1.91 22.45 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.416 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.7 166.2 16.01 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 121.608 -0.329 . . . . 0.0 112.335 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.32 146.27 29.64 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.85 136.95 54.27 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.078 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 133' ' ' ALA . . . -158.97 161.71 32.13 Favored Glycine 0 C--O 1.228 -0.277 0 O-C-N 124.785 1.303 . . . . 0.0 112.573 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.442 HD22 ' C ' ' A' ' 42' ' ' GLY . 2.9 mt -117.35 133.77 55.59 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.943 0.371 . . . . 0.0 111.267 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 78' ' ' GLY . 10.7 t -66.13 122.88 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.538 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.12 54.44 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.607 0.718 . . . . 0.0 112.104 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.848 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.6 t-20 -147.49 -3.93 0.53 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.145 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -129.56 87.82 51.78 Favored Pre-proline 0 CA--C 1.556 1.181 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.487 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 40.4 Cg_exo -58.74 143.15 99.11 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 121.716 1.611 . . . . 0.0 112.415 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.426 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 66.5 m -93.28 158.67 15.63 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.485 0.491 . . . . 0.0 111.497 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.14 51.04 1.06 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.658 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.41 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -133.17 156.1 48.09 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.961 0.448 . . . . 0.0 110.054 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.476 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 15.6 p-10 -112.23 158.25 19.93 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.552 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.452 ' HG ' ' CD1' ' A' ' 57' ' ' LEU . 15.5 tp -57.4 -37.09 72.15 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.46 -37.27 62.49 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.476 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 36.8 mt-10 -64.97 -42.48 94.53 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.006 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.855 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -62.63 -46.32 96.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.452 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 4.1 mp -54.37 -36.8 64.25 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 123.81 0.694 . . . . 0.0 110.674 177.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.76 -27.86 50.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.486 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.417 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -78.41 -30.41 47.72 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.309 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.855 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.2 mt -77.64 -44.95 26.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.848 -1.523 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -132.38 116.54 15.28 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.496 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -77.49 -33.13 2.56 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.619 2.879 . . . . 0.0 112.823 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.08 -13.87 56.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.398 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.46 149.72 24.24 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 123.382 0.426 . . . . 0.0 111.752 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.16 123.88 29.64 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.021 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.16 145.68 35.32 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.204 1.936 . . . . 0.0 112.444 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.499 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.8 Cg_endo -92.2 -169.78 0.28 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.652 2.235 . . . . 0.0 111.932 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.499 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -64.44 -24.95 67.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.04 0.536 . . . . 0.0 112.135 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -66.11 -53.17 41.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.442 ' SG ' HD23 ' A' ' 53' ' ' LEU . 61.6 m -71.79 -25.05 61.85 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 48.3 mt-30 -67.88 -35.81 79.15 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.499 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 21.4 p80 -90.52 23.78 2.87 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.164 0.507 . . . . 0.0 111.689 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 53.5 mt -121.52 138.46 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.487 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.554 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.7 m-20 -106.27 163.11 13.08 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 51' ' ' LEU . 17.1 mm -112.25 153.41 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.141 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.701 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -117.36 155.62 29.27 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -85.67 118.57 25.25 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.825 0.284 . . . . 0.0 110.551 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.564 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.52 -23.72 8.22 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 120.05 -1.071 . . . . 0.0 114.135 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.46 -167.84 34.11 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.511 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.44 -14.44 3.16 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 123.526 2.817 . . . . 0.0 114.412 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.9 124.07 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 123.103 0.252 . . . . 0.0 111.036 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.611 HE21 ' HH ' ' A' ' 132' ' ' TYR . 43.6 mt-30 50.84 77.0 0.14 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.196 0.999 . . . . 0.0 112.512 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.8 m -79.37 -12.86 59.91 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.561 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.7 0.51 52.56 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.587 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.16 153.73 51.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.587 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.47 132.38 11.08 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.137 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.791 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.76 145.7 27.13 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.486 1.114 . . . . 0.0 110.69 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.16 103.89 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.401 0.438 . . . . 0.0 110.771 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 126' ' ' SER . 13.7 tp -107.2 129.1 54.91 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.876 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.422 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 3.9 p80 -127.03 168.5 14.51 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-O 118.921 -0.561 . . . . 0.0 111.705 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.651 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.4 Cg_endo -97.03 12.2 1.05 Allowed 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 122.829 2.353 . . . . 0.0 113.793 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.422 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 8.9 t -99.76 160.67 14.12 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.791 -178.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.96 21.12 47.88 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.532 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -86.73 154.2 21.14 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.625 0.37 . . . . 0.0 110.568 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.8 p -127.34 156.85 41.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.556 ' CE2' HG21 ' A' ' 113' ' ' VAL . 52.3 m-85 -129.19 -151.57 0.48 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.668 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -59.14 -46.5 88.19 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.547 0.339 . . . . 0.0 111.413 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 57.9 m -134.37 83.22 2.02 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.495 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.6 m -130.98 128.97 41.5 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.847 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.518 HD11 ' OE2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.57 124.23 50.16 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.506 178.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.38 128.17 34.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.089 0.471 . . . . 0.0 110.972 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.28 48.08 1.89 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.378 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.72 -109.86 3.14 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 114.724 -1.126 . . . . 0.0 113.056 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.09 -8.41 5.38 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.498 HD22 ' OH ' ' A' ' 31' ' ' TYR . 2.8 pp -152.84 152.77 31.94 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.29 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.74 157.16 28.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.839 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.568 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.8 ttm -121.13 126.63 50.23 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.9 m -122.7 128.78 51.0 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.834 0.349 . . . . 0.0 110.176 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.4 p -119.39 16.54 13.03 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.318 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.6 t -88.9 127.61 35.65 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.515 0.674 . . . . 0.0 111.445 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.49 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 10.1 pt20 -59.98 -30.49 69.15 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.235 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -64.58 -42.15 95.81 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.732 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.721 ' O ' HG23 ' A' ' 117' ' ' ILE . 4.5 p -67.78 -37.98 79.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.545 HD21 ' NH2' ' A' ' 85' ' ' ARG . 3.9 tp -59.27 -48.64 80.87 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 123.449 0.468 . . . . 0.0 110.19 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.49 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 36.8 m-85 -68.52 -38.25 80.71 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.959 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.68 -51.76 67.11 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.21 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.721 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.69 -43.43 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.304 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.3 -31.3 65.5 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.759 0.662 . . . . 0.0 109.6 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.23 -19.95 30.88 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.129 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.79 16.4 28.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 114.705 -1.134 . . . . 0.0 114.623 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.1 p -106.86 7.46 30.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.16 -138.18 9.71 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-O 119.23 -0.761 . . . . 0.0 112.625 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.85 173.68 11.8 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.205 2.603 . . . . 0.0 113.554 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.06 -54.57 45.3 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.735 0.814 . . . . 0.0 111.988 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.651 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.2 mmtt -140.98 143.7 34.63 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.82 -178.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.0 m -141.09 165.01 28.72 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.0 tp -127.61 117.02 21.23 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.466 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.791 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.5 pt -98.33 102.46 13.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-O 121.934 0.873 . . . . 0.0 109.82 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.493 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 9.0 t -119.34 124.05 45.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.784 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.4 tp -67.09 113.73 5.29 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.385 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.82 175.16 8.49 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 114.665 -1.152 . . . . 0.0 114.576 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.611 ' HH ' HE21 ' A' ' 82' ' ' GLN . 0.2 OUTLIER -128.49 176.3 7.85 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.342 0.591 . . . . 0.0 110.474 178.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -115.92 130.68 56.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.062 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.04 145.9 16.61 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.476 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -121.24 136.47 54.97 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.242 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.05 158.08 25.21 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.824 0.703 . . . . 0.0 110.746 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.78 90.71 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.24 -25.19 7.5 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.164 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -57.57 -44.24 85.16 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.558 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.9 -47.96 64.51 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.16 0.287 . . . . 0.0 110.634 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.52 -28.79 68.67 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.002 0.43 . . . . 0.0 110.665 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.82 -50.74 32.23 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.797 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.0 pt-20 -69.67 -26.62 64.47 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.845 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.91 -38.37 57.82 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.722 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -77.82 -28.42 50.26 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -83.2 0.75 44.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.426 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 59.41 29.11 18.63 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.796 0.838 . . . . 0.0 111.818 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.76 -43.18 18.74 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.956 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -124.38 114.29 19.33 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.9 tp -85.59 139.88 31.06 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.629 0.252 . . . . 0.0 111.418 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -104.46 137.31 42.52 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.038 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.0 m -150.94 154.88 34.9 Favored Pre-proline 0 N--CA 1.469 0.51 0 O-C-N 123.515 0.509 . . . . 0.0 110.909 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.429 ' HA ' ' CD2' ' A' ' 12' ' ' HIS . 31.7 Cg_exo -59.28 152.58 59.34 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.32 2.013 . . . . 0.0 111.055 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.76 167.84 16.71 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.76 135.62 23.74 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.105 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.3 -26.47 14.51 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 122.605 2.203 . . . . 0.0 113.66 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.39 -40.72 62.44 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 123.909 0.756 . . . . 0.0 112.19 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.589 HD12 HH12 ' A' ' 167' ' ' ARG . 4.9 mt -71.36 -34.96 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.304 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.32 -36.99 63.72 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.335 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -84.66 -35.47 22.6 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -84.71 -72.5 0.47 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.963 0.347 . . . . 0.0 111.726 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.655 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -141.82 99.02 6.24 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.848 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 70.9 Cg_endo -91.95 -0.29 4.31 Favored 'Trans proline' 0 CA--C 1.57 2.29 0 C-N-CA 121.773 1.649 . . . . 0.0 114.351 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.628 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 69.0 Cg_endo -74.87 -50.03 0.14 Allowed 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 122.738 2.292 . . . . 0.0 114.519 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.527 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.3 mt-10 -122.39 -33.98 3.36 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.713 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 8.4 mt-10 -68.86 -10.9 59.5 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.077 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.589 HH12 HD12 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.86 -41.8 42.54 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.091 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.9 tp -70.41 -50.07 42.33 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 44.3 m -58.49 -49.12 78.51 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.633 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.658 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.17 -39.82 94.82 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.129 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.15 78.53 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.608 0.568 . . . . 0.0 110.6 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.44 91.09 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.499 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.96 -27.85 69.12 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.611 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.84 -40.05 41.55 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 122.831 0.452 . . . . 0.0 110.355 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -68.58 -33.37 73.95 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.346 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 126.27 43.89 0.26 Allowed Glycine 0 C--N 1.34 0.759 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.155 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.7 t -129.22 136.85 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -89.98 82.1 6.18 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.662 0.744 . . . . 0.0 110.969 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -77.83 -26.36 49.42 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.324 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 53.2 m -58.62 -45.35 89.41 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.37 -26.83 52.28 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 22.0 mt -77.21 -30.14 54.58 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.577 0.351 . . . . 0.0 111.675 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 24.0 p -90.27 -48.21 7.29 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.342 0.402 . . . . 0.0 111.475 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.6 119.09 21.98 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.052 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -100.66 140.43 34.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.925 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.13 130.69 51.54 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.038 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 144.8 142.58 3.88 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.519 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -128.82 144.85 51.28 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.68 0.282 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.091 -0.956 . . . . 0.0 111.118 -179.964 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.584 0.23 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -99.95 138.59 36.82 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.154 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -99.1 -42.19 7.19 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.021 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.0 p -103.13 152.46 21.4 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.824 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 m -94.55 104.47 14.24 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.108 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -87.07 7.77 4.67 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.765 2.31 . . . . 0.0 112.021 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.473 HG21 ' N ' ' A' ' 8' ' ' TYR . 14.7 t -93.74 -47.48 6.76 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.026 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.473 ' N ' HG21 ' A' ' 7' ' ' THR . 3.2 m-85 -109.0 155.16 21.21 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.399 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 mt -95.91 43.94 1.08 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.008 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.425 ' HE3' ' CD2' ' A' ' 8' ' ' TYR . 87.5 mttt -89.81 20.34 4.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.934 0.397 . . . . 0.0 111.242 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 174.53 55.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.126 0.971 . . . . 0.0 110.1 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -133.62 159.38 40.67 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.643 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 15.4 m-30 -97.3 135.72 38.81 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.534 ' O ' HG13 ' A' ' 29' ' ' VAL . 2.8 mt -107.99 137.04 46.67 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.848 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.3 mm -117.01 133.88 62.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 O-C-N 123.493 0.495 . . . . 0.0 109.721 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.05 120.33 18.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.488 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 150' ' ' LEU . 91.4 mtp -110.18 154.88 42.61 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.22 77.71 3.89 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.59 2.193 . . . . 0.0 112.932 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -135.68 -19.41 1.6 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.025 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.98 -164.19 0.91 Allowed 'General case' 0 CA--C 1.541 0.631 0 O-C-N 123.191 0.307 . . . . 0.0 110.495 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.534 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.92 37.84 2.06 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.052 0.453 . . . . 0.0 111.856 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 7.9 m-20 -110.51 83.79 3.55 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.827 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.1 Cg_exo -75.26 -24.62 12.25 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.03 2.486 . . . . 0.0 113.442 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -85.09 -37.84 19.81 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.931 0.492 . . . . 0.0 111.573 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.53 -3.4 57.63 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.84 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 22' ' ' ASP . . . -59.85 0.25 0.16 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -141.19 41.56 1.78 Allowed 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.234 0.54 . . . . 0.0 112.052 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.1 p -124.28 157.27 35.31 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.686 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 14' ' ' LEU . 59.3 t -131.27 132.8 62.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.617 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -114.48 153.54 29.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.615 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.428 ' OH ' HD22 ' A' ' 105' ' ' LEU . 44.4 t80 -107.14 118.71 37.42 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.88 109.1 16.71 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.095 0.474 . . . . 0.0 111.232 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.56 ' O ' HD21 ' A' ' 102' ' ' LEU . 38.9 t -67.28 -62.53 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 113.853 -1.522 . . . . 0.0 110.515 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -140.54 115.68 9.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.163 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -98.22 127.46 44.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.604 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -139.29 152.93 47.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.48 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.542 ' HB3' ' NE2' ' A' ' 38' ' ' GLN . 17.9 tt0 -64.73 -21.02 66.66 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.405 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.542 ' NE2' ' HB3' ' A' ' 37' ' ' GLU . 1.7 mp0 -96.65 0.89 50.49 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.487 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.38 168.35 16.44 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 112.209 -0.356 . . . . 0.0 112.209 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.83 144.33 30.19 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -122.82 136.14 54.77 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.564 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 133' ' ' ALA . . . -157.78 158.83 29.41 Favored Glycine 0 N--CA 1.447 -0.581 0 O-C-N 124.454 1.097 . . . . 0.0 112.529 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mt -113.35 132.92 55.4 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.025 0.412 . . . . 0.0 111.129 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 78' ' ' GLY . 12.4 t -67.98 124.54 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.532 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -127.53 55.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.606 0.717 . . . . 0.0 112.196 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.853 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.0 t-20 -146.43 -3.3 0.64 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.072 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.454 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 2.8 ttt180 -130.11 89.82 44.09 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.455 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 52.6 Cg_exo -57.82 140.65 94.44 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 121.55 1.5 . . . . 0.0 111.763 174.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.406 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 56.4 m -71.23 -44.63 64.97 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.03 -15.94 56.17 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.226 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.66 162.06 16.52 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.506 0.323 . . . . 0.0 110.168 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.596 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.2 p-10 -100.92 160.63 14.21 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 tt -58.48 -28.65 65.55 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.076 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.588 ' HB1' ' ND2' ' A' ' 52' ' ' ASN . . . -62.07 -39.76 93.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.599 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.67 -46.98 85.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.637 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.85 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 17.1 m -62.32 -43.45 98.09 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.6 mt -56.94 -34.95 68.53 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.544 176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -78.15 -27.34 48.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.262 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.81 -30.65 51.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.129 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.85 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.8 mt -77.79 -45.48 24.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.789 -1.551 . . . . 0.0 111.12 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -131.7 116.16 15.96 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.631 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -77.71 -32.62 2.66 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.659 2.906 . . . . 0.0 112.755 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.1 -14.55 55.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.35 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.7 149.9 24.56 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.35 0.407 . . . . 0.0 111.685 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.5 mp -118.34 122.52 30.13 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.178 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.98 153.02 41.58 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.307 2.005 . . . . 0.0 112.26 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 7.1 Cg_endo -94.21 -165.31 0.12 Allowed 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.596 2.198 . . . . 0.0 112.263 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.448 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -71.38 -24.84 62.15 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.196 0.598 . . . . 0.0 111.964 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 12.0 ptp180 -67.1 -46.99 72.54 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 16.6 m -72.84 -25.57 61.16 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 48.8 mt-30 -70.54 -26.99 63.82 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.448 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 25.3 p80 -99.21 16.51 22.6 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 123.439 0.462 . . . . 0.0 111.722 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 70.0 mt -114.35 138.63 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.313 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.589 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.9 m-20 -106.16 151.46 24.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.3 mm -102.61 151.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.613 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.738 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.9 t80 -118.27 155.23 30.94 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.625 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.94 121.34 28.43 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.535 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -103.35 -23.53 8.4 Favored Glycine 0 C--N 1.345 1.042 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.195 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.67 -167.77 35.31 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.313 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -88.59 -12.21 3.8 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.588 2.859 . . . . 0.0 114.358 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -86.37 128.75 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 123.07 0.231 . . . . 0.0 111.171 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 45.35 82.15 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.564 1.145 . . . . 0.0 113.132 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.0 p -84.04 -8.25 59.18 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.206 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.62 -3.87 59.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.631 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.72 152.98 51.6 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.631 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.58 135.39 12.82 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.073 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.708 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -86.16 146.16 26.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.304 1.042 . . . . 0.0 110.573 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.9 103.58 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 123.47 0.481 . . . . 0.0 110.533 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 126' ' ' SER . 11.4 tp -107.18 128.59 54.54 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.981 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.44 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 4.0 p80 -128.29 167.44 18.92 Favored Pre-proline 0 CA--C 1.554 1.122 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.799 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.669 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 17.9 Cg_endo -97.42 19.91 0.43 Allowed 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.67 2.247 . . . . 0.0 113.563 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.44 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 9.1 t -107.69 160.56 15.61 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.835 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.27 22.08 41.84 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.587 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -84.98 152.88 23.15 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 122.618 0.367 . . . . 0.0 110.487 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.7 p -128.0 156.81 42.13 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.563 ' CE2' HG23 ' A' ' 113' ' ' VAL . 56.4 m-85 -130.44 -150.97 0.45 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.726 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -58.91 -46.16 88.57 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.655 0.382 . . . . 0.0 111.511 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.8 m -137.41 82.64 1.94 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.285 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 107' ' ' MET . 12.8 m -127.77 123.42 35.25 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.425 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -102.71 120.92 41.42 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.744 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.53 125.01 29.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.172 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.56 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -119.51 43.59 2.59 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.722 -179.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.81 -100.59 0.29 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.264 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -56.08 -14.53 2.71 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.428 HD22 ' OH ' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -160.91 160.23 30.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.842 0.457 . . . . 0.0 110.951 -179.283 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.77 156.97 27.38 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.625 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.575 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.4 ttm -123.3 129.7 51.7 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.3 m -125.99 129.22 48.79 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.9 p -119.98 14.56 12.39 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.658 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.3 m -87.14 130.15 34.65 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.425 0.631 . . . . 0.0 112.042 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.498 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 21.0 pt20 -61.45 -28.67 69.45 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.101 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.37 -44.14 92.3 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.452 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.722 ' O ' HG23 ' A' ' 117' ' ' ILE . 4.4 p -67.9 -34.83 69.58 Favored 'Isoleucine or valine' 0 C--N 1.354 0.792 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.472 ' N ' HG13 ' A' ' 113' ' ' VAL . 2.5 tm? -59.13 -49.61 77.22 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 123.693 0.62 . . . . 0.0 109.81 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.498 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 31.5 m-85 -67.19 -39.63 86.42 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.955 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -52.97 62.59 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.456 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.722 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.0 -43.86 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.524 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.93 -32.03 65.55 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.72 0.637 . . . . 0.0 109.594 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.44 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.69 -19.7 32.38 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.232 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.69 14.93 33.17 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.718 -1.128 . . . . 0.0 114.633 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.5 p -105.58 7.9 33.02 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.18 -138.35 9.14 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.283 -0.732 . . . . 0.0 112.731 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.64 168.02 18.25 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.141 2.561 . . . . 0.0 113.968 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.485 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -49.39 -59.67 3.52 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.537 1.135 . . . . 0.0 111.837 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.669 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.5 mmtt -141.43 139.81 33.48 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 69.5 m -138.02 169.07 18.43 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 tp -126.41 118.14 24.37 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.296 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 10.1 pt -96.95 102.14 13.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 121.465 0.65 . . . . 0.0 109.711 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 7.2 t -118.9 119.13 33.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.099 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.19 112.93 4.74 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.136 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 169.81 11.26 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.005 -0.998 . . . . 0.0 114.186 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.6 177.54 6.95 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.196 0.522 . . . . 0.0 110.83 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -117.72 131.93 56.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.51 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.47 149.67 18.72 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.363 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 24.4 m-90 -129.09 135.55 49.05 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 123.855 0.385 . . . . 0.0 110.465 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.05 158.17 29.3 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.784 0.678 . . . . 0.0 111.129 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.23 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.54 -26.75 6.83 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.935 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -55.93 -45.59 78.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.076 0.55 . . . . 0.0 112.06 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.557 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.2 tp -67.37 -47.16 71.21 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.58 -30.51 65.32 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.426 0.454 . . . . 0.0 110.747 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.5 -50.19 40.52 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.91 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -71.61 -26.64 62.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.945 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.3 tp -75.11 -39.21 60.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.937 0.895 . . . . 0.0 110.806 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 m -78.15 -30.21 49.09 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.553 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -80.38 0.19 34.24 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.701 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 60.42 29.47 19.04 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.757 0.823 . . . . 0.0 111.723 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.92 -42.46 19.46 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.813 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -123.97 112.07 16.77 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 123.383 0.427 . . . . 0.0 109.865 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.536 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 7.0 tp -83.57 138.65 33.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.275 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.5 p -103.6 137.66 41.35 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.578 0.549 . . . . 0.0 111.307 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 73.0 m -152.86 155.6 32.36 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.544 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.51 159.81 22.43 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.2 1.933 . . . . 0.0 111.366 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -131.74 167.24 19.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -134.85 135.14 22.68 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.941 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.45 -26.42 14.23 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 122.613 2.208 . . . . 0.0 113.81 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.89 -40.64 63.67 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.857 0.723 . . . . 0.0 112.147 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.553 HD13 HH12 ' A' ' 167' ' ' ARG . 4.5 mt -71.08 -35.52 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.348 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.74 -38.7 64.68 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.417 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.38 -32.36 22.44 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -87.01 -72.68 0.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.145 0.429 . . . . 0.0 111.656 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.914 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.79 98.81 6.29 Favored Pre-proline 0 C--N 1.35 0.608 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.853 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 62.4 Cg_endo -92.71 0.37 3.81 Favored 'Trans proline' 0 CA--C 1.57 2.306 0 C-N-CA 121.715 1.61 . . . . 0.0 114.288 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.632 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 98.0 Cg_endo -73.25 -52.41 0.15 Allowed 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.583 2.189 . . . . 0.0 114.245 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.54 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -122.82 -29.85 3.92 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.7 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.914 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.05 -11.14 60.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.437 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.553 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -77.02 -40.39 46.71 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -71.07 -50.21 36.33 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.6 m -58.49 -48.49 80.62 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.611 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.646 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.86 -40.16 94.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.298 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.43 -46.78 80.11 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 123.498 0.499 . . . . 0.0 110.368 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.83 88.81 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.406 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.27 -27.83 68.91 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.59 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.53 -39.79 44.89 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 122.841 0.456 . . . . 0.0 110.3 178.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.2 -31.47 67.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.455 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 108.24 51.66 0.71 Allowed Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.963 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.8 t -128.47 149.54 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -88.77 78.95 7.55 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.666 0.746 . . . . 0.0 110.769 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.78 -26.34 49.64 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.025 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.8 t -59.76 -43.13 94.44 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.6 -26.45 50.71 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.61 -37.84 55.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.551 0.34 . . . . 0.0 111.893 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.8 p -94.59 -48.57 6.03 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.285 0.366 . . . . 0.0 111.373 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 56.8 115.36 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.063 0.945 . . . . 0.0 112.775 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -110.75 131.84 54.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -102.37 131.1 49.22 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.067 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.24 -95.43 0.11 Allowed Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.508 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -99.32 -40.39 7.94 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.665 0.274 . . . . 0.0 111.291 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.21 0 CA-C-O 118.472 -0.775 . . . . 0.0 111.114 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 120.318 0.104 . . . . 0.0 111.272 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -100.25 118.18 36.01 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.428 0.455 . . . . 0.0 110.99 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -136.74 -55.01 0.73 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.064 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.1 m -141.84 -50.89 0.4 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.256 0.348 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 55.4 m -132.79 87.07 41.97 Favored Pre-proline 0 CA--C 1.543 0.71 0 O-C-N 123.362 0.414 . . . . 0.0 110.849 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -87.6 7.26 4.75 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.006 2.471 . . . . 0.0 112.537 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 m -117.7 -54.85 2.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.836 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -108.34 155.87 20.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.713 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.414 ' H ' ' HD1' ' A' ' 35' ' ' HIS . 12.6 mt -97.77 50.36 1.04 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.865 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -92.66 21.3 5.6 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.897 0.38 . . . . 0.0 110.686 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.602 ' CE1' ' HH ' ' A' ' 31' ' ' TYR . 4.3 t60 178.01 54.64 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.586 0.754 . . . . 0.0 110.268 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -139.17 160.14 40.5 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 30' ' ' THR . 11.5 m-30 -100.57 138.09 38.1 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.089 0.471 . . . . 0.0 112.021 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 4.3 mt -107.47 141.09 39.43 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.341 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.406 HD11 ' O ' ' A' ' 150' ' ' LEU . 2.8 mp -120.73 134.32 64.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 O-C-N 123.522 0.514 . . . . 0.0 109.759 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.73 126.18 30.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.085 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.2 mtt -110.32 157.15 38.92 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.222 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.52 29.84 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.611 2.207 . . . . 0.0 113.188 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -86.14 -16.29 38.37 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.15 -167.45 1.22 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.009 0.193 . . . . 0.0 110.641 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.503 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.28 40.39 1.48 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.995 0.426 . . . . 0.0 111.694 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.32 80.5 3.45 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.781 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.2 Cg_exo -75.41 -21.92 14.64 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.008 2.472 . . . . 0.0 113.327 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -84.44 -36.07 22.61 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.966 0.507 . . . . 0.0 111.852 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.29 4.01 51.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.098 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.35 163.47 20.63 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.896 0.379 . . . . 0.0 111.849 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 49.4 32.04 4.33 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.2 p -117.55 153.66 32.83 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 120.469 0.176 . . . . 0.0 110.556 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.549 HG11 HH11 ' A' ' 167' ' ' ARG . 77.4 t -128.49 133.71 66.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.583 0.706 . . . . 0.0 110.596 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 6.2 m -114.76 152.98 31.15 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.87 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.602 ' HH ' ' CE1' ' A' ' 11' ' ' HIS . 13.2 t80 -106.29 118.63 37.13 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.474 HD11 ' O ' ' A' ' 41' ' ' MET . 0.2 OUTLIER -82.84 108.55 16.27 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.432 0.634 . . . . 0.0 110.927 -179.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.513 ' O ' HD21 ' A' ' 102' ' ' LEU . 35.8 t -68.89 -60.36 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 113.228 -1.805 . . . . 0.0 110.576 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -142.26 113.48 7.65 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.62 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.414 ' HD1' ' H ' ' A' ' 9' ' ' LEU . 16.6 t-80 -97.34 128.74 44.43 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.672 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -139.71 153.27 47.19 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.604 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.25 -18.82 65.62 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.701 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.44 0.88 43.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.414 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.88 166.99 15.44 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.37 143.4 30.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.474 ' O ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -124.62 137.95 54.34 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.341 178.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' O ' ' HB1' ' A' ' 133' ' ' ALA . . . -160.23 158.65 30.03 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.531 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 mt -112.83 131.54 55.66 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.935 0.367 . . . . 0.0 110.939 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 78' ' ' GLY . 41.2 t -67.93 124.68 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.554 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.1 pt -129.85 55.35 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.524 0.678 . . . . 0.0 112.347 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.863 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 24.7 t-20 -144.27 -7.76 0.7 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.286 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -130.39 92.26 35.97 Favored Pre-proline 0 CA--C 1.555 1.145 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.49 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.5 Cg_exo -61.09 146.4 97.68 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 121.747 1.631 . . . . 0.0 112.602 175.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.411 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 44.9 t -89.14 162.96 15.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.557 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.69 -5.78 62.78 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-O 119.75 -0.472 . . . . 0.0 114.242 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.424 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -88.89 151.45 22.33 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.104 0.452 . . . . 0.0 111.566 -179.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.49 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 41.2 p-10 -98.55 165.74 11.68 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.655 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 57' ' ' LEU . 13.9 tp -59.03 -26.88 64.96 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.601 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . . . -61.95 -42.5 99.18 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.49 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 41.4 mt-10 -62.39 -47.35 84.52 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.072 0.233 . . . . 0.0 111.492 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.869 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.7 m -61.68 -45.34 98.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 53' ' ' LEU . 6.9 mt -54.48 -35.97 63.64 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.972 0.795 . . . . 0.0 110.742 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -78.13 -28.0 48.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.467 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.418 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.98 -30.38 50.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.375 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.869 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.1 mt -77.93 -46.62 20.7 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.749 -1.569 . . . . 0.0 111.376 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -131.89 118.18 16.42 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.003 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.33 -32.33 3.07 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.665 2.91 . . . . 0.0 112.56 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -82.22 -15.07 54.41 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.296 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.42 149.15 26.86 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.368 0.418 . . . . 0.0 111.425 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.57 121.78 31.59 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.743 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.66 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 46.4 Cg_endo -71.26 138.16 32.6 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.575 2.183 . . . . 0.0 112.423 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.454 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 2.7 Cg_endo -90.38 -157.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.733 2.289 . . . . 0.0 112.403 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.04 -25.07 52.1 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.249 0.62 . . . . 0.0 111.824 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.466 ' HA ' ' NE2' ' A' ' 72' ' ' HIS . 6.4 ptp180 -66.54 -46.14 77.12 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' A' ' 66' ' ' PRO . 18.5 p -67.49 -29.57 69.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 71.4 mt-30 -65.75 -32.85 74.63 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.466 ' NE2' ' HA ' ' A' ' 69' ' ' ARG . 32.9 p80 -95.37 9.94 38.11 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.432 0.458 . . . . 0.0 112.021 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 69' ' ' ARG . 71.0 mt -108.64 137.68 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.519 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.7 m-20 -109.55 153.07 24.65 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.822 0.702 . . . . 0.0 112.711 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 51' ' ' LEU . 25.6 mm -101.21 153.58 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.125 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.698 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -117.13 156.03 28.31 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 32.4 m-20 -89.26 117.4 28.19 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 117.832 0.287 . . . . 0.0 110.465 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.525 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -102.53 -23.24 9.0 Favored Glycine 0 C--N 1.35 1.358 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.817 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.53 -167.86 35.25 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.727 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -88.59 -14.74 2.97 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.501 2.801 . . . . 0.0 114.383 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -82.11 125.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 123.126 0.266 . . . . 0.0 111.166 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.471 HE21 ' HH ' ' A' ' 132' ' ' TYR . 47.9 mt-30 45.36 89.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.582 1.153 . . . . 0.0 113.216 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.2 p -85.65 -10.17 56.17 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.931 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.26 -9.94 59.68 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.8 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.597 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.09 151.5 52.01 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.597 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.28 142.31 16.55 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.153 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.5 m-85 -86.77 149.37 24.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.077 -1.062 . . . . 0.0 110.528 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.594 ' HB ' ' OG ' ' A' ' 108' ' ' SER . 5.1 t -126.83 103.96 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 123.627 0.579 . . . . 0.0 110.194 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 126' ' ' SER . 16.0 tp -106.28 127.55 53.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.309 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.428 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 4.5 p80 -128.57 168.9 14.17 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.444 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.624 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.6 Cg_endo -97.31 17.75 0.56 Allowed 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.682 2.255 . . . . 0.0 113.555 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.428 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 8.5 t -105.32 158.86 16.33 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.895 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.34 22.23 41.98 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.483 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -84.62 155.09 22.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.661 0.384 . . . . 0.0 110.491 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.8 p -125.74 156.49 39.32 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.572 ' CE2' HG22 ' A' ' 113' ' ' VAL . 58.1 m-85 -131.5 -151.24 0.45 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.494 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -60.3 -46.55 89.47 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.44 0.296 . . . . 0.0 111.291 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.1 m -136.68 83.5 2.01 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.21 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 107' ' ' MET . 7.4 m -128.03 121.08 28.86 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.909 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -99.58 120.68 40.05 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.913 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.96 126.89 33.01 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.403 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.513 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -123.98 50.52 1.63 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.578 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.83 -111.94 4.28 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.151 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.77 -6.68 6.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 pp -151.36 151.89 32.38 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.17 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -121.09 158.13 28.56 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.851 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.56 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 25.3 tpp -125.73 140.03 53.04 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.594 ' OG ' ' HB ' ' A' ' 88' ' ' VAL . 25.2 p -134.98 133.23 39.27 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.813 0.339 . . . . 0.0 110.435 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.4 p -118.76 15.44 13.54 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.0 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.2 p -90.27 130.08 36.43 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.661 0.743 . . . . 0.0 112.424 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.486 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 20.3 pt20 -61.75 -27.01 68.42 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.401 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.28 -42.26 93.34 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.495 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 117' ' ' ILE . 4.1 p -69.77 -38.3 75.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.532 ' N ' HG11 ' A' ' 113' ' ' VAL . 6.4 tp -57.93 -48.46 79.87 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 123.68 0.613 . . . . 0.0 110.573 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.486 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 26.1 m-85 -68.77 -39.17 80.36 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.806 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.39 -53.0 62.28 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.306 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.35 -43.86 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.718 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.6 -32.1 64.93 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.782 0.676 . . . . 0.0 109.599 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.02 -20.01 31.11 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.291 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.67 13.82 33.83 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.668 -1.151 . . . . 0.0 114.799 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 p -103.83 6.48 36.61 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.38 -137.57 9.16 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.419 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.74 171.81 14.0 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.069 2.513 . . . . 0.0 113.493 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.19 -55.24 37.29 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.642 0.777 . . . . 0.0 111.998 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.624 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.0 mmtt -141.23 139.69 33.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.691 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 34.5 p -139.01 168.58 19.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.3 tp -126.97 117.38 22.4 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.804 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.642 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.4 pt -98.64 102.45 13.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-O 121.532 0.682 . . . . 0.0 109.536 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.0 t -121.24 122.32 39.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.025 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 tp -66.58 112.97 4.41 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.544 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 173.71 18.5 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 114.545 -1.207 . . . . 0.0 114.764 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.471 ' HH ' HE21 ' A' ' 82' ' ' GLN . 0.1 OUTLIER -127.82 175.06 8.62 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.25 178.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 42' ' ' GLY . . . -115.54 129.01 56.38 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.154 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.73 150.23 18.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.375 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -128.37 138.23 52.26 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.858 0.387 . . . . 0.0 110.344 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.71 157.65 27.13 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.885 0.741 . . . . 0.0 110.622 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.74 91.67 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.54 -23.51 8.95 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.322 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -57.44 -44.55 84.8 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.938 0.495 . . . . 0.0 112.14 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.571 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.9 tm? -67.87 -47.7 68.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.5 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.35 -30.0 68.08 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.05 -49.96 45.92 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.941 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -70.71 -26.76 63.55 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.694 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.4 tp -74.18 -38.98 63.51 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.602 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.9 m -77.84 -28.4 50.16 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.211 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 3.0 t70 -82.25 -1.42 49.29 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.395 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.2 m120 61.03 28.5 18.26 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.857 0.863 . . . . 0.0 111.903 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.96 -43.54 17.91 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.856 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -124.77 113.38 17.86 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.0 tp -86.21 138.49 31.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.5 p -101.66 136.33 41.68 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.502 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 80.6 m -150.78 150.92 29.25 Favored Pre-proline 0 C--O 1.238 0.487 0 O-C-N 123.412 0.445 . . . . 0.0 110.983 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.05 151.06 83.97 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.233 1.956 . . . . 0.0 110.997 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -134.29 176.85 8.23 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -134.56 140.26 35.04 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 113.725 -1.58 . . . . 0.0 108.693 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.83 -26.71 13.14 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.735 2.29 . . . . 0.0 113.646 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.65 -41.79 55.78 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.857 0.723 . . . . 0.0 112.46 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.5 mt -68.83 -33.83 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.526 0.679 . . . . 0.0 110.276 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.66 -37.23 56.58 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.538 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -84.83 -31.21 23.96 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -88.7 -73.24 0.51 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 117.97 0.35 . . . . 0.0 111.628 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.854 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.82 99.8 6.12 Favored Pre-proline 0 C--N 1.35 0.589 0 CA-C-O 121.183 0.516 . . . . 0.0 112.228 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.863 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 72.4 Cg_endo -91.18 -0.11 4.79 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 121.711 1.608 . . . . 0.0 114.381 175.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.634 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 89.3 Cg_endo -74.92 -56.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.395 2.976 0 C-N-CA 122.653 2.235 . . . . 0.0 114.579 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.581 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 4.7 mt-10 -118.43 -30.67 5.15 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.542 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.854 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 28.5 tt0 -69.7 -12.18 61.43 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.235 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.549 HH11 HG11 ' A' ' 29' ' ' VAL . 3.7 tpm_? -77.1 -43.88 32.57 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.59 -49.2 64.25 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.4 m -58.21 -48.66 79.67 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.789 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.558 ' O ' ' HG3' ' A' ' 174' ' ' ARG . . . -63.25 -41.92 99.12 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.494 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.01 87.88 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.577 0.548 . . . . 0.0 110.82 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.51 -37.14 85.89 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.53 -28.19 69.48 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.152 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 170' ' ' ALA . 9.1 mtm105 -77.28 -40.78 43.31 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 123.291 0.636 . . . . 0.0 110.757 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 tp -69.61 -31.24 69.25 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.449 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.39 48.92 0.37 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.129 -0.557 . . . . 0.0 113.046 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.4 t -128.35 140.64 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -89.76 79.38 6.74 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.732 0.777 . . . . 0.0 110.833 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -77.93 -26.16 48.79 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.225 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.7 m -59.1 -43.83 91.9 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.59 -26.52 50.79 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.2 mt -77.04 -36.65 55.92 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 23.7 p -94.22 -48.61 6.11 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.27 0.356 . . . . 0.0 111.204 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 58.11 120.09 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.248 1.019 . . . . 0.0 112.762 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -100.54 149.88 23.26 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.88 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -98.45 130.35 45.06 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.152 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 134.78 66.37 0.07 OUTLIER Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.461 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -127.96 -40.59 1.68 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.609 0.24 . . . . 0.0 111.25 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.116 -179.944 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.496 0.188 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -101.45 131.08 47.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.056 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -100.27 -41.23 7.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.16 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.492 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.5 m -98.71 153.25 18.86 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.449 0.468 . . . . 0.0 111.005 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.7 p -94.5 100.05 4.72 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.074 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.1 Cg_endo -87.08 9.06 4.09 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.86 2.373 . . . . 0.0 112.232 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 8' ' ' TYR . 15.2 t -86.99 -47.92 8.55 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.381 -1.282 . . . . 0.0 112.292 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.456 ' N ' HG22 ' A' ' 7' ' ' THR . 6.2 m-85 -115.76 151.35 35.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.393 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.405 ' O ' HD13 ' A' ' 32' ' ' LEU . 15.8 mt -95.77 48.59 1.14 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.297 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.0 tttt -88.82 16.09 7.37 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.378 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.424 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 17.3 p80 172.83 58.87 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.43 1.092 . . . . 0.0 109.698 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -135.22 159.36 41.78 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.659 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.518 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.7 m-30 -97.1 136.17 38.01 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.533 ' O ' HG13 ' A' ' 29' ' ' VAL . 3.2 mt -108.42 137.12 46.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.793 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.3 mm -117.04 133.23 64.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.545 0.528 . . . . 0.0 109.635 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.54 121.94 21.42 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 123.461 0.475 . . . . 0.0 111.666 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.6 mmt -110.47 152.91 43.63 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.338 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -80.45 73.96 5.77 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.594 2.196 . . . . 0.0 112.622 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -131.46 -19.22 2.75 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.716 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.58 -162.97 0.83 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.3 0.375 . . . . 0.0 110.481 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.516 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.73 36.66 2.24 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.869 0.366 . . . . 0.0 111.968 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.37 82.71 3.66 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.809 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.32 -24.87 11.93 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 123.019 2.48 . . . . 0.0 113.349 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -85.16 -37.11 20.57 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.887 0.475 . . . . 0.0 111.595 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.11 -3.04 57.46 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.8 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -60.51 1.62 0.13 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -141.46 41.48 1.75 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.213 0.53 . . . . 0.0 112.076 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.9 p -124.52 157.68 34.73 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.642 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 14' ' ' LEU . 57.6 t -131.0 133.51 62.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.806 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -115.04 152.37 32.59 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.381 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.546 ' OH ' HD22 ' A' ' 105' ' ' LEU . 43.4 t80 -106.95 120.99 43.54 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 11' ' ' HIS . 0.1 OUTLIER -83.73 108.62 16.9 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 123.481 0.488 . . . . 0.0 111.419 -178.273 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.471 ' O ' HD21 ' A' ' 102' ' ' LEU . 36.9 t -67.76 -59.97 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.623 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -141.93 120.8 12.75 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.433 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -102.35 127.94 49.13 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.988 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.84 151.85 47.35 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.418 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.3 -19.59 65.52 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.893 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -98.4 -1.63 41.07 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.681 0.613 . . . . 0.0 111.533 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.03 169.73 20.56 Favored Glycine 0 C--N 1.344 1.012 0 C-N-CA 121.529 -0.367 . . . . 0.0 112.304 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.32 146.97 30.88 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.81 135.74 53.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.363 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.54 ' O ' ' HB1' ' A' ' 133' ' ' ALA . . . -158.21 158.36 29.13 Favored Glycine 0 N--CA 1.447 -0.619 0 O-C-N 124.472 1.107 . . . . 0.0 112.486 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 mt -112.9 134.59 54.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 117.253 0.526 . . . . 0.0 111.469 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 78' ' ' GLY . 12.0 t -68.35 122.94 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.38 56.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.618 0.723 . . . . 0.0 111.98 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.846 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.8 t-20 -147.04 -3.43 0.58 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.256 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -129.92 88.08 49.91 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.481 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 41.4 Cg_exo -58.44 144.62 96.42 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 121.689 1.593 . . . . 0.0 112.43 175.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.441 ' HG ' ' N ' ' A' ' 77' ' ' ASN . 73.9 m -94.82 160.45 14.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.509 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.72 51.04 0.94 Allowed Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.687 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.475 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.6 OUTLIER -133.19 154.05 50.98 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.871 0.395 . . . . 0.0 110.042 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.596 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 10.3 p-10 -112.43 157.6 20.86 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.25 0.343 . . . . 0.0 110.918 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 tt -57.54 -26.66 61.71 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.596 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -67.94 -40.39 83.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.383 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.42 -45.57 86.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.092 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.849 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.6 m -61.88 -45.06 99.53 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.6 mt -55.74 -35.26 65.97 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.546 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.99 -27.25 49.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.429 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.426 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.82 -30.54 51.19 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.768 0.794 . . . . 0.0 109.318 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.849 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.2 mt -77.86 -46.01 22.64 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.038 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -130.99 116.63 16.91 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.626 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.56 -33.08 2.54 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.687 2.925 . . . . 0.0 112.785 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.63 -14.92 56.1 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.4 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.19 149.69 24.45 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 123.338 0.399 . . . . 0.0 111.689 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.06 123.13 29.09 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.304 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.52 154.15 39.86 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.296 1.997 . . . . 0.0 112.301 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.476 ' HD2' ' HG ' ' A' ' 70' ' ' CYS . 6.8 Cg_endo -94.14 -163.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.67 2.247 . . . . 0.0 112.064 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.44 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -74.05 -24.76 59.57 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.782 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.512 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 7.9 ptp180 -67.11 -46.49 74.04 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.476 ' HG ' ' HD2' ' A' ' 67' ' ' PRO . 20.8 m -73.31 -25.58 60.71 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 46.3 mt-30 -70.45 -29.09 65.57 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.44 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 25.7 p80 -96.09 21.31 8.96 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.16 0.505 . . . . 0.0 111.582 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 57.0 mt -119.53 137.12 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.204 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.584 ' O ' HD13 ' A' ' 128' ' ' ILE . 2.1 m-20 -106.06 163.12 13.02 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 51' ' ' LEU . 14.2 mm -113.63 154.18 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.996 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.719 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -118.11 155.83 29.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.594 0.358 . . . . 0.0 110.33 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.441 ' N ' ' HG ' ' A' ' 49' ' ' SER . 2.4 t-20 -85.76 119.99 26.7 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.531 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -101.85 -23.64 9.15 Favored Glycine 0 C--N 1.346 1.109 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.158 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.86 -167.91 34.87 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.272 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -88.73 -13.03 3.39 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 123.618 2.878 . . . . 0.0 114.413 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.55 130.52 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 123.075 0.235 . . . . 0.0 111.518 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 46.66 82.85 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.551 1.141 . . . . 0.0 113.301 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 77.2 p -82.85 -12.02 57.76 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.197 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.76 -13.46 59.42 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.62 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.81 149.73 52.23 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.62 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.29 144.42 17.02 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.46 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.574 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.2 m-85 -86.85 149.4 24.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.021 -1.09 . . . . 0.0 110.94 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 17.4 t -127.32 105.93 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 O-C-N 123.587 0.554 . . . . 0.0 110.351 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 126' ' ' SER . 14.6 tp -106.74 127.63 53.55 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.281 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -128.08 168.41 15.53 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.548 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.3 Cg_endo -97.7 21.78 0.34 Allowed 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 122.677 2.251 . . . . 0.0 113.748 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.2 t -109.83 158.88 17.71 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.686 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.06 22.42 38.51 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.609 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.02 151.79 22.07 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.539 0.335 . . . . 0.0 110.514 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 m -128.82 157.12 42.39 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.555 ' CE2' HG22 ' A' ' 113' ' ' VAL . 55.0 m-85 -126.95 -150.97 0.46 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.757 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -58.85 -46.32 88.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.655 0.382 . . . . 0.0 111.415 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.9 m -133.12 81.03 1.91 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.848 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 107' ' ' MET . 42.4 m -129.49 122.62 29.64 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.381 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.33 123.48 46.89 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.879 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.88 130.13 34.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.979 0.419 . . . . 0.0 110.878 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.471 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -125.43 46.35 2.4 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.667 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.16 -106.85 1.65 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 114.863 -1.062 . . . . 0.0 113.381 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.28 -10.63 3.14 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.546 HD22 ' OH ' ' A' ' 31' ' ' TYR . 1.7 pp -155.22 152.15 28.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.609 0.364 . . . . 0.0 111.25 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.06 157.5 26.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.863 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.524 ' O ' HG23 ' A' ' 99' ' ' THR . 17.3 ttm -123.9 134.2 53.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.0 m -136.44 133.8 37.02 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.7 p -127.49 19.07 6.84 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.144 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.758 ' O ' HG11 ' A' ' 113' ' ' VAL . 46.8 p -90.16 131.19 36.14 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.393 0.616 . . . . 0.0 112.037 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.482 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 5.3 mt-30 -58.16 -26.96 63.36 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.759 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -64.12 -40.44 96.2 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.902 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.758 HG11 ' O ' ' A' ' 110' ' ' SER . 2.6 p -71.1 -38.43 71.28 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.423 HD11 HH12 ' A' ' 85' ' ' ARG . 4.4 mm? -55.51 -50.1 70.85 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.533 0.521 . . . . 0.0 110.495 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.482 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 39.9 m-85 -67.8 -40.6 83.86 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.222 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.69 -54.17 48.48 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.753 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.755 HG21 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.11 -43.73 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.45 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.6 -32.27 65.08 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 123.674 0.609 . . . . 0.0 109.59 178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.512 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.66 -20.2 31.68 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.363 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.05 17.0 26.4 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.841 -1.072 . . . . 0.0 114.64 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.6 p -107.08 7.08 29.49 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.57 -137.29 8.74 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.113 -0.826 . . . . 0.0 112.47 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.51 169.3 13.94 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.942 2.428 . . . . 0.0 113.652 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.61 -56.46 21.04 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.776 0.831 . . . . 0.0 112.106 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.646 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.5 mmtt -139.63 139.76 36.79 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.502 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 35.8 p -141.04 168.97 18.5 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.3 tp -125.63 115.18 19.72 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.695 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.584 HD13 ' O ' ' A' ' 74' ' ' ASP . 7.9 pt -99.29 104.43 16.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 O-C-N 123.751 0.657 . . . . 0.0 109.229 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -124.55 122.08 36.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.21 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.34 113.64 5.39 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.346 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.432 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 73.87 167.92 16.04 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 115.093 -0.958 . . . . 0.0 114.461 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -128.64 179.95 5.4 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.115 0.483 . . . . 0.0 110.655 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 42' ' ' GLY . . . -118.2 130.37 56.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.368 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.57 146.04 16.58 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.539 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 31.4 m-90 -122.31 135.71 54.77 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 122.655 0.382 . . . . 0.0 110.35 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.36 158.11 26.13 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.935 0.772 . . . . 0.0 110.663 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.1 90.86 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.14 -25.01 7.61 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.172 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -57.59 -44.17 85.2 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.938 0.495 . . . . 0.0 112.252 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.563 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.98 -47.57 65.25 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.118 0.261 . . . . 0.0 110.527 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.33 -29.22 68.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.088 0.47 . . . . 0.0 110.643 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.63 -50.66 34.63 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.788 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.1 pt-20 -69.57 -26.64 64.58 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.816 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.7 tp -75.2 -39.16 60.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.637 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.2 m -77.82 -27.83 50.13 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.492 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -82.96 0.1 46.14 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.518 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.5 m120 60.09 29.39 18.96 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.811 0.844 . . . . 0.0 111.761 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.61 -43.28 17.2 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.917 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -124.17 113.61 18.54 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.6 tp -83.92 139.22 32.73 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.205 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.3 p -104.66 138.1 41.48 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.32 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 24.7 p -152.88 155.5 32.27 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.595 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.08 158.24 26.41 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.259 1.972 . . . . 0.0 111.214 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.518 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.97 166.24 21.4 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.11 134.89 23.37 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 114.317 -1.311 . . . . 0.0 107.983 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.13 -26.47 14.86 Favored 'Trans proline' 0 C--N 1.364 1.354 0 C-N-CA 122.594 2.196 . . . . 0.0 113.616 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.67 -40.04 62.48 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 123.787 0.68 . . . . 0.0 112.211 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.55 HD12 HH12 ' A' ' 167' ' ' ARG . 4.6 mt -72.07 -35.1 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 121.411 0.624 . . . . 0.0 110.351 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.26 -37.22 63.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.343 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -85.45 -34.9 21.54 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -84.85 -72.16 0.49 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 117.98 0.354 . . . . 0.0 111.657 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.888 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.85 99.04 6.21 Favored Pre-proline 0 C--N 1.348 0.539 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.846 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.7 Cg_endo -91.99 -0.15 4.28 Favored 'Trans proline' 0 CA--C 1.569 2.259 0 C-N-CA 121.64 1.56 . . . . 0.0 114.253 175.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.626 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 81.3 Cg_endo -73.89 -52.34 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 122.539 2.159 . . . . 0.0 114.43 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.541 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.5 mt-10 -122.54 -30.19 3.95 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.672 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.888 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.8 tt0 -70.02 -10.84 60.01 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.338 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.55 HH12 HD12 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.91 -41.52 43.21 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.9 tp -70.62 -50.33 38.1 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.7 m -58.07 -49.61 76.32 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.666 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.649 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -63.66 -40.0 95.75 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.069 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.76 -45.32 78.11 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.54 0.525 . . . . 0.0 110.485 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 -38.35 90.77 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.497 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.95 -27.63 68.3 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.65 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.649 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -78.05 -40.29 39.18 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.963 0.505 . . . . 0.0 110.378 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.66 -32.76 71.6 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.353 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.37 54.19 0.41 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.944 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 13.3 t -127.26 145.98 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -87.0 75.33 9.55 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.753 0.787 . . . . 0.0 110.703 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.7 -26.09 49.9 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.847 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 51.7 p -59.65 -42.28 92.43 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.61 -26.58 50.77 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.2 mt -76.96 -38.08 53.97 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.308 0.38 . . . . 0.0 111.977 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.4 p -93.92 -47.72 6.59 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.317 0.386 . . . . 0.0 111.286 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 58.87 120.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.243 1.017 . . . . 0.0 112.819 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -113.43 150.64 32.48 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -98.18 143.8 28.31 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.213 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 163.63 121.2 0.55 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.513 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -100.62 147.21 26.22 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 123.64 0.259 . . . . 0.0 110.908 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.073 -179.947 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.505 0.193 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -111.47 131.31 55.31 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.051 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -104.67 -40.68 5.92 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.166 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.502 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 43.7 p -97.56 154.99 17.17 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.412 0.445 . . . . 0.0 111.077 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.9 m -95.18 99.26 4.18 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.988 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.2 Cg_endo -87.1 8.87 4.16 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.875 2.383 . . . . 0.0 112.376 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 t -87.93 -47.34 8.64 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.19 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -123.3 154.82 38.35 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.487 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.4 mt -99.15 46.68 0.97 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.928 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -90.06 18.68 5.59 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 120.893 0.377 . . . . 0.0 111.058 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.1 p80 176.82 55.49 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.04 0.936 . . . . 0.0 110.265 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -134.32 159.78 39.94 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.625 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.542 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 18.9 m-30 -98.6 136.59 38.47 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.035 0.445 . . . . 0.0 112.02 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 4.3 mt -108.34 141.86 39.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.919 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.669 HD12 ' SG ' ' A' ' 152' ' ' CYS . 2.3 mp -124.87 137.36 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 O-C-N 123.274 0.358 . . . . 0.0 110.351 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.05 120.13 19.22 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.748 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.5 mmt -97.86 159.0 31.95 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.565 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.04 6.81 4.36 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.678 2.252 . . . . 0.0 113.727 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.489 ' ND1' HD22 ' A' ' 147' ' ' ASN . 4.2 t60 -79.82 -12.94 59.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.303 0.241 . . . . 0.0 111.549 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.722 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -105.82 153.13 22.34 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.175 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.91 42.95 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.376 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.722 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.1 m-20 -116.55 87.6 21.47 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.526 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.51 -20.0 18.54 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.926 2.417 . . . . 0.0 113.331 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -84.52 -34.67 23.26 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.828 0.451 . . . . 0.0 111.708 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -94.02 3.83 54.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.024 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.72 163.65 21.12 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 48.87 32.07 3.54 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.9 p -116.29 154.22 30.55 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 120.568 0.223 . . . . 0.0 110.738 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 47.2 t -129.33 132.2 66.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.781 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 6.1 m -113.34 153.39 28.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.755 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.504 ' OH ' HD22 ' A' ' 105' ' ' LEU . 45.2 t80 -107.18 120.5 42.27 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.451 HD11 ' O ' ' A' ' 41' ' ' MET . 0.2 OUTLIER -85.26 109.75 18.57 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.639 0.587 . . . . 0.0 111.128 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.466 ' O ' HD22 ' A' ' 102' ' ' LEU . 34.9 t -69.13 -60.22 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 113.569 -1.651 . . . . 0.0 110.841 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -141.32 115.81 9.54 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.407 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -99.07 128.13 45.15 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.802 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -139.28 152.64 47.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.398 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.87 -18.98 65.64 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.787 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.45 2.35 42.09 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.536 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.46 166.79 15.01 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 121.517 -0.373 . . . . 0.0 112.375 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.91 145.82 31.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.451 ' O ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -125.56 136.82 53.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.966 178.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 133' ' ' ALA . . . -160.93 159.78 31.37 Favored Glycine 0 N--CA 1.452 -0.284 0 O-C-N 124.575 1.172 . . . . 0.0 112.59 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.405 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.2 mt -115.12 135.08 54.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.08 0.44 . . . . 0.0 111.228 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 78' ' ' GLY . 11.0 t -66.83 124.11 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.65 54.08 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.538 0.685 . . . . 0.0 112.015 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.825 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.6 t-20 -147.32 -3.42 0.56 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.996 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.422 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 2.8 ttt180 -129.7 87.61 51.98 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.503 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 35.2 Cg_exo -59.73 142.45 98.74 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 121.658 1.572 . . . . 0.0 112.273 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.414 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.2 m -89.44 159.39 17.3 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.465 0.478 . . . . 0.0 111.589 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.84 48.54 1.47 Allowed Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.513 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mt -133.48 157.02 46.67 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 124.002 0.471 . . . . 0.0 110.141 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 18.4 p-10 -112.22 158.74 19.34 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.245 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.53 -29.23 64.2 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.38 96.0 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.33 -47.02 77.96 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.854 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.3 m -62.06 -43.92 98.32 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.7 mt -57.34 -34.57 68.92 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.587 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -78.18 -27.72 48.0 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.325 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.67 -30.29 51.97 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.263 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.854 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 14.7 mt -77.87 -45.55 23.9 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 113.667 -1.606 . . . . 0.0 111.056 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -130.94 116.01 16.81 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.609 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.43 -32.91 2.7 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 123.604 2.869 . . . . 0.0 112.744 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.36 -15.38 55.46 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.315 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.3 150.49 23.83 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.611 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.78 122.79 28.29 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.167 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.7 149.74 49.22 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.357 2.038 . . . . 0.0 112.189 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.458 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 8.7 Cg_endo -94.69 -171.5 0.23 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.639 2.226 . . . . 0.0 112.477 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.475 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -64.72 -24.79 67.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.113 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.512 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 7.4 ptp180 -68.73 -46.73 68.15 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 15.4 m -75.49 -25.44 57.31 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 52.3 mt-30 -68.63 -26.92 65.58 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.475 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 23.6 p80 -99.46 21.68 11.81 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.138 0.494 . . . . 0.0 111.318 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 63.4 mt -117.79 139.1 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.268 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.505 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.7 m-20 -107.18 154.62 20.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.5 mm -101.28 152.59 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.235 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.699 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.9 t80 -118.81 154.87 32.15 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -85.94 119.2 25.99 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.613 0.188 . . . . 0.0 110.555 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.567 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -103.29 -23.72 8.31 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.022 -1.085 . . . . 0.0 114.047 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.15 -168.24 35.11 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.359 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -88.66 -13.26 3.37 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.47 2.78 . . . . 0.0 114.37 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.3 t -82.39 125.19 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 123.082 0.239 . . . . 0.0 111.233 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 47.23 85.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.488 1.115 . . . . 0.0 113.027 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -86.8 1.45 52.27 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.288 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -94.63 -4.23 48.08 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.636 ' NH2' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -133.05 152.85 51.92 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.625 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.63 137.4 14.12 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.413 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.719 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.6 OUTLIER -86.49 144.55 27.2 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.029 0.932 . . . . 0.0 110.635 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -125.28 103.67 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 123.636 0.585 . . . . 0.0 110.046 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 126' ' ' SER . 15.5 tp -107.51 128.38 54.46 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.138 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.411 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 4.1 p80 -127.55 169.09 13.12 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.612 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.644 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.4 Cg_endo -97.25 15.2 0.75 Allowed 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.756 2.304 . . . . 0.0 113.818 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.411 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 9.4 t -102.77 159.91 15.06 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.668 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.76 22.47 37.7 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.636 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -89.4 153.01 21.19 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.56 0.344 . . . . 0.0 110.622 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.6 m -130.31 156.65 44.32 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 112.196 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.695 ' H ' ' HG1' ' A' ' 99' ' ' THR . 46.4 m-85 -126.27 -150.59 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.844 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -56.78 -46.86 81.25 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.975 0.51 . . . . 0.0 111.633 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 m -134.5 82.25 1.96 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.86 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.695 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 30.4 m -130.1 124.51 32.92 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.229 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.71 123.54 47.22 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.844 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.21 129.22 34.9 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.081 0.467 . . . . 0.0 110.787 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.55 45.88 2.43 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.411 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.06 -105.87 1.33 Allowed Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.155 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.55 -10.67 3.65 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.504 HD22 ' OH ' ' A' ' 31' ' ' TYR . 2.2 pp -155.46 153.19 29.94 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 123.26 0.35 . . . . 0.0 111.392 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.39 156.2 29.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.716 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.557 ' O ' ' HA ' ' A' ' 99' ' ' THR . 18.6 ttm -122.52 130.58 53.19 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 m -131.52 130.86 42.9 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.8 p -120.36 18.63 12.17 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.549 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.746 ' O ' HG13 ' A' ' 113' ' ' VAL . 68.3 m -88.09 133.99 33.86 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.963 0.887 . . . . 0.0 112.694 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.631 ' HA ' ' NH2' ' A' ' 85' ' ' ARG . 3.9 mt-30 -62.7 -30.81 71.68 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.96 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.79 -40.31 95.02 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.735 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 110' ' ' SER . 3.5 p -70.46 -39.41 76.29 Favored 'Isoleucine or valine' 0 C--N 1.353 0.745 0 O-C-N 123.142 0.276 . . . . 0.0 110.502 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.636 HD23 ' NH2' ' A' ' 85' ' ' ARG . 4.2 tp -59.36 -46.54 88.36 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 123.471 0.482 . . . . 0.0 110.164 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.495 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 24.1 m-85 -67.22 -40.96 86.45 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 178.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -53.21 59.78 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.599 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.727 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.91 -43.57 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.527 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.466 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.33 -32.72 64.94 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.815 0.697 . . . . 0.0 109.59 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.512 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.89 -19.64 32.0 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.376 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.06 15.21 31.43 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.689 -1.141 . . . . 0.0 114.755 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 p -105.1 6.77 33.49 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.2 -137.35 8.99 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.481 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -81.62 172.6 12.2 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.046 2.497 . . . . 0.0 113.526 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.64 -55.16 37.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.695 0.798 . . . . 0.0 111.962 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.644 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.8 mmtt -141.76 139.74 32.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.656 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 36.6 p -139.02 167.82 21.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.0 tp -126.88 118.49 24.7 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.574 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.5 pt -98.46 102.18 13.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.575 0.703 . . . . 0.0 109.725 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.7 t -121.02 122.05 39.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.713 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 tp -67.33 118.03 10.14 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.464 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.86 173.24 5.63 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 114.763 -1.108 . . . . 0.0 114.524 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.41 175.5 8.46 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.179 0.514 . . . . 0.0 110.659 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -115.86 129.68 56.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.271 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.47 146.75 17.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.631 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -121.86 136.83 54.94 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.149 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.32 157.81 26.28 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.848 0.718 . . . . 0.0 110.786 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.23 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.51 -25.82 7.55 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.119 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -58.54 -44.22 89.52 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.885 0.474 . . . . 0.0 112.272 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.562 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.89 -47.58 65.5 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.16 0.287 . . . . 0.0 110.481 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.29 -29.55 68.9 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.014 0.435 . . . . 0.0 110.555 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.56 -49.91 49.79 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.84 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.32 -26.81 63.0 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.696 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.5 tp -74.55 -37.31 63.03 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.492 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.0 t -77.88 -29.83 50.51 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.712 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.0 t70 -84.11 1.15 45.54 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.072 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.489 HD22 ' ND1' ' A' ' 19' ' ' HIS . 3.6 p-10 52.63 33.98 14.85 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.841 1.256 . . . . 0.0 112.201 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.53 -41.61 21.4 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.372 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -122.14 113.02 18.92 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.0 tp -83.92 136.18 34.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.5 p -101.13 136.91 40.22 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.967 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.669 ' SG ' HD12 ' A' ' 15' ' ' ILE . 26.2 p -150.79 154.98 35.42 Favored Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 123.458 0.474 . . . . 0.0 110.738 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.63 152.6 61.37 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.189 1.926 . . . . 0.0 110.989 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.542 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.93 167.45 17.41 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.74 134.22 21.9 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.943 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.87 -26.48 15.55 Favored 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 122.493 2.129 . . . . 0.0 113.434 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.14 -48.49 53.72 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 124.032 0.832 . . . . 0.0 111.441 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.554 HD11 HH12 ' A' ' 167' ' ' ARG . 4.7 mt -64.06 -34.87 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.371 0.668 . . . . 0.0 110.839 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -73.55 -35.62 65.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.281 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -83.66 -34.89 24.91 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.484 ' O ' HD11 ' A' ' 162' ' ' LEU . 2.2 p30 -86.81 -67.22 0.83 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.744 0.702 . . . . 0.0 112.729 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.657 ' C ' ' HD2' ' A' ' 164' ' ' PRO . 1.1 tp -145.73 98.98 4.44 Favored Pre-proline 0 C--N 1.344 0.333 0 CA-C-O 121.042 0.448 . . . . 0.0 111.786 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.825 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 65.7 Cg_endo -91.54 -0.14 4.56 Favored 'Trans proline' 0 CA--C 1.57 2.282 0 C-N-CA 121.795 1.663 . . . . 0.0 114.488 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.657 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 79.4 Cg_endo -74.67 -50.41 0.14 Allowed 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.76 2.307 . . . . 0.0 114.438 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.539 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 10.8 mt-10 -121.61 -33.98 3.51 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.705 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 6.0 mt-10 -68.6 -11.28 59.81 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.045 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.554 HH12 HD11 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -77.06 -41.7 41.32 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -69.82 -49.78 49.33 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.8 m -58.33 -49.05 78.58 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.682 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.653 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.39 -40.21 95.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.265 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.82 79.46 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 123.538 0.524 . . . . 0.0 110.489 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.69 88.27 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.466 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.25 -27.76 68.87 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.507 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.653 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.6 mmp_? -77.52 -40.03 44.12 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.899 0.479 . . . . 0.0 110.192 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -71.3 -31.29 67.26 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.461 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.38 54.95 0.56 Allowed Glycine 0 C--N 1.341 0.806 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.911 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 10.7 t -127.69 148.13 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.83 77.88 7.71 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.707 0.765 . . . . 0.0 110.69 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.78 -26.14 49.53 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.113 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 51.7 m -58.36 -43.6 88.44 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.45 -26.76 51.76 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.3 mt -77.26 -31.24 54.82 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.636 0.374 . . . . 0.0 111.693 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.4 p -89.81 -47.3 7.99 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.399 0.437 . . . . 0.0 111.408 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.22 118.07 21.76 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.513 0.508 . . . . 0.0 111.147 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -100.13 150.11 22.83 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.957 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -98.95 145.34 27.14 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.122 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 163.76 -134.86 3.53 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.535 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -99.34 132.57 44.57 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.311 0.244 . . . . 0.0 111.079 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 C-N-CA 123.884 0.874 . . . . 0.0 112.241 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.21 0.052 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -100.15 136.6 39.81 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.407 0.442 . . . . 0.0 111.039 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -99.33 -40.59 7.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.24 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.8 m -98.33 153.5 18.49 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.4 t -93.2 106.97 22.1 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.812 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -86.73 6.97 5.12 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.808 2.339 . . . . 0.0 112.339 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.8 m -112.99 -57.24 2.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.537 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.562 ' CD1' ' HE3' ' A' ' 10' ' ' LYS . 2.4 m-85 -111.41 157.85 19.78 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.312 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.724 ' HB3' ' ND1' ' A' ' 12' ' ' HIS . 14.2 mt -100.04 41.2 1.18 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.044 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.562 ' HE3' ' CD1' ' A' ' 8' ' ' TYR . 75.0 mttt -89.53 26.77 1.63 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.95 0.405 . . . . 0.0 110.63 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 178.37 53.9 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.668 0.787 . . . . 0.0 109.979 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.724 ' ND1' ' HB3' ' A' ' 9' ' ' LEU . 6.9 p-80 -131.11 156.29 45.5 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 11.0 m-30 -98.68 133.72 42.61 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.843 0.354 . . . . 0.0 111.205 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 8.6 mt -106.58 140.98 38.59 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.299 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.21 131.19 73.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.25 132.84 38.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.885 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 55.5 mtt -121.46 156.6 57.93 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.191 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.85 75.83 4.61 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.629 2.219 . . . . 0.0 112.885 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -134.02 -21.99 1.84 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.787 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.57 -162.91 0.86 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.25 0.344 . . . . 0.0 110.382 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -101.79 32.94 3.19 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 8.1 m-20 -111.47 82.49 3.66 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.41 -24.17 12.45 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 123.034 2.489 . . . . 0.0 113.361 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -85.01 -37.81 19.96 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.953 0.501 . . . . 0.0 111.612 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.61 -3.4 57.57 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.791 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 22' ' ' ASP . . . -60.83 1.93 0.13 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -141.33 39.37 1.74 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.191 0.519 . . . . 0.0 111.981 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.7 p -123.22 158.52 30.67 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.788 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.518 HG12 ' HE ' ' A' ' 167' ' ' ARG . 97.0 t -130.85 132.3 64.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.955 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -113.25 153.75 27.89 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.343 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.507 ' OH ' HD21 ' A' ' 105' ' ' LEU . 34.9 t80 -108.61 119.6 40.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.581 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.51 107.8 15.43 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 123.491 0.494 . . . . 0.0 111.295 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.485 ' O ' HD21 ' A' ' 102' ' ' LEU . 39.0 t -68.12 -60.65 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.203 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.504 ' OE1' HD13 ' A' ' 100' ' ' LEU . 12.8 tt0 -142.16 114.76 8.49 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.426 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.489 ' CE1' HD11 ' A' ' 9' ' ' LEU . 15.7 t-80 -96.75 129.78 44.11 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.9 151.54 47.03 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.068 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.39 -17.82 64.12 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -104.79 6.32 33.91 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.664 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.61 164.39 12.62 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 121.511 -0.376 . . . . 0.0 112.295 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -146.02 141.13 27.36 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.94 134.9 54.51 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.584 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 133' ' ' ALA . . . -159.04 160.56 31.29 Favored Glycine 0 N--CA 1.449 -0.444 0 O-C-N 124.5 1.125 . . . . 0.0 112.573 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.5 mt -115.95 135.26 54.14 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.148 0.474 . . . . 0.0 111.503 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 78' ' ' GLY . 12.0 t -68.64 123.55 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.3 pt -126.83 56.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.679 0.752 . . . . 0.0 111.798 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.85 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.9 t-20 -147.45 -4.17 0.53 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.42 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.436 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 2.4 ttm180 -129.7 88.21 50.21 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.48 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.2 Cg_exo -59.58 142.26 98.57 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.655 1.57 . . . . 0.0 112.151 175.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.407 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 43.7 m -91.43 159.48 15.94 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.346 0.404 . . . . 0.0 111.574 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.53 46.76 1.24 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.362 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.466 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.69 155.1 51.12 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.48 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 14.7 p-10 -105.79 161.08 14.73 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.889 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.445 HD22 ' SG ' ' A' ' 70' ' ' CYS . 13.5 tp -58.77 -37.85 77.21 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.59 -36.58 56.44 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.48 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 37.4 mt-10 -64.37 -43.04 95.75 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.171 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.854 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -62.77 -46.48 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.432 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 4.5 mp -54.01 -36.77 63.35 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.858 0.724 . . . . 0.0 110.788 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.93 -28.22 49.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.525 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -30.05 48.82 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.358 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.854 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.1 mt -77.75 -45.03 25.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.945 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -132.3 116.48 15.35 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.543 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.5 -32.75 2.74 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.566 2.844 . . . . 0.0 112.803 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.29 -14.17 55.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.426 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.89 149.93 24.46 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 123.38 0.425 . . . . 0.0 111.716 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.3 123.65 29.79 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.046 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -74.17 145.42 34.92 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 122.271 1.981 . . . . 0.0 112.371 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.483 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.7 Cg_endo -92.58 -171.34 0.33 Allowed 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.561 2.174 . . . . 0.0 111.978 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.504 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -63.15 -24.79 68.05 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.215 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.556 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.3 ptp180 -66.22 -53.27 39.16 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.445 ' SG ' HD22 ' A' ' 53' ' ' LEU . 60.7 m -72.38 -25.0 61.34 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 49.5 mt-30 -67.11 -35.69 80.3 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.504 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 20.2 p80 -91.62 23.99 3.28 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.256 0.551 . . . . 0.0 111.689 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 55.8 mt -120.42 138.97 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.573 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.589 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.5 m-20 -107.62 154.79 20.92 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.768 0.668 . . . . 0.0 112.639 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 51' ' ' LEU . 16.6 mm -102.74 152.57 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.207 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.5 t80 -119.27 152.75 36.14 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -83.45 120.59 26.09 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.899 0.318 . . . . 0.0 110.796 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.535 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -103.6 -23.66 8.22 Favored Glycine 0 C--N 1.348 1.206 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.984 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.6 -167.86 35.29 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.333 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -88.66 -11.51 4.0 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.511 2.807 . . . . 0.0 114.378 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -86.06 127.34 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 123.054 0.221 . . . . 0.0 111.266 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 46.04 84.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.528 1.131 . . . . 0.0 113.289 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 p -85.69 -4.41 59.16 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.072 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.91 -5.64 59.2 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.729 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.615 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.43 154.27 50.92 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.615 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.28 133.69 11.8 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.986 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.741 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.61 145.07 27.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.377 1.071 . . . . 0.0 110.426 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.28 103.94 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 123.414 0.446 . . . . 0.0 110.726 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 126' ' ' SER . 14.1 tp -106.75 128.29 54.09 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.727 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.452 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 3.6 p80 -125.51 166.42 21.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-O 118.937 -0.554 . . . . 0.0 112.048 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.5 Cg_endo -96.16 14.84 0.97 Allowed 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.663 2.242 . . . . 0.0 113.59 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.452 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 8.8 t -101.93 160.84 14.14 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.808 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.65 19.42 54.77 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.794 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mp -85.62 154.1 21.93 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.481 0.312 . . . . 0.0 111.057 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 p -127.07 156.86 41.02 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.596 ' H ' ' HG1' ' A' ' 99' ' ' THR . 51.4 m-85 -129.8 -152.57 0.52 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.821 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -57.27 -46.43 83.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.847 0.459 . . . . 0.0 111.721 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.7 m -136.27 81.67 1.9 Allowed 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.209 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.596 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 11.3 m -129.33 126.84 39.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.691 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.504 HD13 ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -105.68 123.26 47.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.743 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -82.89 128.81 34.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.53 . . . . 0.0 110.763 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.485 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.54 46.69 2.25 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.337 -179.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.47 -107.95 2.2 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.04 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -61.22 -9.24 4.59 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.507 HD21 ' OH ' ' A' ' 31' ' ' TYR . 2.6 pp -154.29 152.39 30.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.41 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.14 156.74 28.17 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.706 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.571 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.8 ttm -121.45 127.21 50.88 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.2 m -123.84 129.47 51.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.182 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 58.7 p -119.57 15.12 12.81 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.71 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.8 m -87.76 129.71 35.08 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.358 0.599 . . . . 0.0 111.872 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.485 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.6 pt20 -61.55 -29.4 69.99 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.158 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -64.98 -42.86 94.17 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.627 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.72 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.2 p -67.75 -38.17 79.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 O-C-N 123.171 0.294 . . . . 0.0 110.291 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.578 HD23 ' NH2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -59.13 -48.99 79.58 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 123.572 0.545 . . . . 0.0 110.323 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.485 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 32.0 m-85 -69.12 -37.52 78.39 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.995 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.04 -51.7 66.93 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.085 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.81 -43.44 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.257 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.1 -31.68 65.52 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 123.734 0.646 . . . . 0.0 109.544 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.556 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.74 -20.08 31.65 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.233 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.05 15.1 31.76 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.689 -1.141 . . . . 0.0 114.67 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.5 p -105.8 8.16 32.68 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.3 -138.49 9.91 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.203 -0.776 . . . . 0.0 112.774 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.9 172.11 13.49 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.283 2.656 . . . . 0.0 113.87 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.478 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -52.05 -57.23 10.16 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.417 1.087 . . . . 0.0 111.624 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.525 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -139.6 152.91 47.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.811 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.5 m -147.34 164.21 33.98 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.79 117.81 22.57 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.449 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.741 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.7 pt -98.44 102.35 13.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 121.842 0.83 . . . . 0.0 109.833 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 7.2 t -118.94 122.27 41.87 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.727 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -66.95 115.21 6.43 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.109 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.01 174.15 5.25 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.694 -1.139 . . . . 0.0 114.355 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -128.64 179.9 5.43 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.251 0.548 . . . . 0.0 110.842 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -117.43 130.49 56.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.215 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.86 139.56 11.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.757 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.403 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 32.6 m-90 -113.88 135.01 54.44 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.934 0.432 . . . . 0.0 110.151 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.62 158.03 25.8 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.887 0.742 . . . . 0.0 110.501 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.91 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 122.26 -26.11 6.48 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.015 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.71 -45.07 86.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.558 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.32 -47.93 66.22 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.156 0.285 . . . . 0.0 110.502 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.62 -28.54 68.62 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.411 0.445 . . . . 0.0 110.729 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.53 -51.13 30.83 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.74 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -69.47 -26.49 64.59 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.7 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.2 tp -75.37 -39.34 59.32 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.873 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.6 m -77.75 -28.46 50.72 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.532 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -82.93 0.55 43.92 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.438 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 59.31 28.89 18.35 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.777 0.831 . . . . 0.0 111.7 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.93 -43.4 19.82 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.304 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -125.69 118.07 24.83 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 4.8 tp -87.97 150.88 23.19 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.484 0.183 . . . . 0.0 111.357 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.575 HG21 ' NE2' ' A' ' 12' ' ' HIS . 80.8 p -111.25 137.11 49.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.792 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 78.6 m -149.86 154.5 37.36 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 123.315 0.384 . . . . 0.0 111.357 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.37 148.37 86.91 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.555 2.17 . . . . 0.0 110.993 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -123.21 166.92 14.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -135.53 134.53 21.09 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.929 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.46 -26.38 17.02 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.604 2.202 . . . . 0.0 113.542 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.91 -40.12 63.29 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.862 0.726 . . . . 0.0 112.116 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.566 HD12 HH12 ' A' ' 167' ' ' ARG . 4.8 mt -71.75 -35.66 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 121.382 0.611 . . . . 0.0 110.277 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.5 tt -73.65 -37.72 65.21 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.455 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -85.3 -34.71 21.82 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -84.92 -72.58 0.47 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 117.967 0.349 . . . . 0.0 111.627 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.888 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.28 98.97 6.56 Favored Pre-proline 0 C--N 1.348 0.529 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.85 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 66.3 Cg_endo -92.19 -0.05 4.15 Favored 'Trans proline' 0 CA--C 1.569 2.269 0 C-N-CA 121.702 1.601 . . . . 0.0 114.226 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.619 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 77.4 Cg_endo -74.03 -52.5 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.899 0 C-N-CA 122.605 2.204 . . . . 0.0 114.389 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.542 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.3 mt-10 -122.43 -29.92 4.03 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.707 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.888 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.9 tt0 -70.09 -10.89 60.21 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.37 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.566 HH12 HD12 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.83 -39.62 50.64 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.9 tt -72.64 -49.98 28.21 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.1 m -58.0 -47.96 81.47 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.508 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.656 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.96 -39.9 90.82 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.17 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.32 79.94 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 123.393 0.433 . . . . 0.0 110.594 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.23 -38.49 90.55 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.523 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.29 -28.55 69.79 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.601 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.656 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.86 -40.45 40.05 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 122.905 0.482 . . . . 0.0 110.35 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.98 -33.24 74.26 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.533 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 124.4 45.65 0.26 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.108 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 6.2 t -129.15 139.13 52.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -90.7 81.06 5.85 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.682 0.753 . . . . 0.0 110.765 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -77.84 -26.27 49.33 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.218 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 13.5 t -58.5 -45.28 89.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.099 0.56 . . . . 0.0 112.486 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.47 -26.81 51.7 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 21.3 mt -77.23 -29.86 54.28 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.292 0.37 . . . . 0.0 111.699 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 23.5 p -90.41 -48.22 7.25 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.385 0.428 . . . . 0.0 111.3 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.62 119.13 22.02 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 123.459 0.474 . . . . 0.0 111.056 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -100.45 140.72 34.3 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.56 141.63 51.8 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.641 0.588 . . . . 0.0 111.041 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 151.58 104.98 0.28 Allowed Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.514 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -128.55 145.29 51.17 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.664 0.273 . . . . 0.0 110.838 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.192 0 C-N-CA 123.895 0.878 . . . . 0.0 112.28 -179.93 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.485 0.183 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -100.39 129.95 46.42 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.199 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -98.7 -42.48 7.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.841 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.529 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.8 m -101.61 158.52 16.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.618 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.6 p -95.03 98.84 3.61 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.213 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.4 Cg_endo -87.57 8.36 4.28 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.914 2.409 . . . . 0.0 112.103 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.488 HG22 ' N ' ' A' ' 8' ' ' TYR . 13.4 t -90.53 -45.85 8.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.178 -1.374 . . . . 0.0 112.228 -178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.488 ' N ' HG22 ' A' ' 7' ' ' THR . 3.1 m-85 -100.01 155.27 17.79 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.525 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.8 45.52 1.26 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.715 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -89.92 16.03 8.9 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.441 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 173.94 54.86 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.967 0.907 . . . . 0.0 110.518 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -133.14 163.58 28.96 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.303 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -100.69 140.73 34.55 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.242 0.544 . . . . 0.0 112.258 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.605 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.6 mp -111.75 137.49 49.59 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.185 -1.371 . . . . 0.0 109.807 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 150' ' ' LEU . 2.9 mp -119.98 136.2 57.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.81 127.21 32.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.117 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.406 ' HB3' ' HD1' ' A' ' 19' ' ' HIS . 33.1 mtt -110.79 157.88 37.26 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.196 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.12 29.36 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.577 2.184 . . . . 0.0 113.127 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.406 ' HD1' ' HB3' ' A' ' 17' ' ' MET . 43.3 m80 -85.81 -17.62 35.2 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -167.76 1.26 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.088 0.242 . . . . 0.0 110.598 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.514 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.42 40.9 1.39 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.036 0.446 . . . . 0.0 111.732 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -111.92 80.69 3.18 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.844 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.5 Cg_exo -75.55 -23.06 13.27 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.036 2.491 . . . . 0.0 113.28 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -84.53 -34.96 23.18 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.916 0.487 . . . . 0.0 111.708 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.63 3.82 53.09 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.077 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.12 163.18 20.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.767 0.318 . . . . 0.0 111.807 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 49.69 32.32 5.05 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.9 p -118.22 154.82 31.59 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 122.395 -0.191 . . . . 0.0 110.508 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 68.7 t -128.54 134.7 64.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-O 121.416 0.627 . . . . 0.0 110.789 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.8 m -116.11 151.95 34.61 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.658 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.475 ' OH ' HD23 ' A' ' 105' ' ' LEU . 12.8 t80 -105.32 118.88 37.69 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.72 107.84 15.65 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.365 0.602 . . . . 0.0 110.065 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.477 HG22 ' HA2' ' A' ' 42' ' ' GLY . 23.5 t -71.87 -59.6 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.76 -178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -137.25 119.23 15.33 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.51 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -103.94 126.2 50.89 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -139.94 153.2 46.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.577 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.23 -18.34 65.23 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.522 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -98.31 -3.55 36.94 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.391 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.0 171.48 21.75 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 121.564 -0.35 . . . . 0.0 112.29 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.67 144.43 29.47 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.42 137.2 54.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.747 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.477 ' HA2' HG22 ' A' ' 33' ' ' VAL . . . -159.82 158.44 29.69 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.858 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.437 HD21 ' C ' ' A' ' 42' ' ' GLY . 2.4 mt -115.6 134.67 54.82 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.952 0.376 . . . . 0.0 111.287 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.544 HG21 ' O ' ' A' ' 78' ' ' GLY . 6.1 t -68.75 121.73 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.27 54.71 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.586 0.707 . . . . 0.0 112.221 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.849 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 21.9 t-20 -148.7 -1.55 0.51 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.104 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -129.75 85.51 57.97 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.51 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.2 Cg_exo -60.55 144.79 99.56 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 121.74 1.627 . . . . 0.0 112.582 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.421 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.6 m -94.41 153.77 17.79 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.075 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.82 51.9 1.97 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.851 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mt -134.07 160.27 38.27 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.903 0.413 . . . . 0.0 110.28 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.3 p-10 -112.1 157.37 20.89 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.459 HD22 ' SG ' ' A' ' 70' ' ' CYS . 12.4 tp -58.02 -36.13 72.26 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.04 -39.27 66.06 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -63.48 -41.08 98.58 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.678 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.841 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.8 t -61.53 -50.29 80.94 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.409 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 5.0 mp -52.44 -36.39 54.38 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 123.975 0.797 . . . . 0.0 110.995 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.13 -28.53 48.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.489 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -78.44 -31.8 48.2 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.457 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.841 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.1 mt -77.5 -45.04 26.77 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.0 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -132.11 116.88 15.69 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.412 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.5 -33.11 2.56 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 123.65 2.9 . . . . 0.0 112.807 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.16 -14.02 56.28 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.462 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.3 149.81 24.29 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.33 0.394 . . . . 0.0 111.737 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.77 123.43 29.7 Favored Pre-proline 0 C--O 1.235 0.333 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.038 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.88 145.34 31.81 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.217 1.944 . . . . 0.0 112.462 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.513 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.8 Cg_endo -92.15 -169.34 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.612 2.208 . . . . 0.0 111.895 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.501 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -64.89 -24.89 67.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.12 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -66.63 -51.56 54.92 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.459 ' SG ' HD22 ' A' ' 53' ' ' LEU . 59.6 m -72.74 -25.05 61.06 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 47.0 mt-30 -68.16 -35.3 77.85 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.501 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 21.6 p80 -90.92 22.98 3.35 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.099 0.476 . . . . 0.0 111.718 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 61.2 mt -119.84 139.02 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.464 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.608 ' O ' HD13 ' A' ' 128' ' ' ILE . 1.9 m-20 -104.65 156.71 17.74 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.854 0.721 . . . . 0.0 112.564 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.8 mm -102.84 155.38 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.432 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.69 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.8 t80 -124.84 155.83 38.81 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -88.37 122.69 32.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 119.691 -0.195 . . . . 0.0 110.512 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.544 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -101.87 -23.68 9.12 Favored Glycine 0 C--N 1.351 1.413 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.793 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.77 -167.31 35.25 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.086 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -87.11 -10.56 5.71 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 123.266 2.644 . . . . 0.0 113.84 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.64 ' O ' ' HA3' ' A' ' 131' ' ' GLY . 4.1 t -86.19 126.74 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.178 0.299 . . . . 0.0 110.383 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 43.78 87.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.292 1.037 . . . . 0.0 113.099 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.573 ' O ' HD21 ' A' ' 130' ' ' LEU . 76.9 p -86.04 -12.44 50.2 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.306 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -84.94 0.26 51.86 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -132.7 153.57 51.02 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.96 126.0 7.97 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.35 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.645 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 0.2 OUTLIER -85.77 145.74 27.1 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.86 1.264 . . . . 0.0 109.92 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 t -121.57 103.53 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.741 0.305 . . . . 0.0 110.824 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 126' ' ' SER . 2.2 tt -99.43 126.76 45.39 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.484 ' CE1' ' HB1' ' A' ' 106' ' ' ALA . 3.9 p80 -131.86 164.11 45.27 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-O 118.93 -0.557 . . . . 0.0 112.193 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.2 Cg_endo -96.9 9.84 1.31 Allowed 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 122.733 2.289 . . . . 0.0 113.945 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.471 ' OG ' HD21 ' A' ' 94' ' ' LEU . 8.7 t -94.35 158.98 15.32 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.976 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.12 19.06 56.03 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.789 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.471 HD21 ' OG ' ' A' ' 92' ' ' SER . 4.6 mm? -86.8 154.24 21.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.431 0.292 . . . . 0.0 110.77 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 p -123.02 155.36 37.0 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.696 ' H ' ' HG1' ' A' ' 99' ' ' THR . 62.2 m-85 -130.57 -152.79 0.53 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.344 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -58.6 -47.24 84.97 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.896 0.316 . . . . 0.0 111.446 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 56.2 m -134.3 85.19 2.17 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.488 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.696 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 8.1 m -130.78 128.75 41.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.922 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.41 124.38 50.3 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.427 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.63 128.19 34.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.237 0.541 . . . . 0.0 111.172 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -121.48 47.2 1.9 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.214 -179.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.88 -106.81 1.69 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-N 114.706 -1.134 . . . . 0.0 113.081 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.38 -9.93 4.18 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.475 HD23 ' OH ' ' A' ' 31' ' ' TYR . 3.5 pp -156.27 160.44 39.76 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.53 0.332 . . . . 0.0 111.252 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.484 ' HB1' ' CE1' ' A' ' 90' ' ' HIS . . . -123.38 162.59 22.47 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 123.625 0.578 . . . . 0.0 110.526 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.645 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 22.4 ttm -123.6 130.18 52.27 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.6 m -124.7 127.94 48.04 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 120.844 0.354 . . . . 0.0 110.21 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.4 p -117.21 20.15 13.84 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.466 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.1 p -98.18 127.75 44.29 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 122.011 0.91 . . . . 0.0 112.03 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.497 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 2.3 mt-30 -61.59 -25.96 67.67 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.314 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -64.54 -42.41 95.73 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.104 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.718 ' O ' HG22 ' A' ' 117' ' ' ILE . 5.2 p -69.02 -38.18 78.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.521 ' N ' HG13 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -56.98 -47.67 80.23 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 123.732 0.645 . . . . 0.0 110.303 178.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.497 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 28.2 m-85 -69.61 -39.8 77.02 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.068 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.3 -51.37 69.18 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.146 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.44 -43.31 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.123 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.49 -30.89 65.46 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.792 0.682 . . . . 0.0 109.731 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.56 -19.73 30.66 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.16 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.15 17.77 26.32 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.682 -1.145 . . . . 0.0 114.558 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.5 p -109.49 9.93 25.32 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.88 -138.5 9.5 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-O 119.374 -0.681 . . . . 0.0 113.038 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.26 173.08 12.92 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.338 2.692 . . . . 0.0 113.793 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.482 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -52.13 -56.64 13.19 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.258 1.023 . . . . 0.0 111.27 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.505 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -139.34 154.38 47.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.509 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.5 m -150.03 162.81 39.67 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.4 tp -129.93 115.79 17.7 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.872 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.608 HD13 ' O ' ' A' ' 74' ' ' ASP . 16.4 pt -95.67 102.5 13.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-O 121.807 0.813 . . . . 0.0 109.242 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 59.7 p -125.07 130.65 52.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.263 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.573 HD21 ' O ' ' A' ' 83' ' ' THR . 16.2 mt -67.03 118.22 10.17 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.031 0.444 . . . . 0.0 111.372 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 81' ' ' VAL . . . 55.93 -172.86 1.53 Allowed Glycine 0 C--N 1.343 0.934 0 CA-C-N 114.232 -1.349 . . . . 0.0 115.012 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -128.53 -176.0 3.69 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.641 0.734 . . . . 0.0 111.358 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -119.39 130.38 55.28 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 113.866 -1.516 . . . . 0.0 108.367 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.37 152.3 19.12 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.667 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -129.88 136.92 50.08 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 124.011 0.477 . . . . 0.0 110.169 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.15 158.44 27.72 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.93 0.769 . . . . 0.0 110.631 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.47 89.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.96 -22.28 9.18 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.356 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -56.99 -47.44 80.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.985 0.514 . . . . 0.0 112.162 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.6 tp -66.89 -47.89 70.44 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.18 -29.95 64.1 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.43 0.456 . . . . 0.0 110.895 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.92 -49.32 47.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.042 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.6 pt-20 -72.45 -26.71 61.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.681 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 4.6 tp -75.43 -38.44 59.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.822 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.2 t -78.23 -30.44 48.78 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.286 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.5 t70 -80.3 0.92 30.8 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.604 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 60.79 28.33 18.08 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.981 0.912 . . . . 0.0 111.813 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.81 -42.53 19.56 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.639 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -123.55 111.14 15.91 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.938 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.552 ' O ' HD12 ' A' ' 15' ' ' ILE . 6.0 tp -85.31 130.82 34.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.67 0.272 . . . . 0.0 111.484 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.2 p -104.64 141.98 35.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.862 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.9 m -154.91 157.11 31.91 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.83 146.77 96.97 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.242 1.962 . . . . 0.0 111.188 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -131.66 175.86 8.82 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -133.18 139.93 35.78 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.278 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.73 -26.62 11.31 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 122.771 2.314 . . . . 0.0 114.015 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -49.98 -43.13 50.18 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.809 0.693 . . . . 0.0 112.355 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.616 HD11 HH12 ' A' ' 167' ' ' ARG . 4.7 mt -67.71 -32.88 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 121.504 0.669 . . . . 0.0 110.318 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.1 tt -75.29 -41.23 57.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.673 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.68 -24.39 25.25 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -90.18 -72.02 0.59 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.313 0.506 . . . . 0.0 110.944 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.874 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.09 98.58 6.15 Favored Pre-proline 0 C--N 1.348 0.538 0 CA-C-O 121.078 0.466 . . . . 0.0 112.171 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.849 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 64.8 Cg_endo -91.39 -0.17 4.66 Favored 'Trans proline' 0 CA--C 1.57 2.321 0 C-N-CA 121.691 1.594 . . . . 0.0 114.266 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.643 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 83.6 Cg_endo -74.14 -54.14 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.627 2.218 . . . . 0.0 114.554 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.574 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -121.74 -29.39 4.35 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.783 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.874 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.07 -12.24 61.46 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.321 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.616 HH12 HD11 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.1 -44.12 40.21 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -68.97 -50.37 49.67 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -57.61 -50.55 72.76 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.773 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.512 ' O ' ' HG3' ' A' ' 174' ' ' ARG . . . -61.68 -40.39 94.8 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.154 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.11 -46.38 82.66 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.625 0.578 . . . . 0.0 110.489 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.53 87.72 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.477 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.55 69.71 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.31 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 170' ' ' ALA . 7.9 mtm105 -77.16 -41.09 43.1 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.196 0.598 . . . . 0.0 110.893 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.7 tp -71.28 -29.86 65.57 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.542 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.39 54.76 1.06 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.797 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 12.4 t -123.69 149.27 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -82.18 77.33 8.99 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.752 0.787 . . . . 0.0 110.755 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -26.21 49.93 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.791 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.5 m -56.46 -38.7 72.02 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.16 -26.52 53.11 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 11.3 mt -76.57 -35.19 58.33 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.332 0.395 . . . . 0.0 111.435 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 13.9 p -85.86 -46.16 10.88 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.507 0.505 . . . . 0.0 111.647 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.65 120.17 24.77 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.137 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -93.3 145.75 24.22 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.459 ' HB1' ' OXT' ' A' ' 189' ' ' ALA . . . -98.94 149.89 22.5 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.266 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -130.26 -54.69 0.1 OUTLIER Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.642 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -99.05 -41.07 7.72 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.342 0.257 . . . . 0.0 111.429 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.459 ' OXT' ' HB1' ' A' ' 186' ' ' ALA . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.209 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.298 0.094 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.5 mttt 62.58 125.54 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.957 0.903 . . . . 0.0 112.355 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -98.3 -41.52 7.82 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.943 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.558 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 18.7 t -99.78 161.17 13.78 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.516 0.51 . . . . 0.0 110.539 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.1 t -97.37 96.38 3.03 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.6 Cg_endo -87.93 8.52 4.13 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.852 2.368 . . . . 0.0 112.37 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 t -89.93 -47.87 7.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.308 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -126.62 154.95 43.28 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.585 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.7 mt -99.34 49.21 0.94 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.824 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -90.8 19.5 5.46 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 120.772 0.32 . . . . 0.0 111.349 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 15.8 p80 174.51 57.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.025 0.93 . . . . 0.0 110.174 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -135.13 159.57 41.11 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.859 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.519 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.8 m-30 -96.96 138.0 35.17 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.147 0.499 . . . . 0.0 112.29 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.564 ' O ' HG12 ' A' ' 29' ' ' VAL . 1.7 mp -111.97 133.36 54.2 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.198 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 150' ' ' LEU . 2.6 mp -119.02 133.12 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.56 122.8 19.77 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.036 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.9 mmt -103.83 160.46 26.01 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.262 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.31 20.6 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.713 2.276 . . . . 0.0 113.659 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -81.24 -14.94 56.93 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.578 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -113.53 160.8 18.12 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.606 0.363 . . . . 0.0 110.238 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.45 52.84 2.54 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.419 0.628 . . . . 0.0 112.084 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.578 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.2 m-20 -128.12 87.47 55.39 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.528 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.03 -13.92 21.21 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.924 2.416 . . . . 0.0 113.558 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -85.08 -38.27 19.32 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.388 0.43 . . . . 0.0 111.534 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -98.26 -1.36 42.07 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.606 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 22' ' ' ASP . . . -63.65 2.52 0.44 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -139.57 42.3 2.02 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.276 0.56 . . . . 0.0 112.071 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.4 p -125.39 154.06 42.48 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.588 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 14' ' ' LEU . 25.2 t -130.56 133.65 63.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.742 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -115.85 152.43 33.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.585 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.505 ' OH ' HD23 ' A' ' 105' ' ' LEU . 41.8 t80 -106.58 120.79 42.87 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 41' ' ' MET . 0.1 OUTLIER -84.24 108.98 17.42 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.079 0.466 . . . . 0.0 111.043 -178.356 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' O ' HD21 ' A' ' 102' ' ' LEU . 35.3 t -66.8 -60.18 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.732 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -144.66 115.54 7.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.304 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -97.78 128.22 44.27 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.45 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -139.58 153.3 47.36 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.69 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.55 -18.62 65.46 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.601 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.66 4.4 43.21 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.392 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.17 165.37 12.81 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.229 -0.349 . . . . 0.0 112.229 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.61 139.4 29.63 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.471 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -121.1 136.98 54.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.959 178.714 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.559 ' O ' ' HB1' ' A' ' 133' ' ' ALA . . . -159.05 157.52 28.57 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 124.372 1.045 . . . . 0.0 112.465 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 mt -112.26 134.9 53.53 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.206 0.503 . . . . 0.0 110.957 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 78' ' ' GLY . 11.9 t -69.83 123.41 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.72 56.28 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.666 0.746 . . . . 0.0 112.117 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.856 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.0 t-20 -147.41 -2.45 0.59 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.115 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -130.27 88.52 47.57 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.473 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 47.5 Cg_exo -58.29 141.87 97.1 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 121.533 1.489 . . . . 0.0 111.86 174.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.416 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 8.9 t -77.79 -39.51 43.71 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.62 -8.7 74.28 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.873 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 5.7 mt -81.43 170.27 16.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.706 0.402 . . . . 0.0 110.161 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.627 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.9 p-10 -112.79 156.28 23.14 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.477 ' O ' HG21 ' A' ' 56' ' ' VAL . 1.6 tt -57.69 -26.69 62.08 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 123.478 0.486 . . . . 0.0 111.992 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.08 99.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.959 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.528 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 34.1 mt-10 -63.01 -46.79 85.96 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.139 0.275 . . . . 0.0 111.586 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.859 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 20.5 m -62.0 -44.06 98.43 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.6 mt -56.66 -34.89 67.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.639 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.01 -27.64 48.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.327 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.93 -30.9 50.71 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.308 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.859 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.0 mt -77.83 -45.47 24.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.243 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -131.32 116.23 16.42 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.643 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -77.76 -32.73 2.57 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.637 2.891 . . . . 0.0 112.791 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.95 -14.52 55.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.374 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.98 149.5 24.73 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.382 0.426 . . . . 0.0 111.667 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.74 122.91 30.19 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.239 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.5 149.55 34.89 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.277 1.985 . . . . 0.0 112.374 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -94.59 -167.53 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.631 2.22 . . . . 0.0 112.56 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.94 -24.57 64.29 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.288 0.635 . . . . 0.0 112.095 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.421 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 11.6 ptp180 -67.9 -48.21 66.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 24.5 m -72.58 -26.13 61.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.169 0.587 . . . . 0.0 112.338 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -70.86 -27.54 63.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.674 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -95.39 16.72 16.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.61 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 53.9 mt -120.07 139.41 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.666 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.621 ' O ' HD13 ' A' ' 128' ' ' ILE . 1.8 m-20 -104.92 155.64 18.76 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.9 mm -107.17 150.45 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.206 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.722 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -119.2 157.08 28.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.588 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -87.98 122.2 31.3 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.526 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -102.0 -23.6 9.09 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 120.263 -0.97 . . . . 0.0 114.257 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.91 -167.81 34.87 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.289 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -88.75 -11.67 3.86 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.635 2.89 . . . . 0.0 114.421 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.09 131.85 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.569 0.223 . . . . 0.0 111.375 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.477 HE21 ' HH ' ' A' ' 132' ' ' TYR . 47.4 mt-30 45.18 89.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.632 1.173 . . . . 0.0 113.503 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -87.02 1.04 54.15 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.378 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -92.7 -18.31 23.14 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.594 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.17 147.44 52.06 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.373 0.421 . . . . 0.0 111.441 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.594 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -113.34 151.01 18.44 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.149 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.404 ' CE2' ' SD ' ' A' ' 107' ' ' MET . 1.2 m-85 -86.66 151.33 23.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.951 -1.124 . . . . 0.0 110.829 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 3.6 t -127.76 107.99 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.087 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 126' ' ' SER . 13.8 tp -104.93 127.74 52.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.619 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.407 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 3.4 p80 -124.37 162.18 43.59 Favored Pre-proline 0 CA--C 1.552 1.022 0 O-C-N 123.653 0.596 . . . . 0.0 111.59 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.0 Cg_endo -97.42 28.89 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.802 2.334 . . . . 0.0 113.579 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.407 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 18.0 t -115.69 156.73 25.39 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.63 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.74 23.18 35.31 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.817 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.01 153.17 21.49 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.472 0.309 . . . . 0.0 110.523 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.7 p -121.55 153.25 38.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.508 ' CG ' HG11 ' A' ' 113' ' ' VAL . 28.5 m-85 -132.89 -151.13 0.44 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.834 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -61.02 -48.69 80.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.791 0.436 . . . . 0.0 111.267 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.529 ' H ' ' HG ' ' A' ' 110' ' ' SER . 38.3 m -134.01 79.05 1.79 Allowed 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.243 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.3 m -126.72 115.95 20.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.956 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.49 122.18 42.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.859 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.97 128.45 34.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.095 0.474 . . . . 0.0 111.15 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.483 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.63 46.76 2.15 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.482 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.93 -107.6 2.02 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 114.819 -1.082 . . . . 0.0 113.25 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.88 -10.28 3.83 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.505 HD23 ' OH ' ' A' ' 31' ' ' TYR . 1.8 pp -155.06 153.15 30.46 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.335 0.397 . . . . 0.0 111.167 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.17 158.05 24.92 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.884 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.585 ' O ' ' HA ' ' A' ' 99' ' ' THR . 16.0 ttm -122.52 135.17 54.58 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 98' ' ' SER . 15.9 m -136.18 134.35 38.11 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 81.1 p -125.42 21.36 7.89 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.64 0.587 . . . . 0.0 111.836 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.849 ' O ' HG21 ' A' ' 113' ' ' VAL . 51.6 m -91.12 131.63 36.56 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.944 0.878 . . . . 0.0 112.885 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.471 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 5.2 mt-30 -61.91 -26.16 68.0 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.419 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.39 -45.45 90.99 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.493 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.849 HG21 ' O ' ' A' ' 110' ' ' SER . 18.6 m -62.28 -43.46 98.04 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.522 HD11 ' NH1' ' A' ' 85' ' ' ARG . 29.3 mt -54.82 -51.48 65.7 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.864 0.727 . . . . 0.0 112.177 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.471 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 43.2 m-85 -65.63 -45.64 82.28 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.4 -52.7 64.49 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.865 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.833 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.4 tp -64.22 -43.91 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.45 -31.18 65.67 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.793 0.683 . . . . 0.0 109.683 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.421 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -85.3 -20.43 30.03 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.156 176.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.26 18.01 22.96 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.731 -1.122 . . . . 0.0 114.581 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.2 p -109.42 7.83 25.11 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.25 -137.51 9.37 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.583 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.82 168.11 19.63 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.251 2.634 . . . . 0.0 113.519 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.475 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -50.94 -57.79 7.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.31 1.044 . . . . 0.0 111.789 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 124' ' ' GLU . 13.7 mmtt -138.48 157.27 46.52 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.619 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 40.8 m -149.99 162.89 39.48 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.9 tp -126.41 113.96 17.57 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.744 177.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 74' ' ' ASP . 10.1 pt -98.81 104.59 16.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.492 0.663 . . . . 0.0 109.507 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.3 t -125.0 124.88 42.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.508 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.59 ' O ' HD12 ' A' ' 130' ' ' LEU . 2.1 pp -67.12 117.2 8.82 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.095 0.474 . . . . 0.0 111.738 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.99 174.69 4.4 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.259 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.477 ' HH ' HE21 ' A' ' 82' ' ' GLN . 10.7 p90 -128.47 -179.87 5.28 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.334 0.588 . . . . 0.0 111.027 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 42' ' ' GLY . . . -116.31 130.63 56.87 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.227 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.55 153.01 19.75 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.488 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -134.17 137.87 44.76 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.84 0.377 . . . . 0.0 110.666 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -78.1 158.36 29.16 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.904 0.753 . . . . 0.0 110.822 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.79 92.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.28 7.72 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.134 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -56.01 -47.38 77.89 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.082 0.553 . . . . 0.0 112.125 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.561 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 16.3 tp -67.51 -46.45 72.85 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.31 -30.54 64.85 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.443 0.465 . . . . 0.0 110.693 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -71.06 -49.33 45.91 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.013 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -72.1 -26.76 62.26 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.749 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.1 tp -75.3 -38.73 60.16 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.84 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.6 m -78.03 -29.91 49.65 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.355 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.17 0.17 33.48 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.533 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 61.29 29.37 18.6 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.89 0.876 . . . . 0.0 111.712 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.94 -41.91 16.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.516 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -122.9 109.62 14.38 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.328 0.393 . . . . 0.0 110.113 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.01 128.46 34.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.387 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.1 p -102.33 141.81 34.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.039 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 80.2 m -155.37 158.6 31.97 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.315 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -57.44 153.93 38.45 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.215 1.943 . . . . 0.0 111.429 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.519 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.33 169.2 14.51 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -177.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -134.93 135.06 22.39 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 114.264 -1.334 . . . . 0.0 107.934 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.77 -26.59 13.37 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.64 2.226 . . . . 0.0 113.907 -177.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -51.95 -40.64 61.16 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.874 0.734 . . . . 0.0 112.284 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.551 HD12 HH12 ' A' ' 167' ' ' ARG . 4.6 mt -71.42 -34.49 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 121.378 0.609 . . . . 0.0 110.328 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.22 -38.47 63.54 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.253 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -84.25 -33.86 23.97 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -85.63 -72.67 0.48 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.026 0.375 . . . . 0.0 111.69 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.887 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.35 99.22 6.48 Favored Pre-proline 0 C--N 1.348 0.54 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.856 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.3 Cg_endo -92.02 -0.03 4.26 Favored 'Trans proline' 0 CA--C 1.57 2.301 0 C-N-CA 121.677 1.585 . . . . 0.0 114.26 175.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.63 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 88.0 Cg_endo -73.85 -52.55 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 122.63 2.22 . . . . 0.0 114.388 -178.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.54 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.61 -30.37 3.91 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.694 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.887 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -69.73 -11.14 60.62 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.303 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.551 HH12 HD12 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.54 -42.95 41.22 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -69.18 -50.68 45.37 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.2 m -57.76 -50.7 72.35 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.734 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.631 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -62.85 -38.57 91.36 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.07 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.27 -45.43 80.11 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.664 0.602 . . . . 0.0 110.441 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.45 91.04 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.552 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 177' ' ' VAL . . . -64.36 -29.12 70.2 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.667 177.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.631 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.99 -40.19 39.95 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 122.865 0.466 . . . . 0.0 110.423 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.14 -34.02 76.67 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.485 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 130.37 40.71 0.25 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.272 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' A' ' 173' ' ' ALA . 5.0 t -129.45 133.42 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -88.32 82.85 6.95 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.651 0.739 . . . . 0.0 111.218 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -77.95 -26.39 48.81 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.31 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 51.9 m -57.95 -45.52 86.51 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.47 -26.89 51.8 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 21.6 mt -77.28 -29.1 53.67 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.338 0.399 . . . . 0.0 111.687 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 24.1 p -91.12 -48.66 6.83 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.544 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -131.69 120.27 22.53 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.28 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -100.92 140.08 35.71 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.95 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -102.14 -42.4 6.08 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.456 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -148.69 -147.53 4.55 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 123.484 0.49 . . . . 0.0 112.448 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -99.95 132.7 45.15 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.633 0.255 . . . . 0.0 111.019 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.172 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.51 0.195 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.5 tttt -100.11 -43.2 6.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.113 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 71.05 -49.35 0.68 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.379 1.072 . . . . 0.0 112.362 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.548 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 16.6 t -99.5 147.32 25.43 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.253 0.346 . . . . 0.0 110.653 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.5 m -105.13 90.31 3.64 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.993 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.4 Cg_endo -87.59 8.25 4.32 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.982 2.454 . . . . 0.0 112.127 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 8' ' ' TYR . 13.5 t -91.66 -48.0 7.07 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.171 -178.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.475 ' N ' HG23 ' A' ' 7' ' ' THR . 26.9 m-85 -122.61 151.55 41.34 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.645 0.59 . . . . 0.0 111.291 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.656 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 7.0 mp -92.63 -3.3 55.19 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.749 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -41.98 9.45 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.618 ' H ' ' C ' ' A' ' 9' ' ' LEU . 13.0 p-80 177.02 52.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.144 0.978 . . . . 0.0 110.513 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -141.82 166.08 25.7 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.759 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 30' ' ' THR . 14.2 m-30 -104.54 138.54 40.74 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.495 ' O ' HG12 ' A' ' 29' ' ' VAL . 6.4 mt -107.19 143.38 35.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.405 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 mp -123.47 137.71 55.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.462 0.476 . . . . 0.0 110.128 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.47 123.48 26.61 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.837 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 mmt -106.32 157.09 35.75 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.202 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.6 30.58 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.678 2.252 . . . . 0.0 113.248 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -87.32 -15.56 37.65 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.93 -168.35 1.41 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 123.075 0.234 . . . . 0.0 110.703 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.82 41.87 1.28 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.082 0.468 . . . . 0.0 111.628 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -111.32 81.05 2.78 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.916 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.3 Cg_exo -75.49 -22.24 14.18 Favored 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 123.017 2.478 . . . . 0.0 113.312 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -84.62 -36.3 22.11 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.875 0.47 . . . . 0.0 111.867 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.8 3.72 53.64 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.021 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.42 163.77 20.16 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 48.75 32.15 3.47 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.2 p -116.68 154.27 30.87 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 122.367 -0.208 . . . . 0.0 110.573 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.501 HG11 ' HE ' ' A' ' 167' ' ' ARG . 60.3 t -129.05 132.69 67.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-O 121.515 0.674 . . . . 0.0 110.857 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.2 m -114.48 154.39 28.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.691 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.406 ' OH ' HD21 ' A' ' 105' ' ' LEU . 13.2 t80 -110.22 115.7 30.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.656 ' HB3' ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -81.08 110.63 16.79 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.684 0.754 . . . . 0.0 110.566 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.432 ' CG2' ' HA2' ' A' ' 42' ' ' GLY . 32.2 t -71.18 -63.93 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 112.819 -1.991 . . . . 0.0 110.614 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' OE1' HD13 ' A' ' 100' ' ' LEU . 12.3 tt0 -132.51 117.63 18.24 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.96 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.593 ' ND1' ' H ' ' A' ' 9' ' ' LEU . 12.9 t-80 -106.92 127.91 53.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.733 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -138.9 153.45 48.27 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.22 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -64.82 -15.63 62.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -104.88 5.41 32.93 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.687 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.6 164.72 12.64 Favored Glycine 0 C--N 1.344 1.015 0 C-N-CA 121.486 -0.388 . . . . 0.0 112.35 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.402 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -144.73 146.46 32.19 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.529 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -125.97 137.58 53.69 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.954 178.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.432 ' HA2' ' CG2' ' A' ' 33' ' ' VAL . . . -158.72 159.95 30.66 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.83 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.431 HD21 ' C ' ' A' ' 42' ' ' GLY . 3.4 mt -114.62 130.66 56.81 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.703 0.252 . . . . 0.0 110.837 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 78' ' ' GLY . 20.7 t -65.96 125.39 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.537 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -128.44 55.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.542 0.686 . . . . 0.0 112.408 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.845 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.8 t-20 -147.63 -3.61 0.53 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.265 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.419 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 3.0 ttm180 -129.78 87.84 51.05 Favored Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.483 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 35.3 Cg_exo -59.09 141.91 98.73 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 121.578 1.518 . . . . 0.0 112.277 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.447 ' HG ' ' C ' ' A' ' 76' ' ' TYR . 59.9 m -88.64 161.96 16.59 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.364 0.415 . . . . 0.0 111.561 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.96 44.69 1.43 Allowed Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.37 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.446 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.97 150.95 50.44 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.1 p-10 -100.52 161.4 13.62 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.268 0.355 . . . . 0.0 110.939 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.454 HD22 ' SG ' ' A' ' 70' ' ' CYS . 12.3 tp -58.7 -37.58 76.4 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.16 -37.14 53.64 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.96 -43.68 95.05 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.206 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.845 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 1.3 t -62.8 -45.77 98.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.406 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 4.5 mp -54.55 -36.51 64.4 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.702 0.626 . . . . 0.0 110.618 177.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.9 -27.86 49.65 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.466 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -78.16 -30.14 49.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.283 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.845 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.9 mt -77.75 -45.12 25.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.945 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -132.26 116.24 15.32 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.524 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.62 -32.64 2.71 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.604 2.869 . . . . 0.0 112.769 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.3 -14.15 55.84 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.361 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.86 149.68 24.65 Favored 'General case' 0 C--N 1.345 0.389 0 O-C-N 123.323 0.389 . . . . 0.0 111.754 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.65 123.88 29.98 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.02 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.82 144.68 35.25 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.226 1.951 . . . . 0.0 112.408 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.465 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.6 Cg_endo -92.52 -170.98 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.566 2.177 . . . . 0.0 111.974 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.502 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -63.37 -24.89 68.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.297 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -66.15 -54.17 28.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.454 ' SG ' HD22 ' A' ' 53' ' ' LEU . 61.3 m -71.58 -25.05 62.03 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 50.4 mt-30 -66.91 -36.02 81.32 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.502 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 19.9 p80 -91.55 23.18 3.6 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.147 0.498 . . . . 0.0 111.65 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 56.8 mt -119.47 140.04 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.517 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.611 ' O ' HD13 ' A' ' 128' ' ' ILE . 1.6 m-20 -109.56 154.91 22.08 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.692 0.62 . . . . 0.0 112.498 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 51' ' ' LEU . 24.4 mm -103.53 153.66 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.093 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.692 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -117.31 155.95 28.65 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.57 118.92 26.3 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.844 0.293 . . . . 0.0 110.698 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -103.08 -23.62 8.46 Favored Glycine 0 C--N 1.348 1.242 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.976 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.76 -167.9 35.4 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.293 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -88.35 -11.38 4.31 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 123.313 2.675 . . . . 0.0 114.263 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.61 126.91 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 123.12 0.263 . . . . 0.0 110.893 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 48.81 82.16 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.309 1.043 . . . . 0.0 112.91 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.454 ' O ' HD23 ' A' ' 130' ' ' LEU . 9.1 t -84.75 1.55 46.14 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -99.13 -0.66 41.22 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.586 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.09 153.27 51.66 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.198 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.586 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.83 133.34 11.6 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.434 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.754 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.8 OUTLIER -85.75 150.87 24.27 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.321 1.048 . . . . 0.0 110.288 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.1 t -127.11 104.81 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 123.429 0.455 . . . . 0.0 111.039 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.598 ' HB2' ' SD ' ' A' ' 107' ' ' MET . 15.2 tp -106.67 127.66 53.54 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.821 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.454 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 4.4 p80 -129.14 169.44 13.1 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.38 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.632 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.6 Cg_endo -97.13 18.06 0.55 Allowed 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.65 2.233 . . . . 0.0 113.52 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.454 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 8.4 t -105.85 159.73 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.951 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.2 20.62 49.31 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.501 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -84.21 154.44 23.04 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.645 0.378 . . . . 0.0 110.438 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.0 p -126.78 157.22 39.75 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.569 ' CE2' HG22 ' A' ' 113' ' ' VAL . 53.0 m-85 -129.51 -150.9 0.45 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.418 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -60.2 -46.84 88.36 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.418 0.287 . . . . 0.0 111.25 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.8 m -135.63 83.05 1.99 Allowed 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.338 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 107' ' ' MET . 7.8 m -129.34 124.39 34.17 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.868 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.416 HD13 ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.93 123.94 46.7 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.902 178.627 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -88.74 130.56 35.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.103 0.478 . . . . 0.0 110.748 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.14 48.67 2.18 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.314 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.47 -106.76 1.64 Allowed Glycine 0 C--N 1.334 0.433 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.279 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.06 -10.18 4.0 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.406 HD21 ' OH ' ' A' ' 31' ' ' TYR . 2.5 pp -155.44 155.19 33.09 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.206 0.317 . . . . 0.0 111.561 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -125.14 157.73 35.66 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.875 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.598 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 27.0 tpp -125.33 141.25 52.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -134.15 133.53 41.12 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.916 0.388 . . . . 0.0 110.275 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.0 p -118.3 16.41 13.95 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.985 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.477 ' O ' HG13 ' A' ' 113' ' ' VAL . 32.9 p -91.51 126.93 36.76 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 121.681 0.753 . . . . 0.0 111.686 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.499 ' HA ' ' NH2' ' A' ' 85' ' ' ARG . 20.3 pt20 -60.87 -26.91 67.73 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.602 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -66.11 -41.06 91.08 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.585 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.735 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.2 p -69.85 -39.74 78.09 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.582 HD23 ' NH2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -58.03 -47.64 82.48 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 123.672 0.608 . . . . 0.0 110.457 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.479 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 25.9 m-85 -69.72 -38.39 76.89 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.924 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.94 -52.1 65.42 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.0 tp -64.66 -42.99 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.173 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.38 -31.04 65.39 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.83 0.706 . . . . 0.0 109.627 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.35 -20.26 30.2 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.167 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.59 15.17 30.22 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 114.626 -1.17 . . . . 0.0 114.735 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.2 p -105.34 7.66 33.43 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.58 -137.52 9.47 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-O 119.093 -0.837 . . . . 0.0 112.598 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.41 171.56 14.67 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.167 2.578 . . . . 0.0 113.615 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.82 -55.64 31.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.776 0.83 . . . . 0.0 112.159 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.632 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.2 mmtt -140.72 139.82 34.77 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.728 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.8 m -140.26 168.35 20.01 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 tp -127.9 119.3 25.3 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.794 -1.093 . . . . 0.0 108.734 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.754 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 15.8 pt -98.26 102.0 12.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.852 0.834 . . . . 0.0 109.814 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.1 t -117.88 122.75 44.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.37 -1.287 . . . . 0.0 110.925 -178.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 83' ' ' THR . 6.1 tp -66.64 114.94 5.95 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.327 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.29 178.16 6.95 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 114.442 -1.254 . . . . 0.0 114.562 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.6 176.81 7.48 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.367 0.603 . . . . 0.0 110.8 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -117.39 130.11 56.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.927 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.44 149.73 18.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.601 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.402 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 20.1 m-90 -126.46 135.96 52.02 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 124.022 0.483 . . . . 0.0 110.235 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.39 158.09 27.46 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.844 0.715 . . . . 0.0 110.766 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.57 90.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.92 -25.06 6.9 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.997 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -56.07 -45.63 79.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.984 0.514 . . . . 0.0 112.058 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.542 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 10.5 tp -66.97 -48.28 69.0 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.22 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.47 -30.26 64.91 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 123.451 0.469 . . . . 0.0 110.861 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.4 -50.7 35.88 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.903 178.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -71.65 -26.61 62.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.026 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 6.1 tp -76.05 -38.48 57.07 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.898 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.0 m -77.98 -30.85 50.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -80.9 0.5 35.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.571 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.45 29.16 18.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.853 0.861 . . . . 0.0 111.735 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.82 -42.52 24.2 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.051 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -123.02 113.0 18.47 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.46 0.475 . . . . 0.0 109.752 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.3 tp -82.76 142.14 31.82 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.408 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 25.3 p -105.0 135.77 45.72 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.088 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 79.5 m -149.22 148.68 27.42 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.24 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.55 153.7 64.83 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.325 2.016 . . . . 0.0 110.772 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -134.75 174.58 10.42 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -135.02 138.89 30.48 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.322 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.58 -26.66 16.33 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 122.686 2.257 . . . . 0.0 113.561 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.84 -41.02 57.37 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.967 0.792 . . . . 0.0 112.451 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.691 HD11 HH12 ' A' ' 167' ' ' ARG . 4.3 mt -69.94 -34.38 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.569 0.7 . . . . 0.0 110.395 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.5 tt -75.71 -36.82 59.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.462 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -84.8 -32.15 23.51 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -88.83 -72.88 0.52 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.982 0.356 . . . . 0.0 111.714 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -141.27 99.26 6.52 Favored Pre-proline 0 C--N 1.349 0.584 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.845 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 73.1 Cg_endo -91.74 -0.43 4.44 Favored 'Trans proline' 0 CA--C 1.571 2.331 0 C-N-CA 121.831 1.687 . . . . 0.0 114.421 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.634 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 69.2 Cg_endo -75.09 -50.01 0.14 Allowed 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.73 2.287 . . . . 0.0 114.532 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.527 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.5 mt-10 -122.22 -34.02 3.39 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.792 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.648 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 8.6 mt-10 -69.01 -10.99 60.31 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.219 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.691 HH12 HD11 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -77.03 -41.55 42.12 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.176 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -70.85 -49.58 44.56 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 t -58.29 -48.03 81.78 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.644 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.613 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.57 -40.37 92.7 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.578 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.62 82.77 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.409 0.443 . . . . 0.0 110.582 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.91 -37.29 85.7 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.795 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.56 71.67 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.497 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 3.4 mmp_? -77.67 -40.33 41.93 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.802 0.441 . . . . 0.0 110.372 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.36 -33.94 76.85 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.526 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.06 45.4 0.45 Allowed Glycine 0 C--N 1.34 0.759 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.133 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 10.5 t -130.16 147.05 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -91.47 77.53 5.75 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.651 0.738 . . . . 0.0 110.45 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.79 -26.09 49.46 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.069 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 51.1 m -58.29 -43.69 88.15 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.38 -27.03 52.42 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.2 mt -77.23 -30.58 54.65 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.712 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.7 p -89.97 -47.57 7.77 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.373 0.421 . . . . 0.0 111.474 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.53 118.73 22.52 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.132 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -101.85 150.47 23.14 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.846 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -97.16 -42.13 7.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.55 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -107.25 122.34 6.84 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 123.431 0.457 . . . . 0.0 112.479 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -100.44 141.98 32.55 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.616 0.245 . . . . 0.0 110.845 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.449 -0.786 . . . . 0.0 111.143 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.568 0.223 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.57 122.99 44.17 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -132.69 -53.92 0.94 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.98 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -142.59 -50.2 0.36 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.346 0.404 . . . . 0.0 111.145 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.6 t -136.44 97.69 11.58 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.889 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.72 7.1 5.24 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.741 2.294 . . . . 0.0 112.296 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 m -115.23 -55.6 2.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.315 -1.312 . . . . 0.0 110.565 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -99.82 157.58 16.41 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 123.53 0.519 . . . . 0.0 111.46 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.542 HD11 ' CE1' ' A' ' 35' ' ' HIS . 11.2 mt -94.3 46.97 1.17 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.081 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -92.68 23.01 4.31 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.964 0.412 . . . . 0.0 110.841 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.576 ' CE1' ' HH ' ' A' ' 31' ' ' TYR . 14.4 t-80 177.08 51.99 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.775 0.83 . . . . 0.0 110.0 -177.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -136.87 160.22 39.52 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 15.1 m-30 -98.17 137.46 36.9 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.267 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.565 ' O ' HG13 ' A' ' 29' ' ' VAL . 3.6 mt -108.63 137.03 47.25 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.033 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mm -117.38 133.79 63.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 123.519 0.512 . . . . 0.0 109.713 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.09 123.03 23.63 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.598 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.9 mmt -114.46 155.12 46.32 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 123.463 0.477 . . . . 0.0 111.341 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -80.68 79.28 3.36 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.652 2.235 . . . . 0.0 112.935 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -136.38 -20.65 1.39 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.994 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -163.29 0.87 Allowed 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.182 0.301 . . . . 0.0 110.431 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.522 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.61 35.84 2.48 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.01 0.433 . . . . 0.0 111.9 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.483 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.32 82.87 3.69 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.36 -24.6 12.11 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.006 2.471 . . . . 0.0 113.316 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -85.2 -37.38 20.19 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.469 0.481 . . . . 0.0 111.619 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.58 -0.53 57.6 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.794 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 22' ' ' ASP . . . -63.5 2.81 0.38 Allowed 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -141.22 40.12 1.76 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.172 0.51 . . . . 0.0 112.237 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 p -123.28 158.04 31.83 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.562 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 14' ' ' LEU . 60.6 t -131.32 132.88 62.79 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.005 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -114.9 152.01 33.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.266 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.576 ' HH ' ' CE1' ' A' ' 11' ' ' HIS . 36.0 t80 -105.95 120.48 41.87 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -84.76 108.32 17.39 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.447 0.642 . . . . 0.0 111.304 -178.387 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.464 ' O ' HD22 ' A' ' 102' ' ' LEU . 24.0 t -67.42 -59.92 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.786 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -144.68 112.64 6.35 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.31 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.542 ' CE1' HD11 ' A' ' 9' ' ' LEU . 15.6 t-80 -95.84 128.74 42.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.606 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -139.85 153.37 47.03 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.624 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.53 -18.39 65.28 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.725 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.33 2.22 42.3 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.418 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.88 167.2 15.21 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.456 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -144.82 136.43 25.49 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.45 ' HE2' ' O ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -114.97 134.37 55.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.399 178.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 133' ' ' ALA . . . -157.9 155.01 26.05 Favored Glycine 0 N--CA 1.45 -0.425 0 O-C-N 124.195 0.935 . . . . 0.0 112.5 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 mt -110.95 133.32 53.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.022 0.411 . . . . 0.0 111.194 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.527 HG21 ' O ' ' A' ' 78' ' ' GLY . 20.5 t -69.34 124.61 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -128.24 56.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.47 0.653 . . . . 0.0 112.276 -177.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.854 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.7 t-20 -147.9 -3.5 0.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.491 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.73 87.75 51.48 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.486 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -59.63 142.51 98.93 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 121.695 1.596 . . . . 0.0 112.177 175.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.427 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 50.2 m -92.73 158.67 15.79 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.504 0.502 . . . . 0.0 111.572 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.44 50.15 1.29 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.67 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mt -133.34 159.14 41.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.226 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.609 ' ND2' ' HB2' ' A' ' 54' ' ' ALA . 7.4 p-10 -112.48 157.71 20.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.621 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.446 ' O ' HG21 ' A' ' 56' ' ' VAL . 1.9 tt -58.5 -26.95 64.01 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.956 0.408 . . . . 0.0 111.765 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.609 ' HB2' ' ND2' ' A' ' 52' ' ' ASN . . . -65.12 -39.97 93.82 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.645 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.71 -46.66 84.45 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.289 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.852 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 19.2 m -62.12 -43.81 98.25 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.8 mt -56.13 -35.13 66.77 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.487 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.05 -27.75 48.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.425 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.427 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.89 -30.57 50.79 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.339 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.852 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.94 -45.58 23.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -131.12 116.31 16.68 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.58 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.63 -32.97 2.54 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 123.677 2.918 . . . . 0.0 112.732 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.86 -14.62 56.0 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.334 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.36 149.94 24.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.445 0.466 . . . . 0.0 111.722 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.3 122.42 29.46 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.184 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.87 153.92 38.12 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.25 1.966 . . . . 0.0 112.299 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.451 ' HD2' ' HG ' ' A' ' 70' ' ' CYS . 8.4 Cg_endo -95.07 -166.0 0.12 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.67 2.247 . . . . 0.0 112.387 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.26 -24.58 62.2 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.311 0.644 . . . . 0.0 111.921 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 73' ' ' ILE . 10.5 ptp180 -67.39 -47.7 69.56 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.451 ' HG ' ' HD2' ' A' ' 67' ' ' PRO . 29.4 m -71.59 -26.02 62.43 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -72.83 -26.89 61.65 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.402 0.62 . . . . 0.0 111.511 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -92.87 15.84 13.88 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.057 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 44.6 mt -122.08 139.55 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.582 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.7 m-20 -108.01 153.55 22.94 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.0 mm -99.78 153.07 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.88 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.687 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.4 t80 -119.98 155.67 32.38 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.16 120.36 27.45 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 117.733 0.242 . . . . 0.0 110.572 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.527 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -102.16 -23.74 8.91 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.949 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.24 -168.48 34.65 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.291 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -88.73 -11.52 3.93 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.546 2.831 . . . . 0.0 114.366 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.56 131.29 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.709 0.29 . . . . 0.0 111.418 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 48.2 86.25 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.532 1.133 . . . . 0.0 113.232 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.9 p -81.74 -18.87 42.77 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.151 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -76.92 -18.1 58.5 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.58 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.97 147.83 52.28 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.0 0.428 . . . . 0.0 111.558 179.526 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.58 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -112.41 141.33 16.73 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.776 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.23 134.44 33.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.65 -1.275 . . . . 0.0 109.493 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 4.8 t -116.31 128.52 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 123.067 0.23 . . . . 0.0 111.376 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.551 HD12 ' SD ' ' A' ' 107' ' ' MET . 13.4 tp -114.23 127.64 55.98 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.608 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.479 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 4.9 p80 -122.01 162.84 35.08 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.18 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -97.52 31.15 0.14 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.588 2.192 . . . . 0.0 113.403 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.479 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 19.5 t -118.33 156.74 28.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.651 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.49 22.13 42.48 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.71 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tp -87.71 153.5 21.31 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.526 0.33 . . . . 0.0 110.479 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.8 p -122.84 153.17 39.94 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.538 ' CD2' HG13 ' A' ' 113' ' ' VAL . 25.6 m-85 -132.99 -149.05 0.36 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.862 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -60.33 -48.91 79.71 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 122.834 0.453 . . . . 0.0 111.395 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 108' ' ' SER . 57.9 m -135.38 80.29 1.83 Allowed 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.434 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.688 ' HG1' ' HG ' ' A' ' 108' ' ' SER . 7.9 m -126.6 116.85 21.67 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.867 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.96 122.16 40.75 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.098 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.35 130.36 34.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.128 0.489 . . . . 0.0 111.135 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.464 HD22 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -127.4 48.64 2.2 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.354 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.42 -109.82 3.12 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.169 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.44 -8.9 4.58 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.507 HD23 ' OH ' ' A' ' 31' ' ' TYR . 2.2 pp -153.34 150.23 28.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.285 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -120.81 160.61 23.04 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.812 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.568 ' O ' ' HA ' ' A' ' 99' ' ' THR . 17.1 tpp -126.46 142.22 51.61 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.688 ' HG ' ' HG1' ' A' ' 99' ' ' THR . 54.3 m -137.32 136.62 38.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.73 0.3 . . . . 0.0 110.478 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.7 p -123.03 18.72 10.05 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.383 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 113' ' ' VAL . 14.5 t -92.31 130.11 38.08 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 122.044 0.926 . . . . 0.0 112.564 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.465 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 4.8 mt-30 -61.48 -26.27 67.79 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.725 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -62.54 -47.14 85.2 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.527 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.841 ' O ' HG22 ' A' ' 117' ' ' ILE . 21.0 m -62.2 -43.12 97.52 Favored 'Isoleucine or valine' 0 C--N 1.36 1.043 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 177.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.527 HD11 ' NH1' ' A' ' 85' ' ' ARG . 22.0 mt -54.57 -50.58 67.63 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.718 0.636 . . . . 0.0 111.984 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.465 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 37.2 m-85 -65.6 -47.2 76.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.771 0.319 . . . . 0.0 111.23 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.08 -52.99 63.23 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.138 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.841 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.02 -43.3 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.75 -30.48 65.63 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 123.618 0.574 . . . . 0.0 109.662 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.21 -19.64 29.72 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.174 176.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.75 17.19 26.57 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 114.652 -1.158 . . . . 0.0 114.904 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.7 p -107.88 8.14 28.45 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -98.17 -136.51 9.26 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-O 119.195 -0.78 . . . . 0.0 112.527 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.78 169.9 19.94 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.333 2.688 . . . . 0.0 113.161 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -51.5 -58.36 6.51 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.695 0.798 . . . . 0.0 110.863 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -133.66 168.41 18.73 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.452 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.6 p -152.52 156.9 40.28 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.8 tp -125.68 106.09 9.47 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.582 HD11 ' O ' ' A' ' 74' ' ' ASP . 15.7 pt -92.82 102.62 13.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.812 0.815 . . . . 0.0 110.044 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.401 ' HG ' ' N ' ' A' ' 78' ' ' GLY . 4.0 t -122.45 122.64 39.43 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.255 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.12 117.07 8.65 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.198 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.435 ' H ' ' HA2' ' A' ' 86' ' ' GLY . . . 66.38 172.94 4.95 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.366 -0.833 . . . . 0.0 114.307 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -128.11 -179.06 4.79 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.231 0.538 . . . . 0.0 110.824 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -116.81 128.98 55.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.246 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.25 148.83 18.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.379 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.456 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 22.3 m-90 -127.14 137.86 53.05 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.803 0.354 . . . . 0.0 110.435 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.85 158.02 26.86 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.818 0.699 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.14 92.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.32 -24.72 8.05 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.177 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -57.57 -44.38 85.27 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.87 0.468 . . . . 0.0 112.15 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.573 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.9 tm? -68.07 -47.64 67.73 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.502 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.21 -30.12 67.99 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.013 0.435 . . . . 0.0 110.644 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.17 -49.91 45.66 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.887 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.55 -26.63 63.64 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.84 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.6 tp -74.71 -38.91 62.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.593 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.0 m -77.88 -28.44 49.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.296 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -81.93 -0.92 46.07 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.553 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 61.19 29.55 18.83 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.801 0.841 . . . . 0.0 111.744 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.53 -43.6 15.55 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.829 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -124.62 113.4 17.99 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.5 tp -84.67 140.43 31.32 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.442 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.4 p -104.61 137.42 42.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.17 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 73.2 m -152.46 155.87 33.12 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.629 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.21 157.66 29.33 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.319 2.013 . . . . 0.0 111.191 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.36 168.32 17.12 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -136.31 135.03 20.33 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 114.405 -1.27 . . . . 0.0 107.84 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.27 -26.57 14.45 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.582 2.188 . . . . 0.0 113.695 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.68 -40.5 62.97 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.768 0.667 . . . . 0.0 112.329 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.55 HD13 HH12 ' A' ' 167' ' ' ARG . 4.8 mt -71.06 -35.37 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-O 121.375 0.607 . . . . 0.0 110.354 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -73.88 -38.58 64.37 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.051 -1.431 . . . . 0.0 111.392 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -84.77 -33.44 23.02 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.35 -72.34 0.49 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.047 0.385 . . . . 0.0 111.532 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.879 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.3 99.52 6.46 Favored Pre-proline 0 C--N 1.348 0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 112.349 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.854 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 73.0 Cg_endo -91.45 -0.68 4.63 Favored 'Trans proline' 0 CA--C 1.569 2.254 0 C-N-CA 121.721 1.614 . . . . 0.0 114.304 175.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.629 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 73.9 Cg_endo -74.37 -52.62 0.12 Allowed 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.643 2.229 . . . . 0.0 114.48 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.547 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.6 mt-10 -122.29 -30.33 4.01 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.75 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.879 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.0 tt0 -69.78 -11.59 60.97 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.367 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.55 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.63 -41.7 44.95 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.272 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.36 -50.28 40.54 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.349 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.8 m -58.09 -49.45 76.91 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.651 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.65 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.26 -39.95 94.99 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.209 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.09 -46.58 79.0 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 123.545 0.528 . . . . 0.0 110.587 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.67 88.33 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.51 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.24 -28.26 69.24 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.492 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.65 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.75 -40.14 42.0 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 122.835 0.454 . . . . 0.0 110.303 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.98 -32.03 70.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.489 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.64 53.68 0.48 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.94 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.3 t -128.03 147.3 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.4 ' O ' HD13 ' A' ' 182' ' ' LEU . 34.5 m-80 -89.5 78.12 7.15 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.684 0.754 . . . . 0.0 110.682 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.65 -26.17 50.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.088 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 53.3 m -58.69 -44.22 90.21 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.51 -26.86 51.52 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 178' ' ' ASN . 17.2 mt -77.08 -30.26 55.38 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.358 0.411 . . . . 0.0 111.658 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.1 p -89.94 -47.68 7.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.38 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.63 119.21 22.12 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 123.514 0.508 . . . . 0.0 111.03 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -100.73 145.21 28.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.918 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.33 145.04 50.59 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 173.97 149.97 7.34 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.582 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -128.16 145.73 50.93 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.619 0.246 . . . . 0.0 110.854 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.07 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.499 0.19 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -100.33 143.45 30.5 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.107 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -98.62 -41.91 7.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.003 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.53 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.7 m -104.12 153.78 20.51 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.708 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.3 m -97.55 97.42 4.0 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.055 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 4' ' ' SER . 2.0 Cg_endo -87.93 7.57 4.52 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.909 2.406 . . . . 0.0 112.093 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 8' ' ' TYR . 13.4 t -93.9 -46.9 6.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.979 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.492 ' N ' HG22 ' A' ' 7' ' ' THR . 2.9 m-85 -104.22 157.92 16.8 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.396 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.09 45.36 1.21 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.143 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -91.23 20.21 5.28 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.846 0.355 . . . . 0.0 111.276 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.2 p80 176.71 52.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.99 0.916 . . . . 0.0 110.257 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -133.2 160.43 37.27 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.716 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 14.4 m-30 -95.59 135.01 37.81 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.531 ' O ' HG13 ' A' ' 29' ' ' VAL . 1.6 mm? -108.04 139.92 41.97 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.525 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.58 134.43 66.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 O-C-N 123.545 0.528 . . . . 0.0 109.936 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.33 133.21 35.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.479 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 24.5 mmt -123.2 157.36 61.28 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.03 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.22 78.01 3.61 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.563 2.175 . . . . 0.0 112.879 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -135.53 -21.79 1.52 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.875 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.53 -162.89 0.86 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 123.209 0.318 . . . . 0.0 110.493 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.53 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.39 30.89 4.64 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.1 m-20 -110.85 83.29 3.49 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.1 Cg_exo -75.37 -20.7 15.9 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.069 2.513 . . . . 0.0 113.417 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -84.93 -39.04 18.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 122.833 0.453 . . . . 0.0 111.649 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.27 -2.72 56.28 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.76 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -61.0 2.29 0.12 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -142.28 38.95 1.57 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.167 0.508 . . . . 0.0 112.03 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 p -123.22 158.45 30.83 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.625 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 14' ' ' LEU . 99.4 t -130.57 131.45 64.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.896 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 2.3 m -113.15 154.55 26.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.363 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.414 ' OH ' HD21 ' A' ' 105' ' ' LEU . 43.3 t80 -106.66 119.93 40.62 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.34 106.86 14.56 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 123.595 0.559 . . . . 0.0 111.391 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.523 ' O ' HD22 ' A' ' 102' ' ' LEU . 34.3 t -67.69 -57.98 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.597 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -144.56 118.84 9.55 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.187 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -99.05 128.12 45.13 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.875 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -139.25 152.44 47.3 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.586 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -62.58 -24.19 67.42 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.644 0.378 . . . . 0.0 111.781 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -93.17 -3.72 53.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 123.492 0.495 . . . . 0.0 111.498 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.3 173.72 24.35 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 121.518 -0.373 . . . . 0.0 112.274 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.85 141.53 26.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -114.55 134.7 54.84 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.09 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.589 ' O ' ' HB2' ' A' ' 133' ' ' ALA . . . -157.26 157.64 28.25 Favored Glycine 0 N--CA 1.443 -0.844 0 O-C-N 124.215 0.947 . . . . 0.0 112.618 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 mt -112.32 128.72 56.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.925 0.363 . . . . 0.0 110.511 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.441 HG11 ' C ' ' A' ' 78' ' ' GLY . 11.1 p -68.29 125.97 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.536 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.05 57.76 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.725 0.774 . . . . 0.0 112.059 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.829 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.6 t-20 -146.28 -1.7 0.72 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.032 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -130.2 88.26 48.56 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.485 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 40.9 Cg_exo -58.67 145.94 93.76 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 121.711 1.607 . . . . 0.0 112.48 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.43 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 73.1 m -96.38 160.23 14.52 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.554 0.534 . . . . 0.0 111.489 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.94 51.53 0.9 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.636 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.479 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -133.35 154.02 51.09 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.929 0.429 . . . . 0.0 110.03 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.592 ' ND2' ' HB2' ' A' ' 54' ' ' ALA . 10.4 p-10 -112.45 157.7 20.76 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.822 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.407 ' O ' HG21 ' A' ' 56' ' ' VAL . 2.4 tt -57.53 -26.74 61.82 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.592 ' HB2' ' ND2' ' A' ' 52' ' ' ASN . . . -67.54 -40.87 84.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.419 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.1 -45.51 88.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.17 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.849 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.1 m -62.04 -44.96 99.66 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.8 mt -56.16 -35.15 66.86 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.494 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.05 -27.25 48.68 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.313 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.423 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.77 -30.46 51.42 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.334 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.849 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.79 -45.91 23.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.099 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -131.22 116.75 16.68 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.52 -33.05 2.58 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.674 2.916 . . . . 0.0 112.78 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.71 -14.99 55.83 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.376 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.99 149.47 24.75 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 123.327 0.392 . . . . 0.0 111.636 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.71 123.21 29.26 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.303 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.61 153.48 38.99 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.298 1.999 . . . . 0.0 112.264 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 6.6 Cg_endo -94.01 -165.07 0.12 Allowed 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.596 2.198 . . . . 0.0 112.119 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.452 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -71.83 -24.74 61.76 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.134 0.574 . . . . 0.0 111.888 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.457 ' HD3' ' O ' ' A' ' 118' ' ' ALA . 12.0 ptp180 -67.33 -46.06 74.57 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 17.5 m -73.82 -25.54 60.15 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 46.8 mt-30 -70.63 -27.62 64.2 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.452 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 25.0 p80 -97.9 20.42 12.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.089 0.471 . . . . 0.0 111.606 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 62.8 mt -118.72 136.76 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.255 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.577 ' O ' HD12 ' A' ' 128' ' ' ILE . 2.2 m-20 -104.83 163.94 12.14 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 51' ' ' LEU . 14.3 mm -115.23 152.69 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.022 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.735 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.5 t80 -116.49 155.1 29.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.895 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.72 125.03 31.48 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 131' ' ' GLY . . . -104.14 -23.53 8.06 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.741 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.86 -167.95 33.3 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.186 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -88.55 -10.38 4.52 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.434 2.756 . . . . 0.0 114.262 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.84 131.34 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 123.08 0.237 . . . . 0.0 111.206 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 45.06 82.98 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.537 1.135 . . . . 0.0 113.385 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.2 p -81.66 -14.6 56.44 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.198 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.91 -17.13 59.13 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.748 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.626 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.61 148.2 52.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.927 0.394 . . . . 0.0 111.882 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.626 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.71 148.48 17.68 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.404 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.5 m-85 -86.84 150.76 23.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.913 -1.144 . . . . 0.0 111.115 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 21.6 t -128.22 105.69 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.163 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 126' ' ' SER . 13.6 tp -106.26 127.95 53.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.456 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.416 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 3.7 p80 -128.43 166.34 25.04 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.421 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.665 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.34 25.22 0.25 Allowed 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.691 2.261 . . . . 0.0 113.691 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.416 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 13.0 t -112.98 158.83 19.77 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.624 -178.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.27 22.94 34.13 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.653 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.27 150.51 22.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.502 0.321 . . . . 0.0 110.534 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.7 m -128.47 157.09 42.1 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.146 0.498 . . . . 0.0 112.189 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.688 ' H ' ' HG1' ' A' ' 99' ' ' THR . 57.6 m-85 -126.81 -150.88 0.46 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.8 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -59.07 -46.87 87.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.595 0.358 . . . . 0.0 111.338 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.8 m -132.58 80.3 1.89 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.943 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.688 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 47.2 m -128.7 121.15 27.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.153 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.5 123.57 46.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.861 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.58 127.82 34.04 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.764 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -120.58 43.11 2.83 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.798 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.61 -100.57 0.28 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.424 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -55.61 -14.83 2.36 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.414 HD21 ' OH ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -160.0 159.87 32.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.907 0.483 . . . . 0.0 110.687 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.73 156.98 28.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.846 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.531 ' O ' HG21 ' A' ' 99' ' ' THR . 16.1 ttm -123.91 134.64 53.49 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 m -136.68 133.72 36.47 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.7 p -127.97 19.7 6.52 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.007 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.762 ' O ' HG12 ' A' ' 113' ' ' VAL . 42.2 p -90.61 130.9 36.58 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.306 0.574 . . . . 0.0 112.021 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.49 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 7.9 mt-30 -57.95 -26.9 62.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.777 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -64.53 -40.02 94.84 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.119 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.762 HG12 ' O ' ' A' ' 110' ' ' SER . 2.7 p -71.49 -38.5 68.39 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.409 HD11 HH12 ' A' ' 85' ' ' ARG . 4.5 mm? -55.77 -49.84 72.07 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.578 0.549 . . . . 0.0 110.495 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.49 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 39.2 m-85 -68.01 -40.79 82.93 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.405 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.64 -53.95 51.23 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.679 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.3 tp -64.56 -43.96 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.457 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.56 -32.31 65.05 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.665 0.603 . . . . 0.0 109.703 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.43 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.38 -20.55 31.75 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.365 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.35 17.23 25.02 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.8 -1.091 . . . . 0.0 114.472 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 p -108.26 8.39 27.79 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -93.84 -138.01 8.83 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 119.204 -0.776 . . . . 0.0 112.863 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.37 165.76 16.34 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.146 2.564 . . . . 0.0 113.998 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.496 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -49.94 -60.14 3.2 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.482 1.113 . . . . 0.0 111.76 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.665 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -140.1 139.72 35.9 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 37.2 p -139.25 169.41 17.82 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.2 tp -125.61 115.81 20.73 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.45 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.577 HD12 ' O ' ' A' ' 74' ' ' ASP . 8.6 pt -99.25 104.98 16.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.3 t -124.16 121.99 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.035 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.0 tp -67.21 113.06 4.84 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.379 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.502 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 72.75 170.51 17.06 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.158 -0.928 . . . . 0.0 114.283 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -128.66 177.77 6.8 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.206 0.526 . . . . 0.0 110.809 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -114.94 131.73 56.79 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.937 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.33 144.05 15.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.598 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -122.15 131.68 54.08 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.046 0.498 . . . . 0.0 110.597 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -78.94 159.19 27.83 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.53 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.16 124.05 10.77 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.671 0.388 . . . . 0.0 111.497 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.27 -28.02 8.64 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.017 -0.611 . . . . 0.0 114.128 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -56.71 -48.88 76.75 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.526 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.0 tp -67.8 -47.77 68.16 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.673 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.83 -31.57 64.88 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.456 0.472 . . . . 0.0 110.814 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.88 -50.35 43.29 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.044 178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -72.29 -26.64 62.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.4 tp -75.65 -38.49 58.81 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.738 0.815 . . . . 0.0 110.784 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.7 m -78.12 -31.09 49.75 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.444 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -80.8 0.4 35.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.649 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 60.13 28.68 18.27 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.908 0.883 . . . . 0.0 111.749 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.99 -43.16 22.49 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.831 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -126.29 116.48 21.31 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -84.72 150.34 25.17 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.8 p -110.78 136.29 50.07 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.363 0.414 . . . . 0.0 110.915 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 74.9 m -151.83 154.87 33.42 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.54 159.04 25.12 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.284 1.989 . . . . 0.0 111.104 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.89 166.09 21.65 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -134.95 134.16 21.57 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 114.368 -1.287 . . . . 0.0 107.863 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.51 -26.43 16.79 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.596 2.198 . . . . 0.0 113.663 -177.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.8 -39.97 62.82 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 123.871 0.732 . . . . 0.0 112.056 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.547 HD13 HH12 ' A' ' 167' ' ' ARG . 4.2 mt -72.27 -35.66 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.363 0.602 . . . . 0.0 110.392 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.61 -37.41 65.43 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.412 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -86.67 -33.75 19.99 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -85.78 -72.33 0.49 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.052 0.387 . . . . 0.0 111.666 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.906 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.75 98.11 6.44 Favored Pre-proline 0 C--N 1.349 0.584 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.829 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 59.5 Cg_endo -92.76 1.2 3.77 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 C-N-CA 121.719 1.613 . . . . 0.0 114.258 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.623 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 80.4 Cg_endo -74.1 -52.14 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.561 2.174 . . . . 0.0 114.224 -178.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.533 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.97 -29.79 3.88 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.658 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.906 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.5 tt0 -70.36 -10.13 58.18 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.247 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.547 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -77.01 -38.2 53.52 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.135 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.7 tt -74.01 -49.58 23.7 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.3 m -58.41 -46.72 85.89 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.487 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.651 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -67.14 -40.66 86.78 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.397 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.15 -45.98 79.43 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 123.362 0.414 . . . . 0.0 110.446 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.99 -38.65 91.87 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.487 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.87 69.25 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.595 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.651 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.69 -40.23 42.14 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 122.931 0.492 . . . . 0.0 110.26 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.0 -31.19 67.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.529 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.08 53.64 0.74 Allowed Glycine 0 C--N 1.34 0.776 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.884 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 6.8 t -127.71 149.48 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -87.7 79.46 8.21 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.665 0.745 . . . . 0.0 110.735 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -26.17 49.76 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.183 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.5 m -58.97 -42.15 89.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.51 -26.71 51.4 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.9 mt -77.02 -37.86 54.13 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.263 0.352 . . . . 0.0 111.944 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.8 p -93.99 -48.68 6.14 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.28 0.363 . . . . 0.0 111.424 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 57.8 120.27 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.114 0.966 . . . . 0.0 112.889 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -99.69 142.83 30.66 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.942 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -124.32 146.54 48.75 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -145.39 130.68 3.91 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.471 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -99.37 -40.5 7.87 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.284 0.234 . . . . 0.0 111.285 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.081 -0.961 . . . . 0.0 111.072 -179.948 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.554 0.216 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -97.98 152.31 19.4 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.816 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.587 ' NE2' ' H ' ' A' ' 104' ' ' GLU . 12.4 mm100 -123.55 -43.74 2.14 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.823 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.1 p -124.76 -57.57 1.53 Allowed 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.196 0.31 . . . . 0.0 111.629 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.4 p -139.18 145.04 43.07 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 119.405 -0.331 . . . . 0.0 111.278 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -86.27 7.52 4.93 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.907 2.405 . . . . 0.0 112.732 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -93.43 -38.3 11.51 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.224 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -90.58 153.32 20.42 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.862 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mt -107.75 51.46 0.74 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.744 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.516 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 14.2 ptmt -95.16 27.65 3.15 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.494 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 176.44 51.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.563 0.745 . . . . 0.0 110.91 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -134.04 159.39 40.95 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.452 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 30' ' ' THR . 12.3 m-30 -98.58 138.33 35.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.168 0.509 . . . . 0.0 112.15 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.9 mp -109.89 135.41 50.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.565 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 mp -120.04 130.72 73.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.53 127.63 33.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.012 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.6 mmt -112.28 154.62 44.37 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.171 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -79.96 72.57 6.45 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.561 2.174 . . . . 0.0 112.611 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -130.79 -16.4 3.32 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.54 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -164.69 0.94 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.303 0.377 . . . . 0.0 110.604 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.519 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.55 37.77 2.05 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 111.85 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 8.0 m-20 -110.99 82.95 3.36 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.832 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.33 -21.88 14.8 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.973 2.449 . . . . 0.0 113.384 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -85.19 -38.52 18.89 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.909 0.484 . . . . 0.0 111.527 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.08 -5.53 55.06 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.842 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 22' ' ' ASP . . . -57.3 -0.67 0.06 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -178.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -142.3 43.86 1.65 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.179 0.514 . . . . 0.0 111.839 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p -127.38 155.58 43.39 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.616 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 48.0 t -129.22 133.54 65.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.676 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 3.9 m -115.15 154.68 28.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.471 -178.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -109.14 116.26 31.59 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.61 108.47 12.03 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-O 121.04 0.448 . . . . 0.0 110.466 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.78 -57.92 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 114.033 -1.439 . . . . 0.0 110.115 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.516 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 32.7 tt0 -151.11 119.67 6.48 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.793 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -95.8 129.24 43.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.629 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -139.48 152.89 47.35 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.475 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.8 -18.98 65.58 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.623 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -95.68 -5.83 41.35 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.346 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.81 172.37 22.51 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.2 143.24 30.19 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.5 136.6 54.26 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.638 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 133' ' ' ALA . . . -159.29 158.53 29.61 Favored Glycine 0 N--CA 1.452 -0.292 0 O-C-N 124.364 1.04 . . . . 0.0 112.529 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mt -115.6 134.86 54.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.099 0.449 . . . . 0.0 111.438 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.549 HG21 ' O ' ' A' ' 78' ' ' GLY . 11.1 t -68.55 122.48 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.91 55.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.638 0.732 . . . . 0.0 112.074 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.859 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.6 t-20 -148.32 -2.75 0.51 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.157 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -130.19 87.23 51.71 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.505 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -59.7 143.15 99.7 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 121.559 1.506 . . . . 0.0 112.14 175.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.0 m -92.54 158.5 15.97 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 123.39 0.431 . . . . 0.0 111.368 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.89 50.29 1.37 Allowed Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.837 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 mt -133.57 158.96 41.85 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.979 0.458 . . . . 0.0 110.229 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.1 p-10 -112.23 157.54 20.77 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.102 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.433 HD21 ' SG ' ' A' ' 70' ' ' CYS . 13.4 tp -57.79 -37.07 73.08 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.07 -37.91 62.06 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -63.66 -43.03 97.93 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.21 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.849 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -62.63 -46.82 95.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.609 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.428 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 4.4 mp -53.56 -36.72 62.17 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.87 0.731 . . . . 0.0 110.784 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.93 -28.34 49.63 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.564 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -29.97 47.9 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.381 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.849 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.9 mt -77.83 -45.14 25.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.884 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -132.02 116.57 15.7 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.535 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -77.59 -32.73 2.69 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 123.615 2.876 . . . . 0.0 112.747 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.22 -14.38 55.63 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.364 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 149.7 24.52 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 123.321 0.388 . . . . 0.0 111.792 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.32 123.75 29.68 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.99 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.45 146.04 34.55 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.185 1.923 . . . . 0.0 112.351 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.504 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.4 Cg_endo -92.43 -170.62 0.3 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.491 2.127 . . . . 0.0 111.83 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.488 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -63.82 -24.89 67.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.142 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.494 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.6 ptp180 -66.18 -53.38 38.14 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -177.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.433 ' SG ' HD21 ' A' ' 53' ' ' LEU . 60.1 m -71.74 -25.02 61.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 47.7 mt-30 -68.12 -35.63 78.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.488 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 20.5 p80 -90.37 22.12 3.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.228 0.537 . . . . 0.0 111.667 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 55.1 mt -119.39 139.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.383 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.555 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.5 m-20 -107.11 153.78 22.14 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.802 0.689 . . . . 0.0 112.728 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.9 mm -100.02 150.3 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.093 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.7 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -116.51 154.98 29.44 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.52 118.94 26.27 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.636 0.198 . . . . 0.0 110.552 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.549 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -101.46 -23.66 9.37 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.826 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.82 -167.77 35.4 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.123 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -88.39 -9.66 4.95 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 123.492 2.794 . . . . 0.0 114.264 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 t -87.07 131.18 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.003 0.19 . . . . 0.0 111.035 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 44.13 87.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.533 1.133 . . . . 0.0 113.316 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.415 ' O ' HD23 ' A' ' 130' ' ' LEU . 9.0 t -88.09 1.51 54.11 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.428 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.87 -5.47 47.91 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.604 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.26 154.45 50.66 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.11 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.604 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.5 134.2 12.1 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.175 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.734 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.54 145.58 27.31 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.366 1.067 . . . . 0.0 110.231 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -123.97 103.42 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 123.366 0.416 . . . . 0.0 110.874 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 126' ' ' SER . 6.2 tp -105.71 129.21 53.97 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.429 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 3.7 p80 -125.6 168.23 14.37 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 118.985 -0.531 . . . . 0.0 112.146 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 16.5 Cg_endo -96.61 13.99 0.96 Allowed 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.862 2.375 . . . . 0.0 113.644 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.429 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 8.6 t -101.89 161.06 13.95 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.874 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.84 19.21 55.5 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.512 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -85.47 153.86 22.19 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.604 0.362 . . . . 0.0 110.403 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.0 p -127.03 157.89 38.39 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.559 ' CE2' HG21 ' A' ' 113' ' ' VAL . 52.0 m-85 -129.34 -151.94 0.5 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.671 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -57.44 -46.26 83.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.776 0.431 . . . . 0.0 111.723 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 m -138.32 78.94 1.71 Allowed 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.642 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 107' ' ' MET . 25.1 m -126.29 120.96 31.3 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tp -77.36 162.02 27.59 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.051 176.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -135.2 125.5 26.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.896 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -135.84 43.99 2.52 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.279 -179.383 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.4 ' HA3' ' NE2' ' A' ' 3' ' ' GLN . . . 61.13 -99.16 0.19 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.815 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.587 ' H ' ' NE2' ' A' ' 3' ' ' GLN . 10.6 pt-20 -57.4 -12.99 2.91 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 pp -158.44 148.11 19.55 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.265 0.555 . . . . 0.0 112.493 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -120.83 158.6 27.24 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.324 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.59 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 8.9 ttm -119.68 134.08 55.37 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.7 m -128.76 127.36 41.86 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.8 p -119.92 11.78 11.88 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.782 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.2 m -85.59 130.38 34.59 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.617 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.496 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.7 pt20 -61.58 -29.52 70.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.382 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.45 -43.16 95.15 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.603 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.731 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.0 p -68.14 -39.77 81.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 123.189 0.306 . . . . 0.0 110.38 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.559 ' N ' HG13 ' A' ' 113' ' ' VAL . 1.5 tt -58.12 -48.34 80.51 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 123.571 0.544 . . . . 0.0 110.47 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.496 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 35.3 m-85 -69.98 -37.57 75.8 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.865 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.25 -51.94 65.72 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.0 tp -64.56 -43.14 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.156 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.02 -31.59 65.28 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 123.826 0.704 . . . . 0.0 109.546 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.494 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.71 -20.8 30.6 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.255 176.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.61 13.1 33.39 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.729 -1.123 . . . . 0.0 114.692 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.1 p -103.39 7.8 38.09 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.68 -137.7 9.6 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.239 -0.756 . . . . 0.0 112.635 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.72 173.72 12.59 Favored 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 123.228 2.619 . . . . 0.0 113.601 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.01 -54.37 47.53 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.757 0.823 . . . . 0.0 111.916 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.572 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.9 mmtt -139.05 151.14 46.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.775 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.0 m -148.05 165.38 30.97 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.7 tp -127.5 118.05 23.26 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.361 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.734 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 18.5 pt -98.63 102.7 13.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.989 0.9 . . . . 0.0 109.819 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 6.8 t -119.75 121.6 39.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.76 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 83' ' ' THR . 6.9 tp -66.84 115.06 6.2 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.01 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.71 174.61 4.11 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.352 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -128.44 -179.49 5.06 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.408 0.623 . . . . 0.0 111.092 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -117.34 130.47 56.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.179 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.46 152.24 19.48 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.354 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 27.4 m-90 -132.69 139.02 47.48 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.898 0.41 . . . . 0.0 110.537 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.25 158.17 27.63 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.851 0.719 . . . . 0.0 110.794 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.92 91.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.82 -22.05 10.11 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.339 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -57.22 -46.35 83.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.866 0.466 . . . . 0.0 111.978 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.573 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.5 tp -66.73 -47.18 73.09 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -56.69 -30.84 63.86 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.453 0.471 . . . . 0.0 110.793 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.43 -49.08 52.57 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.04 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.4 pt-20 -72.69 -26.75 61.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.0 tp -75.48 -38.23 59.68 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.744 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -78.19 -30.31 48.92 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.272 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.06 0.5 31.61 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.605 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 61.38 28.98 18.3 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.871 0.868 . . . . 0.0 111.797 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.45 -42.71 16.63 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.528 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -124.14 111.39 15.86 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 123.495 0.497 . . . . 0.0 109.856 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.3 tp -86.93 128.36 35.06 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.614 0.245 . . . . 0.0 111.506 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.5 p -100.33 142.3 31.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.758 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 78.2 m -154.95 155.83 30.66 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 123.446 0.466 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.51 148.46 92.94 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.325 2.016 . . . . 0.0 110.999 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.522 ' HA ' ' CZ ' ' A' ' 174' ' ' ARG . . . -135.06 177.42 7.82 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -134.29 141.11 38.02 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 113.88 -1.509 . . . . 0.0 108.584 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -74.85 -26.54 11.14 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 122.766 2.311 . . . . 0.0 114.007 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -48.89 -41.71 34.4 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.915 0.759 . . . . 0.0 112.631 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.6 HD11 HH12 ' A' ' 167' ' ' ARG . 4.9 mt -70.26 -32.63 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.467 0.651 . . . . 0.0 110.421 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.6 tt -76.65 -37.12 56.81 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.37 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.61 -33.45 25.32 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -86.84 -72.93 0.48 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.939 0.336 . . . . 0.0 111.657 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.886 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.47 99.93 6.3 Favored Pre-proline 0 C--N 1.349 0.578 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.859 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 70.3 Cg_endo -90.94 -0.91 4.97 Favored 'Trans proline' 0 CA--C 1.57 2.275 0 C-N-CA 121.742 1.628 . . . . 0.0 114.261 175.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.634 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 87.8 Cg_endo -74.28 -54.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 122.636 2.224 . . . . 0.0 114.502 -178.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.566 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.1 mt-10 -120.58 -29.84 4.64 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.729 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.886 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.0 tt0 -70.38 -11.38 60.88 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.422 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.6 HH12 HD11 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.28 -45.5 32.29 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.397 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.5 tp -68.06 -50.19 56.72 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.1 m -57.57 -51.16 70.6 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.922 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.402 ' HB3' HH12 ' A' ' 167' ' ' ARG . . . -61.22 -39.09 88.98 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.158 0.286 . . . . 0.0 110.987 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.28 83.92 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 123.657 0.598 . . . . 0.0 110.457 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.11 84.54 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.646 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 177' ' ' VAL . . . -62.76 -32.28 73.39 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.532 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.522 ' CZ ' ' HA ' ' A' ' 154' ' ' ALA . 10.9 mtm-85 -77.7 -41.57 37.47 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 122.682 0.393 . . . . 0.0 110.702 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.77 -35.47 79.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.634 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 132.29 36.71 0.29 Allowed Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.2 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 173' ' ' ALA . 4.9 t -128.44 127.71 67.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -83.86 83.66 7.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.568 0.699 . . . . 0.0 111.511 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -77.99 -26.42 48.61 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.157 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.0 m -58.39 -45.26 88.67 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.36 -26.85 52.32 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 21.3 mt -77.28 -30.02 54.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.618 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 23.0 p -90.22 -47.98 7.45 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.374 0.421 . . . . 0.0 111.435 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -131.22 120.2 22.92 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.48 0.488 . . . . 0.0 111.04 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -97.25 138.72 34.3 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.976 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -102.79 151.2 22.69 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.215 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -98.14 -103.7 2.33 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.595 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -99.1 -40.56 7.95 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.345 0.258 . . . . 0.0 111.332 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.094 -179.96 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.349 0.118 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -99.88 130.66 46.09 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.034 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -101.5 -40.89 6.84 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.096 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.432 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 16.1 t -98.56 153.21 18.81 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.369 0.418 . . . . 0.0 110.891 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 p -93.74 101.78 6.68 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.038 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.9 Cg_endo -87.65 7.67 4.56 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.769 2.312 . . . . 0.0 112.287 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 t -92.57 166.2 12.62 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.97 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 62.74 151.71 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.933 0.893 . . . . 0.0 112.581 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.4 mt -93.84 46.57 1.18 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.323 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -93.0 19.36 7.89 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.068 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 175.55 55.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.268 1.027 . . . . 0.0 109.209 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -137.96 156.88 47.4 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 154' ' ' ALA . 15.5 m-30 -96.46 135.43 38.34 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.928 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.514 ' O ' HG12 ' A' ' 29' ' ' VAL . 6.2 mt -107.62 138.2 44.27 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.182 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 mm -116.69 132.63 65.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 O-C-N 123.623 0.577 . . . . 0.0 109.617 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.58 128.15 33.67 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.724 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.5 mtt -117.79 154.32 51.06 Favored Pre-proline 0 CA--C 1.538 0.509 0 O-C-N 123.383 0.427 . . . . 0.0 111.336 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.41 74.0 5.76 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.673 2.249 . . . . 0.0 112.661 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -131.63 -17.64 2.86 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.741 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.32 -163.26 0.84 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.272 0.357 . . . . 0.0 110.403 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.514 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -101.96 34.4 2.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.906 0.384 . . . . 0.0 111.979 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.6 82.4 3.75 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.37 -22.3 14.32 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.033 2.488 . . . . 0.0 113.333 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -85.13 -39.13 18.25 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.93 0.492 . . . . 0.0 111.498 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -4.63 56.94 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.889 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 22' ' ' ASP . . . -57.69 0.71 0.05 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -143.13 43.34 1.55 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.212 0.529 . . . . 0.0 111.866 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.6 p -126.49 158.28 36.5 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.674 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 14' ' ' LEU . 58.4 t -130.72 133.07 63.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.641 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.8 m -114.33 155.18 26.71 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.647 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.499 ' OH ' HD21 ' A' ' 105' ' ' LEU . 34.1 t80 -107.71 115.58 30.4 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.08 108.21 13.48 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-O 121.393 0.616 . . . . 0.0 111.236 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.486 ' O ' HD13 ' A' ' 102' ' ' LEU . 43.4 t -68.42 -63.32 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.267 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -136.82 122.65 19.99 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.492 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -104.66 128.79 52.82 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.9 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -139.81 153.14 47.02 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.627 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.61 -21.56 66.43 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.005 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -94.99 -4.66 46.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.398 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.54 176.23 27.48 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.405 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.99 148.95 30.36 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.21 136.17 54.62 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.289 177.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 133' ' ' ALA . . . -157.11 160.39 30.4 Favored Glycine 0 N--CA 1.447 -0.624 0 O-C-N 124.603 1.189 . . . . 0.0 112.509 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mt -112.69 131.19 55.77 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.939 0.37 . . . . 0.0 111.223 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 78' ' ' GLY . 15.7 t -67.05 122.12 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.498 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.49 56.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.648 0.737 . . . . 0.0 112.038 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.858 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.1 t-20 -147.15 -3.25 0.58 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.158 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.45 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 2.5 ttm180 -130.08 88.57 47.99 Favored Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.495 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.3 Cg_exo -59.6 143.68 99.61 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.712 1.608 . . . . 0.0 112.157 175.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.423 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.2 m -93.29 159.71 15.15 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 123.386 0.429 . . . . 0.0 111.639 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.06 50.69 1.18 Allowed Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.588 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mt -133.6 158.44 43.19 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 122.848 0.459 . . . . 0.0 110.143 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.515 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 24.7 p-10 -112.61 157.61 20.99 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 tt -58.1 -26.51 62.68 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 120.947 0.403 . . . . 0.0 111.847 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.68 95.47 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.173 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.56 -45.78 88.92 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.095 0.247 . . . . 0.0 111.457 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.855 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 7.8 m -62.12 -44.51 99.12 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.4 mt -55.99 -35.14 66.43 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.853 0.721 . . . . 0.0 110.618 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.08 -27.41 48.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.391 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.431 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.84 -30.97 51.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.284 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.855 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.2 mt -77.69 -45.76 23.92 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.162 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -131.12 116.52 16.73 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.581 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.7 -32.94 2.51 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.554 2.836 . . . . 0.0 112.75 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.74 -14.77 56.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.313 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.18 149.66 24.48 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.42 0.45 . . . . 0.0 111.672 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.24 123.45 29.39 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.304 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.42 149.48 35.11 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.275 1.983 . . . . 0.0 112.279 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.467 ' CD ' ' HG ' ' A' ' 70' ' ' CYS . 7.6 Cg_endo -94.33 -167.86 0.16 Allowed 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.653 2.235 . . . . 0.0 112.432 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.43 -24.64 64.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.373 0.669 . . . . 0.0 112.095 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.495 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 9.1 ptp180 -67.91 -48.08 67.0 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.467 ' HG ' ' CD ' ' A' ' 67' ' ' PRO . 21.2 m -73.15 -26.19 61.11 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.087 0.555 . . . . 0.0 112.343 -178.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -70.34 -26.96 63.99 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.668 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -96.71 17.66 16.05 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.58 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 52.1 mt -120.97 139.63 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.818 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.59 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.9 m-20 -106.45 154.53 20.7 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.2 mm -102.02 153.12 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.805 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.7 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -117.97 155.21 30.64 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.64 121.23 28.87 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 117.684 0.22 . . . . 0.0 110.59 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.53 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -104.04 -23.6 8.07 Favored Glycine 0 C--N 1.346 1.137 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.888 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.7 -168.36 33.81 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.043 -0.598 . . . . 0.0 113.315 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -88.58 -13.09 3.48 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 123.545 2.83 . . . . 0.0 114.394 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 t -83.41 129.8 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.099 0.249 . . . . 0.0 111.162 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 44.25 86.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.635 1.174 . . . . 0.0 113.392 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.6 p -82.72 -13.88 55.56 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.085 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.05 -17.59 58.66 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.641 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.58 148.87 52.38 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.089 0.471 . . . . 0.0 111.908 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.641 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.71 159.75 13.66 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.429 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.3 m-85 -96.14 151.71 19.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.721 -1.24 . . . . 0.0 110.854 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 t -128.35 102.91 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.654 ' O ' ' HA ' ' A' ' 126' ' ' SER . 0.3 OUTLIER -102.37 127.69 49.27 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.869 -179.216 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' A' ' 106' ' ' ALA . 3.3 p80 -130.07 164.42 40.78 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.499 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.66 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.5 Cg_endo -97.08 19.78 0.46 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.647 2.231 . . . . 0.0 113.78 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.8 t -106.4 158.52 16.83 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.59 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.85 22.82 33.92 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.717 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 95' ' ' SER . 2.8 tt -90.73 149.58 21.97 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.521 0.329 . . . . 0.0 110.435 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.447 ' N ' HD23 ' A' ' 94' ' ' LEU . 27.5 m -126.22 155.51 41.71 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.054 0.454 . . . . 0.0 112.093 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.529 ' CE2' HG22 ' A' ' 113' ' ' VAL . 53.6 m-85 -126.55 -150.4 0.44 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.846 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -58.4 -47.29 84.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.61 0.364 . . . . 0.0 111.491 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 63.2 m -133.05 81.05 1.92 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.964 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 107' ' ' MET . 44.7 m -127.98 120.06 26.78 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.04 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -103.06 122.42 44.62 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.911 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.24 125.47 30.35 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.773 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -121.47 55.29 1.09 Allowed 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.232 1.015 . . . . 0.0 110.626 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.87 -114.35 5.53 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.259 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.5 -3.44 6.25 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.499 HD21 ' OH ' ' A' ' 31' ' ' TYR . 3.5 pp -147.78 157.02 43.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.19 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.401 ' HB2' ' CE1' ' A' ' 90' ' ' HIS . . . -120.44 158.59 26.87 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.368 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.602 ' O ' ' HA ' ' A' ' 99' ' ' THR . 25.6 ttm -124.56 132.14 53.46 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.2 m -133.95 130.99 38.49 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.9 p -124.37 18.82 8.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.433 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.0 t -90.66 133.97 34.74 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.92 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.468 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 5.7 mt-30 -62.35 -26.37 68.41 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.473 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.28 -41.96 93.66 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.496 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.734 ' O ' HG21 ' A' ' 117' ' ' ILE . 4.5 p -71.49 -37.58 64.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.486 ' N ' HG11 ' A' ' 113' ' ' VAL . 5.1 tp -58.89 -47.12 86.09 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 123.511 0.507 . . . . 0.0 110.198 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.468 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 18.4 m-85 -68.5 -40.91 80.67 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.837 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.68 -52.6 64.44 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.385 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.734 HG21 ' O ' ' A' ' 113' ' ' VAL . 4.4 tp -64.82 -44.23 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.718 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.433 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.54 -32.33 65.03 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 123.745 0.653 . . . . 0.0 109.679 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.495 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.56 -20.17 31.94 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.396 176.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.08 16.2 28.59 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.698 -1.137 . . . . 0.0 114.544 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.9 p -107.55 7.96 29.02 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.01 -138.28 9.04 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 119.213 -0.77 . . . . 0.0 112.747 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.75 168.46 15.87 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.191 2.594 . . . . 0.0 113.754 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.479 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -50.76 -58.83 4.96 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.363 1.065 . . . . 0.0 111.748 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.66 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.4 mmtt -141.3 139.93 33.74 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.797 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 36.7 p -137.02 168.05 20.33 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 tp -128.27 117.07 20.84 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.81 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.59 HD11 ' O ' ' A' ' 74' ' ' ASP . 11.5 pt -98.18 103.88 15.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-O 121.415 0.626 . . . . 0.0 109.639 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.0 t -121.37 120.09 34.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.014 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 tp -67.1 115.6 6.98 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.601 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 169.82 11.28 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.405 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -128.42 171.97 11.55 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.278 0.561 . . . . 0.0 110.803 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -108.86 130.89 55.42 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.05 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.5 142.67 13.83 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.387 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 17.4 m-90 -120.53 133.6 55.38 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.967 0.451 . . . . 0.0 110.391 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -82.12 158.86 23.52 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.181 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.77 124.37 9.63 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.364 0.415 . . . . 0.0 111.705 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.57 -26.76 8.72 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.036 -0.602 . . . . 0.0 114.35 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -58.27 -49.03 78.58 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.562 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.7 tm? -66.23 -48.96 68.85 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.983 0.177 . . . . 0.0 110.772 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.86 -31.12 66.37 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 120.927 0.394 . . . . 0.0 110.827 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.18 -50.09 50.69 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.086 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.45 -26.62 62.8 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.966 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.1 tp -75.22 -38.48 60.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.427 0.691 . . . . 0.0 110.668 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.0 m -77.93 -29.65 50.09 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.34 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.8 t70 -81.43 -1.13 44.58 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.615 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 t30 60.5 30.31 19.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.879 0.872 . . . . 0.0 111.402 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.73 -42.17 18.35 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.984 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -126.71 115.86 20.06 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.7 tp -86.78 145.3 26.69 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.514 0.197 . . . . 0.0 111.225 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.4 p -105.31 137.0 43.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.964 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 71.1 m -152.12 149.76 24.03 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.598 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.5 158.47 19.27 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.39 2.06 . . . . 0.0 111.247 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.67 167.22 19.14 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -177.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -133.39 135.64 25.7 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 114.132 -1.395 . . . . 0.0 107.85 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.82 -26.76 13.09 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.61 2.207 . . . . 0.0 114.013 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.77 -40.55 63.25 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.759 0.662 . . . . 0.0 112.104 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.564 HD11 HH12 ' A' ' 167' ' ' ARG . 4.5 mt -70.95 -34.71 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.24 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.3 tt -74.0 -38.62 64.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.654 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.413 ' HE1' ' O ' ' A' ' 89' ' ' LEU . 44.7 m-85 -88.0 -31.1 19.51 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -85.57 -71.73 0.52 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.215 0.461 . . . . 0.0 111.451 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.886 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.43 98.59 5.94 Favored Pre-proline 0 C--N 1.35 0.609 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.858 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 59.3 Cg_endo -91.99 0.35 4.27 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 121.602 1.535 . . . . 0.0 114.206 175.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.628 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 78.7 Cg_endo -74.19 -53.78 0.11 Allowed 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 122.546 2.164 . . . . 0.0 114.461 -178.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.565 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -121.09 -29.66 4.51 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.61 -178.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.886 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.8 tt0 -70.27 -11.49 60.94 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.382 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.564 HH12 HD11 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -77.04 -40.2 47.25 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.325 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -72.02 -49.9 32.98 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.8 m -58.92 -47.36 85.31 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.55 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.659 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.79 -40.69 92.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.158 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.82 -46.28 78.12 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 123.488 0.492 . . . . 0.0 110.472 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.21 90.28 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.428 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.82 -27.29 68.14 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.66 177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.76 -40.21 41.64 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 122.832 0.453 . . . . 0.0 110.306 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.84 -30.28 63.89 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.408 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 102.17 56.67 0.83 Allowed Glycine 0 C--N 1.339 0.745 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.817 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.5 t -126.06 151.52 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -86.77 78.68 9.04 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.73 0.776 . . . . 0.0 110.92 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 -26.23 49.11 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.892 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.7 t -59.64 -42.66 93.25 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.54 -26.54 51.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 15.9 mt -76.09 -37.69 57.88 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.318 0.386 . . . . 0.0 111.816 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.6 p -92.89 -47.74 6.88 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.281 0.363 . . . . 0.0 111.367 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 57.87 118.73 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.221 1.008 . . . . 0.0 112.824 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -112.0 148.25 34.2 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.62 132.67 44.8 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.135 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 152.8 77.54 0.02 OUTLIER Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -128.48 138.34 52.24 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.652 0.266 . . . . 0.0 110.89 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.501 -0.761 . . . . 0.0 111.094 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.462 0.173 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -100.19 130.28 46.3 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.764 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -128.8 -54.67 1.22 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.138 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.8 m -141.86 -53.68 0.44 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.252 0.345 . . . . 0.0 111.164 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.2 m -137.76 95.08 11.24 Favored Pre-proline 0 CA--C 1.544 0.722 0 O-C-N 123.269 0.356 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -88.83 7.27 4.36 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.835 2.357 . . . . 0.0 112.095 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.478 HG21 ' N ' ' A' ' 8' ' ' TYR . 13.1 t -95.09 -47.48 6.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.145 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.478 ' N ' HG21 ' A' ' 7' ' ' THR . 4.6 m-85 -107.63 156.2 19.31 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 123.7 0.625 . . . . 0.0 111.547 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.481 HD13 ' CE1' ' A' ' 35' ' ' HIS . 19.4 mt -91.92 47.27 1.33 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.655 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -89.22 17.3 6.14 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.529 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.415 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 19.0 p80 172.2 58.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.351 1.06 . . . . 0.0 110.108 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -137.19 161.61 35.71 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.465 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 154' ' ' ALA . 18.9 m-30 -97.76 136.95 37.37 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 3.7 mt -108.28 140.18 41.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.949 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.435 HD12 ' O ' ' A' ' 150' ' ' LEU . 2.9 mp -120.62 135.73 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 123.462 0.476 . . . . 0.0 110.02 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.14 125.61 29.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.048 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.9 mtt -110.34 157.44 38.12 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.206 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.21 30.16 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.63 2.22 . . . . 0.0 113.213 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -86.72 -17.02 34.69 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.29 -167.13 1.15 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.094 0.246 . . . . 0.0 110.597 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.509 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.09 40.33 1.47 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.102 0.477 . . . . 0.0 111.764 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -112.19 80.33 3.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.915 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.4 Cg_exo -75.45 -23.12 13.38 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 123.036 2.491 . . . . 0.0 113.315 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -84.54 -34.93 23.15 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.825 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.94 3.92 53.34 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.048 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.16 163.87 19.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.815 0.341 . . . . 0.0 111.761 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 49.23 31.79 3.88 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.0 p -117.53 154.25 31.8 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 96.4 t -128.93 134.2 64.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.487 0.661 . . . . 0.0 110.857 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.2 m -114.66 153.67 29.79 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.914 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.501 ' OH ' HD21 ' A' ' 105' ' ' LEU . 43.3 t80 -106.82 118.54 36.94 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' HIS . 0.2 OUTLIER -82.44 109.97 17.15 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.255 0.55 . . . . 0.0 111.139 -178.601 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.537 ' O ' HD22 ' A' ' 102' ' ' LEU . 38.1 t -71.35 -64.73 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.397 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -133.8 117.25 16.66 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.583 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.481 ' CE1' HD13 ' A' ' 9' ' ' LEU . 12.1 t-80 -102.46 126.8 49.62 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.466 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -139.25 152.01 46.96 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.08 -13.14 59.54 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.042 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -107.77 3.13 24.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.306 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.07 166.27 15.16 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.425 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -148.5 145.29 27.85 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.406 ' O ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -125.86 138.0 53.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.17 178.376 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.488 ' O ' ' HB1' ' A' ' 133' ' ' ALA . . . -158.43 158.94 29.72 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.451 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 mt -112.77 131.89 55.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.042 0.421 . . . . 0.0 111.196 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 78' ' ' GLY . 15.9 t -66.04 123.43 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.69 55.07 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.598 0.713 . . . . 0.0 112.224 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.845 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.4 t-20 -147.55 -3.24 0.55 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.116 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.72 87.03 53.64 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.512 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -60.27 147.29 94.19 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 121.695 1.597 . . . . 0.0 112.721 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.408 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 66.1 m -92.39 160.13 15.24 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.85 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.02 -2.19 64.64 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 116.144 -0.48 . . . . 0.0 113.711 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.457 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -90.16 152.78 20.95 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.731 0.3 . . . . 0.0 111.28 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -101.33 164.85 11.58 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.155 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 tp -60.26 -28.19 67.85 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 120.802 0.334 . . . . 0.0 111.739 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.55 98.79 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -63.99 -46.52 84.19 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.082 0.239 . . . . 0.0 111.625 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.856 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.5 m -61.91 -44.96 99.61 Favored 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.6 mt -56.58 -34.5 67.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.598 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.18 -27.5 48.01 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.317 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.425 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.85 -30.7 51.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.248 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.856 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.8 mt -77.87 -46.1 22.33 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.81 -1.541 . . . . 0.0 110.987 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -130.26 115.9 17.54 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -77.6 -32.9 2.59 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.589 2.859 . . . . 0.0 112.757 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.63 -14.91 56.12 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.291 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.43 150.38 23.82 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.355 0.409 . . . . 0.0 111.709 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.79 122.82 28.87 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.175 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.67 149.0 42.71 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.409 2.073 . . . . 0.0 112.25 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -94.86 -171.79 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.57 2.18 . . . . 0.0 112.6 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -24.5 67.58 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.116 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 7.8 ptp180 -68.55 -49.15 61.71 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 19.0 m -74.17 -26.03 60.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.083 0.553 . . . . 0.0 112.425 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -68.53 -27.54 66.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.949 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -97.51 18.85 14.45 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.439 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 69' ' ' ARG . 65.0 mt -119.64 140.07 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.941 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.535 ' O ' HD13 ' A' ' 128' ' ' ILE . 2.0 m-20 -107.18 154.34 21.34 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.819 0.7 . . . . 0.0 112.851 -178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 51' ' ' LEU . 20.7 mm -102.98 156.74 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.168 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.699 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -121.58 155.23 35.5 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.63 121.06 27.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 117.763 0.256 . . . . 0.0 110.471 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.97 -23.67 8.06 Favored Glycine 0 C--N 1.348 1.213 0 C-N-CA 120.206 -0.997 . . . . 0.0 114.211 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.52 -167.88 34.15 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.431 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -88.46 -13.55 3.43 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.468 2.778 . . . . 0.0 114.376 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.61 127.03 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 123.086 0.241 . . . . 0.0 111.148 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 46.99 84.18 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.406 1.082 . . . . 0.0 113.203 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -85.86 1.23 50.66 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.415 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -92.86 -10.76 35.51 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.611 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.03 150.82 52.11 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.008 0.432 . . . . 0.0 112.108 -179.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.611 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.24 144.88 17.07 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.172 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.8 OUTLIER -86.75 146.12 26.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.923 -1.139 . . . . 0.0 110.525 179.248 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.46 103.71 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 123.601 0.563 . . . . 0.0 109.949 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 126' ' ' SER . 11.4 tp -107.65 127.98 54.14 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.127 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' A' ' 106' ' ' ALA . 4.4 p80 -126.67 168.72 13.66 Favored Pre-proline 0 CA--C 1.556 1.196 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.663 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.665 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.11 17.44 0.6 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.75 2.3 . . . . 0.0 113.691 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.416 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 8.6 t -105.31 159.49 15.85 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.808 -178.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.84 19.58 54.19 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.752 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mp -85.24 154.59 21.85 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.585 0.354 . . . . 0.0 110.912 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.2 p -125.49 156.95 38.15 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.634 ' H ' ' HG1' ' A' ' 99' ' ' THR . 56.7 m-85 -130.0 -149.3 0.4 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.495 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -60.41 -45.69 92.68 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.406 0.283 . . . . 0.0 111.323 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.3 m -137.09 85.24 2.12 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.492 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.634 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 13.8 m -129.89 129.16 43.55 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.712 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -112.42 123.21 49.79 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.871 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.93 125.12 29.33 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.537 HD22 ' O ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -135.09 76.96 1.65 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.973 0.892 . . . . 0.0 112.041 -177.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.574 ' O ' ' HG2' ' A' ' 104' ' ' GLU . . . 43.25 104.88 0.01 OUTLIER Glycine 0 N--CA 1.475 1.279 0 CA-C-N 113.677 -1.601 . . . . 0.0 114.823 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 103' ' ' GLY . 10.4 pt-20 61.36 -15.86 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.777 1.231 . . . . 0.0 113.25 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.504 ' H ' ' C ' ' A' ' 103' ' ' GLY . 2.7 pp -132.88 145.56 51.04 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 120.806 0.336 . . . . 0.0 110.451 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.423 ' HB3' ' NE2' ' A' ' 90' ' ' HIS . . . -114.84 155.46 26.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.986 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' A' ' 99' ' ' THR . 16.9 ttm -121.66 128.96 52.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.9 m -128.57 129.64 46.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 p -119.65 16.39 12.8 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.311 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.0 p -91.17 131.0 36.99 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 121.737 0.78 . . . . 0.0 112.439 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.491 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.7 pt20 -61.43 -27.74 68.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.3 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.17 -43.42 95.19 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.484 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.722 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.6 p -69.56 -36.4 70.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.49 ' N ' HG13 ' A' ' 113' ' ' VAL . 5.4 tp -58.64 -49.43 77.56 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 123.472 0.482 . . . . 0.0 110.372 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.491 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 31.8 m-85 -68.19 -38.74 82.31 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.907 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.1 -52.74 63.64 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.269 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.48 -43.83 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.672 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.435 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.6 -32.59 65.4 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.714 0.634 . . . . 0.0 109.579 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.457 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.71 -19.53 32.61 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.316 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.62 14.99 33.13 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.748 -1.114 . . . . 0.0 114.739 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.9 p -104.88 6.53 33.84 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.52 -138.29 9.59 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.169 -0.795 . . . . 0.0 112.515 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.25 172.99 12.16 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 123.128 2.552 . . . . 0.0 113.611 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.61 -55.0 40.46 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.966 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.665 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.9 mmtt -141.63 139.93 33.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.843 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 67.3 m -137.67 166.83 22.99 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tp -125.38 116.46 21.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.601 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 9.8 pt -99.15 102.57 13.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 O-C-N 123.82 0.7 . . . . 0.0 109.45 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -120.26 120.78 37.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.031 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.08 112.86 4.63 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.488 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.66 171.54 19.13 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.88 -1.055 . . . . 0.0 114.405 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.38 176.12 7.96 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.099 -0.55 . . . . 0.0 110.397 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 42' ' ' GLY . . . -115.36 131.01 57.06 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.161 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.94 150.26 18.72 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.549 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.425 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 26.4 m-90 -127.78 136.12 51.05 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 123.902 0.413 . . . . 0.0 110.408 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.08 158.07 26.52 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.922 0.764 . . . . 0.0 110.725 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.27 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.43 -24.84 7.15 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 115.408 -0.815 . . . . 0.0 113.042 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.71 -45.46 85.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.968 0.507 . . . . 0.0 112.28 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.563 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.04 -48.25 66.15 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.187 0.304 . . . . 0.0 110.594 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.63 -29.39 67.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.98 0.419 . . . . 0.0 110.715 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.4 -50.42 38.87 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.84 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.35 -26.67 63.85 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.847 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.1 tp -76.02 -37.87 57.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.745 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.5 t -77.78 -29.03 50.7 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.202 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -82.64 0.21 44.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.395 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 59.64 29.51 19.08 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.944 0.897 . . . . 0.0 111.507 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.76 -42.76 19.31 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.949 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -124.52 113.65 18.38 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.2 tp -85.04 139.49 31.71 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.634 0.254 . . . . 0.0 111.371 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.5 p -104.46 137.85 41.72 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.047 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 74.3 m -151.69 154.95 33.74 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.816 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.76 153.26 51.16 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.314 2.009 . . . . 0.0 111.074 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.42 166.37 18.85 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -133.66 135.9 25.78 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.207 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.409 ' HG3' ' OE1' ' A' ' 104' ' ' GLU . 72.6 Cg_endo -73.51 -26.44 14.08 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.553 2.168 . . . . 0.0 113.684 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.11 62.17 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.9 0.75 . . . . 0.0 112.157 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.567 HD13 HH12 ' A' ' 167' ' ' ARG . 4.7 mt -72.31 -34.87 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.328 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.35 -36.16 63.59 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.277 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -85.28 -36.87 20.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.65 -71.96 0.48 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 117.927 0.331 . . . . 0.0 111.786 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.664 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -142.29 98.97 5.97 Favored Pre-proline 0 C--N 1.349 0.544 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.845 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.2 Cg_endo -91.8 0.21 4.39 Favored 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 121.652 1.568 . . . . 0.0 114.319 175.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.629 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 66.2 Cg_endo -75.46 -50.67 0.12 Allowed 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.609 2.206 . . . . 0.0 114.607 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.54 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.4 mt-10 -121.44 -34.06 3.52 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.731 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.664 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 9.0 mt-10 -69.04 -10.77 59.23 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.135 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.567 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -77.06 -41.57 41.86 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.217 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.8 tp -70.65 -49.98 41.6 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.8 m -58.5 -48.76 79.74 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.637 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.662 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.31 -40.19 95.41 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.148 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.46 78.25 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.568 0.542 . . . . 0.0 110.435 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.45 91.22 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.423 177.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.25 68.3 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.676 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.82 -39.93 42.09 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 122.823 0.449 . . . . 0.0 110.327 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.83 -31.85 68.71 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.376 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.68 54.81 0.56 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.834 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 12.5 t -127.57 147.36 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -86.81 77.75 9.21 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.676 0.751 . . . . 0.0 110.622 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -26.18 49.81 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.029 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.7 m -58.81 -41.95 87.99 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.59 -26.67 50.94 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 18.0 mt -77.14 -38.12 52.56 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.8 p -94.31 -48.35 6.2 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.277 0.361 . . . . 0.0 111.397 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 57.76 118.75 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.173 0.989 . . . . 0.0 112.74 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -100.81 147.08 26.48 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.04 140.23 34.57 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.078 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -150.92 -96.48 0.15 Allowed Glycine 0 C--N 1.337 0.595 0 O-C-N 123.691 0.619 . . . . 0.0 112.5 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -99.47 -40.46 7.84 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.602 0.237 . . . . 0.0 111.279 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.167 -0.92 . . . . 0.0 111.081 -179.94 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.262 0.077 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -100.34 131.33 46.33 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.425 0.453 . . . . 0.0 111.041 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -99.59 -41.41 7.35 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.188 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 m -99.14 153.0 19.24 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.99 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.9 m -93.35 104.25 11.82 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.047 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -86.36 6.79 5.27 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.821 2.347 . . . . 0.0 112.249 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.8 m -109.14 -53.65 2.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.606 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -114.75 151.39 33.81 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.389 0.431 . . . . 0.0 111.427 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.1 55.07 0.73 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.552 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -91.89 17.21 9.5 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.765 0.317 . . . . 0.0 111.396 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 175.99 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.845 0.858 . . . . 0.0 110.474 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -136.95 158.97 43.25 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.305 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 30' ' ' THR . 13.7 m-30 -98.42 136.15 38.97 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 6.2 mt -105.39 139.2 40.38 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.936 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -120.15 132.53 69.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 123.572 0.545 . . . . 0.0 109.636 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.23 120.57 18.01 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.926 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.8 mmt -103.22 155.24 36.96 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.166 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -82.9 32.92 0.52 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.669 2.246 . . . . 0.0 112.965 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -87.01 -13.28 44.91 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.254 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -169.52 1.83 Allowed 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.984 0.178 . . . . 0.0 110.876 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.526 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -105.09 42.19 1.25 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.079 0.466 . . . . 0.0 111.583 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -111.58 80.72 2.88 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.88 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.1 Cg_exo -75.49 -16.99 18.87 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.081 2.521 . . . . 0.0 113.404 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -84.56 -38.41 20.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.845 0.458 . . . . 0.0 111.875 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.23 3.88 53.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.175 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.97 162.77 21.25 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.803 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 49.39 33.36 5.38 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.9 p -119.96 154.0 35.12 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 120.562 0.22 . . . . 0.0 110.445 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 99.8 t -129.41 134.95 62.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.503 0.668 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.3 m -116.91 155.26 29.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.875 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.435 ' OH ' HD23 ' A' ' 105' ' ' LEU . 22.6 t80 -109.67 117.34 33.65 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.46 108.14 10.4 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 123.499 0.5 . . . . 0.0 110.943 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.486 ' O ' HD21 ' A' ' 102' ' ' LEU . 51.8 t -66.29 -58.74 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.409 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -144.39 122.5 12.15 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.235 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -100.52 129.12 46.43 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.987 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -139.6 152.07 46.53 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.591 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.03 -22.63 66.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.657 0.383 . . . . 0.0 112.0 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -94.12 -5.35 47.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.346 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.94 176.16 27.76 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 121.579 -0.343 . . . . 0.0 112.333 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.57 148.29 30.0 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.1 tpp -121.67 136.45 54.94 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.105 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 133' ' ' ALA . . . -156.4 159.56 29.54 Favored Glycine 0 N--CA 1.447 -0.614 0 O-C-N 124.409 1.068 . . . . 0.0 112.446 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.419 ' C ' HG22 ' A' ' 30' ' ' THR . 3.2 mt -113.71 131.34 56.21 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.118 0.459 . . . . 0.0 111.365 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 78' ' ' GLY . 7.9 t -66.62 121.77 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.87 54.82 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.561 0.696 . . . . 0.0 112.377 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.858 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.6 t-20 -147.96 -2.31 0.55 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.09 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -130.21 88.03 49.23 Favored Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.504 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 42.9 Cg_exo -59.08 145.04 99.02 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 121.648 1.565 . . . . 0.0 112.412 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.411 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 71.5 m -94.57 161.06 14.36 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.41 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.89 51.34 0.97 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.806 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.451 ' C ' HG12 ' A' ' 75' ' ' ILE . 1.1 mt -133.48 156.33 47.94 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 123.86 0.388 . . . . 0.0 110.044 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 20.3 p-10 -112.7 159.67 18.68 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.836 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 56' ' ' VAL . 14.3 tp -59.15 -28.28 66.44 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.08 96.77 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.39 -45.47 87.54 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.068 0.23 . . . . 0.0 111.559 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.858 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 16.7 m -62.45 -44.5 99.33 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.3 mt -57.48 -33.85 68.43 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.552 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -78.25 -27.92 47.64 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.27 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.431 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.87 -30.96 51.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.297 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.858 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.1 mt -77.85 -45.62 23.8 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.851 -1.522 . . . . 0.0 111.113 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -130.34 115.83 17.44 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.623 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.7 -32.91 2.53 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.664 2.91 . . . . 0.0 112.759 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.66 -14.91 56.05 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.423 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.63 149.91 23.99 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.401 0.438 . . . . 0.0 111.679 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.14 123.0 29.13 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.232 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.03 149.7 36.94 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.318 2.012 . . . . 0.0 112.389 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -95.1 -171.61 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.576 2.184 . . . . 0.0 112.532 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.29 -24.52 67.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.294 0.638 . . . . 0.0 112.007 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' O ' HG13 ' A' ' 73' ' ' ILE . 9.8 ptp180 -68.72 -47.93 65.11 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.5 m -74.51 -25.91 59.65 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.555 0.535 . . . . 0.0 112.38 -178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -69.5 -26.97 64.8 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.797 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -97.36 20.46 11.54 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.497 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 59.4 mt -122.16 138.97 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.737 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.496 ' O ' HD11 ' A' ' 128' ' ' ILE . 2.0 m-20 -104.34 164.17 11.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.451 HG12 ' C ' ' A' ' 51' ' ' LEU . 13.6 mm -114.17 152.45 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.822 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.716 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -115.81 156.09 26.69 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.482 0.313 . . . . 0.0 110.429 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.36 119.92 27.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.615 0.189 . . . . 0.0 110.623 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.556 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -102.78 -23.45 8.72 Favored Glycine 0 C--N 1.346 1.1 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.884 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.99 -168.29 32.92 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.371 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -88.42 -13.9 3.35 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.513 2.809 . . . . 0.0 114.356 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.73 131.04 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 123.119 0.262 . . . . 0.0 111.29 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 47.79 83.14 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.366 1.066 . . . . 0.0 113.09 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -84.07 1.03 45.95 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.348 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -93.77 -18.4 22.11 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.587 ' CZ ' ' H ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.2 147.37 52.02 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.968 0.413 . . . . 0.0 111.562 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.587 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -112.65 152.69 17.82 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.646 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.45 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 1.2 m-85 -86.33 153.86 21.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.352 1.061 . . . . 0.0 111.174 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 3.7 t -127.85 103.65 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.666 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.637 ' O ' ' HA ' ' A' ' 126' ' ' SER . 0.3 OUTLIER -98.28 127.39 44.19 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.652 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -129.1 160.76 62.08 Favored Pre-proline 0 CA--C 1.552 1.03 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.614 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 27.2 Cg_endo -99.58 33.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.916 2.41 . . . . 0.0 113.468 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.3 t -118.13 159.08 23.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.749 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.58 21.15 47.65 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.646 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.28 153.62 21.07 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.556 0.342 . . . . 0.0 110.58 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.0 p -122.94 153.58 39.52 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.526 ' H ' ' HG1' ' A' ' 99' ' ' THR . 27.8 m-85 -131.93 -150.98 0.44 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.733 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -62.4 -48.62 78.89 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 122.507 0.323 . . . . 0.0 111.103 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.7 m -132.68 78.41 1.8 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.324 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.526 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 11.1 m -126.49 115.44 19.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.616 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.01 123.45 44.26 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.803 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -83.47 127.48 33.74 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.318 0.58 . . . . 0.0 110.859 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.486 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -120.33 50.01 1.36 Allowed 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.567 -179.422 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.29 -109.62 3.01 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 114.579 -1.191 . . . . 0.0 113.41 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -63.1 -6.85 4.56 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.435 HD23 ' OH ' ' A' ' 31' ' ' TYR . 3.3 pp -152.08 160.01 43.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -122.58 158.84 29.04 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.492 ' O ' ' HA ' ' A' ' 99' ' ' THR . 19.1 ttm -124.48 134.76 52.94 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.7 m -135.65 133.24 37.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.1 p -126.37 21.83 7.19 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.316 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.813 ' O ' HG22 ' A' ' 113' ' ' VAL . 10.7 t -89.26 130.31 35.68 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.13 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.461 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 21.2 pt20 -60.33 -28.3 68.03 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.554 0.692 . . . . 0.0 109.608 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -63.63 -44.7 93.12 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.925 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.83 ' O ' HG23 ' A' ' 117' ' ' ILE . 18.7 m -62.01 -42.64 95.65 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.557 HD13 ' NH1' ' A' ' 85' ' ' ARG . 31.4 mt -54.66 -52.19 63.09 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.795 0.685 . . . . 0.0 111.992 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.461 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 50.2 m-85 -64.86 -46.05 83.47 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.329 0.393 . . . . 0.0 111.585 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.83 63.89 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.83 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.5 tp -63.84 -43.92 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.92 -30.68 66.12 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.797 0.685 . . . . 0.0 109.762 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.63 -19.99 30.16 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.023 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.63 19.04 21.47 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.68 -1.145 . . . . 0.0 114.636 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.8 p -111.03 9.09 22.11 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.91 -137.78 9.42 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-O 119.256 -0.747 . . . . 0.0 112.756 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.72 167.65 22.13 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.284 2.656 . . . . 0.0 113.509 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.477 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -49.65 -58.19 5.74 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.378 1.071 . . . . 0.0 111.754 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.491 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -138.76 154.61 48.53 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 66.3 m -149.63 163.96 36.47 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 2.3 tp -130.31 115.08 16.43 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.883 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.496 HD11 ' O ' ' A' ' 74' ' ' ASP . 11.1 pt -98.03 107.86 20.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.399 0.618 . . . . 0.0 109.508 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 60.1 p -125.4 122.13 35.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.762 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.1 tp -67.5 117.51 9.55 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.604 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.443 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 70.05 167.69 6.43 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.183 -0.917 . . . . 0.0 114.271 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -128.5 174.16 9.6 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.157 0.503 . . . . 0.0 110.958 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -109.98 132.23 54.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.497 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.58 144.34 15.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.496 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -122.49 133.63 54.59 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.961 0.448 . . . . 0.0 110.585 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.77 158.95 23.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.321 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.57 125.42 11.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.746 0.418 . . . . 0.0 111.81 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.01 -26.45 7.64 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.119 -0.562 . . . . 0.0 114.475 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -58.3 -49.1 78.38 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.555 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.6 tm? -66.34 -49.36 67.2 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.0 0.188 . . . . 0.0 110.807 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.45 -31.59 66.07 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.472 0.482 . . . . 0.0 110.567 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -68.83 -50.12 52.69 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.157 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.86 -26.73 62.47 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.059 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.8 tp -75.34 -38.19 60.29 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.673 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.5 m -77.95 -29.99 50.16 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.291 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -81.46 -1.02 44.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.577 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 60.29 30.1 19.55 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.779 0.832 . . . . 0.0 111.658 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.22 -43.04 18.15 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.93 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -125.36 114.76 19.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.7 tp -86.24 138.53 31.79 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.0 p -101.75 137.52 39.94 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.488 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.6 m -149.95 146.19 20.01 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-O 119.192 -0.433 . . . . 0.0 111.4 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.27 148.18 91.0 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 122.286 1.991 . . . . 0.0 110.584 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.528 ' HA ' ' CZ ' ' A' ' 174' ' ' ARG . . . -134.11 176.32 8.69 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 -176.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -132.26 142.17 44.04 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 113.549 -1.66 . . . . 0.0 108.671 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.11 -26.51 9.14 Favored 'Trans proline' 0 C--N 1.364 1.392 0 C-N-CA 122.692 2.262 . . . . 0.0 114.177 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -49.77 -42.11 45.75 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.774 0.671 . . . . 0.0 112.448 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.645 HD13 HH12 ' A' ' 167' ' ' ARG . 4.6 mt -69.52 -32.65 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-O 121.492 0.663 . . . . 0.0 110.229 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.0 tt -75.81 -38.87 57.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.687 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.424 ' HE1' ' O ' ' A' ' 89' ' ' LEU . 42.8 m-85 -86.51 -29.7 22.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -87.02 -72.56 0.5 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.106 0.412 . . . . 0.0 111.378 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.891 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.18 98.73 6.07 Favored Pre-proline 0 C--N 1.348 0.514 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.858 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.4 Cg_endo -91.55 0.08 4.55 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 C-N-CA 121.657 1.571 . . . . 0.0 114.28 175.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.632 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 87.5 Cg_endo -74.11 -54.16 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.655 2.237 . . . . 0.0 114.445 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.57 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.1 mt-10 -121.05 -29.55 4.54 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.7 -177.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.891 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.6 tt0 -70.56 -11.24 60.8 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.417 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.645 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.66 -43.99 35.73 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.42 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -69.37 -50.21 48.28 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 m -57.65 -49.57 76.01 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.769 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.403 ' HB3' HH12 ' A' ' 167' ' ' ARG . . . -62.69 -40.33 96.77 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.096 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.54 -46.61 80.56 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 123.637 0.586 . . . . 0.0 110.729 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.12 82.47 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.7 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.45 -31.44 72.61 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.446 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.528 ' CZ ' ' HA ' ' A' ' 154' ' ' ALA . 11.3 mtm-85 -77.55 -41.5 38.81 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.793 0.437 . . . . 0.0 110.548 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.48 -34.1 77.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.676 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 123.47 44.78 0.3 Allowed Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.017 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 6.9 t -128.58 138.71 53.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -89.56 80.81 6.6 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.653 0.74 . . . . 0.0 110.836 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -77.94 -26.3 48.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.252 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.8 m -59.12 -44.1 91.99 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.53 -26.56 51.14 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.9 mt -76.97 -36.36 56.55 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.334 0.396 . . . . 0.0 111.922 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 24.1 p -94.21 -48.82 6.02 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.319 0.387 . . . . 0.0 111.247 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 57.33 118.27 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.211 1.004 . . . . 0.0 112.771 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -107.11 13.37 27.46 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.479 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.32 145.69 50.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.118 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -160.31 69.74 0.24 Allowed Glycine 0 C--N 1.338 0.681 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.558 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -128.36 141.55 51.39 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 123.625 0.25 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.117 179.966 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.565 0.221 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -108.83 130.4 55.4 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.015 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -100.87 -42.0 6.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.099 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.8 m -100.37 153.07 19.63 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 123.511 0.507 . . . . 0.0 110.944 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.8 t -92.23 106.53 18.26 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.41 7.91 4.86 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.722 2.281 . . . . 0.0 112.263 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.2 m -116.11 -53.52 2.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.776 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -110.94 152.22 27.02 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.654 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.568 ' H ' ' HD1' ' A' ' 35' ' ' HIS . 17.5 mt -97.22 50.64 1.08 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.988 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.408 ' NZ ' ' HG3' ' A' ' 34' ' ' GLU . 27.6 tttm -92.88 19.29 7.84 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.113 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.6 t60 173.79 56.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.039 0.936 . . . . 0.0 109.641 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.426 ' CD2' ' HA ' ' A' ' 153' ' ' PRO . 30.2 m80 -139.28 160.96 38.59 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 17.1 m-30 -99.09 137.44 37.6 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.057 0.456 . . . . 0.0 111.914 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 2.0 mt -108.16 140.97 40.59 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.202 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.55 137.21 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 123.352 0.407 . . . . 0.0 110.139 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.77 119.22 17.69 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.699 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 14.6 mmt -99.44 159.82 29.07 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.617 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.91 5.24 5.07 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.716 2.277 . . . . 0.0 113.652 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -77.34 -14.22 59.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.506 0.322 . . . . 0.0 111.856 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.713 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -104.4 154.98 19.18 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.264 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.44 48.67 1.41 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.253 0.549 . . . . 0.0 112.021 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.713 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.2 m-20 -125.05 89.66 52.27 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.626 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.54 -16.83 21.25 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.905 2.404 . . . . 0.0 113.388 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -84.47 -35.23 23.12 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 122.826 0.45 . . . . 0.0 111.772 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -93.41 3.96 54.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.045 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.49 163.21 21.52 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.847 0.356 . . . . 0.0 111.835 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 49.1 32.41 4.03 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.3 p -118.0 154.51 31.87 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 120.541 0.21 . . . . 0.0 110.694 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 60.7 t -129.76 133.15 65.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.773 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.2 m -113.74 153.57 28.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.759 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.496 ' OH ' HD21 ' A' ' 105' ' ' LEU . 33.4 t80 -107.66 116.82 32.63 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.38 109.52 16.7 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 121.457 0.646 . . . . 0.0 111.03 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.535 ' O ' HD22 ' A' ' 102' ' ' LEU . 29.6 t -70.22 -66.21 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.132 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.408 ' HG3' ' NZ ' ' A' ' 10' ' ' LYS . 6.6 tt0 -132.55 119.83 21.05 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.726 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.568 ' HD1' ' H ' ' A' ' 9' ' ' LEU . 12.5 t-80 -102.97 126.59 50.21 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.428 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -139.51 152.11 46.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.504 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.2 -19.56 65.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.832 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -97.73 -3.73 38.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.428 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.26 171.14 22.24 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 112.277 -0.329 . . . . 0.0 112.277 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.416 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -148.26 146.9 28.82 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -122.81 136.34 54.84 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.615 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 133' ' ' ALA . . . -158.12 158.79 29.48 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.334 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mt -114.75 133.72 55.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.055 0.427 . . . . 0.0 111.367 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.561 HG21 ' O ' ' A' ' 78' ' ' GLY . 14.9 t -67.69 123.21 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.6 54.55 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.57 0.7 . . . . 0.0 112.126 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.855 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.4 t-20 -147.66 -3.21 0.54 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.156 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -129.67 87.24 53.17 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.49 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.6 Cg_exo -59.39 142.77 99.52 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 121.702 1.602 . . . . 0.0 112.252 175.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 62.4 m -91.72 158.27 16.47 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.479 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.29 50.52 1.3 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.842 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mt -133.55 158.04 44.15 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.743 0.417 . . . . 0.0 110.046 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.7 p-10 -112.07 158.98 18.93 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.204 0.315 . . . . 0.0 110.423 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.428 ' HG ' ' CD1' ' A' ' 57' ' ' LEU . 12.7 tp -59.21 -36.16 74.9 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.08 -38.4 65.28 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -64.76 -40.2 94.88 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.36 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.84 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.0 t -61.8 -50.82 78.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.428 ' CD1' ' HG ' ' A' ' 53' ' ' LEU . 4.8 mp -52.31 -36.38 53.01 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.978 0.799 . . . . 0.0 111.099 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.94 -29.18 49.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.451 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.42 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -78.72 -31.72 46.55 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.713 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.84 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 11.5 mt -77.56 -44.63 27.9 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.833 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -131.93 116.8 15.87 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.479 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.49 -33.11 2.57 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.585 2.857 . . . . 0.0 112.844 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.2 -13.79 56.58 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.388 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.42 149.62 24.33 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.291 0.37 . . . . 0.0 111.721 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.68 123.72 29.5 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.972 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.97 143.84 29.66 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.271 1.981 . . . . 0.0 112.414 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.512 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.1 Cg_endo -91.93 -169.65 0.28 Allowed 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.576 2.184 . . . . 0.0 111.85 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.491 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -64.23 -24.92 67.84 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.224 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.511 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.8 ptp180 -66.91 -51.61 53.29 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.427 ' SG ' HD21 ' A' ' 53' ' ' LEU . 58.2 m -72.46 -25.07 61.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 47.4 mt-30 -68.21 -34.84 77.01 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.491 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 21.8 p80 -91.12 22.53 3.7 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.115 0.484 . . . . 0.0 111.649 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 58.9 mt -119.22 139.44 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.312 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.56 ' O ' HD13 ' A' ' 128' ' ' ILE . 1.7 m-20 -106.59 157.05 17.97 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.5 mm -103.7 152.69 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.853 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.7 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -118.68 154.71 32.27 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -85.82 120.48 27.28 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.623 0.192 . . . . 0.0 110.649 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.561 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -103.33 -23.64 8.35 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 120.082 -1.056 . . . . 0.0 114.006 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.98 -167.62 34.34 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.324 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -88.16 -12.17 4.16 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 123.364 2.71 . . . . 0.0 114.136 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.47 126.35 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 123.094 0.246 . . . . 0.0 110.596 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 50.26 79.02 0.09 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.099 0.96 . . . . 0.0 112.46 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.451 ' O ' HD23 ' A' ' 130' ' ' LEU . 9.5 t -83.01 1.57 39.3 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.554 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -102.63 2.74 36.39 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.492 HH21 ' HB3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -133.07 154.62 50.38 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -179.386 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.47 128.58 9.02 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.778 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.64 144.82 27.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.436 1.095 . . . . 0.0 109.936 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.87 105.86 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.142 0.276 . . . . 0.0 110.963 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 126' ' ' SER . 10.9 tp -107.57 127.82 53.98 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.406 ' HD1' ' HB3' ' A' ' 92' ' ' SER . 2.9 p80 -123.35 164.35 28.55 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.762 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 12.4 Cg_endo -94.86 14.62 1.25 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.659 2.239 . . . . 0.0 113.615 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.406 ' HB3' ' HD1' ' A' ' 90' ' ' HIS . 11.1 t -101.81 157.52 16.79 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.73 -178.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.12 20.98 48.38 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.631 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -85.66 154.7 21.49 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.611 0.364 . . . . 0.0 110.321 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.6 p -118.89 151.89 37.3 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.646 ' CD2' HG12 ' A' ' 113' ' ' VAL . 18.2 m-85 -130.68 -150.59 0.43 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.469 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -62.05 -47.6 83.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.775 0.321 . . . . 0.0 111.065 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.535 ' H ' ' HG ' ' A' ' 110' ' ' SER . 66.7 m -135.12 81.22 1.88 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.136 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.645 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 19.2 m -127.48 119.45 26.1 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.412 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -105.0 122.11 45.18 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.96 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -79.3 124.24 28.21 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -136.43 77.85 1.67 Allowed 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.862 0.839 . . . . 0.0 111.829 -177.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.563 ' O ' ' HG2' ' A' ' 104' ' ' GLU . . . 44.33 103.0 0.01 OUTLIER Glycine 0 N--CA 1.474 1.223 0 CA-C-N 113.679 -1.6 . . . . 0.0 114.676 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 103' ' ' GLY . 10.7 pt-20 60.75 -14.72 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.85 1.26 . . . . 0.0 113.426 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.497 ' H ' ' C ' ' A' ' 103' ' ' GLY . 2.8 pp -132.68 145.51 51.11 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-O 120.705 0.288 . . . . 0.0 110.486 178.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.8 155.61 26.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.056 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.574 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 15.2 ttm -120.33 122.15 40.2 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' SER . 51.0 m -121.25 129.59 53.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.209 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.1 p -119.43 22.12 11.86 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.886 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.535 ' HG ' ' H ' ' A' ' 98' ' ' SER . 61.7 m -92.29 126.19 37.27 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.215 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.502 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 10.8 pt20 -59.9 -28.08 67.27 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.394 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.29 -49.15 76.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.872 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.835 ' O ' HG23 ' A' ' 117' ' ' ILE . 16.6 m -59.43 -40.44 81.71 Favored 'Isoleucine or valine' 0 C--N 1.361 1.068 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.472 ' N ' HG22 ' A' ' 113' ' ' VAL . 6.6 tp -56.86 -54.06 50.8 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.684 0.615 . . . . 0.0 111.534 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.502 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 61.4 m-85 -67.02 -42.5 84.8 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.341 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.38 -51.7 68.79 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.542 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.835 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.15 -43.3 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.378 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -57.88 -30.26 65.7 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.893 0.745 . . . . 0.0 109.79 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.511 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -86.16 -19.92 29.37 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.09 176.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.15 15.65 29.96 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.696 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.4 p -107.22 8.42 29.95 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.95 -138.02 9.84 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.261 -0.744 . . . . 0.0 112.641 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.56 171.19 16.14 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 123.332 2.688 . . . . 0.0 113.557 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.47 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -51.11 -57.16 9.43 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.211 1.004 . . . . 0.0 111.604 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.5 mmtt -140.03 156.59 46.54 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.533 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 73.5 m -149.26 161.83 41.24 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.6 tp -126.61 115.7 19.88 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.326 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.649 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 13.3 pt -97.4 102.12 13.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.781 0.801 . . . . 0.0 109.685 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.5 t -119.36 121.86 40.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.606 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 83' ' ' THR . 8.9 tp -67.32 113.7 5.43 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.111 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.24 173.17 6.08 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-N 114.714 -1.13 . . . . 0.0 114.314 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -128.49 178.23 6.44 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.314 0.578 . . . . 0.0 110.73 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -114.23 129.54 56.63 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.151 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.61 147.56 17.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.37 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.416 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 29.6 m-90 -125.33 136.31 53.34 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 123.886 0.403 . . . . 0.0 110.35 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -80.19 158.27 26.32 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.901 0.751 . . . . 0.0 110.66 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.76 89.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.16 -23.79 7.57 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.161 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -56.58 -46.31 80.85 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.949 0.5 . . . . 0.0 112.231 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.555 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.4 tp -67.22 -47.88 69.51 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -57.35 -30.55 64.93 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.467 0.479 . . . . 0.0 110.77 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.19 -50.3 41.56 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.914 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.6 pt-20 -71.85 -26.7 62.47 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.924 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.0 tp -75.06 -39.23 61.02 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.833 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.5 m -78.14 -30.37 49.27 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.507 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.5 t70 -80.24 0.49 32.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.674 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 59.72 29.85 19.43 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.826 0.85 . . . . 0.0 111.645 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.32 -41.75 19.66 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.794 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -123.47 112.21 17.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.9 tp -84.13 138.37 33.06 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.533 0.206 . . . . 0.0 111.148 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.9 p -105.19 138.89 40.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.311 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.2 m -152.57 155.47 32.7 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.725 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' A' ' 12' ' ' HIS . 31.7 Cg_exo -59.06 153.52 51.35 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.332 2.021 . . . . 0.0 111.12 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -129.09 168.36 16.21 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.75 135.76 24.01 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.138 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.48 -26.48 14.12 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 122.591 2.194 . . . . 0.0 113.687 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.43 -40.44 62.2 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.885 0.74 . . . . 0.0 112.132 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.584 HD13 HH12 ' A' ' 167' ' ' ARG . 4.8 mt -71.68 -34.8 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.385 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.33 -36.96 63.69 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.279 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -84.92 -35.32 22.18 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -84.13 -72.45 0.46 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.006 0.367 . . . . 0.0 111.624 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.881 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.67 99.61 6.23 Favored Pre-proline 0 C--N 1.348 0.539 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.855 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 64.7 Cg_endo -91.24 -0.84 4.78 Favored 'Trans proline' 0 CA--C 1.569 2.266 0 C-N-CA 121.637 1.558 . . . . 0.0 114.271 175.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.63 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 74.6 Cg_endo -74.18 -52.95 0.12 Allowed 'Trans proline' 0 C--N 1.392 2.861 0 C-N-CA 122.656 2.238 . . . . 0.0 114.519 -178.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.553 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.5 mt-10 -122.17 -30.35 4.04 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.746 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.881 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 5.0 tp10 -69.8 -11.42 60.84 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.364 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.584 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.96 -41.71 41.99 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.296 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.38 -50.04 42.92 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -58.29 -49.0 78.68 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.717 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.655 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.34 -39.96 94.94 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.122 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.13 -46.72 79.1 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.626 0.579 . . . . 0.0 110.461 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.45 91.24 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.398 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.6 -27.81 68.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.705 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.7 -40.01 42.77 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 122.876 0.47 . . . . 0.0 110.4 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -72.82 -30.37 64.0 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.44 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.67 57.37 0.93 Allowed Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.841 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.09 150.91 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -83.38 78.69 9.6 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.701 0.762 . . . . 0.0 110.868 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.7 -26.2 49.96 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.003 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.1 m -56.29 -38.68 71.55 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.16 -26.54 53.15 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 11.0 mt -76.62 -34.84 58.34 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.307 0.379 . . . . 0.0 111.507 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.9 p -85.92 -48.1 9.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.562 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -128.75 117.94 21.97 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.566 0.541 . . . . 0.0 111.308 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -99.73 140.86 33.32 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.853 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.43 141.69 32.93 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 150.14 97.89 0.18 Allowed Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.53 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -99.56 -40.31 7.88 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.661 0.271 . . . . 0.0 111.32 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.443 -0.789 . . . . 0.0 111.161 179.961 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.517 0.199 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -129.33 149.89 50.93 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -128.55 -50.4 1.27 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.346 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.0 p -138.61 -51.27 0.56 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.313 0.383 . . . . 0.0 111.48 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 54.2 m -134.78 122.97 15.78 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.293 -0.384 . . . . 0.0 111.042 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 5' ' ' SER . 7.1 Cg_endo -90.93 5.0 4.18 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.653 2.235 . . . . 0.0 112.594 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -99.83 162.33 13.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.153 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 60.8 149.0 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.341 1.056 . . . . 0.0 113.162 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.468 ' H ' ' HD1' ' A' ' 35' ' ' HIS . 20.7 mt -98.69 47.78 0.98 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.88 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -89.79 16.37 8.15 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.642 -177.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 173.06 56.75 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.141 0.976 . . . . 0.0 110.161 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -135.82 161.67 34.96 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.654 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 154' ' ' ALA . 16.4 m-30 -97.68 136.29 38.25 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.553 ' O ' HG11 ' A' ' 29' ' ' VAL . 2.8 mt -108.49 136.6 47.83 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.703 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 mp -120.85 131.4 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.44 126.61 30.26 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.588 0.555 . . . . 0.0 111.92 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.2 mmt -114.29 155.26 45.94 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.22 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -79.47 75.82 4.86 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.662 2.241 . . . . 0.0 112.593 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -132.32 -20.35 2.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.779 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.34 -163.54 0.86 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.324 0.39 . . . . 0.0 110.46 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.521 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.51 36.31 2.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.925 0.393 . . . . 0.0 111.861 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.1 m-20 -111.1 82.97 3.49 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.798 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.38 -22.78 13.82 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.969 2.446 . . . . 0.0 113.417 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -85.13 -37.78 19.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.94 0.496 . . . . 0.0 111.713 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.6 -3.22 56.66 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.823 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -61.17 1.99 0.15 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -141.77 40.33 1.68 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.187 0.518 . . . . 0.0 112.005 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 p -123.71 156.09 36.6 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.535 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.553 HG11 ' O ' ' A' ' 14' ' ' LEU . 48.9 t -130.41 132.03 64.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.89 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -114.59 154.01 29.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.341 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.427 ' OH ' HD21 ' A' ' 105' ' ' LEU . 42.9 t80 -107.21 119.24 38.86 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.52 109.95 17.81 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.32 0.581 . . . . 0.0 111.098 -178.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.532 ' O ' HD21 ' A' ' 102' ' ' LEU . 30.3 t -71.85 -63.73 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 113.461 -1.699 . . . . 0.0 110.685 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -133.91 117.96 17.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.537 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.468 ' HD1' ' H ' ' A' ' 9' ' ' LEU . 13.6 t-80 -103.0 126.61 50.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.491 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -139.46 152.1 46.74 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.514 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -65.63 -14.86 62.04 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.046 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -103.79 -0.36 29.38 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.302 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.01 169.2 19.32 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 112.064 -0.414 . . . . 0.0 112.064 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.49 149.22 30.41 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.82 137.85 53.25 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.047 178.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 133' ' ' ALA . . . -157.41 159.46 29.79 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.461 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.3 mt -114.58 131.44 56.68 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.794 0.297 . . . . 0.0 111.111 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 78' ' ' GLY . 14.0 t -66.19 123.74 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.528 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.8 55.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.773 0.797 . . . . 0.0 112.064 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.86 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.1 t-20 -146.82 -4.0 0.58 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.131 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -130.17 89.5 44.89 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.454 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 41.0 Cg_exo -59.39 139.38 89.4 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 121.483 1.456 . . . . 0.0 111.19 174.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.5 m -76.63 -53.32 8.18 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.1 -9.14 20.87 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.173 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 3.1 mp -82.43 169.64 16.18 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.0 p-10 -112.47 156.94 21.72 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.689 0.281 . . . . 0.0 111.7 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.41 -31.71 67.96 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.347 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.46 74.55 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 39.4 mt-10 -65.28 -42.56 93.02 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.735 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.835 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.9 t -61.42 -50.09 81.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 22.1 mt -53.5 -35.23 60.4 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.062 0.851 . . . . 0.0 111.568 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -78.34 -29.46 47.58 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.254 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.4 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -78.46 -31.29 47.85 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.66 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.835 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.3 mt -77.6 -44.93 26.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.83 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -131.35 116.47 16.45 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.583 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.24 -32.82 2.88 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.725 2.95 . . . . 0.0 112.812 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.79 -15.03 55.53 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.293 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.75 149.28 25.39 Favored 'General case' 0 C--N 1.345 0.38 0 O-C-N 123.402 0.439 . . . . 0.0 111.609 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -118.21 123.04 29.73 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.114 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.94 147.77 34.63 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.231 1.954 . . . . 0.0 112.246 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.492 ' HD2' ' HG ' ' A' ' 70' ' ' CYS . 8.2 Cg_endo -94.45 -169.83 0.2 Allowed 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 122.608 2.206 . . . . 0.0 112.172 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.476 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -66.75 -24.84 66.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.089 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HG3' ' HG ' ' A' ' 70' ' ' CYS . 6.5 ptp180 -67.88 -47.02 70.02 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.492 ' HG ' ' HD2' ' A' ' 67' ' ' PRO . 13.1 m -75.24 -25.34 58.01 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 51.1 mt-30 -69.57 -30.4 68.17 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.476 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 22.9 p80 -94.9 22.33 6.6 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.144 0.497 . . . . 0.0 111.461 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 62.8 mt -118.3 136.17 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.318 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.611 ' O ' HD12 ' A' ' 128' ' ' ILE . 1.7 m-20 -103.49 158.39 16.39 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 mm -108.23 149.1 11.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.991 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.725 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -115.54 156.62 25.4 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.82 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -86.4 120.32 27.62 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.55 ' O ' HG22 ' A' ' 44' ' ' VAL . . . -102.0 -23.42 9.21 Favored Glycine 0 C--N 1.345 1.044 0 C-N-CA 120.322 -0.942 . . . . 0.0 114.134 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.23 -167.59 35.01 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.261 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -88.15 -11.39 4.47 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.521 2.814 . . . . 0.0 114.173 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 t -86.84 127.16 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.088 0.242 . . . . 0.0 110.563 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 49.68 76.88 0.12 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.127 0.971 . . . . 0.0 112.518 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.446 ' O ' HD23 ' A' ' 130' ' ' LEU . 9.8 t -80.87 1.96 28.54 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.687 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -103.78 3.95 34.61 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.491 HH21 ' HB3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -132.91 155.18 49.53 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.211 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.42 127.4 8.47 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.982 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.707 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -85.91 144.24 27.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.482 1.113 . . . . 0.0 110.383 179.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.6 t -121.82 104.71 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 123.231 0.332 . . . . 0.0 110.852 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 126' ' ' SER . 9.9 tp -106.98 129.03 54.84 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.946 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -127.8 168.77 14.17 Favored Pre-proline 0 CA--C 1.555 1.136 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.54 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.659 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.03 13.77 0.89 Allowed 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.784 2.322 . . . . 0.0 113.857 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.0 t -101.82 160.38 14.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.726 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.14 21.35 44.59 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.617 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -88.81 152.7 21.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.616 0.366 . . . . 0.0 110.511 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.0 m -131.02 156.9 44.35 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.559 ' CE2' HG23 ' A' ' 113' ' ' VAL . 40.1 m-85 -123.87 -150.86 0.46 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.753 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -58.27 -46.68 85.58 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.604 0.362 . . . . 0.0 111.488 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.9 m -132.77 80.81 1.91 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.097 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.543 ' HG1' ' H ' ' A' ' 96' ' ' TYR . 31.7 m -130.45 130.04 43.75 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.756 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -110.16 123.6 50.04 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.791 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.36 125.41 30.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.271 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.532 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -119.39 44.63 2.31 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.609 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.41 -101.6 0.4 Allowed Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.354 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -56.29 -14.27 2.75 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.427 HD21 ' OH ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -160.81 160.95 31.8 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.844 0.458 . . . . 0.0 110.821 -179.31 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -119.49 158.23 26.69 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.76 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.526 ' O ' HG22 ' A' ' 99' ' ' THR . 15.8 ttm -123.23 130.07 52.25 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.2 m -124.83 129.27 50.09 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.871 0.367 . . . . 0.0 110.257 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.7 p -120.87 21.0 11.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.335 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.5 p -93.48 127.81 39.3 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.518 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 20.8 pt20 -60.99 -28.67 69.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.926 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.31 -39.68 94.39 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.497 -1.228 . . . . 0.0 110.198 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.739 ' O ' HG23 ' A' ' 117' ' ' ILE . 2.9 p -70.11 -37.7 72.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.486 ' N ' HG11 ' A' ' 113' ' ' VAL . 6.4 mt -56.82 -47.96 79.09 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.532 0.52 . . . . 0.0 110.239 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.518 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 32.1 m-85 -66.54 -42.61 86.91 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.017 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.72 -53.88 52.07 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.888 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.69 -43.2 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.549 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.34 -31.73 66.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.716 0.635 . . . . 0.0 109.602 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.98 -19.44 32.08 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.331 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.97 17.06 28.78 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.697 -1.138 . . . . 0.0 114.575 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.8 p -107.39 7.7 29.21 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.08 -137.34 8.58 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-O 119.168 -0.795 . . . . 0.0 112.628 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -80.78 172.1 13.62 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 123.13 2.554 . . . . 0.0 113.545 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.01 -55.34 33.99 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.86 0.864 . . . . 0.0 111.994 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.659 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.0 mmtt -141.16 139.82 33.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.667 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 73.1 m -139.51 166.39 24.7 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 tp -127.19 117.79 23.02 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.273 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.707 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 10.9 pt -97.49 102.31 13.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-O 121.724 0.774 . . . . 0.0 109.778 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.2 t -118.98 121.08 39.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.907 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 10.9 tp -67.51 112.73 4.84 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.355 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.65 172.44 11.82 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 115.012 -0.994 . . . . 0.0 114.376 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -128.68 176.36 7.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.333 0.587 . . . . 0.0 110.908 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -115.82 130.71 56.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.029 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.52 149.11 18.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.447 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 21.1 m-90 -127.26 135.89 51.23 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 122.579 0.351 . . . . 0.0 110.381 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.34 158.15 27.52 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.863 0.727 . . . . 0.0 110.876 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.95 91.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.8 -24.47 7.51 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.11 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.88 -45.35 86.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.573 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -67.97 -48.05 66.9 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.136 0.273 . . . . 0.0 110.516 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.01 -29.11 68.26 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.008 0.432 . . . . 0.0 110.667 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.38 -50.48 38.29 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.938 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -70.09 -26.5 64.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.773 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.8 tp -75.79 -38.91 57.79 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.804 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.0 m -77.8 -28.37 50.38 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.572 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -82.66 0.96 40.78 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.496 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.88 29.54 19.1 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.874 0.87 . . . . 0.0 111.622 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.66 -43.11 17.32 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.94 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -123.52 113.4 18.68 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.348 0.405 . . . . 0.0 110.043 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.4 tp -83.61 139.81 32.6 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.245 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.4 p -105.81 138.09 42.58 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.513 0.508 . . . . 0.0 111.335 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.6 m -152.73 155.35 32.39 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.713 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.75 157.24 28.89 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.298 1.998 . . . . 0.0 111.182 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.69 166.97 19.58 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -177.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.22 135.35 23.98 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.997 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.39 -26.46 14.33 Favored 'Trans proline' 0 C--N 1.364 1.363 0 C-N-CA 122.54 2.16 . . . . 0.0 113.785 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.85 -40.6 63.51 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.818 0.699 . . . . 0.0 112.158 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.55 HD13 HH12 ' A' ' 167' ' ' ARG . 4.6 mt -71.18 -35.24 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.408 0.623 . . . . 0.0 110.388 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.5 tt -73.98 -38.2 64.23 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.437 -177.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -85.57 -32.76 21.94 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -86.69 -72.58 0.5 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.054 0.388 . . . . 0.0 111.636 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.911 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.72 98.84 6.32 Favored Pre-proline 0 C--N 1.349 0.56 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.86 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.5 Cg_endo -92.68 0.2 3.83 Favored 'Trans proline' 0 CA--C 1.57 2.281 0 C-N-CA 121.737 1.625 . . . . 0.0 114.256 175.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.629 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 94.8 Cg_endo -73.28 -52.39 0.15 Allowed 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 122.656 2.237 . . . . 0.0 114.195 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.54 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -122.79 -29.93 3.92 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.664 -178.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.911 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.07 -10.91 60.28 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.407 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.55 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -77.03 -41.21 43.54 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.151 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -70.47 -50.21 40.47 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.5 m -58.38 -49.25 77.93 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.689 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.655 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.05 -39.81 94.91 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.228 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.42 79.63 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 123.536 0.523 . . . . 0.0 110.424 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.4 90.99 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.448 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.29 -27.87 68.93 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.673 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.66 -40.01 43.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 122.908 0.483 . . . . 0.0 110.412 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.53 -31.96 69.24 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.413 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.66 54.65 0.56 Allowed Glycine 0 C--N 1.34 0.784 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.81 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.7 t -127.55 147.58 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -87.07 77.79 9.06 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.738 0.78 . . . . 0.0 110.616 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.79 -26.1 49.45 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.059 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 53.5 m -58.93 -41.96 88.59 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.64 -26.7 50.68 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.8 mt -77.08 -38.13 53.05 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.7 p -94.26 -48.32 6.23 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.242 0.339 . . . . 0.0 111.355 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 57.42 117.66 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.192 0.997 . . . . 0.0 112.786 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -103.74 145.25 30.36 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -122.31 -42.66 2.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.457 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 100.1 -70.53 0.48 Allowed Glycine 0 C--N 1.339 0.72 0 O-C-N 123.46 0.475 . . . . 0.0 112.555 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -100.85 135.37 42.41 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.63 0.253 . . . . 0.0 110.843 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.115 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.407 HD12 ' CE1' ' A' ' 35' ' ' HIS . 13.1 mt . . . . . 0 N--CA 1.468 0.475 0 CA-C-O 120.746 0.308 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.403 ' O ' HD21 ' A' ' 102' ' ' LEU . 85.6 mttt -90.19 20.0 4.67 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.928 0.394 . . . . 0.0 111.214 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 175.33 55.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.124 0.97 . . . . 0.0 110.116 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -134.25 159.47 40.86 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.654 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.458 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.5 m-30 -97.75 135.17 39.91 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.737 HD11 HD23 ' A' ' 32' ' ' LEU . 6.0 mt -107.64 138.99 42.87 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.968 177.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.468 HG23 HG22 ' A' ' 29' ' ' VAL . 2.3 mm -117.26 134.11 61.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.14 128.54 33.41 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.749 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 43.2 mtt -113.75 157.4 41.79 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.268 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.56 32.74 0.52 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.655 2.237 . . . . 0.0 113.143 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -86.0 -18.3 32.94 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.71 -163.46 0.86 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.096 0.248 . . . . 0.0 110.451 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.532 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -99.24 31.73 2.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 7.9 m-20 -112.42 80.78 3.68 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.0 Cg_exo -75.44 -21.17 15.32 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 123.11 2.54 . . . . 0.0 113.276 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -85.53 -38.5 18.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.515 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -93.27 2.67 56.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.69 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -68.23 8.24 0.47 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -141.87 39.42 1.65 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.152 0.501 . . . . 0.0 112.186 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.2 p -123.16 156.12 35.68 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.426 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.762 HG11 ' HE ' ' A' ' 167' ' ' ARG . 59.5 t -130.25 132.7 64.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.902 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -113.41 152.91 29.42 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.415 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.521 ' OH ' HD21 ' A' ' 105' ' ' LEU . 43.6 t80 -107.23 120.07 41.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.737 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.04 108.57 17.06 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 123.515 0.509 . . . . 0.0 111.402 -178.361 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.93 HG23 ' HA2' ' A' ' 42' ' ' GLY . 31.2 t -67.45 -59.24 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.713 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -143.65 115.61 8.32 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.1 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.407 ' CE1' HD12 ' A' ' 9' ' ' LEU . 15.5 t-80 -98.01 128.32 44.49 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.912 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -138.92 152.21 47.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.358 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.02 -17.91 64.85 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.881 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -102.31 3.29 37.91 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.52 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.54 166.89 15.16 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.285 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.538 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.92 141.07 27.44 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.91 133.92 55.45 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.125 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.93 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.24 156.84 27.95 Favored Glycine 0 N--CA 1.449 -0.461 0 O-C-N 124.268 0.98 . . . . 0.0 112.492 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.2 mt -113.31 135.24 54.06 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.226 0.513 . . . . 0.0 111.638 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 78' ' ' GLY . 11.6 t -68.77 124.06 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -127.41 55.83 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.688 0.756 . . . . 0.0 111.961 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.841 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -146.87 -4.16 0.57 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.23 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -129.72 87.89 51.09 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.507 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.1 Cg_exo -58.87 141.75 98.37 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 121.635 1.557 . . . . 0.0 112.176 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.446 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.9 m -90.29 158.02 17.37 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.41 0.444 . . . . 0.0 111.649 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.12 49.39 1.38 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.585 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.445 ' C ' HG12 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -133.22 155.36 49.5 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.337 -0.432 . . . . 0.0 109.99 -179.281 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.466 HD22 ' HA ' ' A' ' 71' ' ' GLN . 44.8 p-10 -112.39 161.08 17.08 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.578 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.412 HD13 HD13 ' A' ' 128' ' ' ILE . 8.6 tp -58.36 -27.03 63.83 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.653 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . . . -61.86 -42.79 99.48 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.45 -47.42 79.11 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.052 0.22 . . . . 0.0 111.423 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.875 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.8 m -61.76 -44.49 98.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.73 ' HA ' HD12 ' A' ' 60' ' ' LEU . 12.6 mt -55.54 -36.04 66.32 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.748 177.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.05 -28.14 48.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.409 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.07 -30.04 49.5 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.269 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.875 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.94 -46.22 21.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.759 -1.564 . . . . 0.0 111.372 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -132.7 118.68 15.72 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.003 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.4 -32.36 3.01 Favored 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.628 2.885 . . . . 0.0 112.556 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -82.18 -15.29 53.74 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.294 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.21 149.27 26.92 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 123.283 0.365 . . . . 0.0 111.42 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.94 121.45 31.55 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.64 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.718 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 47.2 Cg_endo -71.4 138.07 32.03 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.555 2.17 . . . . 0.0 112.339 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 66' ' ' PRO . 2.4 Cg_endo -90.07 -156.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.705 2.27 . . . . 0.0 112.532 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.09 -24.88 51.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.264 0.626 . . . . 0.0 111.824 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.511 ' O ' HG13 ' A' ' 73' ' ' ILE . 10.0 ptp180 -67.86 -45.42 74.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 66' ' ' PRO . 19.5 p -65.59 -32.66 74.36 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.466 ' HA ' HD22 ' A' ' 52' ' ' ASN . 48.5 mt-30 -66.97 -26.84 67.02 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.664 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -97.49 8.28 44.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.734 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 69' ' ' ARG . 64.2 mt -113.58 137.73 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.179 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -106.75 163.31 13.03 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.873 0.733 . . . . 0.0 112.937 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.462 ' CD1' HD12 ' A' ' 128' ' ' ILE . 14.0 mm -111.81 152.95 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.598 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.72 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -119.5 153.72 34.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.21 118.76 24.36 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -99.53 -23.93 10.59 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 120.185 -1.007 . . . . 0.0 113.797 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.41 -167.74 35.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.218 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -88.62 -10.53 4.4 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.702 2.935 . . . . 0.0 114.227 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.96 130.39 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 123.023 0.202 . . . . 0.0 111.098 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 45.94 85.02 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.431 1.092 . . . . 0.0 113.194 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 68.6 p -85.91 -5.81 59.17 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.953 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.87 -2.43 58.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.766 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.614 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.66 152.13 51.77 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.47 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.614 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.6 132.21 10.98 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.56 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.696 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -86.19 144.85 27.25 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.047 0.939 . . . . 0.0 110.756 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.29 104.49 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 123.474 0.484 . . . . 0.0 110.514 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.892 HD11 HD13 ' A' ' 105' ' ' LEU . 13.0 tp -108.32 129.53 55.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.213 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -127.04 169.07 12.89 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-O 118.874 -0.584 . . . . 0.0 111.769 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.697 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.5 Cg_endo -98.06 13.83 0.74 Allowed 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.856 2.37 . . . . 0.0 113.802 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.2 t -101.26 160.94 13.98 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.881 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.38 22.03 42.24 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.537 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 tp -86.8 154.05 21.2 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.613 0.365 . . . . 0.0 110.642 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.6 p -127.66 156.3 42.55 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.573 ' CE2' HG23 ' A' ' 113' ' ' VAL . 54.9 m-85 -129.96 -152.31 0.51 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.811 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -57.64 -46.58 83.98 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.76 0.424 . . . . 0.0 111.615 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 64.4 m -135.92 83.56 2.02 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.259 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.3 m -130.63 130.37 43.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.835 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.99 123.34 48.97 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.626 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.19 129.14 34.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.071 0.462 . . . . 0.0 110.747 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -125.12 46.27 2.39 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.419 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.12 -106.12 1.41 Allowed Glycine 0 C--N 1.336 0.575 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.162 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.6 -10.64 3.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.892 HD13 HD11 ' A' ' 89' ' ' LEU . 2.3 pp -156.12 153.29 29.09 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.237 0.335 . . . . 0.0 111.508 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.641 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -117.43 156.12 28.49 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.545 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.58 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 17.5 ttm -121.48 126.14 48.55 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.7 ' HB3' HG11 ' A' ' 113' ' ' VAL . 22.7 m -122.29 128.05 50.61 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.192 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.5 p -118.05 13.04 13.82 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.44 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.771 ' O ' HG12 ' A' ' 113' ' ' VAL . 32.2 p -87.91 127.06 35.36 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.644 0.735 . . . . 0.0 111.952 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.49 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 21.1 pt20 -59.32 -29.11 67.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.358 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.97 -43.07 96.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.541 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 110' ' ' SER . 4.7 p -67.76 -37.62 78.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.521 HD22 ' NH2' ' A' ' 85' ' ' ARG . 5.0 tp -58.4 -47.86 82.53 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 123.552 0.532 . . . . 0.0 110.266 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.49 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 26.4 m-85 -67.66 -39.91 84.51 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.813 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -52.45 64.74 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.351 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.719 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.93 -43.65 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.546 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.65 -32.32 65.25 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.774 0.671 . . . . 0.0 109.642 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.55 -20.03 32.18 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.238 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.44 14.41 32.77 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 114.693 -1.14 . . . . 0.0 114.785 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.8 p -104.58 7.55 35.14 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.23 -138.1 9.68 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 119.207 -0.774 . . . . 0.0 112.625 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.9 173.88 11.55 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 123.292 2.661 . . . . 0.0 113.536 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.21 -54.75 43.24 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.716 0.806 . . . . 0.0 111.962 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.697 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.9 mmtt -141.58 139.96 33.26 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.873 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 34.6 p -137.45 166.33 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.0 tp -126.97 116.06 20.2 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.577 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.696 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 11.5 pt -98.47 102.7 13.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.779 0.799 . . . . 0.0 109.647 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.4 t -123.01 123.98 42.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.818 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.36 115.79 7.4 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.493 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.414 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 66.75 172.47 5.09 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.633 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -128.41 -177.51 4.2 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.313 0.578 . . . . 0.0 110.864 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -118.48 127.9 54.08 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.093 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.23 143.06 14.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.474 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.406 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 27.9 m-90 -119.28 137.37 53.72 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.773 0.337 . . . . 0.0 110.404 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -81.75 158.15 24.27 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.878 0.737 . . . . 0.0 110.539 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.56 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.81 -25.2 7.27 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.072 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -57.95 -44.58 87.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.93 0.492 . . . . 0.0 112.275 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.581 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.6 -47.76 65.87 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.146 0.279 . . . . 0.0 110.605 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.1 -29.53 68.65 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.958 0.408 . . . . 0.0 110.619 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.14 -50.36 41.31 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.872 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.0 pt-20 -70.17 -26.68 64.03 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.787 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tp -74.77 -38.94 62.04 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.645 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.3 m -77.84 -28.34 50.15 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.352 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.8 t70 -82.64 -0.28 46.45 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.472 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 60.07 29.01 18.62 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.865 0.866 . . . . 0.0 111.787 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.13 -42.8 18.62 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.942 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -125.58 115.25 19.87 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.0 tp -86.45 143.14 27.92 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.506 0.194 . . . . 0.0 111.465 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.9 p -103.7 135.91 44.39 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.058 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 76.9 m -151.23 155.06 34.55 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.626 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.88 159.19 26.02 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.253 1.969 . . . . 0.0 111.244 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.458 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -131.94 166.59 21.31 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -135.69 135.12 21.4 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.963 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.19 -26.41 14.81 Favored 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.597 2.198 . . . . 0.0 113.682 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.81 -40.57 63.38 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.847 0.717 . . . . 0.0 112.135 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.565 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.5 mt -71.43 -35.5 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.366 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.71 -37.79 65.04 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.482 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -84.86 -34.71 22.57 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -84.71 -72.52 0.47 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.924 0.329 . . . . 0.0 111.637 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.894 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.64 99.42 6.28 Favored Pre-proline 0 C--N 1.349 0.563 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.841 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.4 Cg_endo -91.86 -0.45 4.36 Favored 'Trans proline' 0 CA--C 1.57 2.284 0 C-N-CA 121.716 1.611 . . . . 0.0 114.262 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.642 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 77.6 Cg_endo -73.96 -52.34 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 122.589 2.193 . . . . 0.0 114.437 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.519 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.7 mt-10 -122.45 -30.02 4.01 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.714 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.894 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.1 tt0 -70.23 -10.85 60.14 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.391 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.762 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.06 -40.52 45.92 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.145 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -71.36 -49.88 37.79 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.207 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.1 t -58.41 -49.03 78.76 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.504 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.67 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.7 -40.25 95.05 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.249 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.21 78.52 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 123.516 0.51 . . . . 0.0 110.534 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.16 90.07 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.495 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.3 -27.69 68.8 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.538 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.67 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.73 -40.15 42.11 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 122.92 0.488 . . . . 0.0 110.264 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.37 -32.0 69.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.38 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.789 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.933 179.539 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 32' ' ' LEU . 15.0 mt . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 120.775 0.321 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -90.58 19.14 5.57 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.908 0.385 . . . . 0.0 111.072 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 175.88 55.96 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.087 0.955 . . . . 0.0 110.17 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -134.94 159.35 41.74 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.618 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.462 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.6 m-30 -98.08 135.12 40.21 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.09 0.471 . . . . 0.0 112.153 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.743 HD11 HD23 ' A' ' 32' ' ' LEU . 6.1 mt -108.7 137.6 46.37 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.785 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.416 HG23 HG22 ' A' ' 29' ' ' VAL . 2.9 mp -120.51 132.69 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.82 127.57 33.17 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.722 0.639 . . . . 0.0 112.003 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.8 mmt -110.26 158.19 35.94 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.179 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -80.55 21.4 0.86 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.693 2.262 . . . . 0.0 113.549 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -83.07 -19.38 36.94 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.592 ' SD ' ' HB1' ' A' ' 148' ' ' ALA . 15.9 ptt? -102.31 -164.75 1.12 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.272 0.357 . . . . 0.0 110.38 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.545 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -106.74 30.9 5.68 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 7.9 m-20 -110.44 84.84 4.15 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.712 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.3 Cg_exo -75.31 -23.8 12.96 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.059 2.506 . . . . 0.0 113.48 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -85.11 -37.01 20.75 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.794 0.438 . . . . 0.0 111.557 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.85 3.06 55.97 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.499 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -66.78 5.82 0.58 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -140.83 38.84 1.81 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.116 0.484 . . . . 0.0 112.156 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 p -123.14 155.02 37.84 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.417 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.701 HG11 ' HE ' ' A' ' 167' ' ' ARG . 50.1 t -130.5 131.95 64.85 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.856 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -113.6 153.58 28.6 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.365 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.493 ' OH ' HD21 ' A' ' 105' ' ' LEU . 42.9 t80 -106.99 119.63 39.89 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.743 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -83.84 109.24 17.4 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.3 0.571 . . . . 0.0 111.25 -178.39 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.938 HG23 ' HA2' ' A' ' 42' ' ' GLY . 31.6 t -69.03 -59.65 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.674 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -141.96 114.34 8.3 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.337 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -97.45 128.29 44.11 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.754 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -139.4 152.64 47.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.34 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -65.11 -18.13 65.04 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.797 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -100.56 1.56 41.01 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.432 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.32 167.3 15.57 Favored Glycine 0 C--N 1.345 1.055 0 C-N-CA 121.541 -0.361 . . . . 0.0 112.205 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.02 142.49 29.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -120.62 135.51 55.08 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.57 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.75 156.95 27.97 Favored Glycine 0 N--CA 1.449 -0.448 0 O-C-N 124.364 1.04 . . . . 0.0 112.817 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.0 mt -111.93 131.63 55.26 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.9 0.35 . . . . 0.0 110.974 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 78' ' ' GLY . 18.1 t -66.89 125.35 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -128.22 55.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.715 0.769 . . . . 0.0 112.22 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.839 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -147.19 -4.61 0.53 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.308 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.68 87.89 51.21 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.507 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.1 Cg_exo -59.3 141.11 97.32 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.631 1.554 . . . . 0.0 112.004 175.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.419 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 46.0 m -89.32 159.12 17.53 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.253 0.346 . . . . 0.0 111.638 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.28 45.55 1.46 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.363 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.7 154.37 51.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.442 HD22 ' HA ' ' A' ' 71' ' ' GLN . 16.6 p-10 -104.17 161.09 14.32 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.294 0.371 . . . . 0.0 110.783 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.664 ' HA ' HD11 ' A' ' 75' ' ' ILE . 15.3 tp -58.19 -35.78 72.11 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.25 61.14 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.525 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.65 -43.22 97.42 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.855 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -62.28 -48.31 88.96 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.545 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.747 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.5 mp -52.89 -36.63 59.6 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.977 0.798 . . . . 0.0 111.024 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -78.06 -28.62 48.94 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.466 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.29 -30.27 48.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.368 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.855 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.0 mt -77.89 -44.98 25.45 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.86 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -132.48 116.79 15.24 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.441 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.72 -32.66 2.64 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.619 2.879 . . . . 0.0 112.835 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -82.38 -13.99 55.96 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.429 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.3 148.63 25.53 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 123.329 0.393 . . . . 0.0 111.734 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.6 123.03 31.91 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.149 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 58.8 Cg_endo -75.17 144.46 29.71 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.244 1.963 . . . . 0.0 112.553 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 66' ' ' PRO . 5.8 Cg_endo -92.8 -169.73 0.25 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.657 2.238 . . . . 0.0 112.248 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.48 -24.61 67.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.303 0.641 . . . . 0.0 112.202 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.58 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 9.1 ptp180 -66.76 -55.58 14.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.707 ' HA ' HD12 ' A' ' 73' ' ' ILE . 69.1 m -70.89 -25.56 62.84 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.442 ' HA ' HD22 ' A' ' 52' ' ' ASN . 49.6 mt-30 -68.77 -32.76 72.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.772 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -91.77 19.56 6.38 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.614 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 70' ' ' CYS . 52.0 mt -122.28 140.92 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.858 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.414 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.6 m-20 -109.02 152.37 25.09 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.814 0.696 . . . . 0.0 112.44 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.826 HD13 HD12 ' A' ' 128' ' ' ILE . 14.6 mm -99.6 153.48 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.237 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.717 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -120.24 152.48 37.68 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.7 119.42 24.28 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.76 0.254 . . . . 0.0 110.823 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -100.58 -23.76 9.9 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.732 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.04 -167.75 34.93 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.182 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -88.49 -8.28 5.4 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.614 2.876 . . . . 0.0 114.235 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.29 128.83 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 123.07 0.231 . . . . 0.0 111.087 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 45.01 86.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.532 1.133 . . . . 0.0 113.326 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.405 ' O ' HD21 ' A' ' 130' ' ' LEU . 78.3 p -86.68 -2.45 58.53 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.995 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -88.68 -4.46 58.54 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.895 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.599 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.2 153.01 51.93 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.134 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.599 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.51 131.12 10.41 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.07 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.714 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.6 OUTLIER -85.59 151.13 24.15 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.253 1.021 . . . . 0.0 110.428 -179.647 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.633 ' HB ' ' OG ' ' A' ' 108' ' ' SER . 3.4 t -128.37 106.39 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 O-C-N 123.312 0.383 . . . . 0.0 111.159 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.923 HD11 HD13 ' A' ' 105' ' ' LEU . 14.6 tp -108.45 127.79 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.041 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.402 ' NE2' ' HB3' ' A' ' 106' ' ' ALA . 4.2 p80 -128.42 168.27 16.25 Favored Pre-proline 0 CA--C 1.554 1.11 0 O-C-N 123.669 0.606 . . . . 0.0 111.411 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.667 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 14.8 Cg_endo -95.39 14.21 1.19 Allowed 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 122.526 2.151 . . . . 0.0 113.39 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 t -101.17 159.7 15.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.861 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.3 18.9 55.84 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.714 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.99 154.83 24.29 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.499 0.32 . . . . 0.0 110.922 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.4 p -126.37 157.64 37.97 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.593 ' CE2' HG23 ' A' ' 113' ' ' VAL . 50.3 m-85 -129.9 -149.54 0.4 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.433 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -61.15 -45.73 93.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.55 0.34 . . . . 0.0 111.18 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.3 m -137.54 83.06 1.96 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.234 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 107' ' ' MET . 8.0 m -128.22 122.35 31.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.718 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -99.89 120.77 40.3 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.987 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -83.54 127.26 33.59 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.167 0.508 . . . . 0.0 110.331 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.503 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.43 46.91 2.1 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.44 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.28 -107.72 2.09 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.103 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.41 -10.03 4.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.923 HD13 HD11 ' A' ' 89' ' ' LEU . 2.0 pp -155.14 153.63 31.08 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.256 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.593 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -121.47 158.57 28.12 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.783 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.592 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 25.8 tpp -125.28 140.12 53.11 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.689 ' HB2' HG11 ' A' ' 113' ' ' VAL . 21.4 p -134.06 133.16 40.85 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.933 0.396 . . . . 0.0 110.351 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.4 p -117.14 16.51 14.95 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.049 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.739 ' O ' HG12 ' A' ' 113' ' ' VAL . 67.0 m -89.66 127.78 35.97 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.636 0.731 . . . . 0.0 112.023 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.479 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 10.1 pt20 -61.43 -28.81 69.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.973 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -65.81 -42.17 90.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.669 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 110' ' ' SER . 3.8 p -67.38 -39.9 83.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.466 HD22 ' NH2' ' A' ' 85' ' ' ARG . 6.4 tp -58.97 -47.36 85.41 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 123.592 0.557 . . . . 0.0 110.469 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.479 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 24.1 m-85 -69.36 -38.47 78.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.914 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.81 66.76 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.043 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.75 -43.47 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.348 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.25 -31.56 65.67 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.74 0.65 . . . . 0.0 109.588 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.58 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.63 -20.15 31.81 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.238 176.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.15 14.85 32.23 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.648 -1.16 . . . . 0.0 114.602 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.1 p -105.14 7.3 33.71 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.19 -138.74 10.01 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.715 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.8 168.06 17.94 Favored 'Trans proline' 0 C--N 1.367 1.526 0 C-N-CA 123.255 2.637 . . . . 0.0 113.956 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.501 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -51.11 -59.2 4.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.511 1.125 . . . . 0.0 111.897 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.667 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -140.19 139.88 35.78 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.783 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 32.6 p -137.93 168.38 19.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.66 118.25 23.5 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.685 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.826 HD12 HD13 ' A' ' 75' ' ' ILE . 12.0 pt -98.12 102.24 13.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 121.782 0.801 . . . . 0.0 109.738 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 5.6 t -119.35 122.36 41.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.847 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.405 HD21 ' O ' ' A' ' 83' ' ' THR . 6.5 tp -66.85 114.62 5.84 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.195 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.43 176.02 5.69 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.737 -1.119 . . . . 0.0 114.385 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -128.58 -178.55 4.63 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.437 0.636 . . . . 0.0 110.957 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -118.49 128.77 54.91 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.977 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.7 147.27 17.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.532 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 -125.46 136.86 53.82 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.93 0.429 . . . . 0.0 110.303 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.43 158.27 27.37 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.94 0.775 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.0 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.21 -25.6 7.75 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.182 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -57.84 -44.15 86.32 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.886 0.474 . . . . 0.0 112.257 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.59 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.72 -47.13 67.12 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.575 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -60.49 -29.4 69.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.025 0.44 . . . . 0.0 110.38 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.14 -50.09 43.98 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.802 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.35 -26.65 63.84 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.766 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.7 tp -75.0 -38.38 61.62 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.623 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.6 t -77.87 -28.65 50.05 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.12 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -82.46 0.02 44.19 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.429 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.44 29.82 19.43 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.839 0.856 . . . . 0.0 111.869 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.592 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -83.16 -42.44 17.31 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.942 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -124.03 113.6 18.62 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.5 tp -84.36 141.9 30.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.643 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.0 p -103.27 134.85 45.98 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.651 0.595 . . . . 0.0 111.057 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 153' ' ' PRO . 48.8 t -150.02 144.53 17.71 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.414 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 152' ' ' CYS . 57.1 Cg_exo -53.0 157.45 8.12 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.467 2.111 . . . . 0.0 111.595 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.462 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.02 167.39 18.34 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -135.21 135.4 22.63 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 114.173 -1.376 . . . . 0.0 107.919 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.46 -26.4 14.25 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.601 2.2 . . . . 0.0 113.727 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.71 -40.66 63.2 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.832 0.708 . . . . 0.0 112.199 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.577 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.8 mt -71.25 -35.35 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.4 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -74.06 -37.55 64.23 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.438 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -84.87 -33.88 22.73 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -85.89 -72.63 0.48 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.016 0.371 . . . . 0.0 111.654 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.905 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.36 99.49 6.43 Favored Pre-proline 0 C--N 1.348 0.531 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.839 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 67.9 Cg_endo -92.01 -0.22 4.26 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 C-N-CA 121.678 1.585 . . . . 0.0 114.317 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.643 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 81.7 Cg_endo -73.98 -52.62 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.894 0 C-N-CA 122.61 2.206 . . . . 0.0 114.361 -178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.52 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.15 -30.09 4.09 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.691 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.905 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 4.9 tp10 -70.0 -11.12 60.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.388 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.701 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.93 -41.61 42.71 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.259 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -70.36 -50.24 41.03 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.4 m -58.39 -49.57 76.8 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.656 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -63.99 -39.58 94.43 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.037 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.95 -45.48 78.82 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.583 0.552 . . . . 0.0 110.508 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.03 93.12 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.441 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.58 -28.06 69.38 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.663 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.96 -40.18 40.25 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 122.865 0.466 . . . . 0.0 110.43 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.83 -33.77 75.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.407 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.78 0 C-N-CA 121.06 -0.591 . . . . 0.0 113.175 179.378 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.437 ' O ' HD12 ' A' ' 32' ' ' LEU . 8.9 mt . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.779 0.323 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -89.44 20.8 3.67 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.846 0.355 . . . . 0.0 111.355 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 174.66 54.62 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.024 0.929 . . . . 0.0 110.172 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -133.42 160.64 36.8 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.721 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.48 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.2 m-30 -97.97 137.68 36.42 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.821 HD11 HD23 ' A' ' 32' ' ' LEU . 2.8 mt -110.49 140.56 44.64 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.913 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mp -125.43 135.53 63.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.77 122.86 21.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.075 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -105.53 156.07 37.01 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -80.92 31.94 0.51 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.67 2.247 . . . . 0.0 113.197 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -87.36 -17.63 31.93 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.53 -169.6 1.65 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 123.076 0.235 . . . . 0.0 110.783 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.559 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -105.62 42.94 1.17 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.141 0.496 . . . . 0.0 111.561 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.48 81.83 2.54 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.934 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.2 Cg_exo -75.45 -22.16 14.32 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 123.083 2.522 . . . . 0.0 113.431 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -84.49 -36.49 22.2 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.871 0.468 . . . . 0.0 111.791 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.62 3.98 52.63 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.948 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.7 163.6 21.18 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 48.6 31.88 3.18 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.8 p -115.57 153.95 30.29 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 120.564 0.221 . . . . 0.0 110.735 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.968 HG11 HH11 ' A' ' 167' ' ' ARG . 24.6 t -127.58 132.1 69.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.805 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 m -114.84 152.59 31.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.889 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.496 ' OH ' HD21 ' A' ' 105' ' ' LEU . 38.0 t80 -106.59 118.43 36.64 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.821 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.4 107.95 15.45 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 111.122 -178.633 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.939 HG23 ' HA2' ' A' ' 42' ' ' GLY . 54.0 t -63.66 -61.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.811 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -145.49 116.41 7.79 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.09 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -98.06 127.74 44.18 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.559 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -139.09 152.9 47.89 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.545 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.83 -19.2 65.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.804 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.38 7.48 42.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.393 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.81 166.22 12.49 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.394 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.455 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.92 145.27 30.63 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.408 ' O ' HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -124.72 137.41 54.35 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.474 178.383 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.939 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.93 156.53 27.42 Favored Glycine 0 N--CA 1.447 -0.617 0 O-C-N 124.403 1.065 . . . . 0.0 112.566 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.408 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.6 mt -111.16 133.32 53.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 117.108 0.454 . . . . 0.0 111.042 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 78' ' ' GLY . 15.0 t -69.09 123.68 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.714 ' O ' ' HG3' ' A' ' 167' ' ' ARG . 1.5 pt -127.68 52.52 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.232 0.539 . . . . 0.0 112.335 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.93 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.5 t30 -144.56 -1.36 0.9 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.133 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -129.53 87.08 54.03 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.511 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 31.4 Cg_exo -59.2 144.58 99.33 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.805 1.67 . . . . 0.0 112.65 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.428 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 51.5 m -94.33 158.65 15.48 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.503 0.502 . . . . 0.0 111.371 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.75 50.69 1.22 Allowed Glycine 0 C--N 1.339 0.696 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.742 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mt -133.77 157.74 45.1 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 122.851 0.461 . . . . 0.0 110.151 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -112.25 157.37 21.01 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.198 0.311 . . . . 0.0 110.172 178.251 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.675 HD13 HD13 ' A' ' 128' ' ' ILE . 14.0 tp -56.81 -36.47 69.96 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.464 ' HB3' ' OD1' ' A' ' 52' ' ' ASN . . . -55.53 -35.32 65.53 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -64.67 -45.27 87.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.286 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.891 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 31.6 m -63.24 -43.48 98.76 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.713 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.0 mp -54.98 -36.75 65.72 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.83 0.706 . . . . 0.0 110.205 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -77.84 -27.78 49.98 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.499 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -30.46 49.2 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.286 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.891 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.3 mt -77.87 -44.96 25.63 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.923 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -132.04 116.1 15.54 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.459 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.72 -32.88 2.52 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 123.611 2.874 . . . . 0.0 112.841 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.09 -14.09 56.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.414 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.35 149.26 24.62 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 123.33 0.394 . . . . 0.0 111.814 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -116.55 122.78 31.34 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.949 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.43 151.05 37.18 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.297 1.998 . . . . 0.0 112.506 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.2 Cg_endo -92.36 -162.59 0.1 Allowed 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.617 2.211 . . . . 0.0 111.706 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.446 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -73.25 -24.95 60.53 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.75 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.434 ' HA ' ' CD2' ' A' ' 72' ' ' HIS . 6.0 ptp180 -64.81 -50.78 65.41 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.593 ' SG ' HD23 ' A' ' 53' ' ' LEU . 61.2 m -72.61 -24.97 61.14 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 43.5 mt-30 -68.69 -34.84 76.35 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.446 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 23.5 p80 -90.73 22.57 3.48 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.193 0.52 . . . . 0.0 111.74 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' A' ' 70' ' ' CYS . 60.5 mt -121.8 139.52 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.188 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -105.81 154.73 20.11 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.715 HD13 HD12 ' A' ' 128' ' ' ILE . 24.0 mm -102.09 151.62 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.739 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -119.44 154.66 33.37 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -85.18 121.27 27.69 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 117.789 0.268 . . . . 0.0 110.806 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -104.07 -23.7 8.0 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 120.209 -0.996 . . . . 0.0 114.207 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.01 -167.98 33.89 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.907 -0.664 . . . . 0.0 113.353 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -88.72 -16.17 2.48 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.404 2.736 . . . . 0.0 114.439 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.66 129.19 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.725 0.298 . . . . 0.0 111.518 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 47.72 82.97 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.527 1.131 . . . . 0.0 113.2 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.4 p -80.9 -14.83 57.64 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.918 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -76.94 -18.02 58.53 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.211 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.641 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -133.08 146.84 52.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.939 0.4 . . . . 0.0 111.825 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.591 ' H ' ' NH1' ' A' ' 85' ' ' ARG . . . -112.18 150.42 18.19 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.782 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.513 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 1.3 m-85 -86.51 152.59 22.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.346 1.058 . . . . 0.0 111.321 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.483 HG21 ' HG ' ' A' ' 114' ' ' LEU . 3.4 t -126.3 103.76 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.627 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 126' ' ' SER . 1.1 mt -98.85 126.72 44.58 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.181 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.401 ' CE1' ' HB3' ' A' ' 106' ' ' ALA . 4.7 p80 -129.44 164.06 42.25 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.76 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.57 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 23.2 Cg_endo -99.27 23.74 0.21 Allowed 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 122.888 2.392 . . . . 0.0 113.92 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.5 t -107.6 160.82 15.39 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.756 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.25 18.98 56.51 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.685 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -91.78 153.78 19.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.553 0.341 . . . . 0.0 110.528 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.598 ' HA ' HG21 ' A' ' 99' ' ' THR . 27.9 m -126.97 155.58 42.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.108 0.48 . . . . 0.0 112.112 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.538 ' CE2' HG23 ' A' ' 113' ' ' VAL . 51.2 m-85 -126.09 -150.89 0.46 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.837 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -58.82 -47.08 86.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.605 0.362 . . . . 0.0 111.372 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 m -132.19 81.26 1.95 Allowed 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.912 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.598 HG21 ' HA ' ' A' ' 95' ' ' SER . 42.5 m -129.38 121.69 27.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.327 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 124.7 49.99 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.794 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -82.72 127.99 33.94 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.133 0.492 . . . . 0.0 111.141 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -120.28 46.47 1.97 Allowed 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.574 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.62 -107.07 1.76 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.281 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.69 -10.44 3.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.496 HD21 ' OH ' ' A' ' 31' ' ' TYR . 2.9 pp -154.86 158.76 39.85 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.335 0.397 . . . . 0.0 110.99 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.401 ' HB3' ' CE1' ' A' ' 90' ' ' HIS . . . -118.92 161.51 20.07 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.472 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.569 ' O ' ' HA ' ' A' ' 99' ' ' THR . 24.6 ttm -125.22 134.34 52.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.514 ' HB3' HG11 ' A' ' 113' ' ' VAL . 51.7 m -136.08 133.03 36.92 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 75.6 p -124.53 21.23 8.58 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.717 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.707 ' O ' HG12 ' A' ' 113' ' ' VAL . 47.4 p -93.71 134.15 36.33 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 121.648 0.737 . . . . 0.0 112.345 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.499 ' HA ' HD12 ' A' ' 114' ' ' LEU . 4.9 mt-30 -62.51 -26.62 68.65 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.403 178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.41 -40.43 93.37 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.169 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.769 ' O ' HG22 ' A' ' 117' ' ' ILE . 3.4 p -71.68 -39.03 68.62 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 111' ' ' GLN . 6.6 mt -57.25 -49.04 77.31 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 123.507 0.504 . . . . 0.0 110.874 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.475 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 35.5 m-85 -69.69 -38.55 77.03 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.216 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.64 -52.68 63.37 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.212 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.84 -43.74 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.432 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.93 -31.57 65.09 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 123.754 0.658 . . . . 0.0 109.615 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.09 -20.23 30.68 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.273 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.82 17.67 25.02 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.704 -1.134 . . . . 0.0 114.634 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.9 p -108.33 7.48 27.21 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.6 -137.76 9.32 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.793 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.45 175.21 9.81 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 123.216 2.611 . . . . 0.0 113.347 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -58.33 -53.08 62.32 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.509 0.723 . . . . 0.0 111.584 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.8 mmtt -139.24 153.76 47.89 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.71 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.4 m -150.05 163.33 38.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.1 tp -129.05 117.56 21.08 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.14 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.715 HD12 HD13 ' A' ' 75' ' ' ILE . 12.3 pt -98.94 103.16 14.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.579 0.704 . . . . 0.0 109.475 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.1 t -121.21 120.46 35.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.846 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.45 115.34 6.96 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.335 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.42 167.9 10.76 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.226 -0.897 . . . . 0.0 114.091 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -128.45 178.0 6.6 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.167 0.508 . . . . 0.0 110.703 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -116.33 131.48 56.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.916 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.08 149.89 18.66 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.315 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.402 ' HZ2' ' CZ3' ' A' ' 149' ' ' TRP . 25.7 m-90 -130.15 136.9 49.78 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.833 0.372 . . . . 0.0 110.602 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.06 158.34 27.87 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.941 0.776 . . . . 0.0 111.064 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.88 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.12 -28.09 6.19 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.826 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -56.38 -46.4 80.09 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.006 0.522 . . . . 0.0 112.135 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.57 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.4 tp -67.33 -47.54 70.2 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -57.36 -30.27 64.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.473 0.483 . . . . 0.0 110.602 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.65 -49.97 41.75 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.887 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -72.12 -26.66 62.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.899 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 4.8 tp -75.78 -38.41 58.3 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.85 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -78.18 -30.9 49.31 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.315 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.43 0.77 31.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.641 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.74 29.88 19.45 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.813 0.845 . . . . 0.0 111.682 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.65 -42.92 19.27 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.78 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.402 ' CZ3' ' HZ2' ' A' ' 135' ' ' TRP . 11.3 m95 -122.42 112.04 17.6 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 123.388 0.43 . . . . 0.0 109.966 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -80.19 141.55 35.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.326 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.427 ' H ' HD23 ' A' ' 150' ' ' LEU . 16.0 p -110.56 138.47 46.91 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.312 0.383 . . . . 0.0 111.212 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.5 m -152.89 155.6 32.31 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.527 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.02 155.96 36.43 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.226 1.951 . . . . 0.0 111.098 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.48 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.73 169.33 14.64 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -138.08 137.55 21.35 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 114.295 -1.321 . . . . 0.0 107.906 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.41 -26.46 12.14 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.491 2.128 . . . . 0.0 113.959 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.22 -36.31 60.88 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.824 0.703 . . . . 0.0 112.571 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.561 HD13 HH21 ' A' ' 167' ' ' ARG . 4.6 mt -75.68 -38.35 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.41 0.624 . . . . 0.0 110.254 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.1 tt -69.44 -36.65 76.86 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.906 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -86.38 -42.78 13.37 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -77.91 -71.24 0.43 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.783 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.42 96.35 6.36 Favored Pre-proline 0 C--N 1.346 0.445 0 CA-C-O 121.18 0.514 . . . . 0.0 111.966 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.93 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 63.7 Cg_endo -91.78 3.31 4.11 Favored 'Trans proline' 0 CA--C 1.567 2.156 0 C-N-CA 121.626 1.551 . . . . 0.0 114.407 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.657 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 60.9 Cg_endo -76.93 -52.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 122.435 2.09 . . . . 0.0 114.168 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.509 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 4.3 mt-10 -126.42 -24.36 3.64 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.468 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.783 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 27.6 tt0 -76.53 -12.97 60.11 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.762 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.968 HH11 HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.19 -36.66 54.77 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.651 177.297 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.1 tp -73.47 -48.74 31.1 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 52.4 m -58.87 -45.31 90.49 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.527 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.68 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -67.22 -42.81 83.44 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.445 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.53 ' HB2' ' NH1' ' A' ' 167' ' ' ARG . . . -55.97 -45.86 78.78 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.494 0.496 . . . . 0.0 110.499 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.05 93.33 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.357 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.96 -26.95 68.52 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.663 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.76 -40.3 41.38 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 122.929 0.491 . . . . 0.0 110.175 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -71.87 -30.79 65.78 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.466 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.724 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.933 179.59 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 121.125 0.488 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -92.41 17.7 9.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.1 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 175.51 55.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.841 0.856 . . . . 0.0 109.79 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.418 ' CD2' ' HA ' ' A' ' 153' ' ' PRO . 30.0 m80 -138.57 160.8 38.69 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.474 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 18.6 m-30 -99.2 137.37 37.81 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.01 0.433 . . . . 0.0 111.867 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.794 HD11 HD23 ' A' ' 32' ' ' LEU . 3.7 mt -107.43 141.4 38.89 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.118 177.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.421 HD12 ' O ' ' A' ' 150' ' ' LEU . 2.8 mp -121.24 136.76 57.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 O-C-N 123.419 0.449 . . . . 0.0 110.006 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.23 124.83 28.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.027 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.3 mtt -109.78 157.54 37.35 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.211 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.78 30.93 0.52 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.686 2.257 . . . . 0.0 113.185 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -86.06 -18.89 31.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.65 -167.13 1.15 Allowed 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.068 0.23 . . . . 0.0 110.617 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.532 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.33 40.4 1.48 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.993 0.425 . . . . 0.0 111.737 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -111.98 80.88 3.32 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.883 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.8 Cg_exo -75.55 -22.99 13.34 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.045 2.497 . . . . 0.0 113.187 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -84.56 -34.97 23.12 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.933 0.493 . . . . 0.0 111.753 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.56 3.85 52.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.992 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 164.34 19.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.82 0.343 . . . . 0.0 111.82 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 49.04 31.1 3.16 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.5 p -116.87 154.7 30.32 Favored 'General case' 0 C--O 1.24 0.59 0 O-C-N 122.347 -0.221 . . . . 0.0 110.553 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.702 HG11 ' HE ' ' A' ' 167' ' ' ARG . 85.2 t -129.16 133.64 65.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-O 121.429 0.633 . . . . 0.0 110.832 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -113.85 153.78 28.6 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.755 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.463 ' OH ' HD21 ' A' ' 105' ' ' LEU . 32.4 t80 -107.66 118.77 37.62 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.794 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -83.73 109.97 17.93 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-O 121.465 0.65 . . . . 0.0 110.935 -178.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.938 HG23 ' HA2' ' A' ' 42' ' ' GLY . 33.5 t -72.03 -63.2 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.639 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.527 ' OE2' HD11 ' A' ' 100' ' ' LEU . 7.7 tt0 -134.11 118.49 17.78 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.592 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -103.67 127.49 51.11 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.737 0.303 . . . . 0.0 110.754 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -138.88 151.51 47.02 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.246 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.57 -12.64 54.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -108.2 1.91 22.45 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.416 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.7 166.2 16.01 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 121.608 -0.329 . . . . 0.0 112.335 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.556 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -147.32 146.27 29.64 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.85 136.95 54.27 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.078 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.97 161.71 32.13 Favored Glycine 0 C--O 1.228 -0.277 0 O-C-N 124.785 1.303 . . . . 0.0 112.573 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.9 mt -117.35 133.77 55.59 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.943 0.371 . . . . 0.0 111.267 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 78' ' ' GLY . 10.7 t -66.13 122.88 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.12 54.44 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.607 0.718 . . . . 0.0 112.104 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.852 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -147.49 -3.93 0.53 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.145 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -129.56 87.82 51.78 Favored Pre-proline 0 CA--C 1.556 1.181 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.513 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 40.4 Cg_exo -58.74 143.15 99.11 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 121.716 1.611 . . . . 0.0 112.415 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.444 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 66.5 m -93.28 158.67 15.63 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.485 0.491 . . . . 0.0 111.497 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.14 51.04 1.06 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.658 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.42 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -133.17 156.1 48.09 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.961 0.448 . . . . 0.0 110.054 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 15.6 p-10 -112.23 158.25 19.93 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.552 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.6 HD23 ' SG ' ' A' ' 70' ' ' CYS . 15.5 tp -57.4 -37.09 72.15 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.46 -37.27 62.49 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 36.8 mt-10 -64.97 -42.48 94.53 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.006 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.867 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -62.63 -46.32 96.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.675 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.741 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.1 mp -54.37 -36.8 64.25 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 123.81 0.694 . . . . 0.0 110.674 177.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.76 -27.86 50.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.486 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.403 HE21 HD23 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -78.41 -30.41 47.72 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.309 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.867 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.2 mt -77.64 -44.95 26.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.848 -1.523 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -132.38 116.54 15.28 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.496 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -77.49 -33.13 2.56 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.619 2.879 . . . . 0.0 112.823 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.08 -13.87 56.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.398 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.46 149.72 24.24 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 123.382 0.426 . . . . 0.0 111.752 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.16 123.88 29.64 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.021 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.16 145.68 35.32 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.204 1.936 . . . . 0.0 112.444 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.8 Cg_endo -92.2 -169.78 0.28 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.652 2.235 . . . . 0.0 111.932 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.44 -24.95 67.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.04 0.536 . . . . 0.0 112.135 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -66.11 -53.17 41.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.696 ' HA ' HD12 ' A' ' 73' ' ' ILE . 61.6 m -71.79 -25.05 61.85 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 49.3 mt-30 -67.88 -35.81 79.15 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -90.52 23.78 2.87 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.164 0.507 . . . . 0.0 111.689 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 70' ' ' CYS . 53.5 mt -121.52 138.46 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.487 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.27 163.11 13.08 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.433 ' CD1' HD12 ' A' ' 128' ' ' ILE . 17.1 mm -112.25 153.41 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.141 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.716 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -117.36 155.62 29.27 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -85.67 118.57 25.25 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.825 0.284 . . . . 0.0 110.551 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.574 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.52 -23.72 8.22 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 120.05 -1.071 . . . . 0.0 114.135 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.46 -167.84 34.11 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.511 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.44 -14.44 3.16 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 123.526 2.817 . . . . 0.0 114.412 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.9 124.07 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 123.103 0.252 . . . . 0.0 111.036 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 50.84 77.0 0.14 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.196 0.999 . . . . 0.0 112.512 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.8 m -79.37 -12.86 59.91 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.561 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.7 0.51 52.56 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.589 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.16 153.73 51.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.589 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.47 132.38 11.08 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.137 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.786 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.76 145.7 27.13 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.486 1.114 . . . . 0.0 110.69 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.16 103.89 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.401 0.438 . . . . 0.0 110.771 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.873 HD11 HD13 ' A' ' 105' ' ' LEU . 13.7 tp -107.2 129.1 54.91 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.876 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -127.03 168.5 14.51 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-O 118.921 -0.561 . . . . 0.0 111.705 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.671 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.4 Cg_endo -97.03 12.2 1.05 Allowed 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 122.829 2.353 . . . . 0.0 113.793 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.9 t -99.76 160.67 14.12 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.791 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.96 21.12 47.88 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.532 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -86.73 154.2 21.14 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.625 0.37 . . . . 0.0 110.568 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.8 p -127.34 156.85 41.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.566 ' CE2' HG23 ' A' ' 113' ' ' VAL . 52.3 m-85 -129.19 -151.57 0.48 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.668 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -59.14 -46.5 88.19 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.547 0.339 . . . . 0.0 111.413 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 57.9 m -134.37 83.22 2.02 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.495 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.6 m -130.98 128.97 41.5 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.847 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.527 HD11 ' OE2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.57 124.23 50.16 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.506 178.444 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.38 128.17 34.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.089 0.471 . . . . 0.0 110.972 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.449 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.28 48.08 1.89 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.378 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.72 -109.86 3.14 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 114.724 -1.126 . . . . 0.0 113.056 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.09 -8.41 5.38 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.873 HD13 HD11 ' A' ' 89' ' ' LEU . 2.8 pp -152.84 152.77 31.94 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.29 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.612 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.74 157.16 28.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.839 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.566 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.8 ttm -121.13 126.63 50.23 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.711 ' HB3' HG11 ' A' ' 113' ' ' VAL . 22.9 m -122.7 128.78 51.0 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.834 0.349 . . . . 0.0 110.176 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.4 p -119.39 16.54 13.03 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.318 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.767 ' O ' HG12 ' A' ' 113' ' ' VAL . 11.6 t -88.9 127.61 35.65 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.515 0.674 . . . . 0.0 111.445 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.49 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 10.1 pt20 -59.98 -30.49 69.15 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.235 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -64.58 -42.15 95.81 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.732 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 110' ' ' SER . 4.5 p -67.78 -37.98 79.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.538 HD22 ' NH2' ' A' ' 85' ' ' ARG . 3.9 tp -59.27 -48.64 80.87 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 123.449 0.468 . . . . 0.0 110.19 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.49 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 36.8 m-85 -68.52 -38.25 80.71 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.959 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.68 -51.76 67.11 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.21 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.69 -43.43 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.304 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.3 -31.3 65.5 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.759 0.662 . . . . 0.0 109.6 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.23 -19.95 30.88 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.129 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.79 16.4 28.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 114.705 -1.134 . . . . 0.0 114.623 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.1 p -106.86 7.46 30.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.16 -138.18 9.71 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-O 119.23 -0.761 . . . . 0.0 112.625 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.85 173.68 11.8 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.205 2.603 . . . . 0.0 113.554 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.06 -54.57 45.3 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.735 0.814 . . . . 0.0 111.988 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.671 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.2 mmtt -140.98 143.7 34.63 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.82 -178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.0 m -141.09 165.01 28.72 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.0 tp -127.61 117.02 21.23 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.466 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.786 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.5 pt -98.33 102.46 13.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-O 121.934 0.873 . . . . 0.0 109.82 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.509 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 9.0 t -119.34 124.05 45.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.784 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.4 tp -67.09 113.73 5.29 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.385 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.82 175.16 8.49 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 114.665 -1.152 . . . . 0.0 114.576 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.49 176.3 7.85 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.342 0.591 . . . . 0.0 110.474 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -115.92 130.68 56.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.062 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.04 145.9 16.61 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.476 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -121.24 136.47 54.97 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.242 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.05 158.08 25.21 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.824 0.703 . . . . 0.0 110.746 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.78 90.71 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.24 -25.19 7.5 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.164 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -57.57 -44.24 85.16 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.9 -47.96 64.51 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.16 0.287 . . . . 0.0 110.634 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.52 -28.79 68.67 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.002 0.43 . . . . 0.0 110.665 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.82 -50.74 32.23 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.797 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.0 pt-20 -69.67 -26.62 64.47 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.845 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.91 -38.37 57.82 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.722 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -77.82 -28.42 50.26 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -83.2 0.75 44.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.426 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 59.41 29.11 18.63 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.796 0.838 . . . . 0.0 111.818 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.76 -43.18 18.74 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.956 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -124.38 114.29 19.33 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.9 tp -85.59 139.88 31.06 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.629 0.252 . . . . 0.0 111.418 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -104.46 137.31 42.52 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.038 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.0 m -150.94 154.88 34.9 Favored Pre-proline 0 N--CA 1.469 0.51 0 O-C-N 123.515 0.509 . . . . 0.0 110.909 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.418 ' HA ' ' CD2' ' A' ' 12' ' ' HIS . 31.7 Cg_exo -59.28 152.58 59.34 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.32 2.013 . . . . 0.0 111.055 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.474 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.76 167.84 16.71 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.76 135.62 23.74 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.105 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.3 -26.47 14.51 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 122.605 2.203 . . . . 0.0 113.66 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.39 -40.72 62.44 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 123.909 0.756 . . . . 0.0 112.19 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.609 HD13 HH12 ' A' ' 167' ' ' ARG . 4.9 mt -71.36 -34.96 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.304 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.32 -36.99 63.72 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.335 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -84.66 -35.47 22.6 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -84.71 -72.5 0.47 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.963 0.347 . . . . 0.0 111.726 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.676 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -141.82 99.02 6.24 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.852 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 70.9 Cg_endo -91.95 -0.29 4.31 Favored 'Trans proline' 0 CA--C 1.57 2.29 0 C-N-CA 121.773 1.649 . . . . 0.0 114.351 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.641 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 69.0 Cg_endo -74.87 -50.03 0.14 Allowed 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 122.738 2.292 . . . . 0.0 114.519 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.5 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.3 mt-10 -122.39 -33.98 3.36 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.713 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.676 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 8.4 mt-10 -68.86 -10.9 59.5 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.077 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.702 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.86 -41.8 42.54 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.091 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.9 tp -70.41 -50.07 42.33 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 44.3 m -58.49 -49.12 78.51 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.633 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.673 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.17 -39.82 94.82 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.129 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.15 78.53 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.608 0.568 . . . . 0.0 110.6 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.44 91.09 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.499 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.96 -27.85 69.12 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.611 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.84 -40.05 41.55 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 122.831 0.452 . . . . 0.0 110.355 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -68.58 -33.37 73.95 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.346 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.759 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.155 179.405 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 32' ' ' LEU . 10.5 mt . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.811 0.339 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -89.81 20.34 4.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.934 0.397 . . . . 0.0 111.242 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 174.53 55.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.126 0.971 . . . . 0.0 110.1 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -133.62 159.38 40.67 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.643 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.454 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.4 m-30 -97.3 135.72 38.81 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.85 HD11 HD23 ' A' ' 32' ' ' LEU . 2.8 mt -107.99 137.04 46.67 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.848 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.438 HG23 HG22 ' A' ' 29' ' ' VAL . 2.3 mm -117.01 133.88 62.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 O-C-N 123.493 0.495 . . . . 0.0 109.721 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.05 120.33 18.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.488 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 150' ' ' LEU . 91.4 mtp -110.18 154.88 42.61 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.22 77.71 3.89 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.59 2.193 . . . . 0.0 112.932 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -135.68 -19.41 1.6 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.025 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.98 -164.19 0.91 Allowed 'General case' 0 CA--C 1.541 0.631 0 O-C-N 123.191 0.307 . . . . 0.0 110.495 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.554 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.92 37.84 2.06 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.052 0.453 . . . . 0.0 111.856 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 7.9 m-20 -110.51 83.79 3.55 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.827 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.1 Cg_exo -75.26 -24.62 12.25 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.03 2.486 . . . . 0.0 113.442 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -85.09 -37.84 19.81 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.931 0.492 . . . . 0.0 111.573 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.53 -3.4 57.63 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.84 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -59.85 0.25 0.16 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -141.19 41.56 1.78 Allowed 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.234 0.54 . . . . 0.0 112.052 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.1 p -124.28 157.27 35.31 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.686 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.789 HG11 ' HE ' ' A' ' 167' ' ' ARG . 59.3 t -131.27 132.8 62.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.617 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -114.48 153.54 29.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.615 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.409 ' OH ' HD21 ' A' ' 105' ' ' LEU . 44.4 t80 -107.14 118.71 37.42 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.85 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.88 109.1 16.71 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.095 0.474 . . . . 0.0 111.232 -178.441 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.932 HG23 ' HA2' ' A' ' 42' ' ' GLY . 38.9 t -67.28 -62.53 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 113.853 -1.522 . . . . 0.0 110.515 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -140.54 115.68 9.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.163 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -98.22 127.46 44.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.604 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -139.29 152.93 47.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.48 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' HB3' ' OE1' ' A' ' 38' ' ' GLN . 17.9 tt0 -64.73 -21.02 66.66 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.405 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.408 ' OE1' ' HB3' ' A' ' 37' ' ' GLU . 1.1 mp0 -96.65 0.89 50.49 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.487 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.38 168.35 16.44 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 112.209 -0.356 . . . . 0.0 112.209 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.493 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.83 144.33 30.19 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -122.82 136.14 54.77 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.564 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.932 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.78 158.83 29.41 Favored Glycine 0 N--CA 1.447 -0.581 0 O-C-N 124.454 1.097 . . . . 0.0 112.529 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.6 mt -113.35 132.92 55.4 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.025 0.412 . . . . 0.0 111.129 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 78' ' ' GLY . 12.4 t -67.98 124.54 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.538 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -127.53 55.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.606 0.717 . . . . 0.0 112.196 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.846 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.2 t30 -146.43 -3.3 0.64 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.072 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -130.11 89.82 44.09 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.477 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 52.6 Cg_exo -57.82 140.65 94.44 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 121.55 1.5 . . . . 0.0 111.763 174.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.407 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 56.4 m -71.23 -44.63 64.97 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.03 -15.94 56.17 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.226 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.66 162.06 16.52 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.506 0.323 . . . . 0.0 110.168 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.617 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 7.2 p-10 -100.92 160.63 14.21 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.725 ' HA ' HD11 ' A' ' 75' ' ' ILE . 4.7 tt -58.48 -28.65 65.55 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.076 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.617 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -62.07 -39.76 93.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.599 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.67 -46.98 85.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.637 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.86 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 17.1 m -62.32 -43.45 98.09 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.722 ' HA ' HD12 ' A' ' 60' ' ' LEU . 13.6 mt -56.94 -34.95 68.53 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.544 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -78.15 -27.34 48.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.262 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -30.65 51.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.129 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.86 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.8 mt -77.79 -45.48 24.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.789 -1.551 . . . . 0.0 111.12 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -131.7 116.16 15.96 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.631 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -77.71 -32.62 2.66 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.659 2.906 . . . . 0.0 112.755 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.1 -14.55 55.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.35 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.7 149.9 24.56 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.35 0.407 . . . . 0.0 111.685 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.5 mp -118.34 122.52 30.13 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.178 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.98 153.02 41.58 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.307 2.005 . . . . 0.0 112.26 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 7.1 Cg_endo -94.21 -165.31 0.12 Allowed 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.596 2.198 . . . . 0.0 112.263 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.38 -24.84 62.15 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.196 0.598 . . . . 0.0 111.964 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.568 ' HA ' ' CE1' ' A' ' 72' ' ' HIS . 12.0 ptp180 -67.1 -46.99 72.54 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.488 ' HA ' HD12 ' A' ' 73' ' ' ILE . 16.6 m -72.84 -25.57 61.16 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.439 ' HA ' HD22 ' A' ' 52' ' ' ASN . 48.0 mt-30 -70.54 -26.99 63.82 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.568 ' CE1' ' HA ' ' A' ' 69' ' ' ARG . 15.3 p-80 -99.21 16.51 22.6 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 123.439 0.462 . . . . 0.0 111.722 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 70.0 mt -114.35 138.63 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.313 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.16 151.46 24.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.943 HD13 HD12 ' A' ' 128' ' ' ILE . 21.3 mm -102.61 151.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.613 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.747 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.9 t80 -118.27 155.23 30.94 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.625 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.94 121.34 28.43 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.35 -23.53 8.4 Favored Glycine 0 C--N 1.345 1.042 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.195 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.67 -167.77 35.31 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.313 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -88.59 -12.21 3.8 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.588 2.859 . . . . 0.0 114.358 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -86.37 128.75 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 123.07 0.231 . . . . 0.0 111.171 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 45.35 82.15 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.564 1.145 . . . . 0.0 113.132 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.0 p -84.04 -8.25 59.18 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.206 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.62 -3.87 59.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.621 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.72 152.98 51.6 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.621 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.58 135.39 12.82 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.073 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -86.16 146.16 26.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.304 1.042 . . . . 0.0 110.573 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.9 103.58 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 123.47 0.481 . . . . 0.0 110.533 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.923 HD11 HD13 ' A' ' 105' ' ' LEU . 11.4 tp -107.18 128.59 54.54 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.981 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -128.29 167.44 18.92 Favored Pre-proline 0 CA--C 1.554 1.122 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.799 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.689 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 17.9 Cg_endo -97.42 19.91 0.43 Allowed 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.67 2.247 . . . . 0.0 113.563 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.1 t -107.69 160.56 15.61 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.835 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.27 22.08 41.84 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.587 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -84.98 152.88 23.15 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 122.618 0.367 . . . . 0.0 110.487 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.7 p -128.0 156.81 42.13 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.571 ' CE2' HG23 ' A' ' 113' ' ' VAL . 56.4 m-85 -130.44 -150.97 0.45 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.726 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -58.91 -46.16 88.57 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.655 0.382 . . . . 0.0 111.511 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.8 m -137.41 82.64 1.94 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.285 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 107' ' ' MET . 12.8 m -127.77 123.42 35.25 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.425 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -102.71 120.92 41.42 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.744 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.53 125.01 29.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.172 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.571 ' HB3' HD12 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -119.51 43.59 2.59 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.722 -179.277 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.81 -100.59 0.29 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.264 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -56.08 -14.53 2.71 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.923 HD13 HD11 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -160.91 160.23 30.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.842 0.457 . . . . 0.0 110.951 -179.283 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.589 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -117.77 156.97 27.38 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.625 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.573 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.4 ttm -123.3 129.7 51.7 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.702 ' HB3' HG11 ' A' ' 113' ' ' VAL . 31.3 m -125.99 129.22 48.79 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.9 p -119.98 14.56 12.39 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.658 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.727 ' O ' HG12 ' A' ' 113' ' ' VAL . 68.3 m -87.14 130.15 34.65 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.425 0.631 . . . . 0.0 112.042 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.499 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 21.0 pt20 -61.45 -28.67 69.45 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.101 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.37 -44.14 92.3 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.452 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.4 p -67.9 -34.83 69.58 Favored 'Isoleucine or valine' 0 C--N 1.354 0.792 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.42 ' HG ' ' NH2' ' A' ' 85' ' ' ARG . 2.5 tm? -59.13 -49.61 77.22 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 123.693 0.62 . . . . 0.0 109.81 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.499 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 31.5 m-85 -67.19 -39.63 86.42 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.955 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -52.97 62.59 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.456 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.0 -43.86 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.524 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.428 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.93 -32.03 65.55 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.72 0.637 . . . . 0.0 109.594 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.448 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.69 -19.7 32.38 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.232 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.69 14.93 33.17 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.718 -1.128 . . . . 0.0 114.633 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.5 p -105.58 7.9 33.02 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.18 -138.35 9.14 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.283 -0.732 . . . . 0.0 112.731 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.64 168.02 18.25 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.141 2.561 . . . . 0.0 113.968 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.493 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -49.39 -59.67 3.52 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.537 1.135 . . . . 0.0 111.837 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.689 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.5 mmtt -141.43 139.81 33.48 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 69.5 m -138.02 169.07 18.43 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 tp -126.41 118.14 24.37 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.296 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.943 HD12 HD13 ' A' ' 75' ' ' ILE . 10.1 pt -96.95 102.14 13.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 121.465 0.65 . . . . 0.0 109.711 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 7.2 t -118.9 119.13 33.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.099 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.19 112.93 4.74 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.136 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 169.81 11.26 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.005 -0.998 . . . . 0.0 114.186 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.6 177.54 6.95 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.196 0.522 . . . . 0.0 110.83 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -117.72 131.93 56.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.51 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.47 149.67 18.72 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.363 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 24.4 m-90 -129.09 135.55 49.05 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 123.855 0.385 . . . . 0.0 110.465 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.05 158.17 29.3 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.784 0.678 . . . . 0.0 111.129 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.23 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.54 -26.75 6.83 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.935 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -55.93 -45.59 78.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.076 0.55 . . . . 0.0 112.06 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.2 tp -67.37 -47.16 71.21 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.58 -30.51 65.32 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.426 0.454 . . . . 0.0 110.747 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.5 -50.19 40.52 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.91 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -71.61 -26.64 62.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.945 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.3 tp -75.11 -39.21 60.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.937 0.895 . . . . 0.0 110.806 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 m -78.15 -30.21 49.09 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.553 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -80.38 0.19 34.24 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.701 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 60.42 29.47 19.04 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.757 0.823 . . . . 0.0 111.723 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.92 -42.46 19.46 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.813 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -123.97 112.07 16.77 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 123.383 0.427 . . . . 0.0 109.865 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.542 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 7.0 tp -83.57 138.65 33.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.275 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.5 p -103.6 137.66 41.35 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.578 0.549 . . . . 0.0 111.307 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 73.0 m -152.86 155.6 32.36 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.544 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.51 159.81 22.43 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.2 1.933 . . . . 0.0 111.366 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.454 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -131.74 167.24 19.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -134.85 135.14 22.68 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.941 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.45 -26.42 14.23 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 122.613 2.208 . . . . 0.0 113.81 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.89 -40.64 63.67 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.857 0.723 . . . . 0.0 112.147 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.569 HG21 HH11 ' A' ' 167' ' ' ARG . 4.5 mt -71.08 -35.52 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.348 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.74 -38.7 64.68 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.417 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.38 -32.36 22.44 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -87.01 -72.68 0.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.145 0.429 . . . . 0.0 111.656 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.92 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.79 98.81 6.29 Favored Pre-proline 0 C--N 1.35 0.608 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.846 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 62.4 Cg_endo -92.71 0.37 3.81 Favored 'Trans proline' 0 CA--C 1.57 2.306 0 C-N-CA 121.715 1.61 . . . . 0.0 114.288 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.644 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 98.0 Cg_endo -73.25 -52.41 0.15 Allowed 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.583 2.189 . . . . 0.0 114.245 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.513 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -122.82 -29.85 3.92 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.7 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.92 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.05 -11.14 60.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.437 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.789 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.02 -40.39 46.71 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.139 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -71.07 -50.21 36.33 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.6 m -58.49 -48.49 80.62 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.611 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.664 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.86 -40.16 94.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.298 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.43 -46.78 80.11 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 123.498 0.499 . . . . 0.0 110.368 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.83 88.81 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.406 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.27 -27.83 68.91 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.59 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.53 -39.79 44.89 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 122.841 0.456 . . . . 0.0 110.3 178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.2 -31.47 67.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.455 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.734 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.963 179.404 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 32' ' ' LEU . 12.6 mt . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.808 0.337 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -92.66 21.3 5.6 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.897 0.38 . . . . 0.0 110.686 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.3 t60 178.01 54.64 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.586 0.754 . . . . 0.0 110.268 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -139.17 160.14 40.5 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 30' ' ' THR . 11.5 m-30 -100.57 138.09 38.1 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.089 0.471 . . . . 0.0 112.021 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.769 HD11 HD23 ' A' ' 32' ' ' LEU . 4.3 mt -107.47 141.09 39.43 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.341 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.8 mp -120.73 134.32 64.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 O-C-N 123.522 0.514 . . . . 0.0 109.759 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.73 126.18 30.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.085 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.2 mtt -110.32 157.15 38.92 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.222 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.52 29.84 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.611 2.207 . . . . 0.0 113.188 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -86.14 -16.29 38.37 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.15 -167.45 1.22 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.009 0.193 . . . . 0.0 110.641 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.524 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.28 40.39 1.48 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.995 0.426 . . . . 0.0 111.694 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.32 80.5 3.45 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.781 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.2 Cg_exo -75.41 -21.92 14.64 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.008 2.472 . . . . 0.0 113.327 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -84.44 -36.07 22.61 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.966 0.507 . . . . 0.0 111.852 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.29 4.01 51.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.098 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.35 163.47 20.63 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.896 0.379 . . . . 0.0 111.849 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 49.4 32.04 4.33 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.2 p -117.55 153.66 32.83 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 120.469 0.176 . . . . 0.0 110.556 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.869 HG11 HH11 ' A' ' 167' ' ' ARG . 77.4 t -128.49 133.71 66.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.583 0.706 . . . . 0.0 110.596 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 6.2 m -114.76 152.98 31.15 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.87 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.492 ' OH ' HD11 ' A' ' 105' ' ' LEU . 13.2 t80 -106.29 118.63 37.13 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.769 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.84 108.55 16.27 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.432 0.634 . . . . 0.0 110.927 -179.077 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.93 HG23 ' HA2' ' A' ' 42' ' ' GLY . 35.8 t -68.89 -60.36 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 113.228 -1.805 . . . . 0.0 110.576 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -142.26 113.48 7.65 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.62 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -97.34 128.74 44.43 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.672 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -139.71 153.27 47.19 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.604 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.25 -18.82 65.62 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.701 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.44 0.88 43.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.414 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.88 166.99 15.44 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.37 143.4 30.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.47 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -124.62 137.95 54.34 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.341 178.367 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.93 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -160.23 158.65 30.03 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.531 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.433 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.2 mt -112.83 131.54 55.66 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.935 0.367 . . . . 0.0 110.939 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 78' ' ' GLY . 41.2 t -67.93 124.68 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.558 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.1 pt -129.85 55.35 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.524 0.678 . . . . 0.0 112.347 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.869 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 3.3 t30 -144.27 -7.76 0.7 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.286 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.553 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -130.39 92.26 35.97 Favored Pre-proline 0 CA--C 1.555 1.145 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.1 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.514 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.5 Cg_exo -61.09 146.4 97.68 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 121.747 1.631 . . . . 0.0 112.602 175.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.43 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 44.9 t -89.14 162.96 15.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.557 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.69 -5.78 62.78 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-O 119.75 -0.472 . . . . 0.0 114.242 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -88.89 151.45 22.33 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.104 0.452 . . . . 0.0 111.566 -179.83 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.486 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 41.2 p-10 -98.55 165.74 11.68 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.655 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.65 ' HA ' HD11 ' A' ' 75' ' ' ILE . 13.9 tp -59.03 -26.88 64.96 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.617 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . . . -61.95 -42.5 99.18 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.486 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 41.4 mt-10 -62.39 -47.35 84.52 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.072 0.233 . . . . 0.0 111.492 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.882 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.7 m -61.68 -45.34 98.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.746 ' HA ' HD12 ' A' ' 60' ' ' LEU . 6.9 mt -54.48 -35.97 63.64 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.972 0.795 . . . . 0.0 110.742 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -78.13 -28.0 48.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.467 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.98 -30.38 50.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.375 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.882 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.1 mt -77.93 -46.62 20.7 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.749 -1.569 . . . . 0.0 111.376 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -131.89 118.18 16.42 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.003 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.33 -32.33 3.07 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.665 2.91 . . . . 0.0 112.56 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -82.22 -15.07 54.41 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.296 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.42 149.15 26.86 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.368 0.418 . . . . 0.0 111.425 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.57 121.78 31.59 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.743 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.671 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 46.4 Cg_endo -71.26 138.16 32.6 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.575 2.183 . . . . 0.0 112.423 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 2.7 Cg_endo -90.38 -157.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.733 2.289 . . . . 0.0 112.403 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.04 -25.07 52.1 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.249 0.62 . . . . 0.0 111.824 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.479 ' HA ' ' NE2' ' A' ' 72' ' ' HIS . 6.4 ptp180 -66.54 -46.14 77.12 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.671 ' SG ' ' HB2' ' A' ' 66' ' ' PRO . 18.5 p -67.49 -29.57 69.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 71.4 mt-30 -65.75 -32.85 74.63 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.479 ' NE2' ' HA ' ' A' ' 69' ' ' ARG . 32.9 p80 -95.37 9.94 38.11 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.432 0.458 . . . . 0.0 112.021 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 69' ' ' ARG . 71.0 mt -108.64 137.68 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.55 153.07 24.65 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.822 0.702 . . . . 0.0 112.711 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.761 HD13 HD12 ' A' ' 128' ' ' ILE . 25.6 mm -101.21 153.58 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.125 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.717 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -117.13 156.03 28.31 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.553 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 32.4 m-20 -89.26 117.4 28.19 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 117.832 0.287 . . . . 0.0 110.465 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.53 -23.24 9.0 Favored Glycine 0 C--N 1.35 1.358 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.817 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.53 -167.86 35.25 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.727 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -88.59 -14.74 2.97 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.501 2.801 . . . . 0.0 114.383 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -82.11 125.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 123.126 0.266 . . . . 0.0 111.166 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 45.36 89.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.582 1.153 . . . . 0.0 113.216 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.2 p -85.65 -10.17 56.17 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.931 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.26 -9.94 59.68 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.8 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.651 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -133.09 151.5 52.01 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.642 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -110.28 142.31 16.55 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.153 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.634 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.5 m-85 -86.77 149.37 24.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.077 -1.062 . . . . 0.0 110.528 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.6 ' HB ' ' OG ' ' A' ' 108' ' ' SER . 5.1 t -126.83 103.96 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 123.627 0.579 . . . . 0.0 110.194 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.912 HD11 HD13 ' A' ' 105' ' ' LEU . 16.0 tp -106.28 127.55 53.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.309 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -128.57 168.9 14.17 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.444 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.6 Cg_endo -97.31 17.75 0.56 Allowed 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.682 2.255 . . . . 0.0 113.555 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.5 t -105.32 158.86 16.33 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.895 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.34 22.23 41.98 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.483 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -84.62 155.09 22.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.661 0.384 . . . . 0.0 110.491 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.8 p -125.74 156.49 39.32 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.582 ' CE2' HG23 ' A' ' 113' ' ' VAL . 58.1 m-85 -131.5 -151.24 0.45 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.494 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -60.3 -46.55 89.47 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.44 0.296 . . . . 0.0 111.291 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.1 m -136.68 83.5 2.01 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.21 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 107' ' ' MET . 7.4 m -128.03 121.08 28.86 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.909 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -99.58 120.68 40.05 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.913 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.96 126.89 33.01 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.403 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.474 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -123.98 50.52 1.63 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.578 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.83 -111.94 4.28 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.151 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.77 -6.68 6.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 89' ' ' LEU . 2.5 pp -151.36 151.89 32.38 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.17 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.588 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -121.09 158.13 28.56 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.851 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.563 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 25.3 tpp -125.73 140.03 53.04 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.674 ' HB2' HG11 ' A' ' 113' ' ' VAL . 25.2 p -134.98 133.23 39.27 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.813 0.339 . . . . 0.0 110.435 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.4 p -118.76 15.44 13.54 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.0 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.713 ' O ' HG12 ' A' ' 113' ' ' VAL . 44.2 p -90.27 130.08 36.43 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.661 0.743 . . . . 0.0 112.424 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.485 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 20.3 pt20 -61.75 -27.01 68.42 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.401 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.28 -42.26 93.34 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.495 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.743 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.1 p -69.77 -38.3 75.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.513 HD13 HH12 ' A' ' 85' ' ' ARG . 6.4 tp -57.93 -48.46 79.87 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 123.68 0.613 . . . . 0.0 110.573 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.485 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 26.1 m-85 -68.77 -39.17 80.36 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.806 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.39 -53.0 62.28 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.306 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.35 -43.86 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.718 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.6 -32.1 64.93 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.782 0.676 . . . . 0.0 109.599 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.02 -20.01 31.11 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.291 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.67 13.82 33.83 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.668 -1.151 . . . . 0.0 114.799 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 p -103.83 6.48 36.61 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.38 -137.57 9.16 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.419 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.74 171.81 14.0 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.069 2.513 . . . . 0.0 113.493 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.19 -55.24 37.29 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.642 0.777 . . . . 0.0 111.998 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.646 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.0 mmtt -141.23 139.69 33.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.691 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 34.5 p -139.01 168.58 19.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.3 tp -126.97 117.38 22.4 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.804 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.761 HD12 HD13 ' A' ' 75' ' ' ILE . 12.4 pt -98.64 102.45 13.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-O 121.532 0.682 . . . . 0.0 109.536 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.0 t -121.24 122.32 39.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.025 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 tp -66.58 112.97 4.41 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.544 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 173.71 18.5 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 114.545 -1.207 . . . . 0.0 114.764 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -127.82 175.06 8.62 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.25 178.708 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -115.54 129.01 56.38 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.154 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.73 150.23 18.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.375 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -128.37 138.23 52.26 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.858 0.387 . . . . 0.0 110.344 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.71 157.65 27.13 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.885 0.741 . . . . 0.0 110.622 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.74 91.67 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.54 -23.51 8.95 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.322 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -57.44 -44.55 84.8 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.938 0.495 . . . . 0.0 112.14 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.9 tm? -67.87 -47.7 68.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.5 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.35 -30.0 68.08 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.05 -49.96 45.92 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.941 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -70.71 -26.76 63.55 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.694 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.4 tp -74.18 -38.98 63.51 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.602 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.9 m -77.84 -28.4 50.16 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.211 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 3.0 t70 -82.25 -1.42 49.29 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.395 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.2 m120 61.03 28.5 18.26 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.857 0.863 . . . . 0.0 111.903 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 143' ' ' GLU . . . -81.96 -43.54 17.91 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.856 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -124.77 113.38 17.86 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.0 tp -86.21 138.49 31.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.5 p -101.66 136.33 41.68 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.502 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 80.6 m -150.78 150.92 29.25 Favored Pre-proline 0 C--O 1.238 0.487 0 O-C-N 123.412 0.445 . . . . 0.0 110.983 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.05 151.06 83.97 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.233 1.956 . . . . 0.0 110.997 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -134.29 176.85 8.23 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -134.56 140.26 35.04 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 113.725 -1.58 . . . . 0.0 108.693 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.83 -26.71 13.14 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.735 2.29 . . . . 0.0 113.646 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.65 -41.79 55.78 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.857 0.723 . . . . 0.0 112.46 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.46 HG21 ' HE ' ' A' ' 167' ' ' ARG . 5.5 mt -68.83 -33.83 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.526 0.679 . . . . 0.0 110.276 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.66 -37.23 56.58 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.538 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -84.83 -31.21 23.96 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -88.7 -73.24 0.51 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 117.97 0.35 . . . . 0.0 111.628 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.862 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.82 99.8 6.12 Favored Pre-proline 0 C--N 1.35 0.589 0 CA-C-O 121.183 0.516 . . . . 0.0 112.228 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.869 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 72.4 Cg_endo -91.18 -0.11 4.79 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 121.711 1.608 . . . . 0.0 114.381 175.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.649 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 89.3 Cg_endo -74.92 -56.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.395 2.976 0 C-N-CA 122.653 2.235 . . . . 0.0 114.579 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.565 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 4.7 mt-10 -118.43 -30.67 5.15 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.542 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.862 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 28.5 tt0 -69.7 -12.18 61.43 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.235 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.869 HH11 HG11 ' A' ' 29' ' ' VAL . 3.7 tpm_? -77.1 -43.88 32.57 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.59 -49.2 64.25 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.4 m -58.21 -48.66 79.67 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.789 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.58 ' O ' ' HG3' ' A' ' 174' ' ' ARG . . . -63.25 -41.92 99.12 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.494 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.01 87.88 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.577 0.548 . . . . 0.0 110.82 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.51 -37.14 85.89 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.53 -28.19 69.48 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.152 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.58 ' HG3' ' O ' ' A' ' 170' ' ' ALA . 9.1 mtm105 -77.28 -40.78 43.31 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 123.291 0.636 . . . . 0.0 110.757 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 tp -69.61 -31.24 69.25 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.449 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.798 0 C-N-CA 121.129 -0.557 . . . . 0.0 113.046 179.475 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 32' ' ' LEU . 15.8 mt . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 121.112 0.482 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.42 ' O ' HD21 ' A' ' 102' ' ' LEU . 48.0 tttt -88.82 16.09 7.37 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.378 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 17.3 p80 172.83 58.87 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.43 1.092 . . . . 0.0 109.698 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -135.22 159.36 41.78 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.659 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.465 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.7 m-30 -97.1 136.17 38.01 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.813 HD11 HD23 ' A' ' 32' ' ' LEU . 3.2 mt -108.42 137.12 46.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.793 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.443 HG23 HG22 ' A' ' 29' ' ' VAL . 2.3 mm -117.04 133.23 64.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.545 0.528 . . . . 0.0 109.635 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.54 121.94 21.42 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 123.461 0.475 . . . . 0.0 111.666 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.6 mmt -110.47 152.91 43.63 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.338 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -80.45 73.96 5.77 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.594 2.196 . . . . 0.0 112.622 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -131.46 -19.22 2.75 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.716 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.58 -162.97 0.83 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.3 0.375 . . . . 0.0 110.481 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.73 36.66 2.24 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.869 0.366 . . . . 0.0 111.968 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.37 82.71 3.66 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.809 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.32 -24.87 11.93 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 123.019 2.48 . . . . 0.0 113.349 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -85.16 -37.11 20.57 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.887 0.475 . . . . 0.0 111.595 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.11 -3.04 57.46 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.8 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -60.51 1.62 0.13 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -141.46 41.48 1.75 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.213 0.53 . . . . 0.0 112.076 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.9 p -124.52 157.68 34.73 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.642 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.781 HG11 ' HE ' ' A' ' 167' ' ' ARG . 57.6 t -131.0 133.51 62.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.806 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -115.04 152.37 32.59 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.381 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.52 ' OH ' HD21 ' A' ' 105' ' ' LEU . 43.4 t80 -106.95 120.99 43.54 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.813 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -83.73 108.62 16.9 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 123.481 0.488 . . . . 0.0 111.419 -178.273 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.946 HG23 ' HA2' ' A' ' 42' ' ' GLY . 36.9 t -67.76 -59.97 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.623 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -141.93 120.8 12.75 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.433 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -102.35 127.94 49.13 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.988 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.84 151.85 47.35 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.418 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.3 -19.59 65.52 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.893 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -98.4 -1.63 41.07 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.681 0.613 . . . . 0.0 111.533 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.03 169.73 20.56 Favored Glycine 0 C--N 1.344 1.012 0 C-N-CA 121.529 -0.367 . . . . 0.0 112.304 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -146.32 146.97 30.88 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.81 135.74 53.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.363 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.946 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.21 158.36 29.13 Favored Glycine 0 N--CA 1.447 -0.619 0 O-C-N 124.472 1.107 . . . . 0.0 112.486 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.4 mt -112.9 134.59 54.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 117.253 0.526 . . . . 0.0 111.469 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 78' ' ' GLY . 12.0 t -68.35 122.94 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.38 56.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.618 0.723 . . . . 0.0 111.98 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.844 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -147.04 -3.43 0.58 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.256 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -129.92 88.08 49.91 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.504 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 41.4 Cg_exo -58.44 144.62 96.42 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 121.689 1.593 . . . . 0.0 112.43 175.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.452 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 73.9 m -94.82 160.45 14.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.509 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.72 51.04 0.94 Allowed Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.687 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.488 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.6 OUTLIER -133.19 154.05 50.98 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.871 0.395 . . . . 0.0 110.042 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.61 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 10.3 p-10 -112.43 157.6 20.86 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.25 0.343 . . . . 0.0 110.918 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.567 HD12 HD13 ' A' ' 128' ' ' ILE . 1.6 tt -57.54 -26.66 61.71 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.61 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -67.94 -40.39 83.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.383 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.42 -45.57 86.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.092 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.86 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.6 m -61.88 -45.06 99.53 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.736 ' HA ' HD12 ' A' ' 60' ' ' LEU . 15.6 mt -55.74 -35.26 65.97 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.546 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.99 -27.25 49.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.429 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.82 -30.54 51.19 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.768 0.794 . . . . 0.0 109.318 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.86 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.2 mt -77.86 -46.01 22.64 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.038 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -130.99 116.63 16.91 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.626 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.56 -33.08 2.54 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.687 2.925 . . . . 0.0 112.785 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.63 -14.92 56.1 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.4 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.19 149.69 24.45 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 123.338 0.399 . . . . 0.0 111.689 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.06 123.13 29.09 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.304 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.52 154.15 39.86 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.296 1.997 . . . . 0.0 112.301 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.439 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 6.8 Cg_endo -94.14 -163.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.67 2.247 . . . . 0.0 112.064 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.05 -24.76 59.57 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.782 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.573 ' HA ' ' CE1' ' A' ' 72' ' ' HIS . 7.9 ptp180 -67.11 -46.49 74.04 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.638 ' HA ' HD12 ' A' ' 73' ' ' ILE . 20.8 m -73.31 -25.58 60.71 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.464 ' HA ' HD22 ' A' ' 52' ' ' ASN . 46.5 mt-30 -70.45 -29.09 65.57 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.573 ' CE1' ' HA ' ' A' ' 69' ' ' ARG . 15.3 p-80 -96.09 21.31 8.96 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.16 0.505 . . . . 0.0 111.582 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' A' ' 70' ' ' CYS . 57.0 mt -119.53 137.12 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.204 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -106.06 163.12 13.02 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 51' ' ' LEU . 14.2 mm -113.63 154.18 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.996 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.733 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -118.11 155.83 29.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.594 0.358 . . . . 0.0 110.33 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -85.76 119.99 26.7 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.54 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -101.85 -23.64 9.15 Favored Glycine 0 C--N 1.346 1.109 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.158 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.86 -167.91 34.87 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.272 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -88.73 -13.03 3.39 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 123.618 2.878 . . . . 0.0 114.413 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.55 130.52 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 123.075 0.235 . . . . 0.0 111.518 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 46.66 82.85 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.551 1.141 . . . . 0.0 113.301 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 77.2 p -82.85 -12.02 57.76 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.197 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.76 -13.46 59.42 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.759 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -132.81 149.73 52.23 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.594 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.29 144.42 17.02 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.46 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.2 m-85 -86.85 149.4 24.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.021 -1.09 . . . . 0.0 110.94 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 17.4 t -127.32 105.93 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 O-C-N 123.587 0.554 . . . . 0.0 110.351 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.935 HD11 HD13 ' A' ' 105' ' ' LEU . 14.6 tp -106.74 127.63 53.55 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.281 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.41 ' ND1' ' HB3' ' A' ' 123' ' ' PRO . 4.0 p80 -128.08 168.41 15.53 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.548 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.667 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.3 Cg_endo -97.7 21.78 0.34 Allowed 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 122.677 2.251 . . . . 0.0 113.748 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.2 t -109.83 158.88 17.71 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.686 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.06 22.42 38.51 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.609 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.02 151.79 22.07 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.539 0.335 . . . . 0.0 110.514 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.598 ' HA ' HG21 ' A' ' 99' ' ' THR . 22.4 m -128.82 157.12 42.39 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.564 ' CE2' HG23 ' A' ' 113' ' ' VAL . 55.0 m-85 -126.95 -150.97 0.46 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.757 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -58.85 -46.32 88.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.655 0.382 . . . . 0.0 111.415 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.9 m -133.12 81.03 1.91 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.848 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.598 HG21 ' HA ' ' A' ' 95' ' ' SER . 42.4 m -129.49 122.62 29.64 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.381 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.33 123.48 46.89 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.879 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.88 130.13 34.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.979 0.419 . . . . 0.0 110.878 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.427 ' HB3' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -125.43 46.35 2.4 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.667 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.16 -106.85 1.65 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 114.863 -1.062 . . . . 0.0 113.381 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.28 -10.63 3.14 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.935 HD13 HD11 ' A' ' 89' ' ' LEU . 1.7 pp -155.22 152.15 28.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.609 0.364 . . . . 0.0 111.25 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.586 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.06 157.5 26.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.863 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.527 ' O ' ' HA ' ' A' ' 99' ' ' THR . 17.3 ttm -123.9 134.2 53.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.0 m -136.44 133.8 37.02 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.7 p -127.49 19.07 6.84 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.144 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 113' ' ' VAL . 46.8 p -90.16 131.19 36.14 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.393 0.616 . . . . 0.0 112.037 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.482 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 5.3 mt-30 -58.16 -26.96 63.36 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.759 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -64.12 -40.44 96.2 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.902 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.765 ' O ' HG22 ' A' ' 117' ' ' ILE . 2.6 p -71.1 -38.43 71.28 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.418 HD11 HH12 ' A' ' 85' ' ' ARG . 4.4 mm? -55.51 -50.1 70.85 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.533 0.521 . . . . 0.0 110.495 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.482 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 39.9 m-85 -67.8 -40.6 83.86 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.222 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.69 -54.17 48.48 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.753 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.765 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.11 -43.73 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.6 -32.27 65.08 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 123.674 0.609 . . . . 0.0 109.59 178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.531 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.66 -20.2 31.68 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.363 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.05 17.0 26.4 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.841 -1.072 . . . . 0.0 114.64 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.6 p -107.08 7.08 29.49 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.57 -137.29 8.74 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.113 -0.826 . . . . 0.0 112.47 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.41 ' HB3' ' ND1' ' A' ' 90' ' ' HIS . 2.1 Cg_endo -82.51 169.3 13.94 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.942 2.428 . . . . 0.0 113.652 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.61 -56.46 21.04 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.776 0.831 . . . . 0.0 112.106 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.667 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.5 mmtt -139.63 139.76 36.79 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.502 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 35.8 p -141.04 168.97 18.5 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.3 tp -125.63 115.18 19.72 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.695 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.567 HD13 HD12 ' A' ' 53' ' ' LEU . 7.9 pt -99.29 104.43 16.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 O-C-N 123.751 0.657 . . . . 0.0 109.229 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -124.55 122.08 36.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.21 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.34 113.64 5.39 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.346 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.433 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 73.87 167.92 16.04 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 115.093 -0.958 . . . . 0.0 114.461 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -128.64 179.95 5.4 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.115 0.483 . . . . 0.0 110.655 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -118.2 130.37 56.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.368 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.57 146.04 16.58 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.539 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 31.4 m-90 -122.31 135.71 54.77 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 122.655 0.382 . . . . 0.0 110.35 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.36 158.11 26.13 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.935 0.772 . . . . 0.0 110.663 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.1 90.86 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.14 -25.01 7.61 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.172 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -57.59 -44.17 85.2 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.938 0.495 . . . . 0.0 112.252 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.582 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.98 -47.57 65.25 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.118 0.261 . . . . 0.0 110.527 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.33 -29.22 68.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.088 0.47 . . . . 0.0 110.643 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.63 -50.66 34.63 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.788 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.1 pt-20 -69.57 -26.64 64.58 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.816 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.7 tp -75.2 -39.16 60.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.637 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.2 m -77.82 -27.83 50.13 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.492 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -82.96 0.1 46.14 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.518 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.5 m120 60.09 29.39 18.96 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.811 0.844 . . . . 0.0 111.761 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.61 -43.28 17.2 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.917 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -124.17 113.61 18.54 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.6 tp -83.92 139.22 32.73 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.205 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.3 p -104.66 138.1 41.48 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.32 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 24.7 p -152.88 155.5 32.27 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.595 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.08 158.24 26.41 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.259 1.972 . . . . 0.0 111.214 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.465 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.97 166.24 21.4 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.11 134.89 23.37 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 114.317 -1.311 . . . . 0.0 107.983 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.13 -26.47 14.86 Favored 'Trans proline' 0 C--N 1.364 1.354 0 C-N-CA 122.594 2.196 . . . . 0.0 113.616 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.67 -40.04 62.48 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 123.787 0.68 . . . . 0.0 112.211 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.567 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.6 mt -72.07 -35.1 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 121.411 0.624 . . . . 0.0 110.351 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.26 -37.22 63.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.343 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -85.45 -34.9 21.54 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -84.85 -72.16 0.49 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 117.98 0.354 . . . . 0.0 111.657 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.897 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.85 99.04 6.21 Favored Pre-proline 0 C--N 1.348 0.539 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.844 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.7 Cg_endo -91.99 -0.15 4.28 Favored 'Trans proline' 0 CA--C 1.569 2.259 0 C-N-CA 121.64 1.56 . . . . 0.0 114.253 175.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.642 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 81.3 Cg_endo -73.89 -52.34 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 122.539 2.159 . . . . 0.0 114.43 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.518 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.5 mt-10 -122.54 -30.19 3.95 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.672 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.897 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.8 tt0 -70.02 -10.84 60.01 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.338 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.781 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.91 -41.52 43.21 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.9 tp -70.62 -50.33 38.1 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.7 m -58.07 -49.61 76.32 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.666 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -63.66 -40.0 95.75 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.069 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.76 -45.32 78.11 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.54 0.525 . . . . 0.0 110.485 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 -38.35 90.77 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.497 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.95 -27.63 68.3 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.65 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -78.05 -40.29 39.18 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.963 0.505 . . . . 0.0 110.378 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.66 -32.76 71.6 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.353 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.757 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.944 179.47 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.4 mt . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.842 0.353 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.401 ' O ' HD21 ' A' ' 102' ' ' LEU . 85.3 mttt -90.06 18.68 5.59 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 120.893 0.377 . . . . 0.0 111.058 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.1 p80 176.82 55.49 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.04 0.936 . . . . 0.0 110.265 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -134.32 159.78 39.94 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.625 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.492 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 18.9 m-30 -98.6 136.59 38.47 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.035 0.445 . . . . 0.0 112.02 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.784 HD11 HD23 ' A' ' 32' ' ' LEU . 4.3 mt -108.34 141.86 39.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.919 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.674 HD11 ' SG ' ' A' ' 152' ' ' CYS . 2.3 mp -124.87 137.36 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 O-C-N 123.274 0.358 . . . . 0.0 110.351 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.05 120.13 19.22 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.748 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.5 mmt -97.86 159.0 31.95 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.565 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.04 6.81 4.36 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.678 2.252 . . . . 0.0 113.727 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -79.82 -12.94 59.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.303 0.241 . . . . 0.0 111.549 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.727 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -105.82 153.13 22.34 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.175 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.91 42.95 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.376 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.727 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.1 m-20 -116.55 87.6 21.47 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.526 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.51 -20.0 18.54 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.926 2.417 . . . . 0.0 113.331 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -84.52 -34.67 23.26 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.828 0.451 . . . . 0.0 111.708 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -94.02 3.83 54.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.024 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.72 163.65 21.12 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 48.87 32.07 3.54 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.9 p -116.29 154.22 30.55 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 120.568 0.223 . . . . 0.0 110.738 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.739 HG11 ' HE ' ' A' ' 167' ' ' ARG . 47.2 t -129.33 132.2 66.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.781 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 6.1 m -113.34 153.39 28.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.755 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.543 ' OH ' HD21 ' A' ' 105' ' ' LEU . 45.2 t80 -107.18 120.5 42.27 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.784 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -85.26 109.75 18.57 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.639 0.587 . . . . 0.0 111.128 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.95 HG23 ' HA2' ' A' ' 42' ' ' GLY . 34.9 t -69.13 -60.22 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 113.569 -1.651 . . . . 0.0 110.841 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -141.32 115.81 9.54 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.407 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -99.07 128.13 45.15 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.802 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -139.28 152.64 47.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.398 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.87 -18.98 65.64 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.787 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.45 2.35 42.09 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.536 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.46 166.79 15.01 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 121.517 -0.373 . . . . 0.0 112.375 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -144.91 145.82 31.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.457 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -125.56 136.82 53.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.966 178.263 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.95 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -160.93 159.78 31.37 Favored Glycine 0 N--CA 1.452 -0.284 0 O-C-N 124.575 1.172 . . . . 0.0 112.59 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.2 mt -115.12 135.08 54.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.08 0.44 . . . . 0.0 111.228 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 78' ' ' GLY . 11.0 t -66.83 124.11 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.551 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.65 54.08 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.538 0.685 . . . . 0.0 112.015 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.83 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.1 t30 -147.32 -3.42 0.56 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.996 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -129.7 87.61 51.98 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.528 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 35.2 Cg_exo -59.73 142.45 98.74 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 121.658 1.572 . . . . 0.0 112.273 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.434 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.2 m -89.44 159.39 17.3 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.465 0.478 . . . . 0.0 111.589 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.84 48.54 1.47 Allowed Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.513 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mt -133.48 157.02 46.67 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 124.002 0.471 . . . . 0.0 110.141 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 18.4 p-10 -112.22 158.74 19.34 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.245 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.658 HD13 HD13 ' A' ' 128' ' ' ILE . 13.3 tp -57.53 -29.23 64.2 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.38 96.0 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.33 -47.02 77.96 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.865 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.3 m -62.06 -43.92 98.32 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.707 ' HA ' HD12 ' A' ' 60' ' ' LEU . 16.7 mt -57.34 -34.57 68.92 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.587 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -78.18 -27.72 48.0 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.325 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -30.29 51.97 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.263 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.865 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 14.7 mt -77.87 -45.55 23.9 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 113.667 -1.606 . . . . 0.0 111.056 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -130.94 116.01 16.81 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.609 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.43 -32.91 2.7 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 123.604 2.869 . . . . 0.0 112.744 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.36 -15.38 55.46 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.315 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.3 150.49 23.83 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.611 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.78 122.79 28.29 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.167 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.7 149.74 49.22 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.357 2.038 . . . . 0.0 112.189 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 8.7 Cg_endo -94.69 -171.5 0.23 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.639 2.226 . . . . 0.0 112.477 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.79 67.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.113 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.53 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 7.4 ptp180 -68.73 -46.73 68.15 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.682 ' HA ' HD12 ' A' ' 73' ' ' ILE . 15.4 m -75.49 -25.44 57.31 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 50.5 mt-30 -68.63 -26.92 65.58 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.441 ' CE1' ' HA ' ' A' ' 69' ' ' ARG . 15.8 p-80 -99.46 21.68 11.81 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.138 0.494 . . . . 0.0 111.318 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 70' ' ' CYS . 63.4 mt -117.79 139.1 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.268 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.18 154.62 20.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.707 HD13 HD12 ' A' ' 128' ' ' ILE . 23.5 mm -101.28 152.59 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.235 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.714 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.9 t80 -118.81 154.87 32.15 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -85.94 119.2 25.99 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.613 0.188 . . . . 0.0 110.555 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.577 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.29 -23.72 8.31 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.022 -1.085 . . . . 0.0 114.047 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.15 -168.24 35.11 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.359 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -88.66 -13.26 3.37 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.47 2.78 . . . . 0.0 114.37 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.3 t -82.39 125.19 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 123.082 0.239 . . . . 0.0 111.233 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 47.23 85.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.488 1.115 . . . . 0.0 113.027 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.41 ' O ' HD21 ' A' ' 130' ' ' LEU . 8.8 t -86.8 1.45 52.27 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.288 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -94.63 -4.23 48.08 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.633 ' NH2' ' HA ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -133.05 152.85 51.92 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.552 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.611 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.63 137.4 14.12 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.413 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.71 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.6 OUTLIER -86.49 144.55 27.2 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.029 0.932 . . . . 0.0 110.635 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -125.28 103.67 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 123.636 0.585 . . . . 0.0 110.046 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.884 HD11 HD13 ' A' ' 105' ' ' LEU . 15.5 tp -107.51 128.38 54.46 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.138 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -127.55 169.09 13.12 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.612 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.659 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.4 Cg_endo -97.25 15.2 0.75 Allowed 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.756 2.304 . . . . 0.0 113.818 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.4 t -102.77 159.91 15.06 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.668 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.76 22.47 37.7 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.636 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -89.4 153.01 21.19 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.56 0.344 . . . . 0.0 110.622 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.563 ' HA ' HG21 ' A' ' 99' ' ' THR . 13.6 m -130.31 156.65 44.32 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 112.196 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.569 ' CE2' HG23 ' A' ' 113' ' ' VAL . 46.4 m-85 -126.27 -150.59 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.844 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -56.78 -46.86 81.25 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.975 0.51 . . . . 0.0 111.633 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 m -134.5 82.25 1.96 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.86 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 107' ' ' MET . 30.4 m -130.1 124.51 32.92 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.229 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.71 123.54 47.22 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.844 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.21 129.22 34.9 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.081 0.467 . . . . 0.0 110.787 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.461 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.55 45.88 2.43 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.411 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.06 -105.87 1.33 Allowed Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.155 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.55 -10.67 3.65 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.884 HD13 HD11 ' A' ' 89' ' ' LEU . 2.2 pp -155.46 153.19 29.94 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 123.26 0.35 . . . . 0.0 111.392 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.623 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.39 156.2 29.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.716 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 99' ' ' THR . 18.6 ttm -122.52 130.58 53.19 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 m -131.52 130.86 42.9 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.8 p -120.36 18.63 12.17 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.549 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.746 ' O ' HG12 ' A' ' 113' ' ' VAL . 68.3 m -88.09 133.99 33.86 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.963 0.887 . . . . 0.0 112.694 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.633 ' HA ' ' NH2' ' A' ' 85' ' ' ARG . 2.7 mt-30 -62.7 -30.81 71.68 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.96 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.79 -40.31 95.02 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.735 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 110' ' ' SER . 3.5 p -70.46 -39.41 76.29 Favored 'Isoleucine or valine' 0 C--N 1.353 0.745 0 O-C-N 123.142 0.276 . . . . 0.0 110.502 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.618 HD22 ' NH2' ' A' ' 85' ' ' ARG . 4.2 tp -59.36 -46.54 88.36 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 123.471 0.482 . . . . 0.0 110.164 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.496 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 24.1 m-85 -67.22 -40.96 86.45 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 178.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -53.21 59.78 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.599 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.736 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.91 -43.57 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.527 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.483 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.33 -32.72 64.94 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.815 0.697 . . . . 0.0 109.59 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.53 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.89 -19.64 32.0 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.376 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.06 15.21 31.43 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.689 -1.141 . . . . 0.0 114.755 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 p -105.1 6.77 33.49 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.2 -137.35 8.99 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.481 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -81.62 172.6 12.2 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.046 2.497 . . . . 0.0 113.526 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.64 -55.16 37.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.695 0.798 . . . . 0.0 111.962 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.659 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.8 mmtt -141.76 139.74 32.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.656 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 36.6 p -139.02 167.82 21.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.0 tp -126.88 118.49 24.7 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.574 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.71 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.5 pt -98.46 102.18 13.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.575 0.703 . . . . 0.0 109.725 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.7 t -121.02 122.05 39.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.713 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.41 HD21 ' O ' ' A' ' 83' ' ' THR . 7.0 tp -67.33 118.03 10.14 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.464 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.86 173.24 5.63 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 114.763 -1.108 . . . . 0.0 114.524 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.41 175.5 8.46 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.179 0.514 . . . . 0.0 110.659 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -115.86 129.68 56.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.271 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.47 146.75 17.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.631 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -121.86 136.83 54.94 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.149 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.32 157.81 26.28 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.848 0.718 . . . . 0.0 110.786 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.23 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.51 -25.82 7.55 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.119 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -58.54 -44.22 89.52 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.885 0.474 . . . . 0.0 112.272 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.582 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.89 -47.58 65.5 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.16 0.287 . . . . 0.0 110.481 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.29 -29.55 68.9 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.014 0.435 . . . . 0.0 110.555 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.56 -49.91 49.79 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.84 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.32 -26.81 63.0 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.696 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.5 tp -74.55 -37.31 63.03 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.492 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.0 t -77.88 -29.83 50.51 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.712 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.0 t70 -84.11 1.15 45.54 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.072 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 52.63 33.98 14.85 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.841 1.256 . . . . 0.0 112.201 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 143' ' ' GLU . . . -81.53 -41.61 21.4 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.372 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -122.14 113.02 18.92 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.0 tp -83.92 136.18 34.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.5 p -101.13 136.91 40.22 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.967 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.674 ' SG ' HD11 ' A' ' 15' ' ' ILE . 26.2 p -150.79 154.98 35.42 Favored Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 123.458 0.474 . . . . 0.0 110.738 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.63 152.6 61.37 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.189 1.926 . . . . 0.0 110.989 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.492 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.93 167.45 17.41 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.74 134.22 21.9 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.943 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.87 -26.48 15.55 Favored 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 122.493 2.129 . . . . 0.0 113.434 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.14 -48.49 53.72 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 124.032 0.832 . . . . 0.0 111.441 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.586 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.7 mt -64.06 -34.87 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.371 0.668 . . . . 0.0 110.839 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -73.55 -35.62 65.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.281 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -83.66 -34.89 24.91 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 162' ' ' LEU . 2.2 p30 -86.81 -67.22 0.83 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.744 0.702 . . . . 0.0 112.729 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.67 ' C ' ' HD2' ' A' ' 164' ' ' PRO . 1.1 tp -145.73 98.98 4.44 Favored Pre-proline 0 C--N 1.344 0.333 0 CA-C-O 121.042 0.448 . . . . 0.0 111.786 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.83 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 65.7 Cg_endo -91.54 -0.14 4.56 Favored 'Trans proline' 0 CA--C 1.57 2.282 0 C-N-CA 121.795 1.663 . . . . 0.0 114.488 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.67 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 79.4 Cg_endo -74.67 -50.41 0.14 Allowed 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.76 2.307 . . . . 0.0 114.438 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.513 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 10.8 mt-10 -121.61 -33.98 3.51 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.705 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 6.0 mt-10 -68.6 -11.28 59.81 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.045 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.739 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.06 -41.7 41.32 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -69.82 -49.78 49.33 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.8 m -58.33 -49.05 78.58 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.682 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.67 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.39 -40.21 95.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.265 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.82 79.46 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 123.538 0.524 . . . . 0.0 110.489 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.69 88.27 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.466 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.25 -27.76 68.87 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.507 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.67 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.6 mmp_? -77.52 -40.03 44.12 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.899 0.479 . . . . 0.0 110.192 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -71.3 -31.29 67.26 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.461 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.806 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.911 179.603 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.736 ' HB3' ' ND1' ' A' ' 12' ' ' HIS . 14.2 mt . . . . . 0 C--O 1.239 0.504 0 CA-C-O 120.948 0.404 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.401 ' CG ' ' H ' ' A' ' 35' ' ' HIS . 75.0 mttt -89.53 26.77 1.63 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.95 0.405 . . . . 0.0 110.63 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 178.37 53.9 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.668 0.787 . . . . 0.0 109.979 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.736 ' ND1' ' HB3' ' A' ' 9' ' ' LEU . 6.9 p-80 -131.11 156.29 45.5 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.436 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 11.0 m-30 -98.68 133.72 42.61 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.843 0.354 . . . . 0.0 111.205 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 8.6 mt -106.58 140.98 38.59 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.299 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.21 131.19 73.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.25 132.84 38.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.885 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 55.5 mtt -121.46 156.6 57.93 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.191 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.85 75.83 4.61 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.629 2.219 . . . . 0.0 112.885 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -134.02 -21.99 1.84 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.787 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.57 -162.91 0.86 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.25 0.344 . . . . 0.0 110.382 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.536 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -101.79 32.94 3.19 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.1 m-20 -111.47 82.49 3.66 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.41 -24.17 12.45 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 123.034 2.489 . . . . 0.0 113.361 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -85.01 -37.81 19.96 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.953 0.501 . . . . 0.0 111.612 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.61 -3.4 57.57 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.791 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -60.83 1.93 0.13 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -141.33 39.37 1.74 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.191 0.519 . . . . 0.0 111.981 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.7 p -123.22 158.52 30.67 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.788 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.783 HG11 ' HE ' ' A' ' 167' ' ' ARG . 97.0 t -130.85 132.3 64.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.955 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -113.25 153.75 27.89 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.343 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.473 ' OH ' HD21 ' A' ' 105' ' ' LEU . 34.9 t80 -108.61 119.6 40.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.581 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.525 HD11 ' HB1' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -82.51 107.8 15.43 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 123.491 0.494 . . . . 0.0 111.295 -178.568 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.947 HG23 ' HA2' ' A' ' 42' ' ' GLY . 39.0 t -68.12 -60.65 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.203 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.515 ' OE1' HD11 ' A' ' 100' ' ' LEU . 12.8 tt0 -142.16 114.76 8.49 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.426 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.494 ' CE1' HD12 ' A' ' 9' ' ' LEU . 15.7 t-80 -96.75 129.78 44.11 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.9 151.54 47.03 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.068 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.39 -17.82 64.12 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -104.79 6.32 33.91 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.664 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.61 164.39 12.62 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 121.511 -0.376 . . . . 0.0 112.295 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -146.02 141.13 27.36 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.94 134.9 54.51 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.584 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.947 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.04 160.56 31.29 Favored Glycine 0 N--CA 1.449 -0.444 0 O-C-N 124.5 1.125 . . . . 0.0 112.573 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.5 mt -115.95 135.26 54.14 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.148 0.474 . . . . 0.0 111.503 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 78' ' ' GLY . 12.0 t -68.64 123.55 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.518 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.3 pt -126.83 56.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.679 0.752 . . . . 0.0 111.798 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.859 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -147.45 -4.17 0.53 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.42 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -129.7 88.21 50.21 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.504 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.2 Cg_exo -59.58 142.26 98.57 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.655 1.57 . . . . 0.0 112.151 175.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.419 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 43.7 m -91.43 159.48 15.94 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.346 0.404 . . . . 0.0 111.574 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.53 46.76 1.24 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.362 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.488 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.69 155.1 51.12 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.473 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 14.7 p-10 -105.79 161.08 14.73 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.889 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.668 HD13 HD13 ' A' ' 128' ' ' ILE . 13.5 tp -58.77 -37.85 77.21 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.59 -36.58 56.44 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 37.4 mt-10 -64.37 -43.04 95.75 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.171 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.868 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -62.77 -46.48 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.621 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.739 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.5 mp -54.01 -36.77 63.35 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.858 0.724 . . . . 0.0 110.788 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.93 -28.22 49.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.525 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -30.05 48.82 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.358 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.868 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.1 mt -77.75 -45.03 25.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.945 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -132.3 116.48 15.35 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.543 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.5 -32.75 2.74 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.566 2.844 . . . . 0.0 112.803 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.29 -14.17 55.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.426 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.89 149.93 24.46 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 123.38 0.425 . . . . 0.0 111.716 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.3 123.65 29.79 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.046 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 56.5 Cg_endo -74.17 145.42 34.92 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 122.271 1.981 . . . . 0.0 112.371 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.7 Cg_endo -92.58 -171.34 0.33 Allowed 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.561 2.174 . . . . 0.0 111.978 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.15 -24.79 68.05 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.215 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.566 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.3 ptp180 -66.22 -53.27 39.16 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.693 ' HA ' HD12 ' A' ' 73' ' ' ILE . 60.7 m -72.38 -25.0 61.34 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 51.3 mt-30 -67.11 -35.69 80.3 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -91.62 23.99 3.28 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.256 0.551 . . . . 0.0 111.689 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 70' ' ' CYS . 55.8 mt -120.42 138.97 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.573 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.62 154.79 20.92 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.768 0.668 . . . . 0.0 112.639 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.767 HD13 HD12 ' A' ' 128' ' ' ILE . 16.6 mm -102.74 152.57 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.207 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.717 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.5 t80 -119.27 152.75 36.14 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -83.45 120.59 26.09 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.899 0.318 . . . . 0.0 110.796 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.6 -23.66 8.22 Favored Glycine 0 C--N 1.348 1.206 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.984 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.6 -167.86 35.29 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.333 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -88.66 -11.51 4.0 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.511 2.807 . . . . 0.0 114.378 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -86.06 127.34 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 123.054 0.221 . . . . 0.0 111.266 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 46.04 84.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.528 1.131 . . . . 0.0 113.289 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 p -85.69 -4.41 59.16 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.072 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.91 -5.64 59.2 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.729 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.614 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.43 154.27 50.92 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.614 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.28 133.69 11.8 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.986 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.731 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.61 145.07 27.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.377 1.071 . . . . 0.0 110.426 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.28 103.94 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 123.414 0.446 . . . . 0.0 110.726 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.877 HD11 HD13 ' A' ' 105' ' ' LEU . 14.1 tp -106.75 128.29 54.09 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.727 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.405 ' CE1' ' HB3' ' A' ' 106' ' ' ALA . 3.6 p80 -125.51 166.42 21.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-O 118.937 -0.554 . . . . 0.0 112.048 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.5 Cg_endo -96.16 14.84 0.97 Allowed 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.663 2.242 . . . . 0.0 113.59 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.8 t -101.93 160.84 14.14 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.808 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.65 19.42 54.77 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.794 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mp -85.62 154.1 21.93 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.481 0.312 . . . . 0.0 111.057 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 p -127.07 156.86 41.02 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.57 ' CE2' HG23 ' A' ' 113' ' ' VAL . 51.4 m-85 -129.8 -152.57 0.52 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.821 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -57.27 -46.43 83.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.847 0.459 . . . . 0.0 111.721 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.7 m -136.27 81.67 1.9 Allowed 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.209 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 107' ' ' MET . 11.3 m -129.33 126.84 39.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.691 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.515 HD11 ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -105.68 123.26 47.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.743 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -82.89 128.81 34.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.53 . . . . 0.0 110.763 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.476 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.54 46.69 2.25 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.337 -179.367 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.47 -107.95 2.2 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.04 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -61.22 -9.24 4.59 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.877 HD13 HD11 ' A' ' 89' ' ' LEU . 2.6 pp -154.29 152.39 30.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.41 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.641 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.14 156.74 28.17 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.706 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.568 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.8 ttm -121.45 127.21 50.88 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.712 ' HB3' HG11 ' A' ' 113' ' ' VAL . 20.2 m -123.84 129.47 51.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.182 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 58.7 p -119.57 15.12 12.81 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.71 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.741 ' O ' HG12 ' A' ' 113' ' ' VAL . 61.8 m -87.76 129.71 35.08 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.358 0.599 . . . . 0.0 111.872 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.483 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.6 pt20 -61.55 -29.4 69.99 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.158 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -64.98 -42.86 94.17 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.627 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 110' ' ' SER . 4.2 p -67.75 -38.17 79.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 O-C-N 123.171 0.294 . . . . 0.0 110.291 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.603 HD22 ' NH2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -59.13 -48.99 79.58 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 123.572 0.545 . . . . 0.0 110.323 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.483 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 32.0 m-85 -69.12 -37.52 78.39 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.995 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.04 -51.7 66.93 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.085 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.81 -43.44 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.257 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.1 -31.68 65.52 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 123.734 0.646 . . . . 0.0 109.544 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.566 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.74 -20.08 31.65 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.233 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.05 15.1 31.76 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.689 -1.141 . . . . 0.0 114.67 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.5 p -105.8 8.16 32.68 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.3 -138.49 9.91 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.203 -0.776 . . . . 0.0 112.774 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.9 172.11 13.49 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.283 2.656 . . . . 0.0 113.87 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.49 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -52.05 -57.23 10.16 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.417 1.087 . . . . 0.0 111.624 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.549 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -139.6 152.91 47.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.811 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.5 m -147.34 164.21 33.98 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.79 117.81 22.57 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.449 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.767 HD12 HD13 ' A' ' 75' ' ' ILE . 12.7 pt -98.44 102.35 13.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 121.842 0.83 . . . . 0.0 109.833 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 7.2 t -118.94 122.27 41.87 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.727 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -66.95 115.21 6.43 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.109 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.01 174.15 5.25 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.694 -1.139 . . . . 0.0 114.355 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -128.64 179.9 5.43 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.251 0.548 . . . . 0.0 110.842 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -117.43 130.49 56.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.215 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.86 139.56 11.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.757 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.402 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 32.6 m-90 -113.88 135.01 54.44 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.934 0.432 . . . . 0.0 110.151 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.62 158.03 25.8 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.887 0.742 . . . . 0.0 110.501 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.91 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 122.26 -26.11 6.48 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.015 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.71 -45.07 86.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.32 -47.93 66.22 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.156 0.285 . . . . 0.0 110.502 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.62 -28.54 68.62 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.411 0.445 . . . . 0.0 110.729 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.53 -51.13 30.83 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.74 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -69.47 -26.49 64.59 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.7 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.2 tp -75.37 -39.34 59.32 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.873 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.6 m -77.75 -28.46 50.72 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.532 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.8 t70 -82.93 0.55 43.92 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.438 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 59.31 28.89 18.35 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.777 0.831 . . . . 0.0 111.7 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.93 -43.4 19.82 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.304 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -125.69 118.07 24.83 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 4.8 tp -87.97 150.88 23.19 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.484 0.183 . . . . 0.0 111.357 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.54 HG22 ' NE2' ' A' ' 12' ' ' HIS . 80.8 p -111.25 137.11 49.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.792 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 78.6 m -149.86 154.5 37.36 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 123.315 0.384 . . . . 0.0 111.357 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.37 148.37 86.91 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.555 2.17 . . . . 0.0 110.993 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.436 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -123.21 166.92 14.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -135.53 134.53 21.09 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.929 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.46 -26.38 17.02 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.604 2.202 . . . . 0.0 113.542 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.91 -40.12 63.29 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.862 0.726 . . . . 0.0 112.116 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.578 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.8 mt -71.75 -35.66 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 121.382 0.611 . . . . 0.0 110.277 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.5 tt -73.65 -37.72 65.21 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.455 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -85.3 -34.71 21.82 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -84.92 -72.58 0.47 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 117.967 0.349 . . . . 0.0 111.627 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.897 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.28 98.97 6.56 Favored Pre-proline 0 C--N 1.348 0.529 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.859 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 66.3 Cg_endo -92.19 -0.05 4.15 Favored 'Trans proline' 0 CA--C 1.569 2.269 0 C-N-CA 121.702 1.601 . . . . 0.0 114.226 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.634 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 77.4 Cg_endo -74.03 -52.5 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.899 0 C-N-CA 122.605 2.204 . . . . 0.0 114.389 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.516 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.3 mt-10 -122.43 -29.92 4.03 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.707 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.897 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.9 tt0 -70.09 -10.89 60.21 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.37 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.783 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.83 -39.62 50.64 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.231 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.9 tt -72.64 -49.98 28.21 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.1 m -58.0 -47.96 81.47 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.508 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.671 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.96 -39.9 90.82 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.17 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.32 79.94 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 123.393 0.433 . . . . 0.0 110.594 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.23 -38.49 90.55 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.523 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.29 -28.55 69.79 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.601 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.86 -40.45 40.05 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 122.905 0.482 . . . . 0.0 110.35 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.98 -33.24 74.26 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.533 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.789 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.108 179.429 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.6 mt . . . . . 0 N--CA 1.47 0.538 0 CA-C-O 121.046 0.451 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -89.92 16.03 8.9 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.441 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 173.94 54.86 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.967 0.907 . . . . 0.0 110.518 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -133.14 163.58 28.96 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.303 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -100.69 140.73 34.55 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.242 0.544 . . . . 0.0 112.258 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.6 mp -111.75 137.49 49.59 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.185 -1.371 . . . . 0.0 109.807 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.511 HD12 ' O ' ' A' ' 150' ' ' LEU . 2.9 mp -119.98 136.2 57.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.81 127.21 32.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.117 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 33.1 mtt -110.79 157.88 37.26 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.196 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.12 29.36 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.577 2.184 . . . . 0.0 113.127 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -85.81 -17.62 35.2 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -167.76 1.26 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.088 0.242 . . . . 0.0 110.598 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.42 40.9 1.39 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.036 0.446 . . . . 0.0 111.732 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -111.92 80.69 3.18 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.844 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.5 Cg_exo -75.55 -23.06 13.27 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.036 2.491 . . . . 0.0 113.28 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -84.53 -34.96 23.18 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.916 0.487 . . . . 0.0 111.708 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.63 3.82 53.09 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.077 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.12 163.18 20.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.767 0.318 . . . . 0.0 111.807 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 49.69 32.32 5.05 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.9 p -118.22 154.82 31.59 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 122.395 -0.191 . . . . 0.0 110.508 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.685 HG11 ' HE ' ' A' ' 167' ' ' ARG . 68.7 t -128.54 134.7 64.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-O 121.416 0.627 . . . . 0.0 110.789 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.8 m -116.11 151.95 34.61 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.658 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.472 ' OH ' HD21 ' A' ' 105' ' ' LEU . 12.8 t80 -105.32 118.88 37.69 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.608 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -82.72 107.84 15.65 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.365 0.602 . . . . 0.0 110.065 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.951 HG23 ' HA2' ' A' ' 42' ' ' GLY . 23.5 t -71.87 -59.6 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.76 -178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -137.25 119.23 15.33 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.51 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -103.94 126.2 50.89 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -139.94 153.2 46.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.577 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.23 -18.34 65.23 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.522 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -98.31 -3.55 36.94 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.391 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.0 171.48 21.75 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 121.564 -0.35 . . . . 0.0 112.29 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -146.67 144.43 29.47 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.42 137.2 54.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.747 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.951 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.82 158.44 29.69 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.858 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.4 mt -115.6 134.67 54.82 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.952 0.376 . . . . 0.0 111.287 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 78' ' ' GLY . 6.1 t -68.75 121.73 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.27 54.71 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.586 0.707 . . . . 0.0 112.221 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.846 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -148.7 -1.55 0.51 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.104 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -129.75 85.51 57.97 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.535 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.2 Cg_exo -60.55 144.79 99.56 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 121.74 1.627 . . . . 0.0 112.582 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.432 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.6 m -94.41 153.77 17.79 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.075 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.82 51.9 1.97 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.851 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mt -134.07 160.27 38.27 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.903 0.413 . . . . 0.0 110.28 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.3 p-10 -112.1 157.37 20.89 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.63 HD23 ' SG ' ' A' ' 70' ' ' CYS . 12.4 tp -58.02 -36.13 72.26 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.04 -39.27 66.06 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -63.48 -41.08 98.58 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.678 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.857 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.8 t -61.53 -50.29 80.94 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.669 ' HA ' HD12 ' A' ' 60' ' ' LEU . 5.0 mp -52.44 -36.39 54.38 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 123.975 0.797 . . . . 0.0 110.995 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.13 -28.53 48.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.489 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.436 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -78.44 -31.8 48.2 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.457 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.857 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.1 mt -77.5 -45.04 26.77 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.0 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -132.11 116.88 15.69 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.412 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.5 -33.11 2.56 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 123.65 2.9 . . . . 0.0 112.807 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.16 -14.02 56.28 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.462 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.3 149.81 24.29 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.33 0.394 . . . . 0.0 111.737 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.77 123.43 29.7 Favored Pre-proline 0 C--O 1.235 0.333 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.038 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 58.0 Cg_endo -74.88 145.34 31.81 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.217 1.944 . . . . 0.0 112.462 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.8 Cg_endo -92.15 -169.34 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.612 2.208 . . . . 0.0 111.895 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.89 -24.89 67.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.12 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -66.63 -51.56 54.92 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.701 ' HA ' HD12 ' A' ' 73' ' ' ILE . 59.6 m -72.74 -25.05 61.06 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 47.8 mt-30 -68.16 -35.3 77.85 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -90.92 22.98 3.35 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.099 0.476 . . . . 0.0 111.718 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 70' ' ' CYS . 61.2 mt -119.84 139.02 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.464 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.426 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.9 m-20 -104.65 156.71 17.74 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.854 0.721 . . . . 0.0 112.564 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 53' ' ' LEU . 28.8 mm -102.84 155.38 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.432 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.8 t80 -124.84 155.83 38.81 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -88.37 122.69 32.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 119.691 -0.195 . . . . 0.0 110.512 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -101.87 -23.68 9.12 Favored Glycine 0 C--N 1.351 1.413 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.793 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.77 -167.31 35.25 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.086 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -87.11 -10.56 5.71 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 123.266 2.644 . . . . 0.0 113.84 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.653 ' O ' ' HA3' ' A' ' 131' ' ' GLY . 4.1 t -86.19 126.74 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.178 0.299 . . . . 0.0 110.383 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 43.78 87.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.292 1.037 . . . . 0.0 113.099 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.583 ' O ' HD22 ' A' ' 130' ' ' LEU . 76.9 p -86.04 -12.44 50.2 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.306 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -84.94 0.26 51.86 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -132.7 153.57 51.02 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.96 126.0 7.97 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.35 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.643 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 0.2 OUTLIER -85.77 145.74 27.1 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.86 1.264 . . . . 0.0 109.92 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 t -121.57 103.53 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.741 0.305 . . . . 0.0 110.824 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 126' ' ' SER . 2.2 tt -99.43 126.76 45.39 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.477 ' CE1' ' HB3' ' A' ' 106' ' ' ALA . 3.9 p80 -131.86 164.11 45.27 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-O 118.93 -0.557 . . . . 0.0 112.193 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.2 Cg_endo -96.9 9.84 1.31 Allowed 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 122.733 2.289 . . . . 0.0 113.945 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.48 ' OG ' HD23 ' A' ' 94' ' ' LEU . 8.7 t -94.35 158.98 15.32 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.976 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.12 19.06 56.03 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.789 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.48 HD23 ' OG ' ' A' ' 92' ' ' SER . 4.6 mm? -86.8 154.24 21.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.431 0.292 . . . . 0.0 110.77 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 p -123.02 155.36 37.0 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.552 ' CE2' HG23 ' A' ' 113' ' ' VAL . 62.2 m-85 -130.57 -152.79 0.53 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.344 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -58.6 -47.24 84.97 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.896 0.316 . . . . 0.0 111.446 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 56.2 m -134.3 85.19 2.17 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.488 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 107' ' ' MET . 8.1 m -130.78 128.75 41.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.922 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.41 124.38 50.3 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.427 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.63 128.19 34.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.237 0.541 . . . . 0.0 111.172 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.458 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -121.48 47.2 1.9 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.214 -179.621 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.88 -106.81 1.69 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-N 114.706 -1.134 . . . . 0.0 113.081 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.38 -9.93 4.18 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.472 HD21 ' OH ' ' A' ' 31' ' ' TYR . 3.5 pp -156.27 160.44 39.76 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.53 0.332 . . . . 0.0 111.252 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.477 ' HB3' ' CE1' ' A' ' 90' ' ' HIS . . . -123.38 162.59 22.47 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 123.625 0.578 . . . . 0.0 110.526 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.643 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 22.4 ttm -123.6 130.18 52.27 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.676 ' HB3' HG11 ' A' ' 113' ' ' VAL . 47.6 m -124.7 127.94 48.04 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 120.844 0.354 . . . . 0.0 110.21 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.4 p -117.21 20.15 13.84 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.466 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.82 ' O ' HG12 ' A' ' 113' ' ' VAL . 43.1 p -98.18 127.75 44.29 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 122.011 0.91 . . . . 0.0 112.03 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.495 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 2.3 mt-30 -61.59 -25.96 67.67 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.314 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -64.54 -42.41 95.73 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.104 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.82 HG12 ' O ' ' A' ' 110' ' ' SER . 5.2 p -69.02 -38.18 78.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.98 -47.67 80.23 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 123.732 0.645 . . . . 0.0 110.303 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.495 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 28.2 m-85 -69.61 -39.8 77.02 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.068 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.3 -51.37 69.18 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.146 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.44 -43.31 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.123 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.49 -30.89 65.46 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.792 0.682 . . . . 0.0 109.731 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.56 -19.73 30.66 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.16 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.15 17.77 26.32 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.682 -1.145 . . . . 0.0 114.558 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.5 p -109.49 9.93 25.32 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.88 -138.5 9.5 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-O 119.374 -0.681 . . . . 0.0 113.038 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.26 173.08 12.92 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.338 2.692 . . . . 0.0 113.793 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.491 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -52.13 -56.64 13.19 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.258 1.023 . . . . 0.0 111.27 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -139.34 154.38 47.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.509 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.5 m -150.03 162.81 39.67 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.4 tp -129.93 115.79 17.7 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.872 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 16.4 pt -95.67 102.5 13.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-O 121.807 0.813 . . . . 0.0 109.242 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 59.7 p -125.07 130.65 52.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.263 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.583 HD22 ' O ' ' A' ' 83' ' ' THR . 16.2 mt -67.03 118.22 10.17 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.031 0.444 . . . . 0.0 111.372 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 81' ' ' VAL . . . 55.93 -172.86 1.53 Allowed Glycine 0 C--N 1.343 0.934 0 CA-C-N 114.232 -1.349 . . . . 0.0 115.012 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -128.53 -176.0 3.69 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.641 0.734 . . . . 0.0 111.358 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -119.39 130.38 55.28 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 113.866 -1.516 . . . . 0.0 108.367 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.37 152.3 19.12 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.667 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -129.88 136.92 50.08 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 124.011 0.477 . . . . 0.0 110.169 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.15 158.44 27.72 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.93 0.769 . . . . 0.0 110.631 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.47 89.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.96 -22.28 9.18 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.356 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -56.99 -47.44 80.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.985 0.514 . . . . 0.0 112.162 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.583 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.6 tp -66.89 -47.89 70.44 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.18 -29.95 64.1 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.43 0.456 . . . . 0.0 110.895 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.92 -49.32 47.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.042 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.6 pt-20 -72.45 -26.71 61.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.681 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 4.6 tp -75.43 -38.44 59.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.822 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.2 t -78.23 -30.44 48.78 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.286 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.5 t70 -80.3 0.92 30.8 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.604 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 60.79 28.33 18.08 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.981 0.912 . . . . 0.0 111.813 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.81 -42.53 19.56 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.639 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -123.55 111.14 15.91 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.938 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 15' ' ' ILE . 6.0 tp -85.31 130.82 34.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.67 0.272 . . . . 0.0 111.484 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.2 p -104.64 141.98 35.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.862 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.9 m -154.91 157.11 31.91 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.83 146.77 96.97 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.242 1.962 . . . . 0.0 111.188 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -131.66 175.86 8.82 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -133.18 139.93 35.78 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.278 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.73 -26.62 11.31 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 122.771 2.314 . . . . 0.0 114.015 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -49.98 -43.13 50.18 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.809 0.693 . . . . 0.0 112.355 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.692 HD13 HH12 ' A' ' 167' ' ' ARG . 4.7 mt -67.71 -32.88 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 121.504 0.669 . . . . 0.0 110.318 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.1 tt -75.29 -41.23 57.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.673 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.68 -24.39 25.25 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -90.18 -72.02 0.59 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.313 0.506 . . . . 0.0 110.944 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.878 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.09 98.58 6.15 Favored Pre-proline 0 C--N 1.348 0.538 0 CA-C-O 121.078 0.466 . . . . 0.0 112.171 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.846 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 64.8 Cg_endo -91.39 -0.17 4.66 Favored 'Trans proline' 0 CA--C 1.57 2.321 0 C-N-CA 121.691 1.594 . . . . 0.0 114.266 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.659 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 83.6 Cg_endo -74.14 -54.14 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.627 2.218 . . . . 0.0 114.554 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.553 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -121.74 -29.39 4.35 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.783 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.878 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.07 -12.24 61.46 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.321 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.692 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.1 -44.12 40.21 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.318 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -68.97 -50.37 49.67 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -57.61 -50.55 72.76 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.773 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 174' ' ' ARG . . . -61.68 -40.39 94.8 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.154 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.11 -46.38 82.66 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.625 0.578 . . . . 0.0 110.489 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.53 87.72 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.477 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.55 69.71 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.31 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 170' ' ' ALA . 7.9 mtm105 -77.16 -41.09 43.1 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.196 0.598 . . . . 0.0 110.893 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.7 tp -71.28 -29.86 65.57 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.542 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.789 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.797 179.597 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.7 mt . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 120.772 0.32 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -90.8 19.5 5.46 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 120.772 0.32 . . . . 0.0 111.349 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 15.8 p80 174.51 57.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.025 0.93 . . . . 0.0 110.174 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -135.13 159.57 41.11 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.859 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.479 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.8 m-30 -96.96 138.0 35.17 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.147 0.499 . . . . 0.0 112.29 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.681 HD11 HD23 ' A' ' 32' ' ' LEU . 1.7 mp -111.97 133.36 54.2 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.198 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.45 HG23 HG22 ' A' ' 29' ' ' VAL . 2.6 mp -119.02 133.12 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.56 122.8 19.77 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.036 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.9 mmt -103.83 160.46 26.01 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.262 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.31 20.6 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.713 2.276 . . . . 0.0 113.659 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -81.24 -14.94 56.93 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.581 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -113.53 160.8 18.12 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.606 0.363 . . . . 0.0 110.238 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.45 52.84 2.54 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.419 0.628 . . . . 0.0 112.084 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.581 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.2 m-20 -128.12 87.47 55.39 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.528 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.03 -13.92 21.21 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.924 2.416 . . . . 0.0 113.558 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -85.08 -38.27 19.32 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.388 0.43 . . . . 0.0 111.534 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -98.26 -1.36 42.07 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.606 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -63.65 2.52 0.44 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -139.57 42.3 2.02 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.276 0.56 . . . . 0.0 112.071 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.4 p -125.39 154.06 42.48 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.588 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.72 HG11 ' HE ' ' A' ' 167' ' ' ARG . 25.2 t -130.56 133.65 63.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.742 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -115.85 152.43 33.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.585 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.5 ' OH ' HD21 ' A' ' 105' ' ' LEU . 41.8 t80 -106.58 120.79 42.87 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.681 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -84.24 108.98 17.42 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.079 0.466 . . . . 0.0 111.043 -178.356 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.945 HG23 ' HA2' ' A' ' 42' ' ' GLY . 35.3 t -66.8 -60.18 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.732 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -144.66 115.54 7.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.304 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -97.78 128.22 44.27 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.45 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -139.58 153.3 47.36 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.69 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.55 -18.62 65.46 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.601 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.66 4.4 43.21 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.392 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.17 165.37 12.81 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.229 -0.349 . . . . 0.0 112.229 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.61 139.4 29.63 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.527 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -121.1 136.98 54.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.959 178.714 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.945 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.05 157.52 28.57 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 124.372 1.045 . . . . 0.0 112.465 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.2 mt -112.26 134.9 53.53 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.206 0.503 . . . . 0.0 110.957 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 78' ' ' GLY . 11.9 t -69.83 123.41 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.72 56.28 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.666 0.746 . . . . 0.0 112.117 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.85 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -147.41 -2.45 0.59 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.115 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -130.27 88.52 47.57 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.498 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 47.5 Cg_exo -58.29 141.87 97.1 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 121.533 1.489 . . . . 0.0 111.86 174.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.412 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 8.9 t -77.79 -39.51 43.71 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.62 -8.7 74.28 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.873 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 5.7 mt -81.43 170.27 16.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.706 0.402 . . . . 0.0 110.161 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.646 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.9 p-10 -112.79 156.28 23.14 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.783 HD12 HD13 ' A' ' 128' ' ' ILE . 1.6 tt -57.69 -26.69 62.08 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 123.478 0.486 . . . . 0.0 111.992 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.08 99.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.959 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.521 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 34.1 mt-10 -63.01 -46.79 85.96 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.139 0.275 . . . . 0.0 111.586 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.872 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 20.5 m -62.0 -44.06 98.43 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.715 ' HA ' HD12 ' A' ' 60' ' ' LEU . 13.6 mt -56.66 -34.89 67.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.639 176.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.01 -27.64 48.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.327 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.402 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.93 -30.9 50.71 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.308 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.872 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.0 mt -77.83 -45.47 24.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.243 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -131.32 116.23 16.42 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.643 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -77.76 -32.73 2.57 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.637 2.891 . . . . 0.0 112.791 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.95 -14.52 55.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.374 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.98 149.5 24.73 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.382 0.426 . . . . 0.0 111.667 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.74 122.91 30.19 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.239 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.5 149.55 34.89 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.277 1.985 . . . . 0.0 112.374 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 8.2 Cg_endo -94.59 -167.53 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.631 2.22 . . . . 0.0 112.56 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.94 -24.57 64.29 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.288 0.635 . . . . 0.0 112.095 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.443 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 11.6 ptp180 -67.9 -48.21 66.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.711 ' HA ' HD12 ' A' ' 73' ' ' ILE . 24.5 m -72.58 -26.13 61.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.169 0.587 . . . . 0.0 112.338 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.449 ' HA ' HD22 ' A' ' 52' ' ' ASN . 43.4 mt-30 -70.86 -27.54 63.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.674 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -95.39 16.72 16.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.61 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 70' ' ' CYS . 53.9 mt -120.07 139.41 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.666 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 1.8 m-20 -104.92 155.64 18.76 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.804 HD13 HD12 ' A' ' 128' ' ' ILE . 22.9 mm -107.17 150.45 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.206 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.734 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -119.2 157.08 28.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.588 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -87.98 122.2 31.3 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.0 -23.6 9.09 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 120.263 -0.97 . . . . 0.0 114.257 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.91 -167.81 34.87 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.289 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -88.75 -11.67 3.86 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.635 2.89 . . . . 0.0 114.421 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.09 131.85 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.569 0.223 . . . . 0.0 111.375 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 45.18 89.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.632 1.173 . . . . 0.0 113.503 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -87.02 1.04 54.15 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.378 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -92.7 -18.31 23.14 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.629 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -133.17 147.44 52.06 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.373 0.421 . . . . 0.0 111.441 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.601 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -113.34 151.01 18.44 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.149 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.404 ' CE2' ' SD ' ' A' ' 107' ' ' MET . 1.2 m-85 -86.66 151.33 23.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.951 -1.124 . . . . 0.0 110.829 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 3.6 t -127.76 107.99 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.087 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.898 HD11 HD13 ' A' ' 105' ' ' LEU . 13.8 tp -104.93 127.74 52.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.619 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.405 ' ND1' ' HB3' ' A' ' 123' ' ' PRO . 3.4 p80 -124.37 162.18 43.59 Favored Pre-proline 0 CA--C 1.552 1.022 0 O-C-N 123.653 0.596 . . . . 0.0 111.59 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.0 Cg_endo -97.42 28.89 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.802 2.334 . . . . 0.0 113.579 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.0 t -115.69 156.73 25.39 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.63 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.74 23.18 35.31 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.817 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.01 153.17 21.49 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.472 0.309 . . . . 0.0 110.523 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.7 p -121.55 153.25 38.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.664 ' CD2' HG12 ' A' ' 113' ' ' VAL . 28.5 m-85 -132.89 -151.13 0.44 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.834 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -61.02 -48.69 80.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.791 0.436 . . . . 0.0 111.267 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 108' ' ' SER . 38.3 m -134.01 79.05 1.79 Allowed 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.243 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.3 m -126.72 115.95 20.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.956 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.49 122.18 42.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.859 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.97 128.45 34.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.095 0.474 . . . . 0.0 111.15 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.449 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.63 46.76 2.15 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.482 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.93 -107.6 2.02 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 114.819 -1.082 . . . . 0.0 113.25 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.88 -10.28 3.83 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.898 HD13 HD11 ' A' ' 89' ' ' LEU . 1.8 pp -155.06 153.15 30.46 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.335 0.397 . . . . 0.0 111.167 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.558 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -117.17 158.05 24.92 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.884 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.594 ' O ' ' HA ' ' A' ' 99' ' ' THR . 16.0 ttm -122.52 135.17 54.58 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 98' ' ' SER . 15.9 m -136.18 134.35 38.11 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 81.1 p -125.42 21.36 7.89 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.64 0.587 . . . . 0.0 111.836 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.877 ' O ' HG22 ' A' ' 113' ' ' VAL . 51.6 m -91.12 131.63 36.56 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.944 0.878 . . . . 0.0 112.885 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.614 ' HA ' HD12 ' A' ' 114' ' ' LEU . 5.2 mt-30 -61.91 -26.16 68.0 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.419 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.39 -45.45 90.99 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.493 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 110' ' ' SER . 18.6 m -62.28 -43.46 98.04 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.614 HD12 ' HA ' ' A' ' 111' ' ' GLN . 29.3 mt -54.82 -51.48 65.7 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.864 0.727 . . . . 0.0 112.177 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.471 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 43.2 m-85 -65.63 -45.64 82.28 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.4 -52.7 64.49 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.865 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.841 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.4 tp -64.22 -43.91 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.45 -31.18 65.67 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.793 0.683 . . . . 0.0 109.683 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.443 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -85.3 -20.43 30.03 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.156 176.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.26 18.01 22.96 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.731 -1.122 . . . . 0.0 114.581 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.2 p -109.42 7.83 25.11 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.25 -137.51 9.37 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.583 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.405 ' HB3' ' ND1' ' A' ' 90' ' ' HIS . 5.9 Cg_exo -79.82 168.11 19.63 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.251 2.634 . . . . 0.0 113.519 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.484 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -50.94 -57.79 7.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.31 1.044 . . . . 0.0 111.789 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.486 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.7 mmtt -138.48 157.27 46.52 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.619 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 40.8 m -149.99 162.89 39.48 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.9 tp -126.41 113.96 17.57 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.744 177.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.804 HD12 HD13 ' A' ' 75' ' ' ILE . 10.1 pt -98.81 104.59 16.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.492 0.663 . . . . 0.0 109.507 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.3 t -125.0 124.88 42.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.508 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.608 ' O ' HD12 ' A' ' 130' ' ' LEU . 2.1 pp -67.12 117.2 8.82 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.095 0.474 . . . . 0.0 111.738 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.99 174.69 4.4 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.259 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -128.47 -179.87 5.28 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.334 0.588 . . . . 0.0 111.027 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -116.31 130.63 56.87 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.227 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.55 153.01 19.75 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.488 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -134.17 137.87 44.76 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.84 0.377 . . . . 0.0 110.666 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -78.1 158.36 29.16 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.904 0.753 . . . . 0.0 110.822 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.79 92.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.28 7.72 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.134 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -56.01 -47.38 77.89 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.082 0.553 . . . . 0.0 112.125 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.58 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 16.3 tp -67.51 -46.45 72.85 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.31 -30.54 64.85 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.443 0.465 . . . . 0.0 110.693 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -71.06 -49.33 45.91 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.013 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -72.1 -26.76 62.26 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.749 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.1 tp -75.3 -38.73 60.16 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.84 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.6 m -78.03 -29.91 49.65 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.355 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.17 0.17 33.48 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.533 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 61.29 29.37 18.6 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.89 0.876 . . . . 0.0 111.712 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.94 -41.91 16.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.516 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.404 ' HE1' ' CE ' ' A' ' 20' ' ' MET . 13.2 m95 -122.9 109.62 14.38 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.328 0.393 . . . . 0.0 110.113 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.01 128.46 34.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.387 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.1 p -102.33 141.81 34.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.039 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 80.2 m -155.37 158.6 31.97 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.315 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -57.44 153.93 38.45 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.215 1.943 . . . . 0.0 111.429 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.479 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.33 169.2 14.51 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -177.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -134.93 135.06 22.39 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 114.264 -1.334 . . . . 0.0 107.934 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.77 -26.59 13.37 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.64 2.226 . . . . 0.0 113.907 -177.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -51.95 -40.64 61.16 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.874 0.734 . . . . 0.0 112.284 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.573 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.6 mt -71.42 -34.49 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 121.378 0.609 . . . . 0.0 110.328 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.22 -38.47 63.54 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.253 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -84.25 -33.86 23.97 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -85.63 -72.67 0.48 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.026 0.375 . . . . 0.0 111.69 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.892 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.35 99.22 6.48 Favored Pre-proline 0 C--N 1.348 0.54 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.85 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.3 Cg_endo -92.02 -0.03 4.26 Favored 'Trans proline' 0 CA--C 1.57 2.301 0 C-N-CA 121.677 1.585 . . . . 0.0 114.26 175.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.644 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 88.0 Cg_endo -73.85 -52.55 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 122.63 2.22 . . . . 0.0 114.388 -178.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.518 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.61 -30.37 3.91 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.694 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.892 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -69.73 -11.14 60.62 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.303 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.72 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.54 -42.95 41.22 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.255 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -69.18 -50.68 45.37 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.2 m -57.76 -50.7 72.35 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.734 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.646 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -62.85 -38.57 91.36 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.07 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.27 -45.43 80.11 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.664 0.602 . . . . 0.0 110.441 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.45 91.04 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.552 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.36 -29.12 70.2 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.667 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.99 -40.19 39.95 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 122.865 0.466 . . . . 0.0 110.423 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.14 -34.02 76.67 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.485 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.771 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.272 179.477 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.668 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 7.0 mp . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -41.98 9.45 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.612 ' N ' ' O ' ' A' ' 9' ' ' LEU . 13.0 p-80 177.02 52.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.144 0.978 . . . . 0.0 110.513 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -141.82 166.08 25.7 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.759 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 30' ' ' THR . 14.2 m-30 -104.54 138.54 40.74 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 6.4 mt -107.19 143.38 35.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.405 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 mp -123.47 137.71 55.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.462 0.476 . . . . 0.0 110.128 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.47 123.48 26.61 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.837 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 mmt -106.32 157.09 35.75 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.202 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.6 30.58 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.678 2.252 . . . . 0.0 113.248 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -87.32 -15.56 37.65 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.93 -168.35 1.41 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 123.075 0.234 . . . . 0.0 110.703 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.541 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.82 41.87 1.28 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.082 0.468 . . . . 0.0 111.628 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -111.32 81.05 2.78 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.916 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.3 Cg_exo -75.49 -22.24 14.18 Favored 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 123.017 2.478 . . . . 0.0 113.312 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -84.62 -36.3 22.11 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.875 0.47 . . . . 0.0 111.867 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.8 3.72 53.64 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.021 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.42 163.77 20.16 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 48.75 32.15 3.47 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.2 p -116.68 154.27 30.87 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 122.367 -0.208 . . . . 0.0 110.573 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.739 HG11 ' HE ' ' A' ' 167' ' ' ARG . 60.3 t -129.05 132.69 67.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-O 121.515 0.674 . . . . 0.0 110.857 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.2 m -114.48 154.39 28.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.691 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.461 ' OH ' HD11 ' A' ' 105' ' ' LEU . 13.2 t80 -110.22 115.7 30.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.668 ' HB3' ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -81.08 110.63 16.79 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.684 0.754 . . . . 0.0 110.566 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.975 HG23 ' HA2' ' A' ' 42' ' ' GLY . 32.2 t -71.18 -63.93 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 112.819 -1.991 . . . . 0.0 110.614 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.426 ' OE1' HD11 ' A' ' 100' ' ' LEU . 12.3 tt0 -132.51 117.63 18.24 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.96 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -106.92 127.91 53.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.733 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -138.9 153.45 48.27 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.22 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -64.82 -15.63 62.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -104.88 5.41 32.93 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.687 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.6 164.72 12.64 Favored Glycine 0 C--N 1.344 1.015 0 C-N-CA 121.486 -0.388 . . . . 0.0 112.35 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.645 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -144.73 146.46 32.19 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.482 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -125.97 137.58 53.69 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.954 178.001 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.975 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.72 159.95 30.66 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.83 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.436 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.4 mt -114.62 130.66 56.81 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.703 0.252 . . . . 0.0 110.837 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 78' ' ' GLY . 20.7 t -65.96 125.39 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -128.44 55.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.542 0.686 . . . . 0.0 112.408 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.842 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.1 t30 -147.63 -3.61 0.53 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.265 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -129.78 87.84 51.05 Favored Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.51 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 35.3 Cg_exo -59.09 141.91 98.73 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 121.578 1.518 . . . . 0.0 112.277 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 59.9 m -88.64 161.96 16.59 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.364 0.415 . . . . 0.0 111.561 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.96 44.69 1.43 Allowed Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.37 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.463 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.97 150.95 50.44 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.1 p-10 -100.52 161.4 13.62 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.268 0.355 . . . . 0.0 110.939 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.678 ' HA ' HD11 ' A' ' 75' ' ' ILE . 12.3 tp -58.7 -37.58 76.4 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.16 -37.14 53.64 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.96 -43.68 95.05 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.206 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.859 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 1.3 t -62.8 -45.77 98.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.742 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.5 mp -54.55 -36.51 64.4 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.702 0.626 . . . . 0.0 110.618 177.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.9 -27.86 49.65 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.466 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.16 -30.14 49.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.283 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.859 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.9 mt -77.75 -45.12 25.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.945 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -132.26 116.24 15.32 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.524 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.62 -32.64 2.71 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.604 2.869 . . . . 0.0 112.769 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.3 -14.15 55.84 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.361 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.86 149.68 24.65 Favored 'General case' 0 C--N 1.345 0.389 0 O-C-N 123.323 0.389 . . . . 0.0 111.754 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.65 123.88 29.98 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.02 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 55.4 Cg_endo -73.82 144.68 35.25 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.226 1.951 . . . . 0.0 112.408 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.458 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.6 Cg_endo -92.52 -170.98 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.566 2.177 . . . . 0.0 111.974 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.37 -24.89 68.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.297 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -66.15 -54.17 28.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.701 ' HA ' HD12 ' A' ' 73' ' ' ILE . 61.3 m -71.58 -25.05 62.03 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 53.3 mt-30 -66.91 -36.02 81.32 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -91.55 23.18 3.6 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.147 0.498 . . . . 0.0 111.65 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 70' ' ' CYS . 56.8 mt -119.47 140.04 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.517 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.56 154.91 22.08 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.692 0.62 . . . . 0.0 112.498 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.763 HD13 HD12 ' A' ' 128' ' ' ILE . 24.4 mm -103.53 153.66 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.093 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.709 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -117.31 155.95 28.65 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.57 118.92 26.3 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.844 0.293 . . . . 0.0 110.698 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.575 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.08 -23.62 8.46 Favored Glycine 0 C--N 1.348 1.242 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.976 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.76 -167.9 35.4 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.293 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -88.35 -11.38 4.31 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 123.313 2.675 . . . . 0.0 114.263 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.61 126.91 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 123.12 0.263 . . . . 0.0 110.893 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 48.81 82.16 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.309 1.043 . . . . 0.0 112.91 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.473 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.1 t -84.75 1.55 46.14 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -99.13 -0.66 41.22 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.603 ' NH2' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -133.09 153.27 51.66 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.198 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.586 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.83 133.34 11.6 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.434 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.75 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.8 OUTLIER -85.75 150.87 24.27 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.321 1.048 . . . . 0.0 110.288 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.1 t -127.11 104.81 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 123.429 0.455 . . . . 0.0 111.039 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.9 HD11 HD13 ' A' ' 105' ' ' LEU . 15.2 tp -106.67 127.66 53.54 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.821 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -129.14 169.44 13.1 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.38 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.654 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.6 Cg_endo -97.13 18.06 0.55 Allowed 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.65 2.233 . . . . 0.0 113.52 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.4 t -105.85 159.73 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.951 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.2 20.62 49.31 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.501 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -84.21 154.44 23.04 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.645 0.378 . . . . 0.0 110.438 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.0 p -126.78 157.22 39.75 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.579 ' CE2' HG23 ' A' ' 113' ' ' VAL . 53.0 m-85 -129.51 -150.9 0.45 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.418 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -60.2 -46.84 88.36 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.418 0.287 . . . . 0.0 111.25 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.8 m -135.63 83.05 1.99 Allowed 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.338 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 107' ' ' MET . 7.8 m -129.34 124.39 34.17 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.868 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.426 HD11 ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.93 123.94 46.7 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.902 178.627 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -88.74 130.56 35.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.103 0.478 . . . . 0.0 110.748 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.14 48.67 2.18 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.314 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.47 -106.76 1.64 Allowed Glycine 0 C--N 1.334 0.433 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.279 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.06 -10.18 4.0 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.9 HD13 HD11 ' A' ' 89' ' ' LEU . 2.5 pp -155.44 155.19 33.09 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.206 0.317 . . . . 0.0 111.561 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.593 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -125.14 157.73 35.66 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.875 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.598 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 27.0 tpp -125.33 141.25 52.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.52 ' CB ' HG11 ' A' ' 113' ' ' VAL . 1.9 m -134.15 133.53 41.12 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.916 0.388 . . . . 0.0 110.275 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.0 p -118.3 16.41 13.95 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.985 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.742 ' O ' HG12 ' A' ' 113' ' ' VAL . 32.9 p -91.51 126.93 36.76 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 121.681 0.753 . . . . 0.0 111.686 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.519 ' HA ' ' NH2' ' A' ' 85' ' ' ARG . 20.3 pt20 -60.87 -26.91 67.73 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.602 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -66.11 -41.06 91.08 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.585 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.744 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.2 p -69.85 -39.74 78.09 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.603 HD22 ' NH2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -58.03 -47.64 82.48 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 123.672 0.608 . . . . 0.0 110.457 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.478 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 25.9 m-85 -69.72 -38.39 76.89 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.924 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.94 -52.1 65.42 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.0 tp -64.66 -42.99 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.173 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.38 -31.04 65.39 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.83 0.706 . . . . 0.0 109.627 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.35 -20.26 30.2 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.167 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.59 15.17 30.22 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 114.626 -1.17 . . . . 0.0 114.735 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.2 p -105.34 7.66 33.43 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.58 -137.52 9.47 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-O 119.093 -0.837 . . . . 0.0 112.598 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.41 171.56 14.67 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.167 2.578 . . . . 0.0 113.615 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.82 -55.64 31.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.776 0.83 . . . . 0.0 112.159 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.654 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.2 mmtt -140.72 139.82 34.77 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.728 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.8 m -140.26 168.35 20.01 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 tp -127.9 119.3 25.3 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.794 -1.093 . . . . 0.0 108.734 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.763 HD12 HD13 ' A' ' 75' ' ' ILE . 15.8 pt -98.26 102.0 12.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.852 0.834 . . . . 0.0 109.814 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.1 t -117.88 122.75 44.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.37 -1.287 . . . . 0.0 110.925 -178.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.473 HD21 ' O ' ' A' ' 83' ' ' THR . 6.1 tp -66.64 114.94 5.95 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.327 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.29 178.16 6.95 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 114.442 -1.254 . . . . 0.0 114.562 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.6 176.81 7.48 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.367 0.603 . . . . 0.0 110.8 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.39 130.11 56.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.927 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.44 149.73 18.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.601 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.4 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 20.1 m-90 -126.46 135.96 52.02 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 124.022 0.483 . . . . 0.0 110.235 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.39 158.09 27.46 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.844 0.715 . . . . 0.0 110.766 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.57 90.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.92 -25.06 6.9 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.997 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -56.07 -45.63 79.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.984 0.514 . . . . 0.0 112.058 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.556 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 10.5 tp -66.97 -48.28 69.0 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.22 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.47 -30.26 64.91 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 123.451 0.469 . . . . 0.0 110.861 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.4 -50.7 35.88 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.903 178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -71.65 -26.61 62.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.026 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 6.1 tp -76.05 -38.48 57.07 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.898 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.0 m -77.98 -30.85 50.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -80.9 0.5 35.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.571 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.45 29.16 18.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.853 0.861 . . . . 0.0 111.735 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.82 -42.52 24.2 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.051 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -123.02 113.0 18.47 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.46 0.475 . . . . 0.0 109.752 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.3 tp -82.76 142.14 31.82 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.408 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 25.3 p -105.0 135.77 45.72 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.088 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 79.5 m -149.22 148.68 27.42 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.24 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.55 153.7 64.83 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.325 2.016 . . . . 0.0 110.772 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -134.75 174.58 10.42 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -135.02 138.89 30.48 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.322 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.58 -26.66 16.33 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 122.686 2.257 . . . . 0.0 113.561 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.84 -41.02 57.37 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.967 0.792 . . . . 0.0 112.451 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.725 HD13 HH12 ' A' ' 167' ' ' ARG . 4.3 mt -69.94 -34.38 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.569 0.7 . . . . 0.0 110.395 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.5 tt -75.71 -36.82 59.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.462 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -84.8 -32.15 23.51 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -88.83 -72.88 0.52 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.982 0.356 . . . . 0.0 111.714 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.67 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -141.27 99.26 6.52 Favored Pre-proline 0 C--N 1.349 0.584 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.842 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 73.1 Cg_endo -91.74 -0.43 4.44 Favored 'Trans proline' 0 CA--C 1.571 2.331 0 C-N-CA 121.831 1.687 . . . . 0.0 114.421 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.647 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 69.2 Cg_endo -75.09 -50.01 0.14 Allowed 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.73 2.287 . . . . 0.0 114.532 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.502 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.5 mt-10 -122.22 -34.02 3.39 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.792 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 8.6 mt-10 -69.01 -10.99 60.31 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.219 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.739 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.03 -41.55 42.12 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.176 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -70.85 -49.58 44.56 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 t -58.29 -48.03 81.78 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.644 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.63 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.57 -40.37 92.7 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.578 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.62 82.77 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.409 0.443 . . . . 0.0 110.582 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.91 -37.29 85.7 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.795 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.56 71.67 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.497 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.63 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 3.4 mmp_? -77.67 -40.33 41.93 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.802 0.441 . . . . 0.0 110.372 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.36 -33.94 76.85 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.526 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.759 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.133 179.454 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 32' ' ' LEU . 11.2 mt . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 120.671 0.272 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -92.68 23.01 4.31 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.964 0.412 . . . . 0.0 110.841 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 177.08 51.99 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.775 0.83 . . . . 0.0 110.0 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -136.87 160.22 39.52 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.455 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.1 m-30 -98.17 137.46 36.9 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.267 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.821 HD11 HD23 ' A' ' 32' ' ' LEU . 3.6 mt -108.63 137.03 47.25 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.033 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.434 HD13 HG13 ' A' ' 29' ' ' VAL . 2.4 mm -117.38 133.79 63.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 123.519 0.512 . . . . 0.0 109.713 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.09 123.03 23.63 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.598 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.9 mmt -114.46 155.12 46.32 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 123.463 0.477 . . . . 0.0 111.341 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -80.68 79.28 3.36 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.652 2.235 . . . . 0.0 112.935 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -136.38 -20.65 1.39 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.994 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -163.29 0.87 Allowed 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.182 0.301 . . . . 0.0 110.431 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.61 35.84 2.48 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.01 0.433 . . . . 0.0 111.9 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.32 82.87 3.69 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.36 -24.6 12.11 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.006 2.471 . . . . 0.0 113.316 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -85.2 -37.38 20.19 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.469 0.481 . . . . 0.0 111.619 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.58 -0.53 57.6 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.794 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -63.5 2.81 0.38 Allowed 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -141.22 40.12 1.76 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.172 0.51 . . . . 0.0 112.237 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 p -123.28 158.04 31.83 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.562 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.857 HG11 ' HE ' ' A' ' 167' ' ' ARG . 60.6 t -131.32 132.88 62.79 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.005 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -114.9 152.01 33.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.266 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.45 ' OH ' HD21 ' A' ' 105' ' ' LEU . 36.0 t80 -105.95 120.48 41.87 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.821 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.76 108.32 17.39 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.447 0.642 . . . . 0.0 111.304 -178.387 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.934 HG23 ' HA2' ' A' ' 42' ' ' GLY . 24.0 t -67.42 -59.92 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.786 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -144.68 112.64 6.35 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.31 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.447 ' CD2' HD12 ' A' ' 9' ' ' LEU . 54.9 t60 -95.84 128.74 42.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.606 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -139.85 153.37 47.03 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.624 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.53 -18.39 65.28 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.725 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.33 2.22 42.3 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.418 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.88 167.2 15.21 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.455 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -144.82 136.43 25.49 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.97 134.37 55.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.399 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.934 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.9 155.01 26.05 Favored Glycine 0 N--CA 1.45 -0.425 0 O-C-N 124.195 0.935 . . . . 0.0 112.5 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.423 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.4 mt -110.95 133.32 53.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.022 0.411 . . . . 0.0 111.194 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 78' ' ' GLY . 20.5 t -69.34 124.61 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -128.24 56.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.47 0.653 . . . . 0.0 112.276 -177.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.86 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -147.9 -3.5 0.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.491 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.73 87.75 51.48 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.512 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -59.63 142.51 98.93 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 121.695 1.596 . . . . 0.0 112.177 175.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.444 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 50.2 m -92.73 158.67 15.79 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.504 0.502 . . . . 0.0 111.572 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.44 50.15 1.29 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.67 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mt -133.34 159.14 41.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.226 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.622 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 7.4 p-10 -112.48 157.71 20.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.621 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.812 HD12 HD13 ' A' ' 128' ' ' ILE . 1.9 tt -58.5 -26.95 64.01 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.956 0.408 . . . . 0.0 111.765 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.622 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -65.12 -39.97 93.82 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.645 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.71 -46.66 84.45 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.289 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.867 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 19.2 m -62.12 -43.81 98.25 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.722 ' HA ' HD12 ' A' ' 60' ' ' LEU . 15.8 mt -56.13 -35.13 66.77 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.487 176.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.05 -27.75 48.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.425 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.4 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.89 -30.57 50.79 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.339 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.867 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.94 -45.58 23.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -131.12 116.31 16.68 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.58 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.63 -32.97 2.54 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 123.677 2.918 . . . . 0.0 112.732 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.86 -14.62 56.0 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.334 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.36 149.94 24.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.445 0.466 . . . . 0.0 111.722 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.3 122.42 29.46 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.184 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.87 153.92 38.12 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.25 1.966 . . . . 0.0 112.299 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -95.07 -166.0 0.12 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.67 2.247 . . . . 0.0 112.387 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.26 -24.58 62.2 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.311 0.644 . . . . 0.0 111.921 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.437 ' O ' HG13 ' A' ' 73' ' ' ILE . 10.5 ptp180 -67.39 -47.7 69.56 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.703 ' HA ' HD12 ' A' ' 73' ' ' ILE . 29.4 m -71.59 -26.02 62.43 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.451 ' HA ' HD22 ' A' ' 52' ' ' ASN . 40.8 mt-30 -72.83 -26.89 61.65 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.402 0.62 . . . . 0.0 111.511 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -92.87 15.84 13.88 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.057 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 70' ' ' CYS . 44.6 mt -122.08 139.55 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.01 153.55 22.94 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.733 HD13 HD12 ' A' ' 128' ' ' ILE . 25.0 mm -99.78 153.07 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.88 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.4 t80 -119.98 155.67 32.38 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.16 120.36 27.45 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 117.733 0.242 . . . . 0.0 110.572 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.16 -23.74 8.91 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.949 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.24 -168.48 34.65 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.291 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -88.73 -11.52 3.93 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.546 2.831 . . . . 0.0 114.366 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.56 131.29 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.709 0.29 . . . . 0.0 111.418 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 48.2 86.25 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.532 1.133 . . . . 0.0 113.232 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.9 p -81.74 -18.87 42.77 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.151 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -76.92 -18.1 58.5 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.601 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -132.97 147.83 52.28 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.0 0.428 . . . . 0.0 111.558 179.526 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.595 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -112.41 141.33 16.73 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.776 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.23 134.44 33.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.65 -1.275 . . . . 0.0 109.493 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 4.8 t -116.31 128.52 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 123.067 0.23 . . . . 0.0 111.376 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.878 HD11 HD13 ' A' ' 105' ' ' LEU . 13.4 tp -114.23 127.64 55.98 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.608 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.408 ' ND1' ' HB3' ' A' ' 123' ' ' PRO . 4.9 p80 -122.01 162.84 35.08 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.18 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -97.52 31.15 0.14 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.588 2.192 . . . . 0.0 113.403 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.5 t -118.33 156.74 28.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.651 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.49 22.13 42.48 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.71 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tp -87.71 153.5 21.31 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.526 0.33 . . . . 0.0 110.479 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.8 p -122.84 153.17 39.94 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.636 ' CD2' HG12 ' A' ' 113' ' ' VAL . 25.6 m-85 -132.99 -149.05 0.36 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.862 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -60.33 -48.91 79.71 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 122.834 0.453 . . . . 0.0 111.395 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 108' ' ' SER . 57.9 m -135.38 80.29 1.83 Allowed 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.434 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 107' ' ' MET . 7.9 m -126.6 116.85 21.67 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.867 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.96 122.16 40.75 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.098 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.35 130.36 34.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.128 0.489 . . . . 0.0 111.135 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.42 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -127.4 48.64 2.2 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.354 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.42 -109.82 3.12 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.169 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.44 -8.9 4.58 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.878 HD13 HD11 ' A' ' 89' ' ' LEU . 2.2 pp -153.34 150.23 28.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.285 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.495 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -120.81 160.61 23.04 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.812 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' A' ' 99' ' ' THR . 17.1 tpp -126.46 142.22 51.61 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 98' ' ' SER . 54.3 m -137.32 136.62 38.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.73 0.3 . . . . 0.0 110.478 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.7 p -123.03 18.72 10.05 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.383 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.829 ' O ' HG22 ' A' ' 113' ' ' VAL . 14.5 t -92.31 130.11 38.08 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 122.044 0.926 . . . . 0.0 112.564 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.645 ' HA ' HD12 ' A' ' 114' ' ' LEU . 4.8 mt-30 -61.48 -26.27 67.79 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.725 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -62.54 -47.14 85.2 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.527 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.849 ' O ' HG22 ' A' ' 117' ' ' ILE . 21.0 m -62.2 -43.12 97.52 Favored 'Isoleucine or valine' 0 C--N 1.36 1.043 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 177.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 111' ' ' GLN . 22.0 mt -54.57 -50.58 67.63 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.718 0.636 . . . . 0.0 111.984 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.464 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 37.2 m-85 -65.6 -47.2 76.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.771 0.319 . . . . 0.0 111.23 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.08 -52.99 63.23 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.138 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.849 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.02 -43.3 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.75 -30.48 65.63 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 123.618 0.574 . . . . 0.0 109.662 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.401 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -86.21 -19.64 29.72 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.174 176.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.75 17.19 26.57 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 114.652 -1.158 . . . . 0.0 114.904 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.7 p -107.88 8.14 28.45 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -98.17 -136.51 9.26 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-O 119.195 -0.78 . . . . 0.0 112.527 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.408 ' HB3' ' ND1' ' A' ' 90' ' ' HIS . 3.2 Cg_exo -77.78 169.9 19.94 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.333 2.688 . . . . 0.0 113.161 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -51.5 -58.36 6.51 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.695 0.798 . . . . 0.0 110.863 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -133.66 168.41 18.73 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.452 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.4 ' HB2' ' CG1' ' A' ' 88' ' ' VAL . 31.6 p -152.52 156.9 40.28 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.8 tp -125.68 106.09 9.47 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.812 HD13 HD12 ' A' ' 53' ' ' LEU . 15.7 pt -92.82 102.62 13.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.812 0.815 . . . . 0.0 110.044 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.0 t -122.45 122.64 39.43 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.255 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.12 117.07 8.65 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.198 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.44 ' H ' ' HA2' ' A' ' 86' ' ' GLY . . . 66.38 172.94 4.95 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.366 -0.833 . . . . 0.0 114.307 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -128.11 -179.06 4.79 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.231 0.538 . . . . 0.0 110.824 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -116.81 128.98 55.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.246 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.25 148.83 18.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.379 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.455 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 22.3 m-90 -127.14 137.86 53.05 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.803 0.354 . . . . 0.0 110.435 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.85 158.02 26.86 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.818 0.699 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.14 92.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.32 -24.72 8.05 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.177 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -57.57 -44.38 85.27 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.87 0.468 . . . . 0.0 112.15 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.9 tm? -68.07 -47.64 67.73 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.502 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.21 -30.12 67.99 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.013 0.435 . . . . 0.0 110.644 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.17 -49.91 45.66 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.887 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.55 -26.63 63.64 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.84 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.6 tp -74.71 -38.91 62.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.593 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.0 m -77.88 -28.44 49.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.296 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -81.93 -0.92 46.07 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.553 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 61.19 29.55 18.83 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.801 0.841 . . . . 0.0 111.744 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 143' ' ' GLU . . . -83.53 -43.6 15.55 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.829 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -124.62 113.4 17.99 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.5 tp -84.67 140.43 31.32 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.442 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.4 p -104.61 137.42 42.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.17 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 73.2 m -152.46 155.87 33.12 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.629 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.21 157.66 29.33 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.319 2.013 . . . . 0.0 111.191 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.455 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.36 168.32 17.12 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -136.31 135.03 20.33 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 114.405 -1.27 . . . . 0.0 107.84 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.27 -26.57 14.45 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.582 2.188 . . . . 0.0 113.695 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.68 -40.5 62.97 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.768 0.667 . . . . 0.0 112.329 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.576 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.8 mt -71.06 -35.37 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-O 121.375 0.607 . . . . 0.0 110.354 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -73.88 -38.58 64.37 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.051 -1.431 . . . . 0.0 111.392 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -84.77 -33.44 23.02 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.35 -72.34 0.49 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.047 0.385 . . . . 0.0 111.532 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.883 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.3 99.52 6.46 Favored Pre-proline 0 C--N 1.348 0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 112.349 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.86 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 73.0 Cg_endo -91.45 -0.68 4.63 Favored 'Trans proline' 0 CA--C 1.569 2.254 0 C-N-CA 121.721 1.614 . . . . 0.0 114.304 175.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.646 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 73.9 Cg_endo -74.37 -52.62 0.12 Allowed 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.643 2.229 . . . . 0.0 114.48 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.523 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.6 mt-10 -122.29 -30.33 4.01 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.75 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.883 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.0 tt0 -69.78 -11.59 60.97 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.367 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.857 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.63 -41.7 44.95 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.272 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.36 -50.28 40.54 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.349 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.8 m -58.09 -49.45 76.91 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.651 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.26 -39.95 94.99 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.209 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.09 -46.58 79.0 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 123.545 0.528 . . . . 0.0 110.587 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.67 88.33 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.51 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.24 -28.26 69.24 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.492 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.75 -40.14 42.0 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 122.835 0.454 . . . . 0.0 110.303 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.98 -32.03 70.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.489 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.755 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.94 179.505 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 mt . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 120.924 0.392 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -91.23 20.21 5.28 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.846 0.355 . . . . 0.0 111.276 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.2 p80 176.71 52.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.99 0.916 . . . . 0.0 110.257 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -133.2 160.43 37.27 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.716 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.434 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 14.4 m-30 -95.59 135.01 37.81 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 1.6 mm? -108.04 139.92 41.97 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.525 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 29' ' ' VAL . 3.0 mp -124.58 134.43 66.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 O-C-N 123.545 0.528 . . . . 0.0 109.936 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.33 133.21 35.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.479 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 24.5 mmt -123.2 157.36 61.28 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.03 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.22 78.01 3.61 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.563 2.175 . . . . 0.0 112.879 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -135.53 -21.79 1.52 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.875 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.53 -162.89 0.86 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 123.209 0.318 . . . . 0.0 110.493 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.545 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.39 30.89 4.64 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.1 m-20 -110.85 83.29 3.49 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.1 Cg_exo -75.37 -20.7 15.9 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.069 2.513 . . . . 0.0 113.417 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -84.93 -39.04 18.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 122.833 0.453 . . . . 0.0 111.649 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.27 -2.72 56.28 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.76 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -61.0 2.29 0.12 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -142.28 38.95 1.57 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.167 0.508 . . . . 0.0 112.03 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 p -123.22 158.45 30.83 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.625 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.78 HG11 ' HE ' ' A' ' 167' ' ' ARG . 99.4 t -130.57 131.45 64.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.896 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.464 HG21 ' HH2' ' A' ' 135' ' ' TRP . 2.3 m -113.15 154.55 26.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.363 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.429 ' OH ' HD11 ' A' ' 105' ' ' LEU . 43.3 t80 -106.66 119.93 40.62 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.659 HD11 ' HB1' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -82.34 106.86 14.56 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 123.595 0.559 . . . . 0.0 111.391 -178.131 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.94 HG23 ' HA2' ' A' ' 42' ' ' GLY . 34.3 t -67.69 -57.98 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.597 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -144.56 118.84 9.55 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.187 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -99.05 128.12 45.13 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.875 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -139.25 152.44 47.3 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.586 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -62.58 -24.19 67.42 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.644 0.378 . . . . 0.0 111.781 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -93.17 -3.72 53.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 123.492 0.495 . . . . 0.0 111.498 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.3 173.72 24.35 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 121.518 -0.373 . . . . 0.0 112.274 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.659 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -146.85 141.53 26.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -114.55 134.7 54.84 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.09 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.94 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.26 157.64 28.25 Favored Glycine 0 N--CA 1.443 -0.844 0 O-C-N 124.215 0.947 . . . . 0.0 112.618 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.4 HD23 ' C ' ' A' ' 42' ' ' GLY . 1.8 mt -112.32 128.72 56.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.925 0.363 . . . . 0.0 110.511 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.451 HG12 ' C ' ' A' ' 78' ' ' GLY . 11.1 p -68.29 125.97 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.05 57.76 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.725 0.774 . . . . 0.0 112.059 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.829 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.2 t30 -146.28 -1.7 0.72 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.032 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -130.2 88.26 48.56 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.508 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 40.9 Cg_exo -58.67 145.94 93.76 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 121.711 1.607 . . . . 0.0 112.48 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.447 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 73.1 m -96.38 160.23 14.52 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.554 0.534 . . . . 0.0 111.489 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.94 51.53 0.9 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.636 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -133.35 154.02 51.09 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.929 0.429 . . . . 0.0 110.03 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.611 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 10.4 p-10 -112.45 157.7 20.76 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.822 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.537 HD12 HD13 ' A' ' 128' ' ' ILE . 2.4 tt -57.53 -26.74 61.82 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.611 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -67.54 -40.87 84.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.419 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.1 -45.51 88.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.17 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.861 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.1 m -62.04 -44.96 99.66 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 60' ' ' LEU . 14.8 mt -56.16 -35.15 66.86 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.494 176.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.05 -27.25 48.68 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.313 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -30.46 51.42 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.334 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.861 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.79 -45.91 23.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.099 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -131.22 116.75 16.68 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.52 -33.05 2.58 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.674 2.916 . . . . 0.0 112.78 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.71 -14.99 55.83 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.376 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.99 149.47 24.75 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 123.327 0.392 . . . . 0.0 111.636 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.71 123.21 29.26 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.303 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.61 153.48 38.99 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.298 1.999 . . . . 0.0 112.264 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 6.6 Cg_endo -94.01 -165.07 0.12 Allowed 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.596 2.198 . . . . 0.0 112.119 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.83 -24.74 61.76 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.134 0.574 . . . . 0.0 111.888 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.565 ' HA ' ' CE1' ' A' ' 72' ' ' HIS . 12.0 ptp180 -67.33 -46.06 74.57 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.542 ' HA ' HD12 ' A' ' 73' ' ' ILE . 17.5 m -73.82 -25.54 60.15 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.468 ' HA ' HD22 ' A' ' 52' ' ' ASN . 47.3 mt-30 -70.63 -27.62 64.2 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.565 ' CE1' ' HA ' ' A' ' 69' ' ' ARG . 15.3 p-80 -97.9 20.42 12.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.089 0.471 . . . . 0.0 111.606 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 70' ' ' CYS . 62.8 mt -118.72 136.76 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.255 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.83 163.94 12.14 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 51' ' ' LEU . 14.3 mm -115.23 152.69 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.022 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.744 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.5 t80 -116.49 155.1 29.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.895 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.72 125.03 31.48 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 131' ' ' GLY . . . -104.14 -23.53 8.06 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.741 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.86 -167.95 33.3 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.186 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -88.55 -10.38 4.52 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.434 2.756 . . . . 0.0 114.262 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.84 131.34 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 123.08 0.237 . . . . 0.0 111.206 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 45.06 82.98 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.537 1.135 . . . . 0.0 113.385 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.2 p -81.66 -14.6 56.44 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.198 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.91 -17.13 59.13 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.748 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.771 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -132.61 148.2 52.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.927 0.394 . . . . 0.0 111.882 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.603 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.71 148.48 17.68 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.404 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.5 m-85 -86.84 150.76 23.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.913 -1.144 . . . . 0.0 111.115 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 21.6 t -128.22 105.69 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.163 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.932 HD11 HD13 ' A' ' 105' ' ' LEU . 13.6 tp -106.26 127.95 53.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.456 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.404 ' ND1' ' HB3' ' A' ' 123' ' ' PRO . 3.7 p80 -128.43 166.34 25.04 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.421 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.684 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.34 25.22 0.25 Allowed 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.691 2.261 . . . . 0.0 113.691 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.0 t -112.98 158.83 19.77 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.624 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.27 22.94 34.13 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.653 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.27 150.51 22.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.502 0.321 . . . . 0.0 110.534 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.6 ' HA ' HG21 ' A' ' 99' ' ' THR . 24.7 m -128.47 157.09 42.1 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.146 0.498 . . . . 0.0 112.189 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.556 ' CE2' HG23 ' A' ' 113' ' ' VAL . 57.6 m-85 -126.81 -150.88 0.46 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.8 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -59.07 -46.87 87.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.595 0.358 . . . . 0.0 111.338 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.8 m -132.58 80.3 1.89 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.943 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.6 HG21 ' HA ' ' A' ' 95' ' ' SER . 47.2 m -128.7 121.15 27.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.153 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.5 123.57 46.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.861 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.58 127.82 34.04 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.764 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.56 ' HB3' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -120.58 43.11 2.83 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.798 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.61 -100.57 0.28 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.424 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -55.61 -14.83 2.36 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.932 HD13 HD11 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -160.0 159.87 32.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.907 0.483 . . . . 0.0 110.687 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.574 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.73 156.98 28.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.846 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.49 ' CE ' HD13 ' A' ' 89' ' ' LEU . 16.1 ttm -123.91 134.64 53.49 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 m -136.68 133.72 36.47 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.7 p -127.97 19.7 6.52 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.007 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.755 ' O ' HG12 ' A' ' 113' ' ' VAL . 42.2 p -90.61 130.9 36.58 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.306 0.574 . . . . 0.0 112.021 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.489 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 5.4 mt-30 -57.95 -26.9 62.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.777 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -64.53 -40.02 94.84 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.119 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.77 ' O ' HG22 ' A' ' 117' ' ' ILE . 2.7 p -71.49 -38.5 68.39 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.77 -49.84 72.07 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.578 0.549 . . . . 0.0 110.495 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.489 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 39.2 m-85 -68.01 -40.79 82.93 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.405 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.64 -53.95 51.23 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.679 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.3 tp -64.56 -43.96 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.56 -32.31 65.05 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.665 0.603 . . . . 0.0 109.703 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.438 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.38 -20.55 31.75 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.365 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.35 17.23 25.02 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.8 -1.091 . . . . 0.0 114.472 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 p -108.26 8.39 27.79 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -93.84 -138.01 8.83 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 119.204 -0.776 . . . . 0.0 112.863 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.404 ' HB3' ' ND1' ' A' ' 90' ' ' HIS . 2.2 Cg_endo -82.37 165.76 16.34 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.146 2.564 . . . . 0.0 113.998 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.506 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -49.94 -60.14 3.2 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.482 1.113 . . . . 0.0 111.76 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.684 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -140.1 139.72 35.9 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 37.2 p -139.25 169.41 17.82 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.2 tp -125.61 115.81 20.73 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.45 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.537 HD13 HD12 ' A' ' 53' ' ' LEU . 8.6 pt -99.25 104.98 16.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.3 t -124.16 121.99 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.035 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.0 tp -67.21 113.06 4.84 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.379 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.502 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 72.75 170.51 17.06 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.158 -0.928 . . . . 0.0 114.283 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -128.66 177.77 6.8 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.206 0.526 . . . . 0.0 110.809 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -114.94 131.73 56.79 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.937 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.33 144.05 15.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.598 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.464 ' HH2' HG21 ' A' ' 30' ' ' THR . 16.8 m-90 -122.15 131.68 54.08 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.046 0.498 . . . . 0.0 110.597 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -78.94 159.19 27.83 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.53 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.16 124.05 10.77 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.671 0.388 . . . . 0.0 111.497 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.27 -28.02 8.64 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.017 -0.611 . . . . 0.0 114.128 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -56.71 -48.88 76.75 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.543 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.0 tp -67.8 -47.77 68.16 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.673 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.83 -31.57 64.88 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.456 0.472 . . . . 0.0 110.814 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.88 -50.35 43.29 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.044 178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -72.29 -26.64 62.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.4 tp -75.65 -38.49 58.81 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.738 0.815 . . . . 0.0 110.784 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.7 m -78.12 -31.09 49.75 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.444 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -80.8 0.4 35.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.649 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 60.13 28.68 18.27 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.908 0.883 . . . . 0.0 111.749 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.99 -43.16 22.49 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.831 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -126.29 116.48 21.31 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -84.72 150.34 25.17 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.487 ' H ' HD23 ' A' ' 150' ' ' LEU . 16.8 p -110.78 136.29 50.07 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.363 0.414 . . . . 0.0 110.915 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 74.9 m -151.83 154.87 33.42 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.54 159.04 25.12 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.284 1.989 . . . . 0.0 111.104 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.434 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.89 166.09 21.65 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -134.95 134.16 21.57 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 114.368 -1.287 . . . . 0.0 107.863 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.51 -26.43 16.79 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.596 2.198 . . . . 0.0 113.663 -177.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.8 -39.97 62.82 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 123.871 0.732 . . . . 0.0 112.056 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.565 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.2 mt -72.27 -35.66 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.363 0.602 . . . . 0.0 110.392 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.61 -37.41 65.43 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.412 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -86.67 -33.75 19.99 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -85.78 -72.33 0.49 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.052 0.387 . . . . 0.0 111.666 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.913 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.75 98.11 6.44 Favored Pre-proline 0 C--N 1.349 0.584 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.829 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 59.5 Cg_endo -92.76 1.2 3.77 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 C-N-CA 121.719 1.613 . . . . 0.0 114.258 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.636 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 80.4 Cg_endo -74.1 -52.14 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.561 2.174 . . . . 0.0 114.224 -178.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.507 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.97 -29.79 3.88 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.658 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.913 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.5 tt0 -70.36 -10.13 58.18 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.247 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.78 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.01 -38.2 53.52 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.135 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.7 tt -74.01 -49.58 23.7 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.3 m -58.41 -46.72 85.89 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.487 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -67.14 -40.66 86.78 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.397 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.15 -45.98 79.43 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 123.362 0.414 . . . . 0.0 110.446 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.99 -38.65 91.87 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.487 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.87 69.25 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.595 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.69 -40.23 42.14 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 122.931 0.492 . . . . 0.0 110.26 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.0 -31.19 67.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.529 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.776 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.884 179.524 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 C--O 1.236 0.373 0 CA-C-O 120.585 0.231 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.539 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 14.2 ptmt -95.16 27.65 3.15 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.494 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 176.44 51.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.563 0.745 . . . . 0.0 110.91 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -134.04 159.39 40.95 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.452 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 30' ' ' THR . 12.3 m-30 -98.58 138.33 35.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.168 0.509 . . . . 0.0 112.15 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.672 HD11 HD23 ' A' ' 32' ' ' LEU . 1.9 mp -109.89 135.41 50.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.565 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.432 HG23 HG22 ' A' ' 29' ' ' VAL . 2.9 mp -120.04 130.72 73.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.53 127.63 33.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.012 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.6 mmt -112.28 154.62 44.37 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.171 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -79.96 72.57 6.45 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.561 2.174 . . . . 0.0 112.611 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -130.79 -16.4 3.32 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.54 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -164.69 0.94 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.303 0.377 . . . . 0.0 110.604 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.541 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.55 37.77 2.05 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 111.85 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -110.99 82.95 3.36 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.832 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.33 -21.88 14.8 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.973 2.449 . . . . 0.0 113.384 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -85.19 -38.52 18.89 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.909 0.484 . . . . 0.0 111.527 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.08 -5.53 55.06 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.842 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -57.3 -0.67 0.06 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -178.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -142.3 43.86 1.65 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.179 0.514 . . . . 0.0 111.839 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p -127.38 155.58 43.39 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.616 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.651 HG11 ' HE ' ' A' ' 167' ' ' ARG . 48.0 t -129.22 133.54 65.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.676 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 3.9 m -115.15 154.68 28.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.471 -178.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.408 ' OH ' HD11 ' A' ' 105' ' ' LEU . 17.7 t80 -109.14 116.26 31.59 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.672 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -78.61 108.47 12.03 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-O 121.04 0.448 . . . . 0.0 110.466 -179.33 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.891 HG23 ' HA2' ' A' ' 42' ' ' GLY . 56.4 t -64.78 -57.92 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 114.033 -1.439 . . . . 0.0 110.115 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.539 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 32.7 tt0 -151.11 119.67 6.48 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.793 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -95.8 129.24 43.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.629 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -139.48 152.89 47.35 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.475 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.8 -18.98 65.58 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.623 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 137' ' ' ALA . 46.5 mt-30 -95.68 -5.83 41.35 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.346 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.81 172.37 22.51 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.2 143.24 30.19 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.461 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -119.5 136.6 54.26 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.638 178.573 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.891 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.29 158.53 29.61 Favored Glycine 0 N--CA 1.452 -0.292 0 O-C-N 124.364 1.04 . . . . 0.0 112.529 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.8 mt -115.6 134.86 54.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.099 0.449 . . . . 0.0 111.438 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 78' ' ' GLY . 11.1 t -68.55 122.48 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.91 55.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.638 0.732 . . . . 0.0 112.074 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.854 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 1.9 t30 -148.32 -2.75 0.51 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.157 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -130.19 87.23 51.71 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.53 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -59.7 143.15 99.7 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 121.559 1.506 . . . . 0.0 112.14 175.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 50.0 m -92.54 158.5 15.97 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 123.39 0.431 . . . . 0.0 111.368 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.89 50.29 1.37 Allowed Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.837 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 mt -133.57 158.96 41.85 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.979 0.458 . . . . 0.0 110.229 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.1 p-10 -112.23 157.54 20.77 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.102 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.642 HD13 HD13 ' A' ' 128' ' ' ILE . 13.4 tp -57.79 -37.07 73.08 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.07 -37.91 62.06 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -63.66 -43.03 97.93 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.21 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.864 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -62.63 -46.82 95.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.609 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.744 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.4 mp -53.56 -36.72 62.17 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.87 0.731 . . . . 0.0 110.784 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.93 -28.34 49.63 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.564 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -29.97 47.9 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.381 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.864 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.9 mt -77.83 -45.14 25.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.884 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -132.02 116.57 15.7 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.535 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -77.59 -32.73 2.69 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 123.615 2.876 . . . . 0.0 112.747 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.22 -14.38 55.63 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.364 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 149.7 24.52 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 123.321 0.388 . . . . 0.0 111.792 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.32 123.75 29.68 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.99 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 57.5 Cg_endo -74.45 146.04 34.55 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.185 1.923 . . . . 0.0 112.351 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.502 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.4 Cg_endo -92.43 -170.62 0.3 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.491 2.127 . . . . 0.0 111.83 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.82 -24.89 67.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.142 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.504 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.6 ptp180 -66.18 -53.38 38.14 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -177.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.706 ' HA ' HD12 ' A' ' 73' ' ' ILE . 60.1 m -71.74 -25.02 61.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 49.1 mt-30 -68.12 -35.63 78.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -90.37 22.12 3.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.228 0.537 . . . . 0.0 111.667 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.706 HD12 ' HA ' ' A' ' 70' ' ' CYS . 55.1 mt -119.39 139.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.383 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.11 153.78 22.14 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.802 0.689 . . . . 0.0 112.728 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.689 HD13 HD12 ' A' ' 128' ' ' ILE . 25.9 mm -100.02 150.3 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.093 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.715 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -116.51 154.98 29.44 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.52 118.94 26.27 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.636 0.198 . . . . 0.0 110.552 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -101.46 -23.66 9.37 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.826 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.82 -167.77 35.4 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.123 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -88.39 -9.66 4.95 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 123.492 2.794 . . . . 0.0 114.264 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 t -87.07 131.18 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.003 0.19 . . . . 0.0 111.035 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 44.13 87.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.533 1.133 . . . . 0.0 113.316 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.428 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.0 t -88.09 1.51 54.11 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.428 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.87 -5.47 47.91 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.604 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.26 154.45 50.66 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.11 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.604 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.5 134.2 12.1 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.175 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.727 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.54 145.58 27.31 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.366 1.067 . . . . 0.0 110.231 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -123.97 103.42 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 123.366 0.416 . . . . 0.0 110.874 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.785 HD11 HD13 ' A' ' 105' ' ' LEU . 6.2 tp -105.71 129.21 53.97 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -125.6 168.23 14.37 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 118.985 -0.531 . . . . 0.0 112.146 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 16.5 Cg_endo -96.61 13.99 0.96 Allowed 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.862 2.375 . . . . 0.0 113.644 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 t -101.89 161.06 13.95 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.874 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.84 19.21 55.5 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.512 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -85.47 153.86 22.19 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.604 0.362 . . . . 0.0 110.403 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.0 p -127.03 157.89 38.39 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CE2' HG23 ' A' ' 113' ' ' VAL . 52.0 m-85 -129.34 -151.94 0.5 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.671 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -57.44 -46.26 83.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.776 0.431 . . . . 0.0 111.723 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 m -138.32 78.94 1.71 Allowed 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.642 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 107' ' ' MET . 25.1 m -126.29 120.96 31.3 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 107' ' ' MET . 3.3 tp -77.36 162.02 27.59 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.051 176.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -135.2 125.5 26.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.896 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.506 HD11 ' O ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -135.84 43.99 2.52 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.279 -179.383 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.13 -99.16 0.19 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.815 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -57.4 -12.99 2.91 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.785 HD13 HD11 ' A' ' 89' ' ' LEU . 3.2 pp -158.44 148.11 19.55 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.265 0.555 . . . . 0.0 112.493 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.52 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -120.83 158.6 27.24 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.324 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 8.9 ttm -119.68 134.08 55.37 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.754 ' HB3' HG11 ' A' ' 113' ' ' VAL . 16.7 m -128.76 127.36 41.86 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.8 p -119.92 11.78 11.88 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.782 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.745 ' O ' HG12 ' A' ' 113' ' ' VAL . 49.2 m -85.59 130.38 34.59 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.617 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.497 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.7 pt20 -61.58 -29.52 70.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.382 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.45 -43.16 95.15 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.603 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.754 HG11 ' HB3' ' A' ' 108' ' ' SER . 4.0 p -68.14 -39.77 81.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 123.189 0.306 . . . . 0.0 110.38 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.53 HD22 ' NH2' ' A' ' 85' ' ' ARG . 1.5 tt -58.12 -48.34 80.51 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 123.571 0.544 . . . . 0.0 110.47 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.497 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 35.3 m-85 -69.98 -37.57 75.8 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.865 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.25 -51.94 65.72 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.0 tp -64.56 -43.14 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.156 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.02 -31.59 65.28 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 123.826 0.704 . . . . 0.0 109.546 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.504 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.71 -20.8 30.6 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.255 176.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.61 13.1 33.39 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.729 -1.123 . . . . 0.0 114.692 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.1 p -103.39 7.8 38.09 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.68 -137.7 9.6 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.239 -0.756 . . . . 0.0 112.635 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.72 173.72 12.59 Favored 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 123.228 2.619 . . . . 0.0 113.601 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.01 -54.37 47.53 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.757 0.823 . . . . 0.0 111.916 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.594 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.9 mmtt -139.05 151.14 46.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.775 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.0 m -148.05 165.38 30.97 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.7 tp -127.5 118.05 23.26 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.361 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.727 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 18.5 pt -98.63 102.7 13.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.989 0.9 . . . . 0.0 109.819 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 6.8 t -119.75 121.6 39.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.76 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.428 HD21 ' O ' ' A' ' 83' ' ' THR . 6.9 tp -66.84 115.06 6.2 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.01 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.71 174.61 4.11 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.352 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -128.44 -179.49 5.06 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.408 0.623 . . . . 0.0 111.092 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -117.34 130.47 56.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.179 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.46 152.24 19.48 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.354 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 27.4 m-90 -132.69 139.02 47.48 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.898 0.41 . . . . 0.0 110.537 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.25 158.17 27.63 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.851 0.719 . . . . 0.0 110.794 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . . . -50.92 91.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.82 -22.05 10.11 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.339 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -57.22 -46.35 83.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.866 0.466 . . . . 0.0 111.978 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.5 tp -66.73 -47.18 73.09 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -56.69 -30.84 63.86 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.453 0.471 . . . . 0.0 110.793 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.43 -49.08 52.57 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.04 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.4 pt-20 -72.69 -26.75 61.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.0 tp -75.48 -38.23 59.68 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.744 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -78.19 -30.31 48.92 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.272 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.06 0.5 31.61 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.605 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 61.38 28.98 18.3 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.871 0.868 . . . . 0.0 111.797 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.45 -42.71 16.63 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.528 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -124.14 111.39 15.86 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 123.495 0.497 . . . . 0.0 109.856 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.3 tp -86.93 128.36 35.06 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.614 0.245 . . . . 0.0 111.506 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.5 p -100.33 142.3 31.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.758 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 78.2 m -154.95 155.83 30.66 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 123.446 0.466 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.51 148.46 92.94 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.325 2.016 . . . . 0.0 110.999 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 174' ' ' ARG . . . -135.06 177.42 7.82 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -134.29 141.11 38.02 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 113.88 -1.509 . . . . 0.0 108.584 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -74.85 -26.54 11.14 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 122.766 2.311 . . . . 0.0 114.007 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -48.89 -41.71 34.4 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.915 0.759 . . . . 0.0 112.631 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.704 HD13 HH12 ' A' ' 167' ' ' ARG . 4.9 mt -70.26 -32.63 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.467 0.651 . . . . 0.0 110.421 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.6 tt -76.65 -37.12 56.81 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.37 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.61 -33.45 25.32 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -86.84 -72.93 0.48 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.939 0.336 . . . . 0.0 111.657 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.89 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.47 99.93 6.3 Favored Pre-proline 0 C--N 1.349 0.578 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.854 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 70.3 Cg_endo -90.94 -0.91 4.97 Favored 'Trans proline' 0 CA--C 1.57 2.275 0 C-N-CA 121.742 1.628 . . . . 0.0 114.261 175.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.651 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 87.8 Cg_endo -74.28 -54.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 122.636 2.224 . . . . 0.0 114.502 -178.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.542 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.1 mt-10 -120.58 -29.84 4.64 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.729 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.89 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.0 tt0 -70.38 -11.38 60.88 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.422 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.704 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.28 -45.5 32.29 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.397 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.5 tp -68.06 -50.19 56.72 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.1 m -57.57 -51.16 70.6 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.922 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.09 88.98 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.158 0.286 . . . . 0.0 110.987 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.28 83.92 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 123.657 0.598 . . . . 0.0 110.457 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.11 84.54 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.646 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.76 -32.28 73.39 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.532 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.483 ' CZ ' ' HA ' ' A' ' 154' ' ' ALA . 10.9 mtm-85 -77.7 -41.57 37.47 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 122.682 0.393 . . . . 0.0 110.702 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.77 -35.47 79.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.634 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.681 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.2 179.441 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 32' ' ' LEU . 18.4 mt . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 121.102 0.477 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -93.0 19.36 7.89 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.068 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 175.55 55.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.268 1.027 . . . . 0.0 109.209 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -137.96 156.88 47.4 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.462 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.5 m-30 -96.46 135.43 38.34 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.928 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.762 HD11 HD23 ' A' ' 32' ' ' LEU . 6.2 mt -107.62 138.2 44.27 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.182 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.459 HG23 HG22 ' A' ' 29' ' ' VAL . 2.2 mm -116.69 132.63 65.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 O-C-N 123.623 0.577 . . . . 0.0 109.617 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.58 128.15 33.67 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.724 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.5 mtt -117.79 154.32 51.06 Favored Pre-proline 0 CA--C 1.538 0.509 0 O-C-N 123.383 0.427 . . . . 0.0 111.336 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.41 74.0 5.76 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.673 2.249 . . . . 0.0 112.661 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -131.63 -17.64 2.86 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.741 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.32 -163.26 0.84 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.272 0.357 . . . . 0.0 110.403 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -101.96 34.4 2.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.906 0.384 . . . . 0.0 111.979 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.6 82.4 3.75 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.37 -22.3 14.32 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.033 2.488 . . . . 0.0 113.333 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -85.13 -39.13 18.25 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.93 0.492 . . . . 0.0 111.498 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -4.63 56.94 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.889 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -57.69 0.71 0.05 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -143.13 43.34 1.55 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.212 0.529 . . . . 0.0 111.866 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.6 p -126.49 158.28 36.5 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.674 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.794 HG11 ' HE ' ' A' ' 167' ' ' ARG . 58.4 t -130.72 133.07 63.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.641 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.446 HG21 ' HH2' ' A' ' 135' ' ' TRP . 1.8 m -114.33 155.18 26.71 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.647 -178.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.479 ' OH ' HD21 ' A' ' 105' ' ' LEU . 34.1 t80 -107.71 115.58 30.4 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.762 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -80.08 108.21 13.48 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-O 121.393 0.616 . . . . 0.0 111.236 -178.553 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.947 HG23 ' HA2' ' A' ' 42' ' ' GLY . 43.4 t -68.42 -63.32 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.267 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -136.82 122.65 19.99 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.492 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -104.66 128.79 52.82 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.9 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -139.81 153.14 47.02 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.627 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.61 -21.56 66.43 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.005 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -94.99 -4.66 46.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.398 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.54 176.23 27.48 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.405 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.649 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -148.99 148.95 30.36 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.21 136.17 54.62 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.289 177.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.947 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.11 160.39 30.4 Favored Glycine 0 N--CA 1.447 -0.624 0 O-C-N 124.603 1.189 . . . . 0.0 112.509 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.4 mt -112.69 131.19 55.77 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.939 0.37 . . . . 0.0 111.223 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 78' ' ' GLY . 15.7 t -67.05 122.12 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.49 56.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.648 0.737 . . . . 0.0 112.038 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.852 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.1 t30 -147.15 -3.25 0.58 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.158 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -130.08 88.57 47.99 Favored Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.521 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.3 Cg_exo -59.6 143.68 99.61 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.712 1.608 . . . . 0.0 112.157 175.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.441 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.2 m -93.29 159.71 15.15 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 123.386 0.429 . . . . 0.0 111.639 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.06 50.69 1.18 Allowed Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.588 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mt -133.6 158.44 43.19 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 122.848 0.459 . . . . 0.0 110.143 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 24.7 p-10 -112.61 157.61 20.99 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.808 HD12 HD13 ' A' ' 128' ' ' ILE . 1.6 tt -58.1 -26.51 62.68 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 120.947 0.403 . . . . 0.0 111.847 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.68 95.47 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.173 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.56 -45.78 88.92 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.095 0.247 . . . . 0.0 111.457 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.867 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 7.8 m -62.12 -44.51 99.12 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 60' ' ' LEU . 14.4 mt -55.99 -35.14 66.43 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.853 0.721 . . . . 0.0 110.618 176.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.08 -27.41 48.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.391 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.84 -30.97 51.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.284 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.867 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.2 mt -77.69 -45.76 23.92 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.162 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -131.12 116.52 16.73 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.581 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.7 -32.94 2.51 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.554 2.836 . . . . 0.0 112.75 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.74 -14.77 56.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.313 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.18 149.66 24.48 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.42 0.45 . . . . 0.0 111.672 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.24 123.45 29.39 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.304 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.42 149.48 35.11 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.275 1.983 . . . . 0.0 112.279 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.428 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 7.6 Cg_endo -94.33 -167.86 0.16 Allowed 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.653 2.235 . . . . 0.0 112.432 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.43 -24.64 64.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.373 0.669 . . . . 0.0 112.095 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.514 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 9.1 ptp180 -67.91 -48.08 67.0 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.701 ' HA ' HD12 ' A' ' 73' ' ' ILE . 21.2 m -73.15 -26.19 61.11 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.087 0.555 . . . . 0.0 112.343 -178.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.442 ' HA ' HD22 ' A' ' 52' ' ' ASN . 52.1 mt-30 -70.34 -26.96 63.99 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.668 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -96.71 17.66 16.05 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.58 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 70' ' ' CYS . 52.1 mt -120.97 139.63 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.818 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.45 154.53 20.7 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.731 HD13 HD12 ' A' ' 128' ' ' ILE . 24.2 mm -102.02 153.12 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.805 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.711 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -117.97 155.21 30.64 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.64 121.23 28.87 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 117.684 0.22 . . . . 0.0 110.59 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -104.04 -23.6 8.07 Favored Glycine 0 C--N 1.346 1.137 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.888 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.7 -168.36 33.81 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.043 -0.598 . . . . 0.0 113.315 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -88.58 -13.09 3.48 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 123.545 2.83 . . . . 0.0 114.394 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 t -83.41 129.8 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.099 0.249 . . . . 0.0 111.162 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 44.25 86.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.635 1.174 . . . . 0.0 113.392 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.6 p -82.72 -13.88 55.56 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.085 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.05 -17.59 58.66 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.805 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -132.58 148.87 52.38 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.089 0.471 . . . . 0.0 111.908 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.614 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.71 159.75 13.66 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.429 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.3 m-85 -96.14 151.71 19.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.721 -1.24 . . . . 0.0 110.854 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 t -128.35 102.91 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 126' ' ' SER . 0.3 OUTLIER -102.37 127.69 49.27 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.869 -179.216 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -130.07 164.42 40.78 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.499 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.681 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.5 Cg_endo -97.08 19.78 0.46 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.647 2.231 . . . . 0.0 113.78 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.8 t -106.4 158.52 16.83 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.59 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.85 22.82 33.92 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.717 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 95' ' ' SER . 2.8 tt -90.73 149.58 21.97 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.521 0.329 . . . . 0.0 110.435 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.592 ' HA ' HG21 ' A' ' 99' ' ' THR . 27.5 m -126.22 155.51 41.71 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.054 0.454 . . . . 0.0 112.093 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.538 ' CE2' HG23 ' A' ' 113' ' ' VAL . 53.6 m-85 -126.55 -150.4 0.44 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.846 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.417 ' HB2' ' OG ' ' A' ' 110' ' ' SER . 5.4 mm100 -58.4 -47.29 84.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.61 0.364 . . . . 0.0 111.491 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 63.2 m -133.05 81.05 1.92 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.964 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 107' ' ' MET . 44.7 m -127.98 120.06 26.78 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.04 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -103.06 122.42 44.62 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.911 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.24 125.47 30.35 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.773 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -121.47 55.29 1.09 Allowed 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.232 1.015 . . . . 0.0 110.626 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.87 -114.35 5.53 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.259 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.5 -3.44 6.25 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.479 HD21 ' OH ' ' A' ' 31' ' ' TYR . 3.5 pp -147.78 157.02 43.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.19 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -120.44 158.59 26.87 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.368 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.611 ' O ' ' HA ' ' A' ' 99' ' ' THR . 25.6 ttm -124.56 132.14 53.46 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.631 ' HB3' HG11 ' A' ' 113' ' ' VAL . 49.2 m -133.95 130.99 38.49 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.9 p -124.37 18.82 8.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.433 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.679 ' O ' HG12 ' A' ' 113' ' ' VAL . 19.0 t -90.66 133.97 34.74 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.92 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.467 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 5.7 mt-30 -62.35 -26.37 68.41 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.473 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.28 -41.96 93.66 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.496 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.742 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.5 p -71.49 -37.58 64.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 tp -58.89 -47.12 86.09 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 123.511 0.507 . . . . 0.0 110.198 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.467 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 18.4 m-85 -68.5 -40.91 80.67 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.837 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.68 -52.6 64.44 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.385 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.742 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.4 tp -64.82 -44.23 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.718 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.447 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.54 -32.33 65.03 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 123.745 0.653 . . . . 0.0 109.679 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.514 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.56 -20.17 31.94 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.396 176.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.08 16.2 28.59 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.698 -1.137 . . . . 0.0 114.544 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.9 p -107.55 7.96 29.02 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.01 -138.28 9.04 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 119.213 -0.77 . . . . 0.0 112.747 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.75 168.46 15.87 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.191 2.594 . . . . 0.0 113.754 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.489 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -50.76 -58.83 4.96 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.363 1.065 . . . . 0.0 111.748 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.681 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.4 mmtt -141.3 139.93 33.74 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.797 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 36.7 p -137.02 168.05 20.33 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 tp -128.27 117.07 20.84 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.81 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.808 HD13 HD12 ' A' ' 53' ' ' LEU . 11.5 pt -98.18 103.88 15.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-O 121.415 0.626 . . . . 0.0 109.639 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.0 t -121.37 120.09 34.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.014 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 tp -67.1 115.6 6.98 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.601 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 169.82 11.28 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.405 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -128.42 171.97 11.55 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.278 0.561 . . . . 0.0 110.803 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -108.86 130.89 55.42 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.05 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.5 142.67 13.83 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.387 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.446 ' HH2' HG21 ' A' ' 30' ' ' THR . 17.4 m-90 -120.53 133.6 55.38 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.967 0.451 . . . . 0.0 110.391 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -82.12 158.86 23.52 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.181 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.77 124.37 9.63 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.364 0.415 . . . . 0.0 111.705 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.57 -26.76 8.72 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.036 -0.602 . . . . 0.0 114.35 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -58.27 -49.03 78.58 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.58 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.7 tm? -66.23 -48.96 68.85 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.983 0.177 . . . . 0.0 110.772 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.86 -31.12 66.37 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 120.927 0.394 . . . . 0.0 110.827 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.18 -50.09 50.69 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.086 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.45 -26.62 62.8 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.966 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.1 tp -75.22 -38.48 60.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.427 0.691 . . . . 0.0 110.668 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.0 m -77.93 -29.65 50.09 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.34 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.8 t70 -81.43 -1.13 44.58 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.615 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 60.5 30.31 19.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.879 0.872 . . . . 0.0 111.402 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.73 -42.17 18.35 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.984 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -126.71 115.86 20.06 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.7 tp -86.78 145.3 26.69 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.514 0.197 . . . . 0.0 111.225 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.4 p -105.31 137.0 43.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.964 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 71.1 m -152.12 149.76 24.03 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.598 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.5 158.47 19.27 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.39 2.06 . . . . 0.0 111.247 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.462 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.67 167.22 19.14 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -177.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -133.39 135.64 25.7 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 114.132 -1.395 . . . . 0.0 107.85 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.82 -26.76 13.09 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.61 2.207 . . . . 0.0 114.013 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.77 -40.55 63.25 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.759 0.662 . . . . 0.0 112.104 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.596 HG21 HH11 ' A' ' 167' ' ' ARG . 4.5 mt -70.95 -34.71 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.24 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.3 tt -74.0 -38.62 64.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.654 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.412 ' HE1' ' O ' ' A' ' 89' ' ' LEU . 44.7 m-85 -88.0 -31.1 19.51 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -85.57 -71.73 0.52 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.215 0.461 . . . . 0.0 111.451 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.892 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.43 98.59 5.94 Favored Pre-proline 0 C--N 1.35 0.609 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.852 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 59.3 Cg_endo -91.99 0.35 4.27 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 121.602 1.535 . . . . 0.0 114.206 175.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.643 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 78.7 Cg_endo -74.19 -53.78 0.11 Allowed 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 122.546 2.164 . . . . 0.0 114.461 -178.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.546 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -121.09 -29.66 4.51 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.61 -178.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.892 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.8 tt0 -70.27 -11.49 60.94 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.382 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.794 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.04 -40.2 47.25 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.325 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -72.02 -49.9 32.98 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.8 m -58.92 -47.36 85.31 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.55 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.673 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.79 -40.69 92.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.158 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.82 -46.28 78.12 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 123.488 0.492 . . . . 0.0 110.472 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.21 90.28 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.428 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.82 -27.29 68.14 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.66 177.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.76 -40.21 41.64 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 122.832 0.453 . . . . 0.0 110.306 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.84 -30.28 63.89 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.408 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.745 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.817 179.58 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 32' ' ' LEU . 19.4 mt . . . . . 0 N--CA 1.469 0.514 0 CA-C-O 120.996 0.427 . . . . 0.0 110.655 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -89.22 17.3 6.14 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.529 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 19.0 p80 172.2 58.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.351 1.06 . . . . 0.0 110.108 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -137.19 161.61 35.71 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.465 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.485 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 18.9 m-30 -97.76 136.95 37.37 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.81 HD11 HD23 ' A' ' 32' ' ' LEU . 3.7 mt -108.28 140.18 41.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.949 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 150' ' ' LEU . 2.9 mp -120.62 135.73 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 123.462 0.476 . . . . 0.0 110.02 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.14 125.61 29.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.048 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.9 mtt -110.34 157.44 38.12 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.206 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.21 30.16 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.63 2.22 . . . . 0.0 113.213 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -86.72 -17.02 34.69 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.29 -167.13 1.15 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.094 0.246 . . . . 0.0 110.597 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.531 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.09 40.33 1.47 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.102 0.477 . . . . 0.0 111.764 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -112.19 80.33 3.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.915 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.4 Cg_exo -75.45 -23.12 13.38 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 123.036 2.491 . . . . 0.0 113.315 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -84.54 -34.93 23.15 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.825 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.94 3.92 53.34 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.048 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.16 163.87 19.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.815 0.341 . . . . 0.0 111.761 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 49.23 31.79 3.88 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.0 p -117.53 154.25 31.8 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.753 HG11 ' HE ' ' A' ' 167' ' ' ARG . 96.4 t -128.93 134.2 64.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.487 0.661 . . . . 0.0 110.857 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.2 m -114.66 153.67 29.79 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.914 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.466 ' OH ' HD21 ' A' ' 105' ' ' LEU . 43.3 t80 -106.82 118.54 36.94 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.81 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.44 109.97 17.15 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.255 0.55 . . . . 0.0 111.139 -178.601 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.918 HG23 ' HA2' ' A' ' 42' ' ' GLY . 38.1 t -71.35 -64.73 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.397 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -133.8 117.25 16.66 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.583 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.413 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 37.0 t60 -102.46 126.8 49.62 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.466 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -139.25 152.01 46.96 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.08 -13.14 59.54 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.042 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -107.77 3.13 24.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.306 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.07 166.27 15.16 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.424 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -148.5 145.29 27.85 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.86 138.0 53.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.17 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.918 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.43 158.94 29.72 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.451 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.439 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.1 mt -112.77 131.89 55.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.042 0.421 . . . . 0.0 111.196 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 78' ' ' GLY . 15.9 t -66.04 123.43 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.69 55.07 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.598 0.713 . . . . 0.0 112.224 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.851 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -147.55 -3.24 0.55 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.116 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.72 87.03 53.64 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.537 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -60.27 147.29 94.19 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 121.695 1.597 . . . . 0.0 112.721 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.414 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 66.1 m -92.39 160.13 15.24 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.85 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.02 -2.19 64.64 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 116.144 -0.48 . . . . 0.0 113.711 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.477 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -90.16 152.78 20.95 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.731 0.3 . . . . 0.0 111.28 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 71' ' ' GLN . 17.1 p-10 -101.33 164.85 11.58 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.155 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.64 ' HA ' HD11 ' A' ' 75' ' ' ILE . 13.4 tp -60.26 -28.19 67.85 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 120.802 0.334 . . . . 0.0 111.739 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.55 98.79 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -63.99 -46.52 84.19 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.082 0.239 . . . . 0.0 111.625 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.865 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.5 m -61.91 -44.96 99.61 Favored 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.739 ' HA ' HD12 ' A' ' 60' ' ' LEU . 11.6 mt -56.58 -34.5 67.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.598 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.18 -27.5 48.01 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.317 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.85 -30.7 51.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.248 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.865 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.8 mt -77.87 -46.1 22.33 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.81 -1.541 . . . . 0.0 110.987 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -130.26 115.9 17.54 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -77.6 -32.9 2.59 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.589 2.859 . . . . 0.0 112.757 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.63 -14.91 56.12 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.291 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.43 150.38 23.82 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.355 0.409 . . . . 0.0 111.709 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.79 122.82 28.87 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.175 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.67 149.0 42.71 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.409 2.073 . . . . 0.0 112.25 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.412 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 9.1 Cg_endo -94.86 -171.79 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.57 2.18 . . . . 0.0 112.6 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -24.5 67.58 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.116 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.477 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 7.8 ptp180 -68.55 -49.15 61.71 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.713 ' HA ' HD12 ' A' ' 73' ' ' ILE . 19.0 m -74.17 -26.03 60.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.083 0.553 . . . . 0.0 112.425 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.451 ' HA ' HD22 ' A' ' 52' ' ' ASN . 53.0 mt-30 -68.53 -27.54 66.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.949 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -97.51 18.85 14.45 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.439 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.713 HD12 ' HA ' ' A' ' 70' ' ' CYS . 65.0 mt -119.64 140.07 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.941 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -107.18 154.34 21.34 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.819 0.7 . . . . 0.0 112.851 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.8 HD13 HD12 ' A' ' 128' ' ' ILE . 20.7 mm -102.98 156.74 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.168 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.712 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -121.58 155.23 35.5 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.63 121.06 27.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 117.763 0.256 . . . . 0.0 110.471 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.571 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.97 -23.67 8.06 Favored Glycine 0 C--N 1.348 1.213 0 C-N-CA 120.206 -0.997 . . . . 0.0 114.211 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.52 -167.88 34.15 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.431 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -88.46 -13.55 3.43 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.468 2.778 . . . . 0.0 114.376 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.61 127.03 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 123.086 0.241 . . . . 0.0 111.148 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 46.99 84.18 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.406 1.082 . . . . 0.0 113.203 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -85.86 1.23 50.66 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.415 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -92.86 -10.76 35.51 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.843 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -133.03 150.82 52.11 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.008 0.432 . . . . 0.0 112.108 -179.634 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.598 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -110.24 144.88 17.07 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.172 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.8 OUTLIER -86.75 146.12 26.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.923 -1.139 . . . . 0.0 110.525 179.248 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.46 103.71 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 123.601 0.563 . . . . 0.0 109.949 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.872 HD11 HD13 ' A' ' 105' ' ' LEU . 11.4 tp -107.65 127.98 54.14 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.127 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -126.67 168.72 13.66 Favored Pre-proline 0 CA--C 1.556 1.196 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.663 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.684 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.11 17.44 0.6 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.75 2.3 . . . . 0.0 113.691 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 t -105.31 159.49 15.85 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.808 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.84 19.58 54.19 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.752 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mp -85.24 154.59 21.85 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.585 0.354 . . . . 0.0 110.912 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.2 p -125.49 156.95 38.15 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CE2' HG23 ' A' ' 113' ' ' VAL . 56.7 m-85 -130.0 -149.3 0.4 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.495 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -60.41 -45.69 92.68 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.406 0.283 . . . . 0.0 111.323 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.3 m -137.09 85.24 2.12 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.492 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 107' ' ' MET . 13.8 m -129.89 129.16 43.55 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.712 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -112.42 123.21 49.79 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.871 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.93 125.12 29.33 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.447 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -135.09 76.96 1.65 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.973 0.892 . . . . 0.0 112.041 -177.689 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.592 ' O ' ' HG2' ' A' ' 104' ' ' GLU . . . 43.25 104.88 0.01 OUTLIER Glycine 0 N--CA 1.475 1.279 0 CA-C-N 113.677 -1.601 . . . . 0.0 114.823 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 103' ' ' GLY . 10.4 pt-20 61.36 -15.86 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.777 1.231 . . . . 0.0 113.25 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.872 HD13 HD11 ' A' ' 89' ' ' LEU . 2.7 pp -132.88 145.56 51.04 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 120.806 0.336 . . . . 0.0 110.451 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.578 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -114.84 155.46 26.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.986 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 99' ' ' THR . 16.9 ttm -121.66 128.96 52.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.649 ' HB3' HG11 ' A' ' 113' ' ' VAL . 49.9 m -128.57 129.64 46.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 p -119.65 16.39 12.8 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.311 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.705 ' O ' HG12 ' A' ' 113' ' ' VAL . 45.0 p -91.17 131.0 36.99 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 121.737 0.78 . . . . 0.0 112.439 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.491 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.7 pt20 -61.43 -27.74 68.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.3 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.17 -43.42 95.19 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.484 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.6 p -69.56 -36.4 70.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.46 HD13 HH12 ' A' ' 85' ' ' ARG . 5.4 tp -58.64 -49.43 77.56 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 123.472 0.482 . . . . 0.0 110.372 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.491 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 31.8 m-85 -68.19 -38.74 82.31 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.907 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.1 -52.74 63.64 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.269 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.48 -43.83 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.672 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.6 -32.59 65.4 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.714 0.634 . . . . 0.0 109.579 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.477 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.71 -19.53 32.61 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.316 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.62 14.99 33.13 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.748 -1.114 . . . . 0.0 114.739 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.9 p -104.88 6.53 33.84 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.52 -138.29 9.59 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.169 -0.795 . . . . 0.0 112.515 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.25 172.99 12.16 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 123.128 2.552 . . . . 0.0 113.611 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.61 -55.0 40.46 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.966 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.684 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.9 mmtt -141.63 139.93 33.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.843 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 67.3 m -137.67 166.83 22.99 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tp -125.38 116.46 21.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.601 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.8 HD12 HD13 ' A' ' 75' ' ' ILE . 9.8 pt -99.15 102.57 13.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 O-C-N 123.82 0.7 . . . . 0.0 109.45 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -120.26 120.78 37.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.031 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.08 112.86 4.63 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.488 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.66 171.54 19.13 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.88 -1.055 . . . . 0.0 114.405 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.38 176.12 7.96 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.099 -0.55 . . . . 0.0 110.397 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -115.36 131.01 57.06 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.161 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.94 150.26 18.72 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.549 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.424 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 26.4 m-90 -127.78 136.12 51.05 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 123.902 0.413 . . . . 0.0 110.408 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.08 158.07 26.52 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.922 0.764 . . . . 0.0 110.725 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.27 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.43 -24.84 7.15 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 115.408 -0.815 . . . . 0.0 113.042 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.71 -45.46 85.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.968 0.507 . . . . 0.0 112.28 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.04 -48.25 66.15 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.187 0.304 . . . . 0.0 110.594 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.63 -29.39 67.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.98 0.419 . . . . 0.0 110.715 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.4 -50.42 38.87 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.84 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.35 -26.67 63.85 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.847 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.1 tp -76.02 -37.87 57.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.745 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.5 t -77.78 -29.03 50.7 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.202 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -82.64 0.21 44.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.395 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 59.64 29.51 19.08 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.944 0.897 . . . . 0.0 111.507 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.76 -42.76 19.31 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.949 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -124.52 113.65 18.38 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.2 tp -85.04 139.49 31.71 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.634 0.254 . . . . 0.0 111.371 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.5 p -104.46 137.85 41.72 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.047 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 74.3 m -151.69 154.95 33.74 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.816 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.76 153.26 51.16 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.314 2.009 . . . . 0.0 111.074 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.485 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.42 166.37 18.85 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -133.66 135.9 25.78 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.207 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.433 ' HG3' ' OE1' ' A' ' 104' ' ' GLU . 72.6 Cg_endo -73.51 -26.44 14.08 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.553 2.168 . . . . 0.0 113.684 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.11 62.17 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.9 0.75 . . . . 0.0 112.157 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.589 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.7 mt -72.31 -34.87 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.328 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.35 -36.16 63.59 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.277 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -85.28 -36.87 20.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.65 -71.96 0.48 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 117.927 0.331 . . . . 0.0 111.786 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -142.29 98.97 5.97 Favored Pre-proline 0 C--N 1.349 0.544 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.851 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.2 Cg_endo -91.8 0.21 4.39 Favored 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 121.652 1.568 . . . . 0.0 114.319 175.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.641 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 66.2 Cg_endo -75.46 -50.67 0.12 Allowed 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.609 2.206 . . . . 0.0 114.607 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.516 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.4 mt-10 -121.44 -34.06 3.52 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.731 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 9.0 mt-10 -69.04 -10.77 59.23 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.135 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.753 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.06 -41.57 41.86 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.217 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.8 tp -70.65 -49.98 41.6 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.8 m -58.5 -48.76 79.74 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.637 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.677 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.31 -40.19 95.41 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.148 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.46 78.25 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.568 0.542 . . . . 0.0 110.435 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.45 91.22 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.423 177.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.25 68.3 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.676 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.677 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.82 -39.93 42.09 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 122.823 0.449 . . . . 0.0 110.327 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.83 -31.85 68.71 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.376 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.743 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.834 179.482 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -91.89 17.21 9.5 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.765 0.317 . . . . 0.0 111.396 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 175.99 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.845 0.858 . . . . 0.0 110.474 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -136.95 158.97 43.25 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.305 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 30' ' ' THR . 13.7 m-30 -98.42 136.15 38.97 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.679 HD11 HD23 ' A' ' 32' ' ' LEU . 6.2 mt -105.39 139.2 40.38 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.936 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -120.15 132.53 69.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 123.572 0.545 . . . . 0.0 109.636 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.23 120.57 18.01 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.926 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.8 mmt -103.22 155.24 36.96 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.166 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -82.9 32.92 0.52 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.669 2.246 . . . . 0.0 112.965 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -87.01 -13.28 44.91 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.254 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -169.52 1.83 Allowed 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.984 0.178 . . . . 0.0 110.876 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.543 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -105.09 42.19 1.25 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.079 0.466 . . . . 0.0 111.583 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -111.58 80.72 2.88 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.88 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.1 Cg_exo -75.49 -16.99 18.87 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.081 2.521 . . . . 0.0 113.404 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -84.56 -38.41 20.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.845 0.458 . . . . 0.0 111.875 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.23 3.88 53.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.175 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.97 162.77 21.25 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.803 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 49.39 33.36 5.38 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.9 p -119.96 154.0 35.12 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 120.562 0.22 . . . . 0.0 110.445 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.621 HG11 ' HE ' ' A' ' 167' ' ' ARG . 99.8 t -129.41 134.95 62.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.503 0.668 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.3 m -116.91 155.26 29.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.875 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.422 ' OH ' HD11 ' A' ' 105' ' ' LEU . 22.6 t80 -109.67 117.34 33.65 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.749 HD11 ' HB1' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -77.46 108.14 10.4 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 123.499 0.5 . . . . 0.0 110.943 -179.17 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.945 HG23 ' HA2' ' A' ' 42' ' ' GLY . 51.8 t -66.29 -58.74 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.409 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -144.39 122.5 12.15 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.235 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -100.52 129.12 46.43 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.987 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -139.6 152.07 46.53 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.591 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.03 -22.63 66.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.657 0.383 . . . . 0.0 112.0 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -94.12 -5.35 47.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.346 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.94 176.16 27.76 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 121.579 -0.343 . . . . 0.0 112.333 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.749 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -148.57 148.29 30.0 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.416 ' O ' HD13 ' A' ' 32' ' ' LEU . 1.1 tpp -121.67 136.45 54.94 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.105 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.945 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -156.4 159.56 29.54 Favored Glycine 0 N--CA 1.447 -0.614 0 O-C-N 124.409 1.068 . . . . 0.0 112.446 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.451 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.2 mt -113.71 131.34 56.21 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.118 0.459 . . . . 0.0 111.365 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 78' ' ' GLY . 7.9 t -66.62 121.77 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.87 54.82 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.561 0.696 . . . . 0.0 112.377 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.855 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.1 t30 -147.96 -2.31 0.55 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.09 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -130.21 88.03 49.23 Favored Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.529 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 42.9 Cg_exo -59.08 145.04 99.02 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 121.648 1.565 . . . . 0.0 112.412 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.433 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 71.5 m -94.57 161.06 14.36 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.41 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.89 51.34 0.97 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.806 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' C ' HG12 ' A' ' 75' ' ' ILE . 1.1 mt -133.48 156.33 47.94 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 123.86 0.388 . . . . 0.0 110.044 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.509 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 20.3 p-10 -112.7 159.67 18.68 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.836 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.474 HD13 HD13 ' A' ' 128' ' ' ILE . 14.3 tp -59.15 -28.28 66.44 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.08 96.77 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.39 -45.47 87.54 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.068 0.23 . . . . 0.0 111.559 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.874 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 16.7 m -62.45 -44.5 99.33 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.712 ' HA ' HD12 ' A' ' 60' ' ' LEU . 13.3 mt -57.48 -33.85 68.43 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.552 177.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -78.25 -27.92 47.64 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.27 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.87 -30.96 51.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.297 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.874 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.1 mt -77.85 -45.62 23.8 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.851 -1.522 . . . . 0.0 111.113 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -130.34 115.83 17.44 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.623 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.7 -32.91 2.53 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.664 2.91 . . . . 0.0 112.759 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.66 -14.91 56.05 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.423 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.63 149.91 23.99 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.401 0.438 . . . . 0.0 111.679 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.14 123.0 29.13 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.232 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.03 149.7 36.94 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.318 2.012 . . . . 0.0 112.389 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.409 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 9.5 Cg_endo -95.1 -171.61 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.576 2.184 . . . . 0.0 112.532 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.29 -24.52 67.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.294 0.638 . . . . 0.0 112.007 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 73' ' ' ILE . 9.8 ptp180 -68.72 -47.93 65.11 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.709 ' HA ' HD12 ' A' ' 73' ' ' ILE . 25.5 m -74.51 -25.91 59.65 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.555 0.535 . . . . 0.0 112.38 -178.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.446 ' HA ' HD22 ' A' ' 52' ' ' ASN . 53.0 mt-30 -69.5 -26.97 64.8 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.797 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -97.36 20.46 11.54 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.497 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 70' ' ' CYS . 59.4 mt -122.16 138.97 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.737 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -104.34 164.17 11.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.471 HG12 ' C ' ' A' ' 51' ' ' LEU . 13.6 mm -114.17 152.45 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.822 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.728 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -115.81 156.09 26.69 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.482 0.313 . . . . 0.0 110.429 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.36 119.92 27.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.615 0.189 . . . . 0.0 110.623 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.566 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.78 -23.45 8.72 Favored Glycine 0 C--N 1.346 1.1 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.884 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.99 -168.29 32.92 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.371 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -88.42 -13.9 3.35 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.513 2.809 . . . . 0.0 114.356 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.73 131.04 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 123.119 0.262 . . . . 0.0 111.29 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 47.79 83.14 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.366 1.066 . . . . 0.0 113.09 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -84.07 1.03 45.95 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.348 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -93.77 -18.4 22.11 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.634 ' CZ ' ' H ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.2 147.37 52.02 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.968 0.413 . . . . 0.0 111.562 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.634 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -112.65 152.69 17.82 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.646 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.45 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 1.2 m-85 -86.33 153.86 21.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.352 1.061 . . . . 0.0 111.174 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 3.7 t -127.85 103.65 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.666 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.648 ' O ' ' HA ' ' A' ' 126' ' ' SER . 0.3 OUTLIER -98.28 127.39 44.19 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.652 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -129.1 160.76 62.08 Favored Pre-proline 0 CA--C 1.552 1.03 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.614 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 27.2 Cg_endo -99.58 33.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.916 2.41 . . . . 0.0 113.468 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.3 t -118.13 159.08 23.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.749 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.58 21.15 47.65 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.646 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.28 153.62 21.07 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.556 0.342 . . . . 0.0 110.58 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.0 p -122.94 153.58 39.52 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.653 ' CD2' HG12 ' A' ' 113' ' ' VAL . 27.8 m-85 -131.93 -150.98 0.44 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.733 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -62.4 -48.62 78.89 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 122.507 0.323 . . . . 0.0 111.103 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.7 m -132.68 78.41 1.8 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.324 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 107' ' ' MET . 11.1 m -126.49 115.44 19.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.616 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.01 123.45 44.26 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.803 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -83.47 127.48 33.74 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.318 0.58 . . . . 0.0 110.859 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.496 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -120.33 50.01 1.36 Allowed 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.567 -179.422 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.29 -109.62 3.01 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 114.579 -1.191 . . . . 0.0 113.41 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' OE1' ' HD3' ' A' ' 156' ' ' PRO . 10.8 pt-20 -63.1 -6.85 4.56 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.422 HD11 ' OH ' ' A' ' 31' ' ' TYR . 3.3 pp -152.08 160.01 43.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -122.58 158.84 29.04 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' ' 99' ' ' THR . 19.1 ttm -124.48 134.76 52.94 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.7 m -135.65 133.24 37.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.1 p -126.37 21.83 7.19 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.316 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.871 ' O ' HG22 ' A' ' 113' ' ' VAL . 10.7 t -89.26 130.31 35.68 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.13 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.492 ' HA ' HD12 ' A' ' 114' ' ' LEU . 21.2 pt20 -60.33 -28.3 68.03 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.554 0.692 . . . . 0.0 109.608 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -63.63 -44.7 93.12 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.925 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.871 HG22 ' O ' ' A' ' 110' ' ' SER . 18.7 m -62.01 -42.64 95.65 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 111' ' ' GLN . 31.4 mt -54.66 -52.19 63.09 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.795 0.685 . . . . 0.0 111.992 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.461 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 50.2 m-85 -64.86 -46.05 83.47 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.329 0.393 . . . . 0.0 111.585 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.83 63.89 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.839 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.5 tp -63.84 -43.92 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.92 -30.68 66.12 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.797 0.685 . . . . 0.0 109.762 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.63 -19.99 30.16 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.023 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.63 19.04 21.47 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.68 -1.145 . . . . 0.0 114.636 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.8 p -111.03 9.09 22.11 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.91 -137.78 9.42 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-O 119.256 -0.747 . . . . 0.0 112.756 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.72 167.65 22.13 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.284 2.656 . . . . 0.0 113.509 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.488 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -49.65 -58.19 5.74 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.378 1.071 . . . . 0.0 111.754 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.519 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -138.76 154.61 48.53 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 66.3 m -149.63 163.96 36.47 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 2.3 tp -130.31 115.08 16.43 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.883 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 73' ' ' ILE . 11.1 pt -98.03 107.86 20.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.399 0.618 . . . . 0.0 109.508 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 60.1 p -125.4 122.13 35.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.762 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.1 tp -67.5 117.51 9.55 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.604 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.444 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 70.05 167.69 6.43 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.183 -0.917 . . . . 0.0 114.271 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -128.5 174.16 9.6 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.157 0.503 . . . . 0.0 110.958 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -109.98 132.23 54.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.497 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.58 144.34 15.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.496 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -122.49 133.63 54.59 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.961 0.448 . . . . 0.0 110.585 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.77 158.95 23.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.321 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.57 125.42 11.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.746 0.418 . . . . 0.0 111.81 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.01 -26.45 7.64 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.119 -0.562 . . . . 0.0 114.475 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -58.3 -49.1 78.38 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.574 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.6 tm? -66.34 -49.36 67.2 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.0 0.188 . . . . 0.0 110.807 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.45 -31.59 66.07 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.472 0.482 . . . . 0.0 110.567 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -68.83 -50.12 52.69 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.157 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.86 -26.73 62.47 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.059 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.8 tp -75.34 -38.19 60.29 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.673 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.5 m -77.95 -29.99 50.16 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.291 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -81.46 -1.02 44.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.577 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 60.29 30.1 19.55 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.779 0.832 . . . . 0.0 111.658 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.22 -43.04 18.15 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.93 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -125.36 114.76 19.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.7 tp -86.24 138.53 31.79 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.0 p -101.75 137.52 39.94 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.488 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.6 m -149.95 146.19 20.01 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-O 119.192 -0.433 . . . . 0.0 111.4 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.27 148.18 91.0 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 122.286 1.991 . . . . 0.0 110.584 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.487 ' HA ' ' CZ ' ' A' ' 174' ' ' ARG . . . -134.11 176.32 8.69 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 -176.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -132.26 142.17 44.04 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 113.549 -1.66 . . . . 0.0 108.671 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.418 ' HD3' ' OE1' ' A' ' 104' ' ' GLU . 92.3 Cg_endo -76.11 -26.51 9.14 Favored 'Trans proline' 0 C--N 1.364 1.392 0 C-N-CA 122.692 2.262 . . . . 0.0 114.177 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -49.77 -42.11 45.75 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.774 0.671 . . . . 0.0 112.448 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.73 HD13 HH12 ' A' ' 167' ' ' ARG . 4.6 mt -69.52 -32.65 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-O 121.492 0.663 . . . . 0.0 110.229 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.0 tt -75.81 -38.87 57.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.687 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.425 ' HE1' ' O ' ' A' ' 89' ' ' LEU . 42.8 m-85 -86.51 -29.7 22.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -87.02 -72.56 0.5 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.106 0.412 . . . . 0.0 111.378 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.897 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.18 98.73 6.07 Favored Pre-proline 0 C--N 1.348 0.514 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.855 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.4 Cg_endo -91.55 0.08 4.55 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 C-N-CA 121.657 1.571 . . . . 0.0 114.28 175.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.649 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 87.5 Cg_endo -74.11 -54.16 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.655 2.237 . . . . 0.0 114.445 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.549 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.1 mt-10 -121.05 -29.55 4.54 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.7 -177.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.897 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.6 tt0 -70.56 -11.24 60.8 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.417 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.73 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.66 -43.99 35.73 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.42 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -69.37 -50.21 48.28 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 m -57.65 -49.57 76.01 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.769 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.33 96.77 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.096 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.54 -46.61 80.56 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 123.637 0.586 . . . . 0.0 110.729 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.12 82.47 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.7 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.45 -31.44 72.61 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.446 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.487 ' CZ ' ' HA ' ' A' ' 154' ' ' ALA . 11.3 mtm-85 -77.55 -41.5 38.81 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.793 0.437 . . . . 0.0 110.548 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.48 -34.1 77.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.676 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.747 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.017 179.425 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.454 ' O ' HD12 ' A' ' 32' ' ' LEU . 17.5 mt . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 121.158 0.504 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.422 ' NZ ' ' HG3' ' A' ' 34' ' ' GLU . 27.6 tttm -92.88 19.29 7.84 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.113 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 173.79 56.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.039 0.936 . . . . 0.0 109.641 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 153' ' ' PRO . 30.2 m80 -139.28 160.96 38.59 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.461 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 17.1 m-30 -99.09 137.44 37.6 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.057 0.456 . . . . 0.0 111.914 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.839 HD11 HD23 ' A' ' 32' ' ' LEU . 2.0 mt -108.16 140.97 40.59 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.202 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.55 137.21 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 123.352 0.407 . . . . 0.0 110.139 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.77 119.22 17.69 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.699 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 14.6 mmt -99.44 159.82 29.07 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.617 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.91 5.24 5.07 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.716 2.277 . . . . 0.0 113.652 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -77.34 -14.22 59.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.506 0.322 . . . . 0.0 111.856 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.724 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -104.4 154.98 19.18 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.264 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.44 48.67 1.41 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.253 0.549 . . . . 0.0 112.021 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.724 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.2 m-20 -125.05 89.66 52.27 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.626 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.54 -16.83 21.25 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.905 2.404 . . . . 0.0 113.388 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -84.47 -35.23 23.12 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 122.826 0.45 . . . . 0.0 111.772 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -93.41 3.96 54.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.045 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.49 163.21 21.52 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.847 0.356 . . . . 0.0 111.835 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 49.1 32.41 4.03 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.3 p -118.0 154.51 31.87 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 120.541 0.21 . . . . 0.0 110.694 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.784 HG11 ' HE ' ' A' ' 167' ' ' ARG . 60.7 t -129.76 133.15 65.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.773 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.2 m -113.74 153.57 28.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.759 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.429 ' OH ' HD21 ' A' ' 105' ' ' LEU . 33.4 t80 -107.66 116.82 32.63 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.839 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.38 109.52 16.7 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 121.457 0.646 . . . . 0.0 111.03 -178.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.938 HG23 ' HA2' ' A' ' 42' ' ' GLY . 29.6 t -70.22 -66.21 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.132 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.422 ' HG3' ' NZ ' ' A' ' 10' ' ' LYS . 6.6 tt0 -132.55 119.83 21.05 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.726 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -102.97 126.59 50.21 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.428 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -139.51 152.11 46.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.504 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.2 -19.56 65.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.832 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -97.73 -3.73 38.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.428 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.26 171.14 22.24 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 112.277 -0.329 . . . . 0.0 112.277 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.526 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -148.26 146.9 28.82 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -122.81 136.34 54.84 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.615 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.12 158.79 29.48 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.334 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.3 mt -114.75 133.72 55.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.055 0.427 . . . . 0.0 111.367 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 78' ' ' GLY . 14.9 t -67.69 123.21 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.6 54.55 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.57 0.7 . . . . 0.0 112.126 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.852 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.1 t30 -147.66 -3.21 0.54 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.156 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -129.67 87.24 53.17 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.515 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.6 Cg_exo -59.39 142.77 99.52 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 121.702 1.602 . . . . 0.0 112.252 175.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.432 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 62.4 m -91.72 158.27 16.47 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.479 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.29 50.52 1.3 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.842 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mt -133.55 158.04 44.15 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.743 0.417 . . . . 0.0 110.046 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.517 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.7 p-10 -112.07 158.98 18.93 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.204 0.315 . . . . 0.0 110.423 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 128' ' ' ILE . 12.7 tp -59.21 -36.16 74.9 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.08 -38.4 65.28 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -64.76 -40.2 94.88 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.36 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.847 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.0 t -61.8 -50.82 78.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.65 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.8 mp -52.31 -36.38 53.01 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.978 0.799 . . . . 0.0 111.099 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.94 -29.18 49.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.451 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -31.72 46.55 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.713 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.847 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 11.5 mt -77.56 -44.63 27.9 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.833 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -131.93 116.8 15.87 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.479 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.49 -33.11 2.57 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.585 2.857 . . . . 0.0 112.844 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.2 -13.79 56.58 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.388 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.42 149.62 24.33 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.291 0.37 . . . . 0.0 111.721 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.68 123.72 29.5 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.972 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.97 143.84 29.66 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.271 1.981 . . . . 0.0 112.414 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.1 Cg_endo -91.93 -169.65 0.28 Allowed 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.576 2.184 . . . . 0.0 111.85 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.23 -24.92 67.84 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.224 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.515 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.8 ptp180 -66.91 -51.61 53.29 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.711 ' HA ' HD12 ' A' ' 73' ' ' ILE . 58.2 m -72.46 -25.07 61.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 47.9 mt-30 -68.21 -34.84 77.01 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.434 ' CE1' ' HA ' ' A' ' 69' ' ' ARG . 14.5 p-80 -91.12 22.53 3.7 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.115 0.484 . . . . 0.0 111.649 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 70' ' ' CYS . 58.9 mt -119.22 139.44 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.312 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.59 157.05 17.97 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.625 HD13 HD12 ' A' ' 128' ' ' ILE . 22.5 mm -103.7 152.69 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.853 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.713 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -118.68 154.71 32.27 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -85.82 120.48 27.28 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.623 0.192 . . . . 0.0 110.649 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.33 -23.64 8.35 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 120.082 -1.056 . . . . 0.0 114.006 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.98 -167.62 34.34 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.324 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -88.16 -12.17 4.16 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 123.364 2.71 . . . . 0.0 114.136 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.47 126.35 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 123.094 0.246 . . . . 0.0 110.596 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 50.26 79.02 0.09 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.099 0.96 . . . . 0.0 112.46 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.466 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.5 t -83.01 1.57 39.3 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.554 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -102.63 2.74 36.39 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.477 HH21 ' HB3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -133.07 154.62 50.38 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -179.386 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.47 128.58 9.02 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.778 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.64 144.82 27.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.436 1.095 . . . . 0.0 109.936 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.87 105.86 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.142 0.276 . . . . 0.0 110.963 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.82 HD11 HD13 ' A' ' 105' ' ' LEU . 10.9 tp -107.57 127.82 53.98 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -123.35 164.35 28.55 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.762 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 12.4 Cg_endo -94.86 14.62 1.25 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.659 2.239 . . . . 0.0 113.615 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.1 t -101.81 157.52 16.79 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.73 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.12 20.98 48.38 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.631 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -85.66 154.7 21.49 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.611 0.364 . . . . 0.0 110.321 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.6 p -118.89 151.89 37.3 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.668 ' CD2' HG12 ' A' ' 113' ' ' VAL . 18.2 m-85 -130.68 -150.59 0.43 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.469 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -62.05 -47.6 83.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.775 0.321 . . . . 0.0 111.065 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 108' ' ' SER . 66.7 m -135.12 81.22 1.88 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.136 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 107' ' ' MET . 19.2 m -127.48 119.45 26.1 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.412 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -105.0 122.11 45.18 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.96 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -79.3 124.24 28.21 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.462 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -136.43 77.85 1.67 Allowed 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.862 0.839 . . . . 0.0 111.829 -177.882 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.578 ' O ' ' HG2' ' A' ' 104' ' ' GLU . . . 44.33 103.0 0.01 OUTLIER Glycine 0 N--CA 1.474 1.223 0 CA-C-N 113.679 -1.6 . . . . 0.0 114.676 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 103' ' ' GLY . 10.7 pt-20 60.75 -14.72 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.85 1.26 . . . . 0.0 113.426 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.82 HD13 HD11 ' A' ' 89' ' ' LEU . 2.8 pp -132.68 145.51 51.11 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-O 120.705 0.288 . . . . 0.0 110.486 178.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.614 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -114.8 155.61 26.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.056 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.584 ' O ' ' HA ' ' A' ' 99' ' ' THR . 15.2 ttm -120.33 122.15 40.2 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 98' ' ' SER . 51.0 m -121.25 129.59 53.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.209 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.1 p -119.43 22.12 11.86 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.886 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.815 ' O ' HG22 ' A' ' 113' ' ' VAL . 61.7 m -92.29 126.19 37.27 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.215 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.502 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 10.8 pt20 -59.9 -28.08 67.27 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.394 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.29 -49.15 76.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.872 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.843 ' O ' HG22 ' A' ' 117' ' ' ILE . 16.6 m -59.43 -40.44 81.71 Favored 'Isoleucine or valine' 0 C--N 1.361 1.068 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.6 tp -56.86 -54.06 50.8 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.684 0.615 . . . . 0.0 111.534 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.502 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 61.4 m-85 -67.02 -42.5 84.8 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.341 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.38 -51.7 68.79 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.542 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.843 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.15 -43.3 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.378 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.49 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -57.88 -30.26 65.7 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.893 0.745 . . . . 0.0 109.79 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.515 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -86.16 -19.92 29.37 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.09 176.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.15 15.65 29.96 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.696 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.4 p -107.22 8.42 29.95 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.95 -138.02 9.84 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.261 -0.744 . . . . 0.0 112.641 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.56 171.19 16.14 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 123.332 2.688 . . . . 0.0 113.557 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.481 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -51.11 -57.16 9.43 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.211 1.004 . . . . 0.0 111.604 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.5 mmtt -140.03 156.59 46.54 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.533 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 73.5 m -149.26 161.83 41.24 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.6 tp -126.61 115.7 19.88 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.326 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.648 HD13 HD13 ' A' ' 53' ' ' LEU . 13.3 pt -97.4 102.12 13.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.781 0.801 . . . . 0.0 109.685 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.5 t -119.36 121.86 40.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.606 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 83' ' ' THR . 8.9 tp -67.32 113.7 5.43 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.111 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.24 173.17 6.08 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-N 114.714 -1.13 . . . . 0.0 114.314 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -128.49 178.23 6.44 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.314 0.578 . . . . 0.0 110.73 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -114.23 129.54 56.63 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.151 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.61 147.56 17.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.37 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.413 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 29.6 m-90 -125.33 136.31 53.34 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 123.886 0.403 . . . . 0.0 110.35 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -80.19 158.27 26.32 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.901 0.751 . . . . 0.0 110.66 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.76 89.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.16 -23.79 7.57 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.161 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -56.58 -46.31 80.85 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.949 0.5 . . . . 0.0 112.231 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.573 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.4 tp -67.22 -47.88 69.51 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -57.35 -30.55 64.93 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.467 0.479 . . . . 0.0 110.77 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.19 -50.3 41.56 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.914 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.6 pt-20 -71.85 -26.7 62.47 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.924 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.0 tp -75.06 -39.23 61.02 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.833 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.5 m -78.14 -30.37 49.27 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.507 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.5 t70 -80.24 0.49 32.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.674 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 59.72 29.85 19.43 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.826 0.85 . . . . 0.0 111.645 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.32 -41.75 19.66 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.794 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -123.47 112.21 17.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.9 tp -84.13 138.37 33.06 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.533 0.206 . . . . 0.0 111.148 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.9 p -105.19 138.89 40.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.311 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.2 m -152.57 155.47 32.7 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.725 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.413 ' HA ' ' CD2' ' A' ' 12' ' ' HIS . 31.7 Cg_exo -59.06 153.52 51.35 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.332 2.021 . . . . 0.0 111.12 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.461 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -129.09 168.36 16.21 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.75 135.76 24.01 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.138 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.414 ' HG3' ' OE1' ' A' ' 104' ' ' GLU . 72.9 Cg_endo -73.48 -26.48 14.12 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 122.591 2.194 . . . . 0.0 113.687 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.43 -40.44 62.2 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.885 0.74 . . . . 0.0 112.132 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.604 HD13 HH12 ' A' ' 167' ' ' ARG . 4.8 mt -71.68 -34.8 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.385 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.33 -36.96 63.69 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.279 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -84.92 -35.32 22.18 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -84.13 -72.45 0.46 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.006 0.367 . . . . 0.0 111.624 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.886 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.67 99.61 6.23 Favored Pre-proline 0 C--N 1.348 0.539 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.852 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 64.7 Cg_endo -91.24 -0.84 4.78 Favored 'Trans proline' 0 CA--C 1.569 2.266 0 C-N-CA 121.637 1.558 . . . . 0.0 114.271 175.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.648 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 74.6 Cg_endo -74.18 -52.95 0.12 Allowed 'Trans proline' 0 C--N 1.392 2.861 0 C-N-CA 122.656 2.238 . . . . 0.0 114.519 -178.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.53 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.5 mt-10 -122.17 -30.35 4.04 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.746 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.886 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 5.0 tp10 -69.8 -11.42 60.84 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.364 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.784 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.96 -41.71 41.99 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.296 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.38 -50.04 42.92 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -58.29 -49.0 78.68 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.717 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.672 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.34 -39.96 94.94 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.122 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.13 -46.72 79.1 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.626 0.579 . . . . 0.0 110.461 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.45 91.24 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.398 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.6 -27.81 68.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.705 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.672 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.7 -40.01 42.77 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 122.876 0.47 . . . . 0.0 110.4 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -72.82 -30.37 64.0 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.44 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.744 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.841 179.68 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 32' ' ' LEU . 20.7 mt . . . . . 0 N--CA 1.466 0.37 0 CA-C-O 121.063 0.458 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -89.79 16.37 8.15 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.642 -177.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 173.06 56.75 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.141 0.976 . . . . 0.0 110.161 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -135.82 161.67 34.96 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.654 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.465 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.4 m-30 -97.68 136.29 38.25 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.853 HD11 HD23 ' A' ' 32' ' ' LEU . 2.8 mt -108.49 136.6 47.83 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.703 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.426 HG23 HG22 ' A' ' 29' ' ' VAL . 2.7 mp -120.85 131.4 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.44 126.61 30.26 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.588 0.555 . . . . 0.0 111.92 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.2 mmt -114.29 155.26 45.94 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.22 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -79.47 75.82 4.86 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.662 2.241 . . . . 0.0 112.593 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -132.32 -20.35 2.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.779 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.34 -163.54 0.86 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.324 0.39 . . . . 0.0 110.46 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.51 36.31 2.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.925 0.393 . . . . 0.0 111.861 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.1 m-20 -111.1 82.97 3.49 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.798 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.38 -22.78 13.82 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.969 2.446 . . . . 0.0 113.417 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -85.13 -37.78 19.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.94 0.496 . . . . 0.0 111.713 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.6 -3.22 56.66 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.823 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -61.17 1.99 0.15 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -141.77 40.33 1.68 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.187 0.518 . . . . 0.0 112.005 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 p -123.71 156.09 36.6 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.535 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.702 HG11 ' HE ' ' A' ' 167' ' ' ARG . 48.9 t -130.41 132.03 64.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.89 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -114.59 154.01 29.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.341 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.412 ' OH ' HD21 ' A' ' 105' ' ' LEU . 42.9 t80 -107.21 119.24 38.86 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.853 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -83.52 109.95 17.81 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.32 0.581 . . . . 0.0 111.098 -178.637 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.941 HG23 ' HA2' ' A' ' 42' ' ' GLY . 30.3 t -71.85 -63.73 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 113.461 -1.699 . . . . 0.0 110.685 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -133.91 117.96 17.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.537 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -103.0 126.61 50.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.491 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -139.46 152.1 46.74 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.514 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -65.63 -14.86 62.04 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.046 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -103.79 -0.36 29.38 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.302 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.01 169.2 19.32 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 112.064 -0.414 . . . . 0.0 112.064 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.504 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -149.49 149.22 30.41 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.82 137.85 53.25 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.047 178.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.41 159.46 29.79 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.461 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.3 mt -114.58 131.44 56.68 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.794 0.297 . . . . 0.0 111.111 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 78' ' ' GLY . 14.0 t -66.19 123.74 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.531 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.8 55.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.773 0.797 . . . . 0.0 112.064 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.857 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.1 t30 -146.82 -4.0 0.58 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.131 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -130.17 89.5 44.89 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.477 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 41.0 Cg_exo -59.39 139.38 89.4 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 121.483 1.456 . . . . 0.0 111.19 174.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.5 m -76.63 -53.32 8.18 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.1 -9.14 20.87 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.173 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 3.1 mp -82.43 169.64 16.18 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.633 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.0 p-10 -112.47 156.94 21.72 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.689 0.281 . . . . 0.0 111.7 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.822 HD12 HD13 ' A' ' 128' ' ' ILE . 4.5 tt -58.41 -31.71 67.96 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.347 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.46 74.55 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 39.4 mt-10 -65.28 -42.56 93.02 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.735 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.853 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.9 t -61.42 -50.09 81.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.657 ' HA ' HD12 ' A' ' 60' ' ' LEU . 22.1 mt -53.5 -35.23 60.4 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.062 0.851 . . . . 0.0 111.568 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -78.34 -29.46 47.58 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.254 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -31.29 47.85 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.66 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.853 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.3 mt -77.6 -44.93 26.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.83 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -131.35 116.47 16.45 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.583 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.24 -32.82 2.88 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.725 2.95 . . . . 0.0 112.812 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.79 -15.03 55.53 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.293 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.75 149.28 25.39 Favored 'General case' 0 C--N 1.345 0.38 0 O-C-N 123.402 0.439 . . . . 0.0 111.609 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -118.21 123.04 29.73 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.114 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.94 147.77 34.63 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.231 1.954 . . . . 0.0 112.246 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.472 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 8.2 Cg_endo -94.45 -169.83 0.2 Allowed 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 122.608 2.206 . . . . 0.0 112.172 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.75 -24.84 66.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.089 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.492 ' HA ' ' CE1' ' A' ' 72' ' ' HIS . 6.5 ptp180 -67.88 -47.02 70.02 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.707 ' HA ' HD12 ' A' ' 73' ' ' ILE . 13.1 m -75.24 -25.34 58.01 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 50.7 mt-30 -69.57 -30.4 68.17 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 69' ' ' ARG . 13.7 p-80 -94.9 22.33 6.6 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.144 0.497 . . . . 0.0 111.461 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 70' ' ' CYS . 62.8 mt -118.3 136.17 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.318 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 1.7 m-20 -103.49 158.39 16.39 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.787 HD13 HD12 ' A' ' 128' ' ' ILE . 22.4 mm -108.23 149.1 11.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.991 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.736 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -115.54 156.62 25.4 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.82 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -86.4 120.32 27.62 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.0 -23.42 9.21 Favored Glycine 0 C--N 1.345 1.044 0 C-N-CA 120.322 -0.942 . . . . 0.0 114.134 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.23 -167.59 35.01 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.261 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -88.15 -11.39 4.47 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.521 2.814 . . . . 0.0 114.173 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 t -86.84 127.16 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.088 0.242 . . . . 0.0 110.563 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 49.68 76.88 0.12 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.127 0.971 . . . . 0.0 112.518 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.463 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.8 t -80.87 1.96 28.54 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.687 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -103.78 3.95 34.61 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -132.91 155.18 49.53 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.211 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.42 127.4 8.47 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.982 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -85.91 144.24 27.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.482 1.113 . . . . 0.0 110.383 179.499 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.6 t -121.82 104.71 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 123.231 0.332 . . . . 0.0 110.852 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.862 HD11 HD13 ' A' ' 105' ' ' LEU . 9.9 tp -106.98 129.03 54.84 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.946 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -127.8 168.77 14.17 Favored Pre-proline 0 CA--C 1.555 1.136 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.54 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.677 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.03 13.77 0.89 Allowed 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.784 2.322 . . . . 0.0 113.857 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.0 t -101.82 160.38 14.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.726 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.14 21.35 44.59 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.617 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -88.81 152.7 21.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.616 0.366 . . . . 0.0 110.511 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.526 ' HA ' HG21 ' A' ' 99' ' ' THR . 10.0 m -131.02 156.9 44.35 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.569 ' CE2' HG23 ' A' ' 113' ' ' VAL . 40.1 m-85 -123.87 -150.86 0.46 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.753 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -58.27 -46.68 85.58 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.604 0.362 . . . . 0.0 111.488 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.9 m -132.77 80.81 1.91 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.097 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.526 HG21 ' HA ' ' A' ' 95' ' ' SER . 31.7 m -130.45 130.04 43.75 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.756 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -110.16 123.6 50.04 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.791 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.36 125.41 30.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.271 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.578 ' HB3' HD12 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -119.39 44.63 2.31 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.609 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.41 -101.6 0.4 Allowed Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.354 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -56.29 -14.27 2.75 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.862 HD13 HD11 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -160.81 160.95 31.8 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.844 0.458 . . . . 0.0 110.821 -179.31 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.571 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -119.49 158.23 26.69 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.76 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.508 ' CE ' HD13 ' A' ' 89' ' ' LEU . 15.8 ttm -123.23 130.07 52.25 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.67 ' HB3' HG11 ' A' ' 113' ' ' VAL . 70.2 m -124.83 129.27 50.09 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.871 0.367 . . . . 0.0 110.257 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.7 p -120.87 21.0 11.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.335 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.755 ' O ' HG12 ' A' ' 113' ' ' VAL . 35.5 p -93.48 127.81 39.3 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.517 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 20.8 pt20 -60.99 -28.67 69.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.926 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.31 -39.68 94.39 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.497 -1.228 . . . . 0.0 110.198 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 110' ' ' SER . 2.9 p -70.11 -37.7 72.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mt -56.82 -47.96 79.09 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.532 0.52 . . . . 0.0 110.239 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.517 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 32.1 m-85 -66.54 -42.61 86.91 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.017 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.72 -53.88 52.07 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.888 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.69 -43.2 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.549 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -57.34 -31.73 66.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.716 0.635 . . . . 0.0 109.602 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.417 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.98 -19.44 32.08 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.331 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.97 17.06 28.78 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.697 -1.138 . . . . 0.0 114.575 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.8 p -107.39 7.7 29.21 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.08 -137.34 8.58 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-O 119.168 -0.795 . . . . 0.0 112.628 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -80.78 172.1 13.62 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 123.13 2.554 . . . . 0.0 113.545 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.01 -55.34 33.99 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.86 0.864 . . . . 0.0 111.994 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.677 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.0 mmtt -141.16 139.82 33.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.667 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 73.1 m -139.51 166.39 24.7 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 tp -127.19 117.79 23.02 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.273 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.822 HD13 HD12 ' A' ' 53' ' ' LEU . 10.9 pt -97.49 102.31 13.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-O 121.724 0.774 . . . . 0.0 109.778 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.2 t -118.98 121.08 39.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.907 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 10.9 tp -67.51 112.73 4.84 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.355 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.65 172.44 11.82 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 115.012 -0.994 . . . . 0.0 114.376 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -128.68 176.36 7.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.333 0.587 . . . . 0.0 110.908 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -115.82 130.71 56.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.029 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.52 149.11 18.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.447 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 21.1 m-90 -127.26 135.89 51.23 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 122.579 0.351 . . . . 0.0 110.381 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.34 158.15 27.52 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.863 0.727 . . . . 0.0 110.876 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.95 91.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.8 -24.47 7.51 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.11 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.88 -45.35 86.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -67.97 -48.05 66.9 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.136 0.273 . . . . 0.0 110.516 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.01 -29.11 68.26 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.008 0.432 . . . . 0.0 110.667 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.38 -50.48 38.29 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.938 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -70.09 -26.5 64.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.773 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.8 tp -75.79 -38.91 57.79 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.804 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.0 m -77.8 -28.37 50.38 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.572 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -82.66 0.96 40.78 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.496 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.88 29.54 19.1 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.874 0.87 . . . . 0.0 111.622 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.66 -43.11 17.32 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.94 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -123.52 113.4 18.68 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.348 0.405 . . . . 0.0 110.043 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.4 tp -83.61 139.81 32.6 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.245 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.4 p -105.81 138.09 42.58 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.513 0.508 . . . . 0.0 111.335 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.6 m -152.73 155.35 32.39 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.713 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.75 157.24 28.89 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.298 1.998 . . . . 0.0 111.182 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.465 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.69 166.97 19.58 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -177.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.22 135.35 23.98 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.997 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.39 -26.46 14.33 Favored 'Trans proline' 0 C--N 1.364 1.363 0 C-N-CA 122.54 2.16 . . . . 0.0 113.785 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.85 -40.6 63.51 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.818 0.699 . . . . 0.0 112.158 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.567 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.6 mt -71.18 -35.24 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.408 0.623 . . . . 0.0 110.388 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.5 tt -73.98 -38.2 64.23 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.437 -177.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -85.57 -32.76 21.94 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -86.69 -72.58 0.5 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.054 0.388 . . . . 0.0 111.636 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.917 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.72 98.84 6.32 Favored Pre-proline 0 C--N 1.349 0.56 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.857 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.5 Cg_endo -92.68 0.2 3.83 Favored 'Trans proline' 0 CA--C 1.57 2.281 0 C-N-CA 121.737 1.625 . . . . 0.0 114.256 175.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.642 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 94.8 Cg_endo -73.28 -52.39 0.15 Allowed 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 122.656 2.237 . . . . 0.0 114.195 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.516 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -122.79 -29.93 3.92 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.664 -178.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.917 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.07 -10.91 60.28 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.407 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.702 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.03 -41.21 43.54 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.151 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -70.47 -50.21 40.47 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.5 m -58.38 -49.25 77.93 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.689 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.669 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.05 -39.81 94.91 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.228 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.42 79.63 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 123.536 0.523 . . . . 0.0 110.424 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.4 90.99 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.448 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.29 -27.87 68.93 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.673 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.66 -40.01 43.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 122.908 0.483 . . . . 0.0 110.412 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.53 -31.96 69.24 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.413 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.784 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.81 179.471 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.495 0.188 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.1 mttp -100.58 141.91 32.8 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.091 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -98.67 -42.02 7.43 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.986 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.546 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 54.5 m -100.69 154.47 18.57 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.456 0.473 . . . . 0.0 110.731 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m -98.51 96.63 3.92 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.089 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.3 Cg_endo -87.6 8.48 4.22 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 122.924 2.416 . . . . 0.0 112.083 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -90.02 -46.14 8.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.342 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -101.84 157.02 17.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.465 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.407 HD12 ' CE1' ' A' ' 35' ' ' HIS . 13.1 mt -94.05 45.91 1.15 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.211 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.403 ' O ' HD21 ' A' ' 102' ' ' LEU . 85.6 mttt -90.19 20.0 4.67 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.928 0.394 . . . . 0.0 111.214 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 175.33 55.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.124 0.97 . . . . 0.0 110.116 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -134.25 159.47 40.86 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.654 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.458 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.5 m-30 -97.75 135.17 39.91 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.737 HD11 HD23 ' A' ' 32' ' ' LEU . 6.0 mt -107.64 138.99 42.87 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.968 177.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.468 HG23 HG22 ' A' ' 29' ' ' VAL . 2.3 mm -117.26 134.11 61.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.14 128.54 33.41 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.749 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 43.2 mtt -113.75 157.4 41.79 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.268 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.56 32.74 0.52 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.655 2.237 . . . . 0.0 113.143 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -86.0 -18.3 32.94 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.71 -163.46 0.86 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.096 0.248 . . . . 0.0 110.451 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.532 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -99.24 31.73 2.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 7.9 m-20 -112.42 80.78 3.68 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.0 Cg_exo -75.44 -21.17 15.32 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 123.11 2.54 . . . . 0.0 113.276 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -85.53 -38.5 18.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.515 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -93.27 2.67 56.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.69 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -68.23 8.24 0.47 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -141.87 39.42 1.65 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.152 0.501 . . . . 0.0 112.186 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.2 p -123.16 156.12 35.68 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.426 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.762 HG11 ' HE ' ' A' ' 167' ' ' ARG . 59.5 t -130.25 132.7 64.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.902 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -113.41 152.91 29.42 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.415 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.521 ' OH ' HD21 ' A' ' 105' ' ' LEU . 43.6 t80 -107.23 120.07 41.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.737 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.04 108.57 17.06 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 123.515 0.509 . . . . 0.0 111.402 -178.361 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.93 HG23 ' HA2' ' A' ' 42' ' ' GLY . 31.2 t -67.45 -59.24 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.713 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -143.65 115.61 8.32 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.1 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.407 ' CE1' HD12 ' A' ' 9' ' ' LEU . 15.5 t-80 -98.01 128.32 44.49 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.912 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -138.92 152.21 47.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.358 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.02 -17.91 64.85 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.881 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -102.31 3.29 37.91 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.52 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.54 166.89 15.16 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.285 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.538 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.92 141.07 27.44 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.91 133.92 55.45 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.125 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.93 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.24 156.84 27.95 Favored Glycine 0 N--CA 1.449 -0.461 0 O-C-N 124.268 0.98 . . . . 0.0 112.492 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.2 mt -113.31 135.24 54.06 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.226 0.513 . . . . 0.0 111.638 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 78' ' ' GLY . 11.6 t -68.77 124.06 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -127.41 55.83 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.688 0.756 . . . . 0.0 111.961 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.841 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -146.87 -4.16 0.57 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.23 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -129.72 87.89 51.09 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.507 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.1 Cg_exo -58.87 141.75 98.37 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 121.635 1.557 . . . . 0.0 112.176 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.446 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.9 m -90.29 158.02 17.37 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.41 0.444 . . . . 0.0 111.649 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.12 49.39 1.38 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.585 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.445 ' C ' HG12 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -133.22 155.36 49.5 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.337 -0.432 . . . . 0.0 109.99 -179.281 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.466 HD22 ' HA ' ' A' ' 71' ' ' GLN . 44.8 p-10 -112.39 161.08 17.08 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.578 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.412 HD13 HD13 ' A' ' 128' ' ' ILE . 8.6 tp -58.36 -27.03 63.83 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.653 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . . . -61.86 -42.79 99.48 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.45 -47.42 79.11 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.052 0.22 . . . . 0.0 111.423 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.875 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.8 m -61.76 -44.49 98.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.73 ' HA ' HD12 ' A' ' 60' ' ' LEU . 12.6 mt -55.54 -36.04 66.32 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.748 177.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.05 -28.14 48.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.409 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.07 -30.04 49.5 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.269 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.875 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.94 -46.22 21.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.759 -1.564 . . . . 0.0 111.372 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -132.7 118.68 15.72 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.003 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.4 -32.36 3.01 Favored 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.628 2.885 . . . . 0.0 112.556 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -82.18 -15.29 53.74 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.294 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.21 149.27 26.92 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 123.283 0.365 . . . . 0.0 111.42 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.94 121.45 31.55 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.64 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.718 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 47.2 Cg_endo -71.4 138.07 32.03 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.555 2.17 . . . . 0.0 112.339 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 66' ' ' PRO . 2.4 Cg_endo -90.07 -156.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.705 2.27 . . . . 0.0 112.532 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.09 -24.88 51.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.264 0.626 . . . . 0.0 111.824 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.511 ' O ' HG13 ' A' ' 73' ' ' ILE . 10.0 ptp180 -67.86 -45.42 74.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 66' ' ' PRO . 19.5 p -65.59 -32.66 74.36 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.466 ' HA ' HD22 ' A' ' 52' ' ' ASN . 48.5 mt-30 -66.97 -26.84 67.02 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.664 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -97.49 8.28 44.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.734 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 69' ' ' ARG . 64.2 mt -113.58 137.73 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.179 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -106.75 163.31 13.03 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.873 0.733 . . . . 0.0 112.937 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.462 ' CD1' HD12 ' A' ' 128' ' ' ILE . 14.0 mm -111.81 152.95 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.598 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.72 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -119.5 153.72 34.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.21 118.76 24.36 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -99.53 -23.93 10.59 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 120.185 -1.007 . . . . 0.0 113.797 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.41 -167.74 35.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.218 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -88.62 -10.53 4.4 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.702 2.935 . . . . 0.0 114.227 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.96 130.39 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 123.023 0.202 . . . . 0.0 111.098 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 45.94 85.02 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.431 1.092 . . . . 0.0 113.194 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 68.6 p -85.91 -5.81 59.17 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.953 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.87 -2.43 58.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.766 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.614 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.66 152.13 51.77 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.47 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.614 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.6 132.21 10.98 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.56 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.696 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -86.19 144.85 27.25 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.047 0.939 . . . . 0.0 110.756 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.29 104.49 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 123.474 0.484 . . . . 0.0 110.514 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.892 HD11 HD13 ' A' ' 105' ' ' LEU . 13.0 tp -108.32 129.53 55.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.213 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -127.04 169.07 12.89 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-O 118.874 -0.584 . . . . 0.0 111.769 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.697 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.5 Cg_endo -98.06 13.83 0.74 Allowed 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.856 2.37 . . . . 0.0 113.802 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.2 t -101.26 160.94 13.98 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.881 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.38 22.03 42.24 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.537 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 tp -86.8 154.05 21.2 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.613 0.365 . . . . 0.0 110.642 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.6 p -127.66 156.3 42.55 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.573 ' CE2' HG23 ' A' ' 113' ' ' VAL . 54.9 m-85 -129.96 -152.31 0.51 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.811 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -57.64 -46.58 83.98 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.76 0.424 . . . . 0.0 111.615 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 64.4 m -135.92 83.56 2.02 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.259 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.3 m -130.63 130.37 43.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.835 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.99 123.34 48.97 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.626 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.19 129.14 34.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.071 0.462 . . . . 0.0 110.747 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -125.12 46.27 2.39 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.419 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.12 -106.12 1.41 Allowed Glycine 0 C--N 1.336 0.575 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.162 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.6 -10.64 3.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.892 HD13 HD11 ' A' ' 89' ' ' LEU . 2.3 pp -156.12 153.29 29.09 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.237 0.335 . . . . 0.0 111.508 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.641 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -117.43 156.12 28.49 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.545 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.58 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 17.5 ttm -121.48 126.14 48.55 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.7 ' HB3' HG11 ' A' ' 113' ' ' VAL . 22.7 m -122.29 128.05 50.61 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.192 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.5 p -118.05 13.04 13.82 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.44 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.771 ' O ' HG12 ' A' ' 113' ' ' VAL . 32.2 p -87.91 127.06 35.36 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.644 0.735 . . . . 0.0 111.952 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.49 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 21.1 pt20 -59.32 -29.11 67.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.358 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.97 -43.07 96.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.541 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 110' ' ' SER . 4.7 p -67.76 -37.62 78.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.521 HD22 ' NH2' ' A' ' 85' ' ' ARG . 5.0 tp -58.4 -47.86 82.53 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 123.552 0.532 . . . . 0.0 110.266 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.49 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 26.4 m-85 -67.66 -39.91 84.51 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.813 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -52.45 64.74 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.351 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.719 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.93 -43.65 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.546 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.65 -32.32 65.25 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.774 0.671 . . . . 0.0 109.642 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.55 -20.03 32.18 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.238 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.44 14.41 32.77 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 114.693 -1.14 . . . . 0.0 114.785 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.8 p -104.58 7.55 35.14 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.23 -138.1 9.68 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 119.207 -0.774 . . . . 0.0 112.625 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.9 173.88 11.55 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 123.292 2.661 . . . . 0.0 113.536 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.21 -54.75 43.24 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.716 0.806 . . . . 0.0 111.962 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.697 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.9 mmtt -141.58 139.96 33.26 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.873 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 34.6 p -137.45 166.33 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.0 tp -126.97 116.06 20.2 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.577 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.696 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 11.5 pt -98.47 102.7 13.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.779 0.799 . . . . 0.0 109.647 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.4 t -123.01 123.98 42.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.818 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.36 115.79 7.4 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.493 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.414 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 66.75 172.47 5.09 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.633 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -128.41 -177.51 4.2 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.313 0.578 . . . . 0.0 110.864 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -118.48 127.9 54.08 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.093 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.23 143.06 14.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.474 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.406 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 27.9 m-90 -119.28 137.37 53.72 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.773 0.337 . . . . 0.0 110.404 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -81.75 158.15 24.27 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.878 0.737 . . . . 0.0 110.539 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.56 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.81 -25.2 7.27 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.072 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -57.95 -44.58 87.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.93 0.492 . . . . 0.0 112.275 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.581 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.6 -47.76 65.87 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.146 0.279 . . . . 0.0 110.605 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.1 -29.53 68.65 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.958 0.408 . . . . 0.0 110.619 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.14 -50.36 41.31 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.872 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.0 pt-20 -70.17 -26.68 64.03 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.787 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tp -74.77 -38.94 62.04 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.645 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.3 m -77.84 -28.34 50.15 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.352 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.8 t70 -82.64 -0.28 46.45 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.472 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 60.07 29.01 18.62 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.865 0.866 . . . . 0.0 111.787 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.13 -42.8 18.62 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.942 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -125.58 115.25 19.87 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.0 tp -86.45 143.14 27.92 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.506 0.194 . . . . 0.0 111.465 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.9 p -103.7 135.91 44.39 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.058 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 76.9 m -151.23 155.06 34.55 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.626 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.88 159.19 26.02 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.253 1.969 . . . . 0.0 111.244 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.458 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -131.94 166.59 21.31 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -135.69 135.12 21.4 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.963 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.19 -26.41 14.81 Favored 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.597 2.198 . . . . 0.0 113.682 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.81 -40.57 63.38 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.847 0.717 . . . . 0.0 112.135 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.565 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.5 mt -71.43 -35.5 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.366 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.71 -37.79 65.04 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.482 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -84.86 -34.71 22.57 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -84.71 -72.52 0.47 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.924 0.329 . . . . 0.0 111.637 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.894 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.64 99.42 6.28 Favored Pre-proline 0 C--N 1.349 0.563 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.841 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.4 Cg_endo -91.86 -0.45 4.36 Favored 'Trans proline' 0 CA--C 1.57 2.284 0 C-N-CA 121.716 1.611 . . . . 0.0 114.262 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.642 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 77.6 Cg_endo -73.96 -52.34 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 122.589 2.193 . . . . 0.0 114.437 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.519 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.7 mt-10 -122.45 -30.02 4.01 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.714 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.894 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.1 tt0 -70.23 -10.85 60.14 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.391 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.762 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.06 -40.52 45.92 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.145 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -71.36 -49.88 37.79 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.207 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.1 t -58.41 -49.03 78.76 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.504 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.67 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.7 -40.25 95.05 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.249 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.21 78.52 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 123.516 0.51 . . . . 0.0 110.534 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.16 90.07 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.495 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.3 -27.69 68.8 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.538 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.67 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.73 -40.15 42.11 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 122.92 0.488 . . . . 0.0 110.264 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.37 -32.0 69.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.38 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.93 53.52 0.48 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.933 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.94 147.11 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -89.4 78.47 7.17 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.653 0.74 . . . . 0.0 110.654 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.71 -26.15 49.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.801 -1.09 . . . . 0.0 112.149 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.8 m -58.67 -42.65 88.93 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.55 -26.68 51.15 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.7 mt -77.08 -36.2 56.01 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.249 0.343 . . . . 0.0 111.87 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.0 p -92.71 -48.0 6.8 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.319 0.387 . . . . 0.0 111.198 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 59.03 125.32 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.241 1.017 . . . . 0.0 112.849 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -98.98 151.0 21.4 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.962 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -96.91 131.04 44.09 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.262 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -179.43 -112.68 0.35 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.429 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -101.85 144.04 30.99 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.658 0.269 . . . . 0.0 110.811 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.12 -0.943 . . . . 0.0 111.184 -179.969 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.495 0.188 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -100.34 107.91 19.81 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -140.06 -45.65 0.43 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.156 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.582 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 44.4 p -129.76 -40.0 1.4 Allowed 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.32 0.388 . . . . 0.0 111.504 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.0 m -106.31 88.27 3.12 Favored Pre-proline 0 CA--C 1.545 0.759 0 O-C-N 123.434 0.458 . . . . 0.0 110.978 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.3 Cg_endo -87.73 9.13 3.93 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.011 2.474 . . . . 0.0 112.378 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -86.53 168.33 13.8 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.367 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 65.26 149.76 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.264 1.025 . . . . 0.0 112.6 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 32' ' ' LEU . 15.0 mt -102.87 48.22 0.87 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.961 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -90.58 19.14 5.57 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.908 0.385 . . . . 0.0 111.072 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 175.88 55.96 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.087 0.955 . . . . 0.0 110.17 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -134.94 159.35 41.74 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.618 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.462 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.6 m-30 -98.08 135.12 40.21 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.09 0.471 . . . . 0.0 112.153 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.743 HD11 HD23 ' A' ' 32' ' ' LEU . 6.1 mt -108.7 137.6 46.37 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.785 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.416 HG23 HG22 ' A' ' 29' ' ' VAL . 2.9 mp -120.51 132.69 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.82 127.57 33.17 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.722 0.639 . . . . 0.0 112.003 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.8 mmt -110.26 158.19 35.94 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.179 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -80.55 21.4 0.86 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.693 2.262 . . . . 0.0 113.549 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -83.07 -19.38 36.94 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.592 ' SD ' ' HB1' ' A' ' 148' ' ' ALA . 15.9 ptt? -102.31 -164.75 1.12 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.272 0.357 . . . . 0.0 110.38 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.545 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -106.74 30.9 5.68 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 7.9 m-20 -110.44 84.84 4.15 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.712 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.3 Cg_exo -75.31 -23.8 12.96 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.059 2.506 . . . . 0.0 113.48 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -85.11 -37.01 20.75 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.794 0.438 . . . . 0.0 111.557 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.85 3.06 55.97 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.499 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -66.78 5.82 0.58 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -140.83 38.84 1.81 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.116 0.484 . . . . 0.0 112.156 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 p -123.14 155.02 37.84 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.417 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.701 HG11 ' HE ' ' A' ' 167' ' ' ARG . 50.1 t -130.5 131.95 64.85 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.856 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -113.6 153.58 28.6 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.365 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.493 ' OH ' HD21 ' A' ' 105' ' ' LEU . 42.9 t80 -106.99 119.63 39.89 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.743 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -83.84 109.24 17.4 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.3 0.571 . . . . 0.0 111.25 -178.39 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.938 HG23 ' HA2' ' A' ' 42' ' ' GLY . 31.6 t -69.03 -59.65 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.674 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -141.96 114.34 8.3 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.337 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -97.45 128.29 44.11 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.754 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -139.4 152.64 47.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.34 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -65.11 -18.13 65.04 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.797 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -100.56 1.56 41.01 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.432 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.32 167.3 15.57 Favored Glycine 0 C--N 1.345 1.055 0 C-N-CA 121.541 -0.361 . . . . 0.0 112.205 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.02 142.49 29.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -120.62 135.51 55.08 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.57 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.75 156.95 27.97 Favored Glycine 0 N--CA 1.449 -0.448 0 O-C-N 124.364 1.04 . . . . 0.0 112.817 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.0 mt -111.93 131.63 55.26 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.9 0.35 . . . . 0.0 110.974 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 78' ' ' GLY . 18.1 t -66.89 125.35 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -128.22 55.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.715 0.769 . . . . 0.0 112.22 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.839 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -147.19 -4.61 0.53 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.308 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.68 87.89 51.21 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.507 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.1 Cg_exo -59.3 141.11 97.32 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.631 1.554 . . . . 0.0 112.004 175.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.419 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 46.0 m -89.32 159.12 17.53 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.253 0.346 . . . . 0.0 111.638 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.28 45.55 1.46 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.363 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.7 154.37 51.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.442 HD22 ' HA ' ' A' ' 71' ' ' GLN . 16.6 p-10 -104.17 161.09 14.32 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.294 0.371 . . . . 0.0 110.783 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.664 ' HA ' HD11 ' A' ' 75' ' ' ILE . 15.3 tp -58.19 -35.78 72.11 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.25 61.14 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.525 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.65 -43.22 97.42 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.855 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -62.28 -48.31 88.96 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.545 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.747 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.5 mp -52.89 -36.63 59.6 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.977 0.798 . . . . 0.0 111.024 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -78.06 -28.62 48.94 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.466 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.29 -30.27 48.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.368 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.855 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.0 mt -77.89 -44.98 25.45 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.86 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -132.48 116.79 15.24 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.441 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.72 -32.66 2.64 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.619 2.879 . . . . 0.0 112.835 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -82.38 -13.99 55.96 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.429 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.3 148.63 25.53 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 123.329 0.393 . . . . 0.0 111.734 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.6 123.03 31.91 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.149 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 58.8 Cg_endo -75.17 144.46 29.71 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.244 1.963 . . . . 0.0 112.553 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 66' ' ' PRO . 5.8 Cg_endo -92.8 -169.73 0.25 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.657 2.238 . . . . 0.0 112.248 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.48 -24.61 67.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.303 0.641 . . . . 0.0 112.202 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.58 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 9.1 ptp180 -66.76 -55.58 14.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.707 ' HA ' HD12 ' A' ' 73' ' ' ILE . 69.1 m -70.89 -25.56 62.84 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.442 ' HA ' HD22 ' A' ' 52' ' ' ASN . 49.6 mt-30 -68.77 -32.76 72.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.772 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -91.77 19.56 6.38 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.614 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 70' ' ' CYS . 52.0 mt -122.28 140.92 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.858 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.414 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.6 m-20 -109.02 152.37 25.09 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.814 0.696 . . . . 0.0 112.44 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.826 HD13 HD12 ' A' ' 128' ' ' ILE . 14.6 mm -99.6 153.48 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.237 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.717 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -120.24 152.48 37.68 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.7 119.42 24.28 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.76 0.254 . . . . 0.0 110.823 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -100.58 -23.76 9.9 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.732 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.04 -167.75 34.93 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.182 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -88.49 -8.28 5.4 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.614 2.876 . . . . 0.0 114.235 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.29 128.83 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 123.07 0.231 . . . . 0.0 111.087 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 45.01 86.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.532 1.133 . . . . 0.0 113.326 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.405 ' O ' HD21 ' A' ' 130' ' ' LEU . 78.3 p -86.68 -2.45 58.53 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.995 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -88.68 -4.46 58.54 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.895 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.599 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.2 153.01 51.93 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.134 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.599 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.51 131.12 10.41 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.07 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.714 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.6 OUTLIER -85.59 151.13 24.15 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.253 1.021 . . . . 0.0 110.428 -179.647 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.633 ' HB ' ' OG ' ' A' ' 108' ' ' SER . 3.4 t -128.37 106.39 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 O-C-N 123.312 0.383 . . . . 0.0 111.159 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.923 HD11 HD13 ' A' ' 105' ' ' LEU . 14.6 tp -108.45 127.79 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.041 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.402 ' NE2' ' HB3' ' A' ' 106' ' ' ALA . 4.2 p80 -128.42 168.27 16.25 Favored Pre-proline 0 CA--C 1.554 1.11 0 O-C-N 123.669 0.606 . . . . 0.0 111.411 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.667 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 14.8 Cg_endo -95.39 14.21 1.19 Allowed 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 122.526 2.151 . . . . 0.0 113.39 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 t -101.17 159.7 15.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.861 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.3 18.9 55.84 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.714 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.99 154.83 24.29 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.499 0.32 . . . . 0.0 110.922 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.4 p -126.37 157.64 37.97 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.593 ' CE2' HG23 ' A' ' 113' ' ' VAL . 50.3 m-85 -129.9 -149.54 0.4 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.433 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -61.15 -45.73 93.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.55 0.34 . . . . 0.0 111.18 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.3 m -137.54 83.06 1.96 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.234 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 107' ' ' MET . 8.0 m -128.22 122.35 31.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.718 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -99.89 120.77 40.3 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.987 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -83.54 127.26 33.59 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.167 0.508 . . . . 0.0 110.331 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.503 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.43 46.91 2.1 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.44 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.28 -107.72 2.09 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.103 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.41 -10.03 4.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.923 HD13 HD11 ' A' ' 89' ' ' LEU . 2.0 pp -155.14 153.63 31.08 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.256 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.593 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -121.47 158.57 28.12 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.783 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.592 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 25.8 tpp -125.28 140.12 53.11 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.689 ' HB2' HG11 ' A' ' 113' ' ' VAL . 21.4 p -134.06 133.16 40.85 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.933 0.396 . . . . 0.0 110.351 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.4 p -117.14 16.51 14.95 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.049 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.739 ' O ' HG12 ' A' ' 113' ' ' VAL . 67.0 m -89.66 127.78 35.97 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.636 0.731 . . . . 0.0 112.023 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.479 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 10.1 pt20 -61.43 -28.81 69.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.973 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -65.81 -42.17 90.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.669 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 110' ' ' SER . 3.8 p -67.38 -39.9 83.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.466 HD22 ' NH2' ' A' ' 85' ' ' ARG . 6.4 tp -58.97 -47.36 85.41 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 123.592 0.557 . . . . 0.0 110.469 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.479 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 24.1 m-85 -69.36 -38.47 78.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.914 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.81 66.76 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.043 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.75 -43.47 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.348 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.25 -31.56 65.67 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.74 0.65 . . . . 0.0 109.588 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.58 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.63 -20.15 31.81 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.238 176.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.15 14.85 32.23 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.648 -1.16 . . . . 0.0 114.602 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.1 p -105.14 7.3 33.71 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.19 -138.74 10.01 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.715 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.8 168.06 17.94 Favored 'Trans proline' 0 C--N 1.367 1.526 0 C-N-CA 123.255 2.637 . . . . 0.0 113.956 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.501 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -51.11 -59.2 4.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.511 1.125 . . . . 0.0 111.897 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.667 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -140.19 139.88 35.78 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.783 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 32.6 p -137.93 168.38 19.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.66 118.25 23.5 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.685 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.826 HD12 HD13 ' A' ' 75' ' ' ILE . 12.0 pt -98.12 102.24 13.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 121.782 0.801 . . . . 0.0 109.738 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 5.6 t -119.35 122.36 41.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.847 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.405 HD21 ' O ' ' A' ' 83' ' ' THR . 6.5 tp -66.85 114.62 5.84 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.195 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.43 176.02 5.69 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.737 -1.119 . . . . 0.0 114.385 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -128.58 -178.55 4.63 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.437 0.636 . . . . 0.0 110.957 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -118.49 128.77 54.91 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.977 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.7 147.27 17.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.532 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 -125.46 136.86 53.82 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.93 0.429 . . . . 0.0 110.303 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.43 158.27 27.37 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.94 0.775 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.0 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.21 -25.6 7.75 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.182 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -57.84 -44.15 86.32 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.886 0.474 . . . . 0.0 112.257 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.59 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.72 -47.13 67.12 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.575 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -60.49 -29.4 69.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.025 0.44 . . . . 0.0 110.38 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.14 -50.09 43.98 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.802 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.35 -26.65 63.84 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.766 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.7 tp -75.0 -38.38 61.62 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.623 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.6 t -77.87 -28.65 50.05 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.12 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -82.46 0.02 44.19 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.429 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.44 29.82 19.43 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.839 0.856 . . . . 0.0 111.869 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.592 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -83.16 -42.44 17.31 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.942 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -124.03 113.6 18.62 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.5 tp -84.36 141.9 30.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.643 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.0 p -103.27 134.85 45.98 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.651 0.595 . . . . 0.0 111.057 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 153' ' ' PRO . 48.8 t -150.02 144.53 17.71 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.414 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 152' ' ' CYS . 57.1 Cg_exo -53.0 157.45 8.12 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.467 2.111 . . . . 0.0 111.595 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.462 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.02 167.39 18.34 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -135.21 135.4 22.63 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 114.173 -1.376 . . . . 0.0 107.919 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.46 -26.4 14.25 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.601 2.2 . . . . 0.0 113.727 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.71 -40.66 63.2 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.832 0.708 . . . . 0.0 112.199 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.577 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.8 mt -71.25 -35.35 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.4 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -74.06 -37.55 64.23 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.438 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -84.87 -33.88 22.73 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -85.89 -72.63 0.48 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.016 0.371 . . . . 0.0 111.654 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.905 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.36 99.49 6.43 Favored Pre-proline 0 C--N 1.348 0.531 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.839 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 67.9 Cg_endo -92.01 -0.22 4.26 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 C-N-CA 121.678 1.585 . . . . 0.0 114.317 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.643 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 81.7 Cg_endo -73.98 -52.62 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.894 0 C-N-CA 122.61 2.206 . . . . 0.0 114.361 -178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.52 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.15 -30.09 4.09 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.691 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.905 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 4.9 tp10 -70.0 -11.12 60.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.388 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.701 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.93 -41.61 42.71 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.259 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -70.36 -50.24 41.03 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.4 m -58.39 -49.57 76.8 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.656 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -63.99 -39.58 94.43 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.037 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.95 -45.48 78.82 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.583 0.552 . . . . 0.0 110.508 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.03 93.12 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.441 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 177' ' ' VAL . . . -64.58 -28.06 69.38 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.663 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.96 -40.18 40.25 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 122.865 0.466 . . . . 0.0 110.43 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.83 -33.77 75.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.407 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 129.46 40.86 0.26 Allowed Glycine 0 C--N 1.34 0.78 0 C-N-CA 121.06 -0.591 . . . . 0.0 113.175 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 173' ' ' ALA . 4.3 t -129.2 133.64 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -88.84 83.56 6.66 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.588 0.709 . . . . 0.0 111.033 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.97 -26.29 48.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.803 -1.089 . . . . 0.0 112.421 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.3 m -58.17 -44.85 88.19 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 pp -77.3 -26.98 52.78 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.15 -29.94 54.81 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.579 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.7 p -90.93 -48.03 7.24 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.454 0.471 . . . . 0.0 111.36 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.67 119.19 22.04 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.443 0.464 . . . . 0.0 111.004 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -100.67 137.54 38.93 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.77 136.15 52.02 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.145 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 153.65 -127.13 2.09 Favored Glycine 0 C--N 1.337 0.607 0 O-C-N 123.632 0.583 . . . . 0.0 112.537 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -99.19 -40.67 7.86 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.311 0.245 . . . . 0.0 111.302 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.126 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.572 0.225 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.1 mttp -100.53 137.56 38.78 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.068 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -99.23 -41.85 7.29 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.09 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.53 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.9 m -100.28 153.98 18.85 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.6 m -96.91 97.93 4.06 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.965 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.2 Cg_endo -87.2 8.83 4.16 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.879 2.386 . . . . 0.0 112.212 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.1 t -89.2 -47.32 8.15 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.313 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.537 ' CD1' ' HE3' ' A' ' 10' ' ' LYS . 3.8 m-85 -117.31 153.39 33.05 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.513 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.437 ' O ' HD12 ' A' ' 32' ' ' LEU . 8.9 mt -97.86 43.39 1.07 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.829 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.537 ' HE3' ' CD1' ' A' ' 8' ' ' TYR . 87.8 mttt -89.44 20.8 3.67 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.846 0.355 . . . . 0.0 111.355 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 174.66 54.62 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.024 0.929 . . . . 0.0 110.172 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -133.42 160.64 36.8 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.721 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.48 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.2 m-30 -97.97 137.68 36.42 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.821 HD11 HD23 ' A' ' 32' ' ' LEU . 2.8 mt -110.49 140.56 44.64 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.913 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mp -125.43 135.53 63.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.77 122.86 21.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.075 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -105.53 156.07 37.01 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -80.92 31.94 0.51 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.67 2.247 . . . . 0.0 113.197 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -87.36 -17.63 31.93 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.53 -169.6 1.65 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 123.076 0.235 . . . . 0.0 110.783 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.559 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -105.62 42.94 1.17 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.141 0.496 . . . . 0.0 111.561 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.48 81.83 2.54 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.934 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.2 Cg_exo -75.45 -22.16 14.32 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 123.083 2.522 . . . . 0.0 113.431 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -84.49 -36.49 22.2 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.871 0.468 . . . . 0.0 111.791 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.62 3.98 52.63 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.948 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.7 163.6 21.18 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 48.6 31.88 3.18 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.8 p -115.57 153.95 30.29 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 120.564 0.221 . . . . 0.0 110.735 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.968 HG11 HH11 ' A' ' 167' ' ' ARG . 24.6 t -127.58 132.1 69.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.805 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 m -114.84 152.59 31.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.889 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.496 ' OH ' HD21 ' A' ' 105' ' ' LEU . 38.0 t80 -106.59 118.43 36.64 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.821 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.4 107.95 15.45 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 111.122 -178.633 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.939 HG23 ' HA2' ' A' ' 42' ' ' GLY . 54.0 t -63.66 -61.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.811 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -145.49 116.41 7.79 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.09 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -98.06 127.74 44.18 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.559 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -139.09 152.9 47.89 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.545 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.83 -19.2 65.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.804 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.38 7.48 42.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.393 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.81 166.22 12.49 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.394 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.455 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.92 145.27 30.63 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.408 ' O ' HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -124.72 137.41 54.35 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.474 178.383 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.939 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.93 156.53 27.42 Favored Glycine 0 N--CA 1.447 -0.617 0 O-C-N 124.403 1.065 . . . . 0.0 112.566 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.408 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.6 mt -111.16 133.32 53.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 117.108 0.454 . . . . 0.0 111.042 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 78' ' ' GLY . 15.0 t -69.09 123.68 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.714 ' O ' ' HG3' ' A' ' 167' ' ' ARG . 1.5 pt -127.68 52.52 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.232 0.539 . . . . 0.0 112.335 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.93 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.5 t30 -144.56 -1.36 0.9 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.133 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -129.53 87.08 54.03 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.511 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 31.4 Cg_exo -59.2 144.58 99.33 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.805 1.67 . . . . 0.0 112.65 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.428 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 51.5 m -94.33 158.65 15.48 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.503 0.502 . . . . 0.0 111.371 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.75 50.69 1.22 Allowed Glycine 0 C--N 1.339 0.696 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.742 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mt -133.77 157.74 45.1 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 122.851 0.461 . . . . 0.0 110.151 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -112.25 157.37 21.01 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.198 0.311 . . . . 0.0 110.172 178.251 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.675 HD13 HD13 ' A' ' 128' ' ' ILE . 14.0 tp -56.81 -36.47 69.96 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.464 ' HB3' ' OD1' ' A' ' 52' ' ' ASN . . . -55.53 -35.32 65.53 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -64.67 -45.27 87.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.286 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.891 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 31.6 m -63.24 -43.48 98.76 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.713 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.0 mp -54.98 -36.75 65.72 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.83 0.706 . . . . 0.0 110.205 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -77.84 -27.78 49.98 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.499 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -30.46 49.2 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.286 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.891 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.3 mt -77.87 -44.96 25.63 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.923 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -132.04 116.1 15.54 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.459 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.72 -32.88 2.52 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 123.611 2.874 . . . . 0.0 112.841 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.09 -14.09 56.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.414 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.35 149.26 24.62 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 123.33 0.394 . . . . 0.0 111.814 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -116.55 122.78 31.34 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.949 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.43 151.05 37.18 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.297 1.998 . . . . 0.0 112.506 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.2 Cg_endo -92.36 -162.59 0.1 Allowed 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.617 2.211 . . . . 0.0 111.706 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.446 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -73.25 -24.95 60.53 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.75 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.434 ' HA ' ' CD2' ' A' ' 72' ' ' HIS . 6.0 ptp180 -64.81 -50.78 65.41 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.593 ' SG ' HD23 ' A' ' 53' ' ' LEU . 61.2 m -72.61 -24.97 61.14 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 43.5 mt-30 -68.69 -34.84 76.35 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.446 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 23.5 p80 -90.73 22.57 3.48 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.193 0.52 . . . . 0.0 111.74 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' A' ' 70' ' ' CYS . 60.5 mt -121.8 139.52 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.188 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -105.81 154.73 20.11 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.715 HD13 HD12 ' A' ' 128' ' ' ILE . 24.0 mm -102.09 151.62 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.739 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -119.44 154.66 33.37 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -85.18 121.27 27.69 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 117.789 0.268 . . . . 0.0 110.806 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -104.07 -23.7 8.0 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 120.209 -0.996 . . . . 0.0 114.207 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.01 -167.98 33.89 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.907 -0.664 . . . . 0.0 113.353 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -88.72 -16.17 2.48 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.404 2.736 . . . . 0.0 114.439 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.66 129.19 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.725 0.298 . . . . 0.0 111.518 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 47.72 82.97 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.527 1.131 . . . . 0.0 113.2 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.4 p -80.9 -14.83 57.64 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.918 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -76.94 -18.02 58.53 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.211 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.641 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -133.08 146.84 52.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.939 0.4 . . . . 0.0 111.825 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.591 ' H ' ' NH1' ' A' ' 85' ' ' ARG . . . -112.18 150.42 18.19 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.782 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.513 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 1.3 m-85 -86.51 152.59 22.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.346 1.058 . . . . 0.0 111.321 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.483 HG21 ' HG ' ' A' ' 114' ' ' LEU . 3.4 t -126.3 103.76 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.627 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 126' ' ' SER . 1.1 mt -98.85 126.72 44.58 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.181 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.401 ' CE1' ' HB3' ' A' ' 106' ' ' ALA . 4.7 p80 -129.44 164.06 42.25 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.76 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.57 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 23.2 Cg_endo -99.27 23.74 0.21 Allowed 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 122.888 2.392 . . . . 0.0 113.92 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.5 t -107.6 160.82 15.39 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.756 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.25 18.98 56.51 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.685 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -91.78 153.78 19.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.553 0.341 . . . . 0.0 110.528 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.598 ' HA ' HG21 ' A' ' 99' ' ' THR . 27.9 m -126.97 155.58 42.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.108 0.48 . . . . 0.0 112.112 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.538 ' CE2' HG23 ' A' ' 113' ' ' VAL . 51.2 m-85 -126.09 -150.89 0.46 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.837 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -58.82 -47.08 86.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.605 0.362 . . . . 0.0 111.372 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 m -132.19 81.26 1.95 Allowed 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.912 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.598 HG21 ' HA ' ' A' ' 95' ' ' SER . 42.5 m -129.38 121.69 27.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.327 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 124.7 49.99 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.794 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -82.72 127.99 33.94 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.133 0.492 . . . . 0.0 111.141 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -120.28 46.47 1.97 Allowed 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.574 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.62 -107.07 1.76 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.281 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.69 -10.44 3.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.496 HD21 ' OH ' ' A' ' 31' ' ' TYR . 2.9 pp -154.86 158.76 39.85 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.335 0.397 . . . . 0.0 110.99 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.401 ' HB3' ' CE1' ' A' ' 90' ' ' HIS . . . -118.92 161.51 20.07 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.472 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.569 ' O ' ' HA ' ' A' ' 99' ' ' THR . 24.6 ttm -125.22 134.34 52.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.514 ' HB3' HG11 ' A' ' 113' ' ' VAL . 51.7 m -136.08 133.03 36.92 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 75.6 p -124.53 21.23 8.58 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.717 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.707 ' O ' HG12 ' A' ' 113' ' ' VAL . 47.4 p -93.71 134.15 36.33 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 121.648 0.737 . . . . 0.0 112.345 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.499 ' HA ' HD12 ' A' ' 114' ' ' LEU . 4.9 mt-30 -62.51 -26.62 68.65 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.403 178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.41 -40.43 93.37 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.169 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.769 ' O ' HG22 ' A' ' 117' ' ' ILE . 3.4 p -71.68 -39.03 68.62 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 111' ' ' GLN . 6.6 mt -57.25 -49.04 77.31 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 123.507 0.504 . . . . 0.0 110.874 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.475 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 35.5 m-85 -69.69 -38.55 77.03 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.216 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.64 -52.68 63.37 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.212 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.84 -43.74 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.432 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.93 -31.57 65.09 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 123.754 0.658 . . . . 0.0 109.615 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.09 -20.23 30.68 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.273 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.82 17.67 25.02 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.704 -1.134 . . . . 0.0 114.634 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.9 p -108.33 7.48 27.21 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.6 -137.76 9.32 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.793 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.45 175.21 9.81 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 123.216 2.611 . . . . 0.0 113.347 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -58.33 -53.08 62.32 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.509 0.723 . . . . 0.0 111.584 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.8 mmtt -139.24 153.76 47.89 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.71 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.4 m -150.05 163.33 38.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.1 tp -129.05 117.56 21.08 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.14 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.715 HD12 HD13 ' A' ' 75' ' ' ILE . 12.3 pt -98.94 103.16 14.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.579 0.704 . . . . 0.0 109.475 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.1 t -121.21 120.46 35.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.846 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.45 115.34 6.96 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.335 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.42 167.9 10.76 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.226 -0.897 . . . . 0.0 114.091 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -128.45 178.0 6.6 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.167 0.508 . . . . 0.0 110.703 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -116.33 131.48 56.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.916 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.08 149.89 18.66 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.315 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.402 ' HZ2' ' CZ3' ' A' ' 149' ' ' TRP . 25.7 m-90 -130.15 136.9 49.78 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.833 0.372 . . . . 0.0 110.602 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.06 158.34 27.87 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.941 0.776 . . . . 0.0 111.064 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.88 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.12 -28.09 6.19 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.826 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -56.38 -46.4 80.09 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.006 0.522 . . . . 0.0 112.135 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.57 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.4 tp -67.33 -47.54 70.2 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -57.36 -30.27 64.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.473 0.483 . . . . 0.0 110.602 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.65 -49.97 41.75 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.887 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -72.12 -26.66 62.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.899 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 4.8 tp -75.78 -38.41 58.3 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.85 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -78.18 -30.9 49.31 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.315 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.43 0.77 31.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.641 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.74 29.88 19.45 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.813 0.845 . . . . 0.0 111.682 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.65 -42.92 19.27 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.78 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.402 ' CZ3' ' HZ2' ' A' ' 135' ' ' TRP . 11.3 m95 -122.42 112.04 17.6 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 123.388 0.43 . . . . 0.0 109.966 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -80.19 141.55 35.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.326 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.427 ' H ' HD23 ' A' ' 150' ' ' LEU . 16.0 p -110.56 138.47 46.91 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.312 0.383 . . . . 0.0 111.212 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.5 m -152.89 155.6 32.31 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.527 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.02 155.96 36.43 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.226 1.951 . . . . 0.0 111.098 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.48 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.73 169.33 14.64 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -138.08 137.55 21.35 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 114.295 -1.321 . . . . 0.0 107.906 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.41 -26.46 12.14 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.491 2.128 . . . . 0.0 113.959 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.22 -36.31 60.88 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.824 0.703 . . . . 0.0 112.571 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.561 HD13 HH21 ' A' ' 167' ' ' ARG . 4.6 mt -75.68 -38.35 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.41 0.624 . . . . 0.0 110.254 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.1 tt -69.44 -36.65 76.86 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.906 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -86.38 -42.78 13.37 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -77.91 -71.24 0.43 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.783 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.42 96.35 6.36 Favored Pre-proline 0 C--N 1.346 0.445 0 CA-C-O 121.18 0.514 . . . . 0.0 111.966 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.93 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 63.7 Cg_endo -91.78 3.31 4.11 Favored 'Trans proline' 0 CA--C 1.567 2.156 0 C-N-CA 121.626 1.551 . . . . 0.0 114.407 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.657 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 60.9 Cg_endo -76.93 -52.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 122.435 2.09 . . . . 0.0 114.168 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.509 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 4.3 mt-10 -126.42 -24.36 3.64 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.468 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.783 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 27.6 tt0 -76.53 -12.97 60.11 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.762 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.968 HH11 HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.19 -36.66 54.77 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.651 177.297 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.1 tp -73.47 -48.74 31.1 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 52.4 m -58.87 -45.31 90.49 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.527 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.68 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -67.22 -42.81 83.44 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.445 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.53 ' HB2' ' NH1' ' A' ' 167' ' ' ARG . . . -55.97 -45.86 78.78 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.494 0.496 . . . . 0.0 110.499 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.05 93.33 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.357 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.96 -26.95 68.52 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.663 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.76 -40.3 41.38 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 122.929 0.491 . . . . 0.0 110.175 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -71.87 -30.79 65.78 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.466 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 102.74 52.52 0.96 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.933 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.4 t -127.46 150.56 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -85.77 77.98 9.65 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.735 0.779 . . . . 0.0 110.697 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.66 -26.3 50.27 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.924 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.5 t -56.22 -38.66 71.35 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.364 0.666 . . . . 0.0 112.773 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.08 -26.54 53.57 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 10.8 mt -76.72 -34.69 58.11 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.34 0.4 . . . . 0.0 111.482 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 11.0 p -85.94 -48.25 8.88 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.452 0.47 . . . . 0.0 111.658 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -128.98 118.07 21.99 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 123.53 0.519 . . . . 0.0 111.244 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -99.55 146.04 26.85 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.8 146.48 26.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.136 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 157.25 88.03 0.06 OUTLIER Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.447 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -128.19 143.81 51.07 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.648 0.263 . . . . 0.0 110.867 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.501 -0.761 . . . . 0.0 111.036 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.322 0.106 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -100.7 143.72 30.52 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.418 0.449 . . . . 0.0 110.559 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -108.99 -41.29 4.76 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.977 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.499 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.5 m -97.22 151.34 19.94 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 123.441 0.463 . . . . 0.0 111.109 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.4 m -95.35 99.73 4.96 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.966 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.0 OUTLIER -85.9 7.45 5.03 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.774 2.316 . . . . 0.0 112.281 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.1 m -113.12 -53.76 2.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.716 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -112.58 151.44 30.06 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.39 0.431 . . . . 0.0 111.667 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.2 mt -98.28 50.84 1.01 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.076 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -92.41 17.7 9.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.1 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 175.51 55.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.841 0.856 . . . . 0.0 109.79 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.418 ' CD2' ' HA ' ' A' ' 153' ' ' PRO . 30.0 m80 -138.57 160.8 38.69 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.474 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 18.6 m-30 -99.2 137.37 37.81 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.01 0.433 . . . . 0.0 111.867 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.794 HD11 HD23 ' A' ' 32' ' ' LEU . 3.7 mt -107.43 141.4 38.89 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.118 177.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.421 HD12 ' O ' ' A' ' 150' ' ' LEU . 2.8 mp -121.24 136.76 57.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 O-C-N 123.419 0.449 . . . . 0.0 110.006 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.23 124.83 28.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.027 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.3 mtt -109.78 157.54 37.35 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.211 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.78 30.93 0.52 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.686 2.257 . . . . 0.0 113.185 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -86.06 -18.89 31.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.65 -167.13 1.15 Allowed 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.068 0.23 . . . . 0.0 110.617 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.532 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.33 40.4 1.48 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.993 0.425 . . . . 0.0 111.737 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -111.98 80.88 3.32 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.883 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.8 Cg_exo -75.55 -22.99 13.34 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.045 2.497 . . . . 0.0 113.187 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -84.56 -34.97 23.12 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.933 0.493 . . . . 0.0 111.753 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.56 3.85 52.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.992 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 164.34 19.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.82 0.343 . . . . 0.0 111.82 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 49.04 31.1 3.16 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.5 p -116.87 154.7 30.32 Favored 'General case' 0 C--O 1.24 0.59 0 O-C-N 122.347 -0.221 . . . . 0.0 110.553 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.702 HG11 ' HE ' ' A' ' 167' ' ' ARG . 85.2 t -129.16 133.64 65.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-O 121.429 0.633 . . . . 0.0 110.832 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -113.85 153.78 28.6 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.755 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.463 ' OH ' HD21 ' A' ' 105' ' ' LEU . 32.4 t80 -107.66 118.77 37.62 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.794 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -83.73 109.97 17.93 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-O 121.465 0.65 . . . . 0.0 110.935 -178.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.938 HG23 ' HA2' ' A' ' 42' ' ' GLY . 33.5 t -72.03 -63.2 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.639 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.527 ' OE2' HD11 ' A' ' 100' ' ' LEU . 7.7 tt0 -134.11 118.49 17.78 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.592 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -103.67 127.49 51.11 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.737 0.303 . . . . 0.0 110.754 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -138.88 151.51 47.02 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.246 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.57 -12.64 54.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -108.2 1.91 22.45 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.416 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.7 166.2 16.01 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 121.608 -0.329 . . . . 0.0 112.335 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.556 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -147.32 146.27 29.64 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.85 136.95 54.27 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.078 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.97 161.71 32.13 Favored Glycine 0 C--O 1.228 -0.277 0 O-C-N 124.785 1.303 . . . . 0.0 112.573 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.9 mt -117.35 133.77 55.59 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.943 0.371 . . . . 0.0 111.267 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 78' ' ' GLY . 10.7 t -66.13 122.88 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.12 54.44 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.607 0.718 . . . . 0.0 112.104 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.852 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -147.49 -3.93 0.53 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.145 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -129.56 87.82 51.78 Favored Pre-proline 0 CA--C 1.556 1.181 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.513 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 40.4 Cg_exo -58.74 143.15 99.11 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 121.716 1.611 . . . . 0.0 112.415 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.444 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 66.5 m -93.28 158.67 15.63 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.485 0.491 . . . . 0.0 111.497 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.14 51.04 1.06 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.658 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.42 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -133.17 156.1 48.09 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.961 0.448 . . . . 0.0 110.054 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 15.6 p-10 -112.23 158.25 19.93 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.552 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.6 HD23 ' SG ' ' A' ' 70' ' ' CYS . 15.5 tp -57.4 -37.09 72.15 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.46 -37.27 62.49 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 36.8 mt-10 -64.97 -42.48 94.53 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.006 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.867 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -62.63 -46.32 96.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.741 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.1 mp -54.37 -36.8 64.25 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 123.81 0.694 . . . . 0.0 110.674 177.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.76 -27.86 50.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.486 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.403 HE21 HD23 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -78.41 -30.41 47.72 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.309 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.867 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.2 mt -77.64 -44.95 26.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.848 -1.523 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -132.38 116.54 15.28 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.496 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -77.49 -33.13 2.56 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.619 2.879 . . . . 0.0 112.823 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.08 -13.87 56.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.398 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.46 149.72 24.24 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 123.382 0.426 . . . . 0.0 111.752 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.16 123.88 29.64 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.021 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.16 145.68 35.32 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.204 1.936 . . . . 0.0 112.444 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.8 Cg_endo -92.2 -169.78 0.28 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.652 2.235 . . . . 0.0 111.932 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.44 -24.95 67.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.04 0.536 . . . . 0.0 112.135 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -66.11 -53.17 41.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.696 ' HA ' HD12 ' A' ' 73' ' ' ILE . 61.6 m -71.79 -25.05 61.85 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 49.3 mt-30 -67.88 -35.81 79.15 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -90.52 23.78 2.87 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.164 0.507 . . . . 0.0 111.689 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 70' ' ' CYS . 53.5 mt -121.52 138.46 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.487 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.27 163.11 13.08 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.433 ' CD1' HD12 ' A' ' 128' ' ' ILE . 17.1 mm -112.25 153.41 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.141 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.716 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -117.36 155.62 29.27 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -85.67 118.57 25.25 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.825 0.284 . . . . 0.0 110.551 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.574 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.52 -23.72 8.22 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 120.05 -1.071 . . . . 0.0 114.135 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.46 -167.84 34.11 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.511 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.44 -14.44 3.16 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 123.526 2.817 . . . . 0.0 114.412 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.9 124.07 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 123.103 0.252 . . . . 0.0 111.036 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 50.84 77.0 0.14 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.196 0.999 . . . . 0.0 112.512 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.8 m -79.37 -12.86 59.91 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.561 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.7 0.51 52.56 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.589 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.16 153.73 51.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.589 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.47 132.38 11.08 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.137 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.786 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.76 145.7 27.13 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.486 1.114 . . . . 0.0 110.69 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.16 103.89 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.401 0.438 . . . . 0.0 110.771 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.873 HD11 HD13 ' A' ' 105' ' ' LEU . 13.7 tp -107.2 129.1 54.91 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.876 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -127.03 168.5 14.51 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-O 118.921 -0.561 . . . . 0.0 111.705 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.671 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.4 Cg_endo -97.03 12.2 1.05 Allowed 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 122.829 2.353 . . . . 0.0 113.793 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.9 t -99.76 160.67 14.12 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.791 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.96 21.12 47.88 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.532 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -86.73 154.2 21.14 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.625 0.37 . . . . 0.0 110.568 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.8 p -127.34 156.85 41.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.566 ' CE2' HG23 ' A' ' 113' ' ' VAL . 52.3 m-85 -129.19 -151.57 0.48 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.668 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -59.14 -46.5 88.19 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.547 0.339 . . . . 0.0 111.413 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 57.9 m -134.37 83.22 2.02 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.495 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.6 m -130.98 128.97 41.5 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.847 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.527 HD11 ' OE2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.57 124.23 50.16 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.506 178.444 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.38 128.17 34.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.089 0.471 . . . . 0.0 110.972 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.449 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.28 48.08 1.89 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.378 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.72 -109.86 3.14 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 114.724 -1.126 . . . . 0.0 113.056 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.09 -8.41 5.38 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.873 HD13 HD11 ' A' ' 89' ' ' LEU . 2.8 pp -152.84 152.77 31.94 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.29 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.612 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.74 157.16 28.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.839 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.566 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.8 ttm -121.13 126.63 50.23 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.711 ' HB3' HG11 ' A' ' 113' ' ' VAL . 22.9 m -122.7 128.78 51.0 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.834 0.349 . . . . 0.0 110.176 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.4 p -119.39 16.54 13.03 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.318 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.767 ' O ' HG12 ' A' ' 113' ' ' VAL . 11.6 t -88.9 127.61 35.65 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.515 0.674 . . . . 0.0 111.445 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.49 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 10.1 pt20 -59.98 -30.49 69.15 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.235 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -64.58 -42.15 95.81 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.732 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 110' ' ' SER . 4.5 p -67.78 -37.98 79.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.538 HD22 ' NH2' ' A' ' 85' ' ' ARG . 3.9 tp -59.27 -48.64 80.87 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 123.449 0.468 . . . . 0.0 110.19 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.49 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 36.8 m-85 -68.52 -38.25 80.71 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.959 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.68 -51.76 67.11 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.21 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.69 -43.43 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.304 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.3 -31.3 65.5 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.759 0.662 . . . . 0.0 109.6 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.23 -19.95 30.88 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.129 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.79 16.4 28.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 114.705 -1.134 . . . . 0.0 114.623 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.1 p -106.86 7.46 30.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.16 -138.18 9.71 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-O 119.23 -0.761 . . . . 0.0 112.625 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.85 173.68 11.8 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.205 2.603 . . . . 0.0 113.554 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.06 -54.57 45.3 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.735 0.814 . . . . 0.0 111.988 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.671 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.2 mmtt -140.98 143.7 34.63 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.82 -178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.0 m -141.09 165.01 28.72 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.0 tp -127.61 117.02 21.23 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.466 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.786 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.5 pt -98.33 102.46 13.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-O 121.934 0.873 . . . . 0.0 109.82 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.509 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 9.0 t -119.34 124.05 45.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.784 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.4 tp -67.09 113.73 5.29 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.385 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.82 175.16 8.49 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 114.665 -1.152 . . . . 0.0 114.576 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.49 176.3 7.85 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.342 0.591 . . . . 0.0 110.474 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -115.92 130.68 56.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.062 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.04 145.9 16.61 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.476 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -121.24 136.47 54.97 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.242 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.05 158.08 25.21 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.824 0.703 . . . . 0.0 110.746 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.78 90.71 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.24 -25.19 7.5 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.164 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -57.57 -44.24 85.16 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.9 -47.96 64.51 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.16 0.287 . . . . 0.0 110.634 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.52 -28.79 68.67 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.002 0.43 . . . . 0.0 110.665 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.82 -50.74 32.23 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.797 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.0 pt-20 -69.67 -26.62 64.47 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.845 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.91 -38.37 57.82 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.722 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -77.82 -28.42 50.26 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -83.2 0.75 44.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.426 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 59.41 29.11 18.63 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.796 0.838 . . . . 0.0 111.818 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.76 -43.18 18.74 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.956 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -124.38 114.29 19.33 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.9 tp -85.59 139.88 31.06 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.629 0.252 . . . . 0.0 111.418 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -104.46 137.31 42.52 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.038 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.0 m -150.94 154.88 34.9 Favored Pre-proline 0 N--CA 1.469 0.51 0 O-C-N 123.515 0.509 . . . . 0.0 110.909 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.418 ' HA ' ' CD2' ' A' ' 12' ' ' HIS . 31.7 Cg_exo -59.28 152.58 59.34 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.32 2.013 . . . . 0.0 111.055 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.474 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.76 167.84 16.71 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.76 135.62 23.74 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.105 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.3 -26.47 14.51 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 122.605 2.203 . . . . 0.0 113.66 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.39 -40.72 62.44 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 123.909 0.756 . . . . 0.0 112.19 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.609 HD13 HH12 ' A' ' 167' ' ' ARG . 4.9 mt -71.36 -34.96 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.304 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.32 -36.99 63.72 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.335 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -84.66 -35.47 22.6 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -84.71 -72.5 0.47 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.963 0.347 . . . . 0.0 111.726 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.676 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -141.82 99.02 6.24 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.852 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 70.9 Cg_endo -91.95 -0.29 4.31 Favored 'Trans proline' 0 CA--C 1.57 2.29 0 C-N-CA 121.773 1.649 . . . . 0.0 114.351 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.641 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 69.0 Cg_endo -74.87 -50.03 0.14 Allowed 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 122.738 2.292 . . . . 0.0 114.519 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.5 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.3 mt-10 -122.39 -33.98 3.36 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.713 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.676 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 8.4 mt-10 -68.86 -10.9 59.5 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.077 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.702 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.86 -41.8 42.54 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.091 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.9 tp -70.41 -50.07 42.33 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 44.3 m -58.49 -49.12 78.51 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.633 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.673 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.17 -39.82 94.82 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.129 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.15 78.53 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.608 0.568 . . . . 0.0 110.6 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.44 91.09 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.499 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.96 -27.85 69.12 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.611 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.84 -40.05 41.55 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 122.831 0.452 . . . . 0.0 110.355 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -68.58 -33.37 73.95 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.346 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 126.27 43.89 0.26 Allowed Glycine 0 C--N 1.34 0.759 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.155 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.7 t -129.22 136.85 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -89.98 82.1 6.18 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.662 0.744 . . . . 0.0 110.969 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -77.83 -26.36 49.42 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.324 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 53.2 m -58.62 -45.35 89.41 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.37 -26.83 52.28 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 22.0 mt -77.21 -30.14 54.58 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.577 0.351 . . . . 0.0 111.675 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 24.0 p -90.27 -48.21 7.29 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.342 0.402 . . . . 0.0 111.475 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.6 119.09 21.98 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.052 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -100.66 140.43 34.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.925 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.13 130.69 51.54 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.038 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 144.8 142.58 3.88 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.519 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -128.82 144.85 51.28 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.68 0.282 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.091 -0.956 . . . . 0.0 111.118 -179.964 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.584 0.23 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -99.95 138.59 36.82 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.154 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -99.1 -42.19 7.19 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.021 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.0 p -103.13 152.46 21.4 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.824 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 m -94.55 104.47 14.24 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.108 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -87.07 7.77 4.67 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.765 2.31 . . . . 0.0 112.021 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.7 t -93.74 -47.48 6.76 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.026 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.431 ' CD2' ' HE3' ' A' ' 10' ' ' LYS . 3.2 m-85 -109.0 155.16 21.21 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.399 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 32' ' ' LEU . 10.5 mt -95.91 43.94 1.08 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.008 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.431 ' HE3' ' CD2' ' A' ' 8' ' ' TYR . 87.5 mttt -89.81 20.34 4.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.934 0.397 . . . . 0.0 111.242 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 174.53 55.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.126 0.971 . . . . 0.0 110.1 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -133.62 159.38 40.67 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.643 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.454 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.4 m-30 -97.3 135.72 38.81 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.85 HD11 HD23 ' A' ' 32' ' ' LEU . 2.8 mt -107.99 137.04 46.67 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.848 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.438 HG23 HG22 ' A' ' 29' ' ' VAL . 2.3 mm -117.01 133.88 62.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 O-C-N 123.493 0.495 . . . . 0.0 109.721 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.05 120.33 18.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.488 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 150' ' ' LEU . 91.4 mtp -110.18 154.88 42.61 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.22 77.71 3.89 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.59 2.193 . . . . 0.0 112.932 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -135.68 -19.41 1.6 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.025 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.98 -164.19 0.91 Allowed 'General case' 0 CA--C 1.541 0.631 0 O-C-N 123.191 0.307 . . . . 0.0 110.495 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.554 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.92 37.84 2.06 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.052 0.453 . . . . 0.0 111.856 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 7.9 m-20 -110.51 83.79 3.55 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.827 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.1 Cg_exo -75.26 -24.62 12.25 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.03 2.486 . . . . 0.0 113.442 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -85.09 -37.84 19.81 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.931 0.492 . . . . 0.0 111.573 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.53 -3.4 57.63 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.84 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -59.85 0.25 0.16 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -141.19 41.56 1.78 Allowed 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.234 0.54 . . . . 0.0 112.052 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.1 p -124.28 157.27 35.31 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.686 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.789 HG11 ' HE ' ' A' ' 167' ' ' ARG . 59.3 t -131.27 132.8 62.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.617 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -114.48 153.54 29.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.615 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.409 ' OH ' HD21 ' A' ' 105' ' ' LEU . 44.4 t80 -107.14 118.71 37.42 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.85 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.88 109.1 16.71 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.095 0.474 . . . . 0.0 111.232 -178.441 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.932 HG23 ' HA2' ' A' ' 42' ' ' GLY . 38.9 t -67.28 -62.53 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 113.853 -1.522 . . . . 0.0 110.515 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -140.54 115.68 9.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.163 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -98.22 127.46 44.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.604 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -139.29 152.93 47.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.48 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' HB3' ' OE1' ' A' ' 38' ' ' GLN . 17.9 tt0 -64.73 -21.02 66.66 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.405 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.408 ' OE1' ' HB3' ' A' ' 37' ' ' GLU . 1.1 mp0 -96.65 0.89 50.49 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.487 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.38 168.35 16.44 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 112.209 -0.356 . . . . 0.0 112.209 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.493 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.83 144.33 30.19 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -122.82 136.14 54.77 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.564 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.932 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.78 158.83 29.41 Favored Glycine 0 N--CA 1.447 -0.581 0 O-C-N 124.454 1.097 . . . . 0.0 112.529 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.6 mt -113.35 132.92 55.4 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.025 0.412 . . . . 0.0 111.129 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 78' ' ' GLY . 12.4 t -67.98 124.54 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.538 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -127.53 55.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.606 0.717 . . . . 0.0 112.196 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.846 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.2 t30 -146.43 -3.3 0.64 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.072 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -130.11 89.82 44.09 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 52.6 Cg_exo -57.82 140.65 94.44 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 121.55 1.5 . . . . 0.0 111.763 174.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.407 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 56.4 m -71.23 -44.63 64.97 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.03 -15.94 56.17 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.226 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.66 162.06 16.52 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.506 0.323 . . . . 0.0 110.168 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.617 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 7.2 p-10 -100.92 160.63 14.21 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.725 ' HA ' HD11 ' A' ' 75' ' ' ILE . 4.7 tt -58.48 -28.65 65.55 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.076 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.617 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -62.07 -39.76 93.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.599 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.67 -46.98 85.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.637 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.86 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 17.1 m -62.32 -43.45 98.09 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.722 ' HA ' HD12 ' A' ' 60' ' ' LEU . 13.6 mt -56.94 -34.95 68.53 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.544 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -78.15 -27.34 48.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.262 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -30.65 51.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.129 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.86 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.8 mt -77.79 -45.48 24.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.789 -1.551 . . . . 0.0 111.12 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -131.7 116.16 15.96 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.631 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -77.71 -32.62 2.66 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.659 2.906 . . . . 0.0 112.755 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.1 -14.55 55.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.35 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.7 149.9 24.56 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.35 0.407 . . . . 0.0 111.685 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.5 mp -118.34 122.52 30.13 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.178 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.98 153.02 41.58 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.307 2.005 . . . . 0.0 112.26 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 7.1 Cg_endo -94.21 -165.31 0.12 Allowed 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.596 2.198 . . . . 0.0 112.263 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.38 -24.84 62.15 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.196 0.598 . . . . 0.0 111.964 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.568 ' HA ' ' CE1' ' A' ' 72' ' ' HIS . 12.0 ptp180 -67.1 -46.99 72.54 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.488 ' HA ' HD12 ' A' ' 73' ' ' ILE . 16.6 m -72.84 -25.57 61.16 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.439 ' HA ' HD22 ' A' ' 52' ' ' ASN . 48.0 mt-30 -70.54 -26.99 63.82 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.568 ' CE1' ' HA ' ' A' ' 69' ' ' ARG . 15.3 p-80 -99.21 16.51 22.6 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 123.439 0.462 . . . . 0.0 111.722 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 70.0 mt -114.35 138.63 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.313 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.16 151.46 24.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.943 HD13 HD12 ' A' ' 128' ' ' ILE . 21.3 mm -102.61 151.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.613 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.747 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.9 t80 -118.27 155.23 30.94 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.625 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.94 121.34 28.43 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.35 -23.53 8.4 Favored Glycine 0 C--N 1.345 1.042 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.195 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.67 -167.77 35.31 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.313 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -88.59 -12.21 3.8 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.588 2.859 . . . . 0.0 114.358 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -86.37 128.75 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 123.07 0.231 . . . . 0.0 111.171 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 45.35 82.15 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.564 1.145 . . . . 0.0 113.132 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.0 p -84.04 -8.25 59.18 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.206 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.62 -3.87 59.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.621 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.72 152.98 51.6 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.621 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.58 135.39 12.82 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.073 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -86.16 146.16 26.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.304 1.042 . . . . 0.0 110.573 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.9 103.58 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 123.47 0.481 . . . . 0.0 110.533 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.923 HD11 HD13 ' A' ' 105' ' ' LEU . 11.4 tp -107.18 128.59 54.54 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.981 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -128.29 167.44 18.92 Favored Pre-proline 0 CA--C 1.554 1.122 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.799 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.689 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 17.9 Cg_endo -97.42 19.91 0.43 Allowed 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.67 2.247 . . . . 0.0 113.563 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.1 t -107.69 160.56 15.61 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.835 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.27 22.08 41.84 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.587 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -84.98 152.88 23.15 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 122.618 0.367 . . . . 0.0 110.487 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.7 p -128.0 156.81 42.13 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.571 ' CE2' HG23 ' A' ' 113' ' ' VAL . 56.4 m-85 -130.44 -150.97 0.45 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.726 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -58.91 -46.16 88.57 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.655 0.382 . . . . 0.0 111.511 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.8 m -137.41 82.64 1.94 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.285 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 107' ' ' MET . 12.8 m -127.77 123.42 35.25 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.425 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -102.71 120.92 41.42 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.744 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.53 125.01 29.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.172 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.571 ' HB3' HD12 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -119.51 43.59 2.59 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.722 -179.277 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.81 -100.59 0.29 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.264 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -56.08 -14.53 2.71 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.923 HD13 HD11 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -160.91 160.23 30.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.842 0.457 . . . . 0.0 110.951 -179.283 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.589 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -117.77 156.97 27.38 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.625 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.573 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.4 ttm -123.3 129.7 51.7 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.702 ' HB3' HG11 ' A' ' 113' ' ' VAL . 31.3 m -125.99 129.22 48.79 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.9 p -119.98 14.56 12.39 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.658 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.727 ' O ' HG12 ' A' ' 113' ' ' VAL . 68.3 m -87.14 130.15 34.65 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.425 0.631 . . . . 0.0 112.042 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.499 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 21.0 pt20 -61.45 -28.67 69.45 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.101 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.37 -44.14 92.3 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.452 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.4 p -67.9 -34.83 69.58 Favored 'Isoleucine or valine' 0 C--N 1.354 0.792 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.42 ' HG ' ' NH2' ' A' ' 85' ' ' ARG . 2.5 tm? -59.13 -49.61 77.22 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 123.693 0.62 . . . . 0.0 109.81 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.499 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 31.5 m-85 -67.19 -39.63 86.42 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.955 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -52.97 62.59 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.456 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.0 -43.86 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.524 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.428 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.93 -32.03 65.55 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.72 0.637 . . . . 0.0 109.594 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.448 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.69 -19.7 32.38 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.232 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.69 14.93 33.17 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.718 -1.128 . . . . 0.0 114.633 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.5 p -105.58 7.9 33.02 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.18 -138.35 9.14 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.283 -0.732 . . . . 0.0 112.731 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.64 168.02 18.25 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.141 2.561 . . . . 0.0 113.968 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.493 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -49.39 -59.67 3.52 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.537 1.135 . . . . 0.0 111.837 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.689 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.5 mmtt -141.43 139.81 33.48 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 69.5 m -138.02 169.07 18.43 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 tp -126.41 118.14 24.37 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.296 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.943 HD12 HD13 ' A' ' 75' ' ' ILE . 10.1 pt -96.95 102.14 13.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 121.465 0.65 . . . . 0.0 109.711 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 7.2 t -118.9 119.13 33.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.099 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.19 112.93 4.74 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.136 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 169.81 11.26 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.005 -0.998 . . . . 0.0 114.186 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.6 177.54 6.95 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.196 0.522 . . . . 0.0 110.83 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -117.72 131.93 56.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.51 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.47 149.67 18.72 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.363 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 24.4 m-90 -129.09 135.55 49.05 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 123.855 0.385 . . . . 0.0 110.465 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.05 158.17 29.3 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.784 0.678 . . . . 0.0 111.129 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.23 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.54 -26.75 6.83 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.935 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -55.93 -45.59 78.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.076 0.55 . . . . 0.0 112.06 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.2 tp -67.37 -47.16 71.21 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.58 -30.51 65.32 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.426 0.454 . . . . 0.0 110.747 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.5 -50.19 40.52 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.91 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -71.61 -26.64 62.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.945 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.3 tp -75.11 -39.21 60.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.937 0.895 . . . . 0.0 110.806 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 m -78.15 -30.21 49.09 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.553 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -80.38 0.19 34.24 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.701 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 60.42 29.47 19.04 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.757 0.823 . . . . 0.0 111.723 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.92 -42.46 19.46 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.813 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -123.97 112.07 16.77 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 123.383 0.427 . . . . 0.0 109.865 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.542 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 7.0 tp -83.57 138.65 33.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.275 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.5 p -103.6 137.66 41.35 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.578 0.549 . . . . 0.0 111.307 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 73.0 m -152.86 155.6 32.36 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.544 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.51 159.81 22.43 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.2 1.933 . . . . 0.0 111.366 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.454 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -131.74 167.24 19.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -134.85 135.14 22.68 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.941 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.45 -26.42 14.23 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 122.613 2.208 . . . . 0.0 113.81 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.89 -40.64 63.67 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.857 0.723 . . . . 0.0 112.147 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.569 HG21 HH11 ' A' ' 167' ' ' ARG . 4.5 mt -71.08 -35.52 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.348 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.74 -38.7 64.68 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.417 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.38 -32.36 22.44 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -87.01 -72.68 0.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.145 0.429 . . . . 0.0 111.656 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.92 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.79 98.81 6.29 Favored Pre-proline 0 C--N 1.35 0.608 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.846 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 62.4 Cg_endo -92.71 0.37 3.81 Favored 'Trans proline' 0 CA--C 1.57 2.306 0 C-N-CA 121.715 1.61 . . . . 0.0 114.288 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.644 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 98.0 Cg_endo -73.25 -52.41 0.15 Allowed 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.583 2.189 . . . . 0.0 114.245 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.513 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -122.82 -29.85 3.92 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.7 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.92 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.05 -11.14 60.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.437 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.789 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.02 -40.39 46.71 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.139 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -71.07 -50.21 36.33 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.6 m -58.49 -48.49 80.62 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.611 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.664 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.86 -40.16 94.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.298 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.43 -46.78 80.11 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 123.498 0.499 . . . . 0.0 110.368 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.83 88.81 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.406 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.27 -27.83 68.91 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.59 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.53 -39.79 44.89 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 122.841 0.456 . . . . 0.0 110.3 178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.2 -31.47 67.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.455 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 108.24 51.66 0.71 Allowed Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.963 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.8 t -128.47 149.54 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -88.77 78.95 7.55 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.666 0.746 . . . . 0.0 110.769 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.78 -26.34 49.64 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.025 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.8 t -59.76 -43.13 94.44 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.6 -26.45 50.71 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.61 -37.84 55.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.551 0.34 . . . . 0.0 111.893 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.8 p -94.59 -48.57 6.03 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.285 0.366 . . . . 0.0 111.373 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 56.8 115.36 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.063 0.945 . . . . 0.0 112.775 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -110.75 131.84 54.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -102.37 131.1 49.22 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.067 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.24 -95.43 0.11 Allowed Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.508 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -99.32 -40.39 7.94 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.665 0.274 . . . . 0.0 111.291 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.21 0 CA-C-O 118.472 -0.775 . . . . 0.0 111.114 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 120.318 0.104 . . . . 0.0 111.272 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -100.25 118.18 36.01 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.428 0.455 . . . . 0.0 110.99 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -136.74 -55.01 0.73 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.064 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.1 m -141.84 -50.89 0.4 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.256 0.348 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 55.4 m -132.79 87.07 41.97 Favored Pre-proline 0 CA--C 1.543 0.71 0 O-C-N 123.362 0.414 . . . . 0.0 110.849 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -87.6 7.26 4.75 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.006 2.471 . . . . 0.0 112.537 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 m -117.7 -54.85 2.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.836 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -108.34 155.87 20.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.713 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 32' ' ' LEU . 12.6 mt -97.77 50.36 1.04 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.865 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -92.66 21.3 5.6 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.897 0.38 . . . . 0.0 110.686 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.3 t60 178.01 54.64 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.586 0.754 . . . . 0.0 110.268 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -139.17 160.14 40.5 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 30' ' ' THR . 11.5 m-30 -100.57 138.09 38.1 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.089 0.471 . . . . 0.0 112.021 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.769 HD11 HD23 ' A' ' 32' ' ' LEU . 4.3 mt -107.47 141.09 39.43 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.341 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.8 mp -120.73 134.32 64.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 O-C-N 123.522 0.514 . . . . 0.0 109.759 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.73 126.18 30.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.085 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.2 mtt -110.32 157.15 38.92 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.222 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.52 29.84 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.611 2.207 . . . . 0.0 113.188 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -86.14 -16.29 38.37 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.15 -167.45 1.22 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.009 0.193 . . . . 0.0 110.641 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.524 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.28 40.39 1.48 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.995 0.426 . . . . 0.0 111.694 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.32 80.5 3.45 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.781 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.2 Cg_exo -75.41 -21.92 14.64 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.008 2.472 . . . . 0.0 113.327 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -84.44 -36.07 22.61 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.966 0.507 . . . . 0.0 111.852 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.29 4.01 51.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.098 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.35 163.47 20.63 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.896 0.379 . . . . 0.0 111.849 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 49.4 32.04 4.33 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.2 p -117.55 153.66 32.83 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 120.469 0.176 . . . . 0.0 110.556 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.869 HG11 HH11 ' A' ' 167' ' ' ARG . 77.4 t -128.49 133.71 66.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.583 0.706 . . . . 0.0 110.596 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 6.2 m -114.76 152.98 31.15 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.87 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.492 ' OH ' HD11 ' A' ' 105' ' ' LEU . 13.2 t80 -106.29 118.63 37.13 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.769 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.84 108.55 16.27 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.432 0.634 . . . . 0.0 110.927 -179.077 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.93 HG23 ' HA2' ' A' ' 42' ' ' GLY . 35.8 t -68.89 -60.36 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 113.228 -1.805 . . . . 0.0 110.576 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -142.26 113.48 7.65 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.62 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -97.34 128.74 44.43 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.672 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -139.71 153.27 47.19 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.604 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.25 -18.82 65.62 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.701 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.44 0.88 43.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.414 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.88 166.99 15.44 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.37 143.4 30.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.47 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -124.62 137.95 54.34 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.341 178.367 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.93 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -160.23 158.65 30.03 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.531 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.433 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.2 mt -112.83 131.54 55.66 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.935 0.367 . . . . 0.0 110.939 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 78' ' ' GLY . 41.2 t -67.93 124.68 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.558 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.1 pt -129.85 55.35 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.524 0.678 . . . . 0.0 112.347 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.869 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 3.3 t30 -144.27 -7.76 0.7 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.286 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.553 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -130.39 92.26 35.97 Favored Pre-proline 0 CA--C 1.555 1.145 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.1 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.514 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.5 Cg_exo -61.09 146.4 97.68 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 121.747 1.631 . . . . 0.0 112.602 175.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.43 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 44.9 t -89.14 162.96 15.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.557 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.69 -5.78 62.78 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-O 119.75 -0.472 . . . . 0.0 114.242 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -88.89 151.45 22.33 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.104 0.452 . . . . 0.0 111.566 -179.83 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.486 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 41.2 p-10 -98.55 165.74 11.68 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.655 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.65 ' HA ' HD11 ' A' ' 75' ' ' ILE . 13.9 tp -59.03 -26.88 64.96 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.617 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . . . -61.95 -42.5 99.18 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.486 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 41.4 mt-10 -62.39 -47.35 84.52 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.072 0.233 . . . . 0.0 111.492 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.882 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.7 m -61.68 -45.34 98.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.746 ' HA ' HD12 ' A' ' 60' ' ' LEU . 6.9 mt -54.48 -35.97 63.64 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.972 0.795 . . . . 0.0 110.742 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -78.13 -28.0 48.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.467 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.98 -30.38 50.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.375 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.882 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.1 mt -77.93 -46.62 20.7 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.749 -1.569 . . . . 0.0 111.376 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -131.89 118.18 16.42 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.003 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.33 -32.33 3.07 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.665 2.91 . . . . 0.0 112.56 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -82.22 -15.07 54.41 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.296 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.42 149.15 26.86 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.368 0.418 . . . . 0.0 111.425 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.57 121.78 31.59 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.743 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.671 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 46.4 Cg_endo -71.26 138.16 32.6 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.575 2.183 . . . . 0.0 112.423 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 2.7 Cg_endo -90.38 -157.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.733 2.289 . . . . 0.0 112.403 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.04 -25.07 52.1 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.249 0.62 . . . . 0.0 111.824 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.479 ' HA ' ' NE2' ' A' ' 72' ' ' HIS . 6.4 ptp180 -66.54 -46.14 77.12 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.671 ' SG ' ' HB2' ' A' ' 66' ' ' PRO . 18.5 p -67.49 -29.57 69.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 71.4 mt-30 -65.75 -32.85 74.63 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.479 ' NE2' ' HA ' ' A' ' 69' ' ' ARG . 32.9 p80 -95.37 9.94 38.11 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.432 0.458 . . . . 0.0 112.021 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 69' ' ' ARG . 71.0 mt -108.64 137.68 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.55 153.07 24.65 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.822 0.702 . . . . 0.0 112.711 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.761 HD13 HD12 ' A' ' 128' ' ' ILE . 25.6 mm -101.21 153.58 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.125 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.717 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -117.13 156.03 28.31 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.553 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 32.4 m-20 -89.26 117.4 28.19 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 117.832 0.287 . . . . 0.0 110.465 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.53 -23.24 9.0 Favored Glycine 0 C--N 1.35 1.358 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.817 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.53 -167.86 35.25 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.727 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -88.59 -14.74 2.97 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.501 2.801 . . . . 0.0 114.383 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -82.11 125.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 123.126 0.266 . . . . 0.0 111.166 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 45.36 89.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.582 1.153 . . . . 0.0 113.216 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.2 p -85.65 -10.17 56.17 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.931 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.26 -9.94 59.68 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.8 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.651 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -133.09 151.5 52.01 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.642 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -110.28 142.31 16.55 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.153 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.634 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.5 m-85 -86.77 149.37 24.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.077 -1.062 . . . . 0.0 110.528 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.6 ' HB ' ' OG ' ' A' ' 108' ' ' SER . 5.1 t -126.83 103.96 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 123.627 0.579 . . . . 0.0 110.194 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.912 HD11 HD13 ' A' ' 105' ' ' LEU . 16.0 tp -106.28 127.55 53.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.309 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -128.57 168.9 14.17 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.444 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.6 Cg_endo -97.31 17.75 0.56 Allowed 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.682 2.255 . . . . 0.0 113.555 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.5 t -105.32 158.86 16.33 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.895 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.34 22.23 41.98 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.483 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -84.62 155.09 22.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.661 0.384 . . . . 0.0 110.491 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.8 p -125.74 156.49 39.32 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.582 ' CE2' HG23 ' A' ' 113' ' ' VAL . 58.1 m-85 -131.5 -151.24 0.45 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.494 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -60.3 -46.55 89.47 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.44 0.296 . . . . 0.0 111.291 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.1 m -136.68 83.5 2.01 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.21 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 107' ' ' MET . 7.4 m -128.03 121.08 28.86 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.909 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -99.58 120.68 40.05 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.913 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.96 126.89 33.01 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.403 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.474 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -123.98 50.52 1.63 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.578 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.83 -111.94 4.28 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.151 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.77 -6.68 6.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 89' ' ' LEU . 2.5 pp -151.36 151.89 32.38 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.17 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.588 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -121.09 158.13 28.56 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.851 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.563 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 25.3 tpp -125.73 140.03 53.04 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.674 ' HB2' HG11 ' A' ' 113' ' ' VAL . 25.2 p -134.98 133.23 39.27 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.813 0.339 . . . . 0.0 110.435 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.4 p -118.76 15.44 13.54 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.0 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.713 ' O ' HG12 ' A' ' 113' ' ' VAL . 44.2 p -90.27 130.08 36.43 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.661 0.743 . . . . 0.0 112.424 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.485 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 20.3 pt20 -61.75 -27.01 68.42 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.401 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.28 -42.26 93.34 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.495 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.743 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.1 p -69.77 -38.3 75.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.513 HD13 HH12 ' A' ' 85' ' ' ARG . 6.4 tp -57.93 -48.46 79.87 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 123.68 0.613 . . . . 0.0 110.573 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.485 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 26.1 m-85 -68.77 -39.17 80.36 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.806 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.39 -53.0 62.28 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.306 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.35 -43.86 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.718 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.6 -32.1 64.93 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.782 0.676 . . . . 0.0 109.599 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.02 -20.01 31.11 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.291 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.67 13.82 33.83 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.668 -1.151 . . . . 0.0 114.799 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 p -103.83 6.48 36.61 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.38 -137.57 9.16 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.419 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.74 171.81 14.0 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.069 2.513 . . . . 0.0 113.493 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.19 -55.24 37.29 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.642 0.777 . . . . 0.0 111.998 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.646 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.0 mmtt -141.23 139.69 33.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.691 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 34.5 p -139.01 168.58 19.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.3 tp -126.97 117.38 22.4 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.804 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.761 HD12 HD13 ' A' ' 75' ' ' ILE . 12.4 pt -98.64 102.45 13.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-O 121.532 0.682 . . . . 0.0 109.536 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.0 t -121.24 122.32 39.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.025 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 tp -66.58 112.97 4.41 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.544 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 173.71 18.5 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 114.545 -1.207 . . . . 0.0 114.764 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -127.82 175.06 8.62 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.25 178.708 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -115.54 129.01 56.38 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.154 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.73 150.23 18.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.375 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -128.37 138.23 52.26 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.858 0.387 . . . . 0.0 110.344 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.71 157.65 27.13 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.885 0.741 . . . . 0.0 110.622 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.74 91.67 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.54 -23.51 8.95 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.322 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -57.44 -44.55 84.8 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.938 0.495 . . . . 0.0 112.14 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.9 tm? -67.87 -47.7 68.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.5 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.35 -30.0 68.08 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.05 -49.96 45.92 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.941 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -70.71 -26.76 63.55 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.694 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.4 tp -74.18 -38.98 63.51 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.602 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.9 m -77.84 -28.4 50.16 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.211 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 3.0 t70 -82.25 -1.42 49.29 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.395 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.2 m120 61.03 28.5 18.26 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.857 0.863 . . . . 0.0 111.903 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 143' ' ' GLU . . . -81.96 -43.54 17.91 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.856 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -124.77 113.38 17.86 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.0 tp -86.21 138.49 31.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.5 p -101.66 136.33 41.68 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.502 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 80.6 m -150.78 150.92 29.25 Favored Pre-proline 0 C--O 1.238 0.487 0 O-C-N 123.412 0.445 . . . . 0.0 110.983 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.05 151.06 83.97 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.233 1.956 . . . . 0.0 110.997 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -134.29 176.85 8.23 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -134.56 140.26 35.04 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 113.725 -1.58 . . . . 0.0 108.693 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.83 -26.71 13.14 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.735 2.29 . . . . 0.0 113.646 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.65 -41.79 55.78 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.857 0.723 . . . . 0.0 112.46 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.46 HG21 ' HE ' ' A' ' 167' ' ' ARG . 5.5 mt -68.83 -33.83 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.526 0.679 . . . . 0.0 110.276 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.66 -37.23 56.58 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.538 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -84.83 -31.21 23.96 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -88.7 -73.24 0.51 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 117.97 0.35 . . . . 0.0 111.628 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.862 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.82 99.8 6.12 Favored Pre-proline 0 C--N 1.35 0.589 0 CA-C-O 121.183 0.516 . . . . 0.0 112.228 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.869 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 72.4 Cg_endo -91.18 -0.11 4.79 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 121.711 1.608 . . . . 0.0 114.381 175.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.649 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 89.3 Cg_endo -74.92 -56.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.395 2.976 0 C-N-CA 122.653 2.235 . . . . 0.0 114.579 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.565 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 4.7 mt-10 -118.43 -30.67 5.15 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.542 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.862 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 28.5 tt0 -69.7 -12.18 61.43 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.235 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.869 HH11 HG11 ' A' ' 29' ' ' VAL . 3.7 tpm_? -77.1 -43.88 32.57 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.59 -49.2 64.25 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.4 m -58.21 -48.66 79.67 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.789 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.58 ' O ' ' HG3' ' A' ' 174' ' ' ARG . . . -63.25 -41.92 99.12 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.494 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.01 87.88 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.577 0.548 . . . . 0.0 110.82 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.51 -37.14 85.89 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.53 -28.19 69.48 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.152 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.58 ' HG3' ' O ' ' A' ' 170' ' ' ALA . 9.1 mtm105 -77.28 -40.78 43.31 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 123.291 0.636 . . . . 0.0 110.757 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 tp -69.61 -31.24 69.25 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.449 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.39 48.92 0.37 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.129 -0.557 . . . . 0.0 113.046 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.4 t -128.35 140.64 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -89.76 79.38 6.74 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.732 0.777 . . . . 0.0 110.833 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -77.93 -26.16 48.79 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.225 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.7 m -59.1 -43.83 91.9 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.59 -26.52 50.79 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.2 mt -77.04 -36.65 55.92 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 23.7 p -94.22 -48.61 6.11 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.27 0.356 . . . . 0.0 111.204 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 58.11 120.09 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.248 1.019 . . . . 0.0 112.762 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -100.54 149.88 23.26 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.88 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -98.45 130.35 45.06 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.152 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 134.78 66.37 0.07 OUTLIER Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.461 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -127.96 -40.59 1.68 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.609 0.24 . . . . 0.0 111.25 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.116 -179.944 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.496 0.188 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -101.45 131.08 47.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.056 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -100.27 -41.23 7.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.16 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.492 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.5 m -98.71 153.25 18.86 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.449 0.468 . . . . 0.0 111.005 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.7 p -94.5 100.05 4.72 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.074 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.1 Cg_endo -87.08 9.06 4.09 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.86 2.373 . . . . 0.0 112.232 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -86.99 -47.92 8.55 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.381 -1.282 . . . . 0.0 112.292 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -115.76 151.35 35.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.393 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 32' ' ' LEU . 15.8 mt -95.77 48.59 1.14 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.297 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.42 ' O ' HD21 ' A' ' 102' ' ' LEU . 48.0 tttt -88.82 16.09 7.37 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.378 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 17.3 p80 172.83 58.87 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.43 1.092 . . . . 0.0 109.698 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -135.22 159.36 41.78 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.659 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.465 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.7 m-30 -97.1 136.17 38.01 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.813 HD11 HD23 ' A' ' 32' ' ' LEU . 3.2 mt -108.42 137.12 46.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.793 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.443 HG23 HG22 ' A' ' 29' ' ' VAL . 2.3 mm -117.04 133.23 64.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.545 0.528 . . . . 0.0 109.635 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.54 121.94 21.42 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 123.461 0.475 . . . . 0.0 111.666 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.6 mmt -110.47 152.91 43.63 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.338 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -80.45 73.96 5.77 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.594 2.196 . . . . 0.0 112.622 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -131.46 -19.22 2.75 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.716 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.58 -162.97 0.83 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.3 0.375 . . . . 0.0 110.481 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.73 36.66 2.24 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.869 0.366 . . . . 0.0 111.968 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.37 82.71 3.66 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.809 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.32 -24.87 11.93 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 123.019 2.48 . . . . 0.0 113.349 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -85.16 -37.11 20.57 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.887 0.475 . . . . 0.0 111.595 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.11 -3.04 57.46 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.8 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -60.51 1.62 0.13 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -141.46 41.48 1.75 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.213 0.53 . . . . 0.0 112.076 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.9 p -124.52 157.68 34.73 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.642 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.781 HG11 ' HE ' ' A' ' 167' ' ' ARG . 57.6 t -131.0 133.51 62.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.806 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -115.04 152.37 32.59 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.381 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.52 ' OH ' HD21 ' A' ' 105' ' ' LEU . 43.4 t80 -106.95 120.99 43.54 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.813 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -83.73 108.62 16.9 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 123.481 0.488 . . . . 0.0 111.419 -178.273 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.946 HG23 ' HA2' ' A' ' 42' ' ' GLY . 36.9 t -67.76 -59.97 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.623 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -141.93 120.8 12.75 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.433 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -102.35 127.94 49.13 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.988 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.84 151.85 47.35 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.418 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.3 -19.59 65.52 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.893 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -98.4 -1.63 41.07 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.681 0.613 . . . . 0.0 111.533 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.03 169.73 20.56 Favored Glycine 0 C--N 1.344 1.012 0 C-N-CA 121.529 -0.367 . . . . 0.0 112.304 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -146.32 146.97 30.88 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.81 135.74 53.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.363 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.946 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.21 158.36 29.13 Favored Glycine 0 N--CA 1.447 -0.619 0 O-C-N 124.472 1.107 . . . . 0.0 112.486 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.4 mt -112.9 134.59 54.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 117.253 0.526 . . . . 0.0 111.469 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 78' ' ' GLY . 12.0 t -68.35 122.94 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.38 56.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.618 0.723 . . . . 0.0 111.98 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.844 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -147.04 -3.43 0.58 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.256 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -129.92 88.08 49.91 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.504 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 41.4 Cg_exo -58.44 144.62 96.42 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 121.689 1.593 . . . . 0.0 112.43 175.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.452 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 73.9 m -94.82 160.45 14.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.509 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.72 51.04 0.94 Allowed Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.687 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.6 OUTLIER -133.19 154.05 50.98 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.871 0.395 . . . . 0.0 110.042 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.61 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 10.3 p-10 -112.43 157.6 20.86 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.25 0.343 . . . . 0.0 110.918 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.567 HD12 HD13 ' A' ' 128' ' ' ILE . 1.6 tt -57.54 -26.66 61.71 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.61 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -67.94 -40.39 83.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.383 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.42 -45.57 86.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.092 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.86 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.6 m -61.88 -45.06 99.53 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.736 ' HA ' HD12 ' A' ' 60' ' ' LEU . 15.6 mt -55.74 -35.26 65.97 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.546 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.99 -27.25 49.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.429 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.82 -30.54 51.19 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.768 0.794 . . . . 0.0 109.318 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.86 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.2 mt -77.86 -46.01 22.64 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.038 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -130.99 116.63 16.91 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.626 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.56 -33.08 2.54 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.687 2.925 . . . . 0.0 112.785 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.63 -14.92 56.1 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.4 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.19 149.69 24.45 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 123.338 0.399 . . . . 0.0 111.689 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.06 123.13 29.09 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.304 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.52 154.15 39.86 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.296 1.997 . . . . 0.0 112.301 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.439 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 6.8 Cg_endo -94.14 -163.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.67 2.247 . . . . 0.0 112.064 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.05 -24.76 59.57 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.782 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.573 ' HA ' ' CE1' ' A' ' 72' ' ' HIS . 7.9 ptp180 -67.11 -46.49 74.04 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.638 ' HA ' HD12 ' A' ' 73' ' ' ILE . 20.8 m -73.31 -25.58 60.71 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.464 ' HA ' HD22 ' A' ' 52' ' ' ASN . 46.5 mt-30 -70.45 -29.09 65.57 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.573 ' CE1' ' HA ' ' A' ' 69' ' ' ARG . 15.3 p-80 -96.09 21.31 8.96 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.16 0.505 . . . . 0.0 111.582 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' A' ' 70' ' ' CYS . 57.0 mt -119.53 137.12 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.204 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -106.06 163.12 13.02 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 51' ' ' LEU . 14.2 mm -113.63 154.18 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.996 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.733 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -118.11 155.83 29.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.594 0.358 . . . . 0.0 110.33 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -85.76 119.99 26.7 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.54 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -101.85 -23.64 9.15 Favored Glycine 0 C--N 1.346 1.109 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.158 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.86 -167.91 34.87 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.272 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -88.73 -13.03 3.39 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 123.618 2.878 . . . . 0.0 114.413 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.55 130.52 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 123.075 0.235 . . . . 0.0 111.518 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 46.66 82.85 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.551 1.141 . . . . 0.0 113.301 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 77.2 p -82.85 -12.02 57.76 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.197 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.76 -13.46 59.42 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.759 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -132.81 149.73 52.23 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.594 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.29 144.42 17.02 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.46 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.2 m-85 -86.85 149.4 24.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.021 -1.09 . . . . 0.0 110.94 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 17.4 t -127.32 105.93 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 O-C-N 123.587 0.554 . . . . 0.0 110.351 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.935 HD11 HD13 ' A' ' 105' ' ' LEU . 14.6 tp -106.74 127.63 53.55 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.281 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.41 ' ND1' ' HB3' ' A' ' 123' ' ' PRO . 4.0 p80 -128.08 168.41 15.53 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.548 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.667 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.3 Cg_endo -97.7 21.78 0.34 Allowed 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 122.677 2.251 . . . . 0.0 113.748 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.2 t -109.83 158.88 17.71 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.686 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.06 22.42 38.51 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.609 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.02 151.79 22.07 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.539 0.335 . . . . 0.0 110.514 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.598 ' HA ' HG21 ' A' ' 99' ' ' THR . 22.4 m -128.82 157.12 42.39 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.564 ' CE2' HG23 ' A' ' 113' ' ' VAL . 55.0 m-85 -126.95 -150.97 0.46 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.757 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -58.85 -46.32 88.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.655 0.382 . . . . 0.0 111.415 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.9 m -133.12 81.03 1.91 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.848 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.598 HG21 ' HA ' ' A' ' 95' ' ' SER . 42.4 m -129.49 122.62 29.64 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.381 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.33 123.48 46.89 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.879 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.88 130.13 34.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.979 0.419 . . . . 0.0 110.878 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.427 ' HB3' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -125.43 46.35 2.4 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.667 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.16 -106.85 1.65 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 114.863 -1.062 . . . . 0.0 113.381 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.28 -10.63 3.14 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.935 HD13 HD11 ' A' ' 89' ' ' LEU . 1.7 pp -155.22 152.15 28.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.609 0.364 . . . . 0.0 111.25 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.586 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.06 157.5 26.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.863 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.527 ' O ' ' HA ' ' A' ' 99' ' ' THR . 17.3 ttm -123.9 134.2 53.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.0 m -136.44 133.8 37.02 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.7 p -127.49 19.07 6.84 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.144 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 113' ' ' VAL . 46.8 p -90.16 131.19 36.14 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.393 0.616 . . . . 0.0 112.037 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.482 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 5.3 mt-30 -58.16 -26.96 63.36 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.759 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -64.12 -40.44 96.2 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.902 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.765 ' O ' HG22 ' A' ' 117' ' ' ILE . 2.6 p -71.1 -38.43 71.28 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.418 HD11 HH12 ' A' ' 85' ' ' ARG . 4.4 mm? -55.51 -50.1 70.85 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.533 0.521 . . . . 0.0 110.495 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.482 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 39.9 m-85 -67.8 -40.6 83.86 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.222 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.69 -54.17 48.48 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.753 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.765 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.11 -43.73 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.6 -32.27 65.08 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 123.674 0.609 . . . . 0.0 109.59 178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.531 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.66 -20.2 31.68 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.363 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.05 17.0 26.4 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.841 -1.072 . . . . 0.0 114.64 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.6 p -107.08 7.08 29.49 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.57 -137.29 8.74 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.113 -0.826 . . . . 0.0 112.47 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.41 ' HB3' ' ND1' ' A' ' 90' ' ' HIS . 2.1 Cg_endo -82.51 169.3 13.94 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.942 2.428 . . . . 0.0 113.652 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.61 -56.46 21.04 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.776 0.831 . . . . 0.0 112.106 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.667 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.5 mmtt -139.63 139.76 36.79 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.502 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 35.8 p -141.04 168.97 18.5 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.3 tp -125.63 115.18 19.72 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.695 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.567 HD13 HD12 ' A' ' 53' ' ' LEU . 7.9 pt -99.29 104.43 16.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 O-C-N 123.751 0.657 . . . . 0.0 109.229 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -124.55 122.08 36.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.21 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.34 113.64 5.39 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.346 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.433 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 73.87 167.92 16.04 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 115.093 -0.958 . . . . 0.0 114.461 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -128.64 179.95 5.4 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.115 0.483 . . . . 0.0 110.655 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -118.2 130.37 56.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.368 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.57 146.04 16.58 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.539 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 31.4 m-90 -122.31 135.71 54.77 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 122.655 0.382 . . . . 0.0 110.35 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.36 158.11 26.13 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.935 0.772 . . . . 0.0 110.663 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.1 90.86 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.14 -25.01 7.61 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.172 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -57.59 -44.17 85.2 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.938 0.495 . . . . 0.0 112.252 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.582 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.98 -47.57 65.25 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.118 0.261 . . . . 0.0 110.527 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.33 -29.22 68.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.088 0.47 . . . . 0.0 110.643 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.63 -50.66 34.63 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.788 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.1 pt-20 -69.57 -26.64 64.58 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.816 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.7 tp -75.2 -39.16 60.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.637 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.2 m -77.82 -27.83 50.13 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.492 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -82.96 0.1 46.14 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.518 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.5 m120 60.09 29.39 18.96 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.811 0.844 . . . . 0.0 111.761 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.61 -43.28 17.2 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.917 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -124.17 113.61 18.54 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.6 tp -83.92 139.22 32.73 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.205 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.3 p -104.66 138.1 41.48 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.32 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 24.7 p -152.88 155.5 32.27 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.595 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.08 158.24 26.41 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.259 1.972 . . . . 0.0 111.214 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.465 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.97 166.24 21.4 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.11 134.89 23.37 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 114.317 -1.311 . . . . 0.0 107.983 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.13 -26.47 14.86 Favored 'Trans proline' 0 C--N 1.364 1.354 0 C-N-CA 122.594 2.196 . . . . 0.0 113.616 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.67 -40.04 62.48 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 123.787 0.68 . . . . 0.0 112.211 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.567 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.6 mt -72.07 -35.1 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 121.411 0.624 . . . . 0.0 110.351 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.26 -37.22 63.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.343 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -85.45 -34.9 21.54 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -84.85 -72.16 0.49 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 117.98 0.354 . . . . 0.0 111.657 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.897 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.85 99.04 6.21 Favored Pre-proline 0 C--N 1.348 0.539 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.844 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.7 Cg_endo -91.99 -0.15 4.28 Favored 'Trans proline' 0 CA--C 1.569 2.259 0 C-N-CA 121.64 1.56 . . . . 0.0 114.253 175.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.642 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 81.3 Cg_endo -73.89 -52.34 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 122.539 2.159 . . . . 0.0 114.43 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.518 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.5 mt-10 -122.54 -30.19 3.95 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.672 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.897 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.8 tt0 -70.02 -10.84 60.01 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.338 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.781 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.91 -41.52 43.21 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.9 tp -70.62 -50.33 38.1 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.7 m -58.07 -49.61 76.32 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.666 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -63.66 -40.0 95.75 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.069 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.76 -45.32 78.11 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.54 0.525 . . . . 0.0 110.485 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 -38.35 90.77 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.497 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.95 -27.63 68.3 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.65 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -78.05 -40.29 39.18 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.963 0.505 . . . . 0.0 110.378 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.66 -32.76 71.6 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.353 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.37 54.19 0.41 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.944 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 13.3 t -127.26 145.98 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -87.0 75.33 9.55 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.753 0.787 . . . . 0.0 110.703 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.7 -26.09 49.9 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.847 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 51.7 p -59.65 -42.28 92.43 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.61 -26.58 50.77 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.2 mt -76.96 -38.08 53.97 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.308 0.38 . . . . 0.0 111.977 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.4 p -93.92 -47.72 6.59 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.317 0.386 . . . . 0.0 111.286 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 58.87 120.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.243 1.017 . . . . 0.0 112.819 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -113.43 150.64 32.48 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -98.18 143.8 28.31 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.213 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 163.63 121.2 0.55 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.513 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -100.62 147.21 26.22 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 123.64 0.259 . . . . 0.0 110.908 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.073 -179.947 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.505 0.193 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -111.47 131.31 55.31 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.051 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -104.67 -40.68 5.92 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.166 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.505 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 43.7 p -97.56 154.99 17.17 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.412 0.445 . . . . 0.0 111.077 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.9 m -95.18 99.26 4.18 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.988 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.2 Cg_endo -87.1 8.87 4.16 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.875 2.383 . . . . 0.0 112.376 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 t -87.93 -47.34 8.64 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.19 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -123.3 154.82 38.35 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.487 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.4 mt -99.15 46.68 0.97 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.928 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.401 ' O ' HD21 ' A' ' 102' ' ' LEU . 85.3 mttt -90.06 18.68 5.59 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 120.893 0.377 . . . . 0.0 111.058 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.1 p80 176.82 55.49 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.04 0.936 . . . . 0.0 110.265 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -134.32 159.78 39.94 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.625 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.492 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 18.9 m-30 -98.6 136.59 38.47 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.035 0.445 . . . . 0.0 112.02 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.784 HD11 HD23 ' A' ' 32' ' ' LEU . 4.3 mt -108.34 141.86 39.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.919 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.674 HD11 ' SG ' ' A' ' 152' ' ' CYS . 2.3 mp -124.87 137.36 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 O-C-N 123.274 0.358 . . . . 0.0 110.351 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.05 120.13 19.22 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.748 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.5 mmt -97.86 159.0 31.95 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.565 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.04 6.81 4.36 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.678 2.252 . . . . 0.0 113.727 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -79.82 -12.94 59.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.303 0.241 . . . . 0.0 111.549 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.727 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -105.82 153.13 22.34 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.175 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.91 42.95 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.376 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.727 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.1 m-20 -116.55 87.6 21.47 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.526 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.51 -20.0 18.54 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.926 2.417 . . . . 0.0 113.331 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -84.52 -34.67 23.26 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.828 0.451 . . . . 0.0 111.708 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -94.02 3.83 54.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.024 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.72 163.65 21.12 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 48.87 32.07 3.54 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.9 p -116.29 154.22 30.55 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 120.568 0.223 . . . . 0.0 110.738 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.739 HG11 ' HE ' ' A' ' 167' ' ' ARG . 47.2 t -129.33 132.2 66.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.781 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 6.1 m -113.34 153.39 28.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.755 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.543 ' OH ' HD21 ' A' ' 105' ' ' LEU . 45.2 t80 -107.18 120.5 42.27 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.784 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -85.26 109.75 18.57 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.639 0.587 . . . . 0.0 111.128 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.95 HG23 ' HA2' ' A' ' 42' ' ' GLY . 34.9 t -69.13 -60.22 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 113.569 -1.651 . . . . 0.0 110.841 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -141.32 115.81 9.54 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.407 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -99.07 128.13 45.15 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.802 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -139.28 152.64 47.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.398 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.87 -18.98 65.64 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.787 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.45 2.35 42.09 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.536 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.46 166.79 15.01 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 121.517 -0.373 . . . . 0.0 112.375 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -144.91 145.82 31.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.457 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -125.56 136.82 53.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.966 178.263 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.95 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -160.93 159.78 31.37 Favored Glycine 0 N--CA 1.452 -0.284 0 O-C-N 124.575 1.172 . . . . 0.0 112.59 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.2 mt -115.12 135.08 54.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.08 0.44 . . . . 0.0 111.228 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 78' ' ' GLY . 11.0 t -66.83 124.11 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.551 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.65 54.08 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.538 0.685 . . . . 0.0 112.015 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.83 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.1 t30 -147.32 -3.42 0.56 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.996 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -129.7 87.61 51.98 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.528 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 35.2 Cg_exo -59.73 142.45 98.74 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 121.658 1.572 . . . . 0.0 112.273 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.434 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.2 m -89.44 159.39 17.3 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.465 0.478 . . . . 0.0 111.589 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.84 48.54 1.47 Allowed Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.513 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mt -133.48 157.02 46.67 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 124.002 0.471 . . . . 0.0 110.141 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 18.4 p-10 -112.22 158.74 19.34 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.245 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.658 HD13 HD13 ' A' ' 128' ' ' ILE . 13.3 tp -57.53 -29.23 64.2 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.38 96.0 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.33 -47.02 77.96 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.865 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.3 m -62.06 -43.92 98.32 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.707 ' HA ' HD12 ' A' ' 60' ' ' LEU . 16.7 mt -57.34 -34.57 68.92 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.587 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -78.18 -27.72 48.0 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.325 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -30.29 51.97 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.263 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.865 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 14.7 mt -77.87 -45.55 23.9 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 113.667 -1.606 . . . . 0.0 111.056 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -130.94 116.01 16.81 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.609 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.43 -32.91 2.7 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 123.604 2.869 . . . . 0.0 112.744 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.36 -15.38 55.46 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.315 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.3 150.49 23.83 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.611 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.78 122.79 28.29 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.167 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.7 149.74 49.22 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.357 2.038 . . . . 0.0 112.189 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 8.7 Cg_endo -94.69 -171.5 0.23 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.639 2.226 . . . . 0.0 112.477 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.79 67.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.113 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.53 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 7.4 ptp180 -68.73 -46.73 68.15 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.682 ' HA ' HD12 ' A' ' 73' ' ' ILE . 15.4 m -75.49 -25.44 57.31 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 50.5 mt-30 -68.63 -26.92 65.58 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.441 ' CE1' ' HA ' ' A' ' 69' ' ' ARG . 15.8 p-80 -99.46 21.68 11.81 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.138 0.494 . . . . 0.0 111.318 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 70' ' ' CYS . 63.4 mt -117.79 139.1 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.268 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.18 154.62 20.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.707 HD13 HD12 ' A' ' 128' ' ' ILE . 23.5 mm -101.28 152.59 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.235 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.714 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.9 t80 -118.81 154.87 32.15 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -85.94 119.2 25.99 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.613 0.188 . . . . 0.0 110.555 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.577 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.29 -23.72 8.31 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.022 -1.085 . . . . 0.0 114.047 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.15 -168.24 35.11 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.359 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -88.66 -13.26 3.37 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.47 2.78 . . . . 0.0 114.37 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.3 t -82.39 125.19 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 123.082 0.239 . . . . 0.0 111.233 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 47.23 85.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.488 1.115 . . . . 0.0 113.027 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.41 ' O ' HD21 ' A' ' 130' ' ' LEU . 8.8 t -86.8 1.45 52.27 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.288 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -94.63 -4.23 48.08 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.633 ' NH2' ' HA ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -133.05 152.85 51.92 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.552 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.611 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.63 137.4 14.12 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.413 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.71 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.6 OUTLIER -86.49 144.55 27.2 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.029 0.932 . . . . 0.0 110.635 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -125.28 103.67 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 123.636 0.585 . . . . 0.0 110.046 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.884 HD11 HD13 ' A' ' 105' ' ' LEU . 15.5 tp -107.51 128.38 54.46 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.138 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -127.55 169.09 13.12 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.612 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.659 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.4 Cg_endo -97.25 15.2 0.75 Allowed 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.756 2.304 . . . . 0.0 113.818 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.4 t -102.77 159.91 15.06 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.668 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.76 22.47 37.7 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.636 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -89.4 153.01 21.19 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.56 0.344 . . . . 0.0 110.622 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.563 ' HA ' HG21 ' A' ' 99' ' ' THR . 13.6 m -130.31 156.65 44.32 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 112.196 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.569 ' CE2' HG23 ' A' ' 113' ' ' VAL . 46.4 m-85 -126.27 -150.59 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.844 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -56.78 -46.86 81.25 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.975 0.51 . . . . 0.0 111.633 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 m -134.5 82.25 1.96 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.86 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 107' ' ' MET . 30.4 m -130.1 124.51 32.92 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.229 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.71 123.54 47.22 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.844 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.21 129.22 34.9 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.081 0.467 . . . . 0.0 110.787 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.461 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.55 45.88 2.43 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.411 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.06 -105.87 1.33 Allowed Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.155 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.55 -10.67 3.65 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.884 HD13 HD11 ' A' ' 89' ' ' LEU . 2.2 pp -155.46 153.19 29.94 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 123.26 0.35 . . . . 0.0 111.392 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.623 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.39 156.2 29.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.716 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 99' ' ' THR . 18.6 ttm -122.52 130.58 53.19 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 m -131.52 130.86 42.9 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.8 p -120.36 18.63 12.17 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.549 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.746 ' O ' HG12 ' A' ' 113' ' ' VAL . 68.3 m -88.09 133.99 33.86 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.963 0.887 . . . . 0.0 112.694 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.633 ' HA ' ' NH2' ' A' ' 85' ' ' ARG . 2.7 mt-30 -62.7 -30.81 71.68 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.96 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.79 -40.31 95.02 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.735 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 110' ' ' SER . 3.5 p -70.46 -39.41 76.29 Favored 'Isoleucine or valine' 0 C--N 1.353 0.745 0 O-C-N 123.142 0.276 . . . . 0.0 110.502 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.618 HD22 ' NH2' ' A' ' 85' ' ' ARG . 4.2 tp -59.36 -46.54 88.36 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 123.471 0.482 . . . . 0.0 110.164 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.496 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 24.1 m-85 -67.22 -40.96 86.45 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 178.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -53.21 59.78 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.599 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.736 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.91 -43.57 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.527 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.483 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.33 -32.72 64.94 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.815 0.697 . . . . 0.0 109.59 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.53 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.89 -19.64 32.0 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.376 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.06 15.21 31.43 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.689 -1.141 . . . . 0.0 114.755 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 p -105.1 6.77 33.49 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.2 -137.35 8.99 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.481 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -81.62 172.6 12.2 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.046 2.497 . . . . 0.0 113.526 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.64 -55.16 37.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.695 0.798 . . . . 0.0 111.962 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.659 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.8 mmtt -141.76 139.74 32.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.656 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 36.6 p -139.02 167.82 21.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.0 tp -126.88 118.49 24.7 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.574 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.71 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.5 pt -98.46 102.18 13.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.575 0.703 . . . . 0.0 109.725 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.7 t -121.02 122.05 39.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.713 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.41 HD21 ' O ' ' A' ' 83' ' ' THR . 7.0 tp -67.33 118.03 10.14 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.464 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.86 173.24 5.63 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 114.763 -1.108 . . . . 0.0 114.524 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.41 175.5 8.46 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.179 0.514 . . . . 0.0 110.659 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -115.86 129.68 56.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.271 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.47 146.75 17.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.631 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -121.86 136.83 54.94 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.149 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.32 157.81 26.28 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.848 0.718 . . . . 0.0 110.786 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.23 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.51 -25.82 7.55 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.119 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -58.54 -44.22 89.52 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.885 0.474 . . . . 0.0 112.272 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.582 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.89 -47.58 65.5 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.16 0.287 . . . . 0.0 110.481 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.29 -29.55 68.9 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.014 0.435 . . . . 0.0 110.555 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.56 -49.91 49.79 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.84 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.32 -26.81 63.0 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.696 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.5 tp -74.55 -37.31 63.03 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.492 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.0 t -77.88 -29.83 50.51 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.712 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.0 t70 -84.11 1.15 45.54 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.072 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 52.63 33.98 14.85 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.841 1.256 . . . . 0.0 112.201 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 143' ' ' GLU . . . -81.53 -41.61 21.4 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.372 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -122.14 113.02 18.92 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.0 tp -83.92 136.18 34.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.5 p -101.13 136.91 40.22 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.967 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.674 ' SG ' HD11 ' A' ' 15' ' ' ILE . 26.2 p -150.79 154.98 35.42 Favored Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 123.458 0.474 . . . . 0.0 110.738 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.63 152.6 61.37 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.189 1.926 . . . . 0.0 110.989 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.492 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.93 167.45 17.41 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.74 134.22 21.9 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.943 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.87 -26.48 15.55 Favored 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 122.493 2.129 . . . . 0.0 113.434 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.14 -48.49 53.72 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 124.032 0.832 . . . . 0.0 111.441 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.586 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.7 mt -64.06 -34.87 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.371 0.668 . . . . 0.0 110.839 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -73.55 -35.62 65.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.281 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -83.66 -34.89 24.91 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 162' ' ' LEU . 2.2 p30 -86.81 -67.22 0.83 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.744 0.702 . . . . 0.0 112.729 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.67 ' C ' ' HD2' ' A' ' 164' ' ' PRO . 1.1 tp -145.73 98.98 4.44 Favored Pre-proline 0 C--N 1.344 0.333 0 CA-C-O 121.042 0.448 . . . . 0.0 111.786 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.83 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 65.7 Cg_endo -91.54 -0.14 4.56 Favored 'Trans proline' 0 CA--C 1.57 2.282 0 C-N-CA 121.795 1.663 . . . . 0.0 114.488 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.67 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 79.4 Cg_endo -74.67 -50.41 0.14 Allowed 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.76 2.307 . . . . 0.0 114.438 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.513 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 10.8 mt-10 -121.61 -33.98 3.51 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.705 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 6.0 mt-10 -68.6 -11.28 59.81 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.045 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.739 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.06 -41.7 41.32 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -69.82 -49.78 49.33 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.8 m -58.33 -49.05 78.58 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.682 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.67 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.39 -40.21 95.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.265 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.82 79.46 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 123.538 0.524 . . . . 0.0 110.489 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.69 88.27 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.466 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.25 -27.76 68.87 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.507 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.67 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.6 mmp_? -77.52 -40.03 44.12 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.899 0.479 . . . . 0.0 110.192 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -71.3 -31.29 67.26 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.461 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.38 54.95 0.56 Allowed Glycine 0 C--N 1.341 0.806 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.911 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 10.7 t -127.69 148.13 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.83 77.88 7.71 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.707 0.765 . . . . 0.0 110.69 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.78 -26.14 49.53 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.113 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 51.7 m -58.36 -43.6 88.44 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.45 -26.76 51.76 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.3 mt -77.26 -31.24 54.82 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.636 0.374 . . . . 0.0 111.693 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.4 p -89.81 -47.3 7.99 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.399 0.437 . . . . 0.0 111.408 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.22 118.07 21.76 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.513 0.508 . . . . 0.0 111.147 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -100.13 150.11 22.83 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.957 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -98.95 145.34 27.14 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.122 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 163.76 -134.86 3.53 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.535 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -99.34 132.57 44.57 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.311 0.244 . . . . 0.0 111.079 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 C-N-CA 123.884 0.874 . . . . 0.0 112.241 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.21 0.052 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -100.15 136.6 39.81 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.407 0.442 . . . . 0.0 111.039 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -99.33 -40.59 7.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.24 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.8 m -98.33 153.5 18.49 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.4 t -93.2 106.97 22.1 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.812 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -86.73 6.97 5.12 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.808 2.339 . . . . 0.0 112.339 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.8 m -112.99 -57.24 2.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.537 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.57 ' CD1' ' HE3' ' A' ' 10' ' ' LYS . 2.4 m-85 -111.41 157.85 19.78 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.312 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.736 ' HB3' ' ND1' ' A' ' 12' ' ' HIS . 14.2 mt -100.04 41.2 1.18 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.044 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.57 ' HE3' ' CD1' ' A' ' 8' ' ' TYR . 75.0 mttt -89.53 26.77 1.63 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.95 0.405 . . . . 0.0 110.63 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 178.37 53.9 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.668 0.787 . . . . 0.0 109.979 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.736 ' ND1' ' HB3' ' A' ' 9' ' ' LEU . 6.9 p-80 -131.11 156.29 45.5 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.436 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 11.0 m-30 -98.68 133.72 42.61 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.843 0.354 . . . . 0.0 111.205 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 8.6 mt -106.58 140.98 38.59 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.299 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.21 131.19 73.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.25 132.84 38.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.885 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 55.5 mtt -121.46 156.6 57.93 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.191 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.85 75.83 4.61 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.629 2.219 . . . . 0.0 112.885 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -134.02 -21.99 1.84 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.787 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.57 -162.91 0.86 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.25 0.344 . . . . 0.0 110.382 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.536 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -101.79 32.94 3.19 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.1 m-20 -111.47 82.49 3.66 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.41 -24.17 12.45 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 123.034 2.489 . . . . 0.0 113.361 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -85.01 -37.81 19.96 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.953 0.501 . . . . 0.0 111.612 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.61 -3.4 57.57 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.791 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -60.83 1.93 0.13 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -141.33 39.37 1.74 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.191 0.519 . . . . 0.0 111.981 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.7 p -123.22 158.52 30.67 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.788 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.783 HG11 ' HE ' ' A' ' 167' ' ' ARG . 97.0 t -130.85 132.3 64.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.955 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -113.25 153.75 27.89 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.343 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.473 ' OH ' HD21 ' A' ' 105' ' ' LEU . 34.9 t80 -108.61 119.6 40.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.581 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.525 HD11 ' HB1' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -82.51 107.8 15.43 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 123.491 0.494 . . . . 0.0 111.295 -178.568 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.947 HG23 ' HA2' ' A' ' 42' ' ' GLY . 39.0 t -68.12 -60.65 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.203 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.515 ' OE1' HD11 ' A' ' 100' ' ' LEU . 12.8 tt0 -142.16 114.76 8.49 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.426 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.494 ' CE1' HD12 ' A' ' 9' ' ' LEU . 15.7 t-80 -96.75 129.78 44.11 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.9 151.54 47.03 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.068 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.39 -17.82 64.12 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -104.79 6.32 33.91 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.664 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.61 164.39 12.62 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 121.511 -0.376 . . . . 0.0 112.295 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -146.02 141.13 27.36 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.94 134.9 54.51 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.584 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.947 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.04 160.56 31.29 Favored Glycine 0 N--CA 1.449 -0.444 0 O-C-N 124.5 1.125 . . . . 0.0 112.573 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.5 mt -115.95 135.26 54.14 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.148 0.474 . . . . 0.0 111.503 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 78' ' ' GLY . 12.0 t -68.64 123.55 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.518 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.3 pt -126.83 56.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.679 0.752 . . . . 0.0 111.798 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.859 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -147.45 -4.17 0.53 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.42 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -129.7 88.21 50.21 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.504 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.2 Cg_exo -59.58 142.26 98.57 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.655 1.57 . . . . 0.0 112.151 175.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.419 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 43.7 m -91.43 159.48 15.94 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.346 0.404 . . . . 0.0 111.574 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.53 46.76 1.24 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.362 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.69 155.1 51.12 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.473 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 14.7 p-10 -105.79 161.08 14.73 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.889 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.668 HD13 HD13 ' A' ' 128' ' ' ILE . 13.5 tp -58.77 -37.85 77.21 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.59 -36.58 56.44 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 37.4 mt-10 -64.37 -43.04 95.75 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.171 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.868 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -62.77 -46.48 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.739 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.5 mp -54.01 -36.77 63.35 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.858 0.724 . . . . 0.0 110.788 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.93 -28.22 49.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.525 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -30.05 48.82 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.358 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.868 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.1 mt -77.75 -45.03 25.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.945 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -132.3 116.48 15.35 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.543 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.5 -32.75 2.74 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.566 2.844 . . . . 0.0 112.803 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.29 -14.17 55.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.426 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.89 149.93 24.46 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 123.38 0.425 . . . . 0.0 111.716 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.3 123.65 29.79 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.046 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 56.5 Cg_endo -74.17 145.42 34.92 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 122.271 1.981 . . . . 0.0 112.371 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.7 Cg_endo -92.58 -171.34 0.33 Allowed 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.561 2.174 . . . . 0.0 111.978 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.15 -24.79 68.05 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.215 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.566 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.3 ptp180 -66.22 -53.27 39.16 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.693 ' HA ' HD12 ' A' ' 73' ' ' ILE . 60.7 m -72.38 -25.0 61.34 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 51.3 mt-30 -67.11 -35.69 80.3 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -91.62 23.99 3.28 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.256 0.551 . . . . 0.0 111.689 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 70' ' ' CYS . 55.8 mt -120.42 138.97 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.573 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.62 154.79 20.92 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.768 0.668 . . . . 0.0 112.639 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.767 HD13 HD12 ' A' ' 128' ' ' ILE . 16.6 mm -102.74 152.57 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.207 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.717 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.5 t80 -119.27 152.75 36.14 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -83.45 120.59 26.09 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.899 0.318 . . . . 0.0 110.796 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.6 -23.66 8.22 Favored Glycine 0 C--N 1.348 1.206 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.984 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.6 -167.86 35.29 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.333 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -88.66 -11.51 4.0 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.511 2.807 . . . . 0.0 114.378 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -86.06 127.34 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 123.054 0.221 . . . . 0.0 111.266 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 46.04 84.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.528 1.131 . . . . 0.0 113.289 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 p -85.69 -4.41 59.16 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.072 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.91 -5.64 59.2 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.729 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.614 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.43 154.27 50.92 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.614 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.28 133.69 11.8 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.986 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.731 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.61 145.07 27.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.377 1.071 . . . . 0.0 110.426 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.28 103.94 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 123.414 0.446 . . . . 0.0 110.726 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.877 HD11 HD13 ' A' ' 105' ' ' LEU . 14.1 tp -106.75 128.29 54.09 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.727 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.405 ' CE1' ' HB3' ' A' ' 106' ' ' ALA . 3.6 p80 -125.51 166.42 21.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-O 118.937 -0.554 . . . . 0.0 112.048 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.5 Cg_endo -96.16 14.84 0.97 Allowed 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.663 2.242 . . . . 0.0 113.59 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.8 t -101.93 160.84 14.14 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.808 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.65 19.42 54.77 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.794 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mp -85.62 154.1 21.93 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.481 0.312 . . . . 0.0 111.057 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 p -127.07 156.86 41.02 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.57 ' CE2' HG23 ' A' ' 113' ' ' VAL . 51.4 m-85 -129.8 -152.57 0.52 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.821 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -57.27 -46.43 83.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.847 0.459 . . . . 0.0 111.721 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.7 m -136.27 81.67 1.9 Allowed 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.209 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 107' ' ' MET . 11.3 m -129.33 126.84 39.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.691 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.515 HD11 ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -105.68 123.26 47.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.743 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -82.89 128.81 34.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.53 . . . . 0.0 110.763 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.476 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.54 46.69 2.25 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.337 -179.367 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.47 -107.95 2.2 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.04 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -61.22 -9.24 4.59 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.877 HD13 HD11 ' A' ' 89' ' ' LEU . 2.6 pp -154.29 152.39 30.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.41 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.641 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.14 156.74 28.17 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.706 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.568 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.8 ttm -121.45 127.21 50.88 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.712 ' HB3' HG11 ' A' ' 113' ' ' VAL . 20.2 m -123.84 129.47 51.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.182 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 58.7 p -119.57 15.12 12.81 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.71 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.741 ' O ' HG12 ' A' ' 113' ' ' VAL . 61.8 m -87.76 129.71 35.08 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.358 0.599 . . . . 0.0 111.872 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.483 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.6 pt20 -61.55 -29.4 69.99 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.158 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -64.98 -42.86 94.17 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.627 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 110' ' ' SER . 4.2 p -67.75 -38.17 79.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 O-C-N 123.171 0.294 . . . . 0.0 110.291 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.603 HD22 ' NH2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -59.13 -48.99 79.58 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 123.572 0.545 . . . . 0.0 110.323 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.483 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 32.0 m-85 -69.12 -37.52 78.39 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.995 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.04 -51.7 66.93 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.085 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.81 -43.44 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.257 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.1 -31.68 65.52 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 123.734 0.646 . . . . 0.0 109.544 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.566 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.74 -20.08 31.65 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.233 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.05 15.1 31.76 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.689 -1.141 . . . . 0.0 114.67 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.5 p -105.8 8.16 32.68 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.3 -138.49 9.91 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.203 -0.776 . . . . 0.0 112.774 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.9 172.11 13.49 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.283 2.656 . . . . 0.0 113.87 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.49 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -52.05 -57.23 10.16 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.417 1.087 . . . . 0.0 111.624 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.549 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -139.6 152.91 47.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.811 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.5 m -147.34 164.21 33.98 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.79 117.81 22.57 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.449 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.767 HD12 HD13 ' A' ' 75' ' ' ILE . 12.7 pt -98.44 102.35 13.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 121.842 0.83 . . . . 0.0 109.833 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 7.2 t -118.94 122.27 41.87 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.727 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -66.95 115.21 6.43 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.109 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.01 174.15 5.25 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.694 -1.139 . . . . 0.0 114.355 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -128.64 179.9 5.43 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.251 0.548 . . . . 0.0 110.842 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -117.43 130.49 56.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.215 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.86 139.56 11.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.757 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.402 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 32.6 m-90 -113.88 135.01 54.44 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.934 0.432 . . . . 0.0 110.151 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.62 158.03 25.8 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.887 0.742 . . . . 0.0 110.501 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.91 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 122.26 -26.11 6.48 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.015 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.71 -45.07 86.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.32 -47.93 66.22 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.156 0.285 . . . . 0.0 110.502 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.62 -28.54 68.62 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.411 0.445 . . . . 0.0 110.729 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.53 -51.13 30.83 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.74 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -69.47 -26.49 64.59 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.7 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.2 tp -75.37 -39.34 59.32 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.873 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.6 m -77.75 -28.46 50.72 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.532 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.8 t70 -82.93 0.55 43.92 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.438 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 59.31 28.89 18.35 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.777 0.831 . . . . 0.0 111.7 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.93 -43.4 19.82 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.304 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -125.69 118.07 24.83 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 4.8 tp -87.97 150.88 23.19 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.484 0.183 . . . . 0.0 111.357 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.54 HG22 ' NE2' ' A' ' 12' ' ' HIS . 80.8 p -111.25 137.11 49.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.792 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 78.6 m -149.86 154.5 37.36 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 123.315 0.384 . . . . 0.0 111.357 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.37 148.37 86.91 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.555 2.17 . . . . 0.0 110.993 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.436 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -123.21 166.92 14.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -135.53 134.53 21.09 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.929 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.46 -26.38 17.02 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.604 2.202 . . . . 0.0 113.542 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.91 -40.12 63.29 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.862 0.726 . . . . 0.0 112.116 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.578 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.8 mt -71.75 -35.66 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 121.382 0.611 . . . . 0.0 110.277 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.5 tt -73.65 -37.72 65.21 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.455 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -85.3 -34.71 21.82 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -84.92 -72.58 0.47 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 117.967 0.349 . . . . 0.0 111.627 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.897 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.28 98.97 6.56 Favored Pre-proline 0 C--N 1.348 0.529 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.859 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 66.3 Cg_endo -92.19 -0.05 4.15 Favored 'Trans proline' 0 CA--C 1.569 2.269 0 C-N-CA 121.702 1.601 . . . . 0.0 114.226 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.634 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 77.4 Cg_endo -74.03 -52.5 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.899 0 C-N-CA 122.605 2.204 . . . . 0.0 114.389 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.516 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.3 mt-10 -122.43 -29.92 4.03 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.707 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.897 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.9 tt0 -70.09 -10.89 60.21 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.37 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.783 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.83 -39.62 50.64 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.231 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.9 tt -72.64 -49.98 28.21 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.1 m -58.0 -47.96 81.47 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.508 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.671 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.96 -39.9 90.82 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.17 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.32 79.94 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 123.393 0.433 . . . . 0.0 110.594 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.23 -38.49 90.55 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.523 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.29 -28.55 69.79 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.601 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.86 -40.45 40.05 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 122.905 0.482 . . . . 0.0 110.35 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.98 -33.24 74.26 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.533 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 124.4 45.65 0.26 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.108 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 6.2 t -129.15 139.13 52.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -90.7 81.06 5.85 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.682 0.753 . . . . 0.0 110.765 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -77.84 -26.27 49.33 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.218 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 13.5 t -58.5 -45.28 89.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.099 0.56 . . . . 0.0 112.486 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.47 -26.81 51.7 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 21.3 mt -77.23 -29.86 54.28 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.292 0.37 . . . . 0.0 111.699 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 23.5 p -90.41 -48.22 7.25 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.385 0.428 . . . . 0.0 111.3 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.62 119.13 22.02 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 123.459 0.474 . . . . 0.0 111.056 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -100.45 140.72 34.3 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.56 141.63 51.8 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.641 0.588 . . . . 0.0 111.041 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 151.58 104.98 0.28 Allowed Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.514 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -128.55 145.29 51.17 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.664 0.273 . . . . 0.0 110.838 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.192 0 C-N-CA 123.895 0.878 . . . . 0.0 112.28 -179.93 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.485 0.183 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -100.39 129.95 46.42 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.199 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -98.7 -42.48 7.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.841 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.537 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.8 m -101.61 158.52 16.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.618 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.6 p -95.03 98.84 3.61 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.213 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.4 Cg_endo -87.57 8.36 4.28 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.914 2.409 . . . . 0.0 112.103 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.4 t -90.53 -45.85 8.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.178 -1.374 . . . . 0.0 112.228 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -100.01 155.27 17.79 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.525 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.8 45.52 1.26 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.715 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -89.92 16.03 8.9 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.441 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 18.6 p80 173.94 54.86 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.967 0.907 . . . . 0.0 110.518 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -133.14 163.58 28.96 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.303 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -100.69 140.73 34.55 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.242 0.544 . . . . 0.0 112.258 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.6 mp -111.75 137.49 49.59 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.185 -1.371 . . . . 0.0 109.807 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.511 HD12 ' O ' ' A' ' 150' ' ' LEU . 2.9 mp -119.98 136.2 57.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.81 127.21 32.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.117 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 33.1 mtt -110.79 157.88 37.26 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.196 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.12 29.36 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.577 2.184 . . . . 0.0 113.127 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -85.81 -17.62 35.2 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -167.76 1.26 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.088 0.242 . . . . 0.0 110.598 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.42 40.9 1.39 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.036 0.446 . . . . 0.0 111.732 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -111.92 80.69 3.18 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.844 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.5 Cg_exo -75.55 -23.06 13.27 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.036 2.491 . . . . 0.0 113.28 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -84.53 -34.96 23.18 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.916 0.487 . . . . 0.0 111.708 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.63 3.82 53.09 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.077 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.12 163.18 20.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.767 0.318 . . . . 0.0 111.807 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 49.69 32.32 5.05 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.9 p -118.22 154.82 31.59 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 122.395 -0.191 . . . . 0.0 110.508 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.685 HG11 ' HE ' ' A' ' 167' ' ' ARG . 68.7 t -128.54 134.7 64.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-O 121.416 0.627 . . . . 0.0 110.789 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.8 m -116.11 151.95 34.61 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.658 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.472 ' OH ' HD21 ' A' ' 105' ' ' LEU . 12.8 t80 -105.32 118.88 37.69 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.608 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -82.72 107.84 15.65 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.365 0.602 . . . . 0.0 110.065 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.951 HG23 ' HA2' ' A' ' 42' ' ' GLY . 23.5 t -71.87 -59.6 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.76 -178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -137.25 119.23 15.33 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.51 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -103.94 126.2 50.89 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -139.94 153.2 46.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.577 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.23 -18.34 65.23 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.522 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -98.31 -3.55 36.94 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.391 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.0 171.48 21.75 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 121.564 -0.35 . . . . 0.0 112.29 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -146.67 144.43 29.47 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.42 137.2 54.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.747 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.951 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.82 158.44 29.69 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.858 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.4 mt -115.6 134.67 54.82 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.952 0.376 . . . . 0.0 111.287 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 78' ' ' GLY . 6.1 t -68.75 121.73 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.27 54.71 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.586 0.707 . . . . 0.0 112.221 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.846 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -148.7 -1.55 0.51 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.104 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -129.75 85.51 57.97 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.535 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.2 Cg_exo -60.55 144.79 99.56 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 121.74 1.627 . . . . 0.0 112.582 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.432 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.6 m -94.41 153.77 17.79 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.075 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.82 51.9 1.97 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.851 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mt -134.07 160.27 38.27 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.903 0.413 . . . . 0.0 110.28 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.3 p-10 -112.1 157.37 20.89 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.63 HD23 ' SG ' ' A' ' 70' ' ' CYS . 12.4 tp -58.02 -36.13 72.26 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.04 -39.27 66.06 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -63.48 -41.08 98.58 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.678 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.857 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.8 t -61.53 -50.29 80.94 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.669 ' HA ' HD12 ' A' ' 60' ' ' LEU . 5.0 mp -52.44 -36.39 54.38 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 123.975 0.797 . . . . 0.0 110.995 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.13 -28.53 48.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.489 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.436 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -78.44 -31.8 48.2 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.457 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.857 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.1 mt -77.5 -45.04 26.77 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.0 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -132.11 116.88 15.69 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.412 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.5 -33.11 2.56 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 123.65 2.9 . . . . 0.0 112.807 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.16 -14.02 56.28 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.462 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.3 149.81 24.29 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.33 0.394 . . . . 0.0 111.737 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.77 123.43 29.7 Favored Pre-proline 0 C--O 1.235 0.333 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.038 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 58.0 Cg_endo -74.88 145.34 31.81 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.217 1.944 . . . . 0.0 112.462 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.8 Cg_endo -92.15 -169.34 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.612 2.208 . . . . 0.0 111.895 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.89 -24.89 67.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.12 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -66.63 -51.56 54.92 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.701 ' HA ' HD12 ' A' ' 73' ' ' ILE . 59.6 m -72.74 -25.05 61.06 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 47.8 mt-30 -68.16 -35.3 77.85 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -90.92 22.98 3.35 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.099 0.476 . . . . 0.0 111.718 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 70' ' ' CYS . 61.2 mt -119.84 139.02 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.464 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.426 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.9 m-20 -104.65 156.71 17.74 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.854 0.721 . . . . 0.0 112.564 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 53' ' ' LEU . 28.8 mm -102.84 155.38 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.432 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.8 t80 -124.84 155.83 38.81 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -88.37 122.69 32.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 119.691 -0.195 . . . . 0.0 110.512 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -101.87 -23.68 9.12 Favored Glycine 0 C--N 1.351 1.413 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.793 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.77 -167.31 35.25 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.086 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -87.11 -10.56 5.71 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 123.266 2.644 . . . . 0.0 113.84 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.653 ' O ' ' HA3' ' A' ' 131' ' ' GLY . 4.1 t -86.19 126.74 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.178 0.299 . . . . 0.0 110.383 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 43.78 87.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.292 1.037 . . . . 0.0 113.099 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.583 ' O ' HD22 ' A' ' 130' ' ' LEU . 76.9 p -86.04 -12.44 50.2 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.306 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -84.94 0.26 51.86 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -132.7 153.57 51.02 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.96 126.0 7.97 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.35 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.643 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 0.2 OUTLIER -85.77 145.74 27.1 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.86 1.264 . . . . 0.0 109.92 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 t -121.57 103.53 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.741 0.305 . . . . 0.0 110.824 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 126' ' ' SER . 2.2 tt -99.43 126.76 45.39 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.477 ' CE1' ' HB3' ' A' ' 106' ' ' ALA . 3.9 p80 -131.86 164.11 45.27 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-O 118.93 -0.557 . . . . 0.0 112.193 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.2 Cg_endo -96.9 9.84 1.31 Allowed 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 122.733 2.289 . . . . 0.0 113.945 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.48 ' OG ' HD23 ' A' ' 94' ' ' LEU . 8.7 t -94.35 158.98 15.32 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.976 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.12 19.06 56.03 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.789 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.48 HD23 ' OG ' ' A' ' 92' ' ' SER . 4.6 mm? -86.8 154.24 21.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.431 0.292 . . . . 0.0 110.77 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 p -123.02 155.36 37.0 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.552 ' CE2' HG23 ' A' ' 113' ' ' VAL . 62.2 m-85 -130.57 -152.79 0.53 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.344 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -58.6 -47.24 84.97 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.896 0.316 . . . . 0.0 111.446 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 56.2 m -134.3 85.19 2.17 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.488 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 107' ' ' MET . 8.1 m -130.78 128.75 41.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.922 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.41 124.38 50.3 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.427 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.63 128.19 34.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.237 0.541 . . . . 0.0 111.172 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.458 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -121.48 47.2 1.9 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.214 -179.621 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.88 -106.81 1.69 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-N 114.706 -1.134 . . . . 0.0 113.081 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.38 -9.93 4.18 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.472 HD21 ' OH ' ' A' ' 31' ' ' TYR . 3.5 pp -156.27 160.44 39.76 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.53 0.332 . . . . 0.0 111.252 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.477 ' HB3' ' CE1' ' A' ' 90' ' ' HIS . . . -123.38 162.59 22.47 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 123.625 0.578 . . . . 0.0 110.526 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.643 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 22.4 ttm -123.6 130.18 52.27 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.676 ' HB3' HG11 ' A' ' 113' ' ' VAL . 47.6 m -124.7 127.94 48.04 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 120.844 0.354 . . . . 0.0 110.21 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.4 p -117.21 20.15 13.84 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.466 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.82 ' O ' HG12 ' A' ' 113' ' ' VAL . 43.1 p -98.18 127.75 44.29 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 122.011 0.91 . . . . 0.0 112.03 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.495 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 2.3 mt-30 -61.59 -25.96 67.67 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.314 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -64.54 -42.41 95.73 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.104 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.82 HG12 ' O ' ' A' ' 110' ' ' SER . 5.2 p -69.02 -38.18 78.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.98 -47.67 80.23 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 123.732 0.645 . . . . 0.0 110.303 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.495 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 28.2 m-85 -69.61 -39.8 77.02 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.068 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.3 -51.37 69.18 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.146 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.44 -43.31 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.123 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.49 -30.89 65.46 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.792 0.682 . . . . 0.0 109.731 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.56 -19.73 30.66 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.16 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.15 17.77 26.32 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.682 -1.145 . . . . 0.0 114.558 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.5 p -109.49 9.93 25.32 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.88 -138.5 9.5 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-O 119.374 -0.681 . . . . 0.0 113.038 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.26 173.08 12.92 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.338 2.692 . . . . 0.0 113.793 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.491 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -52.13 -56.64 13.19 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.258 1.023 . . . . 0.0 111.27 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -139.34 154.38 47.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.509 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.5 m -150.03 162.81 39.67 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.4 tp -129.93 115.79 17.7 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.872 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 16.4 pt -95.67 102.5 13.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-O 121.807 0.813 . . . . 0.0 109.242 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 59.7 p -125.07 130.65 52.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.263 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.583 HD22 ' O ' ' A' ' 83' ' ' THR . 16.2 mt -67.03 118.22 10.17 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.031 0.444 . . . . 0.0 111.372 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 81' ' ' VAL . . . 55.93 -172.86 1.53 Allowed Glycine 0 C--N 1.343 0.934 0 CA-C-N 114.232 -1.349 . . . . 0.0 115.012 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -128.53 -176.0 3.69 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.641 0.734 . . . . 0.0 111.358 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -119.39 130.38 55.28 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 113.866 -1.516 . . . . 0.0 108.367 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.37 152.3 19.12 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.667 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -129.88 136.92 50.08 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 124.011 0.477 . . . . 0.0 110.169 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.15 158.44 27.72 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.93 0.769 . . . . 0.0 110.631 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.47 89.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.96 -22.28 9.18 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.356 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -56.99 -47.44 80.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.985 0.514 . . . . 0.0 112.162 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.583 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.6 tp -66.89 -47.89 70.44 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.18 -29.95 64.1 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.43 0.456 . . . . 0.0 110.895 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.92 -49.32 47.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.042 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.6 pt-20 -72.45 -26.71 61.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.681 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 4.6 tp -75.43 -38.44 59.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.822 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.2 t -78.23 -30.44 48.78 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.286 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.5 t70 -80.3 0.92 30.8 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.604 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 60.79 28.33 18.08 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.981 0.912 . . . . 0.0 111.813 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.81 -42.53 19.56 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.639 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -123.55 111.14 15.91 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.938 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 15' ' ' ILE . 6.0 tp -85.31 130.82 34.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.67 0.272 . . . . 0.0 111.484 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.2 p -104.64 141.98 35.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.862 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.9 m -154.91 157.11 31.91 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.83 146.77 96.97 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.242 1.962 . . . . 0.0 111.188 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -131.66 175.86 8.82 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -133.18 139.93 35.78 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.278 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.73 -26.62 11.31 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 122.771 2.314 . . . . 0.0 114.015 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -49.98 -43.13 50.18 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.809 0.693 . . . . 0.0 112.355 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.692 HD13 HH12 ' A' ' 167' ' ' ARG . 4.7 mt -67.71 -32.88 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 121.504 0.669 . . . . 0.0 110.318 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.1 tt -75.29 -41.23 57.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.673 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.68 -24.39 25.25 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -90.18 -72.02 0.59 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.313 0.506 . . . . 0.0 110.944 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.878 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.09 98.58 6.15 Favored Pre-proline 0 C--N 1.348 0.538 0 CA-C-O 121.078 0.466 . . . . 0.0 112.171 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.846 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 64.8 Cg_endo -91.39 -0.17 4.66 Favored 'Trans proline' 0 CA--C 1.57 2.321 0 C-N-CA 121.691 1.594 . . . . 0.0 114.266 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.659 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 83.6 Cg_endo -74.14 -54.14 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.627 2.218 . . . . 0.0 114.554 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.553 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -121.74 -29.39 4.35 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.783 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.878 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.07 -12.24 61.46 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.321 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.692 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.1 -44.12 40.21 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.318 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -68.97 -50.37 49.67 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -57.61 -50.55 72.76 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.773 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 174' ' ' ARG . . . -61.68 -40.39 94.8 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.154 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.11 -46.38 82.66 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.625 0.578 . . . . 0.0 110.489 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.53 87.72 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.477 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.55 69.71 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.31 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 170' ' ' ALA . 7.9 mtm105 -77.16 -41.09 43.1 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.196 0.598 . . . . 0.0 110.893 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.7 tp -71.28 -29.86 65.57 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.542 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.39 54.76 1.06 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.797 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 12.4 t -123.69 149.27 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -82.18 77.33 8.99 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.752 0.787 . . . . 0.0 110.755 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -26.21 49.93 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.791 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.5 m -56.46 -38.7 72.02 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.16 -26.52 53.11 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 11.3 mt -76.57 -35.19 58.33 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.332 0.395 . . . . 0.0 111.435 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 13.9 p -85.86 -46.16 10.88 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.507 0.505 . . . . 0.0 111.647 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.65 120.17 24.77 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.137 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -93.3 145.75 24.22 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.444 ' HB1' ' OXT' ' A' ' 189' ' ' ALA . . . -98.94 149.89 22.5 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.266 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -130.26 -54.69 0.1 OUTLIER Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.642 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -99.05 -41.07 7.72 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.342 0.257 . . . . 0.0 111.429 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.444 ' OXT' ' HB1' ' A' ' 186' ' ' ALA . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.209 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.298 0.094 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.5 mttt 62.58 125.54 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.957 0.903 . . . . 0.0 112.355 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -98.3 -41.52 7.82 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.943 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.565 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 18.7 t -99.78 161.17 13.78 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.516 0.51 . . . . 0.0 110.539 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.1 t -97.37 96.38 3.03 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.6 Cg_endo -87.93 8.52 4.13 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.852 2.368 . . . . 0.0 112.37 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 t -89.93 -47.87 7.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.308 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -126.62 154.95 43.28 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.585 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.7 mt -99.34 49.21 0.94 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.824 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -90.8 19.5 5.46 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 120.772 0.32 . . . . 0.0 111.349 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 15.8 p80 174.51 57.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.025 0.93 . . . . 0.0 110.174 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -135.13 159.57 41.11 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.859 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.479 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.8 m-30 -96.96 138.0 35.17 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.147 0.499 . . . . 0.0 112.29 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.681 HD11 HD23 ' A' ' 32' ' ' LEU . 1.7 mp -111.97 133.36 54.2 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.198 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.45 HG23 HG22 ' A' ' 29' ' ' VAL . 2.6 mp -119.02 133.12 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.56 122.8 19.77 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.036 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.9 mmt -103.83 160.46 26.01 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.262 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.31 20.6 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.713 2.276 . . . . 0.0 113.659 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -81.24 -14.94 56.93 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.581 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -113.53 160.8 18.12 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.606 0.363 . . . . 0.0 110.238 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.45 52.84 2.54 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.419 0.628 . . . . 0.0 112.084 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.581 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.2 m-20 -128.12 87.47 55.39 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.528 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.03 -13.92 21.21 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.924 2.416 . . . . 0.0 113.558 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -85.08 -38.27 19.32 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.388 0.43 . . . . 0.0 111.534 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -98.26 -1.36 42.07 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.606 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -63.65 2.52 0.44 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -139.57 42.3 2.02 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.276 0.56 . . . . 0.0 112.071 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.4 p -125.39 154.06 42.48 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.588 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.72 HG11 ' HE ' ' A' ' 167' ' ' ARG . 25.2 t -130.56 133.65 63.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.742 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -115.85 152.43 33.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.585 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.5 ' OH ' HD21 ' A' ' 105' ' ' LEU . 41.8 t80 -106.58 120.79 42.87 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.681 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -84.24 108.98 17.42 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.079 0.466 . . . . 0.0 111.043 -178.356 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.945 HG23 ' HA2' ' A' ' 42' ' ' GLY . 35.3 t -66.8 -60.18 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.732 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -144.66 115.54 7.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.304 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -97.78 128.22 44.27 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.45 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -139.58 153.3 47.36 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.69 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.55 -18.62 65.46 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.601 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.66 4.4 43.21 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.392 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.17 165.37 12.81 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.229 -0.349 . . . . 0.0 112.229 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.61 139.4 29.63 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.527 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -121.1 136.98 54.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.959 178.714 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.945 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.05 157.52 28.57 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 124.372 1.045 . . . . 0.0 112.465 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.2 mt -112.26 134.9 53.53 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.206 0.503 . . . . 0.0 110.957 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 78' ' ' GLY . 11.9 t -69.83 123.41 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.72 56.28 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.666 0.746 . . . . 0.0 112.117 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.85 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -147.41 -2.45 0.59 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.115 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -130.27 88.52 47.57 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.498 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 47.5 Cg_exo -58.29 141.87 97.1 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 121.533 1.489 . . . . 0.0 111.86 174.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.412 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 8.9 t -77.79 -39.51 43.71 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.62 -8.7 74.28 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.873 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 5.7 mt -81.43 170.27 16.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.706 0.402 . . . . 0.0 110.161 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.646 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.9 p-10 -112.79 156.28 23.14 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.783 HD12 HD13 ' A' ' 128' ' ' ILE . 1.6 tt -57.69 -26.69 62.08 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 123.478 0.486 . . . . 0.0 111.992 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.08 99.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.959 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.521 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 34.1 mt-10 -63.01 -46.79 85.96 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.139 0.275 . . . . 0.0 111.586 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.872 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 20.5 m -62.0 -44.06 98.43 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.715 ' HA ' HD12 ' A' ' 60' ' ' LEU . 13.6 mt -56.66 -34.89 67.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.639 176.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.01 -27.64 48.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.327 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.402 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.93 -30.9 50.71 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.308 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.872 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.0 mt -77.83 -45.47 24.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.243 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -131.32 116.23 16.42 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.643 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -77.76 -32.73 2.57 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.637 2.891 . . . . 0.0 112.791 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.95 -14.52 55.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.374 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.98 149.5 24.73 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.382 0.426 . . . . 0.0 111.667 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.74 122.91 30.19 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.239 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.5 149.55 34.89 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.277 1.985 . . . . 0.0 112.374 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 8.2 Cg_endo -94.59 -167.53 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.631 2.22 . . . . 0.0 112.56 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.94 -24.57 64.29 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.288 0.635 . . . . 0.0 112.095 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.443 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 11.6 ptp180 -67.9 -48.21 66.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.711 ' HA ' HD12 ' A' ' 73' ' ' ILE . 24.5 m -72.58 -26.13 61.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.169 0.587 . . . . 0.0 112.338 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.449 ' HA ' HD22 ' A' ' 52' ' ' ASN . 43.4 mt-30 -70.86 -27.54 63.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.674 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -95.39 16.72 16.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.61 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 70' ' ' CYS . 53.9 mt -120.07 139.41 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.666 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 1.8 m-20 -104.92 155.64 18.76 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.804 HD13 HD12 ' A' ' 128' ' ' ILE . 22.9 mm -107.17 150.45 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.206 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.734 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -119.2 157.08 28.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.588 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -87.98 122.2 31.3 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.0 -23.6 9.09 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 120.263 -0.97 . . . . 0.0 114.257 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.91 -167.81 34.87 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.289 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -88.75 -11.67 3.86 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.635 2.89 . . . . 0.0 114.421 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.09 131.85 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.569 0.223 . . . . 0.0 111.375 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 45.18 89.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.632 1.173 . . . . 0.0 113.503 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -87.02 1.04 54.15 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.378 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -92.7 -18.31 23.14 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.629 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -133.17 147.44 52.06 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.373 0.421 . . . . 0.0 111.441 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.601 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -113.34 151.01 18.44 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.149 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.404 ' CE2' ' SD ' ' A' ' 107' ' ' MET . 1.2 m-85 -86.66 151.33 23.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.951 -1.124 . . . . 0.0 110.829 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 3.6 t -127.76 107.99 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.087 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.898 HD11 HD13 ' A' ' 105' ' ' LEU . 13.8 tp -104.93 127.74 52.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.619 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.405 ' ND1' ' HB3' ' A' ' 123' ' ' PRO . 3.4 p80 -124.37 162.18 43.59 Favored Pre-proline 0 CA--C 1.552 1.022 0 O-C-N 123.653 0.596 . . . . 0.0 111.59 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.0 Cg_endo -97.42 28.89 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.802 2.334 . . . . 0.0 113.579 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.0 t -115.69 156.73 25.39 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.63 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.74 23.18 35.31 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.817 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.01 153.17 21.49 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.472 0.309 . . . . 0.0 110.523 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.7 p -121.55 153.25 38.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.664 ' CD2' HG12 ' A' ' 113' ' ' VAL . 28.5 m-85 -132.89 -151.13 0.44 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.834 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -61.02 -48.69 80.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.791 0.436 . . . . 0.0 111.267 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 108' ' ' SER . 38.3 m -134.01 79.05 1.79 Allowed 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.243 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.3 m -126.72 115.95 20.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.956 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.49 122.18 42.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.859 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.97 128.45 34.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.095 0.474 . . . . 0.0 111.15 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.449 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.63 46.76 2.15 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.482 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.93 -107.6 2.02 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 114.819 -1.082 . . . . 0.0 113.25 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.88 -10.28 3.83 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.898 HD13 HD11 ' A' ' 89' ' ' LEU . 1.8 pp -155.06 153.15 30.46 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.335 0.397 . . . . 0.0 111.167 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.558 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -117.17 158.05 24.92 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.884 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.594 ' O ' ' HA ' ' A' ' 99' ' ' THR . 16.0 ttm -122.52 135.17 54.58 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 98' ' ' SER . 15.9 m -136.18 134.35 38.11 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 81.1 p -125.42 21.36 7.89 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.64 0.587 . . . . 0.0 111.836 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.877 ' O ' HG22 ' A' ' 113' ' ' VAL . 51.6 m -91.12 131.63 36.56 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.944 0.878 . . . . 0.0 112.885 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.614 ' HA ' HD12 ' A' ' 114' ' ' LEU . 5.2 mt-30 -61.91 -26.16 68.0 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.419 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.39 -45.45 90.99 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.493 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 110' ' ' SER . 18.6 m -62.28 -43.46 98.04 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.614 HD12 ' HA ' ' A' ' 111' ' ' GLN . 29.3 mt -54.82 -51.48 65.7 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.864 0.727 . . . . 0.0 112.177 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.471 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 43.2 m-85 -65.63 -45.64 82.28 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.4 -52.7 64.49 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.865 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.841 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.4 tp -64.22 -43.91 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.45 -31.18 65.67 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.793 0.683 . . . . 0.0 109.683 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.443 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -85.3 -20.43 30.03 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.156 176.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.26 18.01 22.96 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.731 -1.122 . . . . 0.0 114.581 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.2 p -109.42 7.83 25.11 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.25 -137.51 9.37 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.583 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.405 ' HB3' ' ND1' ' A' ' 90' ' ' HIS . 5.9 Cg_exo -79.82 168.11 19.63 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.251 2.634 . . . . 0.0 113.519 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.484 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -50.94 -57.79 7.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.31 1.044 . . . . 0.0 111.789 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.486 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.7 mmtt -138.48 157.27 46.52 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.619 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 40.8 m -149.99 162.89 39.48 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.9 tp -126.41 113.96 17.57 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.744 177.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.804 HD12 HD13 ' A' ' 75' ' ' ILE . 10.1 pt -98.81 104.59 16.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.492 0.663 . . . . 0.0 109.507 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.3 t -125.0 124.88 42.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.508 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.608 ' O ' HD12 ' A' ' 130' ' ' LEU . 2.1 pp -67.12 117.2 8.82 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.095 0.474 . . . . 0.0 111.738 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.99 174.69 4.4 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.259 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -128.47 -179.87 5.28 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.334 0.588 . . . . 0.0 111.027 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -116.31 130.63 56.87 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.227 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.55 153.01 19.75 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.488 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -134.17 137.87 44.76 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.84 0.377 . . . . 0.0 110.666 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -78.1 158.36 29.16 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.904 0.753 . . . . 0.0 110.822 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.79 92.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.28 7.72 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.134 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -56.01 -47.38 77.89 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.082 0.553 . . . . 0.0 112.125 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.58 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 16.3 tp -67.51 -46.45 72.85 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.31 -30.54 64.85 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.443 0.465 . . . . 0.0 110.693 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -71.06 -49.33 45.91 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.013 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -72.1 -26.76 62.26 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.749 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.1 tp -75.3 -38.73 60.16 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.84 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.6 m -78.03 -29.91 49.65 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.355 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.17 0.17 33.48 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.533 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 61.29 29.37 18.6 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.89 0.876 . . . . 0.0 111.712 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.94 -41.91 16.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.516 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.404 ' HE1' ' CE ' ' A' ' 20' ' ' MET . 13.2 m95 -122.9 109.62 14.38 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.328 0.393 . . . . 0.0 110.113 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.01 128.46 34.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.387 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.1 p -102.33 141.81 34.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.039 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 80.2 m -155.37 158.6 31.97 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.315 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -57.44 153.93 38.45 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.215 1.943 . . . . 0.0 111.429 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.479 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.33 169.2 14.51 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -177.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -134.93 135.06 22.39 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 114.264 -1.334 . . . . 0.0 107.934 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.77 -26.59 13.37 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.64 2.226 . . . . 0.0 113.907 -177.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -51.95 -40.64 61.16 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.874 0.734 . . . . 0.0 112.284 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.573 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.6 mt -71.42 -34.49 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 121.378 0.609 . . . . 0.0 110.328 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.22 -38.47 63.54 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.253 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -84.25 -33.86 23.97 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -85.63 -72.67 0.48 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.026 0.375 . . . . 0.0 111.69 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.892 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.35 99.22 6.48 Favored Pre-proline 0 C--N 1.348 0.54 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.85 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.3 Cg_endo -92.02 -0.03 4.26 Favored 'Trans proline' 0 CA--C 1.57 2.301 0 C-N-CA 121.677 1.585 . . . . 0.0 114.26 175.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.644 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 88.0 Cg_endo -73.85 -52.55 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 122.63 2.22 . . . . 0.0 114.388 -178.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.518 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.61 -30.37 3.91 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.694 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.892 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -69.73 -11.14 60.62 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.303 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.72 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.54 -42.95 41.22 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.255 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -69.18 -50.68 45.37 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.2 m -57.76 -50.7 72.35 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.734 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.646 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -62.85 -38.57 91.36 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.07 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.27 -45.43 80.11 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.664 0.602 . . . . 0.0 110.441 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.45 91.04 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.552 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 177' ' ' VAL . . . -64.36 -29.12 70.2 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.667 177.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.99 -40.19 39.95 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 122.865 0.466 . . . . 0.0 110.423 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.14 -34.02 76.67 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.485 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 130.37 40.71 0.25 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.272 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 173' ' ' ALA . 5.0 t -129.45 133.42 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -88.32 82.85 6.95 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.651 0.739 . . . . 0.0 111.218 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -77.95 -26.39 48.81 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.31 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 51.9 m -57.95 -45.52 86.51 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.47 -26.89 51.8 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 21.6 mt -77.28 -29.1 53.67 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.338 0.399 . . . . 0.0 111.687 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 24.1 p -91.12 -48.66 6.83 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.544 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -131.69 120.27 22.53 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.28 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -100.92 140.08 35.71 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.95 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -102.14 -42.4 6.08 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.456 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -148.69 -147.53 4.55 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 123.484 0.49 . . . . 0.0 112.448 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -99.95 132.7 45.15 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.633 0.255 . . . . 0.0 111.019 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.172 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.51 0.195 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.5 tttt -100.11 -43.2 6.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.113 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 71.05 -49.35 0.68 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.379 1.072 . . . . 0.0 112.362 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.56 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 16.6 t -99.5 147.32 25.43 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.253 0.346 . . . . 0.0 110.653 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.5 m -105.13 90.31 3.64 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.993 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.4 Cg_endo -87.59 8.25 4.32 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.982 2.454 . . . . 0.0 112.127 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.5 t -91.66 -48.0 7.07 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.171 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -122.61 151.55 41.34 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.645 0.59 . . . . 0.0 111.291 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.668 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 7.0 mp -92.63 -3.3 55.19 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.749 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -41.98 9.45 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.612 ' N ' ' O ' ' A' ' 9' ' ' LEU . 13.0 p-80 177.02 52.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.144 0.978 . . . . 0.0 110.513 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -141.82 166.08 25.7 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.759 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 30' ' ' THR . 14.2 m-30 -104.54 138.54 40.74 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 6.4 mt -107.19 143.38 35.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.405 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 mp -123.47 137.71 55.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.462 0.476 . . . . 0.0 110.128 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.47 123.48 26.61 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.837 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 mmt -106.32 157.09 35.75 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.202 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.6 30.58 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.678 2.252 . . . . 0.0 113.248 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -87.32 -15.56 37.65 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.93 -168.35 1.41 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 123.075 0.234 . . . . 0.0 110.703 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.541 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.82 41.87 1.28 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.082 0.468 . . . . 0.0 111.628 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -111.32 81.05 2.78 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.916 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.3 Cg_exo -75.49 -22.24 14.18 Favored 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 123.017 2.478 . . . . 0.0 113.312 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -84.62 -36.3 22.11 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.875 0.47 . . . . 0.0 111.867 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.8 3.72 53.64 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.021 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.42 163.77 20.16 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 48.75 32.15 3.47 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.2 p -116.68 154.27 30.87 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 122.367 -0.208 . . . . 0.0 110.573 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.739 HG11 ' HE ' ' A' ' 167' ' ' ARG . 60.3 t -129.05 132.69 67.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-O 121.515 0.674 . . . . 0.0 110.857 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.2 m -114.48 154.39 28.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.691 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.461 ' OH ' HD11 ' A' ' 105' ' ' LEU . 13.2 t80 -110.22 115.7 30.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.668 ' HB3' ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -81.08 110.63 16.79 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.684 0.754 . . . . 0.0 110.566 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.975 HG23 ' HA2' ' A' ' 42' ' ' GLY . 32.2 t -71.18 -63.93 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 112.819 -1.991 . . . . 0.0 110.614 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.426 ' OE1' HD11 ' A' ' 100' ' ' LEU . 12.3 tt0 -132.51 117.63 18.24 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.96 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -106.92 127.91 53.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.733 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -138.9 153.45 48.27 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.22 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -64.82 -15.63 62.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -104.88 5.41 32.93 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.687 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.6 164.72 12.64 Favored Glycine 0 C--N 1.344 1.015 0 C-N-CA 121.486 -0.388 . . . . 0.0 112.35 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.645 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -144.73 146.46 32.19 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.482 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -125.97 137.58 53.69 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.954 178.001 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.975 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.72 159.95 30.66 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.83 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.436 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.4 mt -114.62 130.66 56.81 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.703 0.252 . . . . 0.0 110.837 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 78' ' ' GLY . 20.7 t -65.96 125.39 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -128.44 55.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.542 0.686 . . . . 0.0 112.408 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.842 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.1 t30 -147.63 -3.61 0.53 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.265 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -129.78 87.84 51.05 Favored Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.51 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 35.3 Cg_exo -59.09 141.91 98.73 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 121.578 1.518 . . . . 0.0 112.277 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 59.9 m -88.64 161.96 16.59 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.364 0.415 . . . . 0.0 111.561 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.96 44.69 1.43 Allowed Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.37 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.463 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.97 150.95 50.44 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.1 p-10 -100.52 161.4 13.62 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.268 0.355 . . . . 0.0 110.939 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.678 ' HA ' HD11 ' A' ' 75' ' ' ILE . 12.3 tp -58.7 -37.58 76.4 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.16 -37.14 53.64 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.96 -43.68 95.05 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.206 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.859 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 1.3 t -62.8 -45.77 98.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.742 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.5 mp -54.55 -36.51 64.4 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.702 0.626 . . . . 0.0 110.618 177.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.9 -27.86 49.65 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.466 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.16 -30.14 49.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.283 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.859 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.9 mt -77.75 -45.12 25.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.945 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -132.26 116.24 15.32 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.524 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.62 -32.64 2.71 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.604 2.869 . . . . 0.0 112.769 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.3 -14.15 55.84 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.361 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.86 149.68 24.65 Favored 'General case' 0 C--N 1.345 0.389 0 O-C-N 123.323 0.389 . . . . 0.0 111.754 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.65 123.88 29.98 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.02 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 55.4 Cg_endo -73.82 144.68 35.25 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.226 1.951 . . . . 0.0 112.408 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.458 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.6 Cg_endo -92.52 -170.98 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.566 2.177 . . . . 0.0 111.974 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.37 -24.89 68.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.297 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -66.15 -54.17 28.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.701 ' HA ' HD12 ' A' ' 73' ' ' ILE . 61.3 m -71.58 -25.05 62.03 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 53.3 mt-30 -66.91 -36.02 81.32 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -91.55 23.18 3.6 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.147 0.498 . . . . 0.0 111.65 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 70' ' ' CYS . 56.8 mt -119.47 140.04 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.517 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.56 154.91 22.08 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.692 0.62 . . . . 0.0 112.498 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.763 HD13 HD12 ' A' ' 128' ' ' ILE . 24.4 mm -103.53 153.66 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.093 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.709 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -117.31 155.95 28.65 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.57 118.92 26.3 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.844 0.293 . . . . 0.0 110.698 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.575 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.08 -23.62 8.46 Favored Glycine 0 C--N 1.348 1.242 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.976 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.76 -167.9 35.4 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.293 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -88.35 -11.38 4.31 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 123.313 2.675 . . . . 0.0 114.263 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.61 126.91 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 123.12 0.263 . . . . 0.0 110.893 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 48.81 82.16 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.309 1.043 . . . . 0.0 112.91 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.473 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.1 t -84.75 1.55 46.14 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -99.13 -0.66 41.22 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.603 ' NH2' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -133.09 153.27 51.66 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.198 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.586 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.83 133.34 11.6 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.434 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.75 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.8 OUTLIER -85.75 150.87 24.27 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.321 1.048 . . . . 0.0 110.288 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.1 t -127.11 104.81 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 123.429 0.455 . . . . 0.0 111.039 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.9 HD11 HD13 ' A' ' 105' ' ' LEU . 15.2 tp -106.67 127.66 53.54 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.821 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -129.14 169.44 13.1 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.38 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.654 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.6 Cg_endo -97.13 18.06 0.55 Allowed 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.65 2.233 . . . . 0.0 113.52 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.4 t -105.85 159.73 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.951 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.2 20.62 49.31 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.501 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -84.21 154.44 23.04 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.645 0.378 . . . . 0.0 110.438 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.0 p -126.78 157.22 39.75 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.579 ' CE2' HG23 ' A' ' 113' ' ' VAL . 53.0 m-85 -129.51 -150.9 0.45 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.418 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -60.2 -46.84 88.36 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.418 0.287 . . . . 0.0 111.25 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.8 m -135.63 83.05 1.99 Allowed 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.338 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 107' ' ' MET . 7.8 m -129.34 124.39 34.17 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.868 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.426 HD11 ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.93 123.94 46.7 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.902 178.627 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -88.74 130.56 35.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.103 0.478 . . . . 0.0 110.748 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.14 48.67 2.18 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.314 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.47 -106.76 1.64 Allowed Glycine 0 C--N 1.334 0.433 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.279 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.06 -10.18 4.0 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.9 HD13 HD11 ' A' ' 89' ' ' LEU . 2.5 pp -155.44 155.19 33.09 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.206 0.317 . . . . 0.0 111.561 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.593 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -125.14 157.73 35.66 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.875 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.598 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 27.0 tpp -125.33 141.25 52.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.52 ' CB ' HG11 ' A' ' 113' ' ' VAL . 1.9 m -134.15 133.53 41.12 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.916 0.388 . . . . 0.0 110.275 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.0 p -118.3 16.41 13.95 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.985 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.742 ' O ' HG12 ' A' ' 113' ' ' VAL . 32.9 p -91.51 126.93 36.76 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 121.681 0.753 . . . . 0.0 111.686 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.519 ' HA ' ' NH2' ' A' ' 85' ' ' ARG . 20.3 pt20 -60.87 -26.91 67.73 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.602 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -66.11 -41.06 91.08 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.585 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.744 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.2 p -69.85 -39.74 78.09 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.603 HD22 ' NH2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -58.03 -47.64 82.48 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 123.672 0.608 . . . . 0.0 110.457 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.478 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 25.9 m-85 -69.72 -38.39 76.89 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.924 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.94 -52.1 65.42 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.0 tp -64.66 -42.99 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.173 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.38 -31.04 65.39 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.83 0.706 . . . . 0.0 109.627 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.35 -20.26 30.2 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.167 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.59 15.17 30.22 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 114.626 -1.17 . . . . 0.0 114.735 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.2 p -105.34 7.66 33.43 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.58 -137.52 9.47 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-O 119.093 -0.837 . . . . 0.0 112.598 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.41 171.56 14.67 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.167 2.578 . . . . 0.0 113.615 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.82 -55.64 31.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.776 0.83 . . . . 0.0 112.159 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.654 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.2 mmtt -140.72 139.82 34.77 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.728 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.8 m -140.26 168.35 20.01 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 tp -127.9 119.3 25.3 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.794 -1.093 . . . . 0.0 108.734 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.763 HD12 HD13 ' A' ' 75' ' ' ILE . 15.8 pt -98.26 102.0 12.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.852 0.834 . . . . 0.0 109.814 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.1 t -117.88 122.75 44.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.37 -1.287 . . . . 0.0 110.925 -178.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.473 HD21 ' O ' ' A' ' 83' ' ' THR . 6.1 tp -66.64 114.94 5.95 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.327 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.29 178.16 6.95 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 114.442 -1.254 . . . . 0.0 114.562 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.6 176.81 7.48 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.367 0.603 . . . . 0.0 110.8 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.39 130.11 56.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.927 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.44 149.73 18.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.601 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.4 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 20.1 m-90 -126.46 135.96 52.02 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 124.022 0.483 . . . . 0.0 110.235 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.39 158.09 27.46 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.844 0.715 . . . . 0.0 110.766 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.57 90.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.92 -25.06 6.9 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.997 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -56.07 -45.63 79.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.984 0.514 . . . . 0.0 112.058 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.556 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 10.5 tp -66.97 -48.28 69.0 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.22 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.47 -30.26 64.91 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 123.451 0.469 . . . . 0.0 110.861 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.4 -50.7 35.88 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.903 178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -71.65 -26.61 62.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.026 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 6.1 tp -76.05 -38.48 57.07 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.898 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.0 m -77.98 -30.85 50.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -80.9 0.5 35.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.571 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.45 29.16 18.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.853 0.861 . . . . 0.0 111.735 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.82 -42.52 24.2 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.051 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -123.02 113.0 18.47 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.46 0.475 . . . . 0.0 109.752 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.3 tp -82.76 142.14 31.82 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.408 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 25.3 p -105.0 135.77 45.72 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.088 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 79.5 m -149.22 148.68 27.42 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.24 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.55 153.7 64.83 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.325 2.016 . . . . 0.0 110.772 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -134.75 174.58 10.42 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -135.02 138.89 30.48 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.322 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.58 -26.66 16.33 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 122.686 2.257 . . . . 0.0 113.561 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.84 -41.02 57.37 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.967 0.792 . . . . 0.0 112.451 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.725 HD13 HH12 ' A' ' 167' ' ' ARG . 4.3 mt -69.94 -34.38 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.569 0.7 . . . . 0.0 110.395 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.5 tt -75.71 -36.82 59.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.462 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -84.8 -32.15 23.51 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -88.83 -72.88 0.52 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.982 0.356 . . . . 0.0 111.714 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.67 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -141.27 99.26 6.52 Favored Pre-proline 0 C--N 1.349 0.584 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.842 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 73.1 Cg_endo -91.74 -0.43 4.44 Favored 'Trans proline' 0 CA--C 1.571 2.331 0 C-N-CA 121.831 1.687 . . . . 0.0 114.421 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.647 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 69.2 Cg_endo -75.09 -50.01 0.14 Allowed 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.73 2.287 . . . . 0.0 114.532 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.502 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.5 mt-10 -122.22 -34.02 3.39 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.792 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 8.6 mt-10 -69.01 -10.99 60.31 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.219 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.739 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.03 -41.55 42.12 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.176 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -70.85 -49.58 44.56 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 t -58.29 -48.03 81.78 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.644 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.63 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.57 -40.37 92.7 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.578 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.62 82.77 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.409 0.443 . . . . 0.0 110.582 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.91 -37.29 85.7 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.795 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.56 71.67 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.497 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.63 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 3.4 mmp_? -77.67 -40.33 41.93 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.802 0.441 . . . . 0.0 110.372 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.36 -33.94 76.85 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.526 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.06 45.4 0.45 Allowed Glycine 0 C--N 1.34 0.759 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.133 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 10.5 t -130.16 147.05 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -91.47 77.53 5.75 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.651 0.738 . . . . 0.0 110.45 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.79 -26.09 49.46 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.069 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 51.1 m -58.29 -43.69 88.15 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.38 -27.03 52.42 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.2 mt -77.23 -30.58 54.65 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.712 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.7 p -89.97 -47.57 7.77 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.373 0.421 . . . . 0.0 111.474 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.53 118.73 22.52 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.132 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -101.85 150.47 23.14 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.846 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -97.16 -42.13 7.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.55 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -107.25 122.34 6.84 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 123.431 0.457 . . . . 0.0 112.479 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -100.44 141.98 32.55 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.616 0.245 . . . . 0.0 110.845 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.449 -0.786 . . . . 0.0 111.143 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.568 0.223 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.57 122.99 44.17 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -132.69 -53.92 0.94 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.98 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -142.59 -50.2 0.36 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.346 0.404 . . . . 0.0 111.145 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.6 t -136.44 97.69 11.58 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.889 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.72 7.1 5.24 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.741 2.294 . . . . 0.0 112.296 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 m -115.23 -55.6 2.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.315 -1.312 . . . . 0.0 110.565 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -99.82 157.58 16.41 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 123.53 0.519 . . . . 0.0 111.46 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.55 HD12 ' CE1' ' A' ' 35' ' ' HIS . 11.2 mt -94.3 46.97 1.17 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.081 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -92.68 23.01 4.31 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.964 0.412 . . . . 0.0 110.841 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 177.08 51.99 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.775 0.83 . . . . 0.0 110.0 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -136.87 160.22 39.52 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.455 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.1 m-30 -98.17 137.46 36.9 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.267 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.821 HD11 HD23 ' A' ' 32' ' ' LEU . 3.6 mt -108.63 137.03 47.25 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.033 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.434 HD13 HG13 ' A' ' 29' ' ' VAL . 2.4 mm -117.38 133.79 63.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 123.519 0.512 . . . . 0.0 109.713 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.09 123.03 23.63 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.598 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.9 mmt -114.46 155.12 46.32 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 123.463 0.477 . . . . 0.0 111.341 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -80.68 79.28 3.36 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.652 2.235 . . . . 0.0 112.935 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -136.38 -20.65 1.39 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.994 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -163.29 0.87 Allowed 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.182 0.301 . . . . 0.0 110.431 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.61 35.84 2.48 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.01 0.433 . . . . 0.0 111.9 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.32 82.87 3.69 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.36 -24.6 12.11 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.006 2.471 . . . . 0.0 113.316 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -85.2 -37.38 20.19 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.469 0.481 . . . . 0.0 111.619 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.58 -0.53 57.6 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.794 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -63.5 2.81 0.38 Allowed 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -141.22 40.12 1.76 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.172 0.51 . . . . 0.0 112.237 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 p -123.28 158.04 31.83 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.562 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.857 HG11 ' HE ' ' A' ' 167' ' ' ARG . 60.6 t -131.32 132.88 62.79 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.005 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -114.9 152.01 33.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.266 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.45 ' OH ' HD21 ' A' ' 105' ' ' LEU . 36.0 t80 -105.95 120.48 41.87 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.821 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.76 108.32 17.39 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.447 0.642 . . . . 0.0 111.304 -178.387 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.934 HG23 ' HA2' ' A' ' 42' ' ' GLY . 24.0 t -67.42 -59.92 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.786 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -144.68 112.64 6.35 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.31 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.55 ' CE1' HD12 ' A' ' 9' ' ' LEU . 15.6 t-80 -95.84 128.74 42.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.606 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -139.85 153.37 47.03 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.624 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.53 -18.39 65.28 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.725 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.33 2.22 42.3 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.418 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.88 167.2 15.21 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.455 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -144.82 136.43 25.49 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.97 134.37 55.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.399 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.934 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.9 155.01 26.05 Favored Glycine 0 N--CA 1.45 -0.425 0 O-C-N 124.195 0.935 . . . . 0.0 112.5 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.423 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.4 mt -110.95 133.32 53.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.022 0.411 . . . . 0.0 111.194 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 78' ' ' GLY . 20.5 t -69.34 124.61 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -128.24 56.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.47 0.653 . . . . 0.0 112.276 -177.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.86 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -147.9 -3.5 0.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.491 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.73 87.75 51.48 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.512 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -59.63 142.51 98.93 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 121.695 1.596 . . . . 0.0 112.177 175.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.444 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 50.2 m -92.73 158.67 15.79 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.504 0.502 . . . . 0.0 111.572 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.44 50.15 1.29 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.67 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mt -133.34 159.14 41.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.226 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.622 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 7.4 p-10 -112.48 157.71 20.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.621 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.812 HD12 HD13 ' A' ' 128' ' ' ILE . 1.9 tt -58.5 -26.95 64.01 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.956 0.408 . . . . 0.0 111.765 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.622 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -65.12 -39.97 93.82 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.645 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.71 -46.66 84.45 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.289 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.867 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 19.2 m -62.12 -43.81 98.25 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.722 ' HA ' HD12 ' A' ' 60' ' ' LEU . 15.8 mt -56.13 -35.13 66.77 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.487 176.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.05 -27.75 48.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.425 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.4 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.89 -30.57 50.79 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.339 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.867 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.94 -45.58 23.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -131.12 116.31 16.68 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.58 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.63 -32.97 2.54 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 123.677 2.918 . . . . 0.0 112.732 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.86 -14.62 56.0 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.334 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.36 149.94 24.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.445 0.466 . . . . 0.0 111.722 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.3 122.42 29.46 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.184 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.87 153.92 38.12 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.25 1.966 . . . . 0.0 112.299 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -95.07 -166.0 0.12 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.67 2.247 . . . . 0.0 112.387 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.26 -24.58 62.2 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.311 0.644 . . . . 0.0 111.921 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.437 ' O ' HG13 ' A' ' 73' ' ' ILE . 10.5 ptp180 -67.39 -47.7 69.56 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.703 ' HA ' HD12 ' A' ' 73' ' ' ILE . 29.4 m -71.59 -26.02 62.43 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.451 ' HA ' HD22 ' A' ' 52' ' ' ASN . 40.8 mt-30 -72.83 -26.89 61.65 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.402 0.62 . . . . 0.0 111.511 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -92.87 15.84 13.88 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.057 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 70' ' ' CYS . 44.6 mt -122.08 139.55 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.01 153.55 22.94 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.733 HD13 HD12 ' A' ' 128' ' ' ILE . 25.0 mm -99.78 153.07 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.88 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.4 t80 -119.98 155.67 32.38 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.16 120.36 27.45 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 117.733 0.242 . . . . 0.0 110.572 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.16 -23.74 8.91 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.949 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.24 -168.48 34.65 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.291 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -88.73 -11.52 3.93 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.546 2.831 . . . . 0.0 114.366 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.56 131.29 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.709 0.29 . . . . 0.0 111.418 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 48.2 86.25 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.532 1.133 . . . . 0.0 113.232 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.9 p -81.74 -18.87 42.77 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.151 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -76.92 -18.1 58.5 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.601 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -132.97 147.83 52.28 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.0 0.428 . . . . 0.0 111.558 179.526 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.595 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -112.41 141.33 16.73 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.776 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.23 134.44 33.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.65 -1.275 . . . . 0.0 109.493 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 4.8 t -116.31 128.52 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 123.067 0.23 . . . . 0.0 111.376 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.878 HD11 HD13 ' A' ' 105' ' ' LEU . 13.4 tp -114.23 127.64 55.98 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.608 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.408 ' ND1' ' HB3' ' A' ' 123' ' ' PRO . 4.9 p80 -122.01 162.84 35.08 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.18 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -97.52 31.15 0.14 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.588 2.192 . . . . 0.0 113.403 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.5 t -118.33 156.74 28.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.651 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.49 22.13 42.48 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.71 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tp -87.71 153.5 21.31 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.526 0.33 . . . . 0.0 110.479 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.8 p -122.84 153.17 39.94 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.636 ' CD2' HG12 ' A' ' 113' ' ' VAL . 25.6 m-85 -132.99 -149.05 0.36 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.862 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -60.33 -48.91 79.71 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 122.834 0.453 . . . . 0.0 111.395 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 108' ' ' SER . 57.9 m -135.38 80.29 1.83 Allowed 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.434 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 107' ' ' MET . 7.9 m -126.6 116.85 21.67 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.867 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.96 122.16 40.75 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.098 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.35 130.36 34.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.128 0.489 . . . . 0.0 111.135 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.42 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -127.4 48.64 2.2 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.354 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.42 -109.82 3.12 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.169 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.44 -8.9 4.58 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.878 HD13 HD11 ' A' ' 89' ' ' LEU . 2.2 pp -153.34 150.23 28.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.285 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.495 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -120.81 160.61 23.04 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.812 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' A' ' 99' ' ' THR . 17.1 tpp -126.46 142.22 51.61 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 98' ' ' SER . 54.3 m -137.32 136.62 38.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.73 0.3 . . . . 0.0 110.478 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.7 p -123.03 18.72 10.05 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.383 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.829 ' O ' HG22 ' A' ' 113' ' ' VAL . 14.5 t -92.31 130.11 38.08 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 122.044 0.926 . . . . 0.0 112.564 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.645 ' HA ' HD12 ' A' ' 114' ' ' LEU . 4.8 mt-30 -61.48 -26.27 67.79 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.725 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -62.54 -47.14 85.2 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.527 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.849 ' O ' HG22 ' A' ' 117' ' ' ILE . 21.0 m -62.2 -43.12 97.52 Favored 'Isoleucine or valine' 0 C--N 1.36 1.043 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 177.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 111' ' ' GLN . 22.0 mt -54.57 -50.58 67.63 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.718 0.636 . . . . 0.0 111.984 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.464 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 37.2 m-85 -65.6 -47.2 76.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.771 0.319 . . . . 0.0 111.23 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.08 -52.99 63.23 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.138 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.849 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.02 -43.3 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.75 -30.48 65.63 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 123.618 0.574 . . . . 0.0 109.662 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.401 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -86.21 -19.64 29.72 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.174 176.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.75 17.19 26.57 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 114.652 -1.158 . . . . 0.0 114.904 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.7 p -107.88 8.14 28.45 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -98.17 -136.51 9.26 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-O 119.195 -0.78 . . . . 0.0 112.527 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.408 ' HB3' ' ND1' ' A' ' 90' ' ' HIS . 3.2 Cg_exo -77.78 169.9 19.94 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.333 2.688 . . . . 0.0 113.161 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -51.5 -58.36 6.51 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.695 0.798 . . . . 0.0 110.863 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -133.66 168.41 18.73 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.452 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.4 ' HB2' ' CG1' ' A' ' 88' ' ' VAL . 31.6 p -152.52 156.9 40.28 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.8 tp -125.68 106.09 9.47 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.812 HD13 HD12 ' A' ' 53' ' ' LEU . 15.7 pt -92.82 102.62 13.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.812 0.815 . . . . 0.0 110.044 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.0 t -122.45 122.64 39.43 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.255 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.12 117.07 8.65 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.198 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.44 ' H ' ' HA2' ' A' ' 86' ' ' GLY . . . 66.38 172.94 4.95 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.366 -0.833 . . . . 0.0 114.307 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -128.11 -179.06 4.79 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.231 0.538 . . . . 0.0 110.824 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -116.81 128.98 55.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.246 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.25 148.83 18.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.379 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.455 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 22.3 m-90 -127.14 137.86 53.05 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.803 0.354 . . . . 0.0 110.435 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.85 158.02 26.86 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.818 0.699 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.14 92.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.32 -24.72 8.05 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.177 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -57.57 -44.38 85.27 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.87 0.468 . . . . 0.0 112.15 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.9 tm? -68.07 -47.64 67.73 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.502 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.21 -30.12 67.99 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.013 0.435 . . . . 0.0 110.644 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.17 -49.91 45.66 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.887 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.55 -26.63 63.64 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.84 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.6 tp -74.71 -38.91 62.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.593 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.0 m -77.88 -28.44 49.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.296 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -81.93 -0.92 46.07 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.553 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 61.19 29.55 18.83 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.801 0.841 . . . . 0.0 111.744 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 143' ' ' GLU . . . -83.53 -43.6 15.55 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.829 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -124.62 113.4 17.99 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.5 tp -84.67 140.43 31.32 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.442 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.4 p -104.61 137.42 42.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.17 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 73.2 m -152.46 155.87 33.12 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.629 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.21 157.66 29.33 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.319 2.013 . . . . 0.0 111.191 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.455 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.36 168.32 17.12 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -136.31 135.03 20.33 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 114.405 -1.27 . . . . 0.0 107.84 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.27 -26.57 14.45 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.582 2.188 . . . . 0.0 113.695 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.68 -40.5 62.97 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.768 0.667 . . . . 0.0 112.329 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.576 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.8 mt -71.06 -35.37 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-O 121.375 0.607 . . . . 0.0 110.354 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -73.88 -38.58 64.37 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.051 -1.431 . . . . 0.0 111.392 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -84.77 -33.44 23.02 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.35 -72.34 0.49 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.047 0.385 . . . . 0.0 111.532 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.883 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.3 99.52 6.46 Favored Pre-proline 0 C--N 1.348 0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 112.349 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.86 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 73.0 Cg_endo -91.45 -0.68 4.63 Favored 'Trans proline' 0 CA--C 1.569 2.254 0 C-N-CA 121.721 1.614 . . . . 0.0 114.304 175.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.646 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 73.9 Cg_endo -74.37 -52.62 0.12 Allowed 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.643 2.229 . . . . 0.0 114.48 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.523 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.6 mt-10 -122.29 -30.33 4.01 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.75 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.883 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.0 tt0 -69.78 -11.59 60.97 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.367 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.857 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.63 -41.7 44.95 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.272 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.36 -50.28 40.54 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.349 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.8 m -58.09 -49.45 76.91 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.651 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.26 -39.95 94.99 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.209 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.09 -46.58 79.0 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 123.545 0.528 . . . . 0.0 110.587 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.67 88.33 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.51 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.24 -28.26 69.24 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.492 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.75 -40.14 42.0 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 122.835 0.454 . . . . 0.0 110.303 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.98 -32.03 70.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.489 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.64 53.68 0.48 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.94 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.3 t -128.03 147.3 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -89.5 78.12 7.15 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.684 0.754 . . . . 0.0 110.682 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.65 -26.17 50.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.088 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 53.3 m -58.69 -44.22 90.21 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.51 -26.86 51.52 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.2 mt -77.08 -30.26 55.38 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.358 0.411 . . . . 0.0 111.658 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.1 p -89.94 -47.68 7.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.38 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.63 119.21 22.12 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 123.514 0.508 . . . . 0.0 111.03 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -100.73 145.21 28.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.918 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.33 145.04 50.59 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 173.97 149.97 7.34 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.582 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -128.16 145.73 50.93 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.619 0.246 . . . . 0.0 110.854 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.07 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.499 0.19 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -100.33 143.45 30.5 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.107 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -98.62 -41.91 7.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.003 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.539 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.7 m -104.12 153.78 20.51 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.708 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.3 m -97.55 97.42 4.0 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.055 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 4' ' ' SER . 2.0 Cg_endo -87.93 7.57 4.52 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.909 2.406 . . . . 0.0 112.093 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.4 t -93.9 -46.9 6.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.979 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -104.22 157.92 16.8 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.396 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.09 45.36 1.21 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.143 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -91.23 20.21 5.28 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.846 0.355 . . . . 0.0 111.276 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.2 p80 176.71 52.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.99 0.916 . . . . 0.0 110.257 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -133.2 160.43 37.27 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.716 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.434 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 14.4 m-30 -95.59 135.01 37.81 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 1.6 mm? -108.04 139.92 41.97 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.525 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 29' ' ' VAL . 3.0 mp -124.58 134.43 66.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 O-C-N 123.545 0.528 . . . . 0.0 109.936 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.33 133.21 35.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.479 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 24.5 mmt -123.2 157.36 61.28 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.03 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.22 78.01 3.61 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.563 2.175 . . . . 0.0 112.879 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -135.53 -21.79 1.52 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.875 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.53 -162.89 0.86 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 123.209 0.318 . . . . 0.0 110.493 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.545 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.39 30.89 4.64 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.1 m-20 -110.85 83.29 3.49 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.1 Cg_exo -75.37 -20.7 15.9 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.069 2.513 . . . . 0.0 113.417 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -84.93 -39.04 18.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 122.833 0.453 . . . . 0.0 111.649 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.27 -2.72 56.28 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.76 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -61.0 2.29 0.12 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -142.28 38.95 1.57 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.167 0.508 . . . . 0.0 112.03 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 p -123.22 158.45 30.83 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.625 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.78 HG11 ' HE ' ' A' ' 167' ' ' ARG . 99.4 t -130.57 131.45 64.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.896 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.464 HG21 ' HH2' ' A' ' 135' ' ' TRP . 2.3 m -113.15 154.55 26.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.363 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.429 ' OH ' HD11 ' A' ' 105' ' ' LEU . 43.3 t80 -106.66 119.93 40.62 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.659 HD11 ' HB1' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -82.34 106.86 14.56 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 123.595 0.559 . . . . 0.0 111.391 -178.131 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.94 HG23 ' HA2' ' A' ' 42' ' ' GLY . 34.3 t -67.69 -57.98 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.597 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -144.56 118.84 9.55 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.187 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -99.05 128.12 45.13 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.875 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -139.25 152.44 47.3 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.586 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -62.58 -24.19 67.42 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.644 0.378 . . . . 0.0 111.781 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -93.17 -3.72 53.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 123.492 0.495 . . . . 0.0 111.498 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.3 173.72 24.35 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 121.518 -0.373 . . . . 0.0 112.274 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.659 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -146.85 141.53 26.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -114.55 134.7 54.84 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.09 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.94 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.26 157.64 28.25 Favored Glycine 0 N--CA 1.443 -0.844 0 O-C-N 124.215 0.947 . . . . 0.0 112.618 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.4 HD23 ' C ' ' A' ' 42' ' ' GLY . 1.8 mt -112.32 128.72 56.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.925 0.363 . . . . 0.0 110.511 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.451 HG12 ' C ' ' A' ' 78' ' ' GLY . 11.1 p -68.29 125.97 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.05 57.76 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.725 0.774 . . . . 0.0 112.059 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.829 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.2 t30 -146.28 -1.7 0.72 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.032 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -130.2 88.26 48.56 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.508 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 40.9 Cg_exo -58.67 145.94 93.76 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 121.711 1.607 . . . . 0.0 112.48 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.447 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 73.1 m -96.38 160.23 14.52 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.554 0.534 . . . . 0.0 111.489 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.94 51.53 0.9 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.636 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -133.35 154.02 51.09 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.929 0.429 . . . . 0.0 110.03 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.611 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 10.4 p-10 -112.45 157.7 20.76 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.822 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.537 HD12 HD13 ' A' ' 128' ' ' ILE . 2.4 tt -57.53 -26.74 61.82 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.611 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -67.54 -40.87 84.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.419 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.1 -45.51 88.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.17 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.861 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.1 m -62.04 -44.96 99.66 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 60' ' ' LEU . 14.8 mt -56.16 -35.15 66.86 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.494 176.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.05 -27.25 48.68 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.313 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -30.46 51.42 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.334 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.861 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.79 -45.91 23.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.099 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -131.22 116.75 16.68 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.52 -33.05 2.58 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.674 2.916 . . . . 0.0 112.78 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.71 -14.99 55.83 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.376 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.99 149.47 24.75 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 123.327 0.392 . . . . 0.0 111.636 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.71 123.21 29.26 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.303 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.61 153.48 38.99 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.298 1.999 . . . . 0.0 112.264 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 6.6 Cg_endo -94.01 -165.07 0.12 Allowed 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.596 2.198 . . . . 0.0 112.119 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.83 -24.74 61.76 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.134 0.574 . . . . 0.0 111.888 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.565 ' HA ' ' CE1' ' A' ' 72' ' ' HIS . 12.0 ptp180 -67.33 -46.06 74.57 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.542 ' HA ' HD12 ' A' ' 73' ' ' ILE . 17.5 m -73.82 -25.54 60.15 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.468 ' HA ' HD22 ' A' ' 52' ' ' ASN . 47.3 mt-30 -70.63 -27.62 64.2 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.565 ' CE1' ' HA ' ' A' ' 69' ' ' ARG . 15.3 p-80 -97.9 20.42 12.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.089 0.471 . . . . 0.0 111.606 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 70' ' ' CYS . 62.8 mt -118.72 136.76 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.255 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.83 163.94 12.14 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 51' ' ' LEU . 14.3 mm -115.23 152.69 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.022 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.744 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.5 t80 -116.49 155.1 29.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.895 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.72 125.03 31.48 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 131' ' ' GLY . . . -104.14 -23.53 8.06 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.741 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.86 -167.95 33.3 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.186 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -88.55 -10.38 4.52 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.434 2.756 . . . . 0.0 114.262 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.84 131.34 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 123.08 0.237 . . . . 0.0 111.206 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 45.06 82.98 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.537 1.135 . . . . 0.0 113.385 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.2 p -81.66 -14.6 56.44 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.198 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.91 -17.13 59.13 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.748 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.771 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -132.61 148.2 52.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.927 0.394 . . . . 0.0 111.882 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.603 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.71 148.48 17.68 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.404 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.5 m-85 -86.84 150.76 23.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.913 -1.144 . . . . 0.0 111.115 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 21.6 t -128.22 105.69 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.163 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.932 HD11 HD13 ' A' ' 105' ' ' LEU . 13.6 tp -106.26 127.95 53.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.456 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.404 ' ND1' ' HB3' ' A' ' 123' ' ' PRO . 3.7 p80 -128.43 166.34 25.04 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.421 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.684 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.34 25.22 0.25 Allowed 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.691 2.261 . . . . 0.0 113.691 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.0 t -112.98 158.83 19.77 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.624 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.27 22.94 34.13 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.653 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.27 150.51 22.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.502 0.321 . . . . 0.0 110.534 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.6 ' HA ' HG21 ' A' ' 99' ' ' THR . 24.7 m -128.47 157.09 42.1 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.146 0.498 . . . . 0.0 112.189 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.556 ' CE2' HG23 ' A' ' 113' ' ' VAL . 57.6 m-85 -126.81 -150.88 0.46 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.8 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -59.07 -46.87 87.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.595 0.358 . . . . 0.0 111.338 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.8 m -132.58 80.3 1.89 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.943 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.6 HG21 ' HA ' ' A' ' 95' ' ' SER . 47.2 m -128.7 121.15 27.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.153 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.5 123.57 46.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.861 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.58 127.82 34.04 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.764 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.56 ' HB3' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -120.58 43.11 2.83 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.798 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.61 -100.57 0.28 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.424 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -55.61 -14.83 2.36 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.932 HD13 HD11 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -160.0 159.87 32.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.907 0.483 . . . . 0.0 110.687 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.574 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.73 156.98 28.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.846 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.49 ' CE ' HD13 ' A' ' 89' ' ' LEU . 16.1 ttm -123.91 134.64 53.49 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 m -136.68 133.72 36.47 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.7 p -127.97 19.7 6.52 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.007 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.755 ' O ' HG12 ' A' ' 113' ' ' VAL . 42.2 p -90.61 130.9 36.58 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.306 0.574 . . . . 0.0 112.021 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.489 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 5.4 mt-30 -57.95 -26.9 62.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.777 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -64.53 -40.02 94.84 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.119 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.77 ' O ' HG22 ' A' ' 117' ' ' ILE . 2.7 p -71.49 -38.5 68.39 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.77 -49.84 72.07 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.578 0.549 . . . . 0.0 110.495 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.489 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 39.2 m-85 -68.01 -40.79 82.93 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.405 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.64 -53.95 51.23 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.679 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.3 tp -64.56 -43.96 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.56 -32.31 65.05 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.665 0.603 . . . . 0.0 109.703 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.438 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.38 -20.55 31.75 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.365 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.35 17.23 25.02 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.8 -1.091 . . . . 0.0 114.472 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 p -108.26 8.39 27.79 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -93.84 -138.01 8.83 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 119.204 -0.776 . . . . 0.0 112.863 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.404 ' HB3' ' ND1' ' A' ' 90' ' ' HIS . 2.2 Cg_endo -82.37 165.76 16.34 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.146 2.564 . . . . 0.0 113.998 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.506 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -49.94 -60.14 3.2 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.482 1.113 . . . . 0.0 111.76 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.684 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -140.1 139.72 35.9 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 37.2 p -139.25 169.41 17.82 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.2 tp -125.61 115.81 20.73 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.45 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.537 HD13 HD12 ' A' ' 53' ' ' LEU . 8.6 pt -99.25 104.98 16.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.3 t -124.16 121.99 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.035 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.0 tp -67.21 113.06 4.84 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.379 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.502 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 72.75 170.51 17.06 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.158 -0.928 . . . . 0.0 114.283 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -128.66 177.77 6.8 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.206 0.526 . . . . 0.0 110.809 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -114.94 131.73 56.79 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.937 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.33 144.05 15.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.598 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.464 ' HH2' HG21 ' A' ' 30' ' ' THR . 16.8 m-90 -122.15 131.68 54.08 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.046 0.498 . . . . 0.0 110.597 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -78.94 159.19 27.83 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.53 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.16 124.05 10.77 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.671 0.388 . . . . 0.0 111.497 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.27 -28.02 8.64 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.017 -0.611 . . . . 0.0 114.128 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -56.71 -48.88 76.75 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.543 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.0 tp -67.8 -47.77 68.16 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.673 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.83 -31.57 64.88 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.456 0.472 . . . . 0.0 110.814 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.88 -50.35 43.29 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.044 178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -72.29 -26.64 62.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.4 tp -75.65 -38.49 58.81 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.738 0.815 . . . . 0.0 110.784 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.7 m -78.12 -31.09 49.75 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.444 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -80.8 0.4 35.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.649 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 60.13 28.68 18.27 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.908 0.883 . . . . 0.0 111.749 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.99 -43.16 22.49 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.831 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -126.29 116.48 21.31 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -84.72 150.34 25.17 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.487 ' H ' HD23 ' A' ' 150' ' ' LEU . 16.8 p -110.78 136.29 50.07 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.363 0.414 . . . . 0.0 110.915 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 74.9 m -151.83 154.87 33.42 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.54 159.04 25.12 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.284 1.989 . . . . 0.0 111.104 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.434 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.89 166.09 21.65 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -134.95 134.16 21.57 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 114.368 -1.287 . . . . 0.0 107.863 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.51 -26.43 16.79 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.596 2.198 . . . . 0.0 113.663 -177.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.8 -39.97 62.82 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 123.871 0.732 . . . . 0.0 112.056 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.565 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.2 mt -72.27 -35.66 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.363 0.602 . . . . 0.0 110.392 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.61 -37.41 65.43 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.412 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -86.67 -33.75 19.99 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -85.78 -72.33 0.49 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.052 0.387 . . . . 0.0 111.666 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.913 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.75 98.11 6.44 Favored Pre-proline 0 C--N 1.349 0.584 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.829 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 59.5 Cg_endo -92.76 1.2 3.77 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 C-N-CA 121.719 1.613 . . . . 0.0 114.258 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.636 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 80.4 Cg_endo -74.1 -52.14 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.561 2.174 . . . . 0.0 114.224 -178.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.507 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.97 -29.79 3.88 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.658 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.913 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.5 tt0 -70.36 -10.13 58.18 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.247 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.78 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.01 -38.2 53.52 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.135 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.7 tt -74.01 -49.58 23.7 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.3 m -58.41 -46.72 85.89 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.487 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -67.14 -40.66 86.78 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.397 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.15 -45.98 79.43 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 123.362 0.414 . . . . 0.0 110.446 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.99 -38.65 91.87 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.487 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.87 69.25 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.595 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.69 -40.23 42.14 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 122.931 0.492 . . . . 0.0 110.26 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.0 -31.19 67.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.529 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.08 53.64 0.74 Allowed Glycine 0 C--N 1.34 0.776 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.884 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 6.8 t -127.71 149.48 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -87.7 79.46 8.21 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.665 0.745 . . . . 0.0 110.735 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -26.17 49.76 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.183 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.5 m -58.97 -42.15 89.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.51 -26.71 51.4 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.9 mt -77.02 -37.86 54.13 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.263 0.352 . . . . 0.0 111.944 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.8 p -93.99 -48.68 6.14 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.28 0.363 . . . . 0.0 111.424 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 57.8 120.27 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.114 0.966 . . . . 0.0 112.889 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -99.69 142.83 30.66 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.942 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -124.32 146.54 48.75 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -145.39 130.68 3.91 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.471 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -99.37 -40.5 7.87 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.284 0.234 . . . . 0.0 111.285 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.081 -0.961 . . . . 0.0 111.072 -179.948 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.554 0.216 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -97.98 152.31 19.4 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.816 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -123.55 -43.74 2.14 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.823 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.1 p -124.76 -57.57 1.53 Allowed 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.196 0.31 . . . . 0.0 111.629 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.4 p -139.18 145.04 43.07 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 119.405 -0.331 . . . . 0.0 111.278 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -86.27 7.52 4.93 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.907 2.405 . . . . 0.0 112.732 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -93.43 -38.3 11.51 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.224 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -90.58 153.32 20.42 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.862 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mt -107.75 51.46 0.74 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.744 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.539 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 14.2 ptmt -95.16 27.65 3.15 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.494 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 176.44 51.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.563 0.745 . . . . 0.0 110.91 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -134.04 159.39 40.95 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.452 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 30' ' ' THR . 12.3 m-30 -98.58 138.33 35.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.168 0.509 . . . . 0.0 112.15 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.672 HD11 HD23 ' A' ' 32' ' ' LEU . 1.9 mp -109.89 135.41 50.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.565 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.432 HG23 HG22 ' A' ' 29' ' ' VAL . 2.9 mp -120.04 130.72 73.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.53 127.63 33.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.012 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.6 mmt -112.28 154.62 44.37 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.171 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -79.96 72.57 6.45 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.561 2.174 . . . . 0.0 112.611 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -130.79 -16.4 3.32 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.54 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -164.69 0.94 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.303 0.377 . . . . 0.0 110.604 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.541 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.55 37.77 2.05 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 111.85 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -110.99 82.95 3.36 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.832 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.33 -21.88 14.8 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.973 2.449 . . . . 0.0 113.384 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -85.19 -38.52 18.89 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.909 0.484 . . . . 0.0 111.527 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.08 -5.53 55.06 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.842 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -57.3 -0.67 0.06 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -178.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -142.3 43.86 1.65 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.179 0.514 . . . . 0.0 111.839 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p -127.38 155.58 43.39 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.616 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.651 HG11 ' HE ' ' A' ' 167' ' ' ARG . 48.0 t -129.22 133.54 65.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.676 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 3.9 m -115.15 154.68 28.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.471 -178.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.408 ' OH ' HD11 ' A' ' 105' ' ' LEU . 17.7 t80 -109.14 116.26 31.59 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.672 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -78.61 108.47 12.03 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-O 121.04 0.448 . . . . 0.0 110.466 -179.33 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.891 HG23 ' HA2' ' A' ' 42' ' ' GLY . 56.4 t -64.78 -57.92 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 114.033 -1.439 . . . . 0.0 110.115 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.539 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 32.7 tt0 -151.11 119.67 6.48 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.793 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -95.8 129.24 43.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.629 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -139.48 152.89 47.35 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.475 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.8 -18.98 65.58 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.623 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 137' ' ' ALA . 46.5 mt-30 -95.68 -5.83 41.35 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.346 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.81 172.37 22.51 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.2 143.24 30.19 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.461 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -119.5 136.6 54.26 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.638 178.573 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.891 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.29 158.53 29.61 Favored Glycine 0 N--CA 1.452 -0.292 0 O-C-N 124.364 1.04 . . . . 0.0 112.529 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.8 mt -115.6 134.86 54.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.099 0.449 . . . . 0.0 111.438 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 78' ' ' GLY . 11.1 t -68.55 122.48 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.91 55.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.638 0.732 . . . . 0.0 112.074 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.854 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 1.9 t30 -148.32 -2.75 0.51 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.157 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -130.19 87.23 51.71 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.53 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -59.7 143.15 99.7 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 121.559 1.506 . . . . 0.0 112.14 175.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 50.0 m -92.54 158.5 15.97 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 123.39 0.431 . . . . 0.0 111.368 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.89 50.29 1.37 Allowed Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.837 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 mt -133.57 158.96 41.85 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.979 0.458 . . . . 0.0 110.229 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.1 p-10 -112.23 157.54 20.77 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.102 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.642 HD13 HD13 ' A' ' 128' ' ' ILE . 13.4 tp -57.79 -37.07 73.08 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.07 -37.91 62.06 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -63.66 -43.03 97.93 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.21 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.864 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -62.63 -46.82 95.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.609 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.744 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.4 mp -53.56 -36.72 62.17 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.87 0.731 . . . . 0.0 110.784 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.93 -28.34 49.63 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.564 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -29.97 47.9 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.381 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.864 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.9 mt -77.83 -45.14 25.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.884 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -132.02 116.57 15.7 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.535 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -77.59 -32.73 2.69 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 123.615 2.876 . . . . 0.0 112.747 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.22 -14.38 55.63 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.364 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 149.7 24.52 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 123.321 0.388 . . . . 0.0 111.792 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.32 123.75 29.68 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.99 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 57.5 Cg_endo -74.45 146.04 34.55 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.185 1.923 . . . . 0.0 112.351 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.502 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.4 Cg_endo -92.43 -170.62 0.3 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.491 2.127 . . . . 0.0 111.83 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.82 -24.89 67.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.142 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.504 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.6 ptp180 -66.18 -53.38 38.14 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -177.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.706 ' HA ' HD12 ' A' ' 73' ' ' ILE . 60.1 m -71.74 -25.02 61.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 49.1 mt-30 -68.12 -35.63 78.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -90.37 22.12 3.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.228 0.537 . . . . 0.0 111.667 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.706 HD12 ' HA ' ' A' ' 70' ' ' CYS . 55.1 mt -119.39 139.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.383 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.11 153.78 22.14 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.802 0.689 . . . . 0.0 112.728 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.689 HD13 HD12 ' A' ' 128' ' ' ILE . 25.9 mm -100.02 150.3 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.093 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.715 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -116.51 154.98 29.44 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.52 118.94 26.27 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.636 0.198 . . . . 0.0 110.552 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -101.46 -23.66 9.37 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.826 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.82 -167.77 35.4 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.123 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -88.39 -9.66 4.95 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 123.492 2.794 . . . . 0.0 114.264 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 t -87.07 131.18 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.003 0.19 . . . . 0.0 111.035 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 44.13 87.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.533 1.133 . . . . 0.0 113.316 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.428 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.0 t -88.09 1.51 54.11 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.428 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.87 -5.47 47.91 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.604 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.26 154.45 50.66 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.11 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.604 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.5 134.2 12.1 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.175 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.727 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.54 145.58 27.31 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.366 1.067 . . . . 0.0 110.231 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -123.97 103.42 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 123.366 0.416 . . . . 0.0 110.874 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.785 HD11 HD13 ' A' ' 105' ' ' LEU . 6.2 tp -105.71 129.21 53.97 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -125.6 168.23 14.37 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 118.985 -0.531 . . . . 0.0 112.146 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 16.5 Cg_endo -96.61 13.99 0.96 Allowed 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.862 2.375 . . . . 0.0 113.644 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 t -101.89 161.06 13.95 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.874 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.84 19.21 55.5 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.512 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -85.47 153.86 22.19 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.604 0.362 . . . . 0.0 110.403 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.0 p -127.03 157.89 38.39 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CE2' HG23 ' A' ' 113' ' ' VAL . 52.0 m-85 -129.34 -151.94 0.5 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.671 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -57.44 -46.26 83.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.776 0.431 . . . . 0.0 111.723 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 m -138.32 78.94 1.71 Allowed 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.642 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 107' ' ' MET . 25.1 m -126.29 120.96 31.3 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 107' ' ' MET . 3.3 tp -77.36 162.02 27.59 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.051 176.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -135.2 125.5 26.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.896 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.506 HD11 ' O ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -135.84 43.99 2.52 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.279 -179.383 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.13 -99.16 0.19 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.815 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -57.4 -12.99 2.91 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.785 HD13 HD11 ' A' ' 89' ' ' LEU . 3.2 pp -158.44 148.11 19.55 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.265 0.555 . . . . 0.0 112.493 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.52 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -120.83 158.6 27.24 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.324 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 8.9 ttm -119.68 134.08 55.37 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.754 ' HB3' HG11 ' A' ' 113' ' ' VAL . 16.7 m -128.76 127.36 41.86 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.8 p -119.92 11.78 11.88 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.782 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.745 ' O ' HG12 ' A' ' 113' ' ' VAL . 49.2 m -85.59 130.38 34.59 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.617 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.497 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.7 pt20 -61.58 -29.52 70.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.382 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.45 -43.16 95.15 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.603 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.754 HG11 ' HB3' ' A' ' 108' ' ' SER . 4.0 p -68.14 -39.77 81.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 123.189 0.306 . . . . 0.0 110.38 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.53 HD22 ' NH2' ' A' ' 85' ' ' ARG . 1.5 tt -58.12 -48.34 80.51 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 123.571 0.544 . . . . 0.0 110.47 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.497 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 35.3 m-85 -69.98 -37.57 75.8 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.865 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.25 -51.94 65.72 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.0 tp -64.56 -43.14 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.156 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.02 -31.59 65.28 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 123.826 0.704 . . . . 0.0 109.546 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.504 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.71 -20.8 30.6 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.255 176.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.61 13.1 33.39 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.729 -1.123 . . . . 0.0 114.692 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.1 p -103.39 7.8 38.09 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.68 -137.7 9.6 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.239 -0.756 . . . . 0.0 112.635 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.72 173.72 12.59 Favored 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 123.228 2.619 . . . . 0.0 113.601 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.01 -54.37 47.53 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.757 0.823 . . . . 0.0 111.916 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.594 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.9 mmtt -139.05 151.14 46.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.775 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.0 m -148.05 165.38 30.97 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.7 tp -127.5 118.05 23.26 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.361 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.727 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 18.5 pt -98.63 102.7 13.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.989 0.9 . . . . 0.0 109.819 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 6.8 t -119.75 121.6 39.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.76 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.428 HD21 ' O ' ' A' ' 83' ' ' THR . 6.9 tp -66.84 115.06 6.2 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.01 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.71 174.61 4.11 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.352 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -128.44 -179.49 5.06 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.408 0.623 . . . . 0.0 111.092 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -117.34 130.47 56.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.179 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.46 152.24 19.48 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.354 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 27.4 m-90 -132.69 139.02 47.48 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.898 0.41 . . . . 0.0 110.537 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.25 158.17 27.63 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.851 0.719 . . . . 0.0 110.794 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . . . -50.92 91.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.82 -22.05 10.11 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.339 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -57.22 -46.35 83.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.866 0.466 . . . . 0.0 111.978 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.5 tp -66.73 -47.18 73.09 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -56.69 -30.84 63.86 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.453 0.471 . . . . 0.0 110.793 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.43 -49.08 52.57 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.04 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.4 pt-20 -72.69 -26.75 61.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.0 tp -75.48 -38.23 59.68 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.744 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -78.19 -30.31 48.92 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.272 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.06 0.5 31.61 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.605 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 61.38 28.98 18.3 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.871 0.868 . . . . 0.0 111.797 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.45 -42.71 16.63 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.528 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -124.14 111.39 15.86 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 123.495 0.497 . . . . 0.0 109.856 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.3 tp -86.93 128.36 35.06 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.614 0.245 . . . . 0.0 111.506 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.5 p -100.33 142.3 31.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.758 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 78.2 m -154.95 155.83 30.66 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 123.446 0.466 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.51 148.46 92.94 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.325 2.016 . . . . 0.0 110.999 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 174' ' ' ARG . . . -135.06 177.42 7.82 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -134.29 141.11 38.02 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 113.88 -1.509 . . . . 0.0 108.584 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -74.85 -26.54 11.14 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 122.766 2.311 . . . . 0.0 114.007 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -48.89 -41.71 34.4 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.915 0.759 . . . . 0.0 112.631 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.704 HD13 HH12 ' A' ' 167' ' ' ARG . 4.9 mt -70.26 -32.63 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.467 0.651 . . . . 0.0 110.421 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.6 tt -76.65 -37.12 56.81 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.37 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.61 -33.45 25.32 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -86.84 -72.93 0.48 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.939 0.336 . . . . 0.0 111.657 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.89 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.47 99.93 6.3 Favored Pre-proline 0 C--N 1.349 0.578 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.854 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 70.3 Cg_endo -90.94 -0.91 4.97 Favored 'Trans proline' 0 CA--C 1.57 2.275 0 C-N-CA 121.742 1.628 . . . . 0.0 114.261 175.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.651 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 87.8 Cg_endo -74.28 -54.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 122.636 2.224 . . . . 0.0 114.502 -178.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.542 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.1 mt-10 -120.58 -29.84 4.64 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.729 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.89 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.0 tt0 -70.38 -11.38 60.88 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.422 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.704 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.28 -45.5 32.29 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.397 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.5 tp -68.06 -50.19 56.72 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.1 m -57.57 -51.16 70.6 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.922 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.09 88.98 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.158 0.286 . . . . 0.0 110.987 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.28 83.92 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 123.657 0.598 . . . . 0.0 110.457 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.11 84.54 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.646 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 177' ' ' VAL . . . -62.76 -32.28 73.39 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.532 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.483 ' CZ ' ' HA ' ' A' ' 154' ' ' ALA . 10.9 mtm-85 -77.7 -41.57 37.47 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 122.682 0.393 . . . . 0.0 110.702 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.77 -35.47 79.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.634 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 132.29 36.71 0.29 Allowed Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.2 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 173' ' ' ALA . 4.9 t -128.44 127.71 67.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -83.86 83.66 7.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.568 0.699 . . . . 0.0 111.511 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -77.99 -26.42 48.61 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.157 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.0 m -58.39 -45.26 88.67 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.36 -26.85 52.32 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 21.3 mt -77.28 -30.02 54.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.618 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 23.0 p -90.22 -47.98 7.45 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.374 0.421 . . . . 0.0 111.435 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -131.22 120.2 22.92 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.48 0.488 . . . . 0.0 111.04 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -97.25 138.72 34.3 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.976 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -102.79 151.2 22.69 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.215 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -98.14 -103.7 2.33 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.595 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -99.1 -40.56 7.95 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.345 0.258 . . . . 0.0 111.332 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.094 -179.96 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.349 0.118 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -99.88 130.66 46.09 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.034 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -101.5 -40.89 6.84 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.096 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.432 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 16.1 t -98.56 153.21 18.81 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.369 0.418 . . . . 0.0 110.891 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 p -93.74 101.78 6.68 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.038 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.9 Cg_endo -87.65 7.67 4.56 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.769 2.312 . . . . 0.0 112.287 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 t -92.57 166.2 12.62 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.97 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 62.74 151.71 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.933 0.893 . . . . 0.0 112.581 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 32' ' ' LEU . 18.4 mt -93.84 46.57 1.18 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.323 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -93.0 19.36 7.89 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.068 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 175.55 55.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.268 1.027 . . . . 0.0 109.209 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -137.96 156.88 47.4 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.462 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.5 m-30 -96.46 135.43 38.34 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.928 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.762 HD11 HD23 ' A' ' 32' ' ' LEU . 6.2 mt -107.62 138.2 44.27 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.182 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.459 HG23 HG22 ' A' ' 29' ' ' VAL . 2.2 mm -116.69 132.63 65.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 O-C-N 123.623 0.577 . . . . 0.0 109.617 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.58 128.15 33.67 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.724 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.5 mtt -117.79 154.32 51.06 Favored Pre-proline 0 CA--C 1.538 0.509 0 O-C-N 123.383 0.427 . . . . 0.0 111.336 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.41 74.0 5.76 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.673 2.249 . . . . 0.0 112.661 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -131.63 -17.64 2.86 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.741 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.32 -163.26 0.84 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.272 0.357 . . . . 0.0 110.403 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -101.96 34.4 2.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.906 0.384 . . . . 0.0 111.979 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.6 82.4 3.75 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.37 -22.3 14.32 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.033 2.488 . . . . 0.0 113.333 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -85.13 -39.13 18.25 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.93 0.492 . . . . 0.0 111.498 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -4.63 56.94 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.889 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -57.69 0.71 0.05 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -143.13 43.34 1.55 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.212 0.529 . . . . 0.0 111.866 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.6 p -126.49 158.28 36.5 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.674 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.794 HG11 ' HE ' ' A' ' 167' ' ' ARG . 58.4 t -130.72 133.07 63.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.641 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.446 HG21 ' HH2' ' A' ' 135' ' ' TRP . 1.8 m -114.33 155.18 26.71 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.647 -178.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.479 ' OH ' HD21 ' A' ' 105' ' ' LEU . 34.1 t80 -107.71 115.58 30.4 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.762 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -80.08 108.21 13.48 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-O 121.393 0.616 . . . . 0.0 111.236 -178.553 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.947 HG23 ' HA2' ' A' ' 42' ' ' GLY . 43.4 t -68.42 -63.32 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.267 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -136.82 122.65 19.99 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.492 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -104.66 128.79 52.82 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.9 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -139.81 153.14 47.02 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.627 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.61 -21.56 66.43 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.005 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -94.99 -4.66 46.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.398 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.54 176.23 27.48 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.405 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.649 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -148.99 148.95 30.36 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.21 136.17 54.62 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.289 177.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.947 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.11 160.39 30.4 Favored Glycine 0 N--CA 1.447 -0.624 0 O-C-N 124.603 1.189 . . . . 0.0 112.509 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.4 mt -112.69 131.19 55.77 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.939 0.37 . . . . 0.0 111.223 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 78' ' ' GLY . 15.7 t -67.05 122.12 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.49 56.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.648 0.737 . . . . 0.0 112.038 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.852 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.1 t30 -147.15 -3.25 0.58 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.158 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -130.08 88.57 47.99 Favored Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.521 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.3 Cg_exo -59.6 143.68 99.61 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.712 1.608 . . . . 0.0 112.157 175.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.441 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.2 m -93.29 159.71 15.15 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 123.386 0.429 . . . . 0.0 111.639 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.06 50.69 1.18 Allowed Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.588 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mt -133.6 158.44 43.19 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 122.848 0.459 . . . . 0.0 110.143 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 24.7 p-10 -112.61 157.61 20.99 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.808 HD12 HD13 ' A' ' 128' ' ' ILE . 1.6 tt -58.1 -26.51 62.68 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 120.947 0.403 . . . . 0.0 111.847 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.68 95.47 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.173 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.56 -45.78 88.92 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.095 0.247 . . . . 0.0 111.457 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.867 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 7.8 m -62.12 -44.51 99.12 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 60' ' ' LEU . 14.4 mt -55.99 -35.14 66.43 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.853 0.721 . . . . 0.0 110.618 176.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.08 -27.41 48.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.391 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.84 -30.97 51.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.284 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.867 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.2 mt -77.69 -45.76 23.92 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.162 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -131.12 116.52 16.73 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.581 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.7 -32.94 2.51 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.554 2.836 . . . . 0.0 112.75 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.74 -14.77 56.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.313 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.18 149.66 24.48 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.42 0.45 . . . . 0.0 111.672 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.24 123.45 29.39 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.304 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.42 149.48 35.11 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.275 1.983 . . . . 0.0 112.279 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.428 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 7.6 Cg_endo -94.33 -167.86 0.16 Allowed 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.653 2.235 . . . . 0.0 112.432 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.43 -24.64 64.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.373 0.669 . . . . 0.0 112.095 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.514 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 9.1 ptp180 -67.91 -48.08 67.0 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.701 ' HA ' HD12 ' A' ' 73' ' ' ILE . 21.2 m -73.15 -26.19 61.11 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.087 0.555 . . . . 0.0 112.343 -178.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.442 ' HA ' HD22 ' A' ' 52' ' ' ASN . 52.1 mt-30 -70.34 -26.96 63.99 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.668 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -96.71 17.66 16.05 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.58 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 70' ' ' CYS . 52.1 mt -120.97 139.63 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.818 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.45 154.53 20.7 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.731 HD13 HD12 ' A' ' 128' ' ' ILE . 24.2 mm -102.02 153.12 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.805 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.711 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -117.97 155.21 30.64 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.64 121.23 28.87 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 117.684 0.22 . . . . 0.0 110.59 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -104.04 -23.6 8.07 Favored Glycine 0 C--N 1.346 1.137 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.888 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.7 -168.36 33.81 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.043 -0.598 . . . . 0.0 113.315 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -88.58 -13.09 3.48 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 123.545 2.83 . . . . 0.0 114.394 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 t -83.41 129.8 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.099 0.249 . . . . 0.0 111.162 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 44.25 86.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.635 1.174 . . . . 0.0 113.392 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.6 p -82.72 -13.88 55.56 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.085 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.05 -17.59 58.66 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.805 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -132.58 148.87 52.38 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.089 0.471 . . . . 0.0 111.908 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.614 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.71 159.75 13.66 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.429 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.3 m-85 -96.14 151.71 19.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.721 -1.24 . . . . 0.0 110.854 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 t -128.35 102.91 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 126' ' ' SER . 0.3 OUTLIER -102.37 127.69 49.27 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.869 -179.216 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -130.07 164.42 40.78 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.499 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.681 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.5 Cg_endo -97.08 19.78 0.46 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.647 2.231 . . . . 0.0 113.78 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.8 t -106.4 158.52 16.83 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.59 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.85 22.82 33.92 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.717 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 95' ' ' SER . 2.8 tt -90.73 149.58 21.97 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.521 0.329 . . . . 0.0 110.435 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.592 ' HA ' HG21 ' A' ' 99' ' ' THR . 27.5 m -126.22 155.51 41.71 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.054 0.454 . . . . 0.0 112.093 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.538 ' CE2' HG23 ' A' ' 113' ' ' VAL . 53.6 m-85 -126.55 -150.4 0.44 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.846 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.417 ' HB2' ' OG ' ' A' ' 110' ' ' SER . 5.4 mm100 -58.4 -47.29 84.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.61 0.364 . . . . 0.0 111.491 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 63.2 m -133.05 81.05 1.92 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.964 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 107' ' ' MET . 44.7 m -127.98 120.06 26.78 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.04 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -103.06 122.42 44.62 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.911 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.24 125.47 30.35 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.773 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -121.47 55.29 1.09 Allowed 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.232 1.015 . . . . 0.0 110.626 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.87 -114.35 5.53 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.259 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.5 -3.44 6.25 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.479 HD21 ' OH ' ' A' ' 31' ' ' TYR . 3.5 pp -147.78 157.02 43.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.19 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -120.44 158.59 26.87 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.368 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.611 ' O ' ' HA ' ' A' ' 99' ' ' THR . 25.6 ttm -124.56 132.14 53.46 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.631 ' HB3' HG11 ' A' ' 113' ' ' VAL . 49.2 m -133.95 130.99 38.49 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.9 p -124.37 18.82 8.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.433 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.679 ' O ' HG12 ' A' ' 113' ' ' VAL . 19.0 t -90.66 133.97 34.74 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.92 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.467 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 5.7 mt-30 -62.35 -26.37 68.41 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.473 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.28 -41.96 93.66 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.496 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.742 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.5 p -71.49 -37.58 64.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 tp -58.89 -47.12 86.09 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 123.511 0.507 . . . . 0.0 110.198 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.467 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 18.4 m-85 -68.5 -40.91 80.67 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.837 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.68 -52.6 64.44 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.385 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.742 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.4 tp -64.82 -44.23 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.718 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.447 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.54 -32.33 65.03 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 123.745 0.653 . . . . 0.0 109.679 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.514 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.56 -20.17 31.94 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.396 176.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.08 16.2 28.59 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.698 -1.137 . . . . 0.0 114.544 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.9 p -107.55 7.96 29.02 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.01 -138.28 9.04 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 119.213 -0.77 . . . . 0.0 112.747 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.75 168.46 15.87 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.191 2.594 . . . . 0.0 113.754 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.489 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -50.76 -58.83 4.96 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.363 1.065 . . . . 0.0 111.748 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.681 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.4 mmtt -141.3 139.93 33.74 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.797 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 36.7 p -137.02 168.05 20.33 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 tp -128.27 117.07 20.84 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.81 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.808 HD13 HD12 ' A' ' 53' ' ' LEU . 11.5 pt -98.18 103.88 15.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-O 121.415 0.626 . . . . 0.0 109.639 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.0 t -121.37 120.09 34.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.014 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 tp -67.1 115.6 6.98 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.601 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 169.82 11.28 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.405 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -128.42 171.97 11.55 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.278 0.561 . . . . 0.0 110.803 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -108.86 130.89 55.42 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.05 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.5 142.67 13.83 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.387 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.446 ' HH2' HG21 ' A' ' 30' ' ' THR . 17.4 m-90 -120.53 133.6 55.38 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.967 0.451 . . . . 0.0 110.391 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -82.12 158.86 23.52 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.181 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.77 124.37 9.63 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.364 0.415 . . . . 0.0 111.705 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.57 -26.76 8.72 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.036 -0.602 . . . . 0.0 114.35 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -58.27 -49.03 78.58 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.58 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.7 tm? -66.23 -48.96 68.85 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.983 0.177 . . . . 0.0 110.772 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.86 -31.12 66.37 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 120.927 0.394 . . . . 0.0 110.827 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.18 -50.09 50.69 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.086 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.45 -26.62 62.8 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.966 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.1 tp -75.22 -38.48 60.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.427 0.691 . . . . 0.0 110.668 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.0 m -77.93 -29.65 50.09 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.34 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.8 t70 -81.43 -1.13 44.58 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.615 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 60.5 30.31 19.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.879 0.872 . . . . 0.0 111.402 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.73 -42.17 18.35 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.984 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -126.71 115.86 20.06 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.7 tp -86.78 145.3 26.69 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.514 0.197 . . . . 0.0 111.225 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.4 p -105.31 137.0 43.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.964 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 71.1 m -152.12 149.76 24.03 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.598 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.5 158.47 19.27 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.39 2.06 . . . . 0.0 111.247 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.462 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.67 167.22 19.14 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -177.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -133.39 135.64 25.7 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 114.132 -1.395 . . . . 0.0 107.85 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.82 -26.76 13.09 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.61 2.207 . . . . 0.0 114.013 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.77 -40.55 63.25 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.759 0.662 . . . . 0.0 112.104 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.596 HG21 HH11 ' A' ' 167' ' ' ARG . 4.5 mt -70.95 -34.71 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.24 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.3 tt -74.0 -38.62 64.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.654 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.412 ' HE1' ' O ' ' A' ' 89' ' ' LEU . 44.7 m-85 -88.0 -31.1 19.51 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -85.57 -71.73 0.52 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.215 0.461 . . . . 0.0 111.451 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.892 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.43 98.59 5.94 Favored Pre-proline 0 C--N 1.35 0.609 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.852 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 59.3 Cg_endo -91.99 0.35 4.27 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 121.602 1.535 . . . . 0.0 114.206 175.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.643 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 78.7 Cg_endo -74.19 -53.78 0.11 Allowed 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 122.546 2.164 . . . . 0.0 114.461 -178.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.546 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -121.09 -29.66 4.51 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.61 -178.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.892 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.8 tt0 -70.27 -11.49 60.94 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.382 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.794 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.04 -40.2 47.25 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.325 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -72.02 -49.9 32.98 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.8 m -58.92 -47.36 85.31 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.55 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.673 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.79 -40.69 92.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.158 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.82 -46.28 78.12 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 123.488 0.492 . . . . 0.0 110.472 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.21 90.28 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.428 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.82 -27.29 68.14 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.66 177.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.76 -40.21 41.64 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 122.832 0.453 . . . . 0.0 110.306 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.84 -30.28 63.89 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.408 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 102.17 56.67 0.83 Allowed Glycine 0 C--N 1.339 0.745 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.817 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.5 t -126.06 151.52 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -86.77 78.68 9.04 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.73 0.776 . . . . 0.0 110.92 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 -26.23 49.11 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.892 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.7 t -59.64 -42.66 93.25 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.54 -26.54 51.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 15.9 mt -76.09 -37.69 57.88 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.318 0.386 . . . . 0.0 111.816 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.6 p -92.89 -47.74 6.88 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.281 0.363 . . . . 0.0 111.367 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 57.87 118.73 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.221 1.008 . . . . 0.0 112.824 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -112.0 148.25 34.2 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.62 132.67 44.8 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.135 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 152.8 77.54 0.02 OUTLIER Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -128.48 138.34 52.24 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.652 0.266 . . . . 0.0 110.89 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.501 -0.761 . . . . 0.0 111.094 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.462 0.173 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -100.19 130.28 46.3 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.764 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -128.8 -54.67 1.22 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.138 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.8 m -141.86 -53.68 0.44 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.252 0.345 . . . . 0.0 111.164 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.2 m -137.76 95.08 11.24 Favored Pre-proline 0 CA--C 1.544 0.722 0 O-C-N 123.269 0.356 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -88.83 7.27 4.36 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.835 2.357 . . . . 0.0 112.095 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -95.09 -47.48 6.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.145 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -107.63 156.2 19.31 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 123.7 0.625 . . . . 0.0 111.547 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.487 HD12 ' CE1' ' A' ' 35' ' ' HIS . 19.4 mt -91.92 47.27 1.33 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.655 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -89.22 17.3 6.14 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.529 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 19.0 p80 172.2 58.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.351 1.06 . . . . 0.0 110.108 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -137.19 161.61 35.71 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.465 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.485 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 18.9 m-30 -97.76 136.95 37.37 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.81 HD11 HD23 ' A' ' 32' ' ' LEU . 3.7 mt -108.28 140.18 41.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.949 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 150' ' ' LEU . 2.9 mp -120.62 135.73 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 123.462 0.476 . . . . 0.0 110.02 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.14 125.61 29.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.048 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.9 mtt -110.34 157.44 38.12 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.206 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.21 30.16 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.63 2.22 . . . . 0.0 113.213 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -86.72 -17.02 34.69 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.29 -167.13 1.15 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.094 0.246 . . . . 0.0 110.597 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.531 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.09 40.33 1.47 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.102 0.477 . . . . 0.0 111.764 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -112.19 80.33 3.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.915 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.4 Cg_exo -75.45 -23.12 13.38 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 123.036 2.491 . . . . 0.0 113.315 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -84.54 -34.93 23.15 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.825 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.94 3.92 53.34 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.048 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.16 163.87 19.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.815 0.341 . . . . 0.0 111.761 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 49.23 31.79 3.88 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.0 p -117.53 154.25 31.8 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.753 HG11 ' HE ' ' A' ' 167' ' ' ARG . 96.4 t -128.93 134.2 64.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.487 0.661 . . . . 0.0 110.857 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.2 m -114.66 153.67 29.79 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.914 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.466 ' OH ' HD21 ' A' ' 105' ' ' LEU . 43.3 t80 -106.82 118.54 36.94 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.81 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.44 109.97 17.15 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.255 0.55 . . . . 0.0 111.139 -178.601 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.918 HG23 ' HA2' ' A' ' 42' ' ' GLY . 38.1 t -71.35 -64.73 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.397 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -133.8 117.25 16.66 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.583 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.487 ' CE1' HD12 ' A' ' 9' ' ' LEU . 12.1 t-80 -102.46 126.8 49.62 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.466 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -139.25 152.01 46.96 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.08 -13.14 59.54 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.042 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -107.77 3.13 24.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.306 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.07 166.27 15.16 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.424 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -148.5 145.29 27.85 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.86 138.0 53.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.17 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.918 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.43 158.94 29.72 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.451 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.439 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.1 mt -112.77 131.89 55.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.042 0.421 . . . . 0.0 111.196 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 78' ' ' GLY . 15.9 t -66.04 123.43 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.69 55.07 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.598 0.713 . . . . 0.0 112.224 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.851 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.0 t30 -147.55 -3.24 0.55 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.116 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.72 87.03 53.64 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.537 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -60.27 147.29 94.19 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 121.695 1.597 . . . . 0.0 112.721 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.414 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 66.1 m -92.39 160.13 15.24 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.85 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.02 -2.19 64.64 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 116.144 -0.48 . . . . 0.0 113.711 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.477 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -90.16 152.78 20.95 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.731 0.3 . . . . 0.0 111.28 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 71' ' ' GLN . 17.1 p-10 -101.33 164.85 11.58 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.155 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.64 ' HA ' HD11 ' A' ' 75' ' ' ILE . 13.4 tp -60.26 -28.19 67.85 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 120.802 0.334 . . . . 0.0 111.739 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.55 98.79 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -63.99 -46.52 84.19 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.082 0.239 . . . . 0.0 111.625 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.865 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.5 m -61.91 -44.96 99.61 Favored 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.739 ' HA ' HD12 ' A' ' 60' ' ' LEU . 11.6 mt -56.58 -34.5 67.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.598 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.18 -27.5 48.01 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.317 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.85 -30.7 51.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.248 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.865 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.8 mt -77.87 -46.1 22.33 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.81 -1.541 . . . . 0.0 110.987 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -130.26 115.9 17.54 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -77.6 -32.9 2.59 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.589 2.859 . . . . 0.0 112.757 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.63 -14.91 56.12 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.291 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.43 150.38 23.82 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.355 0.409 . . . . 0.0 111.709 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.79 122.82 28.87 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.175 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.67 149.0 42.71 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.409 2.073 . . . . 0.0 112.25 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.412 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 9.1 Cg_endo -94.86 -171.79 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.57 2.18 . . . . 0.0 112.6 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -24.5 67.58 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.116 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 7.8 ptp180 -68.55 -49.15 61.71 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.713 ' HA ' HD12 ' A' ' 73' ' ' ILE . 19.0 m -74.17 -26.03 60.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.083 0.553 . . . . 0.0 112.425 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.451 ' HA ' HD22 ' A' ' 52' ' ' ASN . 53.0 mt-30 -68.53 -27.54 66.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.949 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -97.51 18.85 14.45 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.439 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.713 HD12 ' HA ' ' A' ' 70' ' ' CYS . 65.0 mt -119.64 140.07 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.941 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -107.18 154.34 21.34 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.819 0.7 . . . . 0.0 112.851 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.8 HD13 HD12 ' A' ' 128' ' ' ILE . 20.7 mm -102.98 156.74 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.168 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.712 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -121.58 155.23 35.5 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.63 121.06 27.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 117.763 0.256 . . . . 0.0 110.471 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.571 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.97 -23.67 8.06 Favored Glycine 0 C--N 1.348 1.213 0 C-N-CA 120.206 -0.997 . . . . 0.0 114.211 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.52 -167.88 34.15 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.431 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -88.46 -13.55 3.43 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.468 2.778 . . . . 0.0 114.376 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.61 127.03 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 123.086 0.241 . . . . 0.0 111.148 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 46.99 84.18 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.406 1.082 . . . . 0.0 113.203 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -85.86 1.23 50.66 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.415 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -92.86 -10.76 35.51 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.843 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -133.03 150.82 52.11 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.008 0.432 . . . . 0.0 112.108 -179.634 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.598 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -110.24 144.88 17.07 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.172 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.8 OUTLIER -86.75 146.12 26.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.923 -1.139 . . . . 0.0 110.525 179.248 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.46 103.71 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 123.601 0.563 . . . . 0.0 109.949 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.872 HD11 HD13 ' A' ' 105' ' ' LEU . 11.4 tp -107.65 127.98 54.14 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.127 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -126.67 168.72 13.66 Favored Pre-proline 0 CA--C 1.556 1.196 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.663 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.684 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.11 17.44 0.6 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.75 2.3 . . . . 0.0 113.691 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 t -105.31 159.49 15.85 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.808 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.84 19.58 54.19 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.752 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mp -85.24 154.59 21.85 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.585 0.354 . . . . 0.0 110.912 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.2 p -125.49 156.95 38.15 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CE2' HG23 ' A' ' 113' ' ' VAL . 56.7 m-85 -130.0 -149.3 0.4 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.495 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -60.41 -45.69 92.68 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.406 0.283 . . . . 0.0 111.323 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.3 m -137.09 85.24 2.12 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.492 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 107' ' ' MET . 13.8 m -129.89 129.16 43.55 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.712 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -112.42 123.21 49.79 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.871 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.93 125.12 29.33 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.447 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -135.09 76.96 1.65 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.973 0.892 . . . . 0.0 112.041 -177.689 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.592 ' O ' ' HG2' ' A' ' 104' ' ' GLU . . . 43.25 104.88 0.01 OUTLIER Glycine 0 N--CA 1.475 1.279 0 CA-C-N 113.677 -1.601 . . . . 0.0 114.823 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 103' ' ' GLY . 10.4 pt-20 61.36 -15.86 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.777 1.231 . . . . 0.0 113.25 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.872 HD13 HD11 ' A' ' 89' ' ' LEU . 2.7 pp -132.88 145.56 51.04 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 120.806 0.336 . . . . 0.0 110.451 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.578 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -114.84 155.46 26.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.986 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 99' ' ' THR . 16.9 ttm -121.66 128.96 52.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.649 ' HB3' HG11 ' A' ' 113' ' ' VAL . 49.9 m -128.57 129.64 46.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 p -119.65 16.39 12.8 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.311 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.705 ' O ' HG12 ' A' ' 113' ' ' VAL . 45.0 p -91.17 131.0 36.99 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 121.737 0.78 . . . . 0.0 112.439 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.491 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.7 pt20 -61.43 -27.74 68.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.3 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.17 -43.42 95.19 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.484 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.6 p -69.56 -36.4 70.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.46 HD13 HH12 ' A' ' 85' ' ' ARG . 5.4 tp -58.64 -49.43 77.56 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 123.472 0.482 . . . . 0.0 110.372 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.491 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 31.8 m-85 -68.19 -38.74 82.31 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.907 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.1 -52.74 63.64 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.269 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.48 -43.83 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.672 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.6 -32.59 65.4 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.714 0.634 . . . . 0.0 109.579 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.477 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.71 -19.53 32.61 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.316 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.62 14.99 33.13 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.748 -1.114 . . . . 0.0 114.739 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.9 p -104.88 6.53 33.84 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.52 -138.29 9.59 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.169 -0.795 . . . . 0.0 112.515 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.25 172.99 12.16 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 123.128 2.552 . . . . 0.0 113.611 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.61 -55.0 40.46 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.966 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.684 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.9 mmtt -141.63 139.93 33.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.843 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 67.3 m -137.67 166.83 22.99 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tp -125.38 116.46 21.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.601 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.8 HD12 HD13 ' A' ' 75' ' ' ILE . 9.8 pt -99.15 102.57 13.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 O-C-N 123.82 0.7 . . . . 0.0 109.45 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -120.26 120.78 37.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.031 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.08 112.86 4.63 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.488 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.66 171.54 19.13 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.88 -1.055 . . . . 0.0 114.405 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.38 176.12 7.96 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.099 -0.55 . . . . 0.0 110.397 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -115.36 131.01 57.06 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.161 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.94 150.26 18.72 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.549 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.424 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 26.4 m-90 -127.78 136.12 51.05 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 123.902 0.413 . . . . 0.0 110.408 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.08 158.07 26.52 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.922 0.764 . . . . 0.0 110.725 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.27 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.43 -24.84 7.15 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 115.408 -0.815 . . . . 0.0 113.042 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.71 -45.46 85.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.968 0.507 . . . . 0.0 112.28 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.04 -48.25 66.15 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.187 0.304 . . . . 0.0 110.594 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.63 -29.39 67.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.98 0.419 . . . . 0.0 110.715 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.4 -50.42 38.87 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.84 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.35 -26.67 63.85 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.847 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.1 tp -76.02 -37.87 57.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.745 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.5 t -77.78 -29.03 50.7 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.202 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -82.64 0.21 44.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.395 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 59.64 29.51 19.08 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.944 0.897 . . . . 0.0 111.507 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.76 -42.76 19.31 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.949 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -124.52 113.65 18.38 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.2 tp -85.04 139.49 31.71 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.634 0.254 . . . . 0.0 111.371 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.5 p -104.46 137.85 41.72 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.047 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 74.3 m -151.69 154.95 33.74 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.816 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.76 153.26 51.16 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.314 2.009 . . . . 0.0 111.074 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.485 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.42 166.37 18.85 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -133.66 135.9 25.78 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.207 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.433 ' HG3' ' OE1' ' A' ' 104' ' ' GLU . 72.6 Cg_endo -73.51 -26.44 14.08 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.553 2.168 . . . . 0.0 113.684 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.11 62.17 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.9 0.75 . . . . 0.0 112.157 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.589 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.7 mt -72.31 -34.87 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.328 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.35 -36.16 63.59 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.277 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -85.28 -36.87 20.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.65 -71.96 0.48 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 117.927 0.331 . . . . 0.0 111.786 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -142.29 98.97 5.97 Favored Pre-proline 0 C--N 1.349 0.544 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.851 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.2 Cg_endo -91.8 0.21 4.39 Favored 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 121.652 1.568 . . . . 0.0 114.319 175.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.641 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 66.2 Cg_endo -75.46 -50.67 0.12 Allowed 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.609 2.206 . . . . 0.0 114.607 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.516 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.4 mt-10 -121.44 -34.06 3.52 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.731 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 9.0 mt-10 -69.04 -10.77 59.23 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.135 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.753 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.06 -41.57 41.86 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.217 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.8 tp -70.65 -49.98 41.6 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.8 m -58.5 -48.76 79.74 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.637 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.677 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.31 -40.19 95.41 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.148 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.46 78.25 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.568 0.542 . . . . 0.0 110.435 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.45 91.22 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.423 177.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.25 68.3 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.676 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.677 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.82 -39.93 42.09 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 122.823 0.449 . . . . 0.0 110.327 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.83 -31.85 68.71 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.376 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.68 54.81 0.56 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.834 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 12.5 t -127.57 147.36 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -86.81 77.75 9.21 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.676 0.751 . . . . 0.0 110.622 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -26.18 49.81 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.029 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.7 m -58.81 -41.95 87.99 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.59 -26.67 50.94 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 18.0 mt -77.14 -38.12 52.56 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.8 p -94.31 -48.35 6.2 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.277 0.361 . . . . 0.0 111.397 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 57.76 118.75 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.173 0.989 . . . . 0.0 112.74 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -100.81 147.08 26.48 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.04 140.23 34.57 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.078 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -150.92 -96.48 0.15 Allowed Glycine 0 C--N 1.337 0.595 0 O-C-N 123.691 0.619 . . . . 0.0 112.5 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -99.47 -40.46 7.84 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.602 0.237 . . . . 0.0 111.279 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.167 -0.92 . . . . 0.0 111.081 -179.94 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.262 0.077 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -100.34 131.33 46.33 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.425 0.453 . . . . 0.0 111.041 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -99.59 -41.41 7.35 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.188 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 m -99.14 153.0 19.24 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.99 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.9 m -93.35 104.25 11.82 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.047 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -86.36 6.79 5.27 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.821 2.347 . . . . 0.0 112.249 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.8 m -109.14 -53.65 2.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.606 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -114.75 151.39 33.81 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.389 0.431 . . . . 0.0 111.427 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.1 55.07 0.73 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.552 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -91.89 17.21 9.5 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.765 0.317 . . . . 0.0 111.396 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 175.99 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.845 0.858 . . . . 0.0 110.474 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -136.95 158.97 43.25 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.305 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 30' ' ' THR . 13.7 m-30 -98.42 136.15 38.97 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.679 HD11 HD23 ' A' ' 32' ' ' LEU . 6.2 mt -105.39 139.2 40.38 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.936 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -120.15 132.53 69.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 123.572 0.545 . . . . 0.0 109.636 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.23 120.57 18.01 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.926 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.8 mmt -103.22 155.24 36.96 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.166 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -82.9 32.92 0.52 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.669 2.246 . . . . 0.0 112.965 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -87.01 -13.28 44.91 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.254 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -169.52 1.83 Allowed 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.984 0.178 . . . . 0.0 110.876 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.543 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -105.09 42.19 1.25 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.079 0.466 . . . . 0.0 111.583 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -111.58 80.72 2.88 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.88 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.1 Cg_exo -75.49 -16.99 18.87 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.081 2.521 . . . . 0.0 113.404 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -84.56 -38.41 20.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.845 0.458 . . . . 0.0 111.875 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.23 3.88 53.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.175 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.97 162.77 21.25 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.803 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 49.39 33.36 5.38 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.9 p -119.96 154.0 35.12 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 120.562 0.22 . . . . 0.0 110.445 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.621 HG11 ' HE ' ' A' ' 167' ' ' ARG . 99.8 t -129.41 134.95 62.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.503 0.668 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.3 m -116.91 155.26 29.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.875 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.422 ' OH ' HD11 ' A' ' 105' ' ' LEU . 22.6 t80 -109.67 117.34 33.65 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.749 HD11 ' HB1' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -77.46 108.14 10.4 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 123.499 0.5 . . . . 0.0 110.943 -179.17 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.945 HG23 ' HA2' ' A' ' 42' ' ' GLY . 51.8 t -66.29 -58.74 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.409 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -144.39 122.5 12.15 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.235 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -100.52 129.12 46.43 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.987 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -139.6 152.07 46.53 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.591 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.03 -22.63 66.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.657 0.383 . . . . 0.0 112.0 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -94.12 -5.35 47.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.346 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.94 176.16 27.76 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 121.579 -0.343 . . . . 0.0 112.333 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.749 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -148.57 148.29 30.0 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.416 ' O ' HD13 ' A' ' 32' ' ' LEU . 1.1 tpp -121.67 136.45 54.94 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.105 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.945 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -156.4 159.56 29.54 Favored Glycine 0 N--CA 1.447 -0.614 0 O-C-N 124.409 1.068 . . . . 0.0 112.446 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.451 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.2 mt -113.71 131.34 56.21 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.118 0.459 . . . . 0.0 111.365 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 78' ' ' GLY . 7.9 t -66.62 121.77 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.87 54.82 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.561 0.696 . . . . 0.0 112.377 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.855 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.1 t30 -147.96 -2.31 0.55 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.09 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -130.21 88.03 49.23 Favored Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.529 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 42.9 Cg_exo -59.08 145.04 99.02 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 121.648 1.565 . . . . 0.0 112.412 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.433 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 71.5 m -94.57 161.06 14.36 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.41 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.89 51.34 0.97 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.806 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' C ' HG12 ' A' ' 75' ' ' ILE . 1.1 mt -133.48 156.33 47.94 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 123.86 0.388 . . . . 0.0 110.044 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.509 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 20.3 p-10 -112.7 159.67 18.68 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.836 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.474 HD13 HD13 ' A' ' 128' ' ' ILE . 14.3 tp -59.15 -28.28 66.44 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.08 96.77 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.39 -45.47 87.54 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.068 0.23 . . . . 0.0 111.559 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.874 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 16.7 m -62.45 -44.5 99.33 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.712 ' HA ' HD12 ' A' ' 60' ' ' LEU . 13.3 mt -57.48 -33.85 68.43 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.552 177.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -78.25 -27.92 47.64 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.27 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.87 -30.96 51.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.297 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.874 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.1 mt -77.85 -45.62 23.8 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.851 -1.522 . . . . 0.0 111.113 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -130.34 115.83 17.44 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.623 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.7 -32.91 2.53 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.664 2.91 . . . . 0.0 112.759 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.66 -14.91 56.05 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.423 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.63 149.91 23.99 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.401 0.438 . . . . 0.0 111.679 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.14 123.0 29.13 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.232 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.03 149.7 36.94 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.318 2.012 . . . . 0.0 112.389 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.409 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 9.5 Cg_endo -95.1 -171.61 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.576 2.184 . . . . 0.0 112.532 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.29 -24.52 67.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.294 0.638 . . . . 0.0 112.007 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 73' ' ' ILE . 9.8 ptp180 -68.72 -47.93 65.11 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.709 ' HA ' HD12 ' A' ' 73' ' ' ILE . 25.5 m -74.51 -25.91 59.65 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.555 0.535 . . . . 0.0 112.38 -178.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.446 ' HA ' HD22 ' A' ' 52' ' ' ASN . 53.0 mt-30 -69.5 -26.97 64.8 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.797 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -97.36 20.46 11.54 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.497 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 70' ' ' CYS . 59.4 mt -122.16 138.97 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.737 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -104.34 164.17 11.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.471 HG12 ' C ' ' A' ' 51' ' ' LEU . 13.6 mm -114.17 152.45 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.822 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.728 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -115.81 156.09 26.69 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.482 0.313 . . . . 0.0 110.429 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.36 119.92 27.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.615 0.189 . . . . 0.0 110.623 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.566 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.78 -23.45 8.72 Favored Glycine 0 C--N 1.346 1.1 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.884 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.99 -168.29 32.92 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.371 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -88.42 -13.9 3.35 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.513 2.809 . . . . 0.0 114.356 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.73 131.04 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 123.119 0.262 . . . . 0.0 111.29 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 47.79 83.14 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.366 1.066 . . . . 0.0 113.09 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -84.07 1.03 45.95 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.348 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -93.77 -18.4 22.11 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.634 ' CZ ' ' H ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.2 147.37 52.02 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.968 0.413 . . . . 0.0 111.562 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.634 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -112.65 152.69 17.82 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.646 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.45 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 1.2 m-85 -86.33 153.86 21.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.352 1.061 . . . . 0.0 111.174 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 3.7 t -127.85 103.65 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.666 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.648 ' O ' ' HA ' ' A' ' 126' ' ' SER . 0.3 OUTLIER -98.28 127.39 44.19 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.652 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -129.1 160.76 62.08 Favored Pre-proline 0 CA--C 1.552 1.03 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.614 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 27.2 Cg_endo -99.58 33.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.916 2.41 . . . . 0.0 113.468 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.3 t -118.13 159.08 23.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.749 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.58 21.15 47.65 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.646 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.28 153.62 21.07 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.556 0.342 . . . . 0.0 110.58 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.0 p -122.94 153.58 39.52 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.653 ' CD2' HG12 ' A' ' 113' ' ' VAL . 27.8 m-85 -131.93 -150.98 0.44 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.733 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -62.4 -48.62 78.89 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 122.507 0.323 . . . . 0.0 111.103 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.7 m -132.68 78.41 1.8 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.324 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 107' ' ' MET . 11.1 m -126.49 115.44 19.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.616 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.01 123.45 44.26 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.803 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -83.47 127.48 33.74 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.318 0.58 . . . . 0.0 110.859 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.496 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -120.33 50.01 1.36 Allowed 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.567 -179.422 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.29 -109.62 3.01 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 114.579 -1.191 . . . . 0.0 113.41 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' OE1' ' HD3' ' A' ' 156' ' ' PRO . 10.8 pt-20 -63.1 -6.85 4.56 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.422 HD11 ' OH ' ' A' ' 31' ' ' TYR . 3.3 pp -152.08 160.01 43.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -122.58 158.84 29.04 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' ' 99' ' ' THR . 19.1 ttm -124.48 134.76 52.94 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.7 m -135.65 133.24 37.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.1 p -126.37 21.83 7.19 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.316 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.871 ' O ' HG22 ' A' ' 113' ' ' VAL . 10.7 t -89.26 130.31 35.68 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.13 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.492 ' HA ' HD12 ' A' ' 114' ' ' LEU . 21.2 pt20 -60.33 -28.3 68.03 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.554 0.692 . . . . 0.0 109.608 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -63.63 -44.7 93.12 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.925 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.871 HG22 ' O ' ' A' ' 110' ' ' SER . 18.7 m -62.01 -42.64 95.65 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 111' ' ' GLN . 31.4 mt -54.66 -52.19 63.09 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.795 0.685 . . . . 0.0 111.992 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.461 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 50.2 m-85 -64.86 -46.05 83.47 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.329 0.393 . . . . 0.0 111.585 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.83 63.89 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.839 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.5 tp -63.84 -43.92 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.92 -30.68 66.12 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.797 0.685 . . . . 0.0 109.762 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.63 -19.99 30.16 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.023 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.63 19.04 21.47 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.68 -1.145 . . . . 0.0 114.636 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.8 p -111.03 9.09 22.11 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.91 -137.78 9.42 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-O 119.256 -0.747 . . . . 0.0 112.756 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.72 167.65 22.13 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.284 2.656 . . . . 0.0 113.509 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.488 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -49.65 -58.19 5.74 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.378 1.071 . . . . 0.0 111.754 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.519 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -138.76 154.61 48.53 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 66.3 m -149.63 163.96 36.47 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 2.3 tp -130.31 115.08 16.43 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.883 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 73' ' ' ILE . 11.1 pt -98.03 107.86 20.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.399 0.618 . . . . 0.0 109.508 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 60.1 p -125.4 122.13 35.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.762 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.1 tp -67.5 117.51 9.55 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.604 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.444 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 70.05 167.69 6.43 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.183 -0.917 . . . . 0.0 114.271 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -128.5 174.16 9.6 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.157 0.503 . . . . 0.0 110.958 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -109.98 132.23 54.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.497 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.58 144.34 15.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.496 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -122.49 133.63 54.59 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.961 0.448 . . . . 0.0 110.585 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.77 158.95 23.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.321 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.57 125.42 11.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.746 0.418 . . . . 0.0 111.81 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.01 -26.45 7.64 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.119 -0.562 . . . . 0.0 114.475 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -58.3 -49.1 78.38 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.574 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.6 tm? -66.34 -49.36 67.2 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.0 0.188 . . . . 0.0 110.807 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.45 -31.59 66.07 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.472 0.482 . . . . 0.0 110.567 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -68.83 -50.12 52.69 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.157 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.86 -26.73 62.47 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.059 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.8 tp -75.34 -38.19 60.29 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.673 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.5 m -77.95 -29.99 50.16 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.291 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -81.46 -1.02 44.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.577 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 60.29 30.1 19.55 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.779 0.832 . . . . 0.0 111.658 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.22 -43.04 18.15 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.93 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -125.36 114.76 19.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.7 tp -86.24 138.53 31.79 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.0 p -101.75 137.52 39.94 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.488 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.6 m -149.95 146.19 20.01 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-O 119.192 -0.433 . . . . 0.0 111.4 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.27 148.18 91.0 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 122.286 1.991 . . . . 0.0 110.584 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.487 ' HA ' ' CZ ' ' A' ' 174' ' ' ARG . . . -134.11 176.32 8.69 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 -176.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -132.26 142.17 44.04 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 113.549 -1.66 . . . . 0.0 108.671 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.418 ' HD3' ' OE1' ' A' ' 104' ' ' GLU . 92.3 Cg_endo -76.11 -26.51 9.14 Favored 'Trans proline' 0 C--N 1.364 1.392 0 C-N-CA 122.692 2.262 . . . . 0.0 114.177 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -49.77 -42.11 45.75 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.774 0.671 . . . . 0.0 112.448 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.73 HD13 HH12 ' A' ' 167' ' ' ARG . 4.6 mt -69.52 -32.65 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-O 121.492 0.663 . . . . 0.0 110.229 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.0 tt -75.81 -38.87 57.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.687 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.425 ' HE1' ' O ' ' A' ' 89' ' ' LEU . 42.8 m-85 -86.51 -29.7 22.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -87.02 -72.56 0.5 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.106 0.412 . . . . 0.0 111.378 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.897 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.18 98.73 6.07 Favored Pre-proline 0 C--N 1.348 0.514 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.855 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.4 Cg_endo -91.55 0.08 4.55 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 C-N-CA 121.657 1.571 . . . . 0.0 114.28 175.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.649 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 87.5 Cg_endo -74.11 -54.16 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.655 2.237 . . . . 0.0 114.445 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.549 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.1 mt-10 -121.05 -29.55 4.54 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.7 -177.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.897 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.6 tt0 -70.56 -11.24 60.8 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.417 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.73 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.66 -43.99 35.73 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.42 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -69.37 -50.21 48.28 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 m -57.65 -49.57 76.01 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.769 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.33 96.77 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.096 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.54 -46.61 80.56 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 123.637 0.586 . . . . 0.0 110.729 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.12 82.47 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.7 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.45 -31.44 72.61 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.446 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.487 ' CZ ' ' HA ' ' A' ' 154' ' ' ALA . 11.3 mtm-85 -77.55 -41.5 38.81 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.793 0.437 . . . . 0.0 110.548 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.48 -34.1 77.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.676 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 123.47 44.78 0.3 Allowed Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.017 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 6.9 t -128.58 138.71 53.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -89.56 80.81 6.6 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.653 0.74 . . . . 0.0 110.836 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -77.94 -26.3 48.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.252 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.8 m -59.12 -44.1 91.99 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.53 -26.56 51.14 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.9 mt -76.97 -36.36 56.55 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.334 0.396 . . . . 0.0 111.922 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 24.1 p -94.21 -48.82 6.02 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.319 0.387 . . . . 0.0 111.247 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 57.33 118.27 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.211 1.004 . . . . 0.0 112.771 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -107.11 13.37 27.46 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.479 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.32 145.69 50.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.118 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -160.31 69.74 0.24 Allowed Glycine 0 C--N 1.338 0.681 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.558 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -128.36 141.55 51.39 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 123.625 0.25 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.117 179.966 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.565 0.221 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -108.83 130.4 55.4 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.015 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -100.87 -42.0 6.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.099 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.8 m -100.37 153.07 19.63 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 123.511 0.507 . . . . 0.0 110.944 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.8 t -92.23 106.53 18.26 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.41 7.91 4.86 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.722 2.281 . . . . 0.0 112.263 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.2 m -116.11 -53.52 2.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.776 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -110.94 152.22 27.02 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.654 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.454 ' O ' HD12 ' A' ' 32' ' ' LEU . 17.5 mt -97.22 50.64 1.08 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.988 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.422 ' NZ ' ' HG3' ' A' ' 34' ' ' GLU . 27.6 tttm -92.88 19.29 7.84 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.113 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 173.79 56.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.039 0.936 . . . . 0.0 109.641 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 153' ' ' PRO . 30.2 m80 -139.28 160.96 38.59 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.461 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 17.1 m-30 -99.09 137.44 37.6 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.057 0.456 . . . . 0.0 111.914 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.839 HD11 HD23 ' A' ' 32' ' ' LEU . 2.0 mt -108.16 140.97 40.59 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.202 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.55 137.21 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 123.352 0.407 . . . . 0.0 110.139 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.77 119.22 17.69 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.699 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 14.6 mmt -99.44 159.82 29.07 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.617 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.91 5.24 5.07 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.716 2.277 . . . . 0.0 113.652 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -77.34 -14.22 59.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.506 0.322 . . . . 0.0 111.856 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.724 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -104.4 154.98 19.18 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.264 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.44 48.67 1.41 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.253 0.549 . . . . 0.0 112.021 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.724 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.2 m-20 -125.05 89.66 52.27 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.626 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.54 -16.83 21.25 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.905 2.404 . . . . 0.0 113.388 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -84.47 -35.23 23.12 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 122.826 0.45 . . . . 0.0 111.772 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -93.41 3.96 54.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.045 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.49 163.21 21.52 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.847 0.356 . . . . 0.0 111.835 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 49.1 32.41 4.03 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.3 p -118.0 154.51 31.87 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 120.541 0.21 . . . . 0.0 110.694 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.784 HG11 ' HE ' ' A' ' 167' ' ' ARG . 60.7 t -129.76 133.15 65.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.773 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.2 m -113.74 153.57 28.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.759 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.429 ' OH ' HD21 ' A' ' 105' ' ' LEU . 33.4 t80 -107.66 116.82 32.63 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.839 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.38 109.52 16.7 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 121.457 0.646 . . . . 0.0 111.03 -178.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.938 HG23 ' HA2' ' A' ' 42' ' ' GLY . 29.6 t -70.22 -66.21 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.132 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' HG3' ' NZ ' ' A' ' 10' ' ' LYS . 6.6 tt0 -132.55 119.83 21.05 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.726 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -102.97 126.59 50.21 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.428 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -139.51 152.11 46.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.504 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.2 -19.56 65.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.832 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -97.73 -3.73 38.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.428 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.26 171.14 22.24 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 112.277 -0.329 . . . . 0.0 112.277 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.526 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -148.26 146.9 28.82 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -122.81 136.34 54.84 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.615 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.12 158.79 29.48 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.334 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.3 mt -114.75 133.72 55.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.055 0.427 . . . . 0.0 111.367 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 78' ' ' GLY . 14.9 t -67.69 123.21 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.6 54.55 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.57 0.7 . . . . 0.0 112.126 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.852 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.1 t30 -147.66 -3.21 0.54 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.156 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -129.67 87.24 53.17 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.515 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.6 Cg_exo -59.39 142.77 99.52 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 121.702 1.602 . . . . 0.0 112.252 175.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.432 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 62.4 m -91.72 158.27 16.47 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.479 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.29 50.52 1.3 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.842 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mt -133.55 158.04 44.15 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.743 0.417 . . . . 0.0 110.046 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.517 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.7 p-10 -112.07 158.98 18.93 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.204 0.315 . . . . 0.0 110.423 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 128' ' ' ILE . 12.7 tp -59.21 -36.16 74.9 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.08 -38.4 65.28 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -64.76 -40.2 94.88 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.36 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.847 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.0 t -61.8 -50.82 78.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.65 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.8 mp -52.31 -36.38 53.01 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.978 0.799 . . . . 0.0 111.099 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.94 -29.18 49.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.451 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -31.72 46.55 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.713 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.847 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 11.5 mt -77.56 -44.63 27.9 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.833 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -131.93 116.8 15.87 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.479 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.49 -33.11 2.57 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.585 2.857 . . . . 0.0 112.844 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.2 -13.79 56.58 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.388 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.42 149.62 24.33 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.291 0.37 . . . . 0.0 111.721 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.68 123.72 29.5 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.972 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.97 143.84 29.66 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.271 1.981 . . . . 0.0 112.414 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.1 Cg_endo -91.93 -169.65 0.28 Allowed 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.576 2.184 . . . . 0.0 111.85 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.23 -24.92 67.84 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.224 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.515 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.8 ptp180 -66.91 -51.61 53.29 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.711 ' HA ' HD12 ' A' ' 73' ' ' ILE . 58.2 m -72.46 -25.07 61.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 47.9 mt-30 -68.21 -34.84 77.01 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.434 ' CE1' ' HA ' ' A' ' 69' ' ' ARG . 14.5 p-80 -91.12 22.53 3.7 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.115 0.484 . . . . 0.0 111.649 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 70' ' ' CYS . 58.9 mt -119.22 139.44 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.312 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.59 157.05 17.97 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.625 HD13 HD12 ' A' ' 128' ' ' ILE . 22.5 mm -103.7 152.69 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.853 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.713 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -118.68 154.71 32.27 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -85.82 120.48 27.28 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.623 0.192 . . . . 0.0 110.649 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.33 -23.64 8.35 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 120.082 -1.056 . . . . 0.0 114.006 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.98 -167.62 34.34 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.324 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -88.16 -12.17 4.16 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 123.364 2.71 . . . . 0.0 114.136 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.47 126.35 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 123.094 0.246 . . . . 0.0 110.596 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 50.26 79.02 0.09 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.099 0.96 . . . . 0.0 112.46 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.466 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.5 t -83.01 1.57 39.3 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.554 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -102.63 2.74 36.39 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.477 HH21 ' HB3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -133.07 154.62 50.38 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -179.386 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.47 128.58 9.02 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.778 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.64 144.82 27.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.436 1.095 . . . . 0.0 109.936 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.87 105.86 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.142 0.276 . . . . 0.0 110.963 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.82 HD11 HD13 ' A' ' 105' ' ' LEU . 10.9 tp -107.57 127.82 53.98 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -123.35 164.35 28.55 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.762 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 12.4 Cg_endo -94.86 14.62 1.25 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.659 2.239 . . . . 0.0 113.615 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.1 t -101.81 157.52 16.79 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.73 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.12 20.98 48.38 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.631 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -85.66 154.7 21.49 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.611 0.364 . . . . 0.0 110.321 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.6 p -118.89 151.89 37.3 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.668 ' CD2' HG12 ' A' ' 113' ' ' VAL . 18.2 m-85 -130.68 -150.59 0.43 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.469 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -62.05 -47.6 83.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.775 0.321 . . . . 0.0 111.065 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 108' ' ' SER . 66.7 m -135.12 81.22 1.88 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.136 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 107' ' ' MET . 19.2 m -127.48 119.45 26.1 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.412 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -105.0 122.11 45.18 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.96 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -79.3 124.24 28.21 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.462 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -136.43 77.85 1.67 Allowed 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.862 0.839 . . . . 0.0 111.829 -177.882 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.578 ' O ' ' HG2' ' A' ' 104' ' ' GLU . . . 44.33 103.0 0.01 OUTLIER Glycine 0 N--CA 1.474 1.223 0 CA-C-N 113.679 -1.6 . . . . 0.0 114.676 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 103' ' ' GLY . 10.7 pt-20 60.75 -14.72 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.85 1.26 . . . . 0.0 113.426 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.82 HD13 HD11 ' A' ' 89' ' ' LEU . 2.8 pp -132.68 145.51 51.11 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-O 120.705 0.288 . . . . 0.0 110.486 178.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.614 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -114.8 155.61 26.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.056 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.584 ' O ' ' HA ' ' A' ' 99' ' ' THR . 15.2 ttm -120.33 122.15 40.2 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 98' ' ' SER . 51.0 m -121.25 129.59 53.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.209 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.1 p -119.43 22.12 11.86 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.886 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.815 ' O ' HG22 ' A' ' 113' ' ' VAL . 61.7 m -92.29 126.19 37.27 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.215 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.502 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 10.8 pt20 -59.9 -28.08 67.27 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.394 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.29 -49.15 76.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.872 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.843 ' O ' HG22 ' A' ' 117' ' ' ILE . 16.6 m -59.43 -40.44 81.71 Favored 'Isoleucine or valine' 0 C--N 1.361 1.068 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.6 tp -56.86 -54.06 50.8 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.684 0.615 . . . . 0.0 111.534 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.502 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 61.4 m-85 -67.02 -42.5 84.8 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.341 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.38 -51.7 68.79 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.542 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.843 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.15 -43.3 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.378 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.49 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -57.88 -30.26 65.7 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.893 0.745 . . . . 0.0 109.79 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.515 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -86.16 -19.92 29.37 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.09 176.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.15 15.65 29.96 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.696 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.4 p -107.22 8.42 29.95 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.95 -138.02 9.84 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.261 -0.744 . . . . 0.0 112.641 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.56 171.19 16.14 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 123.332 2.688 . . . . 0.0 113.557 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.481 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -51.11 -57.16 9.43 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.211 1.004 . . . . 0.0 111.604 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.5 mmtt -140.03 156.59 46.54 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.533 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 73.5 m -149.26 161.83 41.24 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.6 tp -126.61 115.7 19.88 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.326 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.648 HD13 HD13 ' A' ' 53' ' ' LEU . 13.3 pt -97.4 102.12 13.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.781 0.801 . . . . 0.0 109.685 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.5 t -119.36 121.86 40.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.606 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 83' ' ' THR . 8.9 tp -67.32 113.7 5.43 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.111 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.24 173.17 6.08 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-N 114.714 -1.13 . . . . 0.0 114.314 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -128.49 178.23 6.44 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.314 0.578 . . . . 0.0 110.73 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -114.23 129.54 56.63 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.151 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.61 147.56 17.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.37 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.413 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 29.6 m-90 -125.33 136.31 53.34 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 123.886 0.403 . . . . 0.0 110.35 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -80.19 158.27 26.32 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.901 0.751 . . . . 0.0 110.66 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.76 89.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.16 -23.79 7.57 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.161 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -56.58 -46.31 80.85 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.949 0.5 . . . . 0.0 112.231 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.573 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.4 tp -67.22 -47.88 69.51 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -57.35 -30.55 64.93 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.467 0.479 . . . . 0.0 110.77 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.19 -50.3 41.56 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.914 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.6 pt-20 -71.85 -26.7 62.47 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.924 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.0 tp -75.06 -39.23 61.02 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.833 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.5 m -78.14 -30.37 49.27 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.507 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.5 t70 -80.24 0.49 32.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.674 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 59.72 29.85 19.43 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.826 0.85 . . . . 0.0 111.645 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.32 -41.75 19.66 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.794 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -123.47 112.21 17.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.9 tp -84.13 138.37 33.06 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.533 0.206 . . . . 0.0 111.148 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.9 p -105.19 138.89 40.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.311 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.2 m -152.57 155.47 32.7 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.725 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.413 ' HA ' ' CD2' ' A' ' 12' ' ' HIS . 31.7 Cg_exo -59.06 153.52 51.35 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.332 2.021 . . . . 0.0 111.12 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.461 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -129.09 168.36 16.21 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.75 135.76 24.01 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.138 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.414 ' HG3' ' OE1' ' A' ' 104' ' ' GLU . 72.9 Cg_endo -73.48 -26.48 14.12 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 122.591 2.194 . . . . 0.0 113.687 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.43 -40.44 62.2 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.885 0.74 . . . . 0.0 112.132 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.604 HD13 HH12 ' A' ' 167' ' ' ARG . 4.8 mt -71.68 -34.8 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.385 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.33 -36.96 63.69 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.279 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -84.92 -35.32 22.18 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -84.13 -72.45 0.46 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.006 0.367 . . . . 0.0 111.624 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.886 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.67 99.61 6.23 Favored Pre-proline 0 C--N 1.348 0.539 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.852 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 64.7 Cg_endo -91.24 -0.84 4.78 Favored 'Trans proline' 0 CA--C 1.569 2.266 0 C-N-CA 121.637 1.558 . . . . 0.0 114.271 175.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.648 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 74.6 Cg_endo -74.18 -52.95 0.12 Allowed 'Trans proline' 0 C--N 1.392 2.861 0 C-N-CA 122.656 2.238 . . . . 0.0 114.519 -178.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.53 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.5 mt-10 -122.17 -30.35 4.04 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.746 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.886 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 5.0 tp10 -69.8 -11.42 60.84 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.364 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.784 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.96 -41.71 41.99 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.296 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.38 -50.04 42.92 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -58.29 -49.0 78.68 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.717 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.672 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.34 -39.96 94.94 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.122 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.13 -46.72 79.1 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.626 0.579 . . . . 0.0 110.461 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.45 91.24 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.398 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.6 -27.81 68.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.705 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.672 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.7 -40.01 42.77 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 122.876 0.47 . . . . 0.0 110.4 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -72.82 -30.37 64.0 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.44 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.67 57.37 0.93 Allowed Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.841 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.09 150.91 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -83.38 78.69 9.6 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.701 0.762 . . . . 0.0 110.868 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.7 -26.2 49.96 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.003 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.1 m -56.29 -38.68 71.55 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.16 -26.54 53.15 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 11.0 mt -76.62 -34.84 58.34 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.307 0.379 . . . . 0.0 111.507 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.9 p -85.92 -48.1 9.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.562 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -128.75 117.94 21.97 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.566 0.541 . . . . 0.0 111.308 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -99.73 140.86 33.32 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.853 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.43 141.69 32.93 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 150.14 97.89 0.18 Allowed Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.53 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -99.56 -40.31 7.88 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.661 0.271 . . . . 0.0 111.32 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.443 -0.789 . . . . 0.0 111.161 179.961 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.517 0.199 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -129.33 149.89 50.93 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -128.55 -50.4 1.27 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.346 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.0 p -138.61 -51.27 0.56 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.313 0.383 . . . . 0.0 111.48 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 54.2 m -134.78 122.97 15.78 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.293 -0.384 . . . . 0.0 111.042 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 5' ' ' SER . 7.1 Cg_endo -90.93 5.0 4.18 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.653 2.235 . . . . 0.0 112.594 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -99.83 162.33 13.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.153 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 60.8 149.0 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.341 1.056 . . . . 0.0 113.162 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 32' ' ' LEU . 20.7 mt -98.69 47.78 0.98 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.88 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -89.79 16.37 8.15 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.642 -177.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 173.06 56.75 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.141 0.976 . . . . 0.0 110.161 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -135.82 161.67 34.96 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.654 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.465 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.4 m-30 -97.68 136.29 38.25 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.853 HD11 HD23 ' A' ' 32' ' ' LEU . 2.8 mt -108.49 136.6 47.83 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.703 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.426 HG23 HG22 ' A' ' 29' ' ' VAL . 2.7 mp -120.85 131.4 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.44 126.61 30.26 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.588 0.555 . . . . 0.0 111.92 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.2 mmt -114.29 155.26 45.94 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.22 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -79.47 75.82 4.86 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.662 2.241 . . . . 0.0 112.593 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -132.32 -20.35 2.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.779 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.34 -163.54 0.86 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.324 0.39 . . . . 0.0 110.46 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.51 36.31 2.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.925 0.393 . . . . 0.0 111.861 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.1 m-20 -111.1 82.97 3.49 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.798 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.38 -22.78 13.82 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.969 2.446 . . . . 0.0 113.417 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -85.13 -37.78 19.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.94 0.496 . . . . 0.0 111.713 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.6 -3.22 56.66 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.823 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -61.17 1.99 0.15 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -141.77 40.33 1.68 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.187 0.518 . . . . 0.0 112.005 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 p -123.71 156.09 36.6 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.535 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.702 HG11 ' HE ' ' A' ' 167' ' ' ARG . 48.9 t -130.41 132.03 64.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.89 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -114.59 154.01 29.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.341 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.412 ' OH ' HD21 ' A' ' 105' ' ' LEU . 42.9 t80 -107.21 119.24 38.86 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.853 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -83.52 109.95 17.81 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.32 0.581 . . . . 0.0 111.098 -178.637 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.941 HG23 ' HA2' ' A' ' 42' ' ' GLY . 30.3 t -71.85 -63.73 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 113.461 -1.699 . . . . 0.0 110.685 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -133.91 117.96 17.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.537 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -103.0 126.61 50.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.491 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -139.46 152.1 46.74 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.514 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -65.63 -14.86 62.04 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.046 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -103.79 -0.36 29.38 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.302 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.01 169.2 19.32 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 112.064 -0.414 . . . . 0.0 112.064 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.504 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -149.49 149.22 30.41 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.82 137.85 53.25 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.047 178.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.41 159.46 29.79 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.461 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.3 mt -114.58 131.44 56.68 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.794 0.297 . . . . 0.0 111.111 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 78' ' ' GLY . 14.0 t -66.19 123.74 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.531 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.8 55.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.773 0.797 . . . . 0.0 112.064 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.857 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 2.1 t30 -146.82 -4.0 0.58 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.131 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -130.17 89.5 44.89 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 41.0 Cg_exo -59.39 139.38 89.4 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 121.483 1.456 . . . . 0.0 111.19 174.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.5 m -76.63 -53.32 8.18 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.1 -9.14 20.87 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.173 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 3.1 mp -82.43 169.64 16.18 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.633 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.0 p-10 -112.47 156.94 21.72 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.689 0.281 . . . . 0.0 111.7 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.822 HD12 HD13 ' A' ' 128' ' ' ILE . 4.5 tt -58.41 -31.71 67.96 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.347 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.46 74.55 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 39.4 mt-10 -65.28 -42.56 93.02 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.735 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.853 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.9 t -61.42 -50.09 81.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.657 ' HA ' HD12 ' A' ' 60' ' ' LEU . 22.1 mt -53.5 -35.23 60.4 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.062 0.851 . . . . 0.0 111.568 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -78.34 -29.46 47.58 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.254 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -31.29 47.85 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.66 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.853 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.3 mt -77.6 -44.93 26.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.83 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -131.35 116.47 16.45 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.583 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.24 -32.82 2.88 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.725 2.95 . . . . 0.0 112.812 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.79 -15.03 55.53 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.293 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.75 149.28 25.39 Favored 'General case' 0 C--N 1.345 0.38 0 O-C-N 123.402 0.439 . . . . 0.0 111.609 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -118.21 123.04 29.73 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.114 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.94 147.77 34.63 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.231 1.954 . . . . 0.0 112.246 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.472 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 8.2 Cg_endo -94.45 -169.83 0.2 Allowed 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 122.608 2.206 . . . . 0.0 112.172 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.75 -24.84 66.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.089 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.492 ' HA ' ' CE1' ' A' ' 72' ' ' HIS . 6.5 ptp180 -67.88 -47.02 70.02 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.707 ' HA ' HD12 ' A' ' 73' ' ' ILE . 13.1 m -75.24 -25.34 58.01 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 50.7 mt-30 -69.57 -30.4 68.17 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 69' ' ' ARG . 13.7 p-80 -94.9 22.33 6.6 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.144 0.497 . . . . 0.0 111.461 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 70' ' ' CYS . 62.8 mt -118.3 136.17 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.318 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 1.7 m-20 -103.49 158.39 16.39 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.787 HD13 HD12 ' A' ' 128' ' ' ILE . 22.4 mm -108.23 149.1 11.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.991 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.736 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -115.54 156.62 25.4 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.82 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -86.4 120.32 27.62 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.0 -23.42 9.21 Favored Glycine 0 C--N 1.345 1.044 0 C-N-CA 120.322 -0.942 . . . . 0.0 114.134 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.23 -167.59 35.01 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.261 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -88.15 -11.39 4.47 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.521 2.814 . . . . 0.0 114.173 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 t -86.84 127.16 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.088 0.242 . . . . 0.0 110.563 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 49.68 76.88 0.12 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.127 0.971 . . . . 0.0 112.518 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.463 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.8 t -80.87 1.96 28.54 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.687 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -103.78 3.95 34.61 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -132.91 155.18 49.53 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.211 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.42 127.4 8.47 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.982 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -85.91 144.24 27.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.482 1.113 . . . . 0.0 110.383 179.499 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.6 t -121.82 104.71 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 123.231 0.332 . . . . 0.0 110.852 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.862 HD11 HD13 ' A' ' 105' ' ' LEU . 9.9 tp -106.98 129.03 54.84 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.946 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -127.8 168.77 14.17 Favored Pre-proline 0 CA--C 1.555 1.136 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.54 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.677 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.03 13.77 0.89 Allowed 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.784 2.322 . . . . 0.0 113.857 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.0 t -101.82 160.38 14.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.726 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.14 21.35 44.59 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.617 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -88.81 152.7 21.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.616 0.366 . . . . 0.0 110.511 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.526 ' HA ' HG21 ' A' ' 99' ' ' THR . 10.0 m -131.02 156.9 44.35 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.569 ' CE2' HG23 ' A' ' 113' ' ' VAL . 40.1 m-85 -123.87 -150.86 0.46 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.753 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -58.27 -46.68 85.58 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.604 0.362 . . . . 0.0 111.488 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.9 m -132.77 80.81 1.91 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.097 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.526 HG21 ' HA ' ' A' ' 95' ' ' SER . 31.7 m -130.45 130.04 43.75 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.756 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -110.16 123.6 50.04 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.791 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.36 125.41 30.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.271 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.578 ' HB3' HD12 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -119.39 44.63 2.31 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.609 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.41 -101.6 0.4 Allowed Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.354 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -56.29 -14.27 2.75 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.862 HD13 HD11 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -160.81 160.95 31.8 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.844 0.458 . . . . 0.0 110.821 -179.31 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.571 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -119.49 158.23 26.69 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.76 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.508 ' CE ' HD13 ' A' ' 89' ' ' LEU . 15.8 ttm -123.23 130.07 52.25 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.67 ' HB3' HG11 ' A' ' 113' ' ' VAL . 70.2 m -124.83 129.27 50.09 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.871 0.367 . . . . 0.0 110.257 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.7 p -120.87 21.0 11.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.335 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.755 ' O ' HG12 ' A' ' 113' ' ' VAL . 35.5 p -93.48 127.81 39.3 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.517 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 20.8 pt20 -60.99 -28.67 69.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.926 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.31 -39.68 94.39 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.497 -1.228 . . . . 0.0 110.198 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 110' ' ' SER . 2.9 p -70.11 -37.7 72.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mt -56.82 -47.96 79.09 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.532 0.52 . . . . 0.0 110.239 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.517 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 32.1 m-85 -66.54 -42.61 86.91 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.017 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.72 -53.88 52.07 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.888 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.69 -43.2 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.549 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -57.34 -31.73 66.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.716 0.635 . . . . 0.0 109.602 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.417 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.98 -19.44 32.08 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.331 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.97 17.06 28.78 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.697 -1.138 . . . . 0.0 114.575 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.8 p -107.39 7.7 29.21 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.08 -137.34 8.58 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-O 119.168 -0.795 . . . . 0.0 112.628 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -80.78 172.1 13.62 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 123.13 2.554 . . . . 0.0 113.545 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.01 -55.34 33.99 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.86 0.864 . . . . 0.0 111.994 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.677 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.0 mmtt -141.16 139.82 33.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.667 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 73.1 m -139.51 166.39 24.7 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 tp -127.19 117.79 23.02 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.273 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.822 HD13 HD12 ' A' ' 53' ' ' LEU . 10.9 pt -97.49 102.31 13.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-O 121.724 0.774 . . . . 0.0 109.778 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.2 t -118.98 121.08 39.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.907 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 10.9 tp -67.51 112.73 4.84 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.355 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.65 172.44 11.82 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 115.012 -0.994 . . . . 0.0 114.376 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -128.68 176.36 7.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.333 0.587 . . . . 0.0 110.908 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -115.82 130.71 56.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.029 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.52 149.11 18.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.447 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 21.1 m-90 -127.26 135.89 51.23 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 122.579 0.351 . . . . 0.0 110.381 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.34 158.15 27.52 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.863 0.727 . . . . 0.0 110.876 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.95 91.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.8 -24.47 7.51 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.11 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.88 -45.35 86.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -67.97 -48.05 66.9 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.136 0.273 . . . . 0.0 110.516 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.01 -29.11 68.26 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.008 0.432 . . . . 0.0 110.667 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.38 -50.48 38.29 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.938 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -70.09 -26.5 64.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.773 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.8 tp -75.79 -38.91 57.79 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.804 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.0 m -77.8 -28.37 50.38 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.572 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -82.66 0.96 40.78 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.496 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.88 29.54 19.1 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.874 0.87 . . . . 0.0 111.622 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.66 -43.11 17.32 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.94 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -123.52 113.4 18.68 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.348 0.405 . . . . 0.0 110.043 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.4 tp -83.61 139.81 32.6 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.245 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.4 p -105.81 138.09 42.58 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.513 0.508 . . . . 0.0 111.335 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.6 m -152.73 155.35 32.39 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.713 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.75 157.24 28.89 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.298 1.998 . . . . 0.0 111.182 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.465 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.69 166.97 19.58 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -177.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.22 135.35 23.98 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.997 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.39 -26.46 14.33 Favored 'Trans proline' 0 C--N 1.364 1.363 0 C-N-CA 122.54 2.16 . . . . 0.0 113.785 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.85 -40.6 63.51 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.818 0.699 . . . . 0.0 112.158 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.567 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.6 mt -71.18 -35.24 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.408 0.623 . . . . 0.0 110.388 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.5 tt -73.98 -38.2 64.23 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.437 -177.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -85.57 -32.76 21.94 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -86.69 -72.58 0.5 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.054 0.388 . . . . 0.0 111.636 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.917 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.72 98.84 6.32 Favored Pre-proline 0 C--N 1.349 0.56 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.857 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.5 Cg_endo -92.68 0.2 3.83 Favored 'Trans proline' 0 CA--C 1.57 2.281 0 C-N-CA 121.737 1.625 . . . . 0.0 114.256 175.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.642 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 94.8 Cg_endo -73.28 -52.39 0.15 Allowed 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 122.656 2.237 . . . . 0.0 114.195 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.516 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -122.79 -29.93 3.92 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.664 -178.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.917 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.07 -10.91 60.28 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.407 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.702 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.03 -41.21 43.54 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.151 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -70.47 -50.21 40.47 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.5 m -58.38 -49.25 77.93 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.689 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.669 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.05 -39.81 94.91 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.228 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.42 79.63 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 123.536 0.523 . . . . 0.0 110.424 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.4 90.99 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.448 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.29 -27.87 68.93 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.673 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.66 -40.01 43.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 122.908 0.483 . . . . 0.0 110.412 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.53 -31.96 69.24 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.413 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.66 54.65 0.56 Allowed Glycine 0 C--N 1.34 0.784 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.81 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.7 t -127.55 147.58 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -87.07 77.79 9.06 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.738 0.78 . . . . 0.0 110.616 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.79 -26.1 49.45 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.059 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 53.5 m -58.93 -41.96 88.59 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.64 -26.7 50.68 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.8 mt -77.08 -38.13 53.05 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.7 p -94.26 -48.32 6.23 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.242 0.339 . . . . 0.0 111.355 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 57.42 117.66 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.192 0.997 . . . . 0.0 112.786 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -103.74 145.25 30.36 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -122.31 -42.66 2.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.457 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 100.1 -70.53 0.48 Allowed Glycine 0 C--N 1.339 0.72 0 O-C-N 123.46 0.475 . . . . 0.0 112.555 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -100.85 135.37 42.41 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.63 0.253 . . . . 0.0 110.843 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.115 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.407 HD12 ' CE1' ' A' ' 35' ' ' HIS . 13.1 mt . . . . . 0 N--CA 1.468 0.475 0 CA-C-O 120.746 0.308 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.403 ' O ' HD21 ' A' ' 102' ' ' LEU . 85.6 mttt -90.19 20.0 4.67 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.928 0.394 . . . . 0.0 111.214 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 175.33 55.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.124 0.97 . . . . 0.0 110.116 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -134.25 159.47 40.86 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.654 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.458 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.5 m-30 -97.75 135.17 39.91 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.737 HD11 HD23 ' A' ' 32' ' ' LEU . 6.0 mt -107.64 138.99 42.87 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.968 177.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.468 HG23 HG22 ' A' ' 29' ' ' VAL . 2.3 mm -117.26 134.11 61.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.14 128.54 33.41 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.749 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 43.2 mtt -113.75 157.4 41.79 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.268 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.56 32.74 0.52 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.655 2.237 . . . . 0.0 113.143 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -86.0 -18.3 32.94 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.71 -163.46 0.86 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.096 0.248 . . . . 0.0 110.451 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.532 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -99.24 31.73 2.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 7.9 m-20 -112.42 80.78 3.68 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.0 Cg_exo -75.44 -21.17 15.32 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 123.11 2.54 . . . . 0.0 113.276 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -85.53 -38.5 18.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.515 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -93.27 2.67 56.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.69 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -68.23 8.24 0.47 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -141.87 39.42 1.65 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.152 0.501 . . . . 0.0 112.186 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.2 p -123.16 156.12 35.68 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.426 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.762 HG11 ' HE ' ' A' ' 167' ' ' ARG . 59.5 t -130.25 132.7 64.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.902 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -113.41 152.91 29.42 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.415 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.521 ' OH ' HD21 ' A' ' 105' ' ' LEU . 43.6 t80 -107.23 120.07 41.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.737 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.04 108.57 17.06 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 123.515 0.509 . . . . 0.0 111.402 -178.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.93 HG23 ' HA2' ' A' ' 42' ' ' GLY . 31.2 t -67.45 -59.24 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.713 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -143.65 115.61 8.32 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.1 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.407 ' CE1' HD12 ' A' ' 9' ' ' LEU . 15.5 t-80 -98.01 128.32 44.49 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.912 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -138.92 152.21 47.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.358 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.02 -17.91 64.85 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.881 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -102.31 3.29 37.91 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.52 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.54 166.89 15.16 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.285 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.538 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.92 141.07 27.44 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.91 133.92 55.45 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.125 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.93 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.24 156.84 27.95 Favored Glycine 0 N--CA 1.449 -0.461 0 O-C-N 124.268 0.98 . . . . 0.0 112.492 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.2 mt -113.31 135.24 54.06 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.226 0.513 . . . . 0.0 111.638 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 78' ' ' GLY . 11.6 t -68.77 124.06 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -127.41 55.83 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.688 0.756 . . . . 0.0 111.961 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.841 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.0 t-20 -146.87 -4.16 0.57 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.23 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -129.72 87.89 51.09 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.507 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.1 Cg_exo -58.87 141.75 98.37 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 121.635 1.557 . . . . 0.0 112.176 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.446 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.9 m -90.29 158.02 17.37 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.41 0.444 . . . . 0.0 111.649 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.12 49.39 1.38 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.585 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.445 ' C ' HG12 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -133.22 155.36 49.5 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.337 -0.432 . . . . 0.0 109.99 -179.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.466 HD22 ' HA ' ' A' ' 71' ' ' GLN . 44.8 p-10 -112.39 161.08 17.08 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.578 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.412 HD13 HD13 ' A' ' 128' ' ' ILE . 8.6 tp -58.36 -27.03 63.83 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.653 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . . . -61.86 -42.79 99.48 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.45 -47.42 79.11 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.052 0.22 . . . . 0.0 111.423 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.875 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.8 m -61.76 -44.49 98.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.73 ' HA ' HD12 ' A' ' 60' ' ' LEU . 12.6 mt -55.54 -36.04 66.32 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.748 177.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.05 -28.14 48.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.409 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.07 -30.04 49.5 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.269 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.875 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.94 -46.22 21.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.759 -1.564 . . . . 0.0 111.372 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -132.7 118.68 15.72 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.003 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.4 -32.36 3.01 Favored 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.628 2.885 . . . . 0.0 112.556 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -82.18 -15.29 53.74 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.294 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.21 149.27 26.92 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 123.283 0.365 . . . . 0.0 111.42 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.94 121.45 31.55 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.64 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.718 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 47.2 Cg_endo -71.4 138.07 32.03 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.555 2.17 . . . . 0.0 112.339 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 66' ' ' PRO . 2.4 Cg_endo -90.07 -156.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.705 2.27 . . . . 0.0 112.532 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.09 -24.88 51.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.264 0.626 . . . . 0.0 111.824 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.511 ' O ' HG13 ' A' ' 73' ' ' ILE . 10.0 ptp180 -67.86 -45.42 74.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 66' ' ' PRO . 19.5 p -65.59 -32.66 74.36 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.466 ' HA ' HD22 ' A' ' 52' ' ' ASN . 48.5 mt-30 -66.97 -26.84 67.02 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.664 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -97.49 8.28 44.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.734 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 69' ' ' ARG . 64.2 mt -113.58 137.73 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.179 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -106.75 163.31 13.03 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.873 0.733 . . . . 0.0 112.937 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.462 ' CD1' HD12 ' A' ' 128' ' ' ILE . 14.0 mm -111.81 152.95 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.598 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.72 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -119.5 153.72 34.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.21 118.76 24.36 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -99.53 -23.93 10.59 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 120.185 -1.007 . . . . 0.0 113.797 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.41 -167.74 35.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.218 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -88.62 -10.53 4.4 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.702 2.935 . . . . 0.0 114.227 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.96 130.39 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 123.023 0.202 . . . . 0.0 111.098 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 45.94 85.02 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.431 1.092 . . . . 0.0 113.194 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 68.6 p -85.91 -5.81 59.17 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.953 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.87 -2.43 58.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.766 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.614 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.66 152.13 51.77 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.47 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.614 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.6 132.21 10.98 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.56 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.696 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -86.19 144.85 27.25 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.047 0.939 . . . . 0.0 110.756 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.29 104.49 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 123.474 0.484 . . . . 0.0 110.514 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.892 HD11 HD13 ' A' ' 105' ' ' LEU . 13.0 tp -108.32 129.53 55.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.213 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -127.04 169.07 12.89 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-O 118.874 -0.584 . . . . 0.0 111.769 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.697 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.5 Cg_endo -98.06 13.83 0.74 Allowed 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.856 2.37 . . . . 0.0 113.802 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.2 t -101.26 160.94 13.98 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.881 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.38 22.03 42.24 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.537 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 tp -86.8 154.05 21.2 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.613 0.365 . . . . 0.0 110.642 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.6 p -127.66 156.3 42.55 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.573 ' CE2' HG23 ' A' ' 113' ' ' VAL . 54.9 m-85 -129.96 -152.31 0.51 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.811 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -57.64 -46.58 83.98 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.76 0.424 . . . . 0.0 111.615 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 64.4 m -135.92 83.56 2.02 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.259 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.3 m -130.63 130.37 43.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.835 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.99 123.34 48.97 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.626 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.19 129.14 34.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.071 0.462 . . . . 0.0 110.747 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -125.12 46.27 2.39 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.419 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.12 -106.12 1.41 Allowed Glycine 0 C--N 1.336 0.575 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.162 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.6 -10.64 3.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.892 HD13 HD11 ' A' ' 89' ' ' LEU . 2.3 pp -156.12 153.29 29.09 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.237 0.335 . . . . 0.0 111.508 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.641 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -117.43 156.12 28.49 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.545 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.58 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 17.5 ttm -121.48 126.14 48.55 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.7 ' HB3' HG11 ' A' ' 113' ' ' VAL . 22.7 m -122.29 128.05 50.61 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.192 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.5 p -118.05 13.04 13.82 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.44 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.771 ' O ' HG12 ' A' ' 113' ' ' VAL . 32.2 p -87.91 127.06 35.36 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.644 0.735 . . . . 0.0 111.952 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.49 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 21.1 pt20 -59.32 -29.11 67.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.358 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.97 -43.07 96.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.541 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 110' ' ' SER . 4.7 p -67.76 -37.62 78.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.521 HD22 ' NH2' ' A' ' 85' ' ' ARG . 5.0 tp -58.4 -47.86 82.53 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 123.552 0.532 . . . . 0.0 110.266 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.49 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 26.4 m-85 -67.66 -39.91 84.51 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.813 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -52.45 64.74 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.351 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.719 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.93 -43.65 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.546 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.65 -32.32 65.25 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.774 0.671 . . . . 0.0 109.642 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.55 -20.03 32.18 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.238 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.44 14.41 32.77 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 114.693 -1.14 . . . . 0.0 114.785 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.8 p -104.58 7.55 35.14 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.23 -138.1 9.68 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 119.207 -0.774 . . . . 0.0 112.625 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.9 173.88 11.55 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 123.292 2.661 . . . . 0.0 113.536 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.21 -54.75 43.24 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.716 0.806 . . . . 0.0 111.962 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.697 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.9 mmtt -141.58 139.96 33.26 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.873 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 34.6 p -137.45 166.33 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.0 tp -126.97 116.06 20.2 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.577 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.696 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 11.5 pt -98.47 102.7 13.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.779 0.799 . . . . 0.0 109.647 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.4 t -123.01 123.98 42.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.818 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.36 115.79 7.4 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.493 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.414 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 66.75 172.47 5.09 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.633 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -128.41 -177.51 4.2 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.313 0.578 . . . . 0.0 110.864 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -118.48 127.9 54.08 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.093 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.23 143.06 14.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.474 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.406 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 27.9 m-90 -119.28 137.37 53.72 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.773 0.337 . . . . 0.0 110.404 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -81.75 158.15 24.27 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.878 0.737 . . . . 0.0 110.539 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.56 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.81 -25.2 7.27 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.072 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -57.95 -44.58 87.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.93 0.492 . . . . 0.0 112.275 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.581 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.6 -47.76 65.87 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.146 0.279 . . . . 0.0 110.605 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.1 -29.53 68.65 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.958 0.408 . . . . 0.0 110.619 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.14 -50.36 41.31 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.872 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.0 pt-20 -70.17 -26.68 64.03 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.787 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tp -74.77 -38.94 62.04 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.645 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.3 m -77.84 -28.34 50.15 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.352 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.8 t70 -82.64 -0.28 46.45 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.472 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 60.07 29.01 18.62 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.865 0.866 . . . . 0.0 111.787 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.13 -42.8 18.62 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.942 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -125.58 115.25 19.87 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.0 tp -86.45 143.14 27.92 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.506 0.194 . . . . 0.0 111.465 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.9 p -103.7 135.91 44.39 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.058 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 76.9 m -151.23 155.06 34.55 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.626 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.88 159.19 26.02 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.253 1.969 . . . . 0.0 111.244 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.458 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -131.94 166.59 21.31 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -135.69 135.12 21.4 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.963 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.19 -26.41 14.81 Favored 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.597 2.198 . . . . 0.0 113.682 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.81 -40.57 63.38 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.847 0.717 . . . . 0.0 112.135 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.565 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.5 mt -71.43 -35.5 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.366 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.71 -37.79 65.04 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.482 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -84.86 -34.71 22.57 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -84.71 -72.52 0.47 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.924 0.329 . . . . 0.0 111.637 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.894 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.64 99.42 6.28 Favored Pre-proline 0 C--N 1.349 0.563 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.841 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.4 Cg_endo -91.86 -0.45 4.36 Favored 'Trans proline' 0 CA--C 1.57 2.284 0 C-N-CA 121.716 1.611 . . . . 0.0 114.262 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.642 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 77.6 Cg_endo -73.96 -52.34 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 122.589 2.193 . . . . 0.0 114.437 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.519 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.7 mt-10 -122.45 -30.02 4.01 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.714 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.894 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.1 tt0 -70.23 -10.85 60.14 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.391 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.762 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.06 -40.52 45.92 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -71.36 -49.88 37.79 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.207 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.1 t -58.41 -49.03 78.76 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.504 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.67 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.7 -40.25 95.05 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.249 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.21 78.52 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 123.516 0.51 . . . . 0.0 110.534 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.16 90.07 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.495 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.3 -27.69 68.8 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.538 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.67 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.73 -40.15 42.11 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 122.92 0.488 . . . . 0.0 110.264 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.37 -32.0 69.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.38 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.789 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.933 179.539 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 32' ' ' LEU . 15.0 mt . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 120.775 0.321 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -90.58 19.14 5.57 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.908 0.385 . . . . 0.0 111.072 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 175.88 55.96 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.087 0.955 . . . . 0.0 110.17 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -134.94 159.35 41.74 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.618 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.462 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.6 m-30 -98.08 135.12 40.21 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.09 0.471 . . . . 0.0 112.153 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.743 HD11 HD23 ' A' ' 32' ' ' LEU . 6.1 mt -108.7 137.6 46.37 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.785 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.416 HG23 HG22 ' A' ' 29' ' ' VAL . 2.9 mp -120.51 132.69 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.82 127.57 33.17 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.722 0.639 . . . . 0.0 112.003 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.8 mmt -110.26 158.19 35.94 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.179 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -80.55 21.4 0.86 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.693 2.262 . . . . 0.0 113.549 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -83.07 -19.38 36.94 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.592 ' SD ' ' HB1' ' A' ' 148' ' ' ALA . 15.9 ptt? -102.31 -164.75 1.12 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.272 0.357 . . . . 0.0 110.38 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.545 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -106.74 30.9 5.68 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 7.9 m-20 -110.44 84.84 4.15 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.712 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.3 Cg_exo -75.31 -23.8 12.96 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.059 2.506 . . . . 0.0 113.48 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -85.11 -37.01 20.75 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.794 0.438 . . . . 0.0 111.557 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.85 3.06 55.97 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.499 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -66.78 5.82 0.58 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -140.83 38.84 1.81 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.116 0.484 . . . . 0.0 112.156 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 p -123.14 155.02 37.84 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.417 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.701 HG11 ' HE ' ' A' ' 167' ' ' ARG . 50.1 t -130.5 131.95 64.85 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.856 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -113.6 153.58 28.6 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.365 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.493 ' OH ' HD21 ' A' ' 105' ' ' LEU . 42.9 t80 -106.99 119.63 39.89 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.743 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -83.84 109.24 17.4 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.3 0.571 . . . . 0.0 111.25 -178.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.938 HG23 ' HA2' ' A' ' 42' ' ' GLY . 31.6 t -69.03 -59.65 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.674 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -141.96 114.34 8.3 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.337 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -97.45 128.29 44.11 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.754 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -139.4 152.64 47.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.34 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -65.11 -18.13 65.04 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.797 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -100.56 1.56 41.01 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.432 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.32 167.3 15.57 Favored Glycine 0 C--N 1.345 1.055 0 C-N-CA 121.541 -0.361 . . . . 0.0 112.205 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.02 142.49 29.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -120.62 135.51 55.08 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.57 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.75 156.95 27.97 Favored Glycine 0 N--CA 1.449 -0.448 0 O-C-N 124.364 1.04 . . . . 0.0 112.817 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.0 mt -111.93 131.63 55.26 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.9 0.35 . . . . 0.0 110.974 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 78' ' ' GLY . 18.1 t -66.89 125.35 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -128.22 55.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.715 0.769 . . . . 0.0 112.22 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.839 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.0 t-20 -147.19 -4.61 0.53 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.308 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.68 87.89 51.21 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.507 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.1 Cg_exo -59.3 141.11 97.32 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.631 1.554 . . . . 0.0 112.004 175.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.419 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 46.0 m -89.32 159.12 17.53 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.253 0.346 . . . . 0.0 111.638 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.28 45.55 1.46 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.363 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.7 154.37 51.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.442 HD22 ' HA ' ' A' ' 71' ' ' GLN . 16.6 p-10 -104.17 161.09 14.32 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.294 0.371 . . . . 0.0 110.783 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.664 ' HA ' HD11 ' A' ' 75' ' ' ILE . 15.3 tp -58.19 -35.78 72.11 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.25 61.14 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.525 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.65 -43.22 97.42 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.855 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -62.28 -48.31 88.96 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.747 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.5 mp -52.89 -36.63 59.6 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.977 0.798 . . . . 0.0 111.024 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -78.06 -28.62 48.94 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.466 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.29 -30.27 48.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.368 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.855 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.0 mt -77.89 -44.98 25.45 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.86 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -132.48 116.79 15.24 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.441 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.72 -32.66 2.64 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.619 2.879 . . . . 0.0 112.835 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -82.38 -13.99 55.96 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.429 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.3 148.63 25.53 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 123.329 0.393 . . . . 0.0 111.734 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.6 123.03 31.91 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.149 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 58.8 Cg_endo -75.17 144.46 29.71 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.244 1.963 . . . . 0.0 112.553 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.451 ' C ' HE21 ' A' ' 71' ' ' GLN . 5.8 Cg_endo -92.8 -169.73 0.25 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.657 2.238 . . . . 0.0 112.248 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.48 -24.61 67.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.303 0.641 . . . . 0.0 112.202 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.58 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 9.1 ptp180 -66.76 -55.58 14.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.707 ' HA ' HD12 ' A' ' 73' ' ' ILE . 69.1 m -70.89 -25.56 62.84 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.451 HE21 ' C ' ' A' ' 67' ' ' PRO . 42.6 mt-30 -68.77 -32.76 72.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.772 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -91.77 19.56 6.38 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.614 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 70' ' ' CYS . 52.0 mt -122.28 140.92 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.858 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.414 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.6 m-20 -109.02 152.37 25.09 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.814 0.696 . . . . 0.0 112.44 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.826 HD13 HD12 ' A' ' 128' ' ' ILE . 14.6 mm -99.6 153.48 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.237 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.717 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -120.24 152.48 37.68 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.7 119.42 24.28 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.76 0.254 . . . . 0.0 110.823 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -100.58 -23.76 9.9 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.732 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.04 -167.75 34.93 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.182 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -88.49 -8.28 5.4 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.614 2.876 . . . . 0.0 114.235 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.29 128.83 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 123.07 0.231 . . . . 0.0 111.087 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 45.01 86.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.532 1.133 . . . . 0.0 113.326 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.405 ' O ' HD21 ' A' ' 130' ' ' LEU . 78.3 p -86.68 -2.45 58.53 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.995 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -88.68 -4.46 58.54 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.895 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.599 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.2 153.01 51.93 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.134 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.599 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.51 131.12 10.41 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.07 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.714 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.6 OUTLIER -85.59 151.13 24.15 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.253 1.021 . . . . 0.0 110.428 -179.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.633 ' HB ' ' OG ' ' A' ' 108' ' ' SER . 3.4 t -128.37 106.39 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 O-C-N 123.312 0.383 . . . . 0.0 111.159 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.923 HD11 HD13 ' A' ' 105' ' ' LEU . 14.6 tp -108.45 127.79 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.041 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.402 ' NE2' ' HB3' ' A' ' 106' ' ' ALA . 4.2 p80 -128.42 168.27 16.25 Favored Pre-proline 0 CA--C 1.554 1.11 0 O-C-N 123.669 0.606 . . . . 0.0 111.411 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.667 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 14.8 Cg_endo -95.39 14.21 1.19 Allowed 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 122.526 2.151 . . . . 0.0 113.39 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 t -101.17 159.7 15.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.861 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.3 18.9 55.84 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.714 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.99 154.83 24.29 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.499 0.32 . . . . 0.0 110.922 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.4 p -126.37 157.64 37.97 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.593 ' CE2' HG23 ' A' ' 113' ' ' VAL . 50.3 m-85 -129.9 -149.54 0.4 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.433 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -61.15 -45.73 93.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.55 0.34 . . . . 0.0 111.18 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.3 m -137.54 83.06 1.96 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.234 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 107' ' ' MET . 8.0 m -128.22 122.35 31.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.718 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -99.89 120.77 40.3 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.987 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -83.54 127.26 33.59 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.167 0.508 . . . . 0.0 110.331 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.503 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.43 46.91 2.1 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.44 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.28 -107.72 2.09 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.103 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.41 -10.03 4.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.923 HD13 HD11 ' A' ' 89' ' ' LEU . 2.0 pp -155.14 153.63 31.08 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.256 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.593 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -121.47 158.57 28.12 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.783 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.592 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 25.8 tpp -125.28 140.12 53.11 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.689 ' HB2' HG11 ' A' ' 113' ' ' VAL . 21.4 p -134.06 133.16 40.85 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.933 0.396 . . . . 0.0 110.351 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.4 p -117.14 16.51 14.95 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.049 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.739 ' O ' HG12 ' A' ' 113' ' ' VAL . 67.0 m -89.66 127.78 35.97 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.636 0.731 . . . . 0.0 112.023 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.479 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 10.1 pt20 -61.43 -28.81 69.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.973 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -65.81 -42.17 90.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.669 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 110' ' ' SER . 3.8 p -67.38 -39.9 83.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.466 HD22 ' NH2' ' A' ' 85' ' ' ARG . 6.4 tp -58.97 -47.36 85.41 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 123.592 0.557 . . . . 0.0 110.469 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.479 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 24.1 m-85 -69.36 -38.47 78.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.914 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.81 66.76 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.043 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.75 -43.47 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.348 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.25 -31.56 65.67 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.74 0.65 . . . . 0.0 109.588 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.58 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.63 -20.15 31.81 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.238 176.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.15 14.85 32.23 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.648 -1.16 . . . . 0.0 114.602 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.1 p -105.14 7.3 33.71 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.19 -138.74 10.01 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.715 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.8 168.06 17.94 Favored 'Trans proline' 0 C--N 1.367 1.526 0 C-N-CA 123.255 2.637 . . . . 0.0 113.956 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.501 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -51.11 -59.2 4.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.511 1.125 . . . . 0.0 111.897 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.667 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -140.19 139.88 35.78 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.783 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 32.6 p -137.93 168.38 19.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.66 118.25 23.5 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.685 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.826 HD12 HD13 ' A' ' 75' ' ' ILE . 12.0 pt -98.12 102.24 13.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 121.782 0.801 . . . . 0.0 109.738 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 5.6 t -119.35 122.36 41.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.847 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.405 HD21 ' O ' ' A' ' 83' ' ' THR . 6.5 tp -66.85 114.62 5.84 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.195 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.43 176.02 5.69 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.737 -1.119 . . . . 0.0 114.385 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -128.58 -178.55 4.63 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.437 0.636 . . . . 0.0 110.957 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -118.49 128.77 54.91 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.977 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.7 147.27 17.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.532 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 -125.46 136.86 53.82 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.93 0.429 . . . . 0.0 110.303 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.43 158.27 27.37 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.94 0.775 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.0 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.21 -25.6 7.75 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.182 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -57.84 -44.15 86.32 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.886 0.474 . . . . 0.0 112.257 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.59 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.72 -47.13 67.12 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.575 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -60.49 -29.4 69.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.025 0.44 . . . . 0.0 110.38 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.14 -50.09 43.98 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.802 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.35 -26.65 63.84 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.766 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.7 tp -75.0 -38.38 61.62 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.623 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.6 t -77.87 -28.65 50.05 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.12 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -82.46 0.02 44.19 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.429 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.44 29.82 19.43 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.839 0.856 . . . . 0.0 111.869 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.592 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -83.16 -42.44 17.31 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.942 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -124.03 113.6 18.62 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.5 tp -84.36 141.9 30.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.643 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.0 p -103.27 134.85 45.98 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.651 0.595 . . . . 0.0 111.057 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 153' ' ' PRO . 48.8 t -150.02 144.53 17.71 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.414 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 152' ' ' CYS . 57.1 Cg_exo -53.0 157.45 8.12 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.467 2.111 . . . . 0.0 111.595 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.462 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.02 167.39 18.34 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -135.21 135.4 22.63 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 114.173 -1.376 . . . . 0.0 107.919 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.46 -26.4 14.25 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.601 2.2 . . . . 0.0 113.727 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.71 -40.66 63.2 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.832 0.708 . . . . 0.0 112.199 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.577 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.8 mt -71.25 -35.35 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.4 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -74.06 -37.55 64.23 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.438 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -84.87 -33.88 22.73 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -85.89 -72.63 0.48 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.016 0.371 . . . . 0.0 111.654 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.905 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.36 99.49 6.43 Favored Pre-proline 0 C--N 1.348 0.531 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.839 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 67.9 Cg_endo -92.01 -0.22 4.26 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 C-N-CA 121.678 1.585 . . . . 0.0 114.317 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.643 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 81.7 Cg_endo -73.98 -52.62 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.894 0 C-N-CA 122.61 2.206 . . . . 0.0 114.361 -178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.52 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.15 -30.09 4.09 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.691 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.905 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 4.9 tp10 -70.0 -11.12 60.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.388 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.701 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.93 -41.61 42.71 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -70.36 -50.24 41.03 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.4 m -58.39 -49.57 76.8 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.656 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -63.99 -39.58 94.43 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.037 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.95 -45.48 78.82 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.583 0.552 . . . . 0.0 110.508 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.03 93.12 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.441 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.58 -28.06 69.38 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.663 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.96 -40.18 40.25 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 122.865 0.466 . . . . 0.0 110.43 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.83 -33.77 75.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.407 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.78 0 C-N-CA 121.06 -0.591 . . . . 0.0 113.175 179.378 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.437 ' O ' HD12 ' A' ' 32' ' ' LEU . 8.9 mt . . . . . 0 N--CA 1.468 0.438 0 CA-C-O 120.779 0.323 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -89.44 20.8 3.67 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.846 0.355 . . . . 0.0 111.355 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 174.66 54.62 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.024 0.929 . . . . 0.0 110.172 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -133.42 160.64 36.8 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.721 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.48 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.2 m-30 -97.97 137.68 36.42 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.821 HD11 HD23 ' A' ' 32' ' ' LEU . 2.8 mt -110.49 140.56 44.64 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.913 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mp -125.43 135.53 63.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.77 122.86 21.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.075 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -105.53 156.07 37.01 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -80.92 31.94 0.51 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.67 2.247 . . . . 0.0 113.197 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -87.36 -17.63 31.93 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.53 -169.6 1.65 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 123.076 0.235 . . . . 0.0 110.783 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.559 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -105.62 42.94 1.17 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.141 0.496 . . . . 0.0 111.561 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.48 81.83 2.54 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.934 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.2 Cg_exo -75.45 -22.16 14.32 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 123.083 2.522 . . . . 0.0 113.431 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -84.49 -36.49 22.2 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.871 0.468 . . . . 0.0 111.791 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.62 3.98 52.63 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.948 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.7 163.6 21.18 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 48.6 31.88 3.18 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.8 p -115.57 153.95 30.29 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 120.564 0.221 . . . . 0.0 110.735 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.968 HG11 HH11 ' A' ' 167' ' ' ARG . 24.6 t -127.58 132.1 69.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.805 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 m -114.84 152.59 31.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.889 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.496 ' OH ' HD21 ' A' ' 105' ' ' LEU . 38.0 t80 -106.59 118.43 36.64 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.821 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.4 107.95 15.45 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 111.122 -178.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.939 HG23 ' HA2' ' A' ' 42' ' ' GLY . 54.0 t -63.66 -61.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.811 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -145.49 116.41 7.79 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.09 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -98.06 127.74 44.18 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.559 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -139.09 152.9 47.89 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.545 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.83 -19.2 65.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.804 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.38 7.48 42.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.393 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.81 166.22 12.49 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.394 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.455 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.92 145.27 30.63 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.408 ' O ' HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -124.72 137.41 54.35 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.474 178.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.939 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.93 156.53 27.42 Favored Glycine 0 N--CA 1.447 -0.617 0 O-C-N 124.403 1.065 . . . . 0.0 112.566 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.408 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.6 mt -111.16 133.32 53.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 117.108 0.454 . . . . 0.0 111.042 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 78' ' ' GLY . 15.0 t -69.09 123.68 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.714 ' O ' ' HG3' ' A' ' 167' ' ' ARG . 1.5 pt -127.68 52.52 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.232 0.539 . . . . 0.0 112.335 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.93 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 24.1 t-20 -144.56 -1.36 0.9 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.133 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -129.53 87.08 54.03 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.511 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 31.4 Cg_exo -59.2 144.58 99.33 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.805 1.67 . . . . 0.0 112.65 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.428 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 51.5 m -94.33 158.65 15.48 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.503 0.502 . . . . 0.0 111.371 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.75 50.69 1.22 Allowed Glycine 0 C--N 1.339 0.696 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.742 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mt -133.77 157.74 45.1 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 122.851 0.461 . . . . 0.0 110.151 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.614 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 10.1 p-10 -112.25 157.37 21.01 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.198 0.311 . . . . 0.0 110.172 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.675 HD13 HD13 ' A' ' 128' ' ' ILE . 14.0 tp -56.81 -36.47 69.96 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.614 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -55.53 -35.32 65.53 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -64.67 -45.27 87.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.286 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.891 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 31.6 m -63.24 -43.48 98.76 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.713 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.0 mp -54.98 -36.75 65.72 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.83 0.706 . . . . 0.0 110.205 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -77.84 -27.78 49.98 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.499 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.419 HE22 ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -78.16 -30.46 49.2 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.286 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.891 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.3 mt -77.87 -44.96 25.63 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.923 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -132.04 116.1 15.54 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.459 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.72 -32.88 2.52 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 123.611 2.874 . . . . 0.0 112.841 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.09 -14.09 56.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.414 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.35 149.26 24.62 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 123.33 0.394 . . . . 0.0 111.814 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -116.55 122.78 31.34 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.949 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.43 151.05 37.18 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.297 1.998 . . . . 0.0 112.506 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.2 Cg_endo -92.36 -162.59 0.1 Allowed 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.617 2.211 . . . . 0.0 111.706 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.446 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -73.25 -24.95 60.53 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.75 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.434 ' HA ' ' CD2' ' A' ' 72' ' ' HIS . 6.0 ptp180 -64.81 -50.78 65.41 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.593 ' SG ' HD23 ' A' ' 53' ' ' LEU . 61.2 m -72.61 -24.97 61.14 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 42.1 mt-30 -68.69 -34.84 76.35 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.446 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 23.5 p80 -90.73 22.57 3.48 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.193 0.52 . . . . 0.0 111.74 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' A' ' 70' ' ' CYS . 60.5 mt -121.8 139.52 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.188 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -105.81 154.73 20.11 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.715 HD13 HD12 ' A' ' 128' ' ' ILE . 24.0 mm -102.09 151.62 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.739 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -119.44 154.66 33.37 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -85.18 121.27 27.69 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 117.789 0.268 . . . . 0.0 110.806 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -104.07 -23.7 8.0 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 120.209 -0.996 . . . . 0.0 114.207 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.01 -167.98 33.89 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.907 -0.664 . . . . 0.0 113.353 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -88.72 -16.17 2.48 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.404 2.736 . . . . 0.0 114.439 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.66 129.19 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.725 0.298 . . . . 0.0 111.518 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 47.72 82.97 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.527 1.131 . . . . 0.0 113.2 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.4 p -80.9 -14.83 57.64 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.918 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.419 ' HA ' HE22 ' A' ' 59' ' ' GLN . 3.1 t70 -76.94 -18.02 58.53 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.211 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.641 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -133.08 146.84 52.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.939 0.4 . . . . 0.0 111.825 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.591 ' H ' ' NH1' ' A' ' 85' ' ' ARG . . . -112.18 150.42 18.19 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.782 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.513 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 1.3 m-85 -86.51 152.59 22.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.346 1.058 . . . . 0.0 111.321 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.483 HG21 ' HG ' ' A' ' 114' ' ' LEU . 3.4 t -126.3 103.76 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.627 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 126' ' ' SER . 1.1 mt -98.85 126.72 44.58 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.181 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.401 ' CE1' ' HB3' ' A' ' 106' ' ' ALA . 4.7 p80 -129.44 164.06 42.25 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.76 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.57 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 23.2 Cg_endo -99.27 23.74 0.21 Allowed 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 122.888 2.392 . . . . 0.0 113.92 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.5 t -107.6 160.82 15.39 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.756 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.25 18.98 56.51 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.685 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -91.78 153.78 19.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.553 0.341 . . . . 0.0 110.528 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.598 ' HA ' HG21 ' A' ' 99' ' ' THR . 27.9 m -126.97 155.58 42.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.108 0.48 . . . . 0.0 112.112 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.538 ' CE2' HG23 ' A' ' 113' ' ' VAL . 51.2 m-85 -126.09 -150.89 0.46 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.837 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -58.82 -47.08 86.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.605 0.362 . . . . 0.0 111.372 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 m -132.19 81.26 1.95 Allowed 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.912 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.598 HG21 ' HA ' ' A' ' 95' ' ' SER . 42.5 m -129.38 121.69 27.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.327 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 124.7 49.99 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.794 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -82.72 127.99 33.94 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.133 0.492 . . . . 0.0 111.141 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -120.28 46.47 1.97 Allowed 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.574 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.62 -107.07 1.76 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.281 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.69 -10.44 3.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.496 HD21 ' OH ' ' A' ' 31' ' ' TYR . 2.9 pp -154.86 158.76 39.85 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.335 0.397 . . . . 0.0 110.99 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.401 ' HB3' ' CE1' ' A' ' 90' ' ' HIS . . . -118.92 161.51 20.07 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.472 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.569 ' O ' ' HA ' ' A' ' 99' ' ' THR . 24.6 ttm -125.22 134.34 52.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.514 ' HB3' HG11 ' A' ' 113' ' ' VAL . 51.7 m -136.08 133.03 36.92 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 75.6 p -124.53 21.23 8.58 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.717 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.707 ' O ' HG12 ' A' ' 113' ' ' VAL . 47.4 p -93.71 134.15 36.33 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 121.648 0.737 . . . . 0.0 112.345 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.499 ' HA ' HD12 ' A' ' 114' ' ' LEU . 4.9 mt-30 -62.51 -26.62 68.65 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.403 178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.41 -40.43 93.37 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.169 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.769 ' O ' HG22 ' A' ' 117' ' ' ILE . 3.4 p -71.68 -39.03 68.62 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 111' ' ' GLN . 6.6 mt -57.25 -49.04 77.31 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 123.507 0.504 . . . . 0.0 110.874 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.475 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 35.5 m-85 -69.69 -38.55 77.03 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.216 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.64 -52.68 63.37 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.212 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.84 -43.74 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.432 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.93 -31.57 65.09 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 123.754 0.658 . . . . 0.0 109.615 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.09 -20.23 30.68 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.273 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.82 17.67 25.02 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.704 -1.134 . . . . 0.0 114.634 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.9 p -108.33 7.48 27.21 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.6 -137.76 9.32 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.793 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.45 175.21 9.81 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 123.216 2.611 . . . . 0.0 113.347 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -58.33 -53.08 62.32 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.509 0.723 . . . . 0.0 111.584 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.8 mmtt -139.24 153.76 47.89 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.71 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.4 m -150.05 163.33 38.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.1 tp -129.05 117.56 21.08 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.14 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.715 HD12 HD13 ' A' ' 75' ' ' ILE . 12.3 pt -98.94 103.16 14.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.579 0.704 . . . . 0.0 109.475 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.1 t -121.21 120.46 35.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.846 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.45 115.34 6.96 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.335 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.42 167.9 10.76 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.226 -0.897 . . . . 0.0 114.091 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -128.45 178.0 6.6 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.167 0.508 . . . . 0.0 110.703 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -116.33 131.48 56.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.916 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.08 149.89 18.66 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.315 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.402 ' HZ2' ' CZ3' ' A' ' 149' ' ' TRP . 25.7 m-90 -130.15 136.9 49.78 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.833 0.372 . . . . 0.0 110.602 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.06 158.34 27.87 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.941 0.776 . . . . 0.0 111.064 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.88 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.12 -28.09 6.19 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.826 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -56.38 -46.4 80.09 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.006 0.522 . . . . 0.0 112.135 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.57 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.4 tp -67.33 -47.54 70.2 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -57.36 -30.27 64.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.473 0.483 . . . . 0.0 110.602 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.65 -49.97 41.75 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.887 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -72.12 -26.66 62.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.899 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 4.8 tp -75.78 -38.41 58.3 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.85 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -78.18 -30.9 49.31 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.315 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.43 0.77 31.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.641 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.74 29.88 19.45 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.813 0.845 . . . . 0.0 111.682 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.65 -42.92 19.27 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.78 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.402 ' CZ3' ' HZ2' ' A' ' 135' ' ' TRP . 11.3 m95 -122.42 112.04 17.6 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 123.388 0.43 . . . . 0.0 109.966 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -80.19 141.55 35.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.326 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.427 ' H ' HD23 ' A' ' 150' ' ' LEU . 16.0 p -110.56 138.47 46.91 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.312 0.383 . . . . 0.0 111.212 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.5 m -152.89 155.6 32.31 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.527 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.02 155.96 36.43 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.226 1.951 . . . . 0.0 111.098 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.48 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.73 169.33 14.64 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -138.08 137.55 21.35 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 114.295 -1.321 . . . . 0.0 107.906 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.41 -26.46 12.14 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.491 2.128 . . . . 0.0 113.959 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.22 -36.31 60.88 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.824 0.703 . . . . 0.0 112.571 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.561 HD13 HH21 ' A' ' 167' ' ' ARG . 4.6 mt -75.68 -38.35 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.41 0.624 . . . . 0.0 110.254 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.1 tt -69.44 -36.65 76.86 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.906 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -86.38 -42.78 13.37 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -77.91 -71.24 0.43 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.783 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.42 96.35 6.36 Favored Pre-proline 0 C--N 1.346 0.445 0 CA-C-O 121.18 0.514 . . . . 0.0 111.966 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.93 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 63.7 Cg_endo -91.78 3.31 4.11 Favored 'Trans proline' 0 CA--C 1.567 2.156 0 C-N-CA 121.626 1.551 . . . . 0.0 114.407 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.657 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 60.9 Cg_endo -76.93 -52.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 122.435 2.09 . . . . 0.0 114.168 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.509 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 4.3 mt-10 -126.42 -24.36 3.64 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.468 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.783 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 27.6 tt0 -76.53 -12.97 60.11 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.762 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.968 HH11 HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.19 -36.66 54.77 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.651 177.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.1 tp -73.47 -48.74 31.1 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 52.4 m -58.87 -45.31 90.49 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.527 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.68 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -67.22 -42.81 83.44 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.445 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.53 ' HB2' ' NH1' ' A' ' 167' ' ' ARG . . . -55.97 -45.86 78.78 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.494 0.496 . . . . 0.0 110.499 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.05 93.33 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.357 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.96 -26.95 68.52 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.663 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.76 -40.3 41.38 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 122.929 0.491 . . . . 0.0 110.175 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -71.87 -30.79 65.78 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.466 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.724 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.933 179.59 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 121.125 0.488 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -92.41 17.7 9.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.1 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 175.51 55.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.841 0.856 . . . . 0.0 109.79 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.418 ' CD2' ' HA ' ' A' ' 153' ' ' PRO . 30.0 m80 -138.57 160.8 38.69 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.474 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 18.6 m-30 -99.2 137.37 37.81 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.01 0.433 . . . . 0.0 111.867 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.794 HD11 HD23 ' A' ' 32' ' ' LEU . 3.7 mt -107.43 141.4 38.89 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.118 177.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.421 HD12 ' O ' ' A' ' 150' ' ' LEU . 2.8 mp -121.24 136.76 57.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 O-C-N 123.419 0.449 . . . . 0.0 110.006 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.23 124.83 28.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.027 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.3 mtt -109.78 157.54 37.35 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.211 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.78 30.93 0.52 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.686 2.257 . . . . 0.0 113.185 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -86.06 -18.89 31.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.65 -167.13 1.15 Allowed 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.068 0.23 . . . . 0.0 110.617 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.532 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.33 40.4 1.48 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.993 0.425 . . . . 0.0 111.737 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -111.98 80.88 3.32 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.883 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.8 Cg_exo -75.55 -22.99 13.34 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.045 2.497 . . . . 0.0 113.187 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -84.56 -34.97 23.12 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.933 0.493 . . . . 0.0 111.753 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.56 3.85 52.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.992 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 164.34 19.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.82 0.343 . . . . 0.0 111.82 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 49.04 31.1 3.16 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.5 p -116.87 154.7 30.32 Favored 'General case' 0 C--O 1.24 0.59 0 O-C-N 122.347 -0.221 . . . . 0.0 110.553 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.702 HG11 ' HE ' ' A' ' 167' ' ' ARG . 85.2 t -129.16 133.64 65.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-O 121.429 0.633 . . . . 0.0 110.832 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -113.85 153.78 28.6 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.755 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.463 ' OH ' HD21 ' A' ' 105' ' ' LEU . 32.4 t80 -107.66 118.77 37.62 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.794 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -83.73 109.97 17.93 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-O 121.465 0.65 . . . . 0.0 110.935 -178.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.938 HG23 ' HA2' ' A' ' 42' ' ' GLY . 33.5 t -72.03 -63.2 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.639 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.527 ' OE2' HD11 ' A' ' 100' ' ' LEU . 7.7 tt0 -134.11 118.49 17.78 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.592 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -103.67 127.49 51.11 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.737 0.303 . . . . 0.0 110.754 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -138.88 151.51 47.02 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.246 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.57 -12.64 54.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -108.2 1.91 22.45 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.416 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.7 166.2 16.01 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 121.608 -0.329 . . . . 0.0 112.335 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.556 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -147.32 146.27 29.64 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.85 136.95 54.27 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.078 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.97 161.71 32.13 Favored Glycine 0 C--O 1.228 -0.277 0 O-C-N 124.785 1.303 . . . . 0.0 112.573 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.9 mt -117.35 133.77 55.59 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.943 0.371 . . . . 0.0 111.267 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 78' ' ' GLY . 10.7 t -66.13 122.88 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.12 54.44 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.607 0.718 . . . . 0.0 112.104 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.852 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.6 t-20 -147.49 -3.93 0.53 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.145 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -129.56 87.82 51.78 Favored Pre-proline 0 CA--C 1.556 1.181 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.513 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 40.4 Cg_exo -58.74 143.15 99.11 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 121.716 1.611 . . . . 0.0 112.415 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.444 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 66.5 m -93.28 158.67 15.63 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.485 0.491 . . . . 0.0 111.497 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.14 51.04 1.06 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.658 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.42 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -133.17 156.1 48.09 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.961 0.448 . . . . 0.0 110.054 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 15.6 p-10 -112.23 158.25 19.93 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.552 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.6 HD23 ' SG ' ' A' ' 70' ' ' CYS . 15.5 tp -57.4 -37.09 72.15 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.46 -37.27 62.49 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 36.8 mt-10 -64.97 -42.48 94.53 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.006 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.867 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -62.63 -46.32 96.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.741 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.1 mp -54.37 -36.8 64.25 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 123.81 0.694 . . . . 0.0 110.674 177.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.76 -27.86 50.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.486 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.403 HE21 HD23 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -78.41 -30.41 47.72 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.309 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.867 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.2 mt -77.64 -44.95 26.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.848 -1.523 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -132.38 116.54 15.28 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.496 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -77.49 -33.13 2.56 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.619 2.879 . . . . 0.0 112.823 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.08 -13.87 56.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.398 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.46 149.72 24.24 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 123.382 0.426 . . . . 0.0 111.752 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.16 123.88 29.64 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.021 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.16 145.68 35.32 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.204 1.936 . . . . 0.0 112.444 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.8 Cg_endo -92.2 -169.78 0.28 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.652 2.235 . . . . 0.0 111.932 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.495 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -64.44 -24.95 67.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.04 0.536 . . . . 0.0 112.135 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -66.11 -53.17 41.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.696 ' HA ' HD12 ' A' ' 73' ' ' ILE . 61.6 m -71.79 -25.05 61.85 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 48.3 mt-30 -67.88 -35.81 79.15 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.495 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 21.4 p80 -90.52 23.78 2.87 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.164 0.507 . . . . 0.0 111.689 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 70' ' ' CYS . 53.5 mt -121.52 138.46 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.487 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.27 163.11 13.08 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.433 ' CD1' HD12 ' A' ' 128' ' ' ILE . 17.1 mm -112.25 153.41 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.141 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.716 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -117.36 155.62 29.27 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -85.67 118.57 25.25 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.825 0.284 . . . . 0.0 110.551 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.574 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.52 -23.72 8.22 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 120.05 -1.071 . . . . 0.0 114.135 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.46 -167.84 34.11 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.511 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.44 -14.44 3.16 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 123.526 2.817 . . . . 0.0 114.412 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.9 124.07 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 123.103 0.252 . . . . 0.0 111.036 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 50.84 77.0 0.14 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.196 0.999 . . . . 0.0 112.512 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.8 m -79.37 -12.86 59.91 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.561 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.7 0.51 52.56 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.589 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.16 153.73 51.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.589 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.47 132.38 11.08 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.137 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.786 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.76 145.7 27.13 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.486 1.114 . . . . 0.0 110.69 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.16 103.89 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.401 0.438 . . . . 0.0 110.771 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.873 HD11 HD13 ' A' ' 105' ' ' LEU . 13.7 tp -107.2 129.1 54.91 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.876 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -127.03 168.5 14.51 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-O 118.921 -0.561 . . . . 0.0 111.705 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.671 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.4 Cg_endo -97.03 12.2 1.05 Allowed 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 122.829 2.353 . . . . 0.0 113.793 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.9 t -99.76 160.67 14.12 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.791 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.96 21.12 47.88 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.532 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -86.73 154.2 21.14 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.625 0.37 . . . . 0.0 110.568 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.8 p -127.34 156.85 41.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.566 ' CE2' HG23 ' A' ' 113' ' ' VAL . 52.3 m-85 -129.19 -151.57 0.48 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.668 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -59.14 -46.5 88.19 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.547 0.339 . . . . 0.0 111.413 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 57.9 m -134.37 83.22 2.02 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.495 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.6 m -130.98 128.97 41.5 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.847 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.527 HD11 ' OE2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.57 124.23 50.16 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.506 178.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.38 128.17 34.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.089 0.471 . . . . 0.0 110.972 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.449 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.28 48.08 1.89 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.378 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.72 -109.86 3.14 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 114.724 -1.126 . . . . 0.0 113.056 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.09 -8.41 5.38 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.873 HD13 HD11 ' A' ' 89' ' ' LEU . 2.8 pp -152.84 152.77 31.94 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.29 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.612 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.74 157.16 28.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.839 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.566 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.8 ttm -121.13 126.63 50.23 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.711 ' HB3' HG11 ' A' ' 113' ' ' VAL . 22.9 m -122.7 128.78 51.0 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.834 0.349 . . . . 0.0 110.176 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.4 p -119.39 16.54 13.03 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.318 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.767 ' O ' HG12 ' A' ' 113' ' ' VAL . 11.6 t -88.9 127.61 35.65 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.515 0.674 . . . . 0.0 111.445 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.49 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 10.1 pt20 -59.98 -30.49 69.15 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.235 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -64.58 -42.15 95.81 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.732 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 110' ' ' SER . 4.5 p -67.78 -37.98 79.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.538 HD22 ' NH2' ' A' ' 85' ' ' ARG . 3.9 tp -59.27 -48.64 80.87 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 123.449 0.468 . . . . 0.0 110.19 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.49 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 36.8 m-85 -68.52 -38.25 80.71 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.959 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.68 -51.76 67.11 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.21 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.69 -43.43 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.304 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.3 -31.3 65.5 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.759 0.662 . . . . 0.0 109.6 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.23 -19.95 30.88 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.129 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.79 16.4 28.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 114.705 -1.134 . . . . 0.0 114.623 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.1 p -106.86 7.46 30.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.16 -138.18 9.71 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-O 119.23 -0.761 . . . . 0.0 112.625 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.85 173.68 11.8 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.205 2.603 . . . . 0.0 113.554 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.06 -54.57 45.3 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.735 0.814 . . . . 0.0 111.988 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.671 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.2 mmtt -140.98 143.7 34.63 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.82 -178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.0 m -141.09 165.01 28.72 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.0 tp -127.61 117.02 21.23 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.466 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.786 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.5 pt -98.33 102.46 13.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-O 121.934 0.873 . . . . 0.0 109.82 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.509 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 9.0 t -119.34 124.05 45.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.784 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.4 tp -67.09 113.73 5.29 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.385 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.82 175.16 8.49 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 114.665 -1.152 . . . . 0.0 114.576 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.49 176.3 7.85 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.342 0.591 . . . . 0.0 110.474 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -115.92 130.68 56.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.062 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.04 145.9 16.61 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.476 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -121.24 136.47 54.97 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.242 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.05 158.08 25.21 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.824 0.703 . . . . 0.0 110.746 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.78 90.71 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.24 -25.19 7.5 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.164 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -57.57 -44.24 85.16 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.9 -47.96 64.51 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.16 0.287 . . . . 0.0 110.634 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.52 -28.79 68.67 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.002 0.43 . . . . 0.0 110.665 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.82 -50.74 32.23 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.797 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.0 pt-20 -69.67 -26.62 64.47 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.845 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.91 -38.37 57.82 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.722 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -77.82 -28.42 50.26 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -83.2 0.75 44.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.426 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 59.41 29.11 18.63 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.796 0.838 . . . . 0.0 111.818 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.76 -43.18 18.74 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.956 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -124.38 114.29 19.33 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.9 tp -85.59 139.88 31.06 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.629 0.252 . . . . 0.0 111.418 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -104.46 137.31 42.52 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.038 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.0 m -150.94 154.88 34.9 Favored Pre-proline 0 N--CA 1.469 0.51 0 O-C-N 123.515 0.509 . . . . 0.0 110.909 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.418 ' HA ' ' CD2' ' A' ' 12' ' ' HIS . 31.7 Cg_exo -59.28 152.58 59.34 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.32 2.013 . . . . 0.0 111.055 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.474 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.76 167.84 16.71 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.76 135.62 23.74 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.105 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.3 -26.47 14.51 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 122.605 2.203 . . . . 0.0 113.66 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.39 -40.72 62.44 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 123.909 0.756 . . . . 0.0 112.19 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.609 HD13 HH12 ' A' ' 167' ' ' ARG . 4.9 mt -71.36 -34.96 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.304 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.32 -36.99 63.72 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.335 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -84.66 -35.47 22.6 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -84.71 -72.5 0.47 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.963 0.347 . . . . 0.0 111.726 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.676 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -141.82 99.02 6.24 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.852 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 70.9 Cg_endo -91.95 -0.29 4.31 Favored 'Trans proline' 0 CA--C 1.57 2.29 0 C-N-CA 121.773 1.649 . . . . 0.0 114.351 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.641 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 69.0 Cg_endo -74.87 -50.03 0.14 Allowed 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 122.738 2.292 . . . . 0.0 114.519 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.5 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.3 mt-10 -122.39 -33.98 3.36 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.713 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.676 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 8.4 mt-10 -68.86 -10.9 59.5 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.077 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.702 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.86 -41.8 42.54 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.091 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.9 tp -70.41 -50.07 42.33 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 44.3 m -58.49 -49.12 78.51 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.633 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.673 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.17 -39.82 94.82 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.129 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.15 78.53 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.608 0.568 . . . . 0.0 110.6 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.44 91.09 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.499 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.96 -27.85 69.12 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.611 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.84 -40.05 41.55 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 122.831 0.452 . . . . 0.0 110.355 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -68.58 -33.37 73.95 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.346 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.759 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.155 179.405 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 32' ' ' LEU . 10.5 mt . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.811 0.339 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -89.81 20.34 4.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.934 0.397 . . . . 0.0 111.242 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 174.53 55.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.126 0.971 . . . . 0.0 110.1 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -133.62 159.38 40.67 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.643 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.454 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.4 m-30 -97.3 135.72 38.81 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.85 HD11 HD23 ' A' ' 32' ' ' LEU . 2.8 mt -107.99 137.04 46.67 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.848 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.438 HG23 HG22 ' A' ' 29' ' ' VAL . 2.3 mm -117.01 133.88 62.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 O-C-N 123.493 0.495 . . . . 0.0 109.721 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.05 120.33 18.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.488 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 150' ' ' LEU . 91.4 mtp -110.18 154.88 42.61 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.22 77.71 3.89 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.59 2.193 . . . . 0.0 112.932 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -135.68 -19.41 1.6 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.025 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.98 -164.19 0.91 Allowed 'General case' 0 CA--C 1.541 0.631 0 O-C-N 123.191 0.307 . . . . 0.0 110.495 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.554 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.92 37.84 2.06 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.052 0.453 . . . . 0.0 111.856 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 7.9 m-20 -110.51 83.79 3.55 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.827 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.1 Cg_exo -75.26 -24.62 12.25 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.03 2.486 . . . . 0.0 113.442 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -85.09 -37.84 19.81 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.931 0.492 . . . . 0.0 111.573 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.53 -3.4 57.63 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.84 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -59.85 0.25 0.16 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -141.19 41.56 1.78 Allowed 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.234 0.54 . . . . 0.0 112.052 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.1 p -124.28 157.27 35.31 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.686 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.789 HG11 ' HE ' ' A' ' 167' ' ' ARG . 59.3 t -131.27 132.8 62.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.617 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -114.48 153.54 29.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.615 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.409 ' OH ' HD21 ' A' ' 105' ' ' LEU . 44.4 t80 -107.14 118.71 37.42 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.85 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.88 109.1 16.71 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.095 0.474 . . . . 0.0 111.232 -178.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.932 HG23 ' HA2' ' A' ' 42' ' ' GLY . 38.9 t -67.28 -62.53 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 113.853 -1.522 . . . . 0.0 110.515 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -140.54 115.68 9.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.163 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -98.22 127.46 44.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.604 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -139.29 152.93 47.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.48 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.551 ' HB3' ' NE2' ' A' ' 38' ' ' GLN . 17.9 tt0 -64.73 -21.02 66.66 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.405 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.551 ' NE2' ' HB3' ' A' ' 37' ' ' GLU . 1.7 mp0 -96.65 0.89 50.49 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.487 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.38 168.35 16.44 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 112.209 -0.356 . . . . 0.0 112.209 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.493 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.83 144.33 30.19 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -122.82 136.14 54.77 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.564 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.932 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.78 158.83 29.41 Favored Glycine 0 N--CA 1.447 -0.581 0 O-C-N 124.454 1.097 . . . . 0.0 112.529 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.6 mt -113.35 132.92 55.4 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.025 0.412 . . . . 0.0 111.129 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 78' ' ' GLY . 12.4 t -67.98 124.54 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.538 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -127.53 55.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.606 0.717 . . . . 0.0 112.196 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.846 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.0 t-20 -146.43 -3.3 0.64 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.072 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -130.11 89.82 44.09 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.477 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 52.6 Cg_exo -57.82 140.65 94.44 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 121.55 1.5 . . . . 0.0 111.763 174.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.407 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 56.4 m -71.23 -44.63 64.97 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.03 -15.94 56.17 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.226 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.66 162.06 16.52 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.506 0.323 . . . . 0.0 110.168 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.617 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 7.2 p-10 -100.92 160.63 14.21 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.725 ' HA ' HD11 ' A' ' 75' ' ' ILE . 4.7 tt -58.48 -28.65 65.55 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.076 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.617 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -62.07 -39.76 93.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.599 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.67 -46.98 85.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.637 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.86 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 17.1 m -62.32 -43.45 98.09 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.722 ' HA ' HD12 ' A' ' 60' ' ' LEU . 13.6 mt -56.94 -34.95 68.53 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.544 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -78.15 -27.34 48.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.262 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -30.65 51.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.129 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.86 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.8 mt -77.79 -45.48 24.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.789 -1.551 . . . . 0.0 111.12 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -131.7 116.16 15.96 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.631 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -77.71 -32.62 2.66 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.659 2.906 . . . . 0.0 112.755 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.1 -14.55 55.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.35 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.7 149.9 24.56 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.35 0.407 . . . . 0.0 111.685 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.5 mp -118.34 122.52 30.13 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.178 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.98 153.02 41.58 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.307 2.005 . . . . 0.0 112.26 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 7.1 Cg_endo -94.21 -165.31 0.12 Allowed 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.596 2.198 . . . . 0.0 112.263 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.445 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -71.38 -24.84 62.15 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.196 0.598 . . . . 0.0 111.964 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.448 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 12.0 ptp180 -67.1 -46.99 72.54 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.488 ' HA ' HD12 ' A' ' 73' ' ' ILE . 16.6 m -72.84 -25.57 61.16 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.439 ' HA ' HD22 ' A' ' 52' ' ' ASN . 48.8 mt-30 -70.54 -26.99 63.82 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.445 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 25.3 p80 -99.21 16.51 22.6 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 123.439 0.462 . . . . 0.0 111.722 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 70.0 mt -114.35 138.63 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.313 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.16 151.46 24.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.943 HD13 HD12 ' A' ' 128' ' ' ILE . 21.3 mm -102.61 151.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.613 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.747 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.9 t80 -118.27 155.23 30.94 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.625 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.94 121.34 28.43 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.35 -23.53 8.4 Favored Glycine 0 C--N 1.345 1.042 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.195 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.67 -167.77 35.31 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.313 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -88.59 -12.21 3.8 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.588 2.859 . . . . 0.0 114.358 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -86.37 128.75 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 123.07 0.231 . . . . 0.0 111.171 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 45.35 82.15 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.564 1.145 . . . . 0.0 113.132 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.0 p -84.04 -8.25 59.18 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.206 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.62 -3.87 59.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.621 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.72 152.98 51.6 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.621 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.58 135.39 12.82 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.073 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -86.16 146.16 26.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.304 1.042 . . . . 0.0 110.573 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.9 103.58 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 123.47 0.481 . . . . 0.0 110.533 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.923 HD11 HD13 ' A' ' 105' ' ' LEU . 11.4 tp -107.18 128.59 54.54 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.981 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -128.29 167.44 18.92 Favored Pre-proline 0 CA--C 1.554 1.122 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.799 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.689 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 17.9 Cg_endo -97.42 19.91 0.43 Allowed 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.67 2.247 . . . . 0.0 113.563 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.1 t -107.69 160.56 15.61 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.835 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.27 22.08 41.84 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.587 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -84.98 152.88 23.15 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 122.618 0.367 . . . . 0.0 110.487 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.7 p -128.0 156.81 42.13 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.571 ' CE2' HG23 ' A' ' 113' ' ' VAL . 56.4 m-85 -130.44 -150.97 0.45 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.726 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -58.91 -46.16 88.57 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.655 0.382 . . . . 0.0 111.511 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.8 m -137.41 82.64 1.94 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.285 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 107' ' ' MET . 12.8 m -127.77 123.42 35.25 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.425 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -102.71 120.92 41.42 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.744 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.53 125.01 29.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.172 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.571 ' HB3' HD12 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -119.51 43.59 2.59 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.722 -179.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.81 -100.59 0.29 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.264 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -56.08 -14.53 2.71 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.923 HD13 HD11 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -160.91 160.23 30.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.842 0.457 . . . . 0.0 110.951 -179.283 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.589 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -117.77 156.97 27.38 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.625 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.573 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.4 ttm -123.3 129.7 51.7 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.702 ' HB3' HG11 ' A' ' 113' ' ' VAL . 31.3 m -125.99 129.22 48.79 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.9 p -119.98 14.56 12.39 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.658 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.727 ' O ' HG12 ' A' ' 113' ' ' VAL . 68.3 m -87.14 130.15 34.65 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.425 0.631 . . . . 0.0 112.042 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.499 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 21.0 pt20 -61.45 -28.67 69.45 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.101 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.37 -44.14 92.3 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.452 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.4 p -67.9 -34.83 69.58 Favored 'Isoleucine or valine' 0 C--N 1.354 0.792 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.42 ' HG ' ' NH2' ' A' ' 85' ' ' ARG . 2.5 tm? -59.13 -49.61 77.22 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 123.693 0.62 . . . . 0.0 109.81 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.499 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 31.5 m-85 -67.19 -39.63 86.42 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.955 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -52.97 62.59 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.456 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.0 -43.86 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.524 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.428 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.93 -32.03 65.55 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.72 0.637 . . . . 0.0 109.594 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.448 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.69 -19.7 32.38 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.232 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.69 14.93 33.17 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.718 -1.128 . . . . 0.0 114.633 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.5 p -105.58 7.9 33.02 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.18 -138.35 9.14 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.283 -0.732 . . . . 0.0 112.731 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.64 168.02 18.25 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.141 2.561 . . . . 0.0 113.968 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.493 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -49.39 -59.67 3.52 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.537 1.135 . . . . 0.0 111.837 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.689 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.5 mmtt -141.43 139.81 33.48 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 69.5 m -138.02 169.07 18.43 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 tp -126.41 118.14 24.37 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.296 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.943 HD12 HD13 ' A' ' 75' ' ' ILE . 10.1 pt -96.95 102.14 13.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 121.465 0.65 . . . . 0.0 109.711 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 7.2 t -118.9 119.13 33.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.099 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.19 112.93 4.74 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.136 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 169.81 11.26 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.005 -0.998 . . . . 0.0 114.186 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.6 177.54 6.95 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.196 0.522 . . . . 0.0 110.83 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -117.72 131.93 56.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.51 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.47 149.67 18.72 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.363 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 24.4 m-90 -129.09 135.55 49.05 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 123.855 0.385 . . . . 0.0 110.465 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.05 158.17 29.3 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.784 0.678 . . . . 0.0 111.129 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.23 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.54 -26.75 6.83 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.935 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -55.93 -45.59 78.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.076 0.55 . . . . 0.0 112.06 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.2 tp -67.37 -47.16 71.21 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.58 -30.51 65.32 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.426 0.454 . . . . 0.0 110.747 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.5 -50.19 40.52 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.91 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -71.61 -26.64 62.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.945 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.3 tp -75.11 -39.21 60.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.937 0.895 . . . . 0.0 110.806 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 m -78.15 -30.21 49.09 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.553 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -80.38 0.19 34.24 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.701 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 60.42 29.47 19.04 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.757 0.823 . . . . 0.0 111.723 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.92 -42.46 19.46 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.813 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -123.97 112.07 16.77 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 123.383 0.427 . . . . 0.0 109.865 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.542 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 7.0 tp -83.57 138.65 33.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.275 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.5 p -103.6 137.66 41.35 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.578 0.549 . . . . 0.0 111.307 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 73.0 m -152.86 155.6 32.36 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.544 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.51 159.81 22.43 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.2 1.933 . . . . 0.0 111.366 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.454 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -131.74 167.24 19.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -134.85 135.14 22.68 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.941 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.45 -26.42 14.23 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 122.613 2.208 . . . . 0.0 113.81 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.89 -40.64 63.67 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.857 0.723 . . . . 0.0 112.147 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.569 HG21 HH11 ' A' ' 167' ' ' ARG . 4.5 mt -71.08 -35.52 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.348 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.74 -38.7 64.68 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.417 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.38 -32.36 22.44 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -87.01 -72.68 0.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.145 0.429 . . . . 0.0 111.656 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.92 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.79 98.81 6.29 Favored Pre-proline 0 C--N 1.35 0.608 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.846 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 62.4 Cg_endo -92.71 0.37 3.81 Favored 'Trans proline' 0 CA--C 1.57 2.306 0 C-N-CA 121.715 1.61 . . . . 0.0 114.288 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.644 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 98.0 Cg_endo -73.25 -52.41 0.15 Allowed 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.583 2.189 . . . . 0.0 114.245 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.513 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -122.82 -29.85 3.92 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.7 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.92 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.05 -11.14 60.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.437 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.789 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.02 -40.39 46.71 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -71.07 -50.21 36.33 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.6 m -58.49 -48.49 80.62 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.611 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.664 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.86 -40.16 94.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.298 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.43 -46.78 80.11 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 123.498 0.499 . . . . 0.0 110.368 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.83 88.81 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.406 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.27 -27.83 68.91 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.59 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.53 -39.79 44.89 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 122.841 0.456 . . . . 0.0 110.3 178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.2 -31.47 67.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.455 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.734 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.963 179.404 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 32' ' ' LEU . 12.6 mt . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.808 0.337 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -92.66 21.3 5.6 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.897 0.38 . . . . 0.0 110.686 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.3 t60 178.01 54.64 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.586 0.754 . . . . 0.0 110.268 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -139.17 160.14 40.5 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 30' ' ' THR . 11.5 m-30 -100.57 138.09 38.1 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.089 0.471 . . . . 0.0 112.021 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.769 HD11 HD23 ' A' ' 32' ' ' LEU . 4.3 mt -107.47 141.09 39.43 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.341 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.8 mp -120.73 134.32 64.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 O-C-N 123.522 0.514 . . . . 0.0 109.759 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.73 126.18 30.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.085 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.2 mtt -110.32 157.15 38.92 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.222 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.52 29.84 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.611 2.207 . . . . 0.0 113.188 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -86.14 -16.29 38.37 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.15 -167.45 1.22 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.009 0.193 . . . . 0.0 110.641 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.524 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.28 40.39 1.48 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.995 0.426 . . . . 0.0 111.694 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.32 80.5 3.45 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.781 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.2 Cg_exo -75.41 -21.92 14.64 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.008 2.472 . . . . 0.0 113.327 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -84.44 -36.07 22.61 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.966 0.507 . . . . 0.0 111.852 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.29 4.01 51.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.098 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.35 163.47 20.63 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.896 0.379 . . . . 0.0 111.849 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 49.4 32.04 4.33 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.2 p -117.55 153.66 32.83 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 120.469 0.176 . . . . 0.0 110.556 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.869 HG11 HH11 ' A' ' 167' ' ' ARG . 77.4 t -128.49 133.71 66.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.583 0.706 . . . . 0.0 110.596 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 6.2 m -114.76 152.98 31.15 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.87 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.492 ' OH ' HD11 ' A' ' 105' ' ' LEU . 13.2 t80 -106.29 118.63 37.13 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.769 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.84 108.55 16.27 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.432 0.634 . . . . 0.0 110.927 -179.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.93 HG23 ' HA2' ' A' ' 42' ' ' GLY . 35.8 t -68.89 -60.36 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 113.228 -1.805 . . . . 0.0 110.576 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -142.26 113.48 7.65 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.62 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -97.34 128.74 44.43 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.672 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -139.71 153.27 47.19 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.604 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.25 -18.82 65.62 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.701 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.44 0.88 43.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.414 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.88 166.99 15.44 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.37 143.4 30.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.47 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -124.62 137.95 54.34 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.341 178.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.93 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -160.23 158.65 30.03 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.531 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.433 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.2 mt -112.83 131.54 55.66 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.935 0.367 . . . . 0.0 110.939 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 78' ' ' GLY . 41.2 t -67.93 124.68 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.558 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.1 pt -129.85 55.35 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.524 0.678 . . . . 0.0 112.347 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.869 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 24.7 t-20 -144.27 -7.76 0.7 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.286 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.553 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -130.39 92.26 35.97 Favored Pre-proline 0 CA--C 1.555 1.145 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.514 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.5 Cg_exo -61.09 146.4 97.68 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 121.747 1.631 . . . . 0.0 112.602 175.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.43 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 44.9 t -89.14 162.96 15.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.557 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.69 -5.78 62.78 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-O 119.75 -0.472 . . . . 0.0 114.242 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -88.89 151.45 22.33 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.104 0.452 . . . . 0.0 111.566 -179.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.486 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 41.2 p-10 -98.55 165.74 11.68 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.655 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.65 ' HA ' HD11 ' A' ' 75' ' ' ILE . 13.9 tp -59.03 -26.88 64.96 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.617 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . . . -61.95 -42.5 99.18 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.486 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 41.4 mt-10 -62.39 -47.35 84.52 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.072 0.233 . . . . 0.0 111.492 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.882 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.7 m -61.68 -45.34 98.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.746 ' HA ' HD12 ' A' ' 60' ' ' LEU . 6.9 mt -54.48 -35.97 63.64 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.972 0.795 . . . . 0.0 110.742 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -78.13 -28.0 48.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.467 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.98 -30.38 50.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.375 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.882 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.1 mt -77.93 -46.62 20.7 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.749 -1.569 . . . . 0.0 111.376 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -131.89 118.18 16.42 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.003 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.33 -32.33 3.07 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.665 2.91 . . . . 0.0 112.56 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -82.22 -15.07 54.41 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.296 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.42 149.15 26.86 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.368 0.418 . . . . 0.0 111.425 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.57 121.78 31.59 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.743 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.671 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 46.4 Cg_endo -71.26 138.16 32.6 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.575 2.183 . . . . 0.0 112.423 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 2.7 Cg_endo -90.38 -157.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.733 2.289 . . . . 0.0 112.403 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.04 -25.07 52.1 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.249 0.62 . . . . 0.0 111.824 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.479 ' HA ' ' NE2' ' A' ' 72' ' ' HIS . 6.4 ptp180 -66.54 -46.14 77.12 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.671 ' SG ' ' HB2' ' A' ' 66' ' ' PRO . 18.5 p -67.49 -29.57 69.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 71.4 mt-30 -65.75 -32.85 74.63 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.479 ' NE2' ' HA ' ' A' ' 69' ' ' ARG . 32.9 p80 -95.37 9.94 38.11 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.432 0.458 . . . . 0.0 112.021 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 69' ' ' ARG . 71.0 mt -108.64 137.68 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.55 153.07 24.65 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.822 0.702 . . . . 0.0 112.711 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.761 HD13 HD12 ' A' ' 128' ' ' ILE . 25.6 mm -101.21 153.58 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.125 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.717 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -117.13 156.03 28.31 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.553 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 32.4 m-20 -89.26 117.4 28.19 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 117.832 0.287 . . . . 0.0 110.465 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.53 -23.24 9.0 Favored Glycine 0 C--N 1.35 1.358 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.817 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.53 -167.86 35.25 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.727 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -88.59 -14.74 2.97 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.501 2.801 . . . . 0.0 114.383 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -82.11 125.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 123.126 0.266 . . . . 0.0 111.166 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 45.36 89.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.582 1.153 . . . . 0.0 113.216 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.2 p -85.65 -10.17 56.17 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.931 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.26 -9.94 59.68 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.8 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.651 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -133.09 151.5 52.01 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.642 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -110.28 142.31 16.55 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.153 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.634 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.5 m-85 -86.77 149.37 24.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.077 -1.062 . . . . 0.0 110.528 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.6 ' HB ' ' OG ' ' A' ' 108' ' ' SER . 5.1 t -126.83 103.96 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 123.627 0.579 . . . . 0.0 110.194 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.912 HD11 HD13 ' A' ' 105' ' ' LEU . 16.0 tp -106.28 127.55 53.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.309 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -128.57 168.9 14.17 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.444 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.6 Cg_endo -97.31 17.75 0.56 Allowed 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.682 2.255 . . . . 0.0 113.555 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.5 t -105.32 158.86 16.33 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.895 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.34 22.23 41.98 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.483 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -84.62 155.09 22.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.661 0.384 . . . . 0.0 110.491 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.8 p -125.74 156.49 39.32 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.582 ' CE2' HG23 ' A' ' 113' ' ' VAL . 58.1 m-85 -131.5 -151.24 0.45 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.494 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -60.3 -46.55 89.47 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.44 0.296 . . . . 0.0 111.291 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.1 m -136.68 83.5 2.01 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.21 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 107' ' ' MET . 7.4 m -128.03 121.08 28.86 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.909 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -99.58 120.68 40.05 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.913 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.96 126.89 33.01 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.403 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.474 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -123.98 50.52 1.63 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.578 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.83 -111.94 4.28 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.151 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.77 -6.68 6.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 89' ' ' LEU . 2.5 pp -151.36 151.89 32.38 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.17 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.588 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -121.09 158.13 28.56 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.851 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.563 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 25.3 tpp -125.73 140.03 53.04 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.674 ' HB2' HG11 ' A' ' 113' ' ' VAL . 25.2 p -134.98 133.23 39.27 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.813 0.339 . . . . 0.0 110.435 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.4 p -118.76 15.44 13.54 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.0 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.713 ' O ' HG12 ' A' ' 113' ' ' VAL . 44.2 p -90.27 130.08 36.43 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.661 0.743 . . . . 0.0 112.424 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.485 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 20.3 pt20 -61.75 -27.01 68.42 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.401 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.28 -42.26 93.34 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.495 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.743 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.1 p -69.77 -38.3 75.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.513 HD13 HH12 ' A' ' 85' ' ' ARG . 6.4 tp -57.93 -48.46 79.87 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 123.68 0.613 . . . . 0.0 110.573 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.485 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 26.1 m-85 -68.77 -39.17 80.36 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.806 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.39 -53.0 62.28 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.306 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.35 -43.86 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.718 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.6 -32.1 64.93 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.782 0.676 . . . . 0.0 109.599 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.02 -20.01 31.11 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.291 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.67 13.82 33.83 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.668 -1.151 . . . . 0.0 114.799 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 p -103.83 6.48 36.61 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.38 -137.57 9.16 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.419 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.74 171.81 14.0 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.069 2.513 . . . . 0.0 113.493 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.19 -55.24 37.29 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.642 0.777 . . . . 0.0 111.998 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.646 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.0 mmtt -141.23 139.69 33.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.691 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 34.5 p -139.01 168.58 19.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.3 tp -126.97 117.38 22.4 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.804 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.761 HD12 HD13 ' A' ' 75' ' ' ILE . 12.4 pt -98.64 102.45 13.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-O 121.532 0.682 . . . . 0.0 109.536 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.0 t -121.24 122.32 39.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.025 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 tp -66.58 112.97 4.41 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.544 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 173.71 18.5 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 114.545 -1.207 . . . . 0.0 114.764 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -127.82 175.06 8.62 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.25 178.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -115.54 129.01 56.38 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.154 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.73 150.23 18.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.375 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -128.37 138.23 52.26 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.858 0.387 . . . . 0.0 110.344 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.71 157.65 27.13 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.885 0.741 . . . . 0.0 110.622 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.74 91.67 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.54 -23.51 8.95 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.322 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -57.44 -44.55 84.8 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.938 0.495 . . . . 0.0 112.14 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.9 tm? -67.87 -47.7 68.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.5 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.35 -30.0 68.08 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.05 -49.96 45.92 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.941 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -70.71 -26.76 63.55 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.694 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.4 tp -74.18 -38.98 63.51 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.602 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.9 m -77.84 -28.4 50.16 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.211 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 3.0 t70 -82.25 -1.42 49.29 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.395 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.2 m120 61.03 28.5 18.26 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.857 0.863 . . . . 0.0 111.903 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 143' ' ' GLU . . . -81.96 -43.54 17.91 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.856 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -124.77 113.38 17.86 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.0 tp -86.21 138.49 31.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.5 p -101.66 136.33 41.68 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.502 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 80.6 m -150.78 150.92 29.25 Favored Pre-proline 0 C--O 1.238 0.487 0 O-C-N 123.412 0.445 . . . . 0.0 110.983 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.05 151.06 83.97 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.233 1.956 . . . . 0.0 110.997 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -134.29 176.85 8.23 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -134.56 140.26 35.04 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 113.725 -1.58 . . . . 0.0 108.693 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.83 -26.71 13.14 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.735 2.29 . . . . 0.0 113.646 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.65 -41.79 55.78 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.857 0.723 . . . . 0.0 112.46 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.46 HG21 ' HE ' ' A' ' 167' ' ' ARG . 5.5 mt -68.83 -33.83 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.526 0.679 . . . . 0.0 110.276 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.66 -37.23 56.58 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.538 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -84.83 -31.21 23.96 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -88.7 -73.24 0.51 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 117.97 0.35 . . . . 0.0 111.628 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.862 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.82 99.8 6.12 Favored Pre-proline 0 C--N 1.35 0.589 0 CA-C-O 121.183 0.516 . . . . 0.0 112.228 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.869 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 72.4 Cg_endo -91.18 -0.11 4.79 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 121.711 1.608 . . . . 0.0 114.381 175.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.649 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 89.3 Cg_endo -74.92 -56.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.395 2.976 0 C-N-CA 122.653 2.235 . . . . 0.0 114.579 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.565 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 4.7 mt-10 -118.43 -30.67 5.15 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.542 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.862 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 28.5 tt0 -69.7 -12.18 61.43 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.235 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.869 HH11 HG11 ' A' ' 29' ' ' VAL . 3.7 tpm_? -77.1 -43.88 32.57 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.59 -49.2 64.25 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.4 m -58.21 -48.66 79.67 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.789 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.58 ' O ' ' HG3' ' A' ' 174' ' ' ARG . . . -63.25 -41.92 99.12 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.494 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.01 87.88 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.577 0.548 . . . . 0.0 110.82 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.51 -37.14 85.89 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.53 -28.19 69.48 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.152 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.58 ' HG3' ' O ' ' A' ' 170' ' ' ALA . 9.1 mtm105 -77.28 -40.78 43.31 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 123.291 0.636 . . . . 0.0 110.757 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 tp -69.61 -31.24 69.25 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.449 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.798 0 C-N-CA 121.129 -0.557 . . . . 0.0 113.046 179.475 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 32' ' ' LEU . 15.8 mt . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 121.112 0.482 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.42 ' O ' HD21 ' A' ' 102' ' ' LEU . 48.0 tttt -88.82 16.09 7.37 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.378 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 17.3 p80 172.83 58.87 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.43 1.092 . . . . 0.0 109.698 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -135.22 159.36 41.78 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.659 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.465 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.7 m-30 -97.1 136.17 38.01 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.813 HD11 HD23 ' A' ' 32' ' ' LEU . 3.2 mt -108.42 137.12 46.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.793 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.443 HG23 HG22 ' A' ' 29' ' ' VAL . 2.3 mm -117.04 133.23 64.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.545 0.528 . . . . 0.0 109.635 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.54 121.94 21.42 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 123.461 0.475 . . . . 0.0 111.666 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.6 mmt -110.47 152.91 43.63 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.338 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -80.45 73.96 5.77 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.594 2.196 . . . . 0.0 112.622 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -131.46 -19.22 2.75 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.716 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.58 -162.97 0.83 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.3 0.375 . . . . 0.0 110.481 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.73 36.66 2.24 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.869 0.366 . . . . 0.0 111.968 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.37 82.71 3.66 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.809 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.32 -24.87 11.93 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 123.019 2.48 . . . . 0.0 113.349 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -85.16 -37.11 20.57 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.887 0.475 . . . . 0.0 111.595 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.11 -3.04 57.46 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.8 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -60.51 1.62 0.13 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -141.46 41.48 1.75 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.213 0.53 . . . . 0.0 112.076 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.9 p -124.52 157.68 34.73 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.642 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.781 HG11 ' HE ' ' A' ' 167' ' ' ARG . 57.6 t -131.0 133.51 62.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.806 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -115.04 152.37 32.59 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.381 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.52 ' OH ' HD21 ' A' ' 105' ' ' LEU . 43.4 t80 -106.95 120.99 43.54 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.813 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -83.73 108.62 16.9 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 123.481 0.488 . . . . 0.0 111.419 -178.273 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.946 HG23 ' HA2' ' A' ' 42' ' ' GLY . 36.9 t -67.76 -59.97 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.623 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -141.93 120.8 12.75 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.433 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -102.35 127.94 49.13 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.988 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.84 151.85 47.35 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.418 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.3 -19.59 65.52 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.893 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -98.4 -1.63 41.07 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.681 0.613 . . . . 0.0 111.533 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.03 169.73 20.56 Favored Glycine 0 C--N 1.344 1.012 0 C-N-CA 121.529 -0.367 . . . . 0.0 112.304 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -146.32 146.97 30.88 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.81 135.74 53.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.363 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.946 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.21 158.36 29.13 Favored Glycine 0 N--CA 1.447 -0.619 0 O-C-N 124.472 1.107 . . . . 0.0 112.486 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.4 mt -112.9 134.59 54.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 117.253 0.526 . . . . 0.0 111.469 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 78' ' ' GLY . 12.0 t -68.35 122.94 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.38 56.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.618 0.723 . . . . 0.0 111.98 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.844 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.8 t-20 -147.04 -3.43 0.58 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.256 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -129.92 88.08 49.91 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.504 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 41.4 Cg_exo -58.44 144.62 96.42 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 121.689 1.593 . . . . 0.0 112.43 175.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.452 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 73.9 m -94.82 160.45 14.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.509 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.72 51.04 0.94 Allowed Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.687 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.488 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.6 OUTLIER -133.19 154.05 50.98 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.871 0.395 . . . . 0.0 110.042 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.61 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 10.3 p-10 -112.43 157.6 20.86 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.25 0.343 . . . . 0.0 110.918 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.567 HD12 HD13 ' A' ' 128' ' ' ILE . 1.6 tt -57.54 -26.66 61.71 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.61 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -67.94 -40.39 83.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.383 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.42 -45.57 86.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.092 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.86 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.6 m -61.88 -45.06 99.53 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.736 ' HA ' HD12 ' A' ' 60' ' ' LEU . 15.6 mt -55.74 -35.26 65.97 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.546 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.99 -27.25 49.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.429 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.82 -30.54 51.19 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.768 0.794 . . . . 0.0 109.318 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.86 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.2 mt -77.86 -46.01 22.64 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.038 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -130.99 116.63 16.91 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.626 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.56 -33.08 2.54 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.687 2.925 . . . . 0.0 112.785 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.63 -14.92 56.1 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.4 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.19 149.69 24.45 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 123.338 0.399 . . . . 0.0 111.689 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.06 123.13 29.09 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.304 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.52 154.15 39.86 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.296 1.997 . . . . 0.0 112.301 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.439 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 6.8 Cg_endo -94.14 -163.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.67 2.247 . . . . 0.0 112.064 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.437 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -74.05 -24.76 59.57 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.782 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.531 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 7.9 ptp180 -67.11 -46.49 74.04 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.638 ' HA ' HD12 ' A' ' 73' ' ' ILE . 20.8 m -73.31 -25.58 60.71 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.464 ' HA ' HD22 ' A' ' 52' ' ' ASN . 46.3 mt-30 -70.45 -29.09 65.57 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.437 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 25.7 p80 -96.09 21.31 8.96 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.16 0.505 . . . . 0.0 111.582 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' A' ' 70' ' ' CYS . 57.0 mt -119.53 137.12 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.204 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -106.06 163.12 13.02 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 51' ' ' LEU . 14.2 mm -113.63 154.18 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.996 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.733 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -118.11 155.83 29.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.594 0.358 . . . . 0.0 110.33 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -85.76 119.99 26.7 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.54 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -101.85 -23.64 9.15 Favored Glycine 0 C--N 1.346 1.109 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.158 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.86 -167.91 34.87 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.272 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -88.73 -13.03 3.39 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 123.618 2.878 . . . . 0.0 114.413 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.55 130.52 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 123.075 0.235 . . . . 0.0 111.518 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 46.66 82.85 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.551 1.141 . . . . 0.0 113.301 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 77.2 p -82.85 -12.02 57.76 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.197 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.76 -13.46 59.42 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.759 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -132.81 149.73 52.23 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.594 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.29 144.42 17.02 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.46 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.2 m-85 -86.85 149.4 24.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.021 -1.09 . . . . 0.0 110.94 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 17.4 t -127.32 105.93 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 O-C-N 123.587 0.554 . . . . 0.0 110.351 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.935 HD11 HD13 ' A' ' 105' ' ' LEU . 14.6 tp -106.74 127.63 53.55 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.281 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.41 ' ND1' ' HB3' ' A' ' 123' ' ' PRO . 4.0 p80 -128.08 168.41 15.53 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.548 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.667 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.3 Cg_endo -97.7 21.78 0.34 Allowed 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 122.677 2.251 . . . . 0.0 113.748 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.2 t -109.83 158.88 17.71 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.686 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.06 22.42 38.51 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.609 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.02 151.79 22.07 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.539 0.335 . . . . 0.0 110.514 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.598 ' HA ' HG21 ' A' ' 99' ' ' THR . 22.4 m -128.82 157.12 42.39 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.564 ' CE2' HG23 ' A' ' 113' ' ' VAL . 55.0 m-85 -126.95 -150.97 0.46 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.757 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -58.85 -46.32 88.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.655 0.382 . . . . 0.0 111.415 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.9 m -133.12 81.03 1.91 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.848 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.598 HG21 ' HA ' ' A' ' 95' ' ' SER . 42.4 m -129.49 122.62 29.64 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.381 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.33 123.48 46.89 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.879 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.88 130.13 34.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.979 0.419 . . . . 0.0 110.878 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.427 ' HB3' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -125.43 46.35 2.4 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.667 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.16 -106.85 1.65 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 114.863 -1.062 . . . . 0.0 113.381 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.28 -10.63 3.14 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.935 HD13 HD11 ' A' ' 89' ' ' LEU . 1.7 pp -155.22 152.15 28.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.609 0.364 . . . . 0.0 111.25 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.586 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.06 157.5 26.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.863 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.527 ' O ' ' HA ' ' A' ' 99' ' ' THR . 17.3 ttm -123.9 134.2 53.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.0 m -136.44 133.8 37.02 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.7 p -127.49 19.07 6.84 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.144 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 113' ' ' VAL . 46.8 p -90.16 131.19 36.14 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.393 0.616 . . . . 0.0 112.037 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.482 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 5.3 mt-30 -58.16 -26.96 63.36 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.759 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -64.12 -40.44 96.2 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.902 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.765 ' O ' HG22 ' A' ' 117' ' ' ILE . 2.6 p -71.1 -38.43 71.28 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.418 HD11 HH12 ' A' ' 85' ' ' ARG . 4.4 mm? -55.51 -50.1 70.85 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.533 0.521 . . . . 0.0 110.495 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.482 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 39.9 m-85 -67.8 -40.6 83.86 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.222 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.69 -54.17 48.48 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.753 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.765 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.11 -43.73 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.6 -32.27 65.08 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 123.674 0.609 . . . . 0.0 109.59 178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.531 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.66 -20.2 31.68 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.363 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.05 17.0 26.4 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.841 -1.072 . . . . 0.0 114.64 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.6 p -107.08 7.08 29.49 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.57 -137.29 8.74 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.113 -0.826 . . . . 0.0 112.47 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.41 ' HB3' ' ND1' ' A' ' 90' ' ' HIS . 2.1 Cg_endo -82.51 169.3 13.94 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.942 2.428 . . . . 0.0 113.652 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.61 -56.46 21.04 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.776 0.831 . . . . 0.0 112.106 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.667 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.5 mmtt -139.63 139.76 36.79 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.502 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 35.8 p -141.04 168.97 18.5 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.3 tp -125.63 115.18 19.72 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.695 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.567 HD13 HD12 ' A' ' 53' ' ' LEU . 7.9 pt -99.29 104.43 16.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 O-C-N 123.751 0.657 . . . . 0.0 109.229 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -124.55 122.08 36.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.21 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.34 113.64 5.39 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.346 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.433 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 73.87 167.92 16.04 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 115.093 -0.958 . . . . 0.0 114.461 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -128.64 179.95 5.4 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.115 0.483 . . . . 0.0 110.655 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -118.2 130.37 56.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.368 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.57 146.04 16.58 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.539 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 31.4 m-90 -122.31 135.71 54.77 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 122.655 0.382 . . . . 0.0 110.35 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.36 158.11 26.13 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.935 0.772 . . . . 0.0 110.663 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.1 90.86 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.14 -25.01 7.61 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.172 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -57.59 -44.17 85.2 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.938 0.495 . . . . 0.0 112.252 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.582 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.98 -47.57 65.25 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.118 0.261 . . . . 0.0 110.527 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.33 -29.22 68.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.088 0.47 . . . . 0.0 110.643 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.63 -50.66 34.63 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.788 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.1 pt-20 -69.57 -26.64 64.58 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.816 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.7 tp -75.2 -39.16 60.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.637 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.2 m -77.82 -27.83 50.13 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.492 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -82.96 0.1 46.14 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.518 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.5 m120 60.09 29.39 18.96 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.811 0.844 . . . . 0.0 111.761 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.61 -43.28 17.2 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.917 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -124.17 113.61 18.54 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.6 tp -83.92 139.22 32.73 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.205 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.3 p -104.66 138.1 41.48 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.32 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 24.7 p -152.88 155.5 32.27 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.595 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.08 158.24 26.41 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.259 1.972 . . . . 0.0 111.214 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.465 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.97 166.24 21.4 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.11 134.89 23.37 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 114.317 -1.311 . . . . 0.0 107.983 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.13 -26.47 14.86 Favored 'Trans proline' 0 C--N 1.364 1.354 0 C-N-CA 122.594 2.196 . . . . 0.0 113.616 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.67 -40.04 62.48 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 123.787 0.68 . . . . 0.0 112.211 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.567 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.6 mt -72.07 -35.1 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 121.411 0.624 . . . . 0.0 110.351 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.26 -37.22 63.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.343 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -85.45 -34.9 21.54 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -84.85 -72.16 0.49 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 117.98 0.354 . . . . 0.0 111.657 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.897 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.85 99.04 6.21 Favored Pre-proline 0 C--N 1.348 0.539 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.844 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.7 Cg_endo -91.99 -0.15 4.28 Favored 'Trans proline' 0 CA--C 1.569 2.259 0 C-N-CA 121.64 1.56 . . . . 0.0 114.253 175.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.642 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 81.3 Cg_endo -73.89 -52.34 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 122.539 2.159 . . . . 0.0 114.43 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.518 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.5 mt-10 -122.54 -30.19 3.95 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.672 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.897 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.8 tt0 -70.02 -10.84 60.01 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.338 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.781 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.91 -41.52 43.21 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.9 tp -70.62 -50.33 38.1 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.7 m -58.07 -49.61 76.32 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.666 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -63.66 -40.0 95.75 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.069 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.76 -45.32 78.11 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.54 0.525 . . . . 0.0 110.485 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 -38.35 90.77 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.497 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.95 -27.63 68.3 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.65 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -78.05 -40.29 39.18 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.963 0.505 . . . . 0.0 110.378 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.66 -32.76 71.6 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.353 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.757 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.944 179.47 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.4 mt . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 120.842 0.353 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.401 ' O ' HD21 ' A' ' 102' ' ' LEU . 85.3 mttt -90.06 18.68 5.59 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 120.893 0.377 . . . . 0.0 111.058 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.1 p80 176.82 55.49 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.04 0.936 . . . . 0.0 110.265 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -134.32 159.78 39.94 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.625 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.492 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 18.9 m-30 -98.6 136.59 38.47 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.035 0.445 . . . . 0.0 112.02 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.784 HD11 HD23 ' A' ' 32' ' ' LEU . 4.3 mt -108.34 141.86 39.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.919 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.674 HD11 ' SG ' ' A' ' 152' ' ' CYS . 2.3 mp -124.87 137.36 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 O-C-N 123.274 0.358 . . . . 0.0 110.351 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.05 120.13 19.22 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.748 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.5 mmt -97.86 159.0 31.95 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.565 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.04 6.81 4.36 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.678 2.252 . . . . 0.0 113.727 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -79.82 -12.94 59.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.303 0.241 . . . . 0.0 111.549 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.727 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -105.82 153.13 22.34 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.175 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.91 42.95 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.376 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.727 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.1 m-20 -116.55 87.6 21.47 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.526 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.51 -20.0 18.54 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.926 2.417 . . . . 0.0 113.331 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -84.52 -34.67 23.26 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.828 0.451 . . . . 0.0 111.708 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -94.02 3.83 54.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.024 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.72 163.65 21.12 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 48.87 32.07 3.54 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.9 p -116.29 154.22 30.55 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 120.568 0.223 . . . . 0.0 110.738 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.739 HG11 ' HE ' ' A' ' 167' ' ' ARG . 47.2 t -129.33 132.2 66.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.781 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 6.1 m -113.34 153.39 28.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.755 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.543 ' OH ' HD21 ' A' ' 105' ' ' LEU . 45.2 t80 -107.18 120.5 42.27 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.784 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -85.26 109.75 18.57 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.639 0.587 . . . . 0.0 111.128 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.95 HG23 ' HA2' ' A' ' 42' ' ' GLY . 34.9 t -69.13 -60.22 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 113.569 -1.651 . . . . 0.0 110.841 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -141.32 115.81 9.54 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.407 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -99.07 128.13 45.15 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.802 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -139.28 152.64 47.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.398 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.87 -18.98 65.64 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.787 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.45 2.35 42.09 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.536 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.46 166.79 15.01 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 121.517 -0.373 . . . . 0.0 112.375 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -144.91 145.82 31.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.457 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -125.56 136.82 53.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.966 178.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.95 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -160.93 159.78 31.37 Favored Glycine 0 N--CA 1.452 -0.284 0 O-C-N 124.575 1.172 . . . . 0.0 112.59 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.2 mt -115.12 135.08 54.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.08 0.44 . . . . 0.0 111.228 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 78' ' ' GLY . 11.0 t -66.83 124.11 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.551 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.65 54.08 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.538 0.685 . . . . 0.0 112.015 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.83 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.6 t-20 -147.32 -3.42 0.56 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.996 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -129.7 87.61 51.98 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.528 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 35.2 Cg_exo -59.73 142.45 98.74 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 121.658 1.572 . . . . 0.0 112.273 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.434 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.2 m -89.44 159.39 17.3 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.465 0.478 . . . . 0.0 111.589 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.84 48.54 1.47 Allowed Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.513 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mt -133.48 157.02 46.67 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 124.002 0.471 . . . . 0.0 110.141 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 18.4 p-10 -112.22 158.74 19.34 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.245 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.658 HD13 HD13 ' A' ' 128' ' ' ILE . 13.3 tp -57.53 -29.23 64.2 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.38 96.0 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.33 -47.02 77.96 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.865 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.3 m -62.06 -43.92 98.32 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.707 ' HA ' HD12 ' A' ' 60' ' ' LEU . 16.7 mt -57.34 -34.57 68.92 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.587 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -78.18 -27.72 48.0 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.325 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -30.29 51.97 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.263 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.865 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 14.7 mt -77.87 -45.55 23.9 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 113.667 -1.606 . . . . 0.0 111.056 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -130.94 116.01 16.81 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.609 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.43 -32.91 2.7 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 123.604 2.869 . . . . 0.0 112.744 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.36 -15.38 55.46 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.315 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.3 150.49 23.83 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.611 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.78 122.79 28.29 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.167 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.7 149.74 49.22 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.357 2.038 . . . . 0.0 112.189 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 8.7 Cg_endo -94.69 -171.5 0.23 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.639 2.226 . . . . 0.0 112.477 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.471 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -64.72 -24.79 67.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.113 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.53 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 7.4 ptp180 -68.73 -46.73 68.15 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.682 ' HA ' HD12 ' A' ' 73' ' ' ILE . 15.4 m -75.49 -25.44 57.31 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 52.3 mt-30 -68.63 -26.92 65.58 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.471 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 23.6 p80 -99.46 21.68 11.81 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.138 0.494 . . . . 0.0 111.318 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 70' ' ' CYS . 63.4 mt -117.79 139.1 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.268 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.18 154.62 20.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.707 HD13 HD12 ' A' ' 128' ' ' ILE . 23.5 mm -101.28 152.59 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.235 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.714 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.9 t80 -118.81 154.87 32.15 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -85.94 119.2 25.99 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.613 0.188 . . . . 0.0 110.555 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.577 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.29 -23.72 8.31 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.022 -1.085 . . . . 0.0 114.047 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.15 -168.24 35.11 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.359 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -88.66 -13.26 3.37 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.47 2.78 . . . . 0.0 114.37 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.3 t -82.39 125.19 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 123.082 0.239 . . . . 0.0 111.233 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 47.23 85.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.488 1.115 . . . . 0.0 113.027 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.41 ' O ' HD21 ' A' ' 130' ' ' LEU . 8.8 t -86.8 1.45 52.27 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.288 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -94.63 -4.23 48.08 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.633 ' NH2' ' HA ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -133.05 152.85 51.92 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.611 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.63 137.4 14.12 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.413 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.71 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.6 OUTLIER -86.49 144.55 27.2 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.029 0.932 . . . . 0.0 110.635 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -125.28 103.67 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 123.636 0.585 . . . . 0.0 110.046 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.884 HD11 HD13 ' A' ' 105' ' ' LEU . 15.5 tp -107.51 128.38 54.46 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.138 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -127.55 169.09 13.12 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.612 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.659 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.4 Cg_endo -97.25 15.2 0.75 Allowed 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.756 2.304 . . . . 0.0 113.818 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.4 t -102.77 159.91 15.06 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.668 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.76 22.47 37.7 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.636 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -89.4 153.01 21.19 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.56 0.344 . . . . 0.0 110.622 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.563 ' HA ' HG21 ' A' ' 99' ' ' THR . 13.6 m -130.31 156.65 44.32 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 112.196 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.569 ' CE2' HG23 ' A' ' 113' ' ' VAL . 46.4 m-85 -126.27 -150.59 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.844 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -56.78 -46.86 81.25 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.975 0.51 . . . . 0.0 111.633 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 m -134.5 82.25 1.96 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.86 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 107' ' ' MET . 30.4 m -130.1 124.51 32.92 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.229 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.71 123.54 47.22 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.844 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.21 129.22 34.9 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.081 0.467 . . . . 0.0 110.787 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.461 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.55 45.88 2.43 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.411 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.06 -105.87 1.33 Allowed Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.155 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.55 -10.67 3.65 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.884 HD13 HD11 ' A' ' 89' ' ' LEU . 2.2 pp -155.46 153.19 29.94 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 123.26 0.35 . . . . 0.0 111.392 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.623 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.39 156.2 29.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.716 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 99' ' ' THR . 18.6 ttm -122.52 130.58 53.19 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 m -131.52 130.86 42.9 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.8 p -120.36 18.63 12.17 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.549 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.746 ' O ' HG12 ' A' ' 113' ' ' VAL . 68.3 m -88.09 133.99 33.86 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.963 0.887 . . . . 0.0 112.694 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.633 ' HA ' ' NH2' ' A' ' 85' ' ' ARG . 3.9 mt-30 -62.7 -30.81 71.68 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.96 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.79 -40.31 95.02 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.735 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 110' ' ' SER . 3.5 p -70.46 -39.41 76.29 Favored 'Isoleucine or valine' 0 C--N 1.353 0.745 0 O-C-N 123.142 0.276 . . . . 0.0 110.502 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.618 HD22 ' NH2' ' A' ' 85' ' ' ARG . 4.2 tp -59.36 -46.54 88.36 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 123.471 0.482 . . . . 0.0 110.164 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.496 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 24.1 m-85 -67.22 -40.96 86.45 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 178.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -53.21 59.78 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.599 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.736 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.91 -43.57 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.527 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.483 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.33 -32.72 64.94 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.815 0.697 . . . . 0.0 109.59 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.53 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.89 -19.64 32.0 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.376 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.06 15.21 31.43 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.689 -1.141 . . . . 0.0 114.755 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 p -105.1 6.77 33.49 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.2 -137.35 8.99 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.481 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -81.62 172.6 12.2 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.046 2.497 . . . . 0.0 113.526 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.64 -55.16 37.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.695 0.798 . . . . 0.0 111.962 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.659 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.8 mmtt -141.76 139.74 32.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.656 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 36.6 p -139.02 167.82 21.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.0 tp -126.88 118.49 24.7 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.574 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.71 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.5 pt -98.46 102.18 13.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.575 0.703 . . . . 0.0 109.725 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.7 t -121.02 122.05 39.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.713 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.41 HD21 ' O ' ' A' ' 83' ' ' THR . 7.0 tp -67.33 118.03 10.14 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.464 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.86 173.24 5.63 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 114.763 -1.108 . . . . 0.0 114.524 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.41 175.5 8.46 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.179 0.514 . . . . 0.0 110.659 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -115.86 129.68 56.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.271 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.47 146.75 17.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.631 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -121.86 136.83 54.94 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.149 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.32 157.81 26.28 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.848 0.718 . . . . 0.0 110.786 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.23 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.51 -25.82 7.55 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.119 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -58.54 -44.22 89.52 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.885 0.474 . . . . 0.0 112.272 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.582 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.89 -47.58 65.5 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.16 0.287 . . . . 0.0 110.481 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.29 -29.55 68.9 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.014 0.435 . . . . 0.0 110.555 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.56 -49.91 49.79 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.84 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.32 -26.81 63.0 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.696 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.5 tp -74.55 -37.31 63.03 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.492 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.0 t -77.88 -29.83 50.51 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.712 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.0 t70 -84.11 1.15 45.54 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.072 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 52.63 33.98 14.85 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.841 1.256 . . . . 0.0 112.201 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 143' ' ' GLU . . . -81.53 -41.61 21.4 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.372 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -122.14 113.02 18.92 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.0 tp -83.92 136.18 34.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.5 p -101.13 136.91 40.22 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.967 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.674 ' SG ' HD11 ' A' ' 15' ' ' ILE . 26.2 p -150.79 154.98 35.42 Favored Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 123.458 0.474 . . . . 0.0 110.738 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.63 152.6 61.37 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.189 1.926 . . . . 0.0 110.989 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.492 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.93 167.45 17.41 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.74 134.22 21.9 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.943 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.87 -26.48 15.55 Favored 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 122.493 2.129 . . . . 0.0 113.434 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.14 -48.49 53.72 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 124.032 0.832 . . . . 0.0 111.441 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.586 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.7 mt -64.06 -34.87 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.371 0.668 . . . . 0.0 110.839 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -73.55 -35.62 65.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.281 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -83.66 -34.89 24.91 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 162' ' ' LEU . 2.2 p30 -86.81 -67.22 0.83 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.744 0.702 . . . . 0.0 112.729 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.67 ' C ' ' HD2' ' A' ' 164' ' ' PRO . 1.1 tp -145.73 98.98 4.44 Favored Pre-proline 0 C--N 1.344 0.333 0 CA-C-O 121.042 0.448 . . . . 0.0 111.786 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.83 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 65.7 Cg_endo -91.54 -0.14 4.56 Favored 'Trans proline' 0 CA--C 1.57 2.282 0 C-N-CA 121.795 1.663 . . . . 0.0 114.488 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.67 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 79.4 Cg_endo -74.67 -50.41 0.14 Allowed 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.76 2.307 . . . . 0.0 114.438 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.513 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 10.8 mt-10 -121.61 -33.98 3.51 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.705 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 6.0 mt-10 -68.6 -11.28 59.81 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.045 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.739 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.06 -41.7 41.32 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -69.82 -49.78 49.33 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.8 m -58.33 -49.05 78.58 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.682 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.67 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.39 -40.21 95.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.265 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.82 79.46 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 123.538 0.524 . . . . 0.0 110.489 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.69 88.27 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.466 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.25 -27.76 68.87 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.507 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.67 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.6 mmp_? -77.52 -40.03 44.12 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.899 0.479 . . . . 0.0 110.192 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -71.3 -31.29 67.26 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.461 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.806 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.911 179.603 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.736 ' HB3' ' ND1' ' A' ' 12' ' ' HIS . 14.2 mt . . . . . 0 C--O 1.239 0.504 0 CA-C-O 120.948 0.404 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.401 ' CG ' ' H ' ' A' ' 35' ' ' HIS . 75.0 mttt -89.53 26.77 1.63 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.95 0.405 . . . . 0.0 110.63 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 178.37 53.9 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.668 0.787 . . . . 0.0 109.979 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.736 ' ND1' ' HB3' ' A' ' 9' ' ' LEU . 6.9 p-80 -131.11 156.29 45.5 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.436 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 11.0 m-30 -98.68 133.72 42.61 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.843 0.354 . . . . 0.0 111.205 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 8.6 mt -106.58 140.98 38.59 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.299 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.21 131.19 73.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.25 132.84 38.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.885 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 55.5 mtt -121.46 156.6 57.93 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.191 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.85 75.83 4.61 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.629 2.219 . . . . 0.0 112.885 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -134.02 -21.99 1.84 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.787 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.57 -162.91 0.86 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.25 0.344 . . . . 0.0 110.382 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.536 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -101.79 32.94 3.19 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.1 m-20 -111.47 82.49 3.66 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.41 -24.17 12.45 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 123.034 2.489 . . . . 0.0 113.361 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -85.01 -37.81 19.96 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.953 0.501 . . . . 0.0 111.612 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.61 -3.4 57.57 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.791 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -60.83 1.93 0.13 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -141.33 39.37 1.74 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.191 0.519 . . . . 0.0 111.981 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.7 p -123.22 158.52 30.67 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.788 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.783 HG11 ' HE ' ' A' ' 167' ' ' ARG . 97.0 t -130.85 132.3 64.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.955 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -113.25 153.75 27.89 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.343 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.473 ' OH ' HD21 ' A' ' 105' ' ' LEU . 34.9 t80 -108.61 119.6 40.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.581 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.525 HD11 ' HB1' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -82.51 107.8 15.43 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 123.491 0.494 . . . . 0.0 111.295 -178.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.947 HG23 ' HA2' ' A' ' 42' ' ' GLY . 39.0 t -68.12 -60.65 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.203 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.515 ' OE1' HD11 ' A' ' 100' ' ' LEU . 12.8 tt0 -142.16 114.76 8.49 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.426 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.494 ' CE1' HD12 ' A' ' 9' ' ' LEU . 15.7 t-80 -96.75 129.78 44.11 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.9 151.54 47.03 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.068 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.39 -17.82 64.12 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -104.79 6.32 33.91 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.664 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.61 164.39 12.62 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 121.511 -0.376 . . . . 0.0 112.295 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -146.02 141.13 27.36 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.94 134.9 54.51 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.584 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.947 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.04 160.56 31.29 Favored Glycine 0 N--CA 1.449 -0.444 0 O-C-N 124.5 1.125 . . . . 0.0 112.573 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.5 mt -115.95 135.26 54.14 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.148 0.474 . . . . 0.0 111.503 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 78' ' ' GLY . 12.0 t -68.64 123.55 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.518 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.3 pt -126.83 56.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.679 0.752 . . . . 0.0 111.798 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.859 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.9 t-20 -147.45 -4.17 0.53 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.42 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -129.7 88.21 50.21 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.504 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.2 Cg_exo -59.58 142.26 98.57 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.655 1.57 . . . . 0.0 112.151 175.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.419 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 43.7 m -91.43 159.48 15.94 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.346 0.404 . . . . 0.0 111.574 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.53 46.76 1.24 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.362 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.488 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.69 155.1 51.12 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.473 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 14.7 p-10 -105.79 161.08 14.73 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.889 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.668 HD13 HD13 ' A' ' 128' ' ' ILE . 13.5 tp -58.77 -37.85 77.21 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.59 -36.58 56.44 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 37.4 mt-10 -64.37 -43.04 95.75 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.171 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.868 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -62.77 -46.48 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.739 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.5 mp -54.01 -36.77 63.35 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.858 0.724 . . . . 0.0 110.788 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.93 -28.22 49.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.525 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -30.05 48.82 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.358 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.868 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.1 mt -77.75 -45.03 25.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.945 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -132.3 116.48 15.35 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.543 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.5 -32.75 2.74 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.566 2.844 . . . . 0.0 112.803 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.29 -14.17 55.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.426 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.89 149.93 24.46 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 123.38 0.425 . . . . 0.0 111.716 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.3 123.65 29.79 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.046 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 56.5 Cg_endo -74.17 145.42 34.92 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 122.271 1.981 . . . . 0.0 112.371 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.7 Cg_endo -92.58 -171.34 0.33 Allowed 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.561 2.174 . . . . 0.0 111.978 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.502 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -63.15 -24.79 68.05 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.215 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.566 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.3 ptp180 -66.22 -53.27 39.16 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.693 ' HA ' HD12 ' A' ' 73' ' ' ILE . 60.7 m -72.38 -25.0 61.34 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 49.5 mt-30 -67.11 -35.69 80.3 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.502 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 20.2 p80 -91.62 23.99 3.28 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.256 0.551 . . . . 0.0 111.689 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 70' ' ' CYS . 55.8 mt -120.42 138.97 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.573 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.62 154.79 20.92 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.768 0.668 . . . . 0.0 112.639 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.767 HD13 HD12 ' A' ' 128' ' ' ILE . 16.6 mm -102.74 152.57 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.207 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.717 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.5 t80 -119.27 152.75 36.14 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -83.45 120.59 26.09 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.899 0.318 . . . . 0.0 110.796 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.6 -23.66 8.22 Favored Glycine 0 C--N 1.348 1.206 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.984 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.6 -167.86 35.29 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.333 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -88.66 -11.51 4.0 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.511 2.807 . . . . 0.0 114.378 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -86.06 127.34 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 123.054 0.221 . . . . 0.0 111.266 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 46.04 84.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.528 1.131 . . . . 0.0 113.289 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 p -85.69 -4.41 59.16 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.072 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.91 -5.64 59.2 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.729 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.614 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.43 154.27 50.92 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.614 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.28 133.69 11.8 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.986 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.731 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.61 145.07 27.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.377 1.071 . . . . 0.0 110.426 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.28 103.94 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 123.414 0.446 . . . . 0.0 110.726 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.877 HD11 HD13 ' A' ' 105' ' ' LEU . 14.1 tp -106.75 128.29 54.09 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.727 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.405 ' CE1' ' HB3' ' A' ' 106' ' ' ALA . 3.6 p80 -125.51 166.42 21.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-O 118.937 -0.554 . . . . 0.0 112.048 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.5 Cg_endo -96.16 14.84 0.97 Allowed 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.663 2.242 . . . . 0.0 113.59 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.8 t -101.93 160.84 14.14 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.808 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.65 19.42 54.77 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.794 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mp -85.62 154.1 21.93 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.481 0.312 . . . . 0.0 111.057 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 p -127.07 156.86 41.02 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.57 ' CE2' HG23 ' A' ' 113' ' ' VAL . 51.4 m-85 -129.8 -152.57 0.52 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.821 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -57.27 -46.43 83.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.847 0.459 . . . . 0.0 111.721 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.7 m -136.27 81.67 1.9 Allowed 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.209 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 107' ' ' MET . 11.3 m -129.33 126.84 39.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.691 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.515 HD11 ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -105.68 123.26 47.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.743 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -82.89 128.81 34.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.53 . . . . 0.0 110.763 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.476 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.54 46.69 2.25 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.337 -179.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.47 -107.95 2.2 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.04 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -61.22 -9.24 4.59 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.877 HD13 HD11 ' A' ' 89' ' ' LEU . 2.6 pp -154.29 152.39 30.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.41 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.641 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.14 156.74 28.17 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.706 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.568 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.8 ttm -121.45 127.21 50.88 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.712 ' HB3' HG11 ' A' ' 113' ' ' VAL . 20.2 m -123.84 129.47 51.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.182 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 58.7 p -119.57 15.12 12.81 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.71 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.741 ' O ' HG12 ' A' ' 113' ' ' VAL . 61.8 m -87.76 129.71 35.08 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.358 0.599 . . . . 0.0 111.872 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.483 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.6 pt20 -61.55 -29.4 69.99 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.158 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -64.98 -42.86 94.17 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.627 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 110' ' ' SER . 4.2 p -67.75 -38.17 79.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 O-C-N 123.171 0.294 . . . . 0.0 110.291 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.603 HD22 ' NH2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -59.13 -48.99 79.58 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 123.572 0.545 . . . . 0.0 110.323 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.483 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 32.0 m-85 -69.12 -37.52 78.39 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.995 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.04 -51.7 66.93 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.085 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.81 -43.44 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.257 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.1 -31.68 65.52 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 123.734 0.646 . . . . 0.0 109.544 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.566 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.74 -20.08 31.65 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.233 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.05 15.1 31.76 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.689 -1.141 . . . . 0.0 114.67 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.5 p -105.8 8.16 32.68 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.3 -138.49 9.91 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.203 -0.776 . . . . 0.0 112.774 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.9 172.11 13.49 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.283 2.656 . . . . 0.0 113.87 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.49 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -52.05 -57.23 10.16 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.417 1.087 . . . . 0.0 111.624 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.549 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -139.6 152.91 47.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.811 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.5 m -147.34 164.21 33.98 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.79 117.81 22.57 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.449 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.767 HD12 HD13 ' A' ' 75' ' ' ILE . 12.7 pt -98.44 102.35 13.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 121.842 0.83 . . . . 0.0 109.833 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 7.2 t -118.94 122.27 41.87 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.727 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -66.95 115.21 6.43 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.109 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.01 174.15 5.25 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.694 -1.139 . . . . 0.0 114.355 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -128.64 179.9 5.43 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.251 0.548 . . . . 0.0 110.842 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -117.43 130.49 56.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.215 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.86 139.56 11.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.757 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.402 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 32.6 m-90 -113.88 135.01 54.44 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.934 0.432 . . . . 0.0 110.151 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.62 158.03 25.8 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.887 0.742 . . . . 0.0 110.501 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.91 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 122.26 -26.11 6.48 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.015 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.71 -45.07 86.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.32 -47.93 66.22 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.156 0.285 . . . . 0.0 110.502 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.62 -28.54 68.62 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.411 0.445 . . . . 0.0 110.729 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.53 -51.13 30.83 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.74 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -69.47 -26.49 64.59 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.7 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.2 tp -75.37 -39.34 59.32 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.873 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.6 m -77.75 -28.46 50.72 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.532 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.8 t70 -82.93 0.55 43.92 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.438 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 59.31 28.89 18.35 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.777 0.831 . . . . 0.0 111.7 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.93 -43.4 19.82 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.304 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -125.69 118.07 24.83 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 4.8 tp -87.97 150.88 23.19 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.484 0.183 . . . . 0.0 111.357 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.54 HG22 ' NE2' ' A' ' 12' ' ' HIS . 80.8 p -111.25 137.11 49.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.792 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 78.6 m -149.86 154.5 37.36 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 123.315 0.384 . . . . 0.0 111.357 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.37 148.37 86.91 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.555 2.17 . . . . 0.0 110.993 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.436 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -123.21 166.92 14.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -135.53 134.53 21.09 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.929 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.46 -26.38 17.02 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.604 2.202 . . . . 0.0 113.542 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.91 -40.12 63.29 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.862 0.726 . . . . 0.0 112.116 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.578 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.8 mt -71.75 -35.66 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 121.382 0.611 . . . . 0.0 110.277 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.5 tt -73.65 -37.72 65.21 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.455 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -85.3 -34.71 21.82 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -84.92 -72.58 0.47 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 117.967 0.349 . . . . 0.0 111.627 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.897 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.28 98.97 6.56 Favored Pre-proline 0 C--N 1.348 0.529 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.859 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 66.3 Cg_endo -92.19 -0.05 4.15 Favored 'Trans proline' 0 CA--C 1.569 2.269 0 C-N-CA 121.702 1.601 . . . . 0.0 114.226 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.634 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 77.4 Cg_endo -74.03 -52.5 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.899 0 C-N-CA 122.605 2.204 . . . . 0.0 114.389 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.516 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.3 mt-10 -122.43 -29.92 4.03 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.707 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.897 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.9 tt0 -70.09 -10.89 60.21 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.37 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.783 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.83 -39.62 50.64 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.9 tt -72.64 -49.98 28.21 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.1 m -58.0 -47.96 81.47 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.508 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.671 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.96 -39.9 90.82 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.17 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.32 79.94 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 123.393 0.433 . . . . 0.0 110.594 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.23 -38.49 90.55 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.523 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.29 -28.55 69.79 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.601 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.86 -40.45 40.05 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 122.905 0.482 . . . . 0.0 110.35 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.98 -33.24 74.26 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.533 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.789 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.108 179.429 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.6 mt . . . . . 0 N--CA 1.47 0.538 0 CA-C-O 121.046 0.451 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -89.92 16.03 8.9 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.441 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 173.94 54.86 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.967 0.907 . . . . 0.0 110.518 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -133.14 163.58 28.96 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.303 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -100.69 140.73 34.55 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.242 0.544 . . . . 0.0 112.258 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.6 mp -111.75 137.49 49.59 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.185 -1.371 . . . . 0.0 109.807 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.511 HD12 ' O ' ' A' ' 150' ' ' LEU . 2.9 mp -119.98 136.2 57.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.81 127.21 32.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.117 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 33.1 mtt -110.79 157.88 37.26 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.196 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.12 29.36 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.577 2.184 . . . . 0.0 113.127 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -85.81 -17.62 35.2 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -167.76 1.26 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.088 0.242 . . . . 0.0 110.598 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.42 40.9 1.39 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.036 0.446 . . . . 0.0 111.732 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -111.92 80.69 3.18 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.844 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.5 Cg_exo -75.55 -23.06 13.27 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.036 2.491 . . . . 0.0 113.28 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -84.53 -34.96 23.18 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.916 0.487 . . . . 0.0 111.708 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.63 3.82 53.09 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.077 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.12 163.18 20.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.767 0.318 . . . . 0.0 111.807 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 49.69 32.32 5.05 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.9 p -118.22 154.82 31.59 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 122.395 -0.191 . . . . 0.0 110.508 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.685 HG11 ' HE ' ' A' ' 167' ' ' ARG . 68.7 t -128.54 134.7 64.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-O 121.416 0.627 . . . . 0.0 110.789 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.8 m -116.11 151.95 34.61 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.658 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.472 ' OH ' HD21 ' A' ' 105' ' ' LEU . 12.8 t80 -105.32 118.88 37.69 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.608 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -82.72 107.84 15.65 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.365 0.602 . . . . 0.0 110.065 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.951 HG23 ' HA2' ' A' ' 42' ' ' GLY . 23.5 t -71.87 -59.6 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.76 -178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -137.25 119.23 15.33 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.51 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -103.94 126.2 50.89 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -139.94 153.2 46.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.577 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.23 -18.34 65.23 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.522 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -98.31 -3.55 36.94 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.391 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.0 171.48 21.75 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 121.564 -0.35 . . . . 0.0 112.29 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -146.67 144.43 29.47 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.42 137.2 54.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.747 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.951 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.82 158.44 29.69 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.858 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.4 mt -115.6 134.67 54.82 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.952 0.376 . . . . 0.0 111.287 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 78' ' ' GLY . 6.1 t -68.75 121.73 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.27 54.71 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.586 0.707 . . . . 0.0 112.221 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.846 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 21.9 t-20 -148.7 -1.55 0.51 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.104 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -129.75 85.51 57.97 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.535 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.2 Cg_exo -60.55 144.79 99.56 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 121.74 1.627 . . . . 0.0 112.582 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.432 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.6 m -94.41 153.77 17.79 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.075 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.82 51.9 1.97 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.851 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mt -134.07 160.27 38.27 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.903 0.413 . . . . 0.0 110.28 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.3 p-10 -112.1 157.37 20.89 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.63 HD23 ' SG ' ' A' ' 70' ' ' CYS . 12.4 tp -58.02 -36.13 72.26 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.04 -39.27 66.06 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -63.48 -41.08 98.58 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.678 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.857 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.8 t -61.53 -50.29 80.94 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.669 ' HA ' HD12 ' A' ' 60' ' ' LEU . 5.0 mp -52.44 -36.39 54.38 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 123.975 0.797 . . . . 0.0 110.995 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.13 -28.53 48.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.489 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.521 HE21 HD23 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -78.44 -31.8 48.2 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.457 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.857 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.1 mt -77.5 -45.04 26.77 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.0 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -132.11 116.88 15.69 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.412 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.5 -33.11 2.56 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 123.65 2.9 . . . . 0.0 112.807 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.16 -14.02 56.28 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.462 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.3 149.81 24.29 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.33 0.394 . . . . 0.0 111.737 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.77 123.43 29.7 Favored Pre-proline 0 C--O 1.235 0.333 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.038 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 58.0 Cg_endo -74.88 145.34 31.81 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.217 1.944 . . . . 0.0 112.462 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.8 Cg_endo -92.15 -169.34 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.612 2.208 . . . . 0.0 111.895 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.499 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -64.89 -24.89 67.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.12 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -66.63 -51.56 54.92 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.701 ' HA ' HD12 ' A' ' 73' ' ' ILE . 59.6 m -72.74 -25.05 61.06 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 47.0 mt-30 -68.16 -35.3 77.85 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.499 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 21.6 p80 -90.92 22.98 3.35 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.099 0.476 . . . . 0.0 111.718 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 70' ' ' CYS . 61.2 mt -119.84 139.02 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.464 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.426 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.9 m-20 -104.65 156.71 17.74 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.854 0.721 . . . . 0.0 112.564 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 53' ' ' LEU . 28.8 mm -102.84 155.38 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.432 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.8 t80 -124.84 155.83 38.81 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -88.37 122.69 32.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 119.691 -0.195 . . . . 0.0 110.512 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -101.87 -23.68 9.12 Favored Glycine 0 C--N 1.351 1.413 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.793 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.77 -167.31 35.25 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.086 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -87.11 -10.56 5.71 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 123.266 2.644 . . . . 0.0 113.84 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.653 ' O ' ' HA3' ' A' ' 131' ' ' GLY . 4.1 t -86.19 126.74 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.178 0.299 . . . . 0.0 110.383 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 43.78 87.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.292 1.037 . . . . 0.0 113.099 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.583 ' O ' HD22 ' A' ' 130' ' ' LEU . 76.9 p -86.04 -12.44 50.2 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.306 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -84.94 0.26 51.86 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -132.7 153.57 51.02 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.96 126.0 7.97 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.35 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.643 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 0.2 OUTLIER -85.77 145.74 27.1 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.86 1.264 . . . . 0.0 109.92 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 t -121.57 103.53 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.741 0.305 . . . . 0.0 110.824 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 126' ' ' SER . 2.2 tt -99.43 126.76 45.39 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.477 ' CE1' ' HB3' ' A' ' 106' ' ' ALA . 3.9 p80 -131.86 164.11 45.27 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-O 118.93 -0.557 . . . . 0.0 112.193 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.2 Cg_endo -96.9 9.84 1.31 Allowed 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 122.733 2.289 . . . . 0.0 113.945 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.48 ' OG ' HD23 ' A' ' 94' ' ' LEU . 8.7 t -94.35 158.98 15.32 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.976 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.12 19.06 56.03 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.789 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.48 HD23 ' OG ' ' A' ' 92' ' ' SER . 4.6 mm? -86.8 154.24 21.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.431 0.292 . . . . 0.0 110.77 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 p -123.02 155.36 37.0 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.552 ' CE2' HG23 ' A' ' 113' ' ' VAL . 62.2 m-85 -130.57 -152.79 0.53 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.344 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -58.6 -47.24 84.97 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.896 0.316 . . . . 0.0 111.446 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 56.2 m -134.3 85.19 2.17 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.488 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 107' ' ' MET . 8.1 m -130.78 128.75 41.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.922 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.41 124.38 50.3 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.427 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.63 128.19 34.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.237 0.541 . . . . 0.0 111.172 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.458 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -121.48 47.2 1.9 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.214 -179.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.88 -106.81 1.69 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-N 114.706 -1.134 . . . . 0.0 113.081 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.38 -9.93 4.18 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.472 HD21 ' OH ' ' A' ' 31' ' ' TYR . 3.5 pp -156.27 160.44 39.76 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.53 0.332 . . . . 0.0 111.252 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.477 ' HB3' ' CE1' ' A' ' 90' ' ' HIS . . . -123.38 162.59 22.47 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 123.625 0.578 . . . . 0.0 110.526 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.643 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 22.4 ttm -123.6 130.18 52.27 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.676 ' HB3' HG11 ' A' ' 113' ' ' VAL . 47.6 m -124.7 127.94 48.04 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 120.844 0.354 . . . . 0.0 110.21 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.4 p -117.21 20.15 13.84 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.466 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.82 ' O ' HG12 ' A' ' 113' ' ' VAL . 43.1 p -98.18 127.75 44.29 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 122.011 0.91 . . . . 0.0 112.03 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.495 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 2.3 mt-30 -61.59 -25.96 67.67 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.314 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -64.54 -42.41 95.73 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.104 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.82 HG12 ' O ' ' A' ' 110' ' ' SER . 5.2 p -69.02 -38.18 78.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.98 -47.67 80.23 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 123.732 0.645 . . . . 0.0 110.303 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.495 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 28.2 m-85 -69.61 -39.8 77.02 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.068 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.3 -51.37 69.18 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.146 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.44 -43.31 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.123 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.49 -30.89 65.46 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.792 0.682 . . . . 0.0 109.731 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.56 -19.73 30.66 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.16 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.15 17.77 26.32 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.682 -1.145 . . . . 0.0 114.558 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.5 p -109.49 9.93 25.32 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.88 -138.5 9.5 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-O 119.374 -0.681 . . . . 0.0 113.038 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.26 173.08 12.92 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.338 2.692 . . . . 0.0 113.793 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.491 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -52.13 -56.64 13.19 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.258 1.023 . . . . 0.0 111.27 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -139.34 154.38 47.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.509 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.5 m -150.03 162.81 39.67 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.4 tp -129.93 115.79 17.7 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.872 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 16.4 pt -95.67 102.5 13.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-O 121.807 0.813 . . . . 0.0 109.242 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 59.7 p -125.07 130.65 52.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.263 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.583 HD22 ' O ' ' A' ' 83' ' ' THR . 16.2 mt -67.03 118.22 10.17 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.031 0.444 . . . . 0.0 111.372 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 81' ' ' VAL . . . 55.93 -172.86 1.53 Allowed Glycine 0 C--N 1.343 0.934 0 CA-C-N 114.232 -1.349 . . . . 0.0 115.012 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -128.53 -176.0 3.69 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.641 0.734 . . . . 0.0 111.358 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -119.39 130.38 55.28 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 113.866 -1.516 . . . . 0.0 108.367 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.37 152.3 19.12 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.667 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -129.88 136.92 50.08 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 124.011 0.477 . . . . 0.0 110.169 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.15 158.44 27.72 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.93 0.769 . . . . 0.0 110.631 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.47 89.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.96 -22.28 9.18 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.356 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -56.99 -47.44 80.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.985 0.514 . . . . 0.0 112.162 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.583 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.6 tp -66.89 -47.89 70.44 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.18 -29.95 64.1 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.43 0.456 . . . . 0.0 110.895 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.92 -49.32 47.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.042 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.6 pt-20 -72.45 -26.71 61.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.681 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 4.6 tp -75.43 -38.44 59.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.822 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.2 t -78.23 -30.44 48.78 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.286 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.5 t70 -80.3 0.92 30.8 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.604 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 60.79 28.33 18.08 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.981 0.912 . . . . 0.0 111.813 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.81 -42.53 19.56 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.639 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -123.55 111.14 15.91 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.938 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 15' ' ' ILE . 6.0 tp -85.31 130.82 34.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.67 0.272 . . . . 0.0 111.484 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.2 p -104.64 141.98 35.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.862 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.9 m -154.91 157.11 31.91 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.83 146.77 96.97 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.242 1.962 . . . . 0.0 111.188 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -131.66 175.86 8.82 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -133.18 139.93 35.78 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.278 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.73 -26.62 11.31 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 122.771 2.314 . . . . 0.0 114.015 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -49.98 -43.13 50.18 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.809 0.693 . . . . 0.0 112.355 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.692 HD13 HH12 ' A' ' 167' ' ' ARG . 4.7 mt -67.71 -32.88 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 121.504 0.669 . . . . 0.0 110.318 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.1 tt -75.29 -41.23 57.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.673 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.68 -24.39 25.25 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -90.18 -72.02 0.59 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.313 0.506 . . . . 0.0 110.944 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.878 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.09 98.58 6.15 Favored Pre-proline 0 C--N 1.348 0.538 0 CA-C-O 121.078 0.466 . . . . 0.0 112.171 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.846 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 64.8 Cg_endo -91.39 -0.17 4.66 Favored 'Trans proline' 0 CA--C 1.57 2.321 0 C-N-CA 121.691 1.594 . . . . 0.0 114.266 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.659 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 83.6 Cg_endo -74.14 -54.14 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.627 2.218 . . . . 0.0 114.554 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.553 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -121.74 -29.39 4.35 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.783 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.878 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.07 -12.24 61.46 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.321 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.692 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.1 -44.12 40.21 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -68.97 -50.37 49.67 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -57.61 -50.55 72.76 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.773 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 174' ' ' ARG . . . -61.68 -40.39 94.8 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.154 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.11 -46.38 82.66 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.625 0.578 . . . . 0.0 110.489 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.53 87.72 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.477 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.55 69.71 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.31 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 170' ' ' ALA . 7.9 mtm105 -77.16 -41.09 43.1 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.196 0.598 . . . . 0.0 110.893 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.7 tp -71.28 -29.86 65.57 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.542 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.789 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.797 179.597 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.7 mt . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 120.772 0.32 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -90.8 19.5 5.46 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 120.772 0.32 . . . . 0.0 111.349 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 15.8 p80 174.51 57.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.025 0.93 . . . . 0.0 110.174 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -135.13 159.57 41.11 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.859 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.479 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.8 m-30 -96.96 138.0 35.17 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.147 0.499 . . . . 0.0 112.29 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.681 HD11 HD23 ' A' ' 32' ' ' LEU . 1.7 mp -111.97 133.36 54.2 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.198 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.45 HG23 HG22 ' A' ' 29' ' ' VAL . 2.6 mp -119.02 133.12 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.56 122.8 19.77 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.036 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.9 mmt -103.83 160.46 26.01 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.262 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.31 20.6 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.713 2.276 . . . . 0.0 113.659 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -81.24 -14.94 56.93 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.581 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -113.53 160.8 18.12 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.606 0.363 . . . . 0.0 110.238 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.45 52.84 2.54 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.419 0.628 . . . . 0.0 112.084 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.581 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.2 m-20 -128.12 87.47 55.39 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.528 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.03 -13.92 21.21 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.924 2.416 . . . . 0.0 113.558 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -85.08 -38.27 19.32 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.388 0.43 . . . . 0.0 111.534 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -98.26 -1.36 42.07 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.606 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -63.65 2.52 0.44 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -139.57 42.3 2.02 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.276 0.56 . . . . 0.0 112.071 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.4 p -125.39 154.06 42.48 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.588 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.72 HG11 ' HE ' ' A' ' 167' ' ' ARG . 25.2 t -130.56 133.65 63.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.742 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -115.85 152.43 33.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.585 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.5 ' OH ' HD21 ' A' ' 105' ' ' LEU . 41.8 t80 -106.58 120.79 42.87 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.681 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -84.24 108.98 17.42 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.079 0.466 . . . . 0.0 111.043 -178.356 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.945 HG23 ' HA2' ' A' ' 42' ' ' GLY . 35.3 t -66.8 -60.18 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.732 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -144.66 115.54 7.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.304 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -97.78 128.22 44.27 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.45 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -139.58 153.3 47.36 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.69 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.55 -18.62 65.46 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.601 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.66 4.4 43.21 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.392 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.17 165.37 12.81 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.229 -0.349 . . . . 0.0 112.229 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.61 139.4 29.63 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.527 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -121.1 136.98 54.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.959 178.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.945 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.05 157.52 28.57 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 124.372 1.045 . . . . 0.0 112.465 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.2 mt -112.26 134.9 53.53 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.206 0.503 . . . . 0.0 110.957 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 78' ' ' GLY . 11.9 t -69.83 123.41 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.72 56.28 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.666 0.746 . . . . 0.0 112.117 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.85 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.0 t-20 -147.41 -2.45 0.59 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.115 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -130.27 88.52 47.57 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.498 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 47.5 Cg_exo -58.29 141.87 97.1 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 121.533 1.489 . . . . 0.0 111.86 174.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.412 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 8.9 t -77.79 -39.51 43.71 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.62 -8.7 74.28 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.873 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 5.7 mt -81.43 170.27 16.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.706 0.402 . . . . 0.0 110.161 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.646 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.9 p-10 -112.79 156.28 23.14 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.783 HD12 HD13 ' A' ' 128' ' ' ILE . 1.6 tt -57.69 -26.69 62.08 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 123.478 0.486 . . . . 0.0 111.992 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.08 99.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.959 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.521 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 34.1 mt-10 -63.01 -46.79 85.96 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.139 0.275 . . . . 0.0 111.586 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.872 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 20.5 m -62.0 -44.06 98.43 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.715 ' HA ' HD12 ' A' ' 60' ' ' LEU . 13.6 mt -56.66 -34.89 67.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.639 176.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.01 -27.64 48.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.327 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.402 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.93 -30.9 50.71 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.308 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.872 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.0 mt -77.83 -45.47 24.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.243 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -131.32 116.23 16.42 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.643 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -77.76 -32.73 2.57 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.637 2.891 . . . . 0.0 112.791 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.95 -14.52 55.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.374 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.98 149.5 24.73 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.382 0.426 . . . . 0.0 111.667 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.74 122.91 30.19 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.239 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.5 149.55 34.89 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.277 1.985 . . . . 0.0 112.374 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 8.2 Cg_endo -94.59 -167.53 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.631 2.22 . . . . 0.0 112.56 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.94 -24.57 64.29 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.288 0.635 . . . . 0.0 112.095 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.443 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 11.6 ptp180 -67.9 -48.21 66.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.711 ' HA ' HD12 ' A' ' 73' ' ' ILE . 24.5 m -72.58 -26.13 61.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.169 0.587 . . . . 0.0 112.338 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.449 ' HA ' HD22 ' A' ' 52' ' ' ASN . 43.4 mt-30 -70.86 -27.54 63.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.674 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -95.39 16.72 16.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.61 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 70' ' ' CYS . 53.9 mt -120.07 139.41 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.666 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 1.8 m-20 -104.92 155.64 18.76 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.804 HD13 HD12 ' A' ' 128' ' ' ILE . 22.9 mm -107.17 150.45 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.206 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.734 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -119.2 157.08 28.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.588 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -87.98 122.2 31.3 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.0 -23.6 9.09 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 120.263 -0.97 . . . . 0.0 114.257 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.91 -167.81 34.87 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.289 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -88.75 -11.67 3.86 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.635 2.89 . . . . 0.0 114.421 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.09 131.85 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.569 0.223 . . . . 0.0 111.375 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 45.18 89.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.632 1.173 . . . . 0.0 113.503 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -87.02 1.04 54.15 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.378 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -92.7 -18.31 23.14 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.629 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -133.17 147.44 52.06 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.373 0.421 . . . . 0.0 111.441 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.601 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -113.34 151.01 18.44 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.149 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.404 ' CE2' ' SD ' ' A' ' 107' ' ' MET . 1.2 m-85 -86.66 151.33 23.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.951 -1.124 . . . . 0.0 110.829 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 3.6 t -127.76 107.99 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.087 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.898 HD11 HD13 ' A' ' 105' ' ' LEU . 13.8 tp -104.93 127.74 52.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.619 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.405 ' ND1' ' HB3' ' A' ' 123' ' ' PRO . 3.4 p80 -124.37 162.18 43.59 Favored Pre-proline 0 CA--C 1.552 1.022 0 O-C-N 123.653 0.596 . . . . 0.0 111.59 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.0 Cg_endo -97.42 28.89 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.802 2.334 . . . . 0.0 113.579 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.0 t -115.69 156.73 25.39 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.63 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.74 23.18 35.31 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.817 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.01 153.17 21.49 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.472 0.309 . . . . 0.0 110.523 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.7 p -121.55 153.25 38.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.664 ' CD2' HG12 ' A' ' 113' ' ' VAL . 28.5 m-85 -132.89 -151.13 0.44 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.834 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -61.02 -48.69 80.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.791 0.436 . . . . 0.0 111.267 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 108' ' ' SER . 38.3 m -134.01 79.05 1.79 Allowed 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.243 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.3 m -126.72 115.95 20.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.956 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.49 122.18 42.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.859 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.97 128.45 34.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.095 0.474 . . . . 0.0 111.15 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.449 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.63 46.76 2.15 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.482 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.93 -107.6 2.02 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 114.819 -1.082 . . . . 0.0 113.25 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.88 -10.28 3.83 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.898 HD13 HD11 ' A' ' 89' ' ' LEU . 1.8 pp -155.06 153.15 30.46 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.335 0.397 . . . . 0.0 111.167 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.558 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -117.17 158.05 24.92 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.884 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.594 ' O ' ' HA ' ' A' ' 99' ' ' THR . 16.0 ttm -122.52 135.17 54.58 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 98' ' ' SER . 15.9 m -136.18 134.35 38.11 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 81.1 p -125.42 21.36 7.89 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.64 0.587 . . . . 0.0 111.836 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.877 ' O ' HG22 ' A' ' 113' ' ' VAL . 51.6 m -91.12 131.63 36.56 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.944 0.878 . . . . 0.0 112.885 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.614 ' HA ' HD12 ' A' ' 114' ' ' LEU . 5.2 mt-30 -61.91 -26.16 68.0 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.419 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.39 -45.45 90.99 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.493 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 110' ' ' SER . 18.6 m -62.28 -43.46 98.04 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.614 HD12 ' HA ' ' A' ' 111' ' ' GLN . 29.3 mt -54.82 -51.48 65.7 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.864 0.727 . . . . 0.0 112.177 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.471 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 43.2 m-85 -65.63 -45.64 82.28 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.4 -52.7 64.49 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.865 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.841 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.4 tp -64.22 -43.91 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.45 -31.18 65.67 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.793 0.683 . . . . 0.0 109.683 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.443 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -85.3 -20.43 30.03 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.156 176.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.26 18.01 22.96 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.731 -1.122 . . . . 0.0 114.581 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.2 p -109.42 7.83 25.11 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.25 -137.51 9.37 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.583 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.405 ' HB3' ' ND1' ' A' ' 90' ' ' HIS . 5.9 Cg_exo -79.82 168.11 19.63 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.251 2.634 . . . . 0.0 113.519 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.484 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -50.94 -57.79 7.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.31 1.044 . . . . 0.0 111.789 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.486 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.7 mmtt -138.48 157.27 46.52 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.619 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 40.8 m -149.99 162.89 39.48 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.9 tp -126.41 113.96 17.57 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.744 177.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.804 HD12 HD13 ' A' ' 75' ' ' ILE . 10.1 pt -98.81 104.59 16.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.492 0.663 . . . . 0.0 109.507 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.3 t -125.0 124.88 42.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.508 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.608 ' O ' HD12 ' A' ' 130' ' ' LEU . 2.1 pp -67.12 117.2 8.82 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.095 0.474 . . . . 0.0 111.738 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.99 174.69 4.4 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.259 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -128.47 -179.87 5.28 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.334 0.588 . . . . 0.0 111.027 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -116.31 130.63 56.87 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.227 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.55 153.01 19.75 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.488 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -134.17 137.87 44.76 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.84 0.377 . . . . 0.0 110.666 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -78.1 158.36 29.16 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.904 0.753 . . . . 0.0 110.822 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.79 92.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.28 7.72 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.134 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -56.01 -47.38 77.89 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.082 0.553 . . . . 0.0 112.125 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.58 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 16.3 tp -67.51 -46.45 72.85 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.31 -30.54 64.85 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.443 0.465 . . . . 0.0 110.693 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -71.06 -49.33 45.91 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.013 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -72.1 -26.76 62.26 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.749 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.1 tp -75.3 -38.73 60.16 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.84 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.6 m -78.03 -29.91 49.65 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.355 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.17 0.17 33.48 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.533 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 61.29 29.37 18.6 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.89 0.876 . . . . 0.0 111.712 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.94 -41.91 16.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.516 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.404 ' HE1' ' CE ' ' A' ' 20' ' ' MET . 13.2 m95 -122.9 109.62 14.38 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.328 0.393 . . . . 0.0 110.113 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.01 128.46 34.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.387 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.1 p -102.33 141.81 34.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.039 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 80.2 m -155.37 158.6 31.97 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.315 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -57.44 153.93 38.45 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.215 1.943 . . . . 0.0 111.429 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.479 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.33 169.2 14.51 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -177.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -134.93 135.06 22.39 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 114.264 -1.334 . . . . 0.0 107.934 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.77 -26.59 13.37 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.64 2.226 . . . . 0.0 113.907 -177.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -51.95 -40.64 61.16 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.874 0.734 . . . . 0.0 112.284 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.573 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.6 mt -71.42 -34.49 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 121.378 0.609 . . . . 0.0 110.328 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.22 -38.47 63.54 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.253 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -84.25 -33.86 23.97 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -85.63 -72.67 0.48 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.026 0.375 . . . . 0.0 111.69 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.892 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.35 99.22 6.48 Favored Pre-proline 0 C--N 1.348 0.54 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.85 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.3 Cg_endo -92.02 -0.03 4.26 Favored 'Trans proline' 0 CA--C 1.57 2.301 0 C-N-CA 121.677 1.585 . . . . 0.0 114.26 175.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.644 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 88.0 Cg_endo -73.85 -52.55 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 122.63 2.22 . . . . 0.0 114.388 -178.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.518 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.61 -30.37 3.91 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.694 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.892 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -69.73 -11.14 60.62 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.303 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.72 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.54 -42.95 41.22 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.255 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -69.18 -50.68 45.37 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.2 m -57.76 -50.7 72.35 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.734 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.646 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -62.85 -38.57 91.36 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.07 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.27 -45.43 80.11 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.664 0.602 . . . . 0.0 110.441 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.45 91.04 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.552 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.36 -29.12 70.2 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.667 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.99 -40.19 39.95 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 122.865 0.466 . . . . 0.0 110.423 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.14 -34.02 76.67 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.485 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.771 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.272 179.477 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.668 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 7.0 mp . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -41.98 9.45 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.612 ' N ' ' O ' ' A' ' 9' ' ' LEU . 13.0 p-80 177.02 52.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.144 0.978 . . . . 0.0 110.513 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -141.82 166.08 25.7 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.759 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 30' ' ' THR . 14.2 m-30 -104.54 138.54 40.74 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 6.4 mt -107.19 143.38 35.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.405 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 mp -123.47 137.71 55.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.462 0.476 . . . . 0.0 110.128 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.47 123.48 26.61 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.837 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 mmt -106.32 157.09 35.75 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.202 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.6 30.58 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.678 2.252 . . . . 0.0 113.248 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -87.32 -15.56 37.65 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.93 -168.35 1.41 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 123.075 0.234 . . . . 0.0 110.703 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.541 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.82 41.87 1.28 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.082 0.468 . . . . 0.0 111.628 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -111.32 81.05 2.78 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.916 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.3 Cg_exo -75.49 -22.24 14.18 Favored 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 123.017 2.478 . . . . 0.0 113.312 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -84.62 -36.3 22.11 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.875 0.47 . . . . 0.0 111.867 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.8 3.72 53.64 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.021 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.42 163.77 20.16 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 48.75 32.15 3.47 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.2 p -116.68 154.27 30.87 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 122.367 -0.208 . . . . 0.0 110.573 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.739 HG11 ' HE ' ' A' ' 167' ' ' ARG . 60.3 t -129.05 132.69 67.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-O 121.515 0.674 . . . . 0.0 110.857 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.2 m -114.48 154.39 28.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.691 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.461 ' OH ' HD11 ' A' ' 105' ' ' LEU . 13.2 t80 -110.22 115.7 30.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.668 ' HB3' ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -81.08 110.63 16.79 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.684 0.754 . . . . 0.0 110.566 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.975 HG23 ' HA2' ' A' ' 42' ' ' GLY . 32.2 t -71.18 -63.93 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 112.819 -1.991 . . . . 0.0 110.614 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.426 ' OE1' HD11 ' A' ' 100' ' ' LEU . 12.3 tt0 -132.51 117.63 18.24 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.96 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -106.92 127.91 53.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.733 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -138.9 153.45 48.27 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.22 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -64.82 -15.63 62.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -104.88 5.41 32.93 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.687 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.6 164.72 12.64 Favored Glycine 0 C--N 1.344 1.015 0 C-N-CA 121.486 -0.388 . . . . 0.0 112.35 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.645 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -144.73 146.46 32.19 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.482 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -125.97 137.58 53.69 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.954 178.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.975 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.72 159.95 30.66 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.83 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.436 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.4 mt -114.62 130.66 56.81 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.703 0.252 . . . . 0.0 110.837 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 78' ' ' GLY . 20.7 t -65.96 125.39 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -128.44 55.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.542 0.686 . . . . 0.0 112.408 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.842 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.8 t-20 -147.63 -3.61 0.53 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.265 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -129.78 87.84 51.05 Favored Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.51 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 35.3 Cg_exo -59.09 141.91 98.73 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 121.578 1.518 . . . . 0.0 112.277 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 59.9 m -88.64 161.96 16.59 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.364 0.415 . . . . 0.0 111.561 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.96 44.69 1.43 Allowed Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.37 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.463 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.97 150.95 50.44 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.1 p-10 -100.52 161.4 13.62 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.268 0.355 . . . . 0.0 110.939 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.678 ' HA ' HD11 ' A' ' 75' ' ' ILE . 12.3 tp -58.7 -37.58 76.4 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.16 -37.14 53.64 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.96 -43.68 95.05 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.206 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.859 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 1.3 t -62.8 -45.77 98.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.742 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.5 mp -54.55 -36.51 64.4 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.702 0.626 . . . . 0.0 110.618 177.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.9 -27.86 49.65 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.466 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.16 -30.14 49.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.283 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.859 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.9 mt -77.75 -45.12 25.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.945 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -132.26 116.24 15.32 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.524 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.62 -32.64 2.71 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.604 2.869 . . . . 0.0 112.769 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.3 -14.15 55.84 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.361 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.86 149.68 24.65 Favored 'General case' 0 C--N 1.345 0.389 0 O-C-N 123.323 0.389 . . . . 0.0 111.754 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.65 123.88 29.98 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.02 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 55.4 Cg_endo -73.82 144.68 35.25 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.226 1.951 . . . . 0.0 112.408 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.458 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.6 Cg_endo -92.52 -170.98 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.566 2.177 . . . . 0.0 111.974 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -63.37 -24.89 68.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.297 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -66.15 -54.17 28.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.701 ' HA ' HD12 ' A' ' 73' ' ' ILE . 61.3 m -71.58 -25.05 62.03 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 50.4 mt-30 -66.91 -36.02 81.32 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.5 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 19.9 p80 -91.55 23.18 3.6 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.147 0.498 . . . . 0.0 111.65 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 70' ' ' CYS . 56.8 mt -119.47 140.04 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.517 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.56 154.91 22.08 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.692 0.62 . . . . 0.0 112.498 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.763 HD13 HD12 ' A' ' 128' ' ' ILE . 24.4 mm -103.53 153.66 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.093 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.709 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -117.31 155.95 28.65 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.57 118.92 26.3 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.844 0.293 . . . . 0.0 110.698 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.575 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.08 -23.62 8.46 Favored Glycine 0 C--N 1.348 1.242 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.976 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.76 -167.9 35.4 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.293 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -88.35 -11.38 4.31 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 123.313 2.675 . . . . 0.0 114.263 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.61 126.91 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 123.12 0.263 . . . . 0.0 110.893 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 48.81 82.16 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.309 1.043 . . . . 0.0 112.91 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.473 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.1 t -84.75 1.55 46.14 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -99.13 -0.66 41.22 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.603 ' NH2' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -133.09 153.27 51.66 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.586 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.83 133.34 11.6 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.434 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.75 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.8 OUTLIER -85.75 150.87 24.27 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.321 1.048 . . . . 0.0 110.288 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.1 t -127.11 104.81 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 123.429 0.455 . . . . 0.0 111.039 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.9 HD11 HD13 ' A' ' 105' ' ' LEU . 15.2 tp -106.67 127.66 53.54 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.821 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -129.14 169.44 13.1 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.38 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.654 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.6 Cg_endo -97.13 18.06 0.55 Allowed 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.65 2.233 . . . . 0.0 113.52 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.4 t -105.85 159.73 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.951 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.2 20.62 49.31 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.501 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -84.21 154.44 23.04 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.645 0.378 . . . . 0.0 110.438 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.0 p -126.78 157.22 39.75 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.579 ' CE2' HG23 ' A' ' 113' ' ' VAL . 53.0 m-85 -129.51 -150.9 0.45 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.418 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -60.2 -46.84 88.36 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.418 0.287 . . . . 0.0 111.25 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.8 m -135.63 83.05 1.99 Allowed 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.338 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 107' ' ' MET . 7.8 m -129.34 124.39 34.17 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.868 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.426 HD11 ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.93 123.94 46.7 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.902 178.627 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -88.74 130.56 35.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.103 0.478 . . . . 0.0 110.748 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.14 48.67 2.18 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.314 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.47 -106.76 1.64 Allowed Glycine 0 C--N 1.334 0.433 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.279 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.06 -10.18 4.0 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.9 HD13 HD11 ' A' ' 89' ' ' LEU . 2.5 pp -155.44 155.19 33.09 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.206 0.317 . . . . 0.0 111.561 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.593 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -125.14 157.73 35.66 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.875 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.598 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 27.0 tpp -125.33 141.25 52.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.52 ' CB ' HG11 ' A' ' 113' ' ' VAL . 1.9 m -134.15 133.53 41.12 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.916 0.388 . . . . 0.0 110.275 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.0 p -118.3 16.41 13.95 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.985 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.742 ' O ' HG12 ' A' ' 113' ' ' VAL . 32.9 p -91.51 126.93 36.76 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 121.681 0.753 . . . . 0.0 111.686 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.519 ' HA ' ' NH2' ' A' ' 85' ' ' ARG . 20.3 pt20 -60.87 -26.91 67.73 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.602 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -66.11 -41.06 91.08 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.585 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.744 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.2 p -69.85 -39.74 78.09 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.603 HD22 ' NH2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -58.03 -47.64 82.48 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 123.672 0.608 . . . . 0.0 110.457 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.478 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 25.9 m-85 -69.72 -38.39 76.89 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.924 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.94 -52.1 65.42 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.0 tp -64.66 -42.99 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.173 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.38 -31.04 65.39 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.83 0.706 . . . . 0.0 109.627 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.35 -20.26 30.2 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.167 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.59 15.17 30.22 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 114.626 -1.17 . . . . 0.0 114.735 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.2 p -105.34 7.66 33.43 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.58 -137.52 9.47 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-O 119.093 -0.837 . . . . 0.0 112.598 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.41 171.56 14.67 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.167 2.578 . . . . 0.0 113.615 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.82 -55.64 31.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.776 0.83 . . . . 0.0 112.159 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.654 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.2 mmtt -140.72 139.82 34.77 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.728 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.8 m -140.26 168.35 20.01 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 tp -127.9 119.3 25.3 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.794 -1.093 . . . . 0.0 108.734 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.763 HD12 HD13 ' A' ' 75' ' ' ILE . 15.8 pt -98.26 102.0 12.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.852 0.834 . . . . 0.0 109.814 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.1 t -117.88 122.75 44.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.37 -1.287 . . . . 0.0 110.925 -178.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.473 HD21 ' O ' ' A' ' 83' ' ' THR . 6.1 tp -66.64 114.94 5.95 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.327 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.29 178.16 6.95 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 114.442 -1.254 . . . . 0.0 114.562 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.6 176.81 7.48 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.367 0.603 . . . . 0.0 110.8 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.39 130.11 56.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.927 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.44 149.73 18.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.601 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.4 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 20.1 m-90 -126.46 135.96 52.02 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 124.022 0.483 . . . . 0.0 110.235 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.39 158.09 27.46 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.844 0.715 . . . . 0.0 110.766 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.57 90.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.92 -25.06 6.9 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.997 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -56.07 -45.63 79.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.984 0.514 . . . . 0.0 112.058 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.556 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 10.5 tp -66.97 -48.28 69.0 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.22 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.47 -30.26 64.91 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 123.451 0.469 . . . . 0.0 110.861 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.4 -50.7 35.88 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.903 178.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -71.65 -26.61 62.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.026 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 6.1 tp -76.05 -38.48 57.07 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.898 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.0 m -77.98 -30.85 50.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -80.9 0.5 35.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.571 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.45 29.16 18.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.853 0.861 . . . . 0.0 111.735 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.82 -42.52 24.2 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.051 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -123.02 113.0 18.47 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.46 0.475 . . . . 0.0 109.752 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.3 tp -82.76 142.14 31.82 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.408 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 25.3 p -105.0 135.77 45.72 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.088 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 79.5 m -149.22 148.68 27.42 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.24 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.55 153.7 64.83 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.325 2.016 . . . . 0.0 110.772 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -134.75 174.58 10.42 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -135.02 138.89 30.48 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.322 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.58 -26.66 16.33 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 122.686 2.257 . . . . 0.0 113.561 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.84 -41.02 57.37 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.967 0.792 . . . . 0.0 112.451 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.725 HD13 HH12 ' A' ' 167' ' ' ARG . 4.3 mt -69.94 -34.38 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.569 0.7 . . . . 0.0 110.395 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.5 tt -75.71 -36.82 59.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.462 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -84.8 -32.15 23.51 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -88.83 -72.88 0.52 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.982 0.356 . . . . 0.0 111.714 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.67 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -141.27 99.26 6.52 Favored Pre-proline 0 C--N 1.349 0.584 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.842 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 73.1 Cg_endo -91.74 -0.43 4.44 Favored 'Trans proline' 0 CA--C 1.571 2.331 0 C-N-CA 121.831 1.687 . . . . 0.0 114.421 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.647 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 69.2 Cg_endo -75.09 -50.01 0.14 Allowed 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.73 2.287 . . . . 0.0 114.532 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.502 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.5 mt-10 -122.22 -34.02 3.39 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.792 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 8.6 mt-10 -69.01 -10.99 60.31 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.219 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.739 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.03 -41.55 42.12 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -70.85 -49.58 44.56 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 t -58.29 -48.03 81.78 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.644 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.63 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.57 -40.37 92.7 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.578 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.62 82.77 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.409 0.443 . . . . 0.0 110.582 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.91 -37.29 85.7 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.795 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.56 71.67 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.497 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.63 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 3.4 mmp_? -77.67 -40.33 41.93 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.802 0.441 . . . . 0.0 110.372 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.36 -33.94 76.85 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.526 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.759 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.133 179.454 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.55 HD12 ' CE1' ' A' ' 35' ' ' HIS . 11.2 mt . . . . . 0 N--CA 1.468 0.474 0 CA-C-O 120.671 0.272 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -92.68 23.01 4.31 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.964 0.412 . . . . 0.0 110.841 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 177.08 51.99 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.775 0.83 . . . . 0.0 110.0 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -136.87 160.22 39.52 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.455 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.1 m-30 -98.17 137.46 36.9 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.267 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.821 HD11 HD23 ' A' ' 32' ' ' LEU . 3.6 mt -108.63 137.03 47.25 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.033 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.434 HD13 HG13 ' A' ' 29' ' ' VAL . 2.4 mm -117.38 133.79 63.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 123.519 0.512 . . . . 0.0 109.713 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.09 123.03 23.63 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.598 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.9 mmt -114.46 155.12 46.32 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 123.463 0.477 . . . . 0.0 111.341 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -80.68 79.28 3.36 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.652 2.235 . . . . 0.0 112.935 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -136.38 -20.65 1.39 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.994 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -163.29 0.87 Allowed 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.182 0.301 . . . . 0.0 110.431 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.61 35.84 2.48 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.01 0.433 . . . . 0.0 111.9 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.32 82.87 3.69 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.36 -24.6 12.11 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.006 2.471 . . . . 0.0 113.316 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -85.2 -37.38 20.19 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.469 0.481 . . . . 0.0 111.619 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.58 -0.53 57.6 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.794 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -63.5 2.81 0.38 Allowed 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -141.22 40.12 1.76 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.172 0.51 . . . . 0.0 112.237 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 p -123.28 158.04 31.83 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.562 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.857 HG11 ' HE ' ' A' ' 167' ' ' ARG . 60.6 t -131.32 132.88 62.79 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.005 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -114.9 152.01 33.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.266 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.45 ' OH ' HD21 ' A' ' 105' ' ' LEU . 36.0 t80 -105.95 120.48 41.87 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.821 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.76 108.32 17.39 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.447 0.642 . . . . 0.0 111.304 -178.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.934 HG23 ' HA2' ' A' ' 42' ' ' GLY . 24.0 t -67.42 -59.92 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.786 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -144.68 112.64 6.35 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.31 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.55 ' CE1' HD12 ' A' ' 9' ' ' LEU . 15.6 t-80 -95.84 128.74 42.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.606 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -139.85 153.37 47.03 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.624 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.53 -18.39 65.28 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.725 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.33 2.22 42.3 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.418 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.88 167.2 15.21 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.455 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -144.82 136.43 25.49 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.97 134.37 55.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.399 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.934 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.9 155.01 26.05 Favored Glycine 0 N--CA 1.45 -0.425 0 O-C-N 124.195 0.935 . . . . 0.0 112.5 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.423 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.4 mt -110.95 133.32 53.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.022 0.411 . . . . 0.0 111.194 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 78' ' ' GLY . 20.5 t -69.34 124.61 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -128.24 56.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.47 0.653 . . . . 0.0 112.276 -177.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.86 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.7 t-20 -147.9 -3.5 0.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.491 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.73 87.75 51.48 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.512 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -59.63 142.51 98.93 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 121.695 1.596 . . . . 0.0 112.177 175.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.444 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 50.2 m -92.73 158.67 15.79 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.504 0.502 . . . . 0.0 111.572 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.44 50.15 1.29 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.67 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mt -133.34 159.14 41.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.226 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.622 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 7.4 p-10 -112.48 157.71 20.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.621 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.812 HD12 HD13 ' A' ' 128' ' ' ILE . 1.9 tt -58.5 -26.95 64.01 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.956 0.408 . . . . 0.0 111.765 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.622 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -65.12 -39.97 93.82 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.645 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.71 -46.66 84.45 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.289 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.867 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 19.2 m -62.12 -43.81 98.25 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.722 ' HA ' HD12 ' A' ' 60' ' ' LEU . 15.8 mt -56.13 -35.13 66.77 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.487 176.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.05 -27.75 48.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.425 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.417 HE22 ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -77.89 -30.57 50.79 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.339 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.867 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.94 -45.58 23.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -131.12 116.31 16.68 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.58 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.63 -32.97 2.54 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 123.677 2.918 . . . . 0.0 112.732 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.86 -14.62 56.0 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.334 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.36 149.94 24.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.445 0.466 . . . . 0.0 111.722 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.3 122.42 29.46 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.184 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.87 153.92 38.12 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.25 1.966 . . . . 0.0 112.299 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -95.07 -166.0 0.12 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.67 2.247 . . . . 0.0 112.387 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.26 -24.58 62.2 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.311 0.644 . . . . 0.0 111.921 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.437 ' O ' HG13 ' A' ' 73' ' ' ILE . 10.5 ptp180 -67.39 -47.7 69.56 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.703 ' HA ' HD12 ' A' ' 73' ' ' ILE . 29.4 m -71.59 -26.02 62.43 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.451 ' HA ' HD22 ' A' ' 52' ' ' ASN . 40.8 mt-30 -72.83 -26.89 61.65 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.402 0.62 . . . . 0.0 111.511 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -92.87 15.84 13.88 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.057 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 70' ' ' CYS . 44.6 mt -122.08 139.55 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.01 153.55 22.94 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.733 HD13 HD12 ' A' ' 128' ' ' ILE . 25.0 mm -99.78 153.07 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.88 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.4 t80 -119.98 155.67 32.38 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.16 120.36 27.45 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 117.733 0.242 . . . . 0.0 110.572 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.16 -23.74 8.91 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.949 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.24 -168.48 34.65 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.291 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -88.73 -11.52 3.93 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.546 2.831 . . . . 0.0 114.366 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.56 131.29 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.709 0.29 . . . . 0.0 111.418 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 48.2 86.25 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.532 1.133 . . . . 0.0 113.232 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.9 p -81.74 -18.87 42.77 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.151 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.417 ' HA ' HE22 ' A' ' 59' ' ' GLN . 3.4 p-10 -76.92 -18.1 58.5 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.601 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -132.97 147.83 52.28 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.0 0.428 . . . . 0.0 111.558 179.526 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.595 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -112.41 141.33 16.73 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.776 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.23 134.44 33.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.65 -1.275 . . . . 0.0 109.493 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 4.8 t -116.31 128.52 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 123.067 0.23 . . . . 0.0 111.376 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.878 HD11 HD13 ' A' ' 105' ' ' LEU . 13.4 tp -114.23 127.64 55.98 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.608 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.408 ' ND1' ' HB3' ' A' ' 123' ' ' PRO . 4.9 p80 -122.01 162.84 35.08 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.18 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -97.52 31.15 0.14 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.588 2.192 . . . . 0.0 113.403 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.5 t -118.33 156.74 28.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.651 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.49 22.13 42.48 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.71 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tp -87.71 153.5 21.31 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.526 0.33 . . . . 0.0 110.479 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.8 p -122.84 153.17 39.94 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.636 ' CD2' HG12 ' A' ' 113' ' ' VAL . 25.6 m-85 -132.99 -149.05 0.36 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.862 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -60.33 -48.91 79.71 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 122.834 0.453 . . . . 0.0 111.395 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 108' ' ' SER . 57.9 m -135.38 80.29 1.83 Allowed 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.434 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 107' ' ' MET . 7.9 m -126.6 116.85 21.67 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.867 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.96 122.16 40.75 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.098 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.35 130.36 34.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.128 0.489 . . . . 0.0 111.135 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.42 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -127.4 48.64 2.2 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.354 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.42 -109.82 3.12 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.169 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.44 -8.9 4.58 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.878 HD13 HD11 ' A' ' 89' ' ' LEU . 2.2 pp -153.34 150.23 28.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.285 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.495 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -120.81 160.61 23.04 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.812 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' A' ' 99' ' ' THR . 17.1 tpp -126.46 142.22 51.61 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 98' ' ' SER . 54.3 m -137.32 136.62 38.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.73 0.3 . . . . 0.0 110.478 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.7 p -123.03 18.72 10.05 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.383 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.829 ' O ' HG22 ' A' ' 113' ' ' VAL . 14.5 t -92.31 130.11 38.08 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 122.044 0.926 . . . . 0.0 112.564 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.645 ' HA ' HD12 ' A' ' 114' ' ' LEU . 4.8 mt-30 -61.48 -26.27 67.79 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.725 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -62.54 -47.14 85.2 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.527 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.849 ' O ' HG22 ' A' ' 117' ' ' ILE . 21.0 m -62.2 -43.12 97.52 Favored 'Isoleucine or valine' 0 C--N 1.36 1.043 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 177.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 111' ' ' GLN . 22.0 mt -54.57 -50.58 67.63 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.718 0.636 . . . . 0.0 111.984 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.464 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 37.2 m-85 -65.6 -47.2 76.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.771 0.319 . . . . 0.0 111.23 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.08 -52.99 63.23 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.138 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.849 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.02 -43.3 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.75 -30.48 65.63 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 123.618 0.574 . . . . 0.0 109.662 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.401 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -86.21 -19.64 29.72 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.174 176.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.75 17.19 26.57 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 114.652 -1.158 . . . . 0.0 114.904 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.7 p -107.88 8.14 28.45 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -98.17 -136.51 9.26 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-O 119.195 -0.78 . . . . 0.0 112.527 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.408 ' HB3' ' ND1' ' A' ' 90' ' ' HIS . 3.2 Cg_exo -77.78 169.9 19.94 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.333 2.688 . . . . 0.0 113.161 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -51.5 -58.36 6.51 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.695 0.798 . . . . 0.0 110.863 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -133.66 168.41 18.73 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.452 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.4 ' HB2' ' CG1' ' A' ' 88' ' ' VAL . 31.6 p -152.52 156.9 40.28 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.8 tp -125.68 106.09 9.47 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.812 HD13 HD12 ' A' ' 53' ' ' LEU . 15.7 pt -92.82 102.62 13.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.812 0.815 . . . . 0.0 110.044 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.0 t -122.45 122.64 39.43 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.255 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.12 117.07 8.65 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.198 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.44 ' H ' ' HA2' ' A' ' 86' ' ' GLY . . . 66.38 172.94 4.95 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.366 -0.833 . . . . 0.0 114.307 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -128.11 -179.06 4.79 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.231 0.538 . . . . 0.0 110.824 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -116.81 128.98 55.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.246 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.25 148.83 18.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.379 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.455 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 22.3 m-90 -127.14 137.86 53.05 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.803 0.354 . . . . 0.0 110.435 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.85 158.02 26.86 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.818 0.699 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.14 92.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.32 -24.72 8.05 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.177 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -57.57 -44.38 85.27 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.87 0.468 . . . . 0.0 112.15 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.9 tm? -68.07 -47.64 67.73 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.502 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.21 -30.12 67.99 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.013 0.435 . . . . 0.0 110.644 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.17 -49.91 45.66 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.887 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.55 -26.63 63.64 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.84 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.6 tp -74.71 -38.91 62.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.593 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.0 m -77.88 -28.44 49.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.296 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -81.93 -0.92 46.07 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.553 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 61.19 29.55 18.83 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.801 0.841 . . . . 0.0 111.744 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 143' ' ' GLU . . . -83.53 -43.6 15.55 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.829 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -124.62 113.4 17.99 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.5 tp -84.67 140.43 31.32 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.442 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.4 p -104.61 137.42 42.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.17 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 73.2 m -152.46 155.87 33.12 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.629 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.21 157.66 29.33 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.319 2.013 . . . . 0.0 111.191 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.455 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.36 168.32 17.12 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -136.31 135.03 20.33 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 114.405 -1.27 . . . . 0.0 107.84 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.27 -26.57 14.45 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.582 2.188 . . . . 0.0 113.695 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.68 -40.5 62.97 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.768 0.667 . . . . 0.0 112.329 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.576 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.8 mt -71.06 -35.37 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-O 121.375 0.607 . . . . 0.0 110.354 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -73.88 -38.58 64.37 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.051 -1.431 . . . . 0.0 111.392 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -84.77 -33.44 23.02 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.35 -72.34 0.49 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.047 0.385 . . . . 0.0 111.532 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.883 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.3 99.52 6.46 Favored Pre-proline 0 C--N 1.348 0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 112.349 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.86 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 73.0 Cg_endo -91.45 -0.68 4.63 Favored 'Trans proline' 0 CA--C 1.569 2.254 0 C-N-CA 121.721 1.614 . . . . 0.0 114.304 175.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.646 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 73.9 Cg_endo -74.37 -52.62 0.12 Allowed 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.643 2.229 . . . . 0.0 114.48 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.523 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.6 mt-10 -122.29 -30.33 4.01 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.75 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.883 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.0 tt0 -69.78 -11.59 60.97 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.367 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.857 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.63 -41.7 44.95 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.272 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.36 -50.28 40.54 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.349 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.8 m -58.09 -49.45 76.91 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.651 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.26 -39.95 94.99 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.209 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.09 -46.58 79.0 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 123.545 0.528 . . . . 0.0 110.587 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.67 88.33 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.51 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.24 -28.26 69.24 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.492 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.75 -40.14 42.0 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 122.835 0.454 . . . . 0.0 110.303 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.98 -32.03 70.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.489 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.755 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.94 179.505 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 mt . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 120.924 0.392 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -91.23 20.21 5.28 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.846 0.355 . . . . 0.0 111.276 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.2 p80 176.71 52.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.99 0.916 . . . . 0.0 110.257 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -133.2 160.43 37.27 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.716 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.434 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 14.4 m-30 -95.59 135.01 37.81 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 1.6 mm? -108.04 139.92 41.97 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.525 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 29' ' ' VAL . 3.0 mp -124.58 134.43 66.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 O-C-N 123.545 0.528 . . . . 0.0 109.936 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.33 133.21 35.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.479 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 24.5 mmt -123.2 157.36 61.28 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.03 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.22 78.01 3.61 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.563 2.175 . . . . 0.0 112.879 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -135.53 -21.79 1.52 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.875 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.53 -162.89 0.86 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 123.209 0.318 . . . . 0.0 110.493 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.545 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.39 30.89 4.64 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.1 m-20 -110.85 83.29 3.49 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.1 Cg_exo -75.37 -20.7 15.9 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.069 2.513 . . . . 0.0 113.417 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -84.93 -39.04 18.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 122.833 0.453 . . . . 0.0 111.649 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.27 -2.72 56.28 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.76 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -61.0 2.29 0.12 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -142.28 38.95 1.57 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.167 0.508 . . . . 0.0 112.03 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 p -123.22 158.45 30.83 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.625 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.78 HG11 ' HE ' ' A' ' 167' ' ' ARG . 99.4 t -130.57 131.45 64.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.896 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.464 HG21 ' HH2' ' A' ' 135' ' ' TRP . 2.3 m -113.15 154.55 26.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.363 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.429 ' OH ' HD11 ' A' ' 105' ' ' LEU . 43.3 t80 -106.66 119.93 40.62 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.659 HD11 ' HB1' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -82.34 106.86 14.56 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 123.595 0.559 . . . . 0.0 111.391 -178.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.94 HG23 ' HA2' ' A' ' 42' ' ' GLY . 34.3 t -67.69 -57.98 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.597 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -144.56 118.84 9.55 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.187 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -99.05 128.12 45.13 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.875 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -139.25 152.44 47.3 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.586 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -62.58 -24.19 67.42 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.644 0.378 . . . . 0.0 111.781 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -93.17 -3.72 53.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 123.492 0.495 . . . . 0.0 111.498 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.3 173.72 24.35 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 121.518 -0.373 . . . . 0.0 112.274 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.659 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -146.85 141.53 26.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -114.55 134.7 54.84 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.09 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.94 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.26 157.64 28.25 Favored Glycine 0 N--CA 1.443 -0.844 0 O-C-N 124.215 0.947 . . . . 0.0 112.618 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.4 HD23 ' C ' ' A' ' 42' ' ' GLY . 1.8 mt -112.32 128.72 56.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.925 0.363 . . . . 0.0 110.511 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.451 HG12 ' C ' ' A' ' 78' ' ' GLY . 11.1 p -68.29 125.97 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.05 57.76 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.725 0.774 . . . . 0.0 112.059 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.829 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.6 t-20 -146.28 -1.7 0.72 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.032 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -130.2 88.26 48.56 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.508 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 40.9 Cg_exo -58.67 145.94 93.76 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 121.711 1.607 . . . . 0.0 112.48 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.447 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 73.1 m -96.38 160.23 14.52 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.554 0.534 . . . . 0.0 111.489 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.94 51.53 0.9 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.636 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -133.35 154.02 51.09 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.929 0.429 . . . . 0.0 110.03 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.611 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 10.4 p-10 -112.45 157.7 20.76 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.822 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.537 HD12 HD13 ' A' ' 128' ' ' ILE . 2.4 tt -57.53 -26.74 61.82 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.611 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -67.54 -40.87 84.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.419 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.1 -45.51 88.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.17 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.861 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.1 m -62.04 -44.96 99.66 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 60' ' ' LEU . 14.8 mt -56.16 -35.15 66.86 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.494 176.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.05 -27.25 48.68 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.313 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -30.46 51.42 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.334 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.861 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.79 -45.91 23.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.099 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -131.22 116.75 16.68 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.52 -33.05 2.58 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.674 2.916 . . . . 0.0 112.78 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.71 -14.99 55.83 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.376 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.99 149.47 24.75 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 123.327 0.392 . . . . 0.0 111.636 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.71 123.21 29.26 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.303 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.61 153.48 38.99 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.298 1.999 . . . . 0.0 112.264 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 6.6 Cg_endo -94.01 -165.07 0.12 Allowed 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.596 2.198 . . . . 0.0 112.119 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.449 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -71.83 -24.74 61.76 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.134 0.574 . . . . 0.0 111.888 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 118' ' ' ALA . 12.0 ptp180 -67.33 -46.06 74.57 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.542 ' HA ' HD12 ' A' ' 73' ' ' ILE . 17.5 m -73.82 -25.54 60.15 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.468 ' HA ' HD22 ' A' ' 52' ' ' ASN . 46.8 mt-30 -70.63 -27.62 64.2 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.449 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 25.0 p80 -97.9 20.42 12.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.089 0.471 . . . . 0.0 111.606 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 70' ' ' CYS . 62.8 mt -118.72 136.76 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.255 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.83 163.94 12.14 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 51' ' ' LEU . 14.3 mm -115.23 152.69 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.022 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.744 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.5 t80 -116.49 155.1 29.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.895 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.72 125.03 31.48 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 131' ' ' GLY . . . -104.14 -23.53 8.06 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.741 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.86 -167.95 33.3 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.186 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -88.55 -10.38 4.52 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.434 2.756 . . . . 0.0 114.262 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.84 131.34 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 123.08 0.237 . . . . 0.0 111.206 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 45.06 82.98 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.537 1.135 . . . . 0.0 113.385 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.2 p -81.66 -14.6 56.44 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.198 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.91 -17.13 59.13 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.748 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.771 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -132.61 148.2 52.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.927 0.394 . . . . 0.0 111.882 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.603 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.71 148.48 17.68 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.404 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.5 m-85 -86.84 150.76 23.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.913 -1.144 . . . . 0.0 111.115 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 21.6 t -128.22 105.69 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.163 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.932 HD11 HD13 ' A' ' 105' ' ' LEU . 13.6 tp -106.26 127.95 53.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.456 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.404 ' ND1' ' HB3' ' A' ' 123' ' ' PRO . 3.7 p80 -128.43 166.34 25.04 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.421 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.684 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.34 25.22 0.25 Allowed 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.691 2.261 . . . . 0.0 113.691 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.0 t -112.98 158.83 19.77 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.624 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.27 22.94 34.13 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.653 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.27 150.51 22.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.502 0.321 . . . . 0.0 110.534 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.6 ' HA ' HG21 ' A' ' 99' ' ' THR . 24.7 m -128.47 157.09 42.1 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.146 0.498 . . . . 0.0 112.189 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.556 ' CE2' HG23 ' A' ' 113' ' ' VAL . 57.6 m-85 -126.81 -150.88 0.46 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.8 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -59.07 -46.87 87.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.595 0.358 . . . . 0.0 111.338 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.8 m -132.58 80.3 1.89 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.943 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.6 HG21 ' HA ' ' A' ' 95' ' ' SER . 47.2 m -128.7 121.15 27.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.153 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.5 123.57 46.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.861 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.58 127.82 34.04 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.764 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.56 ' HB3' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -120.58 43.11 2.83 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.798 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.61 -100.57 0.28 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.424 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -55.61 -14.83 2.36 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.932 HD13 HD11 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -160.0 159.87 32.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.907 0.483 . . . . 0.0 110.687 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.574 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.73 156.98 28.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.846 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.49 ' CE ' HD13 ' A' ' 89' ' ' LEU . 16.1 ttm -123.91 134.64 53.49 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 m -136.68 133.72 36.47 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.7 p -127.97 19.7 6.52 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.007 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.755 ' O ' HG12 ' A' ' 113' ' ' VAL . 42.2 p -90.61 130.9 36.58 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.306 0.574 . . . . 0.0 112.021 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.489 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 7.9 mt-30 -57.95 -26.9 62.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.777 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -64.53 -40.02 94.84 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.119 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.77 ' O ' HG22 ' A' ' 117' ' ' ILE . 2.7 p -71.49 -38.5 68.39 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.77 -49.84 72.07 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.578 0.549 . . . . 0.0 110.495 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.489 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 39.2 m-85 -68.01 -40.79 82.93 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.405 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.64 -53.95 51.23 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.679 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.3 tp -64.56 -43.96 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.56 -32.31 65.05 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.665 0.603 . . . . 0.0 109.703 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.438 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.38 -20.55 31.75 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.365 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.35 17.23 25.02 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.8 -1.091 . . . . 0.0 114.472 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 p -108.26 8.39 27.79 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -93.84 -138.01 8.83 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 119.204 -0.776 . . . . 0.0 112.863 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.404 ' HB3' ' ND1' ' A' ' 90' ' ' HIS . 2.2 Cg_endo -82.37 165.76 16.34 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.146 2.564 . . . . 0.0 113.998 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.506 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -49.94 -60.14 3.2 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.482 1.113 . . . . 0.0 111.76 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.684 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -140.1 139.72 35.9 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 37.2 p -139.25 169.41 17.82 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.2 tp -125.61 115.81 20.73 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.45 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.537 HD13 HD12 ' A' ' 53' ' ' LEU . 8.6 pt -99.25 104.98 16.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.3 t -124.16 121.99 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.035 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.0 tp -67.21 113.06 4.84 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.379 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.502 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 72.75 170.51 17.06 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.158 -0.928 . . . . 0.0 114.283 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -128.66 177.77 6.8 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.206 0.526 . . . . 0.0 110.809 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -114.94 131.73 56.79 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.937 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.33 144.05 15.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.598 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.464 ' HH2' HG21 ' A' ' 30' ' ' THR . 16.8 m-90 -122.15 131.68 54.08 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.046 0.498 . . . . 0.0 110.597 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -78.94 159.19 27.83 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.53 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.16 124.05 10.77 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.671 0.388 . . . . 0.0 111.497 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.27 -28.02 8.64 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.017 -0.611 . . . . 0.0 114.128 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -56.71 -48.88 76.75 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.543 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.0 tp -67.8 -47.77 68.16 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.673 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.83 -31.57 64.88 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.456 0.472 . . . . 0.0 110.814 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.88 -50.35 43.29 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.044 178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -72.29 -26.64 62.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.4 tp -75.65 -38.49 58.81 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.738 0.815 . . . . 0.0 110.784 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.7 m -78.12 -31.09 49.75 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.444 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -80.8 0.4 35.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.649 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 60.13 28.68 18.27 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.908 0.883 . . . . 0.0 111.749 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.99 -43.16 22.49 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.831 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -126.29 116.48 21.31 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -84.72 150.34 25.17 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.487 ' H ' HD23 ' A' ' 150' ' ' LEU . 16.8 p -110.78 136.29 50.07 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.363 0.414 . . . . 0.0 110.915 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 74.9 m -151.83 154.87 33.42 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.54 159.04 25.12 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.284 1.989 . . . . 0.0 111.104 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.434 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.89 166.09 21.65 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -134.95 134.16 21.57 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 114.368 -1.287 . . . . 0.0 107.863 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.51 -26.43 16.79 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.596 2.198 . . . . 0.0 113.663 -177.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.8 -39.97 62.82 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 123.871 0.732 . . . . 0.0 112.056 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.565 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.2 mt -72.27 -35.66 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.363 0.602 . . . . 0.0 110.392 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.61 -37.41 65.43 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.412 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -86.67 -33.75 19.99 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -85.78 -72.33 0.49 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.052 0.387 . . . . 0.0 111.666 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.913 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.75 98.11 6.44 Favored Pre-proline 0 C--N 1.349 0.584 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.829 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 59.5 Cg_endo -92.76 1.2 3.77 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 C-N-CA 121.719 1.613 . . . . 0.0 114.258 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.636 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 80.4 Cg_endo -74.1 -52.14 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.561 2.174 . . . . 0.0 114.224 -178.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.507 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.97 -29.79 3.88 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.658 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.913 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.5 tt0 -70.36 -10.13 58.18 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.247 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.78 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.01 -38.2 53.52 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.135 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.7 tt -74.01 -49.58 23.7 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.3 m -58.41 -46.72 85.89 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.487 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -67.14 -40.66 86.78 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.397 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.15 -45.98 79.43 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 123.362 0.414 . . . . 0.0 110.446 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.99 -38.65 91.87 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.487 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.87 69.25 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.595 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.69 -40.23 42.14 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 122.931 0.492 . . . . 0.0 110.26 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.0 -31.19 67.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.529 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.776 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.884 179.524 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 C--O 1.236 0.373 0 CA-C-O 120.585 0.231 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.539 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 14.2 ptmt -95.16 27.65 3.15 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.494 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 176.44 51.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.563 0.745 . . . . 0.0 110.91 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -134.04 159.39 40.95 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.452 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 30' ' ' THR . 12.3 m-30 -98.58 138.33 35.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.168 0.509 . . . . 0.0 112.15 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.672 HD11 HD23 ' A' ' 32' ' ' LEU . 1.9 mp -109.89 135.41 50.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.565 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.432 HG23 HG22 ' A' ' 29' ' ' VAL . 2.9 mp -120.04 130.72 73.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.53 127.63 33.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.012 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.6 mmt -112.28 154.62 44.37 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.171 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -79.96 72.57 6.45 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.561 2.174 . . . . 0.0 112.611 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -130.79 -16.4 3.32 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.54 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -164.69 0.94 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.303 0.377 . . . . 0.0 110.604 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.541 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.55 37.77 2.05 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 111.85 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -110.99 82.95 3.36 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.832 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.33 -21.88 14.8 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.973 2.449 . . . . 0.0 113.384 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -85.19 -38.52 18.89 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.909 0.484 . . . . 0.0 111.527 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.08 -5.53 55.06 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.842 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -57.3 -0.67 0.06 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -178.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -142.3 43.86 1.65 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.179 0.514 . . . . 0.0 111.839 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p -127.38 155.58 43.39 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.616 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.651 HG11 ' HE ' ' A' ' 167' ' ' ARG . 48.0 t -129.22 133.54 65.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.676 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 3.9 m -115.15 154.68 28.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.471 -178.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.408 ' OH ' HD11 ' A' ' 105' ' ' LEU . 17.7 t80 -109.14 116.26 31.59 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.672 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -78.61 108.47 12.03 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-O 121.04 0.448 . . . . 0.0 110.466 -179.33 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.891 HG23 ' HA2' ' A' ' 42' ' ' GLY . 56.4 t -64.78 -57.92 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 114.033 -1.439 . . . . 0.0 110.115 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.539 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 32.7 tt0 -151.11 119.67 6.48 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.793 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -95.8 129.24 43.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.629 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -139.48 152.89 47.35 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.475 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.8 -18.98 65.58 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.623 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 137' ' ' ALA . 46.5 mt-30 -95.68 -5.83 41.35 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.346 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.81 172.37 22.51 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.2 143.24 30.19 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.461 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -119.5 136.6 54.26 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.638 178.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.891 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.29 158.53 29.61 Favored Glycine 0 N--CA 1.452 -0.292 0 O-C-N 124.364 1.04 . . . . 0.0 112.529 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.8 mt -115.6 134.86 54.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.099 0.449 . . . . 0.0 111.438 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 78' ' ' GLY . 11.1 t -68.55 122.48 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.91 55.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.638 0.732 . . . . 0.0 112.074 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.854 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.6 t-20 -148.32 -2.75 0.51 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.157 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -130.19 87.23 51.71 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.53 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -59.7 143.15 99.7 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 121.559 1.506 . . . . 0.0 112.14 175.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 50.0 m -92.54 158.5 15.97 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 123.39 0.431 . . . . 0.0 111.368 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.89 50.29 1.37 Allowed Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.837 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 mt -133.57 158.96 41.85 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.979 0.458 . . . . 0.0 110.229 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.1 p-10 -112.23 157.54 20.77 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.102 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.642 HD13 HD13 ' A' ' 128' ' ' ILE . 13.4 tp -57.79 -37.07 73.08 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.07 -37.91 62.06 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -63.66 -43.03 97.93 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.21 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.864 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -62.63 -46.82 95.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.744 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.4 mp -53.56 -36.72 62.17 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.87 0.731 . . . . 0.0 110.784 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.93 -28.34 49.63 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.564 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -29.97 47.9 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.381 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.864 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.9 mt -77.83 -45.14 25.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.884 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -132.02 116.57 15.7 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.535 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -77.59 -32.73 2.69 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 123.615 2.876 . . . . 0.0 112.747 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.22 -14.38 55.63 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.364 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 149.7 24.52 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 123.321 0.388 . . . . 0.0 111.792 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.32 123.75 29.68 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.99 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 57.5 Cg_endo -74.45 146.04 34.55 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.185 1.923 . . . . 0.0 112.351 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.502 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.4 Cg_endo -92.43 -170.62 0.3 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.491 2.127 . . . . 0.0 111.83 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.484 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -63.82 -24.89 67.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.142 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.504 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.6 ptp180 -66.18 -53.38 38.14 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -177.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.706 ' HA ' HD12 ' A' ' 73' ' ' ILE . 60.1 m -71.74 -25.02 61.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 47.7 mt-30 -68.12 -35.63 78.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.484 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 20.5 p80 -90.37 22.12 3.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.228 0.537 . . . . 0.0 111.667 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.706 HD12 ' HA ' ' A' ' 70' ' ' CYS . 55.1 mt -119.39 139.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.383 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.11 153.78 22.14 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.802 0.689 . . . . 0.0 112.728 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.689 HD13 HD12 ' A' ' 128' ' ' ILE . 25.9 mm -100.02 150.3 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.093 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.715 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -116.51 154.98 29.44 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.52 118.94 26.27 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.636 0.198 . . . . 0.0 110.552 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -101.46 -23.66 9.37 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.826 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.82 -167.77 35.4 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.123 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -88.39 -9.66 4.95 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 123.492 2.794 . . . . 0.0 114.264 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 t -87.07 131.18 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.003 0.19 . . . . 0.0 111.035 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 44.13 87.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.533 1.133 . . . . 0.0 113.316 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.428 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.0 t -88.09 1.51 54.11 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.428 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.87 -5.47 47.91 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.604 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.26 154.45 50.66 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.11 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.604 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.5 134.2 12.1 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.175 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.727 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.54 145.58 27.31 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.366 1.067 . . . . 0.0 110.231 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -123.97 103.42 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 123.366 0.416 . . . . 0.0 110.874 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.785 HD11 HD13 ' A' ' 105' ' ' LEU . 6.2 tp -105.71 129.21 53.97 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -125.6 168.23 14.37 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 118.985 -0.531 . . . . 0.0 112.146 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 16.5 Cg_endo -96.61 13.99 0.96 Allowed 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.862 2.375 . . . . 0.0 113.644 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 t -101.89 161.06 13.95 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.874 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.84 19.21 55.5 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.512 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -85.47 153.86 22.19 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.604 0.362 . . . . 0.0 110.403 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.0 p -127.03 157.89 38.39 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CE2' HG23 ' A' ' 113' ' ' VAL . 52.0 m-85 -129.34 -151.94 0.5 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.671 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -57.44 -46.26 83.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.776 0.431 . . . . 0.0 111.723 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 m -138.32 78.94 1.71 Allowed 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.642 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 107' ' ' MET . 25.1 m -126.29 120.96 31.3 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 107' ' ' MET . 3.3 tp -77.36 162.02 27.59 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.051 176.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -135.2 125.5 26.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.896 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.506 HD11 ' O ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -135.84 43.99 2.52 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.279 -179.383 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.13 -99.16 0.19 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.815 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -57.4 -12.99 2.91 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.785 HD13 HD11 ' A' ' 89' ' ' LEU . 3.2 pp -158.44 148.11 19.55 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.265 0.555 . . . . 0.0 112.493 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.52 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -120.83 158.6 27.24 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.324 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 8.9 ttm -119.68 134.08 55.37 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.754 ' HB3' HG11 ' A' ' 113' ' ' VAL . 16.7 m -128.76 127.36 41.86 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.8 p -119.92 11.78 11.88 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.782 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.745 ' O ' HG12 ' A' ' 113' ' ' VAL . 49.2 m -85.59 130.38 34.59 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.617 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.497 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.7 pt20 -61.58 -29.52 70.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.382 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.45 -43.16 95.15 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.603 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.754 HG11 ' HB3' ' A' ' 108' ' ' SER . 4.0 p -68.14 -39.77 81.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 123.189 0.306 . . . . 0.0 110.38 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.53 HD22 ' NH2' ' A' ' 85' ' ' ARG . 1.5 tt -58.12 -48.34 80.51 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 123.571 0.544 . . . . 0.0 110.47 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.497 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 35.3 m-85 -69.98 -37.57 75.8 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.865 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.25 -51.94 65.72 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.0 tp -64.56 -43.14 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.156 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.02 -31.59 65.28 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 123.826 0.704 . . . . 0.0 109.546 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.504 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.71 -20.8 30.6 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.255 176.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.61 13.1 33.39 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.729 -1.123 . . . . 0.0 114.692 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.1 p -103.39 7.8 38.09 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.68 -137.7 9.6 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.239 -0.756 . . . . 0.0 112.635 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.72 173.72 12.59 Favored 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 123.228 2.619 . . . . 0.0 113.601 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.01 -54.37 47.53 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.757 0.823 . . . . 0.0 111.916 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.594 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.9 mmtt -139.05 151.14 46.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.775 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.0 m -148.05 165.38 30.97 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.7 tp -127.5 118.05 23.26 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.361 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.727 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 18.5 pt -98.63 102.7 13.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.989 0.9 . . . . 0.0 109.819 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 6.8 t -119.75 121.6 39.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.76 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.428 HD21 ' O ' ' A' ' 83' ' ' THR . 6.9 tp -66.84 115.06 6.2 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.01 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.71 174.61 4.11 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.352 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -128.44 -179.49 5.06 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.408 0.623 . . . . 0.0 111.092 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -117.34 130.47 56.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.179 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.46 152.24 19.48 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.354 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 27.4 m-90 -132.69 139.02 47.48 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.898 0.41 . . . . 0.0 110.537 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.25 158.17 27.63 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.851 0.719 . . . . 0.0 110.794 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . . . -50.92 91.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.82 -22.05 10.11 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.339 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -57.22 -46.35 83.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.866 0.466 . . . . 0.0 111.978 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.5 tp -66.73 -47.18 73.09 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -56.69 -30.84 63.86 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.453 0.471 . . . . 0.0 110.793 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.43 -49.08 52.57 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.04 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.4 pt-20 -72.69 -26.75 61.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.0 tp -75.48 -38.23 59.68 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.744 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -78.19 -30.31 48.92 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.272 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.06 0.5 31.61 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.605 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 61.38 28.98 18.3 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.871 0.868 . . . . 0.0 111.797 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.45 -42.71 16.63 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.528 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -124.14 111.39 15.86 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 123.495 0.497 . . . . 0.0 109.856 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.3 tp -86.93 128.36 35.06 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.614 0.245 . . . . 0.0 111.506 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.5 p -100.33 142.3 31.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.758 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 78.2 m -154.95 155.83 30.66 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 123.446 0.466 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.51 148.46 92.94 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.325 2.016 . . . . 0.0 110.999 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 174' ' ' ARG . . . -135.06 177.42 7.82 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -134.29 141.11 38.02 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 113.88 -1.509 . . . . 0.0 108.584 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -74.85 -26.54 11.14 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 122.766 2.311 . . . . 0.0 114.007 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -48.89 -41.71 34.4 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.915 0.759 . . . . 0.0 112.631 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.704 HD13 HH12 ' A' ' 167' ' ' ARG . 4.9 mt -70.26 -32.63 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.467 0.651 . . . . 0.0 110.421 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.6 tt -76.65 -37.12 56.81 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.37 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.61 -33.45 25.32 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -86.84 -72.93 0.48 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.939 0.336 . . . . 0.0 111.657 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.89 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.47 99.93 6.3 Favored Pre-proline 0 C--N 1.349 0.578 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.854 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 70.3 Cg_endo -90.94 -0.91 4.97 Favored 'Trans proline' 0 CA--C 1.57 2.275 0 C-N-CA 121.742 1.628 . . . . 0.0 114.261 175.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.651 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 87.8 Cg_endo -74.28 -54.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 122.636 2.224 . . . . 0.0 114.502 -178.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.542 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.1 mt-10 -120.58 -29.84 4.64 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.729 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.89 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.0 tt0 -70.38 -11.38 60.88 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.422 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.704 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.28 -45.5 32.29 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.397 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.5 tp -68.06 -50.19 56.72 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.1 m -57.57 -51.16 70.6 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.922 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.09 88.98 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.158 0.286 . . . . 0.0 110.987 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.28 83.92 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 123.657 0.598 . . . . 0.0 110.457 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.11 84.54 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.646 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.76 -32.28 73.39 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.532 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.483 ' CZ ' ' HA ' ' A' ' 154' ' ' ALA . 10.9 mtm-85 -77.7 -41.57 37.47 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 122.682 0.393 . . . . 0.0 110.702 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.77 -35.47 79.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.634 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.681 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.2 179.441 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 32' ' ' LEU . 18.4 mt . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 121.102 0.477 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -93.0 19.36 7.89 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.068 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 175.55 55.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.268 1.027 . . . . 0.0 109.209 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -137.96 156.88 47.4 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.462 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.5 m-30 -96.46 135.43 38.34 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.928 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.762 HD11 HD23 ' A' ' 32' ' ' LEU . 6.2 mt -107.62 138.2 44.27 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.182 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.459 HG23 HG22 ' A' ' 29' ' ' VAL . 2.2 mm -116.69 132.63 65.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 O-C-N 123.623 0.577 . . . . 0.0 109.617 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.58 128.15 33.67 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.724 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.5 mtt -117.79 154.32 51.06 Favored Pre-proline 0 CA--C 1.538 0.509 0 O-C-N 123.383 0.427 . . . . 0.0 111.336 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.41 74.0 5.76 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.673 2.249 . . . . 0.0 112.661 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -131.63 -17.64 2.86 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.741 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.32 -163.26 0.84 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.272 0.357 . . . . 0.0 110.403 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -101.96 34.4 2.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.906 0.384 . . . . 0.0 111.979 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.6 82.4 3.75 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.37 -22.3 14.32 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.033 2.488 . . . . 0.0 113.333 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -85.13 -39.13 18.25 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.93 0.492 . . . . 0.0 111.498 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -4.63 56.94 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.889 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -57.69 0.71 0.05 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -143.13 43.34 1.55 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.212 0.529 . . . . 0.0 111.866 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.6 p -126.49 158.28 36.5 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.674 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.794 HG11 ' HE ' ' A' ' 167' ' ' ARG . 58.4 t -130.72 133.07 63.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.641 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.446 HG21 ' HH2' ' A' ' 135' ' ' TRP . 1.8 m -114.33 155.18 26.71 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.647 -178.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.479 ' OH ' HD21 ' A' ' 105' ' ' LEU . 34.1 t80 -107.71 115.58 30.4 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.762 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -80.08 108.21 13.48 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-O 121.393 0.616 . . . . 0.0 111.236 -178.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.947 HG23 ' HA2' ' A' ' 42' ' ' GLY . 43.4 t -68.42 -63.32 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.267 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -136.82 122.65 19.99 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.492 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -104.66 128.79 52.82 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.9 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -139.81 153.14 47.02 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.627 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.61 -21.56 66.43 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.005 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -94.99 -4.66 46.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.398 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.54 176.23 27.48 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.405 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.649 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -148.99 148.95 30.36 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.21 136.17 54.62 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.289 177.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.947 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.11 160.39 30.4 Favored Glycine 0 N--CA 1.447 -0.624 0 O-C-N 124.603 1.189 . . . . 0.0 112.509 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.4 mt -112.69 131.19 55.77 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.939 0.37 . . . . 0.0 111.223 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 78' ' ' GLY . 15.7 t -67.05 122.12 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.49 56.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.648 0.737 . . . . 0.0 112.038 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.852 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.1 t-20 -147.15 -3.25 0.58 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.158 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -130.08 88.57 47.99 Favored Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.521 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.3 Cg_exo -59.6 143.68 99.61 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.712 1.608 . . . . 0.0 112.157 175.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.441 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.2 m -93.29 159.71 15.15 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 123.386 0.429 . . . . 0.0 111.639 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.06 50.69 1.18 Allowed Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.588 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mt -133.6 158.44 43.19 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 122.848 0.459 . . . . 0.0 110.143 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 24.7 p-10 -112.61 157.61 20.99 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.808 HD12 HD13 ' A' ' 128' ' ' ILE . 1.6 tt -58.1 -26.51 62.68 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 120.947 0.403 . . . . 0.0 111.847 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.68 95.47 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.173 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.56 -45.78 88.92 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.095 0.247 . . . . 0.0 111.457 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.867 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 7.8 m -62.12 -44.51 99.12 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 60' ' ' LEU . 14.4 mt -55.99 -35.14 66.43 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.853 0.721 . . . . 0.0 110.618 176.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.08 -27.41 48.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.391 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.84 -30.97 51.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.284 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.867 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.2 mt -77.69 -45.76 23.92 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.162 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -131.12 116.52 16.73 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.581 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.7 -32.94 2.51 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.554 2.836 . . . . 0.0 112.75 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.74 -14.77 56.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.313 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.18 149.66 24.48 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.42 0.45 . . . . 0.0 111.672 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.24 123.45 29.39 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.304 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.42 149.48 35.11 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.275 1.983 . . . . 0.0 112.279 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.428 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 7.6 Cg_endo -94.33 -167.86 0.16 Allowed 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.653 2.235 . . . . 0.0 112.432 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.43 -24.64 64.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.373 0.669 . . . . 0.0 112.095 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.514 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 9.1 ptp180 -67.91 -48.08 67.0 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.701 ' HA ' HD12 ' A' ' 73' ' ' ILE . 21.2 m -73.15 -26.19 61.11 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.087 0.555 . . . . 0.0 112.343 -178.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.442 ' HA ' HD22 ' A' ' 52' ' ' ASN . 44.1 mt-30 -70.34 -26.96 63.99 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.668 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -96.71 17.66 16.05 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.58 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 70' ' ' CYS . 52.1 mt -120.97 139.63 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.818 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.45 154.53 20.7 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.731 HD13 HD12 ' A' ' 128' ' ' ILE . 24.2 mm -102.02 153.12 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.805 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.711 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -117.97 155.21 30.64 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.64 121.23 28.87 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 117.684 0.22 . . . . 0.0 110.59 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -104.04 -23.6 8.07 Favored Glycine 0 C--N 1.346 1.137 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.888 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.7 -168.36 33.81 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.043 -0.598 . . . . 0.0 113.315 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -88.58 -13.09 3.48 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 123.545 2.83 . . . . 0.0 114.394 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 t -83.41 129.8 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.099 0.249 . . . . 0.0 111.162 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 44.25 86.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.635 1.174 . . . . 0.0 113.392 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.6 p -82.72 -13.88 55.56 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.085 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.05 -17.59 58.66 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.805 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -132.58 148.87 52.38 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.089 0.471 . . . . 0.0 111.908 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.614 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.71 159.75 13.66 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.429 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.3 m-85 -96.14 151.71 19.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.721 -1.24 . . . . 0.0 110.854 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 t -128.35 102.91 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 126' ' ' SER . 0.3 OUTLIER -102.37 127.69 49.27 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.869 -179.216 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -130.07 164.42 40.78 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.499 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.681 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.5 Cg_endo -97.08 19.78 0.46 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.647 2.231 . . . . 0.0 113.78 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.8 t -106.4 158.52 16.83 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.59 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.85 22.82 33.92 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.717 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 95' ' ' SER . 2.8 tt -90.73 149.58 21.97 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.521 0.329 . . . . 0.0 110.435 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.592 ' HA ' HG21 ' A' ' 99' ' ' THR . 27.5 m -126.22 155.51 41.71 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.054 0.454 . . . . 0.0 112.093 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.538 ' CE2' HG23 ' A' ' 113' ' ' VAL . 53.6 m-85 -126.55 -150.4 0.44 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.846 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.417 ' HB2' ' OG ' ' A' ' 110' ' ' SER . 5.4 mm100 -58.4 -47.29 84.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.61 0.364 . . . . 0.0 111.491 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 63.2 m -133.05 81.05 1.92 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.964 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 107' ' ' MET . 44.7 m -127.98 120.06 26.78 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.04 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -103.06 122.42 44.62 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.911 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.24 125.47 30.35 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.773 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -121.47 55.29 1.09 Allowed 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.232 1.015 . . . . 0.0 110.626 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.87 -114.35 5.53 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.259 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.5 -3.44 6.25 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.479 HD21 ' OH ' ' A' ' 31' ' ' TYR . 3.5 pp -147.78 157.02 43.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.19 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -120.44 158.59 26.87 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.368 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.611 ' O ' ' HA ' ' A' ' 99' ' ' THR . 25.6 ttm -124.56 132.14 53.46 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.631 ' HB3' HG11 ' A' ' 113' ' ' VAL . 49.2 m -133.95 130.99 38.49 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.9 p -124.37 18.82 8.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.433 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.679 ' O ' HG12 ' A' ' 113' ' ' VAL . 19.0 t -90.66 133.97 34.74 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.92 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.467 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 5.7 mt-30 -62.35 -26.37 68.41 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.473 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.28 -41.96 93.66 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.496 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.742 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.5 p -71.49 -37.58 64.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 tp -58.89 -47.12 86.09 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 123.511 0.507 . . . . 0.0 110.198 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.467 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 18.4 m-85 -68.5 -40.91 80.67 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.837 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.68 -52.6 64.44 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.385 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.742 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.4 tp -64.82 -44.23 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.718 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.447 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.54 -32.33 65.03 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 123.745 0.653 . . . . 0.0 109.679 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.514 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.56 -20.17 31.94 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.396 176.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.08 16.2 28.59 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.698 -1.137 . . . . 0.0 114.544 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.9 p -107.55 7.96 29.02 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.01 -138.28 9.04 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 119.213 -0.77 . . . . 0.0 112.747 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.75 168.46 15.87 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.191 2.594 . . . . 0.0 113.754 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.489 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -50.76 -58.83 4.96 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.363 1.065 . . . . 0.0 111.748 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.681 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.4 mmtt -141.3 139.93 33.74 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.797 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 36.7 p -137.02 168.05 20.33 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 tp -128.27 117.07 20.84 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.81 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.808 HD13 HD12 ' A' ' 53' ' ' LEU . 11.5 pt -98.18 103.88 15.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-O 121.415 0.626 . . . . 0.0 109.639 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.0 t -121.37 120.09 34.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.014 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 tp -67.1 115.6 6.98 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.601 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 169.82 11.28 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.405 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -128.42 171.97 11.55 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.278 0.561 . . . . 0.0 110.803 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -108.86 130.89 55.42 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.05 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.5 142.67 13.83 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.387 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.446 ' HH2' HG21 ' A' ' 30' ' ' THR . 17.4 m-90 -120.53 133.6 55.38 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.967 0.451 . . . . 0.0 110.391 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -82.12 158.86 23.52 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.181 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.77 124.37 9.63 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.364 0.415 . . . . 0.0 111.705 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.57 -26.76 8.72 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.036 -0.602 . . . . 0.0 114.35 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -58.27 -49.03 78.58 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.58 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.7 tm? -66.23 -48.96 68.85 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.983 0.177 . . . . 0.0 110.772 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.86 -31.12 66.37 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 120.927 0.394 . . . . 0.0 110.827 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.18 -50.09 50.69 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.086 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.45 -26.62 62.8 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.966 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.1 tp -75.22 -38.48 60.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.427 0.691 . . . . 0.0 110.668 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.0 m -77.93 -29.65 50.09 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.34 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.8 t70 -81.43 -1.13 44.58 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.615 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 t30 60.5 30.31 19.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.879 0.872 . . . . 0.0 111.402 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.73 -42.17 18.35 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.984 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -126.71 115.86 20.06 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.7 tp -86.78 145.3 26.69 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.514 0.197 . . . . 0.0 111.225 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.4 p -105.31 137.0 43.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.964 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 71.1 m -152.12 149.76 24.03 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.598 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.5 158.47 19.27 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.39 2.06 . . . . 0.0 111.247 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.462 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.67 167.22 19.14 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -177.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -133.39 135.64 25.7 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 114.132 -1.395 . . . . 0.0 107.85 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.82 -26.76 13.09 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.61 2.207 . . . . 0.0 114.013 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.77 -40.55 63.25 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.759 0.662 . . . . 0.0 112.104 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.596 HG21 HH11 ' A' ' 167' ' ' ARG . 4.5 mt -70.95 -34.71 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.24 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.3 tt -74.0 -38.62 64.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.654 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.412 ' HE1' ' O ' ' A' ' 89' ' ' LEU . 44.7 m-85 -88.0 -31.1 19.51 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -85.57 -71.73 0.52 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.215 0.461 . . . . 0.0 111.451 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.892 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.43 98.59 5.94 Favored Pre-proline 0 C--N 1.35 0.609 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.852 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 59.3 Cg_endo -91.99 0.35 4.27 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 121.602 1.535 . . . . 0.0 114.206 175.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.643 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 78.7 Cg_endo -74.19 -53.78 0.11 Allowed 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 122.546 2.164 . . . . 0.0 114.461 -178.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.546 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -121.09 -29.66 4.51 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.61 -178.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.892 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.8 tt0 -70.27 -11.49 60.94 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.382 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.794 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.04 -40.2 47.25 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.325 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -72.02 -49.9 32.98 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.8 m -58.92 -47.36 85.31 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.55 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.673 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.79 -40.69 92.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.158 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.82 -46.28 78.12 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 123.488 0.492 . . . . 0.0 110.472 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.21 90.28 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.428 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.82 -27.29 68.14 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.66 177.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.76 -40.21 41.64 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 122.832 0.453 . . . . 0.0 110.306 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.84 -30.28 63.89 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.408 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.745 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.817 179.58 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.487 HD12 ' CE1' ' A' ' 35' ' ' HIS . 19.4 mt . . . . . 0 N--CA 1.469 0.514 0 CA-C-O 120.996 0.427 . . . . 0.0 110.655 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -89.22 17.3 6.14 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.529 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 19.0 p80 172.2 58.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.351 1.06 . . . . 0.0 110.108 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -137.19 161.61 35.71 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.465 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.485 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 18.9 m-30 -97.76 136.95 37.37 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.81 HD11 HD23 ' A' ' 32' ' ' LEU . 3.7 mt -108.28 140.18 41.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.949 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 150' ' ' LEU . 2.9 mp -120.62 135.73 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 123.462 0.476 . . . . 0.0 110.02 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.14 125.61 29.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.048 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.9 mtt -110.34 157.44 38.12 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.206 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.21 30.16 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.63 2.22 . . . . 0.0 113.213 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -86.72 -17.02 34.69 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.29 -167.13 1.15 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.094 0.246 . . . . 0.0 110.597 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.531 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.09 40.33 1.47 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.102 0.477 . . . . 0.0 111.764 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -112.19 80.33 3.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.915 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.4 Cg_exo -75.45 -23.12 13.38 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 123.036 2.491 . . . . 0.0 113.315 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -84.54 -34.93 23.15 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.825 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.94 3.92 53.34 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.048 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.16 163.87 19.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.815 0.341 . . . . 0.0 111.761 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 49.23 31.79 3.88 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.0 p -117.53 154.25 31.8 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.753 HG11 ' HE ' ' A' ' 167' ' ' ARG . 96.4 t -128.93 134.2 64.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.487 0.661 . . . . 0.0 110.857 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.2 m -114.66 153.67 29.79 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.914 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.466 ' OH ' HD21 ' A' ' 105' ' ' LEU . 43.3 t80 -106.82 118.54 36.94 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.81 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.44 109.97 17.15 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.255 0.55 . . . . 0.0 111.139 -178.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.918 HG23 ' HA2' ' A' ' 42' ' ' GLY . 38.1 t -71.35 -64.73 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.397 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -133.8 117.25 16.66 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.583 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.487 ' CE1' HD12 ' A' ' 9' ' ' LEU . 12.1 t-80 -102.46 126.8 49.62 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.466 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -139.25 152.01 46.96 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.08 -13.14 59.54 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.042 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -107.77 3.13 24.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.306 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.07 166.27 15.16 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.424 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -148.5 145.29 27.85 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.86 138.0 53.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.17 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.918 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.43 158.94 29.72 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.451 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.439 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.1 mt -112.77 131.89 55.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.042 0.421 . . . . 0.0 111.196 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 78' ' ' GLY . 15.9 t -66.04 123.43 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.69 55.07 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.598 0.713 . . . . 0.0 112.224 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.851 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.4 t-20 -147.55 -3.24 0.55 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.116 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.72 87.03 53.64 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.537 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -60.27 147.29 94.19 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 121.695 1.597 . . . . 0.0 112.721 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.414 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 66.1 m -92.39 160.13 15.24 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.85 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.02 -2.19 64.64 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 116.144 -0.48 . . . . 0.0 113.711 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.477 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -90.16 152.78 20.95 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.731 0.3 . . . . 0.0 111.28 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 71' ' ' GLN . 17.1 p-10 -101.33 164.85 11.58 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.155 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.64 ' HA ' HD11 ' A' ' 75' ' ' ILE . 13.4 tp -60.26 -28.19 67.85 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 120.802 0.334 . . . . 0.0 111.739 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.55 98.79 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -63.99 -46.52 84.19 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.082 0.239 . . . . 0.0 111.625 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.865 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.5 m -61.91 -44.96 99.61 Favored 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.739 ' HA ' HD12 ' A' ' 60' ' ' LEU . 11.6 mt -56.58 -34.5 67.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.598 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.18 -27.5 48.01 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.317 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.85 -30.7 51.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.248 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.865 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.8 mt -77.87 -46.1 22.33 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.81 -1.541 . . . . 0.0 110.987 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -130.26 115.9 17.54 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -77.6 -32.9 2.59 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.589 2.859 . . . . 0.0 112.757 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.63 -14.91 56.12 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.291 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.43 150.38 23.82 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.355 0.409 . . . . 0.0 111.709 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.79 122.82 28.87 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.175 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.67 149.0 42.71 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.409 2.073 . . . . 0.0 112.25 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.446 ' C ' HE21 ' A' ' 71' ' ' GLN . 9.1 Cg_endo -94.86 -171.79 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.57 2.18 . . . . 0.0 112.6 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -24.5 67.58 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.116 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.477 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 7.8 ptp180 -68.55 -49.15 61.71 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.713 ' HA ' HD12 ' A' ' 73' ' ' ILE . 19.0 m -74.17 -26.03 60.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.083 0.553 . . . . 0.0 112.425 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.451 ' HA ' HD22 ' A' ' 52' ' ' ASN . 45.0 mt-30 -68.53 -27.54 66.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.949 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -97.51 18.85 14.45 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.439 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.713 HD12 ' HA ' ' A' ' 70' ' ' CYS . 65.0 mt -119.64 140.07 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.941 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -107.18 154.34 21.34 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.819 0.7 . . . . 0.0 112.851 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.8 HD13 HD12 ' A' ' 128' ' ' ILE . 20.7 mm -102.98 156.74 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.168 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.712 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -121.58 155.23 35.5 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.63 121.06 27.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 117.763 0.256 . . . . 0.0 110.471 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.571 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.97 -23.67 8.06 Favored Glycine 0 C--N 1.348 1.213 0 C-N-CA 120.206 -0.997 . . . . 0.0 114.211 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.52 -167.88 34.15 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.431 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -88.46 -13.55 3.43 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.468 2.778 . . . . 0.0 114.376 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.61 127.03 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 123.086 0.241 . . . . 0.0 111.148 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 46.99 84.18 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.406 1.082 . . . . 0.0 113.203 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -85.86 1.23 50.66 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.415 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -92.86 -10.76 35.51 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.843 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -133.03 150.82 52.11 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.008 0.432 . . . . 0.0 112.108 -179.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.598 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -110.24 144.88 17.07 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.172 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.8 OUTLIER -86.75 146.12 26.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.923 -1.139 . . . . 0.0 110.525 179.248 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.46 103.71 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 123.601 0.563 . . . . 0.0 109.949 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.872 HD11 HD13 ' A' ' 105' ' ' LEU . 11.4 tp -107.65 127.98 54.14 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.127 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -126.67 168.72 13.66 Favored Pre-proline 0 CA--C 1.556 1.196 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.663 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.684 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.11 17.44 0.6 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.75 2.3 . . . . 0.0 113.691 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 t -105.31 159.49 15.85 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.808 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.84 19.58 54.19 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.752 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mp -85.24 154.59 21.85 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.585 0.354 . . . . 0.0 110.912 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.2 p -125.49 156.95 38.15 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CE2' HG23 ' A' ' 113' ' ' VAL . 56.7 m-85 -130.0 -149.3 0.4 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.495 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -60.41 -45.69 92.68 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.406 0.283 . . . . 0.0 111.323 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.3 m -137.09 85.24 2.12 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.492 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 107' ' ' MET . 13.8 m -129.89 129.16 43.55 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.712 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -112.42 123.21 49.79 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.871 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.93 125.12 29.33 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.447 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -135.09 76.96 1.65 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.973 0.892 . . . . 0.0 112.041 -177.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.592 ' O ' ' HG2' ' A' ' 104' ' ' GLU . . . 43.25 104.88 0.01 OUTLIER Glycine 0 N--CA 1.475 1.279 0 CA-C-N 113.677 -1.601 . . . . 0.0 114.823 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 103' ' ' GLY . 10.4 pt-20 61.36 -15.86 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.777 1.231 . . . . 0.0 113.25 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.872 HD13 HD11 ' A' ' 89' ' ' LEU . 2.7 pp -132.88 145.56 51.04 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 120.806 0.336 . . . . 0.0 110.451 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.578 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -114.84 155.46 26.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.986 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 99' ' ' THR . 16.9 ttm -121.66 128.96 52.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.649 ' HB3' HG11 ' A' ' 113' ' ' VAL . 49.9 m -128.57 129.64 46.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 p -119.65 16.39 12.8 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.311 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.705 ' O ' HG12 ' A' ' 113' ' ' VAL . 45.0 p -91.17 131.0 36.99 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 121.737 0.78 . . . . 0.0 112.439 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.491 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.7 pt20 -61.43 -27.74 68.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.3 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.17 -43.42 95.19 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.484 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.6 p -69.56 -36.4 70.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.46 HD13 HH12 ' A' ' 85' ' ' ARG . 5.4 tp -58.64 -49.43 77.56 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 123.472 0.482 . . . . 0.0 110.372 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.491 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 31.8 m-85 -68.19 -38.74 82.31 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.907 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.1 -52.74 63.64 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.269 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.48 -43.83 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.672 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.6 -32.59 65.4 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.714 0.634 . . . . 0.0 109.579 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.477 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.71 -19.53 32.61 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.316 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.62 14.99 33.13 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.748 -1.114 . . . . 0.0 114.739 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.9 p -104.88 6.53 33.84 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.52 -138.29 9.59 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.169 -0.795 . . . . 0.0 112.515 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.25 172.99 12.16 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 123.128 2.552 . . . . 0.0 113.611 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.61 -55.0 40.46 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.966 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.684 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.9 mmtt -141.63 139.93 33.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.843 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 67.3 m -137.67 166.83 22.99 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tp -125.38 116.46 21.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.601 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.8 HD12 HD13 ' A' ' 75' ' ' ILE . 9.8 pt -99.15 102.57 13.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 O-C-N 123.82 0.7 . . . . 0.0 109.45 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -120.26 120.78 37.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.031 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.08 112.86 4.63 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.488 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.66 171.54 19.13 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.88 -1.055 . . . . 0.0 114.405 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.38 176.12 7.96 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.099 -0.55 . . . . 0.0 110.397 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -115.36 131.01 57.06 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.161 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.94 150.26 18.72 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.549 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.424 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 26.4 m-90 -127.78 136.12 51.05 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 123.902 0.413 . . . . 0.0 110.408 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.08 158.07 26.52 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.922 0.764 . . . . 0.0 110.725 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.27 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.43 -24.84 7.15 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 115.408 -0.815 . . . . 0.0 113.042 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.71 -45.46 85.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.968 0.507 . . . . 0.0 112.28 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.04 -48.25 66.15 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.187 0.304 . . . . 0.0 110.594 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.63 -29.39 67.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.98 0.419 . . . . 0.0 110.715 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.4 -50.42 38.87 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.84 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.35 -26.67 63.85 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.847 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.1 tp -76.02 -37.87 57.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.745 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.5 t -77.78 -29.03 50.7 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.202 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -82.64 0.21 44.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.395 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 59.64 29.51 19.08 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.944 0.897 . . . . 0.0 111.507 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.76 -42.76 19.31 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.949 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -124.52 113.65 18.38 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.2 tp -85.04 139.49 31.71 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.634 0.254 . . . . 0.0 111.371 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.5 p -104.46 137.85 41.72 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.047 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 74.3 m -151.69 154.95 33.74 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.816 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.76 153.26 51.16 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.314 2.009 . . . . 0.0 111.074 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.485 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.42 166.37 18.85 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -133.66 135.9 25.78 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.207 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.433 ' HG3' ' OE1' ' A' ' 104' ' ' GLU . 72.6 Cg_endo -73.51 -26.44 14.08 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.553 2.168 . . . . 0.0 113.684 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.11 62.17 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.9 0.75 . . . . 0.0 112.157 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.589 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.7 mt -72.31 -34.87 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.328 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.35 -36.16 63.59 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.277 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -85.28 -36.87 20.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.65 -71.96 0.48 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 117.927 0.331 . . . . 0.0 111.786 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -142.29 98.97 5.97 Favored Pre-proline 0 C--N 1.349 0.544 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.851 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.2 Cg_endo -91.8 0.21 4.39 Favored 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 121.652 1.568 . . . . 0.0 114.319 175.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.641 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 66.2 Cg_endo -75.46 -50.67 0.12 Allowed 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.609 2.206 . . . . 0.0 114.607 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.516 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.4 mt-10 -121.44 -34.06 3.52 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.731 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 9.0 mt-10 -69.04 -10.77 59.23 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.135 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.753 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.06 -41.57 41.86 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.8 tp -70.65 -49.98 41.6 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.8 m -58.5 -48.76 79.74 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.637 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.677 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.31 -40.19 95.41 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.148 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.46 78.25 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.568 0.542 . . . . 0.0 110.435 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.45 91.22 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.423 177.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.25 68.3 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.676 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.677 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.82 -39.93 42.09 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 122.823 0.449 . . . . 0.0 110.327 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.83 -31.85 68.71 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.376 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.743 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.834 179.482 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.996 0.427 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -91.89 17.21 9.5 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.765 0.317 . . . . 0.0 111.396 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 175.99 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.845 0.858 . . . . 0.0 110.474 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -136.95 158.97 43.25 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.305 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 30' ' ' THR . 13.7 m-30 -98.42 136.15 38.97 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.679 HD11 HD23 ' A' ' 32' ' ' LEU . 6.2 mt -105.39 139.2 40.38 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.936 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -120.15 132.53 69.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 123.572 0.545 . . . . 0.0 109.636 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.23 120.57 18.01 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.926 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.8 mmt -103.22 155.24 36.96 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.166 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -82.9 32.92 0.52 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.669 2.246 . . . . 0.0 112.965 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -87.01 -13.28 44.91 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.254 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -169.52 1.83 Allowed 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.984 0.178 . . . . 0.0 110.876 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.543 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -105.09 42.19 1.25 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.079 0.466 . . . . 0.0 111.583 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -111.58 80.72 2.88 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.88 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.1 Cg_exo -75.49 -16.99 18.87 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.081 2.521 . . . . 0.0 113.404 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -84.56 -38.41 20.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.845 0.458 . . . . 0.0 111.875 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.23 3.88 53.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.175 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.97 162.77 21.25 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.803 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 49.39 33.36 5.38 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.9 p -119.96 154.0 35.12 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 120.562 0.22 . . . . 0.0 110.445 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.621 HG11 ' HE ' ' A' ' 167' ' ' ARG . 99.8 t -129.41 134.95 62.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.503 0.668 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.3 m -116.91 155.26 29.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.875 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.422 ' OH ' HD11 ' A' ' 105' ' ' LEU . 22.6 t80 -109.67 117.34 33.65 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.749 HD11 ' HB1' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -77.46 108.14 10.4 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 123.499 0.5 . . . . 0.0 110.943 -179.17 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.945 HG23 ' HA2' ' A' ' 42' ' ' GLY . 51.8 t -66.29 -58.74 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.409 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -144.39 122.5 12.15 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.235 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -100.52 129.12 46.43 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.987 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -139.6 152.07 46.53 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.591 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.03 -22.63 66.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.657 0.383 . . . . 0.0 112.0 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -94.12 -5.35 47.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.346 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.94 176.16 27.76 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 121.579 -0.343 . . . . 0.0 112.333 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.749 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -148.57 148.29 30.0 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.416 ' O ' HD13 ' A' ' 32' ' ' LEU . 1.1 tpp -121.67 136.45 54.94 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.105 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.945 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -156.4 159.56 29.54 Favored Glycine 0 N--CA 1.447 -0.614 0 O-C-N 124.409 1.068 . . . . 0.0 112.446 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.451 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.2 mt -113.71 131.34 56.21 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.118 0.459 . . . . 0.0 111.365 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 78' ' ' GLY . 7.9 t -66.62 121.77 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.87 54.82 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.561 0.696 . . . . 0.0 112.377 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.855 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.6 t-20 -147.96 -2.31 0.55 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.09 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -130.21 88.03 49.23 Favored Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.529 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 42.9 Cg_exo -59.08 145.04 99.02 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 121.648 1.565 . . . . 0.0 112.412 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.433 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 71.5 m -94.57 161.06 14.36 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.41 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.89 51.34 0.97 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.806 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' C ' HG12 ' A' ' 75' ' ' ILE . 1.1 mt -133.48 156.33 47.94 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 123.86 0.388 . . . . 0.0 110.044 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.509 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 20.3 p-10 -112.7 159.67 18.68 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.836 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.474 HD13 HD13 ' A' ' 128' ' ' ILE . 14.3 tp -59.15 -28.28 66.44 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.08 96.77 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.39 -45.47 87.54 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.068 0.23 . . . . 0.0 111.559 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.874 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 16.7 m -62.45 -44.5 99.33 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.712 ' HA ' HD12 ' A' ' 60' ' ' LEU . 13.3 mt -57.48 -33.85 68.43 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.552 177.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -78.25 -27.92 47.64 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.27 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.87 -30.96 51.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.297 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.874 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.1 mt -77.85 -45.62 23.8 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.851 -1.522 . . . . 0.0 111.113 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -130.34 115.83 17.44 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.623 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.7 -32.91 2.53 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.664 2.91 . . . . 0.0 112.759 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.66 -14.91 56.05 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.423 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.63 149.91 23.99 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.401 0.438 . . . . 0.0 111.679 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.14 123.0 29.13 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.232 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.03 149.7 36.94 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.318 2.012 . . . . 0.0 112.389 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.409 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 9.5 Cg_endo -95.1 -171.61 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.576 2.184 . . . . 0.0 112.532 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.29 -24.52 67.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.294 0.638 . . . . 0.0 112.007 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 73' ' ' ILE . 9.8 ptp180 -68.72 -47.93 65.11 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.709 ' HA ' HD12 ' A' ' 73' ' ' ILE . 25.5 m -74.51 -25.91 59.65 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.555 0.535 . . . . 0.0 112.38 -178.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.446 ' HA ' HD22 ' A' ' 52' ' ' ASN . 44.8 mt-30 -69.5 -26.97 64.8 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.797 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -97.36 20.46 11.54 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.497 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 70' ' ' CYS . 59.4 mt -122.16 138.97 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.737 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -104.34 164.17 11.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.471 HG12 ' C ' ' A' ' 51' ' ' LEU . 13.6 mm -114.17 152.45 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.822 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.728 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -115.81 156.09 26.69 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.482 0.313 . . . . 0.0 110.429 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.36 119.92 27.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.615 0.189 . . . . 0.0 110.623 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.566 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.78 -23.45 8.72 Favored Glycine 0 C--N 1.346 1.1 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.884 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.99 -168.29 32.92 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.371 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -88.42 -13.9 3.35 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.513 2.809 . . . . 0.0 114.356 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.73 131.04 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 123.119 0.262 . . . . 0.0 111.29 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 47.79 83.14 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.366 1.066 . . . . 0.0 113.09 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -84.07 1.03 45.95 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.348 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -93.77 -18.4 22.11 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.634 ' CZ ' ' H ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.2 147.37 52.02 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.968 0.413 . . . . 0.0 111.562 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.634 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -112.65 152.69 17.82 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.646 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.45 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 1.2 m-85 -86.33 153.86 21.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.352 1.061 . . . . 0.0 111.174 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 3.7 t -127.85 103.65 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.666 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.648 ' O ' ' HA ' ' A' ' 126' ' ' SER . 0.3 OUTLIER -98.28 127.39 44.19 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.652 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -129.1 160.76 62.08 Favored Pre-proline 0 CA--C 1.552 1.03 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.614 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 27.2 Cg_endo -99.58 33.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.916 2.41 . . . . 0.0 113.468 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.3 t -118.13 159.08 23.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.749 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.58 21.15 47.65 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.646 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.28 153.62 21.07 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.556 0.342 . . . . 0.0 110.58 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.0 p -122.94 153.58 39.52 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.653 ' CD2' HG12 ' A' ' 113' ' ' VAL . 27.8 m-85 -131.93 -150.98 0.44 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.733 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -62.4 -48.62 78.89 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 122.507 0.323 . . . . 0.0 111.103 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.7 m -132.68 78.41 1.8 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.324 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 107' ' ' MET . 11.1 m -126.49 115.44 19.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.616 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.01 123.45 44.26 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.803 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -83.47 127.48 33.74 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.318 0.58 . . . . 0.0 110.859 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.496 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -120.33 50.01 1.36 Allowed 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.567 -179.422 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.29 -109.62 3.01 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 114.579 -1.191 . . . . 0.0 113.41 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' OE1' ' HD3' ' A' ' 156' ' ' PRO . 10.8 pt-20 -63.1 -6.85 4.56 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.422 HD11 ' OH ' ' A' ' 31' ' ' TYR . 3.3 pp -152.08 160.01 43.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -122.58 158.84 29.04 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' ' 99' ' ' THR . 19.1 ttm -124.48 134.76 52.94 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.7 m -135.65 133.24 37.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.1 p -126.37 21.83 7.19 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.316 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.871 ' O ' HG22 ' A' ' 113' ' ' VAL . 10.7 t -89.26 130.31 35.68 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.13 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.492 ' HA ' HD12 ' A' ' 114' ' ' LEU . 21.2 pt20 -60.33 -28.3 68.03 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.554 0.692 . . . . 0.0 109.608 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -63.63 -44.7 93.12 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.925 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.871 HG22 ' O ' ' A' ' 110' ' ' SER . 18.7 m -62.01 -42.64 95.65 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 111' ' ' GLN . 31.4 mt -54.66 -52.19 63.09 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.795 0.685 . . . . 0.0 111.992 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.461 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 50.2 m-85 -64.86 -46.05 83.47 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.329 0.393 . . . . 0.0 111.585 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.83 63.89 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.839 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.5 tp -63.84 -43.92 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.92 -30.68 66.12 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.797 0.685 . . . . 0.0 109.762 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.63 -19.99 30.16 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.023 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.63 19.04 21.47 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.68 -1.145 . . . . 0.0 114.636 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.8 p -111.03 9.09 22.11 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.91 -137.78 9.42 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-O 119.256 -0.747 . . . . 0.0 112.756 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.72 167.65 22.13 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.284 2.656 . . . . 0.0 113.509 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.488 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -49.65 -58.19 5.74 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.378 1.071 . . . . 0.0 111.754 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.519 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -138.76 154.61 48.53 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 66.3 m -149.63 163.96 36.47 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 2.3 tp -130.31 115.08 16.43 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.883 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 73' ' ' ILE . 11.1 pt -98.03 107.86 20.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.399 0.618 . . . . 0.0 109.508 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 60.1 p -125.4 122.13 35.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.762 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.1 tp -67.5 117.51 9.55 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.604 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.444 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 70.05 167.69 6.43 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.183 -0.917 . . . . 0.0 114.271 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -128.5 174.16 9.6 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.157 0.503 . . . . 0.0 110.958 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -109.98 132.23 54.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.497 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.58 144.34 15.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.496 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -122.49 133.63 54.59 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.961 0.448 . . . . 0.0 110.585 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.77 158.95 23.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.321 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.57 125.42 11.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.746 0.418 . . . . 0.0 111.81 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.01 -26.45 7.64 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.119 -0.562 . . . . 0.0 114.475 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -58.3 -49.1 78.38 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.574 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.6 tm? -66.34 -49.36 67.2 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.0 0.188 . . . . 0.0 110.807 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.45 -31.59 66.07 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.472 0.482 . . . . 0.0 110.567 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -68.83 -50.12 52.69 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.157 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.86 -26.73 62.47 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.059 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.8 tp -75.34 -38.19 60.29 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.673 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.5 m -77.95 -29.99 50.16 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.291 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -81.46 -1.02 44.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.577 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 60.29 30.1 19.55 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.779 0.832 . . . . 0.0 111.658 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.22 -43.04 18.15 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.93 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -125.36 114.76 19.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.7 tp -86.24 138.53 31.79 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.0 p -101.75 137.52 39.94 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.488 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.6 m -149.95 146.19 20.01 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-O 119.192 -0.433 . . . . 0.0 111.4 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.27 148.18 91.0 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 122.286 1.991 . . . . 0.0 110.584 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.487 ' HA ' ' CZ ' ' A' ' 174' ' ' ARG . . . -134.11 176.32 8.69 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 -176.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -132.26 142.17 44.04 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 113.549 -1.66 . . . . 0.0 108.671 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.418 ' HD3' ' OE1' ' A' ' 104' ' ' GLU . 92.3 Cg_endo -76.11 -26.51 9.14 Favored 'Trans proline' 0 C--N 1.364 1.392 0 C-N-CA 122.692 2.262 . . . . 0.0 114.177 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -49.77 -42.11 45.75 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.774 0.671 . . . . 0.0 112.448 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.73 HD13 HH12 ' A' ' 167' ' ' ARG . 4.6 mt -69.52 -32.65 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-O 121.492 0.663 . . . . 0.0 110.229 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.0 tt -75.81 -38.87 57.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.687 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.425 ' HE1' ' O ' ' A' ' 89' ' ' LEU . 42.8 m-85 -86.51 -29.7 22.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -87.02 -72.56 0.5 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.106 0.412 . . . . 0.0 111.378 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.897 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.18 98.73 6.07 Favored Pre-proline 0 C--N 1.348 0.514 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.855 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.4 Cg_endo -91.55 0.08 4.55 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 C-N-CA 121.657 1.571 . . . . 0.0 114.28 175.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.649 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 87.5 Cg_endo -74.11 -54.16 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.655 2.237 . . . . 0.0 114.445 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.549 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.1 mt-10 -121.05 -29.55 4.54 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.7 -177.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.897 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.6 tt0 -70.56 -11.24 60.8 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.417 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.73 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.66 -43.99 35.73 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -69.37 -50.21 48.28 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 m -57.65 -49.57 76.01 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.769 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.33 96.77 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.096 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.54 -46.61 80.56 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 123.637 0.586 . . . . 0.0 110.729 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.12 82.47 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.7 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.45 -31.44 72.61 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.446 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.487 ' CZ ' ' HA ' ' A' ' 154' ' ' ALA . 11.3 mtm-85 -77.55 -41.5 38.81 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.793 0.437 . . . . 0.0 110.548 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.48 -34.1 77.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.676 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.747 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.017 179.425 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.454 ' O ' HD12 ' A' ' 32' ' ' LEU . 17.5 mt . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 121.158 0.504 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.422 ' NZ ' ' HG3' ' A' ' 34' ' ' GLU . 27.6 tttm -92.88 19.29 7.84 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.113 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.6 t60 173.79 56.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.039 0.936 . . . . 0.0 109.641 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 153' ' ' PRO . 30.2 m80 -139.28 160.96 38.59 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.461 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 17.1 m-30 -99.09 137.44 37.6 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.057 0.456 . . . . 0.0 111.914 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.839 HD11 HD23 ' A' ' 32' ' ' LEU . 2.0 mt -108.16 140.97 40.59 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.202 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.55 137.21 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 123.352 0.407 . . . . 0.0 110.139 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.77 119.22 17.69 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.699 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 14.6 mmt -99.44 159.82 29.07 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.617 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.91 5.24 5.07 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.716 2.277 . . . . 0.0 113.652 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -77.34 -14.22 59.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.506 0.322 . . . . 0.0 111.856 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.724 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -104.4 154.98 19.18 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.264 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.44 48.67 1.41 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.253 0.549 . . . . 0.0 112.021 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.724 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.2 m-20 -125.05 89.66 52.27 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.626 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.54 -16.83 21.25 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.905 2.404 . . . . 0.0 113.388 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -84.47 -35.23 23.12 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 122.826 0.45 . . . . 0.0 111.772 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -93.41 3.96 54.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.045 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.49 163.21 21.52 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.847 0.356 . . . . 0.0 111.835 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 49.1 32.41 4.03 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.3 p -118.0 154.51 31.87 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 120.541 0.21 . . . . 0.0 110.694 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.784 HG11 ' HE ' ' A' ' 167' ' ' ARG . 60.7 t -129.76 133.15 65.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.773 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.2 m -113.74 153.57 28.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.759 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.429 ' OH ' HD21 ' A' ' 105' ' ' LEU . 33.4 t80 -107.66 116.82 32.63 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.839 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.38 109.52 16.7 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 121.457 0.646 . . . . 0.0 111.03 -178.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.938 HG23 ' HA2' ' A' ' 42' ' ' GLY . 29.6 t -70.22 -66.21 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.132 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.422 ' HG3' ' NZ ' ' A' ' 10' ' ' LYS . 6.6 tt0 -132.55 119.83 21.05 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.726 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -102.97 126.59 50.21 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.428 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -139.51 152.11 46.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.504 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.2 -19.56 65.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.832 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -97.73 -3.73 38.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.428 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.26 171.14 22.24 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 112.277 -0.329 . . . . 0.0 112.277 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.526 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -148.26 146.9 28.82 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -122.81 136.34 54.84 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.615 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.12 158.79 29.48 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.334 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.3 mt -114.75 133.72 55.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.055 0.427 . . . . 0.0 111.367 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 78' ' ' GLY . 14.9 t -67.69 123.21 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.6 54.55 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.57 0.7 . . . . 0.0 112.126 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.852 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.4 t-20 -147.66 -3.21 0.54 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.156 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -129.67 87.24 53.17 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.515 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.6 Cg_exo -59.39 142.77 99.52 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 121.702 1.602 . . . . 0.0 112.252 175.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.432 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 62.4 m -91.72 158.27 16.47 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.479 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.29 50.52 1.3 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.842 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mt -133.55 158.04 44.15 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.743 0.417 . . . . 0.0 110.046 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.517 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.7 p-10 -112.07 158.98 18.93 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.204 0.315 . . . . 0.0 110.423 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 128' ' ' ILE . 12.7 tp -59.21 -36.16 74.9 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.08 -38.4 65.28 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -64.76 -40.2 94.88 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.36 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.847 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.0 t -61.8 -50.82 78.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.65 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.8 mp -52.31 -36.38 53.01 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.978 0.799 . . . . 0.0 111.099 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.94 -29.18 49.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.451 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -31.72 46.55 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.713 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.847 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 11.5 mt -77.56 -44.63 27.9 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.833 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -131.93 116.8 15.87 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.479 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.49 -33.11 2.57 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.585 2.857 . . . . 0.0 112.844 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.2 -13.79 56.58 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.388 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.42 149.62 24.33 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.291 0.37 . . . . 0.0 111.721 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.68 123.72 29.5 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.972 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.97 143.84 29.66 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.271 1.981 . . . . 0.0 112.414 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.1 Cg_endo -91.93 -169.65 0.28 Allowed 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.576 2.184 . . . . 0.0 111.85 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.487 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -64.23 -24.92 67.84 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.224 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.515 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.8 ptp180 -66.91 -51.61 53.29 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.711 ' HA ' HD12 ' A' ' 73' ' ' ILE . 58.2 m -72.46 -25.07 61.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 47.4 mt-30 -68.21 -34.84 77.01 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.487 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 21.8 p80 -91.12 22.53 3.7 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.115 0.484 . . . . 0.0 111.649 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 70' ' ' CYS . 58.9 mt -119.22 139.44 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.312 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.59 157.05 17.97 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.625 HD13 HD12 ' A' ' 128' ' ' ILE . 22.5 mm -103.7 152.69 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.853 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.713 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -118.68 154.71 32.27 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -85.82 120.48 27.28 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.623 0.192 . . . . 0.0 110.649 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.33 -23.64 8.35 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 120.082 -1.056 . . . . 0.0 114.006 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.98 -167.62 34.34 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.324 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -88.16 -12.17 4.16 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 123.364 2.71 . . . . 0.0 114.136 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.47 126.35 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 123.094 0.246 . . . . 0.0 110.596 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 50.26 79.02 0.09 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.099 0.96 . . . . 0.0 112.46 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.466 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.5 t -83.01 1.57 39.3 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.554 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -102.63 2.74 36.39 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.477 HH21 ' HB3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -133.07 154.62 50.38 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -179.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.47 128.58 9.02 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.778 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.64 144.82 27.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.436 1.095 . . . . 0.0 109.936 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.87 105.86 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.142 0.276 . . . . 0.0 110.963 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.82 HD11 HD13 ' A' ' 105' ' ' LEU . 10.9 tp -107.57 127.82 53.98 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -123.35 164.35 28.55 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.762 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 12.4 Cg_endo -94.86 14.62 1.25 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.659 2.239 . . . . 0.0 113.615 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.1 t -101.81 157.52 16.79 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.73 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.12 20.98 48.38 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.631 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -85.66 154.7 21.49 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.611 0.364 . . . . 0.0 110.321 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.6 p -118.89 151.89 37.3 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.668 ' CD2' HG12 ' A' ' 113' ' ' VAL . 18.2 m-85 -130.68 -150.59 0.43 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.469 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -62.05 -47.6 83.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.775 0.321 . . . . 0.0 111.065 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 108' ' ' SER . 66.7 m -135.12 81.22 1.88 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.136 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 107' ' ' MET . 19.2 m -127.48 119.45 26.1 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.412 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -105.0 122.11 45.18 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.96 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -79.3 124.24 28.21 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.462 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -136.43 77.85 1.67 Allowed 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.862 0.839 . . . . 0.0 111.829 -177.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.578 ' O ' ' HG2' ' A' ' 104' ' ' GLU . . . 44.33 103.0 0.01 OUTLIER Glycine 0 N--CA 1.474 1.223 0 CA-C-N 113.679 -1.6 . . . . 0.0 114.676 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 103' ' ' GLY . 10.7 pt-20 60.75 -14.72 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.85 1.26 . . . . 0.0 113.426 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.82 HD13 HD11 ' A' ' 89' ' ' LEU . 2.8 pp -132.68 145.51 51.11 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-O 120.705 0.288 . . . . 0.0 110.486 178.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.614 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -114.8 155.61 26.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.056 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.584 ' O ' ' HA ' ' A' ' 99' ' ' THR . 15.2 ttm -120.33 122.15 40.2 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 98' ' ' SER . 51.0 m -121.25 129.59 53.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.209 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.1 p -119.43 22.12 11.86 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.886 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.815 ' O ' HG22 ' A' ' 113' ' ' VAL . 61.7 m -92.29 126.19 37.27 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.215 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.502 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 10.8 pt20 -59.9 -28.08 67.27 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.394 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.29 -49.15 76.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.872 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.843 ' O ' HG22 ' A' ' 117' ' ' ILE . 16.6 m -59.43 -40.44 81.71 Favored 'Isoleucine or valine' 0 C--N 1.361 1.068 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.6 tp -56.86 -54.06 50.8 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.684 0.615 . . . . 0.0 111.534 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.502 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 61.4 m-85 -67.02 -42.5 84.8 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.341 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.38 -51.7 68.79 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.542 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.843 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.15 -43.3 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.378 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.49 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -57.88 -30.26 65.7 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.893 0.745 . . . . 0.0 109.79 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.515 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -86.16 -19.92 29.37 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.09 176.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.15 15.65 29.96 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.696 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.4 p -107.22 8.42 29.95 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.95 -138.02 9.84 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.261 -0.744 . . . . 0.0 112.641 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.56 171.19 16.14 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 123.332 2.688 . . . . 0.0 113.557 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.481 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -51.11 -57.16 9.43 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.211 1.004 . . . . 0.0 111.604 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.5 mmtt -140.03 156.59 46.54 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.533 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 73.5 m -149.26 161.83 41.24 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.6 tp -126.61 115.7 19.88 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.326 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.648 HD13 HD13 ' A' ' 53' ' ' LEU . 13.3 pt -97.4 102.12 13.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.781 0.801 . . . . 0.0 109.685 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.5 t -119.36 121.86 40.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.606 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 83' ' ' THR . 8.9 tp -67.32 113.7 5.43 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.111 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.24 173.17 6.08 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-N 114.714 -1.13 . . . . 0.0 114.314 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -128.49 178.23 6.44 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.314 0.578 . . . . 0.0 110.73 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -114.23 129.54 56.63 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.151 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.61 147.56 17.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.37 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.413 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 29.6 m-90 -125.33 136.31 53.34 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 123.886 0.403 . . . . 0.0 110.35 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -80.19 158.27 26.32 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.901 0.751 . . . . 0.0 110.66 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.76 89.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.16 -23.79 7.57 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.161 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -56.58 -46.31 80.85 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.949 0.5 . . . . 0.0 112.231 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.573 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.4 tp -67.22 -47.88 69.51 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -57.35 -30.55 64.93 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.467 0.479 . . . . 0.0 110.77 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.19 -50.3 41.56 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.914 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.6 pt-20 -71.85 -26.7 62.47 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.924 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.0 tp -75.06 -39.23 61.02 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.833 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.5 m -78.14 -30.37 49.27 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.507 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.5 t70 -80.24 0.49 32.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.674 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 59.72 29.85 19.43 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.826 0.85 . . . . 0.0 111.645 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.32 -41.75 19.66 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.794 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -123.47 112.21 17.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.9 tp -84.13 138.37 33.06 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.533 0.206 . . . . 0.0 111.148 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.9 p -105.19 138.89 40.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.311 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.2 m -152.57 155.47 32.7 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.725 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.413 ' HA ' ' CD2' ' A' ' 12' ' ' HIS . 31.7 Cg_exo -59.06 153.52 51.35 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.332 2.021 . . . . 0.0 111.12 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.461 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -129.09 168.36 16.21 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.75 135.76 24.01 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.138 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.414 ' HG3' ' OE1' ' A' ' 104' ' ' GLU . 72.9 Cg_endo -73.48 -26.48 14.12 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 122.591 2.194 . . . . 0.0 113.687 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.43 -40.44 62.2 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.885 0.74 . . . . 0.0 112.132 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.604 HD13 HH12 ' A' ' 167' ' ' ARG . 4.8 mt -71.68 -34.8 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.385 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.33 -36.96 63.69 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.279 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -84.92 -35.32 22.18 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -84.13 -72.45 0.46 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.006 0.367 . . . . 0.0 111.624 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.886 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.67 99.61 6.23 Favored Pre-proline 0 C--N 1.348 0.539 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.852 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 64.7 Cg_endo -91.24 -0.84 4.78 Favored 'Trans proline' 0 CA--C 1.569 2.266 0 C-N-CA 121.637 1.558 . . . . 0.0 114.271 175.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.648 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 74.6 Cg_endo -74.18 -52.95 0.12 Allowed 'Trans proline' 0 C--N 1.392 2.861 0 C-N-CA 122.656 2.238 . . . . 0.0 114.519 -178.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.53 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.5 mt-10 -122.17 -30.35 4.04 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.746 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.886 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 5.0 tp10 -69.8 -11.42 60.84 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.364 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.784 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.96 -41.71 41.99 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.296 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.38 -50.04 42.92 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -58.29 -49.0 78.68 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.717 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.672 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.34 -39.96 94.94 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.122 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.13 -46.72 79.1 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.626 0.579 . . . . 0.0 110.461 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.45 91.24 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.398 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.6 -27.81 68.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.705 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.672 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.7 -40.01 42.77 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 122.876 0.47 . . . . 0.0 110.4 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -72.82 -30.37 64.0 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.44 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.744 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.841 179.68 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 32' ' ' LEU . 20.7 mt . . . . . 0 N--CA 1.466 0.37 0 CA-C-O 121.063 0.458 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -89.79 16.37 8.15 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.642 -177.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 173.06 56.75 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.141 0.976 . . . . 0.0 110.161 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -135.82 161.67 34.96 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.654 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.465 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.4 m-30 -97.68 136.29 38.25 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.853 HD11 HD23 ' A' ' 32' ' ' LEU . 2.8 mt -108.49 136.6 47.83 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.703 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.426 HG23 HG22 ' A' ' 29' ' ' VAL . 2.7 mp -120.85 131.4 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.44 126.61 30.26 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.588 0.555 . . . . 0.0 111.92 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.2 mmt -114.29 155.26 45.94 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.22 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -79.47 75.82 4.86 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.662 2.241 . . . . 0.0 112.593 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -132.32 -20.35 2.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.779 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.34 -163.54 0.86 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.324 0.39 . . . . 0.0 110.46 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.51 36.31 2.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.925 0.393 . . . . 0.0 111.861 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.1 m-20 -111.1 82.97 3.49 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.798 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.38 -22.78 13.82 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.969 2.446 . . . . 0.0 113.417 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -85.13 -37.78 19.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.94 0.496 . . . . 0.0 111.713 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.6 -3.22 56.66 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.823 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -61.17 1.99 0.15 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -141.77 40.33 1.68 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.187 0.518 . . . . 0.0 112.005 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 p -123.71 156.09 36.6 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.535 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.702 HG11 ' HE ' ' A' ' 167' ' ' ARG . 48.9 t -130.41 132.03 64.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.89 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -114.59 154.01 29.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.341 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.412 ' OH ' HD21 ' A' ' 105' ' ' LEU . 42.9 t80 -107.21 119.24 38.86 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.853 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -83.52 109.95 17.81 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.32 0.581 . . . . 0.0 111.098 -178.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.941 HG23 ' HA2' ' A' ' 42' ' ' GLY . 30.3 t -71.85 -63.73 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 113.461 -1.699 . . . . 0.0 110.685 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -133.91 117.96 17.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.537 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -103.0 126.61 50.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.491 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -139.46 152.1 46.74 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.514 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -65.63 -14.86 62.04 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.046 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -103.79 -0.36 29.38 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.302 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.01 169.2 19.32 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 112.064 -0.414 . . . . 0.0 112.064 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.504 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -149.49 149.22 30.41 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.82 137.85 53.25 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.047 178.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.41 159.46 29.79 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.461 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.3 mt -114.58 131.44 56.68 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.794 0.297 . . . . 0.0 111.111 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 78' ' ' GLY . 14.0 t -66.19 123.74 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.531 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.8 55.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.773 0.797 . . . . 0.0 112.064 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.857 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.1 t-20 -146.82 -4.0 0.58 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.131 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -130.17 89.5 44.89 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.477 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 41.0 Cg_exo -59.39 139.38 89.4 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 121.483 1.456 . . . . 0.0 111.19 174.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.5 m -76.63 -53.32 8.18 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.1 -9.14 20.87 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.173 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 3.1 mp -82.43 169.64 16.18 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.633 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.0 p-10 -112.47 156.94 21.72 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.689 0.281 . . . . 0.0 111.7 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.822 HD12 HD13 ' A' ' 128' ' ' ILE . 4.5 tt -58.41 -31.71 67.96 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.347 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.46 74.55 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 39.4 mt-10 -65.28 -42.56 93.02 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.735 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.853 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.9 t -61.42 -50.09 81.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.657 ' HA ' HD12 ' A' ' 60' ' ' LEU . 22.1 mt -53.5 -35.23 60.4 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.062 0.851 . . . . 0.0 111.568 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -78.34 -29.46 47.58 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.254 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -31.29 47.85 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.66 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.853 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.3 mt -77.6 -44.93 26.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.83 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -131.35 116.47 16.45 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.583 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.24 -32.82 2.88 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.725 2.95 . . . . 0.0 112.812 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.79 -15.03 55.53 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.293 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.75 149.28 25.39 Favored 'General case' 0 C--N 1.345 0.38 0 O-C-N 123.402 0.439 . . . . 0.0 111.609 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -118.21 123.04 29.73 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.114 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.94 147.77 34.63 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.231 1.954 . . . . 0.0 112.246 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.472 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 8.2 Cg_endo -94.45 -169.83 0.2 Allowed 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 122.608 2.206 . . . . 0.0 112.172 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.473 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -66.75 -24.84 66.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.089 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.417 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 6.5 ptp180 -67.88 -47.02 70.02 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.707 ' HA ' HD12 ' A' ' 73' ' ' ILE . 13.1 m -75.24 -25.34 58.01 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 51.1 mt-30 -69.57 -30.4 68.17 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.473 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 22.9 p80 -94.9 22.33 6.6 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.144 0.497 . . . . 0.0 111.461 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 70' ' ' CYS . 62.8 mt -118.3 136.17 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.318 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 1.7 m-20 -103.49 158.39 16.39 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.787 HD13 HD12 ' A' ' 128' ' ' ILE . 22.4 mm -108.23 149.1 11.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.991 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.736 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -115.54 156.62 25.4 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.82 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -86.4 120.32 27.62 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.0 -23.42 9.21 Favored Glycine 0 C--N 1.345 1.044 0 C-N-CA 120.322 -0.942 . . . . 0.0 114.134 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.23 -167.59 35.01 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.261 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -88.15 -11.39 4.47 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.521 2.814 . . . . 0.0 114.173 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 t -86.84 127.16 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.088 0.242 . . . . 0.0 110.563 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 49.68 76.88 0.12 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.127 0.971 . . . . 0.0 112.518 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.463 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.8 t -80.87 1.96 28.54 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.687 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -103.78 3.95 34.61 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -132.91 155.18 49.53 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.211 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.42 127.4 8.47 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.982 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -85.91 144.24 27.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.482 1.113 . . . . 0.0 110.383 179.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.6 t -121.82 104.71 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 123.231 0.332 . . . . 0.0 110.852 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.862 HD11 HD13 ' A' ' 105' ' ' LEU . 9.9 tp -106.98 129.03 54.84 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.946 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -127.8 168.77 14.17 Favored Pre-proline 0 CA--C 1.555 1.136 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.54 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.677 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.03 13.77 0.89 Allowed 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.784 2.322 . . . . 0.0 113.857 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.0 t -101.82 160.38 14.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.726 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.14 21.35 44.59 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.617 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -88.81 152.7 21.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.616 0.366 . . . . 0.0 110.511 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.526 ' HA ' HG21 ' A' ' 99' ' ' THR . 10.0 m -131.02 156.9 44.35 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.569 ' CE2' HG23 ' A' ' 113' ' ' VAL . 40.1 m-85 -123.87 -150.86 0.46 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.753 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -58.27 -46.68 85.58 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.604 0.362 . . . . 0.0 111.488 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.9 m -132.77 80.81 1.91 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.097 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.526 HG21 ' HA ' ' A' ' 95' ' ' SER . 31.7 m -130.45 130.04 43.75 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.756 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -110.16 123.6 50.04 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.791 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.36 125.41 30.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.271 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.578 ' HB3' HD12 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -119.39 44.63 2.31 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.609 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.41 -101.6 0.4 Allowed Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.354 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -56.29 -14.27 2.75 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.862 HD13 HD11 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -160.81 160.95 31.8 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.844 0.458 . . . . 0.0 110.821 -179.31 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.571 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -119.49 158.23 26.69 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.76 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.508 ' CE ' HD13 ' A' ' 89' ' ' LEU . 15.8 ttm -123.23 130.07 52.25 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.67 ' HB3' HG11 ' A' ' 113' ' ' VAL . 70.2 m -124.83 129.27 50.09 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.871 0.367 . . . . 0.0 110.257 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.7 p -120.87 21.0 11.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.335 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.755 ' O ' HG12 ' A' ' 113' ' ' VAL . 35.5 p -93.48 127.81 39.3 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.517 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 20.8 pt20 -60.99 -28.67 69.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.926 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.31 -39.68 94.39 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.497 -1.228 . . . . 0.0 110.198 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 110' ' ' SER . 2.9 p -70.11 -37.7 72.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mt -56.82 -47.96 79.09 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.532 0.52 . . . . 0.0 110.239 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.517 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 32.1 m-85 -66.54 -42.61 86.91 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.017 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.72 -53.88 52.07 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.888 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.69 -43.2 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.549 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -57.34 -31.73 66.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.716 0.635 . . . . 0.0 109.602 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.417 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.98 -19.44 32.08 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.331 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.97 17.06 28.78 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.697 -1.138 . . . . 0.0 114.575 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.8 p -107.39 7.7 29.21 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.08 -137.34 8.58 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-O 119.168 -0.795 . . . . 0.0 112.628 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -80.78 172.1 13.62 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 123.13 2.554 . . . . 0.0 113.545 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.01 -55.34 33.99 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.86 0.864 . . . . 0.0 111.994 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.677 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.0 mmtt -141.16 139.82 33.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.667 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 73.1 m -139.51 166.39 24.7 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 tp -127.19 117.79 23.02 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.273 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.822 HD13 HD12 ' A' ' 53' ' ' LEU . 10.9 pt -97.49 102.31 13.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-O 121.724 0.774 . . . . 0.0 109.778 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.2 t -118.98 121.08 39.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.907 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 10.9 tp -67.51 112.73 4.84 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.355 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.65 172.44 11.82 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 115.012 -0.994 . . . . 0.0 114.376 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -128.68 176.36 7.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.333 0.587 . . . . 0.0 110.908 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -115.82 130.71 56.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.029 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.52 149.11 18.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.447 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 21.1 m-90 -127.26 135.89 51.23 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 122.579 0.351 . . . . 0.0 110.381 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.34 158.15 27.52 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.863 0.727 . . . . 0.0 110.876 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.95 91.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.8 -24.47 7.51 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.11 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.88 -45.35 86.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -67.97 -48.05 66.9 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.136 0.273 . . . . 0.0 110.516 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.01 -29.11 68.26 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.008 0.432 . . . . 0.0 110.667 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.38 -50.48 38.29 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.938 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -70.09 -26.5 64.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.773 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.8 tp -75.79 -38.91 57.79 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.804 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.0 m -77.8 -28.37 50.38 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.572 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -82.66 0.96 40.78 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.496 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.88 29.54 19.1 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.874 0.87 . . . . 0.0 111.622 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.66 -43.11 17.32 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.94 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -123.52 113.4 18.68 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.348 0.405 . . . . 0.0 110.043 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.4 tp -83.61 139.81 32.6 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.245 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.4 p -105.81 138.09 42.58 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.513 0.508 . . . . 0.0 111.335 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.6 m -152.73 155.35 32.39 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.713 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.75 157.24 28.89 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.298 1.998 . . . . 0.0 111.182 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.465 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.69 166.97 19.58 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -177.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.22 135.35 23.98 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.997 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.39 -26.46 14.33 Favored 'Trans proline' 0 C--N 1.364 1.363 0 C-N-CA 122.54 2.16 . . . . 0.0 113.785 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.85 -40.6 63.51 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.818 0.699 . . . . 0.0 112.158 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.567 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.6 mt -71.18 -35.24 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.408 0.623 . . . . 0.0 110.388 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.5 tt -73.98 -38.2 64.23 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.437 -177.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -85.57 -32.76 21.94 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -86.69 -72.58 0.5 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.054 0.388 . . . . 0.0 111.636 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.917 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.72 98.84 6.32 Favored Pre-proline 0 C--N 1.349 0.56 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.857 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.5 Cg_endo -92.68 0.2 3.83 Favored 'Trans proline' 0 CA--C 1.57 2.281 0 C-N-CA 121.737 1.625 . . . . 0.0 114.256 175.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.642 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 94.8 Cg_endo -73.28 -52.39 0.15 Allowed 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 122.656 2.237 . . . . 0.0 114.195 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.516 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -122.79 -29.93 3.92 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.664 -178.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.917 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.07 -10.91 60.28 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.407 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.702 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.03 -41.21 43.54 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.151 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -70.47 -50.21 40.47 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.5 m -58.38 -49.25 77.93 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.689 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.669 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.05 -39.81 94.91 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.228 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.42 79.63 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 123.536 0.523 . . . . 0.0 110.424 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.4 90.99 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.448 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.29 -27.87 68.93 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.673 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.66 -40.01 43.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 122.908 0.483 . . . . 0.0 110.412 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.53 -31.96 69.24 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.413 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.784 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.81 179.471 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.495 0.188 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.1 mttp -100.58 141.91 32.8 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.091 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -98.67 -42.02 7.43 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.986 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.546 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 54.5 m -100.69 154.47 18.57 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.456 0.473 . . . . 0.0 110.731 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.3 m -98.51 96.63 3.92 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.089 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.3 Cg_endo -87.6 8.48 4.22 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 122.924 2.416 . . . . 0.0 112.083 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -90.02 -46.14 8.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.342 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -101.84 157.02 17.15 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.465 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.407 HD12 ' CE1' ' A' ' 35' ' ' HIS . 13.1 mt -94.05 45.91 1.15 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.211 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.403 ' O ' HD21 ' A' ' 102' ' ' LEU . 85.6 mttt -90.19 20.0 4.67 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.928 0.394 . . . . 0.0 111.214 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 175.33 55.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.124 0.97 . . . . 0.0 110.116 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -134.25 159.47 40.86 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.654 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.458 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.5 m-30 -97.75 135.17 39.91 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.737 HD11 HD23 ' A' ' 32' ' ' LEU . 6.0 mt -107.64 138.99 42.87 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.968 177.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.468 HG23 HG22 ' A' ' 29' ' ' VAL . 2.3 mm -117.26 134.11 61.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.14 128.54 33.41 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.749 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 43.2 mtt -113.75 157.4 41.79 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.268 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.56 32.74 0.52 Allowed 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.655 2.237 . . . . 0.0 113.143 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -86.0 -18.3 32.94 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.71 -163.46 0.86 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.096 0.248 . . . . 0.0 110.451 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.532 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -99.24 31.73 2.97 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 7.9 m-20 -112.42 80.78 3.68 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.0 Cg_exo -75.44 -21.17 15.32 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 123.11 2.54 . . . . 0.0 113.276 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -85.53 -38.5 18.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.515 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -93.27 2.67 56.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.69 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -68.23 8.24 0.47 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -141.87 39.42 1.65 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.152 0.501 . . . . 0.0 112.186 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.2 p -123.16 156.12 35.68 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.426 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.762 HG11 ' HE ' ' A' ' 167' ' ' ARG . 59.5 t -130.25 132.7 64.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.902 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -113.41 152.91 29.42 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.415 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.521 ' OH ' HD21 ' A' ' 105' ' ' LEU . 43.6 t80 -107.23 120.07 41.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.737 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.04 108.57 17.06 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 123.515 0.509 . . . . 0.0 111.402 -178.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.93 HG23 ' HA2' ' A' ' 42' ' ' GLY . 31.2 t -67.45 -59.24 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.713 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -143.65 115.61 8.32 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.1 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.407 ' CE1' HD12 ' A' ' 9' ' ' LEU . 15.5 t-80 -98.01 128.32 44.49 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.912 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -138.92 152.21 47.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.358 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.02 -17.91 64.85 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.881 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -102.31 3.29 37.91 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.52 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.54 166.89 15.16 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 121.469 -0.396 . . . . 0.0 112.285 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.538 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.92 141.07 27.44 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.91 133.92 55.45 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.125 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.93 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.24 156.84 27.95 Favored Glycine 0 N--CA 1.449 -0.461 0 O-C-N 124.268 0.98 . . . . 0.0 112.492 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.2 mt -113.31 135.24 54.06 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.226 0.513 . . . . 0.0 111.638 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 78' ' ' GLY . 11.6 t -68.77 124.06 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -127.41 55.83 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 121.688 0.756 . . . . 0.0 111.961 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.841 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.0 t-20 -146.87 -4.16 0.57 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.23 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -129.72 87.89 51.09 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.507 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.1 Cg_exo -58.87 141.75 98.37 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 121.635 1.557 . . . . 0.0 112.176 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.446 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.9 m -90.29 158.02 17.37 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.41 0.444 . . . . 0.0 111.649 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.12 49.39 1.38 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.585 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.445 ' C ' HG12 ' A' ' 75' ' ' ILE . 0.8 OUTLIER -133.22 155.36 49.5 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.337 -0.432 . . . . 0.0 109.99 -179.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.466 HD22 ' HA ' ' A' ' 71' ' ' GLN . 44.8 p-10 -112.39 161.08 17.08 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.578 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.412 HD13 HD13 ' A' ' 128' ' ' ILE . 8.6 tp -58.36 -27.03 63.83 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.653 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . . . -61.86 -42.79 99.48 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.45 -47.42 79.11 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.052 0.22 . . . . 0.0 111.423 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.875 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.8 m -61.76 -44.49 98.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.73 ' HA ' HD12 ' A' ' 60' ' ' LEU . 12.6 mt -55.54 -36.04 66.32 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.748 177.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.05 -28.14 48.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.409 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.07 -30.04 49.5 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.269 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.875 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.94 -46.22 21.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.759 -1.564 . . . . 0.0 111.372 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -132.7 118.68 15.72 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.003 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.4 -32.36 3.01 Favored 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 123.628 2.885 . . . . 0.0 112.556 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -82.18 -15.29 53.74 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.294 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.21 149.27 26.92 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 123.283 0.365 . . . . 0.0 111.42 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.94 121.45 31.55 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.64 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.718 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 47.2 Cg_endo -71.4 138.07 32.03 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.555 2.17 . . . . 0.0 112.339 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 66' ' ' PRO . 2.4 Cg_endo -90.07 -156.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.705 2.27 . . . . 0.0 112.532 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.09 -24.88 51.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.264 0.626 . . . . 0.0 111.824 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.511 ' O ' HG13 ' A' ' 73' ' ' ILE . 10.0 ptp180 -67.86 -45.42 74.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 66' ' ' PRO . 19.5 p -65.59 -32.66 74.36 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.466 ' HA ' HD22 ' A' ' 52' ' ' ASN . 48.5 mt-30 -66.97 -26.84 67.02 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.664 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -97.49 8.28 44.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.734 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 69' ' ' ARG . 64.2 mt -113.58 137.73 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.179 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -106.75 163.31 13.03 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.873 0.733 . . . . 0.0 112.937 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.462 ' CD1' HD12 ' A' ' 128' ' ' ILE . 14.0 mm -111.81 152.95 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.598 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.72 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -119.5 153.72 34.89 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -84.21 118.76 24.36 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -99.53 -23.93 10.59 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 120.185 -1.007 . . . . 0.0 113.797 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.41 -167.74 35.15 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.218 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -88.62 -10.53 4.4 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.702 2.935 . . . . 0.0 114.227 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.5 t -87.96 130.39 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 123.023 0.202 . . . . 0.0 111.098 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 45.94 85.02 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.431 1.092 . . . . 0.0 113.194 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 68.6 p -85.91 -5.81 59.17 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.953 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.87 -2.43 58.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.766 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.614 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.66 152.13 51.77 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -179.47 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.614 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.6 132.21 10.98 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.56 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.696 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -86.19 144.85 27.25 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.047 0.939 . . . . 0.0 110.756 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.29 104.49 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 123.474 0.484 . . . . 0.0 110.514 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.892 HD11 HD13 ' A' ' 105' ' ' LEU . 13.0 tp -108.32 129.53 55.22 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.213 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -127.04 169.07 12.89 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-O 118.874 -0.584 . . . . 0.0 111.769 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.697 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.5 Cg_endo -98.06 13.83 0.74 Allowed 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 122.856 2.37 . . . . 0.0 113.802 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.2 t -101.26 160.94 13.98 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.881 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.38 22.03 42.24 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.537 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 tp -86.8 154.05 21.2 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.613 0.365 . . . . 0.0 110.642 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.6 p -127.66 156.3 42.55 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.573 ' CE2' HG23 ' A' ' 113' ' ' VAL . 54.9 m-85 -129.96 -152.31 0.51 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.811 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -57.64 -46.58 83.98 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.76 0.424 . . . . 0.0 111.615 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 64.4 m -135.92 83.56 2.02 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.259 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.3 m -130.63 130.37 43.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.835 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.99 123.34 48.97 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.626 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.19 129.14 34.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.071 0.462 . . . . 0.0 110.747 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -125.12 46.27 2.39 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.419 -179.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.12 -106.12 1.41 Allowed Glycine 0 C--N 1.336 0.575 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.162 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.6 -10.64 3.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.892 HD13 HD11 ' A' ' 89' ' ' LEU . 2.3 pp -156.12 153.29 29.09 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.237 0.335 . . . . 0.0 111.508 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.641 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -117.43 156.12 28.49 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.545 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.58 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 17.5 ttm -121.48 126.14 48.55 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.7 ' HB3' HG11 ' A' ' 113' ' ' VAL . 22.7 m -122.29 128.05 50.61 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.192 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 60.5 p -118.05 13.04 13.82 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.44 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.771 ' O ' HG12 ' A' ' 113' ' ' VAL . 32.2 p -87.91 127.06 35.36 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.644 0.735 . . . . 0.0 111.952 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.49 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 21.1 pt20 -59.32 -29.11 67.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.358 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.97 -43.07 96.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.541 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 110' ' ' SER . 4.7 p -67.76 -37.62 78.86 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.521 HD22 ' NH2' ' A' ' 85' ' ' ARG . 5.0 tp -58.4 -47.86 82.53 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 123.552 0.532 . . . . 0.0 110.266 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.49 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 26.4 m-85 -67.66 -39.91 84.51 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.813 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -52.45 64.74 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.351 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.719 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.93 -43.65 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.546 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.65 -32.32 65.25 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 123.774 0.671 . . . . 0.0 109.642 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.55 -20.03 32.18 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.238 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.44 14.41 32.77 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 114.693 -1.14 . . . . 0.0 114.785 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.8 p -104.58 7.55 35.14 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.23 -138.1 9.68 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-O 119.207 -0.774 . . . . 0.0 112.625 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.9 173.88 11.55 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 123.292 2.661 . . . . 0.0 113.536 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.21 -54.75 43.24 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.716 0.806 . . . . 0.0 111.962 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.697 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.9 mmtt -141.58 139.96 33.26 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.873 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 34.6 p -137.45 166.33 24.11 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.0 tp -126.97 116.06 20.2 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.577 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.696 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 11.5 pt -98.47 102.7 13.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.779 0.799 . . . . 0.0 109.647 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.4 t -123.01 123.98 42.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.818 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.36 115.79 7.4 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.493 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.414 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 66.75 172.47 5.09 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.911 -1.04 . . . . 0.0 114.633 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -128.41 -177.51 4.2 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.313 0.578 . . . . 0.0 110.864 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -118.48 127.9 54.08 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.093 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.23 143.06 14.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.474 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.406 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 27.9 m-90 -119.28 137.37 53.72 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.773 0.337 . . . . 0.0 110.404 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -81.75 158.15 24.27 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.878 0.737 . . . . 0.0 110.539 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.56 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.81 -25.2 7.27 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.072 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -57.95 -44.58 87.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.93 0.492 . . . . 0.0 112.275 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.581 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.6 -47.76 65.87 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.146 0.279 . . . . 0.0 110.605 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.1 -29.53 68.65 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.958 0.408 . . . . 0.0 110.619 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.14 -50.36 41.31 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.872 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.0 pt-20 -70.17 -26.68 64.03 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.787 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tp -74.77 -38.94 62.04 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.645 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.3 m -77.84 -28.34 50.15 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.352 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.8 t70 -82.64 -0.28 46.45 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.472 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 60.07 29.01 18.62 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.865 0.866 . . . . 0.0 111.787 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.13 -42.8 18.62 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.942 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -125.58 115.25 19.87 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.0 tp -86.45 143.14 27.92 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.506 0.194 . . . . 0.0 111.465 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.9 p -103.7 135.91 44.39 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.058 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 76.9 m -151.23 155.06 34.55 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.626 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.88 159.19 26.02 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.253 1.969 . . . . 0.0 111.244 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.458 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -131.94 166.59 21.31 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -135.69 135.12 21.4 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.963 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.19 -26.41 14.81 Favored 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.597 2.198 . . . . 0.0 113.682 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.81 -40.57 63.38 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.847 0.717 . . . . 0.0 112.135 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.565 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.5 mt -71.43 -35.5 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.366 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.71 -37.79 65.04 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.482 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -84.86 -34.71 22.57 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -84.71 -72.52 0.47 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.924 0.329 . . . . 0.0 111.637 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.894 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.64 99.42 6.28 Favored Pre-proline 0 C--N 1.349 0.563 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.841 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.4 Cg_endo -91.86 -0.45 4.36 Favored 'Trans proline' 0 CA--C 1.57 2.284 0 C-N-CA 121.716 1.611 . . . . 0.0 114.262 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.642 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 77.6 Cg_endo -73.96 -52.34 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 122.589 2.193 . . . . 0.0 114.437 -178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.519 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.7 mt-10 -122.45 -30.02 4.01 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.714 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.894 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.1 tt0 -70.23 -10.85 60.14 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.391 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.762 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.06 -40.52 45.92 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -71.36 -49.88 37.79 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.207 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.1 t -58.41 -49.03 78.76 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.504 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.67 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.7 -40.25 95.05 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.249 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.21 78.52 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 123.516 0.51 . . . . 0.0 110.534 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.16 90.07 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.495 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.3 -27.69 68.8 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.538 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.67 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.73 -40.15 42.11 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 122.92 0.488 . . . . 0.0 110.264 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.37 -32.0 69.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.38 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.93 53.52 0.48 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.933 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.94 147.11 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -89.4 78.47 7.17 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.653 0.74 . . . . 0.0 110.654 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.71 -26.15 49.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.801 -1.09 . . . . 0.0 112.149 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.8 m -58.67 -42.65 88.93 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.55 -26.68 51.15 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.7 mt -77.08 -36.2 56.01 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.249 0.343 . . . . 0.0 111.87 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.0 p -92.71 -48.0 6.8 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.319 0.387 . . . . 0.0 111.198 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 59.03 125.32 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.241 1.017 . . . . 0.0 112.849 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -98.98 151.0 21.4 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.962 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -96.91 131.04 44.09 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.262 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -179.43 -112.68 0.35 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.429 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -101.85 144.04 30.99 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.658 0.269 . . . . 0.0 110.811 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.12 -0.943 . . . . 0.0 111.184 -179.969 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.495 0.188 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -100.34 107.91 19.81 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -140.06 -45.65 0.43 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.156 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.582 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 44.4 p -129.76 -40.0 1.4 Allowed 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.32 0.388 . . . . 0.0 111.504 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.0 m -106.31 88.27 3.12 Favored Pre-proline 0 CA--C 1.545 0.759 0 O-C-N 123.434 0.458 . . . . 0.0 110.978 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.3 Cg_endo -87.73 9.13 3.93 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.011 2.474 . . . . 0.0 112.378 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -86.53 168.33 13.8 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.367 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 65.26 149.76 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.264 1.025 . . . . 0.0 112.6 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.408 ' O ' HD12 ' A' ' 32' ' ' LEU . 15.0 mt -102.87 48.22 0.87 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.961 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -90.58 19.14 5.57 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.908 0.385 . . . . 0.0 111.072 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 175.88 55.96 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.087 0.955 . . . . 0.0 110.17 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -134.94 159.35 41.74 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.618 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.462 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.6 m-30 -98.08 135.12 40.21 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.09 0.471 . . . . 0.0 112.153 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.743 HD11 HD23 ' A' ' 32' ' ' LEU . 6.1 mt -108.7 137.6 46.37 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.785 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.416 HG23 HG22 ' A' ' 29' ' ' VAL . 2.9 mp -120.51 132.69 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.82 127.57 33.17 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.722 0.639 . . . . 0.0 112.003 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.8 mmt -110.26 158.19 35.94 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.179 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -80.55 21.4 0.86 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.693 2.262 . . . . 0.0 113.549 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -83.07 -19.38 36.94 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.592 ' SD ' ' HB1' ' A' ' 148' ' ' ALA . 15.9 ptt? -102.31 -164.75 1.12 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.272 0.357 . . . . 0.0 110.38 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.545 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -106.74 30.9 5.68 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 7.9 m-20 -110.44 84.84 4.15 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.712 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.3 Cg_exo -75.31 -23.8 12.96 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.059 2.506 . . . . 0.0 113.48 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -85.11 -37.01 20.75 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.794 0.438 . . . . 0.0 111.557 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.85 3.06 55.97 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.499 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -66.78 5.82 0.58 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -140.83 38.84 1.81 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.116 0.484 . . . . 0.0 112.156 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 p -123.14 155.02 37.84 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.417 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.701 HG11 ' HE ' ' A' ' 167' ' ' ARG . 50.1 t -130.5 131.95 64.85 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.856 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -113.6 153.58 28.6 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.365 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.493 ' OH ' HD21 ' A' ' 105' ' ' LEU . 42.9 t80 -106.99 119.63 39.89 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.743 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -83.84 109.24 17.4 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 121.3 0.571 . . . . 0.0 111.25 -178.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.938 HG23 ' HA2' ' A' ' 42' ' ' GLY . 31.6 t -69.03 -59.65 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 113.644 -1.616 . . . . 0.0 110.674 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -141.96 114.34 8.3 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.337 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -97.45 128.29 44.11 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.754 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -139.4 152.64 47.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.34 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -65.11 -18.13 65.04 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.797 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -100.56 1.56 41.01 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.432 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.32 167.3 15.57 Favored Glycine 0 C--N 1.345 1.055 0 C-N-CA 121.541 -0.361 . . . . 0.0 112.205 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.02 142.49 29.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -120.62 135.51 55.08 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.57 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.75 156.95 27.97 Favored Glycine 0 N--CA 1.449 -0.448 0 O-C-N 124.364 1.04 . . . . 0.0 112.817 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.0 mt -111.93 131.63 55.26 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.9 0.35 . . . . 0.0 110.974 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 78' ' ' GLY . 18.1 t -66.89 125.35 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -128.22 55.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.715 0.769 . . . . 0.0 112.22 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.839 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.0 t-20 -147.19 -4.61 0.53 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.308 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.68 87.89 51.21 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.507 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.1 Cg_exo -59.3 141.11 97.32 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 121.631 1.554 . . . . 0.0 112.004 175.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.419 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 46.0 m -89.32 159.12 17.53 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.253 0.346 . . . . 0.0 111.638 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.28 45.55 1.46 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.363 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.7 154.37 51.58 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.442 HD22 ' HA ' ' A' ' 71' ' ' GLN . 16.6 p-10 -104.17 161.09 14.32 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.294 0.371 . . . . 0.0 110.783 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.664 ' HA ' HD11 ' A' ' 75' ' ' ILE . 15.3 tp -58.19 -35.78 72.11 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.25 61.14 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.525 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.65 -43.22 97.42 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.855 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -62.28 -48.31 88.96 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.747 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.5 mp -52.89 -36.63 59.6 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.977 0.798 . . . . 0.0 111.024 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -78.06 -28.62 48.94 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.466 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.29 -30.27 48.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.368 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.855 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.0 mt -77.89 -44.98 25.45 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.86 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -132.48 116.79 15.24 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.441 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.72 -32.66 2.64 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 123.619 2.879 . . . . 0.0 112.835 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -82.38 -13.99 55.96 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.429 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.3 148.63 25.53 Favored 'General case' 0 C--N 1.345 0.378 0 O-C-N 123.329 0.393 . . . . 0.0 111.734 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.6 123.03 31.91 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.149 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 58.8 Cg_endo -75.17 144.46 29.71 Favored 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.244 1.963 . . . . 0.0 112.553 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.451 ' C ' HE21 ' A' ' 71' ' ' GLN . 5.8 Cg_endo -92.8 -169.73 0.25 Allowed 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.657 2.238 . . . . 0.0 112.248 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.48 -24.61 67.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.303 0.641 . . . . 0.0 112.202 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.58 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 9.1 ptp180 -66.76 -55.58 14.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.707 ' HA ' HD12 ' A' ' 73' ' ' ILE . 69.1 m -70.89 -25.56 62.84 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.451 HE21 ' C ' ' A' ' 67' ' ' PRO . 42.6 mt-30 -68.77 -32.76 72.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.772 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -91.77 19.56 6.38 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.614 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 70' ' ' CYS . 52.0 mt -122.28 140.92 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.858 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.414 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.6 m-20 -109.02 152.37 25.09 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 123.814 0.696 . . . . 0.0 112.44 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.826 HD13 HD12 ' A' ' 128' ' ' ILE . 14.6 mm -99.6 153.48 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.237 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.717 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -120.24 152.48 37.68 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.7 119.42 24.28 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 117.76 0.254 . . . . 0.0 110.823 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -100.58 -23.76 9.9 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.732 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.04 -167.75 34.93 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.182 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -88.49 -8.28 5.4 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.614 2.876 . . . . 0.0 114.235 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.29 128.83 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 123.07 0.231 . . . . 0.0 111.087 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 45.01 86.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.532 1.133 . . . . 0.0 113.326 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.405 ' O ' HD21 ' A' ' 130' ' ' LEU . 78.3 p -86.68 -2.45 58.53 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.995 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -88.68 -4.46 58.54 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.895 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.599 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.2 153.01 51.93 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.134 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.599 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.51 131.12 10.41 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 114.789 -1.096 . . . . 0.0 112.07 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.714 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.6 OUTLIER -85.59 151.13 24.15 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.253 1.021 . . . . 0.0 110.428 -179.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.633 ' HB ' ' OG ' ' A' ' 108' ' ' SER . 3.4 t -128.37 106.39 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 O-C-N 123.312 0.383 . . . . 0.0 111.159 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.923 HD11 HD13 ' A' ' 105' ' ' LEU . 14.6 tp -108.45 127.79 54.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.041 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.402 ' NE2' ' HB3' ' A' ' 106' ' ' ALA . 4.2 p80 -128.42 168.27 16.25 Favored Pre-proline 0 CA--C 1.554 1.11 0 O-C-N 123.669 0.606 . . . . 0.0 111.411 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.667 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 14.8 Cg_endo -95.39 14.21 1.19 Allowed 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 122.526 2.151 . . . . 0.0 113.39 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 t -101.17 159.7 15.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.861 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.3 18.9 55.84 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.714 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.99 154.83 24.29 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.499 0.32 . . . . 0.0 110.922 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.4 p -126.37 157.64 37.97 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.593 ' CE2' HG23 ' A' ' 113' ' ' VAL . 50.3 m-85 -129.9 -149.54 0.4 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.433 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -61.15 -45.73 93.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.55 0.34 . . . . 0.0 111.18 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.3 m -137.54 83.06 1.96 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.234 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 107' ' ' MET . 8.0 m -128.22 122.35 31.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.718 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -99.89 120.77 40.3 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.987 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -83.54 127.26 33.59 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.167 0.508 . . . . 0.0 110.331 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.503 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.43 46.91 2.1 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.44 -179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.28 -107.72 2.09 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.103 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.41 -10.03 4.36 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.923 HD13 HD11 ' A' ' 89' ' ' LEU . 2.0 pp -155.14 153.63 31.08 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.256 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.593 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -121.47 158.57 28.12 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.783 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.592 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 25.8 tpp -125.28 140.12 53.11 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.689 ' HB2' HG11 ' A' ' 113' ' ' VAL . 21.4 p -134.06 133.16 40.85 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.933 0.396 . . . . 0.0 110.351 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.4 p -117.14 16.51 14.95 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.049 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.739 ' O ' HG12 ' A' ' 113' ' ' VAL . 67.0 m -89.66 127.78 35.97 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.636 0.731 . . . . 0.0 112.023 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.479 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 10.1 pt20 -61.43 -28.81 69.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.973 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -65.81 -42.17 90.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.669 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 110' ' ' SER . 3.8 p -67.38 -39.9 83.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 177.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.466 HD22 ' NH2' ' A' ' 85' ' ' ARG . 6.4 tp -58.97 -47.36 85.41 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 123.592 0.557 . . . . 0.0 110.469 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.479 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 24.1 m-85 -69.36 -38.47 78.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.914 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.81 66.76 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.043 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.75 -43.47 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.348 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.25 -31.56 65.67 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.74 0.65 . . . . 0.0 109.588 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.58 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.63 -20.15 31.81 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.238 176.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.15 14.85 32.23 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.648 -1.16 . . . . 0.0 114.602 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.1 p -105.14 7.3 33.71 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.19 -138.74 10.01 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.715 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.8 168.06 17.94 Favored 'Trans proline' 0 C--N 1.367 1.526 0 C-N-CA 123.255 2.637 . . . . 0.0 113.956 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.501 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -51.11 -59.2 4.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.511 1.125 . . . . 0.0 111.897 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.667 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -140.19 139.88 35.78 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.783 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 32.6 p -137.93 168.38 19.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.66 118.25 23.5 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.685 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.826 HD12 HD13 ' A' ' 75' ' ' ILE . 12.0 pt -98.12 102.24 13.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-O 121.782 0.801 . . . . 0.0 109.738 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 5.6 t -119.35 122.36 41.64 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.847 -178.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.405 HD21 ' O ' ' A' ' 83' ' ' THR . 6.5 tp -66.85 114.62 5.84 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.195 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.43 176.02 5.69 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.737 -1.119 . . . . 0.0 114.385 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -128.58 -178.55 4.63 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.437 0.636 . . . . 0.0 110.957 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -118.49 128.77 54.91 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.977 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.7 147.27 17.48 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.532 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 -125.46 136.86 53.82 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.93 0.429 . . . . 0.0 110.303 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.43 158.27 27.37 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.94 0.775 . . . . 0.0 110.908 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.0 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.21 -25.6 7.75 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.182 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -57.84 -44.15 86.32 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.886 0.474 . . . . 0.0 112.257 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.59 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.72 -47.13 67.12 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.575 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -60.49 -29.4 69.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.025 0.44 . . . . 0.0 110.38 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.14 -50.09 43.98 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.802 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.35 -26.65 63.84 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.766 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.7 tp -75.0 -38.38 61.62 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.623 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.6 t -77.87 -28.65 50.05 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.12 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -82.46 0.02 44.19 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.429 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.44 29.82 19.43 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.839 0.856 . . . . 0.0 111.869 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.592 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -83.16 -42.44 17.31 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.942 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -124.03 113.6 18.62 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.5 tp -84.36 141.9 30.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.643 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.0 p -103.27 134.85 45.98 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.651 0.595 . . . . 0.0 111.057 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 153' ' ' PRO . 48.8 t -150.02 144.53 17.71 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.414 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 152' ' ' CYS . 57.1 Cg_exo -53.0 157.45 8.12 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.467 2.111 . . . . 0.0 111.595 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.462 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.02 167.39 18.34 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -135.21 135.4 22.63 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 114.173 -1.376 . . . . 0.0 107.919 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.46 -26.4 14.25 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.601 2.2 . . . . 0.0 113.727 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.71 -40.66 63.2 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.832 0.708 . . . . 0.0 112.199 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.577 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.8 mt -71.25 -35.35 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.4 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -74.06 -37.55 64.23 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.438 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -84.87 -33.88 22.73 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -85.89 -72.63 0.48 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.016 0.371 . . . . 0.0 111.654 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.905 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.36 99.49 6.43 Favored Pre-proline 0 C--N 1.348 0.531 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.839 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 67.9 Cg_endo -92.01 -0.22 4.26 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 C-N-CA 121.678 1.585 . . . . 0.0 114.317 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.643 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 81.7 Cg_endo -73.98 -52.62 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.894 0 C-N-CA 122.61 2.206 . . . . 0.0 114.361 -178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.52 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.15 -30.09 4.09 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.691 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.905 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 4.9 tp10 -70.0 -11.12 60.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.388 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.701 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.93 -41.61 42.71 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -70.36 -50.24 41.03 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.4 m -58.39 -49.57 76.8 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.656 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -63.99 -39.58 94.43 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.037 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.95 -45.48 78.82 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.583 0.552 . . . . 0.0 110.508 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.03 93.12 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.441 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 177' ' ' VAL . . . -64.58 -28.06 69.38 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.663 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.668 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.96 -40.18 40.25 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 122.865 0.466 . . . . 0.0 110.43 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.83 -33.77 75.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.407 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 129.46 40.86 0.26 Allowed Glycine 0 C--N 1.34 0.78 0 C-N-CA 121.06 -0.591 . . . . 0.0 113.175 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 173' ' ' ALA . 4.3 t -129.2 133.64 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -88.84 83.56 6.66 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.588 0.709 . . . . 0.0 111.033 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.97 -26.29 48.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.803 -1.089 . . . . 0.0 112.421 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.3 m -58.17 -44.85 88.19 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 pp -77.3 -26.98 52.78 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.15 -29.94 54.81 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.579 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.7 p -90.93 -48.03 7.24 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.454 0.471 . . . . 0.0 111.36 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.67 119.19 22.04 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.443 0.464 . . . . 0.0 111.004 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -100.67 137.54 38.93 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.77 136.15 52.02 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.145 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 153.65 -127.13 2.09 Favored Glycine 0 C--N 1.337 0.607 0 O-C-N 123.632 0.583 . . . . 0.0 112.537 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -99.19 -40.67 7.86 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.311 0.245 . . . . 0.0 111.302 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.126 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.572 0.225 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.1 mttp -100.53 137.56 38.78 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.068 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -99.23 -41.85 7.29 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.09 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.53 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.9 m -100.28 153.98 18.85 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.6 m -96.91 97.93 4.06 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.965 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.2 Cg_endo -87.2 8.83 4.16 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.879 2.386 . . . . 0.0 112.212 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.1 t -89.2 -47.32 8.15 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.313 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.537 ' CD1' ' HE3' ' A' ' 10' ' ' LYS . 3.8 m-85 -117.31 153.39 33.05 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.513 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.437 ' O ' HD12 ' A' ' 32' ' ' LEU . 8.9 mt -97.86 43.39 1.07 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.829 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.537 ' HE3' ' CD1' ' A' ' 8' ' ' TYR . 87.8 mttt -89.44 20.8 3.67 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.846 0.355 . . . . 0.0 111.355 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 174.66 54.62 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.024 0.929 . . . . 0.0 110.172 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -133.42 160.64 36.8 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.721 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.48 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.2 m-30 -97.97 137.68 36.42 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.821 HD11 HD23 ' A' ' 32' ' ' LEU . 2.8 mt -110.49 140.56 44.64 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.913 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mp -125.43 135.53 63.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.77 122.86 21.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.075 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -105.53 156.07 37.01 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -80.92 31.94 0.51 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.67 2.247 . . . . 0.0 113.197 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -87.36 -17.63 31.93 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.53 -169.6 1.65 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 123.076 0.235 . . . . 0.0 110.783 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.559 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -105.62 42.94 1.17 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.141 0.496 . . . . 0.0 111.561 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.48 81.83 2.54 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.934 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.2 Cg_exo -75.45 -22.16 14.32 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 123.083 2.522 . . . . 0.0 113.431 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -84.49 -36.49 22.2 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.871 0.468 . . . . 0.0 111.791 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.62 3.98 52.63 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.948 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.7 163.6 21.18 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 48.6 31.88 3.18 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.8 p -115.57 153.95 30.29 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 120.564 0.221 . . . . 0.0 110.735 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.968 HG11 HH11 ' A' ' 167' ' ' ARG . 24.6 t -127.58 132.1 69.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.805 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 m -114.84 152.59 31.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.889 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.496 ' OH ' HD21 ' A' ' 105' ' ' LEU . 38.0 t80 -106.59 118.43 36.64 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.821 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.4 107.95 15.45 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-O 121.152 0.501 . . . . 0.0 111.122 -178.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.939 HG23 ' HA2' ' A' ' 42' ' ' GLY . 54.0 t -63.66 -61.2 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.811 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -145.49 116.41 7.79 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.09 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -98.06 127.74 44.18 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.559 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -139.09 152.9 47.89 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.545 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.83 -19.2 65.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.804 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.38 7.48 42.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.393 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.81 166.22 12.49 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 121.465 -0.398 . . . . 0.0 112.394 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.455 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.92 145.27 30.63 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.408 ' O ' HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -124.72 137.41 54.35 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.474 178.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.939 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.93 156.53 27.42 Favored Glycine 0 N--CA 1.447 -0.617 0 O-C-N 124.403 1.065 . . . . 0.0 112.566 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.408 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.6 mt -111.16 133.32 53.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 117.108 0.454 . . . . 0.0 111.042 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 78' ' ' GLY . 15.0 t -69.09 123.68 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.714 ' O ' ' HG3' ' A' ' 167' ' ' ARG . 1.5 pt -127.68 52.52 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 121.232 0.539 . . . . 0.0 112.335 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.93 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 24.1 t-20 -144.56 -1.36 0.9 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.133 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -129.53 87.08 54.03 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.511 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 31.4 Cg_exo -59.2 144.58 99.33 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.805 1.67 . . . . 0.0 112.65 175.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.428 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 51.5 m -94.33 158.65 15.48 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.503 0.502 . . . . 0.0 111.371 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.75 50.69 1.22 Allowed Glycine 0 C--N 1.339 0.696 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.742 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mt -133.77 157.74 45.1 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 122.851 0.461 . . . . 0.0 110.151 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.614 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 10.1 p-10 -112.25 157.37 21.01 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.198 0.311 . . . . 0.0 110.172 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.675 HD13 HD13 ' A' ' 128' ' ' ILE . 14.0 tp -56.81 -36.47 69.96 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.614 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -55.53 -35.32 65.53 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -64.67 -45.27 87.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.286 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.891 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 31.6 m -63.24 -43.48 98.76 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.713 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.0 mp -54.98 -36.75 65.72 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.83 0.706 . . . . 0.0 110.205 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -77.84 -27.78 49.98 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.499 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.419 HE22 ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -78.16 -30.46 49.2 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.286 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.891 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.3 mt -77.87 -44.96 25.63 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.923 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -132.04 116.1 15.54 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.459 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.72 -32.88 2.52 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 123.611 2.874 . . . . 0.0 112.841 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.09 -14.09 56.31 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.414 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.35 149.26 24.62 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 123.33 0.394 . . . . 0.0 111.814 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -116.55 122.78 31.34 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.949 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.43 151.05 37.18 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.297 1.998 . . . . 0.0 112.506 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.2 Cg_endo -92.36 -162.59 0.1 Allowed 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.617 2.211 . . . . 0.0 111.706 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.446 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -73.25 -24.95 60.53 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.75 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.434 ' HA ' ' CD2' ' A' ' 72' ' ' HIS . 6.0 ptp180 -64.81 -50.78 65.41 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.593 ' SG ' HD23 ' A' ' 53' ' ' LEU . 61.2 m -72.61 -24.97 61.14 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 42.1 mt-30 -68.69 -34.84 76.35 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.446 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 23.5 p80 -90.73 22.57 3.48 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 121.193 0.52 . . . . 0.0 111.74 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' A' ' 70' ' ' CYS . 60.5 mt -121.8 139.52 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.188 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -105.81 154.73 20.11 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.715 HD13 HD12 ' A' ' 128' ' ' ILE . 24.0 mm -102.09 151.62 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.739 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -119.44 154.66 33.37 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -85.18 121.27 27.69 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 117.789 0.268 . . . . 0.0 110.806 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -104.07 -23.7 8.0 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 120.209 -0.996 . . . . 0.0 114.207 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.01 -167.98 33.89 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.907 -0.664 . . . . 0.0 113.353 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -88.72 -16.17 2.48 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.404 2.736 . . . . 0.0 114.439 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -82.66 129.19 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.725 0.298 . . . . 0.0 111.518 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 47.72 82.97 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.527 1.131 . . . . 0.0 113.2 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.4 p -80.9 -14.83 57.64 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.918 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.419 ' HA ' HE22 ' A' ' 59' ' ' GLN . 3.1 t70 -76.94 -18.02 58.53 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.211 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.641 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -133.08 146.84 52.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.939 0.4 . . . . 0.0 111.825 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.591 ' H ' ' NH1' ' A' ' 85' ' ' ARG . . . -112.18 150.42 18.19 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.782 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.513 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 1.3 m-85 -86.51 152.59 22.52 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.346 1.058 . . . . 0.0 111.321 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.483 HG21 ' HG ' ' A' ' 114' ' ' LEU . 3.4 t -126.3 103.76 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.627 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 126' ' ' SER . 1.1 mt -98.85 126.72 44.58 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.181 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.401 ' CE1' ' HB3' ' A' ' 106' ' ' ALA . 4.7 p80 -129.44 164.06 42.25 Favored Pre-proline 0 CA--C 1.553 1.062 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.76 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.57 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 23.2 Cg_endo -99.27 23.74 0.21 Allowed 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 122.888 2.392 . . . . 0.0 113.92 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.5 t -107.6 160.82 15.39 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.756 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.25 18.98 56.51 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.685 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -91.78 153.78 19.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.553 0.341 . . . . 0.0 110.528 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.598 ' HA ' HG21 ' A' ' 99' ' ' THR . 27.9 m -126.97 155.58 42.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.108 0.48 . . . . 0.0 112.112 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.538 ' CE2' HG23 ' A' ' 113' ' ' VAL . 51.2 m-85 -126.09 -150.89 0.46 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.837 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -58.82 -47.08 86.05 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.605 0.362 . . . . 0.0 111.372 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 m -132.19 81.26 1.95 Allowed 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.912 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.598 HG21 ' HA ' ' A' ' 95' ' ' SER . 42.5 m -129.38 121.69 27.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.327 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.62 124.7 49.99 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.794 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -82.72 127.99 33.94 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.133 0.492 . . . . 0.0 111.141 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -120.28 46.47 1.97 Allowed 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.574 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.62 -107.07 1.76 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.281 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.69 -10.44 3.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.496 HD21 ' OH ' ' A' ' 31' ' ' TYR . 2.9 pp -154.86 158.76 39.85 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.335 0.397 . . . . 0.0 110.99 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.401 ' HB3' ' CE1' ' A' ' 90' ' ' HIS . . . -118.92 161.51 20.07 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.472 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.569 ' O ' ' HA ' ' A' ' 99' ' ' THR . 24.6 ttm -125.22 134.34 52.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.514 ' HB3' HG11 ' A' ' 113' ' ' VAL . 51.7 m -136.08 133.03 36.92 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 75.6 p -124.53 21.23 8.58 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.717 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.707 ' O ' HG12 ' A' ' 113' ' ' VAL . 47.4 p -93.71 134.15 36.33 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 121.648 0.737 . . . . 0.0 112.345 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.499 ' HA ' HD12 ' A' ' 114' ' ' LEU . 4.9 mt-30 -62.51 -26.62 68.65 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.403 178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.41 -40.43 93.37 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.169 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.769 ' O ' HG22 ' A' ' 117' ' ' ILE . 3.4 p -71.68 -39.03 68.62 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 111' ' ' GLN . 6.6 mt -57.25 -49.04 77.31 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 123.507 0.504 . . . . 0.0 110.874 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.475 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 35.5 m-85 -69.69 -38.55 77.03 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.216 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.64 -52.68 63.37 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.212 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.769 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.84 -43.74 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.432 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.93 -31.57 65.09 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 123.754 0.658 . . . . 0.0 109.615 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.09 -20.23 30.68 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.273 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.82 17.67 25.02 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.704 -1.134 . . . . 0.0 114.634 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.9 p -108.33 7.48 27.21 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.6 -137.76 9.32 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.793 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -81.45 175.21 9.81 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 123.216 2.611 . . . . 0.0 113.347 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -58.33 -53.08 62.32 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.509 0.723 . . . . 0.0 111.584 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.8 mmtt -139.24 153.76 47.89 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.71 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.4 m -150.05 163.33 38.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.1 tp -129.05 117.56 21.08 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.14 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.715 HD12 HD13 ' A' ' 75' ' ' ILE . 12.3 pt -98.94 103.16 14.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.579 0.704 . . . . 0.0 109.475 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.1 t -121.21 120.46 35.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.846 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.45 115.34 6.96 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.335 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.42 167.9 10.76 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.226 -0.897 . . . . 0.0 114.091 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -128.45 178.0 6.6 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.167 0.508 . . . . 0.0 110.703 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -116.33 131.48 56.93 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.916 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.08 149.89 18.66 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.315 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.402 ' HZ2' ' CZ3' ' A' ' 149' ' ' TRP . 25.7 m-90 -130.15 136.9 49.78 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.833 0.372 . . . . 0.0 110.602 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.06 158.34 27.87 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.941 0.776 . . . . 0.0 111.064 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.88 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.12 -28.09 6.19 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.826 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -56.38 -46.4 80.09 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.006 0.522 . . . . 0.0 112.135 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.57 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.4 tp -67.33 -47.54 70.2 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -57.36 -30.27 64.7 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.473 0.483 . . . . 0.0 110.602 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.65 -49.97 41.75 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.887 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -72.12 -26.66 62.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.899 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 4.8 tp -75.78 -38.41 58.3 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.85 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -78.18 -30.9 49.31 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.315 178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.43 0.77 31.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.641 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.74 29.88 19.45 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.813 0.845 . . . . 0.0 111.682 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.65 -42.92 19.27 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.78 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.402 ' CZ3' ' HZ2' ' A' ' 135' ' ' TRP . 11.3 m95 -122.42 112.04 17.6 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 123.388 0.43 . . . . 0.0 109.966 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -80.19 141.55 35.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.326 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.427 ' H ' HD23 ' A' ' 150' ' ' LEU . 16.0 p -110.56 138.47 46.91 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.312 0.383 . . . . 0.0 111.212 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.5 m -152.89 155.6 32.31 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.527 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.02 155.96 36.43 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.226 1.951 . . . . 0.0 111.098 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.48 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.73 169.33 14.64 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -177.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -138.08 137.55 21.35 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 114.295 -1.321 . . . . 0.0 107.906 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.41 -26.46 12.14 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.491 2.128 . . . . 0.0 113.959 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.22 -36.31 60.88 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 123.824 0.703 . . . . 0.0 112.571 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.561 HD13 HH21 ' A' ' 167' ' ' ARG . 4.6 mt -75.68 -38.35 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 121.41 0.624 . . . . 0.0 110.254 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.1 tt -69.44 -36.65 76.86 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.906 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -86.38 -42.78 13.37 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -77.91 -71.24 0.43 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.783 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.42 96.35 6.36 Favored Pre-proline 0 C--N 1.346 0.445 0 CA-C-O 121.18 0.514 . . . . 0.0 111.966 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.93 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 63.7 Cg_endo -91.78 3.31 4.11 Favored 'Trans proline' 0 CA--C 1.567 2.156 0 C-N-CA 121.626 1.551 . . . . 0.0 114.407 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.657 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 60.9 Cg_endo -76.93 -52.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 122.435 2.09 . . . . 0.0 114.168 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.509 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 4.3 mt-10 -126.42 -24.36 3.64 Favored 'General case' 0 C--O 1.247 0.939 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.468 -178.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.783 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 27.6 tt0 -76.53 -12.97 60.11 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.762 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.968 HH11 HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.19 -36.66 54.77 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.651 177.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.1 tp -73.47 -48.74 31.1 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 52.4 m -58.87 -45.31 90.49 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.527 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.68 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -67.22 -42.81 83.44 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.445 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.53 ' HB2' ' NH1' ' A' ' 167' ' ' ARG . . . -55.97 -45.86 78.78 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.494 0.496 . . . . 0.0 110.499 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.05 93.33 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.357 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.96 -26.95 68.52 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.663 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.68 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.76 -40.3 41.38 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 122.929 0.491 . . . . 0.0 110.175 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -71.87 -30.79 65.78 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.466 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 102.74 52.52 0.96 Allowed Glycine 0 C--N 1.339 0.724 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.933 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.4 t -127.46 150.56 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -85.77 77.98 9.65 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.735 0.779 . . . . 0.0 110.697 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.66 -26.3 50.27 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.924 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.5 t -56.22 -38.66 71.35 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.364 0.666 . . . . 0.0 112.773 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.08 -26.54 53.57 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 10.8 mt -76.72 -34.69 58.11 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.34 0.4 . . . . 0.0 111.482 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 11.0 p -85.94 -48.25 8.88 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.452 0.47 . . . . 0.0 111.658 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -128.98 118.07 21.99 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 123.53 0.519 . . . . 0.0 111.244 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -99.55 146.04 26.85 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.8 146.48 26.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.136 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 157.25 88.03 0.06 OUTLIER Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.447 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -128.19 143.81 51.07 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.648 0.263 . . . . 0.0 110.867 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.501 -0.761 . . . . 0.0 111.036 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.322 0.106 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -100.7 143.72 30.52 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.418 0.449 . . . . 0.0 110.559 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -108.99 -41.29 4.76 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.977 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.499 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.5 m -97.22 151.34 19.94 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 123.441 0.463 . . . . 0.0 111.109 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.4 m -95.35 99.73 4.96 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.966 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.0 OUTLIER -85.9 7.45 5.03 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.774 2.316 . . . . 0.0 112.281 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.1 m -113.12 -53.76 2.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.716 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -112.58 151.44 30.06 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.39 0.431 . . . . 0.0 111.667 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.2 mt -98.28 50.84 1.01 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.076 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -92.41 17.7 9.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.1 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 175.51 55.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.841 0.856 . . . . 0.0 109.79 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.418 ' CD2' ' HA ' ' A' ' 153' ' ' PRO . 30.0 m80 -138.57 160.8 38.69 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.474 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 18.6 m-30 -99.2 137.37 37.81 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.01 0.433 . . . . 0.0 111.867 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.794 HD11 HD23 ' A' ' 32' ' ' LEU . 3.7 mt -107.43 141.4 38.89 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.118 177.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.421 HD12 ' O ' ' A' ' 150' ' ' LEU . 2.8 mp -121.24 136.76 57.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 O-C-N 123.419 0.449 . . . . 0.0 110.006 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.23 124.83 28.74 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.027 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.3 mtt -109.78 157.54 37.35 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.211 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.78 30.93 0.52 Allowed 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.686 2.257 . . . . 0.0 113.185 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -86.06 -18.89 31.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.65 -167.13 1.15 Allowed 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.068 0.23 . . . . 0.0 110.617 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.532 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.33 40.4 1.48 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-O 120.993 0.425 . . . . 0.0 111.737 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -111.98 80.88 3.32 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.883 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.8 Cg_exo -75.55 -22.99 13.34 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.045 2.497 . . . . 0.0 113.187 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -84.56 -34.97 23.12 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 122.933 0.493 . . . . 0.0 111.753 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.56 3.85 52.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.992 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.66 164.34 19.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.82 0.343 . . . . 0.0 111.82 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 49.04 31.1 3.16 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.5 p -116.87 154.7 30.32 Favored 'General case' 0 C--O 1.24 0.59 0 O-C-N 122.347 -0.221 . . . . 0.0 110.553 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.702 HG11 ' HE ' ' A' ' 167' ' ' ARG . 85.2 t -129.16 133.64 65.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-O 121.429 0.633 . . . . 0.0 110.832 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -113.85 153.78 28.6 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.755 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.463 ' OH ' HD21 ' A' ' 105' ' ' LEU . 32.4 t80 -107.66 118.77 37.62 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.794 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -83.73 109.97 17.93 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-O 121.465 0.65 . . . . 0.0 110.935 -178.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.938 HG23 ' HA2' ' A' ' 42' ' ' GLY . 33.5 t -72.03 -63.2 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.639 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.527 ' OE2' HD11 ' A' ' 100' ' ' LEU . 7.7 tt0 -134.11 118.49 17.78 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.592 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -103.67 127.49 51.11 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.737 0.303 . . . . 0.0 110.754 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -138.88 151.51 47.02 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.246 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.57 -12.64 54.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -108.2 1.91 22.45 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.416 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.7 166.2 16.01 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 121.608 -0.329 . . . . 0.0 112.335 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.556 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -147.32 146.27 29.64 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.85 136.95 54.27 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.078 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.97 161.71 32.13 Favored Glycine 0 C--O 1.228 -0.277 0 O-C-N 124.785 1.303 . . . . 0.0 112.573 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.9 mt -117.35 133.77 55.59 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.943 0.371 . . . . 0.0 111.267 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 78' ' ' GLY . 10.7 t -66.13 122.88 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.12 54.44 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.607 0.718 . . . . 0.0 112.104 -178.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.852 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.6 t-20 -147.49 -3.93 0.53 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.145 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -129.56 87.82 51.78 Favored Pre-proline 0 CA--C 1.556 1.181 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.513 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 40.4 Cg_exo -58.74 143.15 99.11 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 121.716 1.611 . . . . 0.0 112.415 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.444 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 66.5 m -93.28 158.67 15.63 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.485 0.491 . . . . 0.0 111.497 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.14 51.04 1.06 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.658 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.42 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -133.17 156.1 48.09 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.961 0.448 . . . . 0.0 110.054 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 15.6 p-10 -112.23 158.25 19.93 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.552 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.6 HD23 ' SG ' ' A' ' 70' ' ' CYS . 15.5 tp -57.4 -37.09 72.15 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.46 -37.27 62.49 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 36.8 mt-10 -64.97 -42.48 94.53 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.006 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.867 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -62.63 -46.32 96.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.741 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.1 mp -54.37 -36.8 64.25 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 123.81 0.694 . . . . 0.0 110.674 177.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.76 -27.86 50.47 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.486 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.403 HE21 HD23 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -78.41 -30.41 47.72 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.309 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.867 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.2 mt -77.64 -44.95 26.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.848 -1.523 . . . . 0.0 110.922 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -132.38 116.54 15.28 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.496 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -77.49 -33.13 2.56 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.619 2.879 . . . . 0.0 112.823 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.08 -13.87 56.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.398 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.46 149.72 24.24 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 123.382 0.426 . . . . 0.0 111.752 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.16 123.88 29.64 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.021 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.16 145.68 35.32 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.204 1.936 . . . . 0.0 112.444 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.8 Cg_endo -92.2 -169.78 0.28 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.652 2.235 . . . . 0.0 111.932 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.495 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -64.44 -24.95 67.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.04 0.536 . . . . 0.0 112.135 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -66.11 -53.17 41.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.696 ' HA ' HD12 ' A' ' 73' ' ' ILE . 61.6 m -71.79 -25.05 61.85 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.496 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 48.3 mt-30 -67.88 -35.81 79.15 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.495 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 21.4 p80 -90.52 23.78 2.87 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.164 0.507 . . . . 0.0 111.689 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 70' ' ' CYS . 53.5 mt -121.52 138.46 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.487 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.27 163.11 13.08 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.433 ' CD1' HD12 ' A' ' 128' ' ' ILE . 17.1 mm -112.25 153.41 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.141 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.716 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -117.36 155.62 29.27 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -85.67 118.57 25.25 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.825 0.284 . . . . 0.0 110.551 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.574 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.52 -23.72 8.22 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 120.05 -1.071 . . . . 0.0 114.135 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.46 -167.84 34.11 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.511 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.44 -14.44 3.16 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 123.526 2.817 . . . . 0.0 114.412 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.9 124.07 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 123.103 0.252 . . . . 0.0 111.036 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 50.84 77.0 0.14 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.196 0.999 . . . . 0.0 112.512 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.8 m -79.37 -12.86 59.91 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.561 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.7 0.51 52.56 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.589 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.16 153.73 51.26 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.589 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.47 132.38 11.08 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.137 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.786 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.76 145.7 27.13 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.486 1.114 . . . . 0.0 110.69 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 t -123.16 103.89 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.401 0.438 . . . . 0.0 110.771 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.873 HD11 HD13 ' A' ' 105' ' ' LEU . 13.7 tp -107.2 129.1 54.91 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.876 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -127.03 168.5 14.51 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-O 118.921 -0.561 . . . . 0.0 111.705 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.671 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.4 Cg_endo -97.03 12.2 1.05 Allowed 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 122.829 2.353 . . . . 0.0 113.793 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.9 t -99.76 160.67 14.12 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.791 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.96 21.12 47.88 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.532 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -86.73 154.2 21.14 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.625 0.37 . . . . 0.0 110.568 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.8 p -127.34 156.85 41.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.566 ' CE2' HG23 ' A' ' 113' ' ' VAL . 52.3 m-85 -129.19 -151.57 0.48 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.668 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -59.14 -46.5 88.19 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.547 0.339 . . . . 0.0 111.413 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 57.9 m -134.37 83.22 2.02 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.495 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.6 m -130.98 128.97 41.5 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.847 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.527 HD11 ' OE2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.57 124.23 50.16 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.506 178.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.38 128.17 34.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.089 0.471 . . . . 0.0 110.972 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.449 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.28 48.08 1.89 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.378 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.72 -109.86 3.14 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 114.724 -1.126 . . . . 0.0 113.056 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.09 -8.41 5.38 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.873 HD13 HD11 ' A' ' 89' ' ' LEU . 2.8 pp -152.84 152.77 31.94 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.29 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.612 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.74 157.16 28.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.839 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.566 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.8 ttm -121.13 126.63 50.23 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.711 ' HB3' HG11 ' A' ' 113' ' ' VAL . 22.9 m -122.7 128.78 51.0 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 120.834 0.349 . . . . 0.0 110.176 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.4 p -119.39 16.54 13.03 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.318 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.767 ' O ' HG12 ' A' ' 113' ' ' VAL . 11.6 t -88.9 127.61 35.65 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-O 121.515 0.674 . . . . 0.0 111.445 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.49 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 10.1 pt20 -59.98 -30.49 69.15 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.235 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -64.58 -42.15 95.81 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.732 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 110' ' ' SER . 4.5 p -67.78 -37.98 79.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.538 HD22 ' NH2' ' A' ' 85' ' ' ARG . 3.9 tp -59.27 -48.64 80.87 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 123.449 0.468 . . . . 0.0 110.19 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.49 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 36.8 m-85 -68.52 -38.25 80.71 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.959 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.68 -51.76 67.11 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.21 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.69 -43.43 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.304 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.3 -31.3 65.5 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.759 0.662 . . . . 0.0 109.6 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.23 -19.95 30.88 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.129 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.79 16.4 28.74 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 114.705 -1.134 . . . . 0.0 114.623 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.1 p -106.86 7.46 30.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.16 -138.18 9.71 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-O 119.23 -0.761 . . . . 0.0 112.625 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.85 173.68 11.8 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.205 2.603 . . . . 0.0 113.554 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -57.06 -54.57 45.3 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.735 0.814 . . . . 0.0 111.988 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.671 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.2 mmtt -140.98 143.7 34.63 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.82 -178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.0 m -141.09 165.01 28.72 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.0 tp -127.61 117.02 21.23 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.466 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.786 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.5 pt -98.33 102.46 13.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-O 121.934 0.873 . . . . 0.0 109.82 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.509 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 9.0 t -119.34 124.05 45.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.784 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.4 tp -67.09 113.73 5.29 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.385 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.82 175.16 8.49 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 114.665 -1.152 . . . . 0.0 114.576 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.49 176.3 7.85 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.342 0.591 . . . . 0.0 110.474 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -115.92 130.68 56.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.062 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.04 145.9 16.61 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.476 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -121.24 136.47 54.97 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.242 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -81.05 158.08 25.21 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.824 0.703 . . . . 0.0 110.746 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.78 90.71 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.24 -25.19 7.5 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.164 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -57.57 -44.24 85.16 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.9 -47.96 64.51 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.16 0.287 . . . . 0.0 110.634 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.52 -28.79 68.67 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.002 0.43 . . . . 0.0 110.665 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.82 -50.74 32.23 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.797 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.0 pt-20 -69.67 -26.62 64.47 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.845 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.91 -38.37 57.82 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.722 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -77.82 -28.42 50.26 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -83.2 0.75 44.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.426 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 59.41 29.11 18.63 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.796 0.838 . . . . 0.0 111.818 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.76 -43.18 18.74 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.956 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -124.38 114.29 19.33 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.9 tp -85.59 139.88 31.06 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.629 0.252 . . . . 0.0 111.418 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.1 p -104.46 137.31 42.52 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.038 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.0 m -150.94 154.88 34.9 Favored Pre-proline 0 N--CA 1.469 0.51 0 O-C-N 123.515 0.509 . . . . 0.0 110.909 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.418 ' HA ' ' CD2' ' A' ' 12' ' ' HIS . 31.7 Cg_exo -59.28 152.58 59.34 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.32 2.013 . . . . 0.0 111.055 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.474 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.76 167.84 16.71 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.76 135.62 23.74 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.105 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.3 -26.47 14.51 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 122.605 2.203 . . . . 0.0 113.66 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.39 -40.72 62.44 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 123.909 0.756 . . . . 0.0 112.19 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.609 HD13 HH12 ' A' ' 167' ' ' ARG . 4.9 mt -71.36 -34.96 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.304 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.32 -36.99 63.72 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.335 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -84.66 -35.47 22.6 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -84.71 -72.5 0.47 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.963 0.347 . . . . 0.0 111.726 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.676 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -141.82 99.02 6.24 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.852 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 70.9 Cg_endo -91.95 -0.29 4.31 Favored 'Trans proline' 0 CA--C 1.57 2.29 0 C-N-CA 121.773 1.649 . . . . 0.0 114.351 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.641 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 69.0 Cg_endo -74.87 -50.03 0.14 Allowed 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 122.738 2.292 . . . . 0.0 114.519 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.5 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.3 mt-10 -122.39 -33.98 3.36 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.713 -177.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.676 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 8.4 mt-10 -68.86 -10.9 59.5 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.658 -1.156 . . . . 0.0 111.077 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.702 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.86 -41.8 42.54 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.091 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.9 tp -70.41 -50.07 42.33 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 44.3 m -58.49 -49.12 78.51 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.633 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.673 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.17 -39.82 94.82 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.129 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.92 -46.15 78.53 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.608 0.568 . . . . 0.0 110.6 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.44 91.09 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.499 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.96 -27.85 69.12 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.611 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.84 -40.05 41.55 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 122.831 0.452 . . . . 0.0 110.355 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -68.58 -33.37 73.95 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.346 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 126.27 43.89 0.26 Allowed Glycine 0 C--N 1.34 0.759 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.155 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.7 t -129.22 136.85 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -89.98 82.1 6.18 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.662 0.744 . . . . 0.0 110.969 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -77.83 -26.36 49.42 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.324 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 53.2 m -58.62 -45.35 89.41 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.37 -26.83 52.28 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 22.0 mt -77.21 -30.14 54.58 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.577 0.351 . . . . 0.0 111.675 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 24.0 p -90.27 -48.21 7.29 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.342 0.402 . . . . 0.0 111.475 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.6 119.09 21.98 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.052 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -100.66 140.43 34.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.925 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.13 130.69 51.54 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.038 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 144.8 142.58 3.88 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.519 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -128.82 144.85 51.28 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.68 0.282 . . . . 0.0 110.939 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.091 -0.956 . . . . 0.0 111.118 -179.964 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.584 0.23 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -99.95 138.59 36.82 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.154 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -99.1 -42.19 7.19 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.021 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.0 p -103.13 152.46 21.4 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.824 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 m -94.55 104.47 14.24 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.108 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -87.07 7.77 4.67 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.765 2.31 . . . . 0.0 112.021 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.7 t -93.74 -47.48 6.76 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.026 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.431 ' CD2' ' HE3' ' A' ' 10' ' ' LYS . 3.2 m-85 -109.0 155.16 21.21 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.399 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 32' ' ' LEU . 10.5 mt -95.91 43.94 1.08 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.008 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.431 ' HE3' ' CD2' ' A' ' 8' ' ' TYR . 87.5 mttt -89.81 20.34 4.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 120.934 0.397 . . . . 0.0 111.242 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 174.53 55.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.126 0.971 . . . . 0.0 110.1 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -133.62 159.38 40.67 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.643 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.454 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.4 m-30 -97.3 135.72 38.81 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.85 HD11 HD23 ' A' ' 32' ' ' LEU . 2.8 mt -107.99 137.04 46.67 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.848 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.438 HG23 HG22 ' A' ' 29' ' ' VAL . 2.3 mm -117.01 133.88 62.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 O-C-N 123.493 0.495 . . . . 0.0 109.721 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.05 120.33 18.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.488 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 150' ' ' LEU . 91.4 mtp -110.18 154.88 42.61 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.22 77.71 3.89 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.59 2.193 . . . . 0.0 112.932 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -135.68 -19.41 1.6 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.025 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.98 -164.19 0.91 Allowed 'General case' 0 CA--C 1.541 0.631 0 O-C-N 123.191 0.307 . . . . 0.0 110.495 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.554 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.92 37.84 2.06 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.052 0.453 . . . . 0.0 111.856 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 7.9 m-20 -110.51 83.79 3.55 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.827 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.1 Cg_exo -75.26 -24.62 12.25 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 123.03 2.486 . . . . 0.0 113.442 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -85.09 -37.84 19.81 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.931 0.492 . . . . 0.0 111.573 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.53 -3.4 57.63 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.84 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -59.85 0.25 0.16 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -141.19 41.56 1.78 Allowed 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.234 0.54 . . . . 0.0 112.052 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.1 p -124.28 157.27 35.31 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.686 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.789 HG11 ' HE ' ' A' ' 167' ' ' ARG . 59.3 t -131.27 132.8 62.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.617 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -114.48 153.54 29.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.615 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.409 ' OH ' HD21 ' A' ' 105' ' ' LEU . 44.4 t80 -107.14 118.71 37.42 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.85 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.88 109.1 16.71 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.095 0.474 . . . . 0.0 111.232 -178.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.932 HG23 ' HA2' ' A' ' 42' ' ' GLY . 38.9 t -67.28 -62.53 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 113.853 -1.522 . . . . 0.0 110.515 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -140.54 115.68 9.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.163 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -98.22 127.46 44.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.604 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -139.29 152.93 47.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.48 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.551 ' HB3' ' NE2' ' A' ' 38' ' ' GLN . 17.9 tt0 -64.73 -21.02 66.66 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.405 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.551 ' NE2' ' HB3' ' A' ' 37' ' ' GLU . 1.7 mp0 -96.65 0.89 50.49 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.487 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.38 168.35 16.44 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 112.209 -0.356 . . . . 0.0 112.209 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.493 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.83 144.33 30.19 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -122.82 136.14 54.77 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.564 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.932 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.78 158.83 29.41 Favored Glycine 0 N--CA 1.447 -0.581 0 O-C-N 124.454 1.097 . . . . 0.0 112.529 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.6 mt -113.35 132.92 55.4 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 117.025 0.412 . . . . 0.0 111.129 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 78' ' ' GLY . 12.4 t -67.98 124.54 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.538 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -127.53 55.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.606 0.717 . . . . 0.0 112.196 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.846 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.0 t-20 -146.43 -3.3 0.64 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.072 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -130.11 89.82 44.09 Favored Pre-proline 0 CA--C 1.555 1.168 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 52.6 Cg_exo -57.82 140.65 94.44 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 121.55 1.5 . . . . 0.0 111.763 174.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.407 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 56.4 m -71.23 -44.63 64.97 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.03 -15.94 56.17 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.226 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.66 162.06 16.52 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.506 0.323 . . . . 0.0 110.168 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.617 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 7.2 p-10 -100.92 160.63 14.21 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.725 ' HA ' HD11 ' A' ' 75' ' ' ILE . 4.7 tt -58.48 -28.65 65.55 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.076 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.617 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -62.07 -39.76 93.51 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.599 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.67 -46.98 85.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.637 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.86 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 17.1 m -62.32 -43.45 98.09 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.722 ' HA ' HD12 ' A' ' 60' ' ' LEU . 13.6 mt -56.94 -34.95 68.53 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.544 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -78.15 -27.34 48.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.262 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -30.65 51.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.129 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.86 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.8 mt -77.79 -45.48 24.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 113.789 -1.551 . . . . 0.0 111.12 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -131.7 116.16 15.96 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.631 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -77.71 -32.62 2.66 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.659 2.906 . . . . 0.0 112.755 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.1 -14.55 55.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.35 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.7 149.9 24.56 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.35 0.407 . . . . 0.0 111.685 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.5 mp -118.34 122.52 30.13 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.178 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.98 153.02 41.58 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.307 2.005 . . . . 0.0 112.26 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 7.1 Cg_endo -94.21 -165.31 0.12 Allowed 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.596 2.198 . . . . 0.0 112.263 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.445 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -71.38 -24.84 62.15 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.196 0.598 . . . . 0.0 111.964 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.448 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 12.0 ptp180 -67.1 -46.99 72.54 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.488 ' HA ' HD12 ' A' ' 73' ' ' ILE . 16.6 m -72.84 -25.57 61.16 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.439 ' HA ' HD22 ' A' ' 52' ' ' ASN . 48.8 mt-30 -70.54 -26.99 63.82 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.445 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 25.3 p80 -99.21 16.51 22.6 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 123.439 0.462 . . . . 0.0 111.722 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 52' ' ' ASN . 70.0 mt -114.35 138.63 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.313 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.16 151.46 24.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.943 HD13 HD12 ' A' ' 128' ' ' ILE . 21.3 mm -102.61 151.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.613 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.747 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.9 t80 -118.27 155.23 30.94 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.625 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -85.94 121.34 28.43 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.35 -23.53 8.4 Favored Glycine 0 C--N 1.345 1.042 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.195 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.67 -167.77 35.31 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.313 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -88.59 -12.21 3.8 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.588 2.859 . . . . 0.0 114.358 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 t -86.37 128.75 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 123.07 0.231 . . . . 0.0 111.171 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 45.35 82.15 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.564 1.145 . . . . 0.0 113.132 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.0 p -84.04 -8.25 59.18 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.206 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.62 -3.87 59.0 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.621 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -132.72 152.98 51.6 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.621 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.58 135.39 12.82 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.073 178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -86.16 146.16 26.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.304 1.042 . . . . 0.0 110.573 -179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.9 103.58 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 123.47 0.481 . . . . 0.0 110.533 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.923 HD11 HD13 ' A' ' 105' ' ' LEU . 11.4 tp -107.18 128.59 54.54 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.981 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -128.29 167.44 18.92 Favored Pre-proline 0 CA--C 1.554 1.122 0 CA-C-O 118.816 -0.611 . . . . 0.0 111.799 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.689 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 17.9 Cg_endo -97.42 19.91 0.43 Allowed 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.67 2.247 . . . . 0.0 113.563 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.1 t -107.69 160.56 15.61 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.835 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.27 22.08 41.84 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.587 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -84.98 152.88 23.15 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 122.618 0.367 . . . . 0.0 110.487 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.7 p -128.0 156.81 42.13 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.571 ' CE2' HG23 ' A' ' 113' ' ' VAL . 56.4 m-85 -130.44 -150.97 0.45 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.726 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -58.91 -46.16 88.57 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.655 0.382 . . . . 0.0 111.511 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.8 m -137.41 82.64 1.94 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.285 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 107' ' ' MET . 12.8 m -127.77 123.42 35.25 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.425 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -102.71 120.92 41.42 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.744 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.53 125.01 29.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.172 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.571 ' HB3' HD12 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -119.51 43.59 2.59 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.722 -179.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.81 -100.59 0.29 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.264 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -56.08 -14.53 2.71 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.923 HD13 HD11 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -160.91 160.23 30.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.842 0.457 . . . . 0.0 110.951 -179.283 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.589 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -117.77 156.97 27.38 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.625 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.573 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.4 ttm -123.3 129.7 51.7 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.702 ' HB3' HG11 ' A' ' 113' ' ' VAL . 31.3 m -125.99 129.22 48.79 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.9 p -119.98 14.56 12.39 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.658 -178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.727 ' O ' HG12 ' A' ' 113' ' ' VAL . 68.3 m -87.14 130.15 34.65 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.425 0.631 . . . . 0.0 112.042 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.499 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 21.0 pt20 -61.45 -28.67 69.45 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.101 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -64.37 -44.14 92.3 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.452 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.4 p -67.9 -34.83 69.58 Favored 'Isoleucine or valine' 0 C--N 1.354 0.792 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.42 ' HG ' ' NH2' ' A' ' 85' ' ' ARG . 2.5 tm? -59.13 -49.61 77.22 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 123.693 0.62 . . . . 0.0 109.81 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.499 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 31.5 m-85 -67.19 -39.63 86.42 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.955 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -52.97 62.59 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.456 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.0 -43.86 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.524 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.428 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.93 -32.03 65.55 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.72 0.637 . . . . 0.0 109.594 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.448 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.69 -19.7 32.38 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.232 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.69 14.93 33.17 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.718 -1.128 . . . . 0.0 114.633 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.5 p -105.58 7.9 33.02 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.18 -138.35 9.14 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.283 -0.732 . . . . 0.0 112.731 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.64 168.02 18.25 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.141 2.561 . . . . 0.0 113.968 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.493 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -49.39 -59.67 3.52 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.537 1.135 . . . . 0.0 111.837 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.689 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.5 mmtt -141.43 139.81 33.48 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 69.5 m -138.02 169.07 18.43 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 tp -126.41 118.14 24.37 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.296 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.943 HD12 HD13 ' A' ' 75' ' ' ILE . 10.1 pt -96.95 102.14 13.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 121.465 0.65 . . . . 0.0 109.711 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 7.2 t -118.9 119.13 33.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.099 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.19 112.93 4.74 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.136 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 169.81 11.26 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.005 -0.998 . . . . 0.0 114.186 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.6 177.54 6.95 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.196 0.522 . . . . 0.0 110.83 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -117.72 131.93 56.54 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.51 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.47 149.67 18.72 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.363 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 24.4 m-90 -129.09 135.55 49.05 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 123.855 0.385 . . . . 0.0 110.465 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.05 158.17 29.3 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.784 0.678 . . . . 0.0 111.129 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.23 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.54 -26.75 6.83 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.935 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -55.93 -45.59 78.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.076 0.55 . . . . 0.0 112.06 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.576 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.2 tp -67.37 -47.16 71.21 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.58 -30.51 65.32 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.426 0.454 . . . . 0.0 110.747 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.5 -50.19 40.52 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.91 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -71.61 -26.64 62.67 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.945 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.3 tp -75.11 -39.21 60.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.937 0.895 . . . . 0.0 110.806 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.5 m -78.15 -30.21 49.09 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.553 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -80.38 0.19 34.24 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.701 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 60.42 29.47 19.04 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.757 0.823 . . . . 0.0 111.723 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.92 -42.46 19.46 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.813 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -123.97 112.07 16.77 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 123.383 0.427 . . . . 0.0 109.865 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.542 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 7.0 tp -83.57 138.65 33.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.275 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.5 p -103.6 137.66 41.35 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.578 0.549 . . . . 0.0 111.307 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 73.0 m -152.86 155.6 32.36 Favored Pre-proline 0 N--CA 1.469 0.497 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.544 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.51 159.81 22.43 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.2 1.933 . . . . 0.0 111.366 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.454 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -131.74 167.24 19.85 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -134.85 135.14 22.68 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.941 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.45 -26.42 14.23 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 122.613 2.208 . . . . 0.0 113.81 -177.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.89 -40.64 63.67 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.857 0.723 . . . . 0.0 112.147 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.569 HG21 HH11 ' A' ' 167' ' ' ARG . 4.5 mt -71.08 -35.52 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.348 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.74 -38.7 64.68 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.096 -1.411 . . . . 0.0 111.417 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.38 -32.36 22.44 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -87.01 -72.68 0.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.145 0.429 . . . . 0.0 111.656 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.92 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.79 98.81 6.29 Favored Pre-proline 0 C--N 1.35 0.608 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.846 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 62.4 Cg_endo -92.71 0.37 3.81 Favored 'Trans proline' 0 CA--C 1.57 2.306 0 C-N-CA 121.715 1.61 . . . . 0.0 114.288 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.644 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 98.0 Cg_endo -73.25 -52.41 0.15 Allowed 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.583 2.189 . . . . 0.0 114.245 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.513 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -122.82 -29.85 3.92 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.7 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.92 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.05 -11.14 60.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.437 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.789 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.02 -40.39 46.71 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -71.07 -50.21 36.33 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.6 m -58.49 -48.49 80.62 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.611 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.664 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.86 -40.16 94.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.298 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.43 -46.78 80.11 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 123.498 0.499 . . . . 0.0 110.368 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.83 88.81 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.406 177.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.27 -27.83 68.91 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.59 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.53 -39.79 44.89 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 122.841 0.456 . . . . 0.0 110.3 178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.2 -31.47 67.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.455 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 108.24 51.66 0.71 Allowed Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.963 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.8 t -128.47 149.54 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -88.77 78.95 7.55 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.666 0.746 . . . . 0.0 110.769 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.78 -26.34 49.64 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.025 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.8 t -59.76 -43.13 94.44 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.6 -26.45 50.71 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.61 -37.84 55.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.551 0.34 . . . . 0.0 111.893 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.8 p -94.59 -48.57 6.03 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.285 0.366 . . . . 0.0 111.373 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 56.8 115.36 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.063 0.945 . . . . 0.0 112.775 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -110.75 131.84 54.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -102.37 131.1 49.22 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.067 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -154.24 -95.43 0.11 Allowed Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.508 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -99.32 -40.39 7.94 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.665 0.274 . . . . 0.0 111.291 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.21 0 CA-C-O 118.472 -0.775 . . . . 0.0 111.114 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 120.318 0.104 . . . . 0.0 111.272 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -100.25 118.18 36.01 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.428 0.455 . . . . 0.0 110.99 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -136.74 -55.01 0.73 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.064 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.1 m -141.84 -50.89 0.4 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.256 0.348 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 55.4 m -132.79 87.07 41.97 Favored Pre-proline 0 CA--C 1.543 0.71 0 O-C-N 123.362 0.414 . . . . 0.0 110.849 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -87.6 7.26 4.75 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 123.006 2.471 . . . . 0.0 112.537 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 m -117.7 -54.85 2.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.836 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -108.34 155.87 20.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.713 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 32' ' ' LEU . 12.6 mt -97.77 50.36 1.04 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.865 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -92.66 21.3 5.6 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.897 0.38 . . . . 0.0 110.686 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.3 t60 178.01 54.64 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.586 0.754 . . . . 0.0 110.268 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -139.17 160.14 40.5 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 30' ' ' THR . 11.5 m-30 -100.57 138.09 38.1 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.089 0.471 . . . . 0.0 112.021 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.769 HD11 HD23 ' A' ' 32' ' ' LEU . 4.3 mt -107.47 141.09 39.43 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.341 178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.8 mp -120.73 134.32 64.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 O-C-N 123.522 0.514 . . . . 0.0 109.759 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.73 126.18 30.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.085 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.2 mtt -110.32 157.15 38.92 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.222 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.52 29.84 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.611 2.207 . . . . 0.0 113.188 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -86.14 -16.29 38.37 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.15 -167.45 1.22 Allowed 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.009 0.193 . . . . 0.0 110.641 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.524 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.28 40.39 1.48 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.995 0.426 . . . . 0.0 111.694 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.32 80.5 3.45 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.781 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.2 Cg_exo -75.41 -21.92 14.64 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.008 2.472 . . . . 0.0 113.327 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -84.44 -36.07 22.61 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.966 0.507 . . . . 0.0 111.852 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.29 4.01 51.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.098 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.35 163.47 20.63 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.896 0.379 . . . . 0.0 111.849 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 49.4 32.04 4.33 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.2 p -117.55 153.66 32.83 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 120.469 0.176 . . . . 0.0 110.556 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.869 HG11 HH11 ' A' ' 167' ' ' ARG . 77.4 t -128.49 133.71 66.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.583 0.706 . . . . 0.0 110.596 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 6.2 m -114.76 152.98 31.15 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.87 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.492 ' OH ' HD11 ' A' ' 105' ' ' LEU . 13.2 t80 -106.29 118.63 37.13 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.769 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.84 108.55 16.27 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.432 0.634 . . . . 0.0 110.927 -179.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.93 HG23 ' HA2' ' A' ' 42' ' ' GLY . 35.8 t -68.89 -60.36 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 113.228 -1.805 . . . . 0.0 110.576 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -142.26 113.48 7.65 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.62 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -97.34 128.74 44.43 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.672 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -139.71 153.27 47.19 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.604 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.25 -18.82 65.62 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.701 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.44 0.88 43.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.414 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.88 166.99 15.44 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 112.063 -0.415 . . . . 0.0 112.063 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.37 143.4 30.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.47 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -124.62 137.95 54.34 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.341 178.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.93 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -160.23 158.65 30.03 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.531 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.433 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.2 mt -112.83 131.54 55.66 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.935 0.367 . . . . 0.0 110.939 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 78' ' ' GLY . 41.2 t -67.93 124.68 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.558 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.1 pt -129.85 55.35 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.524 0.678 . . . . 0.0 112.347 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.869 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 24.7 t-20 -144.27 -7.76 0.7 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.286 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.553 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -130.39 92.26 35.97 Favored Pre-proline 0 CA--C 1.555 1.145 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.514 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.5 Cg_exo -61.09 146.4 97.68 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 121.747 1.631 . . . . 0.0 112.602 175.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.43 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 44.9 t -89.14 162.96 15.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.557 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.69 -5.78 62.78 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-O 119.75 -0.472 . . . . 0.0 114.242 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -88.89 151.45 22.33 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.104 0.452 . . . . 0.0 111.566 -179.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.486 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 41.2 p-10 -98.55 165.74 11.68 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.655 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.65 ' HA ' HD11 ' A' ' 75' ' ' ILE . 13.9 tp -59.03 -26.88 64.96 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.617 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . . . -61.95 -42.5 99.18 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.486 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 41.4 mt-10 -62.39 -47.35 84.52 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.072 0.233 . . . . 0.0 111.492 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.882 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.7 m -61.68 -45.34 98.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.746 ' HA ' HD12 ' A' ' 60' ' ' LEU . 6.9 mt -54.48 -35.97 63.64 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.972 0.795 . . . . 0.0 110.742 177.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -78.13 -28.0 48.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.467 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.98 -30.38 50.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.375 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.882 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.1 mt -77.93 -46.62 20.7 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.749 -1.569 . . . . 0.0 111.376 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -131.89 118.18 16.42 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.003 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.33 -32.33 3.07 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.665 2.91 . . . . 0.0 112.56 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -82.22 -15.07 54.41 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.296 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.42 149.15 26.86 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.368 0.418 . . . . 0.0 111.425 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.57 121.78 31.59 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.743 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.671 ' HB2' ' SG ' ' A' ' 70' ' ' CYS . 46.4 Cg_endo -71.26 138.16 32.6 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.575 2.183 . . . . 0.0 112.423 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 2.7 Cg_endo -90.38 -157.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.733 2.289 . . . . 0.0 112.403 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.04 -25.07 52.1 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.249 0.62 . . . . 0.0 111.824 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.479 ' HA ' ' NE2' ' A' ' 72' ' ' HIS . 6.4 ptp180 -66.54 -46.14 77.12 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.671 ' SG ' ' HB2' ' A' ' 66' ' ' PRO . 18.5 p -67.49 -29.57 69.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 71.4 mt-30 -65.75 -32.85 74.63 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.479 ' NE2' ' HA ' ' A' ' 69' ' ' ARG . 32.9 p80 -95.37 9.94 38.11 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.432 0.458 . . . . 0.0 112.021 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 69' ' ' ARG . 71.0 mt -108.64 137.68 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.55 153.07 24.65 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.822 0.702 . . . . 0.0 112.711 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.761 HD13 HD12 ' A' ' 128' ' ' ILE . 25.6 mm -101.21 153.58 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.125 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.717 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -117.13 156.03 28.31 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.553 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 32.4 m-20 -89.26 117.4 28.19 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 117.832 0.287 . . . . 0.0 110.465 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.53 -23.24 9.0 Favored Glycine 0 C--N 1.35 1.358 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.817 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.53 -167.86 35.25 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.727 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -88.59 -14.74 2.97 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.501 2.801 . . . . 0.0 114.383 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 t -82.11 125.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 123.126 0.266 . . . . 0.0 111.166 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 45.36 89.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.582 1.153 . . . . 0.0 113.216 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.2 p -85.65 -10.17 56.17 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.931 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.26 -9.94 59.68 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.8 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.651 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -133.09 151.5 52.01 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.642 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -110.28 142.31 16.55 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.153 178.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.634 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.5 m-85 -86.77 149.37 24.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.077 -1.062 . . . . 0.0 110.528 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.6 ' HB ' ' OG ' ' A' ' 108' ' ' SER . 5.1 t -126.83 103.96 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 123.627 0.579 . . . . 0.0 110.194 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.912 HD11 HD13 ' A' ' 105' ' ' LEU . 16.0 tp -106.28 127.55 53.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.309 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -128.57 168.9 14.17 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-O 118.785 -0.626 . . . . 0.0 111.444 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.6 Cg_endo -97.31 17.75 0.56 Allowed 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.682 2.255 . . . . 0.0 113.555 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.5 t -105.32 158.86 16.33 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.895 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.34 22.23 41.98 Favored Glycine 0 C--N 1.337 0.639 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.483 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -84.62 155.09 22.18 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.661 0.384 . . . . 0.0 110.491 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.8 p -125.74 156.49 39.32 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.582 ' CE2' HG23 ' A' ' 113' ' ' VAL . 58.1 m-85 -131.5 -151.24 0.45 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.494 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -60.3 -46.55 89.47 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.44 0.296 . . . . 0.0 111.291 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.1 m -136.68 83.5 2.01 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.21 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 107' ' ' MET . 7.4 m -128.03 121.08 28.86 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.909 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -99.58 120.68 40.05 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.913 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.96 126.89 33.01 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.403 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.474 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -123.98 50.52 1.63 Allowed 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.578 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.83 -111.94 4.28 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 114.617 -1.174 . . . . 0.0 113.151 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.77 -6.68 6.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 89' ' ' LEU . 2.5 pp -151.36 151.89 32.38 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.17 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.588 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -121.09 158.13 28.56 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.851 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.563 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 25.3 tpp -125.73 140.03 53.04 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.674 ' HB2' HG11 ' A' ' 113' ' ' VAL . 25.2 p -134.98 133.23 39.27 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.813 0.339 . . . . 0.0 110.435 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.4 p -118.76 15.44 13.54 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.0 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.713 ' O ' HG12 ' A' ' 113' ' ' VAL . 44.2 p -90.27 130.08 36.43 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.661 0.743 . . . . 0.0 112.424 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.485 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 20.3 pt20 -61.75 -27.01 68.42 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.401 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -65.28 -42.26 93.34 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.495 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.743 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.1 p -69.77 -38.3 75.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.513 HD13 HH12 ' A' ' 85' ' ' ARG . 6.4 tp -57.93 -48.46 79.87 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 123.68 0.613 . . . . 0.0 110.573 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.485 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 26.1 m-85 -68.77 -39.17 80.36 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.806 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.39 -53.0 62.28 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.306 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.35 -43.86 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.718 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.6 -32.1 64.93 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.782 0.676 . . . . 0.0 109.599 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.02 -20.01 31.11 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.291 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.67 13.82 33.83 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.668 -1.151 . . . . 0.0 114.799 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 p -103.83 6.48 36.61 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.38 -137.57 9.16 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.419 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.74 171.81 14.0 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.069 2.513 . . . . 0.0 113.493 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.19 -55.24 37.29 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.642 0.777 . . . . 0.0 111.998 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.646 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.0 mmtt -141.23 139.69 33.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.691 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 34.5 p -139.01 168.58 19.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.3 tp -126.97 117.38 22.4 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.804 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.761 HD12 HD13 ' A' ' 75' ' ' ILE . 12.4 pt -98.64 102.45 13.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-O 121.532 0.682 . . . . 0.0 109.536 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.0 t -121.24 122.32 39.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.025 -177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 tp -66.58 112.97 4.41 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.544 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 173.71 18.5 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 114.545 -1.207 . . . . 0.0 114.764 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -127.82 175.06 8.62 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.25 178.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -115.54 129.01 56.38 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.154 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.73 150.23 18.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.375 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 -128.37 138.23 52.26 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.858 0.387 . . . . 0.0 110.344 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.71 157.65 27.13 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.885 0.741 . . . . 0.0 110.622 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.74 91.67 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.54 -23.51 8.95 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.322 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -57.44 -44.55 84.8 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.938 0.495 . . . . 0.0 112.14 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.9 tm? -67.87 -47.7 68.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.5 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.35 -30.0 68.08 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.05 -49.96 45.92 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.941 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -70.71 -26.76 63.55 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.694 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.4 tp -74.18 -38.98 63.51 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.602 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.9 m -77.84 -28.4 50.16 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.211 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 3.0 t70 -82.25 -1.42 49.29 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.395 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.2 m120 61.03 28.5 18.26 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.857 0.863 . . . . 0.0 111.903 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 143' ' ' GLU . . . -81.96 -43.54 17.91 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.856 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -124.77 113.38 17.86 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.0 tp -86.21 138.49 31.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.5 p -101.66 136.33 41.68 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.502 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 80.6 m -150.78 150.92 29.25 Favored Pre-proline 0 C--O 1.238 0.487 0 O-C-N 123.412 0.445 . . . . 0.0 110.983 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.05 151.06 83.97 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.233 1.956 . . . . 0.0 110.997 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -134.29 176.85 8.23 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -134.56 140.26 35.04 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 113.725 -1.58 . . . . 0.0 108.693 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.83 -26.71 13.14 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.735 2.29 . . . . 0.0 113.646 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.65 -41.79 55.78 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.857 0.723 . . . . 0.0 112.46 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.46 HG21 ' HE ' ' A' ' 167' ' ' ARG . 5.5 mt -68.83 -33.83 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.526 0.679 . . . . 0.0 110.276 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.66 -37.23 56.58 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.538 -176.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -84.83 -31.21 23.96 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -88.7 -73.24 0.51 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 117.97 0.35 . . . . 0.0 111.628 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.862 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.82 99.8 6.12 Favored Pre-proline 0 C--N 1.35 0.589 0 CA-C-O 121.183 0.516 . . . . 0.0 112.228 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.869 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 72.4 Cg_endo -91.18 -0.11 4.79 Favored 'Trans proline' 0 CA--C 1.57 2.324 0 C-N-CA 121.711 1.608 . . . . 0.0 114.381 175.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.649 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 89.3 Cg_endo -74.92 -56.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.395 2.976 0 C-N-CA 122.653 2.235 . . . . 0.0 114.579 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.565 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 4.7 mt-10 -118.43 -30.67 5.15 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.542 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.862 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 28.5 tt0 -69.7 -12.18 61.43 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.235 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.869 HH11 HG11 ' A' ' 29' ' ' VAL . 3.7 tpm_? -77.1 -43.88 32.57 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.9 tp -67.59 -49.2 64.25 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.4 m -58.21 -48.66 79.67 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.789 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.58 ' O ' ' HG3' ' A' ' 174' ' ' ARG . . . -63.25 -41.92 99.12 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.494 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.09 -45.01 87.88 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.577 0.548 . . . . 0.0 110.82 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.51 -37.14 85.89 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.53 -28.19 69.48 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.152 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.58 ' HG3' ' O ' ' A' ' 170' ' ' ALA . 9.1 mtm105 -77.28 -40.78 43.31 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 123.291 0.636 . . . . 0.0 110.757 178.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 tp -69.61 -31.24 69.25 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.449 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.39 48.92 0.37 Allowed Glycine 0 C--N 1.34 0.798 0 C-N-CA 121.129 -0.557 . . . . 0.0 113.046 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.4 t -128.35 140.64 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -89.76 79.38 6.74 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.732 0.777 . . . . 0.0 110.833 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -77.93 -26.16 48.79 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.225 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.7 m -59.1 -43.83 91.9 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.59 -26.52 50.79 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.2 mt -77.04 -36.65 55.92 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 23.7 p -94.22 -48.61 6.11 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.27 0.356 . . . . 0.0 111.204 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 58.11 120.09 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.248 1.019 . . . . 0.0 112.762 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -100.54 149.88 23.26 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.88 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -98.45 130.35 45.06 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.152 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 134.78 66.37 0.07 OUTLIER Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.461 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -127.96 -40.59 1.68 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.609 0.24 . . . . 0.0 111.25 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.116 -179.944 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.496 0.188 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -101.45 131.08 47.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.056 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -100.27 -41.23 7.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.16 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.492 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.5 m -98.71 153.25 18.86 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.449 0.468 . . . . 0.0 111.005 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.7 p -94.5 100.05 4.72 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.074 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.1 Cg_endo -87.08 9.06 4.09 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.86 2.373 . . . . 0.0 112.232 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -86.99 -47.92 8.55 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.381 -1.282 . . . . 0.0 112.292 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -115.76 151.35 35.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.393 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 32' ' ' LEU . 15.8 mt -95.77 48.59 1.14 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.297 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.42 ' O ' HD21 ' A' ' 102' ' ' LEU . 48.0 tttt -88.82 16.09 7.37 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.378 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 17.3 p80 172.83 58.87 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.43 1.092 . . . . 0.0 109.698 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -135.22 159.36 41.78 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.659 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.465 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.7 m-30 -97.1 136.17 38.01 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.813 HD11 HD23 ' A' ' 32' ' ' LEU . 3.2 mt -108.42 137.12 46.91 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.793 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.443 HG23 HG22 ' A' ' 29' ' ' VAL . 2.3 mm -117.04 133.23 64.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.545 0.528 . . . . 0.0 109.635 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.54 121.94 21.42 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 123.461 0.475 . . . . 0.0 111.666 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.6 mmt -110.47 152.91 43.63 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.338 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -80.45 73.96 5.77 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.594 2.196 . . . . 0.0 112.622 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -131.46 -19.22 2.75 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.716 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.58 -162.97 0.83 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.3 0.375 . . . . 0.0 110.481 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.73 36.66 2.24 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 120.869 0.366 . . . . 0.0 111.968 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.37 82.71 3.66 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.809 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.32 -24.87 11.93 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 123.019 2.48 . . . . 0.0 113.349 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -85.16 -37.11 20.57 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.887 0.475 . . . . 0.0 111.595 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.11 -3.04 57.46 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.8 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -60.51 1.62 0.13 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -141.46 41.48 1.75 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.213 0.53 . . . . 0.0 112.076 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.9 p -124.52 157.68 34.73 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.642 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.781 HG11 ' HE ' ' A' ' 167' ' ' ARG . 57.6 t -131.0 133.51 62.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.806 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.8 m -115.04 152.37 32.59 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.381 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.52 ' OH ' HD21 ' A' ' 105' ' ' LEU . 43.4 t80 -106.95 120.99 43.54 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.813 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -83.73 108.62 16.9 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 123.481 0.488 . . . . 0.0 111.419 -178.273 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.946 HG23 ' HA2' ' A' ' 42' ' ' GLY . 36.9 t -67.76 -59.97 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.623 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -141.93 120.8 12.75 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.433 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -102.35 127.94 49.13 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.988 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.84 151.85 47.35 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.418 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.3 -19.59 65.52 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.893 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -98.4 -1.63 41.07 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.681 0.613 . . . . 0.0 111.533 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.03 169.73 20.56 Favored Glycine 0 C--N 1.344 1.012 0 C-N-CA 121.529 -0.367 . . . . 0.0 112.304 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.564 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -146.32 146.97 30.88 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.81 135.74 53.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.363 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.946 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.21 158.36 29.13 Favored Glycine 0 N--CA 1.447 -0.619 0 O-C-N 124.472 1.107 . . . . 0.0 112.486 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.4 mt -112.9 134.59 54.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 117.253 0.526 . . . . 0.0 111.469 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 78' ' ' GLY . 12.0 t -68.35 122.94 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.38 56.02 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.618 0.723 . . . . 0.0 111.98 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.844 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.8 t-20 -147.04 -3.43 0.58 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.256 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -129.92 88.08 49.91 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.504 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 41.4 Cg_exo -58.44 144.62 96.42 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 121.689 1.593 . . . . 0.0 112.43 175.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.452 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 73.9 m -94.82 160.45 14.59 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.509 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.72 51.04 0.94 Allowed Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.687 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.6 OUTLIER -133.19 154.05 50.98 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.871 0.395 . . . . 0.0 110.042 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.61 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 10.3 p-10 -112.43 157.6 20.86 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.25 0.343 . . . . 0.0 110.918 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.567 HD12 HD13 ' A' ' 128' ' ' ILE . 1.6 tt -57.54 -26.66 61.71 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.61 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -67.94 -40.39 83.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.383 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.42 -45.57 86.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.092 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.86 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.6 m -61.88 -45.06 99.53 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.736 ' HA ' HD12 ' A' ' 60' ' ' LEU . 15.6 mt -55.74 -35.26 65.97 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.546 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.99 -27.25 49.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.429 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.82 -30.54 51.19 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.768 0.794 . . . . 0.0 109.318 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.86 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.2 mt -77.86 -46.01 22.64 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.038 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -130.99 116.63 16.91 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.626 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.56 -33.08 2.54 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.687 2.925 . . . . 0.0 112.785 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.63 -14.92 56.1 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.4 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.19 149.69 24.45 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 123.338 0.399 . . . . 0.0 111.689 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.06 123.13 29.09 Favored Pre-proline 0 C--O 1.235 0.331 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.304 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.52 154.15 39.86 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.296 1.997 . . . . 0.0 112.301 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.439 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 6.8 Cg_endo -94.14 -163.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 122.67 2.247 . . . . 0.0 112.064 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.437 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -74.05 -24.76 59.57 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.782 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.531 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 7.9 ptp180 -67.11 -46.49 74.04 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.638 ' HA ' HD12 ' A' ' 73' ' ' ILE . 20.8 m -73.31 -25.58 60.71 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.464 ' HA ' HD22 ' A' ' 52' ' ' ASN . 46.3 mt-30 -70.45 -29.09 65.57 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.437 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 25.7 p80 -96.09 21.31 8.96 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.16 0.505 . . . . 0.0 111.582 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' A' ' 70' ' ' CYS . 57.0 mt -119.53 137.12 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.204 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -106.06 163.12 13.02 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 51' ' ' LEU . 14.2 mm -113.63 154.18 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.996 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.733 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -118.11 155.83 29.73 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.594 0.358 . . . . 0.0 110.33 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -85.76 119.99 26.7 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.54 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -101.85 -23.64 9.15 Favored Glycine 0 C--N 1.346 1.109 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.158 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.86 -167.91 34.87 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.272 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -88.73 -13.03 3.39 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 123.618 2.878 . . . . 0.0 114.413 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.55 130.52 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 123.075 0.235 . . . . 0.0 111.518 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 46.66 82.85 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.551 1.141 . . . . 0.0 113.301 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 77.2 p -82.85 -12.02 57.76 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.197 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.76 -13.46 59.42 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.759 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -132.81 149.73 52.23 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.594 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.29 144.42 17.02 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.46 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.2 m-85 -86.85 149.4 24.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.021 -1.09 . . . . 0.0 110.94 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 17.4 t -127.32 105.93 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 O-C-N 123.587 0.554 . . . . 0.0 110.351 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.935 HD11 HD13 ' A' ' 105' ' ' LEU . 14.6 tp -106.74 127.63 53.55 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.281 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.41 ' ND1' ' HB3' ' A' ' 123' ' ' PRO . 4.0 p80 -128.08 168.41 15.53 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.548 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.667 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.3 Cg_endo -97.7 21.78 0.34 Allowed 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 122.677 2.251 . . . . 0.0 113.748 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.2 t -109.83 158.88 17.71 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.686 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.06 22.42 38.51 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.609 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.02 151.79 22.07 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.539 0.335 . . . . 0.0 110.514 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.598 ' HA ' HG21 ' A' ' 99' ' ' THR . 22.4 m -128.82 157.12 42.39 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.564 ' CE2' HG23 ' A' ' 113' ' ' VAL . 55.0 m-85 -126.95 -150.97 0.46 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.757 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -58.85 -46.32 88.0 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.655 0.382 . . . . 0.0 111.415 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.9 m -133.12 81.03 1.91 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.848 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.598 HG21 ' HA ' ' A' ' 95' ' ' SER . 42.4 m -129.49 122.62 29.64 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.381 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.33 123.48 46.89 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.879 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -84.88 130.13 34.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.979 0.419 . . . . 0.0 110.878 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.427 ' HB3' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -125.43 46.35 2.4 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.667 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.16 -106.85 1.65 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 114.863 -1.062 . . . . 0.0 113.381 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.28 -10.63 3.14 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.935 HD13 HD11 ' A' ' 89' ' ' LEU . 1.7 pp -155.22 152.15 28.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.609 0.364 . . . . 0.0 111.25 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.586 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.06 157.5 26.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.863 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.527 ' O ' ' HA ' ' A' ' 99' ' ' THR . 17.3 ttm -123.9 134.2 53.59 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.0 m -136.44 133.8 37.02 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.7 p -127.49 19.07 6.84 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.144 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 113' ' ' VAL . 46.8 p -90.16 131.19 36.14 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.393 0.616 . . . . 0.0 112.037 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.482 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 5.3 mt-30 -58.16 -26.96 63.36 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.759 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -64.12 -40.44 96.2 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.902 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.765 ' O ' HG22 ' A' ' 117' ' ' ILE . 2.6 p -71.1 -38.43 71.28 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.418 HD11 HH12 ' A' ' 85' ' ' ARG . 4.4 mm? -55.51 -50.1 70.85 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.533 0.521 . . . . 0.0 110.495 178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.482 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 39.9 m-85 -67.8 -40.6 83.86 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.222 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.69 -54.17 48.48 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.753 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.765 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.11 -43.73 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.6 -32.27 65.08 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 123.674 0.609 . . . . 0.0 109.59 178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.531 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.66 -20.2 31.68 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.363 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.05 17.0 26.4 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 114.841 -1.072 . . . . 0.0 114.64 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.6 p -107.08 7.08 29.49 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.57 -137.29 8.74 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.113 -0.826 . . . . 0.0 112.47 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.41 ' HB3' ' ND1' ' A' ' 90' ' ' HIS . 2.1 Cg_endo -82.51 169.3 13.94 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.942 2.428 . . . . 0.0 113.652 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.61 -56.46 21.04 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.776 0.831 . . . . 0.0 112.106 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.667 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.5 mmtt -139.63 139.76 36.79 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.502 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 35.8 p -141.04 168.97 18.5 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.3 tp -125.63 115.18 19.72 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.695 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.567 HD13 HD12 ' A' ' 53' ' ' LEU . 7.9 pt -99.29 104.43 16.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 O-C-N 123.751 0.657 . . . . 0.0 109.229 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -124.55 122.08 36.58 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.21 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.34 113.64 5.39 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.346 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.433 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 73.87 167.92 16.04 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 115.093 -0.958 . . . . 0.0 114.461 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -128.64 179.95 5.4 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.115 0.483 . . . . 0.0 110.655 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -118.2 130.37 56.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.368 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.57 146.04 16.58 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.539 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 31.4 m-90 -122.31 135.71 54.77 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 122.655 0.382 . . . . 0.0 110.35 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.36 158.11 26.13 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.935 0.772 . . . . 0.0 110.663 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.1 90.86 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.14 -25.01 7.61 Favored Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.172 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -57.59 -44.17 85.2 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.938 0.495 . . . . 0.0 112.252 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.582 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.98 -47.57 65.25 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.118 0.261 . . . . 0.0 110.527 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.33 -29.22 68.74 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.088 0.47 . . . . 0.0 110.643 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.63 -50.66 34.63 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.788 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 5.1 pt-20 -69.57 -26.64 64.58 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.816 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.7 tp -75.2 -39.16 60.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.637 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.2 m -77.82 -27.83 50.13 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.492 178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -82.96 0.1 46.14 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.518 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.5 m120 60.09 29.39 18.96 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.811 0.844 . . . . 0.0 111.761 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.61 -43.28 17.2 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.917 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -124.17 113.61 18.54 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.6 tp -83.92 139.22 32.73 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.205 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.3 p -104.66 138.1 41.48 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.32 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 24.7 p -152.88 155.5 32.27 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.595 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.08 158.24 26.41 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.259 1.972 . . . . 0.0 111.214 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.465 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.97 166.24 21.4 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -134.11 134.89 23.37 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 114.317 -1.311 . . . . 0.0 107.983 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.13 -26.47 14.86 Favored 'Trans proline' 0 C--N 1.364 1.354 0 C-N-CA 122.594 2.196 . . . . 0.0 113.616 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.67 -40.04 62.48 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 123.787 0.68 . . . . 0.0 112.211 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.567 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.6 mt -72.07 -35.1 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 121.411 0.624 . . . . 0.0 110.351 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.26 -37.22 63.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.343 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -85.45 -34.9 21.54 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -84.85 -72.16 0.49 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 117.98 0.354 . . . . 0.0 111.657 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.897 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.85 99.04 6.21 Favored Pre-proline 0 C--N 1.348 0.539 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.844 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.7 Cg_endo -91.99 -0.15 4.28 Favored 'Trans proline' 0 CA--C 1.569 2.259 0 C-N-CA 121.64 1.56 . . . . 0.0 114.253 175.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.642 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 81.3 Cg_endo -73.89 -52.34 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 122.539 2.159 . . . . 0.0 114.43 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.518 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.5 mt-10 -122.54 -30.19 3.95 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.672 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.897 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.8 tt0 -70.02 -10.84 60.01 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.338 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.781 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.91 -41.52 43.21 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.9 tp -70.62 -50.33 38.1 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.7 m -58.07 -49.61 76.32 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.666 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -63.66 -40.0 95.75 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.069 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.76 -45.32 78.11 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 123.54 0.525 . . . . 0.0 110.485 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.04 -38.35 90.77 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.497 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.95 -27.63 68.3 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.65 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -78.05 -40.29 39.18 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.963 0.505 . . . . 0.0 110.378 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -69.66 -32.76 71.6 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.353 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.37 54.19 0.41 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.944 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 13.3 t -127.26 145.98 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -87.0 75.33 9.55 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.753 0.787 . . . . 0.0 110.703 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.7 -26.09 49.9 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.847 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 51.7 p -59.65 -42.28 92.43 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.61 -26.58 50.77 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.2 mt -76.96 -38.08 53.97 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.308 0.38 . . . . 0.0 111.977 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.4 p -93.92 -47.72 6.59 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.317 0.386 . . . . 0.0 111.286 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 58.87 120.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.243 1.017 . . . . 0.0 112.819 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -113.43 150.64 32.48 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -98.18 143.8 28.31 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.213 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 163.63 121.2 0.55 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.513 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -100.62 147.21 26.22 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 123.64 0.259 . . . . 0.0 110.908 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.073 -179.947 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.505 0.193 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -111.47 131.31 55.31 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.051 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -104.67 -40.68 5.92 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.166 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.505 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 43.7 p -97.56 154.99 17.17 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.412 0.445 . . . . 0.0 111.077 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.9 m -95.18 99.26 4.18 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.988 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.2 Cg_endo -87.1 8.87 4.16 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.875 2.383 . . . . 0.0 112.376 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.8 t -87.93 -47.34 8.64 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.442 -1.254 . . . . 0.0 112.19 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -123.3 154.82 38.35 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.487 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.4 mt -99.15 46.68 0.97 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.928 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.401 ' O ' HD21 ' A' ' 102' ' ' LEU . 85.3 mttt -90.06 18.68 5.59 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 120.893 0.377 . . . . 0.0 111.058 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.1 p80 176.82 55.49 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.04 0.936 . . . . 0.0 110.265 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -134.32 159.78 39.94 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.625 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.492 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 18.9 m-30 -98.6 136.59 38.47 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.035 0.445 . . . . 0.0 112.02 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.784 HD11 HD23 ' A' ' 32' ' ' LEU . 4.3 mt -108.34 141.86 39.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.919 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.674 HD11 ' SG ' ' A' ' 152' ' ' CYS . 2.3 mp -124.87 137.36 57.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 O-C-N 123.274 0.358 . . . . 0.0 110.351 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.05 120.13 19.22 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.748 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.5 mmt -97.86 159.0 31.95 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.565 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.04 6.81 4.36 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.678 2.252 . . . . 0.0 113.727 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -79.82 -12.94 59.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.303 0.241 . . . . 0.0 111.549 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.727 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -105.82 153.13 22.34 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.175 179.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.91 42.95 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.376 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.727 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.1 m-20 -116.55 87.6 21.47 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.526 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.51 -20.0 18.54 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.926 2.417 . . . . 0.0 113.331 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -84.52 -34.67 23.26 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.828 0.451 . . . . 0.0 111.708 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -94.02 3.83 54.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.024 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.72 163.65 21.12 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 48.87 32.07 3.54 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.9 p -116.29 154.22 30.55 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 120.568 0.223 . . . . 0.0 110.738 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.739 HG11 ' HE ' ' A' ' 167' ' ' ARG . 47.2 t -129.33 132.2 66.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.781 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 6.1 m -113.34 153.39 28.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.755 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.543 ' OH ' HD21 ' A' ' 105' ' ' LEU . 45.2 t80 -107.18 120.5 42.27 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.784 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -85.26 109.75 18.57 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.639 0.587 . . . . 0.0 111.128 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.95 HG23 ' HA2' ' A' ' 42' ' ' GLY . 34.9 t -69.13 -60.22 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 113.569 -1.651 . . . . 0.0 110.841 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -141.32 115.81 9.54 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.407 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -99.07 128.13 45.15 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.802 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -139.28 152.64 47.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.398 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.87 -18.98 65.64 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.787 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.45 2.35 42.09 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.536 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.46 166.79 15.01 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 121.517 -0.373 . . . . 0.0 112.375 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -144.91 145.82 31.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.457 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -125.56 136.82 53.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.966 178.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.95 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -160.93 159.78 31.37 Favored Glycine 0 N--CA 1.452 -0.284 0 O-C-N 124.575 1.172 . . . . 0.0 112.59 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.2 mt -115.12 135.08 54.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 117.08 0.44 . . . . 0.0 111.228 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 78' ' ' GLY . 11.0 t -66.83 124.11 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.551 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.65 54.08 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 121.538 0.685 . . . . 0.0 112.015 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.83 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.6 t-20 -147.32 -3.42 0.56 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.996 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -129.7 87.61 51.98 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.528 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 35.2 Cg_exo -59.73 142.45 98.74 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 121.658 1.572 . . . . 0.0 112.273 175.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.434 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.2 m -89.44 159.39 17.3 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.465 0.478 . . . . 0.0 111.589 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.84 48.54 1.47 Allowed Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.513 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mt -133.48 157.02 46.67 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 124.002 0.471 . . . . 0.0 110.141 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 18.4 p-10 -112.22 158.74 19.34 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.245 178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.658 HD13 HD13 ' A' ' 128' ' ' ILE . 13.3 tp -57.53 -29.23 64.2 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.38 96.0 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.33 -47.02 77.96 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.865 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.3 m -62.06 -43.92 98.32 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.707 ' HA ' HD12 ' A' ' 60' ' ' LEU . 16.7 mt -57.34 -34.57 68.92 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.587 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -78.18 -27.72 48.0 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.325 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -30.29 51.97 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.263 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.865 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 14.7 mt -77.87 -45.55 23.9 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 113.667 -1.606 . . . . 0.0 111.056 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -130.94 116.01 16.81 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.609 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.43 -32.91 2.7 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 123.604 2.869 . . . . 0.0 112.744 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.36 -15.38 55.46 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.315 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.3 150.49 23.83 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.611 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.78 122.79 28.29 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.167 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.7 149.74 49.22 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.357 2.038 . . . . 0.0 112.189 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 8.7 Cg_endo -94.69 -171.5 0.23 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.639 2.226 . . . . 0.0 112.477 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.471 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -64.72 -24.79 67.68 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.113 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.53 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 7.4 ptp180 -68.73 -46.73 68.15 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.682 ' HA ' HD12 ' A' ' 73' ' ' ILE . 15.4 m -75.49 -25.44 57.31 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 52.3 mt-30 -68.63 -26.92 65.58 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.471 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 23.6 p80 -99.46 21.68 11.81 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.138 0.494 . . . . 0.0 111.318 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 70' ' ' CYS . 63.4 mt -117.79 139.1 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.268 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.18 154.62 20.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.707 HD13 HD12 ' A' ' 128' ' ' ILE . 23.5 mm -101.28 152.59 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.235 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.714 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.9 t80 -118.81 154.87 32.15 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -85.94 119.2 25.99 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.613 0.188 . . . . 0.0 110.555 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.577 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.29 -23.72 8.31 Favored Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.022 -1.085 . . . . 0.0 114.047 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.15 -168.24 35.11 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.359 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -88.66 -13.26 3.37 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.47 2.78 . . . . 0.0 114.37 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.3 t -82.39 125.19 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 123.082 0.239 . . . . 0.0 111.233 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 47.23 85.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.488 1.115 . . . . 0.0 113.027 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.41 ' O ' HD21 ' A' ' 130' ' ' LEU . 8.8 t -86.8 1.45 52.27 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.288 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -94.63 -4.23 48.08 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.633 ' NH2' ' HA ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -133.05 152.85 51.92 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.611 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.63 137.4 14.12 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.413 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.71 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.6 OUTLIER -86.49 144.55 27.2 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.029 0.932 . . . . 0.0 110.635 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 t -125.28 103.67 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 123.636 0.585 . . . . 0.0 110.046 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.884 HD11 HD13 ' A' ' 105' ' ' LEU . 15.5 tp -107.51 128.38 54.46 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.138 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -127.55 169.09 13.12 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.612 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.659 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.4 Cg_endo -97.25 15.2 0.75 Allowed 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.756 2.304 . . . . 0.0 113.818 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.4 t -102.77 159.91 15.06 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.668 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.76 22.47 37.7 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.636 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tp -89.4 153.01 21.19 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.56 0.344 . . . . 0.0 110.622 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.563 ' HA ' HG21 ' A' ' 99' ' ' THR . 13.6 m -130.31 156.65 44.32 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.071 0.463 . . . . 0.0 112.196 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.569 ' CE2' HG23 ' A' ' 113' ' ' VAL . 46.4 m-85 -126.27 -150.59 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.844 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -56.78 -46.86 81.25 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.975 0.51 . . . . 0.0 111.633 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 m -134.5 82.25 1.96 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.86 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 107' ' ' MET . 30.4 m -130.1 124.51 32.92 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.229 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.71 123.54 47.22 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.844 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.21 129.22 34.9 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.081 0.467 . . . . 0.0 110.787 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.461 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.55 45.88 2.43 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.411 -179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.06 -105.87 1.33 Allowed Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.155 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.55 -10.67 3.65 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.884 HD13 HD11 ' A' ' 89' ' ' LEU . 2.2 pp -155.46 153.19 29.94 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 123.26 0.35 . . . . 0.0 111.392 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.623 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.39 156.2 29.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.716 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 99' ' ' THR . 18.6 ttm -122.52 130.58 53.19 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 m -131.52 130.86 42.9 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.8 p -120.36 18.63 12.17 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.549 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.746 ' O ' HG12 ' A' ' 113' ' ' VAL . 68.3 m -88.09 133.99 33.86 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.963 0.887 . . . . 0.0 112.694 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.633 ' HA ' ' NH2' ' A' ' 85' ' ' ARG . 3.9 mt-30 -62.7 -30.81 71.68 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.96 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.79 -40.31 95.02 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.735 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 110' ' ' SER . 3.5 p -70.46 -39.41 76.29 Favored 'Isoleucine or valine' 0 C--N 1.353 0.745 0 O-C-N 123.142 0.276 . . . . 0.0 110.502 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.618 HD22 ' NH2' ' A' ' 85' ' ' ARG . 4.2 tp -59.36 -46.54 88.36 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 123.471 0.482 . . . . 0.0 110.164 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.496 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 24.1 m-85 -67.22 -40.96 86.45 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.701 178.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.2 -53.21 59.78 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.599 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.736 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.91 -43.57 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.527 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.483 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.33 -32.72 64.94 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.815 0.697 . . . . 0.0 109.59 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.53 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.89 -19.64 32.0 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.376 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.06 15.21 31.43 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.689 -1.141 . . . . 0.0 114.755 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 p -105.1 6.77 33.49 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.2 -137.35 8.99 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.481 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -81.62 172.6 12.2 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.046 2.497 . . . . 0.0 113.526 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.64 -55.16 37.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.695 0.798 . . . . 0.0 111.962 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.659 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.8 mmtt -141.76 139.74 32.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.656 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 36.6 p -139.02 167.82 21.21 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.0 tp -126.88 118.49 24.7 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.574 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.71 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 12.5 pt -98.46 102.18 13.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-O 121.575 0.703 . . . . 0.0 109.725 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.7 t -121.02 122.05 39.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.713 -178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.41 HD21 ' O ' ' A' ' 83' ' ' THR . 7.0 tp -67.33 118.03 10.14 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.464 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.86 173.24 5.63 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 114.763 -1.108 . . . . 0.0 114.524 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.41 175.5 8.46 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.179 0.514 . . . . 0.0 110.659 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -115.86 129.68 56.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.271 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.47 146.75 17.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.631 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -121.86 136.83 54.94 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.149 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.32 157.81 26.28 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.848 0.718 . . . . 0.0 110.786 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.23 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.51 -25.82 7.55 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.119 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -58.54 -44.22 89.52 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.885 0.474 . . . . 0.0 112.272 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.582 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.89 -47.58 65.5 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.16 0.287 . . . . 0.0 110.481 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.29 -29.55 68.9 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.014 0.435 . . . . 0.0 110.555 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.56 -49.91 49.79 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.84 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.32 -26.81 63.0 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.696 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.5 tp -74.55 -37.31 63.03 Favored 'General case' 0 C--N 1.345 0.413 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.492 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.0 t -77.88 -29.83 50.51 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.712 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.0 t70 -84.11 1.15 45.54 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.072 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 52.63 33.98 14.85 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.841 1.256 . . . . 0.0 112.201 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 143' ' ' GLU . . . -81.53 -41.61 21.4 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.372 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -122.14 113.02 18.92 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.0 tp -83.92 136.18 34.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.5 p -101.13 136.91 40.22 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.967 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.674 ' SG ' HD11 ' A' ' 15' ' ' ILE . 26.2 p -150.79 154.98 35.42 Favored Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 123.458 0.474 . . . . 0.0 110.738 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.63 152.6 61.37 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.189 1.926 . . . . 0.0 110.989 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.492 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.93 167.45 17.41 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.74 134.22 21.9 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 114.276 -1.329 . . . . 0.0 107.943 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.87 -26.48 15.55 Favored 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 122.493 2.129 . . . . 0.0 113.434 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.14 -48.49 53.72 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 124.032 0.832 . . . . 0.0 111.441 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.586 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.7 mt -64.06 -34.87 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.371 0.668 . . . . 0.0 110.839 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -73.55 -35.62 65.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.281 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -83.66 -34.89 24.91 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 162' ' ' LEU . 2.2 p30 -86.81 -67.22 0.83 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.744 0.702 . . . . 0.0 112.729 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.67 ' C ' ' HD2' ' A' ' 164' ' ' PRO . 1.1 tp -145.73 98.98 4.44 Favored Pre-proline 0 C--N 1.344 0.333 0 CA-C-O 121.042 0.448 . . . . 0.0 111.786 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.83 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 65.7 Cg_endo -91.54 -0.14 4.56 Favored 'Trans proline' 0 CA--C 1.57 2.282 0 C-N-CA 121.795 1.663 . . . . 0.0 114.488 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.67 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 79.4 Cg_endo -74.67 -50.41 0.14 Allowed 'Trans proline' 0 C--N 1.389 2.676 0 C-N-CA 122.76 2.307 . . . . 0.0 114.438 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.513 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 10.8 mt-10 -121.61 -33.98 3.51 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.705 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 6.0 mt-10 -68.6 -11.28 59.81 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.045 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.739 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.06 -41.7 41.32 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -69.82 -49.78 49.33 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.8 m -58.33 -49.05 78.58 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.682 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.67 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.39 -40.21 95.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.265 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.82 79.46 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 123.538 0.524 . . . . 0.0 110.489 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.58 -37.69 88.27 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.466 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.25 -27.76 68.87 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.507 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.67 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.6 mmp_? -77.52 -40.03 44.12 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.899 0.479 . . . . 0.0 110.192 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -71.3 -31.29 67.26 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.461 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.38 54.95 0.56 Allowed Glycine 0 C--N 1.341 0.806 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.911 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 10.7 t -127.69 148.13 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.83 77.88 7.71 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.707 0.765 . . . . 0.0 110.69 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.78 -26.14 49.53 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.113 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 51.7 m -58.36 -43.6 88.44 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.45 -26.76 51.76 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.3 mt -77.26 -31.24 54.82 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.636 0.374 . . . . 0.0 111.693 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.4 p -89.81 -47.3 7.99 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.399 0.437 . . . . 0.0 111.408 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.22 118.07 21.76 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.513 0.508 . . . . 0.0 111.147 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -100.13 150.11 22.83 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.957 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -98.95 145.34 27.14 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.122 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 163.76 -134.86 3.53 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.535 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -99.34 132.57 44.57 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.311 0.244 . . . . 0.0 111.079 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 C-N-CA 123.884 0.874 . . . . 0.0 112.241 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.21 0.052 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -100.15 136.6 39.81 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.407 0.442 . . . . 0.0 111.039 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -99.33 -40.59 7.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.24 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.8 m -98.33 153.5 18.49 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.4 t -93.2 106.97 22.1 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.812 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -86.73 6.97 5.12 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.808 2.339 . . . . 0.0 112.339 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.8 m -112.99 -57.24 2.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.537 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.57 ' CD1' ' HE3' ' A' ' 10' ' ' LYS . 2.4 m-85 -111.41 157.85 19.78 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.312 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.736 ' HB3' ' ND1' ' A' ' 12' ' ' HIS . 14.2 mt -100.04 41.2 1.18 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.044 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.57 ' HE3' ' CD1' ' A' ' 8' ' ' TYR . 75.0 mttt -89.53 26.77 1.63 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 120.95 0.405 . . . . 0.0 110.63 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 178.37 53.9 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.668 0.787 . . . . 0.0 109.979 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.736 ' ND1' ' HB3' ' A' ' 9' ' ' LEU . 6.9 p-80 -131.11 156.29 45.5 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.436 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 11.0 m-30 -98.68 133.72 42.61 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.843 0.354 . . . . 0.0 111.205 178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 8.6 mt -106.58 140.98 38.59 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.299 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.21 131.19 73.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.25 132.84 38.9 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.885 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 55.5 mtt -121.46 156.6 57.93 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.191 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.85 75.83 4.61 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.629 2.219 . . . . 0.0 112.885 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -134.02 -21.99 1.84 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.787 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.57 -162.91 0.86 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.25 0.344 . . . . 0.0 110.382 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.536 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -101.79 32.94 3.19 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.1 m-20 -111.47 82.49 3.66 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.41 -24.17 12.45 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 123.034 2.489 . . . . 0.0 113.361 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -85.01 -37.81 19.96 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.953 0.501 . . . . 0.0 111.612 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.61 -3.4 57.57 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.791 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -60.83 1.93 0.13 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -141.33 39.37 1.74 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.191 0.519 . . . . 0.0 111.981 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.7 p -123.22 158.52 30.67 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.788 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.783 HG11 ' HE ' ' A' ' 167' ' ' ARG . 97.0 t -130.85 132.3 64.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.955 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -113.25 153.75 27.89 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.343 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.473 ' OH ' HD21 ' A' ' 105' ' ' LEU . 34.9 t80 -108.61 119.6 40.01 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.581 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.525 HD11 ' HB1' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -82.51 107.8 15.43 Favored 'General case' 0 C--O 1.247 0.94 0 O-C-N 123.491 0.494 . . . . 0.0 111.295 -178.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.947 HG23 ' HA2' ' A' ' 42' ' ' GLY . 39.0 t -68.12 -60.65 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.203 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.515 ' OE1' HD11 ' A' ' 100' ' ' LEU . 12.8 tt0 -142.16 114.76 8.49 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.426 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.494 ' CE1' HD12 ' A' ' 9' ' ' LEU . 15.7 t-80 -96.75 129.78 44.11 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.153 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -138.9 151.54 47.03 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.068 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.39 -17.82 64.12 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -104.79 6.32 33.91 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.664 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.61 164.39 12.62 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 121.511 -0.376 . . . . 0.0 112.295 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -146.02 141.13 27.36 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -117.94 134.9 54.51 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.584 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.947 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.04 160.56 31.29 Favored Glycine 0 N--CA 1.449 -0.444 0 O-C-N 124.5 1.125 . . . . 0.0 112.573 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.5 mt -115.95 135.26 54.14 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 117.148 0.474 . . . . 0.0 111.503 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 78' ' ' GLY . 12.0 t -68.64 123.55 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.518 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.3 pt -126.83 56.56 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.679 0.752 . . . . 0.0 111.798 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.859 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.9 t-20 -147.45 -4.17 0.53 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.42 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -129.7 88.21 50.21 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.504 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.2 Cg_exo -59.58 142.26 98.57 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.655 1.57 . . . . 0.0 112.151 175.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.419 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 43.7 m -91.43 159.48 15.94 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.346 0.404 . . . . 0.0 111.574 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.53 46.76 1.24 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.362 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.69 155.1 51.12 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.473 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 14.7 p-10 -105.79 161.08 14.73 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.889 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.668 HD13 HD13 ' A' ' 128' ' ' ILE . 13.5 tp -58.77 -37.85 77.21 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.59 -36.58 56.44 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 37.4 mt-10 -64.37 -43.04 95.75 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.171 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.868 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -62.77 -46.48 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.739 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.5 mp -54.01 -36.77 63.35 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.858 0.724 . . . . 0.0 110.788 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -77.93 -28.22 49.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.525 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -30.05 48.82 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.358 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.868 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.1 mt -77.75 -45.03 25.83 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.945 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -132.3 116.48 15.35 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.543 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.5 -32.75 2.74 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 123.566 2.844 . . . . 0.0 112.803 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.29 -14.17 55.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.426 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.89 149.93 24.46 Favored 'General case' 0 C--N 1.344 0.366 0 O-C-N 123.38 0.425 . . . . 0.0 111.716 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.3 123.65 29.79 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.046 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 56.5 Cg_endo -74.17 145.42 34.92 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 122.271 1.981 . . . . 0.0 112.371 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.7 Cg_endo -92.58 -171.34 0.33 Allowed 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.561 2.174 . . . . 0.0 111.978 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.502 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -63.15 -24.79 68.05 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.215 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.566 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.3 ptp180 -66.22 -53.27 39.16 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.693 ' HA ' HD12 ' A' ' 73' ' ' ILE . 60.7 m -72.38 -25.0 61.34 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 49.5 mt-30 -67.11 -35.69 80.3 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.502 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 20.2 p80 -91.62 23.99 3.28 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.256 0.551 . . . . 0.0 111.689 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 70' ' ' CYS . 55.8 mt -120.42 138.97 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.573 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.62 154.79 20.92 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.768 0.668 . . . . 0.0 112.639 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.767 HD13 HD12 ' A' ' 128' ' ' ILE . 16.6 mm -102.74 152.57 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.207 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.717 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.5 t80 -119.27 152.75 36.14 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -83.45 120.59 26.09 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.899 0.318 . . . . 0.0 110.796 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.6 -23.66 8.22 Favored Glycine 0 C--N 1.348 1.206 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.984 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.6 -167.86 35.29 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.333 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -88.66 -11.51 4.0 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.511 2.807 . . . . 0.0 114.378 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -86.06 127.34 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 123.054 0.221 . . . . 0.0 111.266 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 46.04 84.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.528 1.131 . . . . 0.0 113.289 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 p -85.69 -4.41 59.16 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.072 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.91 -5.64 59.2 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.729 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.614 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.43 154.27 50.92 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.614 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.28 133.69 11.8 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.986 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.731 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.61 145.07 27.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.377 1.071 . . . . 0.0 110.426 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.28 103.94 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 123.414 0.446 . . . . 0.0 110.726 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.877 HD11 HD13 ' A' ' 105' ' ' LEU . 14.1 tp -106.75 128.29 54.09 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.727 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.405 ' CE1' ' HB3' ' A' ' 106' ' ' ALA . 3.6 p80 -125.51 166.42 21.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-O 118.937 -0.554 . . . . 0.0 112.048 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.5 Cg_endo -96.16 14.84 0.97 Allowed 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.663 2.242 . . . . 0.0 113.59 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.8 t -101.93 160.84 14.14 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.808 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.65 19.42 54.77 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.794 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mp -85.62 154.1 21.93 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.481 0.312 . . . . 0.0 111.057 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 p -127.07 156.86 41.02 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.57 ' CE2' HG23 ' A' ' 113' ' ' VAL . 51.4 m-85 -129.8 -152.57 0.52 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.821 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -57.27 -46.43 83.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.847 0.459 . . . . 0.0 111.721 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.7 m -136.27 81.67 1.9 Allowed 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.209 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 107' ' ' MET . 11.3 m -129.33 126.84 39.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.691 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.515 HD11 ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -105.68 123.26 47.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.743 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -82.89 128.81 34.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.53 . . . . 0.0 110.763 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.476 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.54 46.69 2.25 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.337 -179.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.47 -107.95 2.2 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.04 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -61.22 -9.24 4.59 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.877 HD13 HD11 ' A' ' 89' ' ' LEU . 2.6 pp -154.29 152.39 30.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.41 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.641 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.14 156.74 28.17 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.706 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.568 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 16.8 ttm -121.45 127.21 50.88 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.712 ' HB3' HG11 ' A' ' 113' ' ' VAL . 20.2 m -123.84 129.47 51.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.182 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 58.7 p -119.57 15.12 12.81 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.71 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.741 ' O ' HG12 ' A' ' 113' ' ' VAL . 61.8 m -87.76 129.71 35.08 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.358 0.599 . . . . 0.0 111.872 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.483 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.6 pt20 -61.55 -29.4 69.99 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.158 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -64.98 -42.86 94.17 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.627 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 110' ' ' SER . 4.2 p -67.75 -38.17 79.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 O-C-N 123.171 0.294 . . . . 0.0 110.291 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.603 HD22 ' NH2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -59.13 -48.99 79.58 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 123.572 0.545 . . . . 0.0 110.323 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.483 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 32.0 m-85 -69.12 -37.52 78.39 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.995 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.04 -51.7 66.93 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.085 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.81 -43.44 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.257 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.1 -31.68 65.52 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 123.734 0.646 . . . . 0.0 109.544 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.566 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.74 -20.08 31.65 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.233 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.05 15.1 31.76 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.689 -1.141 . . . . 0.0 114.67 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.5 p -105.8 8.16 32.68 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.3 -138.49 9.91 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-O 119.203 -0.776 . . . . 0.0 112.774 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.9 172.11 13.49 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.283 2.656 . . . . 0.0 113.87 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.49 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -52.05 -57.23 10.16 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.417 1.087 . . . . 0.0 111.624 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.549 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -139.6 152.91 47.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.811 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 75.5 m -147.34 164.21 33.98 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.1 tp -127.79 117.81 22.57 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.449 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.767 HD12 HD13 ' A' ' 75' ' ' ILE . 12.7 pt -98.44 102.35 13.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-O 121.842 0.83 . . . . 0.0 109.833 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 7.2 t -118.94 122.27 41.87 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.727 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.0 tp -66.95 115.21 6.43 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.109 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 66.01 174.15 5.25 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.694 -1.139 . . . . 0.0 114.355 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -128.64 179.9 5.43 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.251 0.548 . . . . 0.0 110.842 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -117.43 130.49 56.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.215 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.86 139.56 11.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.757 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.402 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 32.6 m-90 -113.88 135.01 54.44 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.934 0.432 . . . . 0.0 110.151 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.62 158.03 25.8 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.887 0.742 . . . . 0.0 110.501 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.91 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 122.26 -26.11 6.48 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.015 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.71 -45.07 86.22 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.32 -47.93 66.22 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.156 0.285 . . . . 0.0 110.502 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.62 -28.54 68.62 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.411 0.445 . . . . 0.0 110.729 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.53 -51.13 30.83 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.74 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -69.47 -26.49 64.59 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.7 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.2 tp -75.37 -39.34 59.32 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.873 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.6 m -77.75 -28.46 50.72 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.532 179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.8 t70 -82.93 0.55 43.92 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.438 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 59.31 28.89 18.35 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.777 0.831 . . . . 0.0 111.7 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -80.93 -43.4 19.82 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.304 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -125.69 118.07 24.83 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 4.8 tp -87.97 150.88 23.19 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 120.484 0.183 . . . . 0.0 111.357 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.54 HG22 ' NE2' ' A' ' 12' ' ' HIS . 80.8 p -111.25 137.11 49.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.792 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 78.6 m -149.86 154.5 37.36 Favored Pre-proline 0 N--CA 1.47 0.552 0 O-C-N 123.315 0.384 . . . . 0.0 111.357 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.37 148.37 86.91 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 122.555 2.17 . . . . 0.0 110.993 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.436 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -123.21 166.92 14.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -135.53 134.53 21.09 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.929 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.46 -26.38 17.02 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.604 2.202 . . . . 0.0 113.542 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.91 -40.12 63.29 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.862 0.726 . . . . 0.0 112.116 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.578 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.8 mt -71.75 -35.66 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-O 121.382 0.611 . . . . 0.0 110.277 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.5 tt -73.65 -37.72 65.21 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.455 -177.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -85.3 -34.71 21.82 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -84.92 -72.58 0.47 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 117.967 0.349 . . . . 0.0 111.627 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.897 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.28 98.97 6.56 Favored Pre-proline 0 C--N 1.348 0.529 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.859 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 66.3 Cg_endo -92.19 -0.05 4.15 Favored 'Trans proline' 0 CA--C 1.569 2.269 0 C-N-CA 121.702 1.601 . . . . 0.0 114.226 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.634 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 77.4 Cg_endo -74.03 -52.5 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.899 0 C-N-CA 122.605 2.204 . . . . 0.0 114.389 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.516 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.3 mt-10 -122.43 -29.92 4.03 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.707 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.897 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.9 tt0 -70.09 -10.89 60.21 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.37 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.783 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.83 -39.62 50.64 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.9 tt -72.64 -49.98 28.21 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.1 m -58.0 -47.96 81.47 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.508 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.671 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.96 -39.9 90.82 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.17 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.32 79.94 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 123.393 0.433 . . . . 0.0 110.594 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.23 -38.49 90.55 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.523 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.29 -28.55 69.79 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.601 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.671 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.86 -40.45 40.05 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 122.905 0.482 . . . . 0.0 110.35 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.98 -33.24 74.26 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.533 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 124.4 45.65 0.26 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.108 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 6.2 t -129.15 139.13 52.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -90.7 81.06 5.85 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.682 0.753 . . . . 0.0 110.765 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -77.84 -26.27 49.33 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.218 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 13.5 t -58.5 -45.28 89.08 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.099 0.56 . . . . 0.0 112.486 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.47 -26.81 51.7 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 21.3 mt -77.23 -29.86 54.28 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.292 0.37 . . . . 0.0 111.699 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 23.5 p -90.41 -48.22 7.25 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.385 0.428 . . . . 0.0 111.3 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.62 119.13 22.02 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 123.459 0.474 . . . . 0.0 111.056 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -100.45 140.72 34.3 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.56 141.63 51.8 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.641 0.588 . . . . 0.0 111.041 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 151.58 104.98 0.28 Allowed Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.514 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -128.55 145.29 51.17 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.664 0.273 . . . . 0.0 110.838 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.192 0 C-N-CA 123.895 0.878 . . . . 0.0 112.28 -179.93 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.485 0.183 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -100.39 129.95 46.42 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.199 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -98.7 -42.48 7.21 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.841 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.537 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.8 m -101.61 158.52 16.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.618 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.6 p -95.03 98.84 3.61 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.213 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.4 Cg_endo -87.57 8.36 4.28 Favored 'Trans proline' 0 C--N 1.372 1.795 0 C-N-CA 122.914 2.409 . . . . 0.0 112.103 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.4 t -90.53 -45.85 8.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.178 -1.374 . . . . 0.0 112.228 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -100.01 155.27 17.79 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.525 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.8 45.52 1.26 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.715 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -89.92 16.03 8.9 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.441 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 173.94 54.86 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.967 0.907 . . . . 0.0 110.518 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -133.14 163.58 28.96 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.303 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -100.69 140.73 34.55 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.242 0.544 . . . . 0.0 112.258 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 1.6 mp -111.75 137.49 49.59 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.185 -1.371 . . . . 0.0 109.807 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.511 HD12 ' O ' ' A' ' 150' ' ' LEU . 2.9 mp -119.98 136.2 57.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.81 127.21 32.32 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.117 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 33.1 mtt -110.79 157.88 37.26 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.196 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.12 29.36 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.577 2.184 . . . . 0.0 113.127 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -85.81 -17.62 35.2 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -167.76 1.26 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.088 0.242 . . . . 0.0 110.598 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.42 40.9 1.39 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.036 0.446 . . . . 0.0 111.732 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -111.92 80.69 3.18 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.844 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.5 Cg_exo -75.55 -23.06 13.27 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.036 2.491 . . . . 0.0 113.28 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -84.53 -34.96 23.18 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.916 0.487 . . . . 0.0 111.708 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.63 3.82 53.09 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.077 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.12 163.18 20.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.767 0.318 . . . . 0.0 111.807 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 49.69 32.32 5.05 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.9 p -118.22 154.82 31.59 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 122.395 -0.191 . . . . 0.0 110.508 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.685 HG11 ' HE ' ' A' ' 167' ' ' ARG . 68.7 t -128.54 134.7 64.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-O 121.416 0.627 . . . . 0.0 110.789 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.8 m -116.11 151.95 34.61 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.658 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.472 ' OH ' HD21 ' A' ' 105' ' ' LEU . 12.8 t80 -105.32 118.88 37.69 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.608 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -82.72 107.84 15.65 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.365 0.602 . . . . 0.0 110.065 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.951 HG23 ' HA2' ' A' ' 42' ' ' GLY . 23.5 t -71.87 -59.6 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.76 -178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -137.25 119.23 15.33 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.51 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -103.94 126.2 50.89 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -139.94 153.2 46.86 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.577 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.23 -18.34 65.23 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.522 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -98.31 -3.55 36.94 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.391 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.0 171.48 21.75 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 121.564 -0.35 . . . . 0.0 112.29 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -146.67 144.43 29.47 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.42 137.2 54.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.747 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.951 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.82 158.44 29.69 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 114.657 -1.156 . . . . 0.0 112.858 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.4 mt -115.6 134.67 54.82 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.952 0.376 . . . . 0.0 111.287 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 78' ' ' GLY . 6.1 t -68.75 121.73 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.27 54.71 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.586 0.707 . . . . 0.0 112.221 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.846 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 21.9 t-20 -148.7 -1.55 0.51 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.104 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -129.75 85.51 57.97 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.535 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.2 Cg_exo -60.55 144.79 99.56 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 121.74 1.627 . . . . 0.0 112.582 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.432 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.6 m -94.41 153.77 17.79 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.075 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.82 51.9 1.97 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.851 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mt -134.07 160.27 38.27 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.903 0.413 . . . . 0.0 110.28 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.3 p-10 -112.1 157.37 20.89 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.63 HD23 ' SG ' ' A' ' 70' ' ' CYS . 12.4 tp -58.02 -36.13 72.26 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.04 -39.27 66.06 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -63.48 -41.08 98.58 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.678 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.857 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.8 t -61.53 -50.29 80.94 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.669 ' HA ' HD12 ' A' ' 60' ' ' LEU . 5.0 mp -52.44 -36.39 54.38 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 123.975 0.797 . . . . 0.0 110.995 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.13 -28.53 48.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.489 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.521 HE21 HD23 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -78.44 -31.8 48.2 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.457 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.857 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.1 mt -77.5 -45.04 26.77 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.0 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -132.11 116.88 15.69 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.412 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.5 -33.11 2.56 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 123.65 2.9 . . . . 0.0 112.807 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.16 -14.02 56.28 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.462 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.3 149.81 24.29 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.33 0.394 . . . . 0.0 111.737 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.77 123.43 29.7 Favored Pre-proline 0 C--O 1.235 0.333 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.038 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 58.0 Cg_endo -74.88 145.34 31.81 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.217 1.944 . . . . 0.0 112.462 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 4.8 Cg_endo -92.15 -169.34 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.612 2.208 . . . . 0.0 111.895 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.499 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -64.89 -24.89 67.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.12 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -66.63 -51.56 54.92 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.701 ' HA ' HD12 ' A' ' 73' ' ' ILE . 59.6 m -72.74 -25.05 61.06 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 47.0 mt-30 -68.16 -35.3 77.85 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.499 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 21.6 p80 -90.92 22.98 3.35 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.099 0.476 . . . . 0.0 111.718 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 70' ' ' CYS . 61.2 mt -119.84 139.02 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.464 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.426 ' O ' HD11 ' A' ' 128' ' ' ILE . 1.9 m-20 -104.65 156.71 17.74 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.854 0.721 . . . . 0.0 112.564 -178.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 53' ' ' LEU . 28.8 mm -102.84 155.38 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.432 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 2.8 t80 -124.84 155.83 38.81 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -88.37 122.69 32.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 119.691 -0.195 . . . . 0.0 110.512 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.554 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -101.87 -23.68 9.12 Favored Glycine 0 C--N 1.351 1.413 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.793 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.77 -167.31 35.25 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.086 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -87.11 -10.56 5.71 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 123.266 2.644 . . . . 0.0 113.84 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.653 ' O ' ' HA3' ' A' ' 131' ' ' GLY . 4.1 t -86.19 126.74 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.178 0.299 . . . . 0.0 110.383 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 43.78 87.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.292 1.037 . . . . 0.0 113.099 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.583 ' O ' HD22 ' A' ' 130' ' ' LEU . 76.9 p -86.04 -12.44 50.2 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.306 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -84.94 0.26 51.86 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -132.7 153.57 51.02 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -108.96 126.0 7.97 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.35 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.643 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 0.2 OUTLIER -85.77 145.74 27.1 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.86 1.264 . . . . 0.0 109.92 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 t -121.57 103.53 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.741 0.305 . . . . 0.0 110.824 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 126' ' ' SER . 2.2 tt -99.43 126.76 45.39 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.477 ' CE1' ' HB3' ' A' ' 106' ' ' ALA . 3.9 p80 -131.86 164.11 45.27 Favored Pre-proline 0 CA--C 1.554 1.105 0 CA-C-O 118.93 -0.557 . . . . 0.0 112.193 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.2 Cg_endo -96.9 9.84 1.31 Allowed 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 122.733 2.289 . . . . 0.0 113.945 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.48 ' OG ' HD23 ' A' ' 94' ' ' LEU . 8.7 t -94.35 158.98 15.32 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.976 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.12 19.06 56.03 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.789 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.48 HD23 ' OG ' ' A' ' 92' ' ' SER . 4.6 mm? -86.8 154.24 21.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.431 0.292 . . . . 0.0 110.77 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 p -123.02 155.36 37.0 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.552 ' CE2' HG23 ' A' ' 113' ' ' VAL . 62.2 m-85 -130.57 -152.79 0.53 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.344 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -58.6 -47.24 84.97 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.896 0.316 . . . . 0.0 111.446 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 56.2 m -134.3 85.19 2.17 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.488 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 107' ' ' MET . 8.1 m -130.78 128.75 41.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.922 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.41 124.38 50.3 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.427 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.63 128.19 34.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.237 0.541 . . . . 0.0 111.172 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.458 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -121.48 47.2 1.9 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.214 -179.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.88 -106.81 1.69 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-N 114.706 -1.134 . . . . 0.0 113.081 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.38 -9.93 4.18 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.472 HD21 ' OH ' ' A' ' 31' ' ' TYR . 3.5 pp -156.27 160.44 39.76 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.53 0.332 . . . . 0.0 111.252 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.477 ' HB3' ' CE1' ' A' ' 90' ' ' HIS . . . -123.38 162.59 22.47 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 123.625 0.578 . . . . 0.0 110.526 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.643 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 22.4 ttm -123.6 130.18 52.27 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.676 ' HB3' HG11 ' A' ' 113' ' ' VAL . 47.6 m -124.7 127.94 48.04 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 120.844 0.354 . . . . 0.0 110.21 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.4 p -117.21 20.15 13.84 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.466 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.82 ' O ' HG12 ' A' ' 113' ' ' VAL . 43.1 p -98.18 127.75 44.29 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 122.011 0.91 . . . . 0.0 112.03 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.495 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 2.3 mt-30 -61.59 -25.96 67.67 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.314 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -64.54 -42.41 95.73 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.104 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.82 HG12 ' O ' ' A' ' 110' ' ' SER . 5.2 p -69.02 -38.18 78.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.98 -47.67 80.23 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 123.732 0.645 . . . . 0.0 110.303 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.495 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 28.2 m-85 -69.61 -39.8 77.02 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.068 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.3 -51.37 69.18 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.146 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.44 -43.31 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.123 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.49 -30.89 65.46 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.792 0.682 . . . . 0.0 109.731 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.56 -19.73 30.66 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.16 176.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.15 17.77 26.32 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.682 -1.145 . . . . 0.0 114.558 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.5 p -109.49 9.93 25.32 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.88 -138.5 9.5 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-O 119.374 -0.681 . . . . 0.0 113.038 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.26 173.08 12.92 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.338 2.692 . . . . 0.0 113.793 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.491 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.9 OUTLIER -52.13 -56.64 13.19 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.258 1.023 . . . . 0.0 111.27 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -139.34 154.38 47.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.509 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.5 m -150.03 162.81 39.67 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.4 tp -129.93 115.79 17.7 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.872 178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 16.4 pt -95.67 102.5 13.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-O 121.807 0.813 . . . . 0.0 109.242 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 76' ' ' TYR . 59.7 p -125.07 130.65 52.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.263 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.583 HD22 ' O ' ' A' ' 83' ' ' THR . 16.2 mt -67.03 118.22 10.17 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.031 0.444 . . . . 0.0 111.372 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 81' ' ' VAL . . . 55.93 -172.86 1.53 Allowed Glycine 0 C--N 1.343 0.934 0 CA-C-N 114.232 -1.349 . . . . 0.0 115.012 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -128.53 -176.0 3.69 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.641 0.734 . . . . 0.0 111.358 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -119.39 130.38 55.28 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 113.866 -1.516 . . . . 0.0 108.367 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.37 152.3 19.12 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.667 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -129.88 136.92 50.08 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 124.011 0.477 . . . . 0.0 110.169 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.15 158.44 27.72 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.93 0.769 . . . . 0.0 110.631 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.47 89.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.96 -22.28 9.18 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.356 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -56.99 -47.44 80.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.985 0.514 . . . . 0.0 112.162 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.583 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.6 tp -66.89 -47.89 70.44 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.18 -29.95 64.1 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.43 0.456 . . . . 0.0 110.895 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.92 -49.32 47.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.042 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.6 pt-20 -72.45 -26.71 61.93 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.681 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 4.6 tp -75.43 -38.44 59.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.822 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.2 t -78.23 -30.44 48.78 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.286 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.5 t70 -80.3 0.92 30.8 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.604 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 60.79 28.33 18.08 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.981 0.912 . . . . 0.0 111.813 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.81 -42.53 19.56 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.639 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -123.55 111.14 15.91 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.938 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 15' ' ' ILE . 6.0 tp -85.31 130.82 34.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.67 0.272 . . . . 0.0 111.484 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.2 p -104.64 141.98 35.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.862 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.9 m -154.91 157.11 31.91 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.913 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.83 146.77 96.97 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.242 1.962 . . . . 0.0 111.188 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -131.66 175.86 8.82 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -133.18 139.93 35.78 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 113.966 -1.47 . . . . 0.0 108.278 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.73 -26.62 11.31 Favored 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 122.771 2.314 . . . . 0.0 114.015 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -49.98 -43.13 50.18 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.809 0.693 . . . . 0.0 112.355 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.692 HD13 HH12 ' A' ' 167' ' ' ARG . 4.7 mt -67.71 -32.88 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 121.504 0.669 . . . . 0.0 110.318 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.1 tt -75.29 -41.23 57.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.673 -177.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.68 -24.39 25.25 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -90.18 -72.02 0.59 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.313 0.506 . . . . 0.0 110.944 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.878 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.09 98.58 6.15 Favored Pre-proline 0 C--N 1.348 0.538 0 CA-C-O 121.078 0.466 . . . . 0.0 112.171 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.846 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 64.8 Cg_endo -91.39 -0.17 4.66 Favored 'Trans proline' 0 CA--C 1.57 2.321 0 C-N-CA 121.691 1.594 . . . . 0.0 114.266 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.659 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 83.6 Cg_endo -74.14 -54.14 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.627 2.218 . . . . 0.0 114.554 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.553 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -121.74 -29.39 4.35 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.783 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.878 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.07 -12.24 61.46 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.321 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.692 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.1 -44.12 40.21 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -68.97 -50.37 49.67 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -57.61 -50.55 72.76 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.773 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 174' ' ' ARG . . . -61.68 -40.39 94.8 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.154 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.11 -46.38 82.66 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.625 0.578 . . . . 0.0 110.489 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.53 87.72 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.477 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.55 69.71 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.31 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 170' ' ' ALA . 7.9 mtm105 -77.16 -41.09 43.1 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.196 0.598 . . . . 0.0 110.893 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.7 tp -71.28 -29.86 65.57 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.542 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.39 54.76 1.06 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.797 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 12.4 t -123.69 149.27 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -82.18 77.33 8.99 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.752 0.787 . . . . 0.0 110.755 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -26.21 49.93 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.791 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.5 m -56.46 -38.7 72.02 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.16 -26.52 53.11 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 11.3 mt -76.57 -35.19 58.33 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.332 0.395 . . . . 0.0 111.435 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 13.9 p -85.86 -46.16 10.88 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.507 0.505 . . . . 0.0 111.647 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.65 120.17 24.77 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.137 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -93.3 145.75 24.22 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.073 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.444 ' HB1' ' OXT' ' A' ' 189' ' ' ALA . . . -98.94 149.89 22.5 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.266 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -130.26 -54.69 0.1 OUTLIER Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.642 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -99.05 -41.07 7.72 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.342 0.257 . . . . 0.0 111.429 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.444 ' OXT' ' HB1' ' A' ' 186' ' ' ALA . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.209 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.298 0.094 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.5 mttt 62.58 125.54 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.957 0.903 . . . . 0.0 112.355 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -98.3 -41.52 7.82 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.943 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.565 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 18.7 t -99.78 161.17 13.78 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.516 0.51 . . . . 0.0 110.539 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.1 t -97.37 96.38 3.03 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.6 Cg_endo -87.93 8.52 4.13 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.852 2.368 . . . . 0.0 112.37 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 t -89.93 -47.87 7.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.308 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -126.62 154.95 43.28 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.585 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.7 mt -99.34 49.21 0.94 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.824 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -90.8 19.5 5.46 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 120.772 0.32 . . . . 0.0 111.349 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 15.8 p80 174.51 57.16 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.025 0.93 . . . . 0.0 110.174 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -135.13 159.57 41.11 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.859 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.479 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.8 m-30 -96.96 138.0 35.17 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.147 0.499 . . . . 0.0 112.29 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.681 HD11 HD23 ' A' ' 32' ' ' LEU . 1.7 mp -111.97 133.36 54.2 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.198 177.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.45 HG23 HG22 ' A' ' 29' ' ' VAL . 2.6 mp -119.02 133.12 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.56 122.8 19.77 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.036 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.9 mmt -103.83 160.46 26.01 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.262 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.31 20.6 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.713 2.276 . . . . 0.0 113.659 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -81.24 -14.94 56.93 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.581 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -113.53 160.8 18.12 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 122.606 0.363 . . . . 0.0 110.238 179.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.45 52.84 2.54 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.419 0.628 . . . . 0.0 112.084 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.581 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.2 m-20 -128.12 87.47 55.39 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.528 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.03 -13.92 21.21 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.924 2.416 . . . . 0.0 113.558 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -85.08 -38.27 19.32 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.388 0.43 . . . . 0.0 111.534 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -98.26 -1.36 42.07 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.606 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -63.65 2.52 0.44 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -139.57 42.3 2.02 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.276 0.56 . . . . 0.0 112.071 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.4 p -125.39 154.06 42.48 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.588 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.72 HG11 ' HE ' ' A' ' 167' ' ' ARG . 25.2 t -130.56 133.65 63.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.742 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -115.85 152.43 33.38 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.585 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.5 ' OH ' HD21 ' A' ' 105' ' ' LEU . 41.8 t80 -106.58 120.79 42.87 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.681 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -84.24 108.98 17.42 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.079 0.466 . . . . 0.0 111.043 -178.356 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.945 HG23 ' HA2' ' A' ' 42' ' ' GLY . 35.3 t -66.8 -60.18 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.732 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -144.66 115.54 7.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.304 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -97.78 128.22 44.27 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.45 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -139.58 153.3 47.36 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.69 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.55 -18.62 65.46 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.601 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.66 4.4 43.21 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.392 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.17 165.37 12.81 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.229 -0.349 . . . . 0.0 112.229 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.61 139.4 29.63 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.527 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -121.1 136.98 54.87 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.959 178.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.945 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.05 157.52 28.57 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 124.372 1.045 . . . . 0.0 112.465 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.2 mt -112.26 134.9 53.53 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.206 0.503 . . . . 0.0 110.957 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 78' ' ' GLY . 11.9 t -69.83 123.41 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.72 56.28 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.666 0.746 . . . . 0.0 112.117 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.85 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.0 t-20 -147.41 -2.45 0.59 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.115 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -130.27 88.52 47.57 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.498 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 47.5 Cg_exo -58.29 141.87 97.1 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 121.533 1.489 . . . . 0.0 111.86 174.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.412 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 8.9 t -77.79 -39.51 43.71 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.62 -8.7 74.28 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.873 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 5.7 mt -81.43 170.27 16.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.706 0.402 . . . . 0.0 110.161 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.646 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.9 p-10 -112.79 156.28 23.14 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.783 HD12 HD13 ' A' ' 128' ' ' ILE . 1.6 tt -57.69 -26.69 62.08 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 123.478 0.486 . . . . 0.0 111.992 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.08 99.06 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.959 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.521 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 34.1 mt-10 -63.01 -46.79 85.96 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.139 0.275 . . . . 0.0 111.586 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.872 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 20.5 m -62.0 -44.06 98.43 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.715 ' HA ' HD12 ' A' ' 60' ' ' LEU . 13.6 mt -56.66 -34.89 67.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.639 176.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.01 -27.64 48.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.327 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.402 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.93 -30.9 50.71 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.308 179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.872 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.0 mt -77.83 -45.47 24.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.243 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -131.32 116.23 16.42 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.643 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -77.76 -32.73 2.57 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.637 2.891 . . . . 0.0 112.791 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.95 -14.52 55.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.374 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.98 149.5 24.73 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.382 0.426 . . . . 0.0 111.667 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.74 122.91 30.19 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.239 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.5 149.55 34.89 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.277 1.985 . . . . 0.0 112.374 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 8.2 Cg_endo -94.59 -167.53 0.14 Allowed 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.631 2.22 . . . . 0.0 112.56 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.94 -24.57 64.29 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.288 0.635 . . . . 0.0 112.095 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.443 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 11.6 ptp180 -67.9 -48.21 66.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.711 ' HA ' HD12 ' A' ' 73' ' ' ILE . 24.5 m -72.58 -26.13 61.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.169 0.587 . . . . 0.0 112.338 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.449 ' HA ' HD22 ' A' ' 52' ' ' ASN . 43.4 mt-30 -70.86 -27.54 63.91 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.674 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -95.39 16.72 16.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.61 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 70' ' ' CYS . 53.9 mt -120.07 139.41 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.666 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 1.8 m-20 -104.92 155.64 18.76 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.804 HD13 HD12 ' A' ' 128' ' ' ILE . 22.9 mm -107.17 150.45 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.206 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.734 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -119.2 157.08 28.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.588 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -87.98 122.2 31.3 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.0 -23.6 9.09 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 120.263 -0.97 . . . . 0.0 114.257 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.91 -167.81 34.87 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.289 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -88.75 -11.67 3.86 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.635 2.89 . . . . 0.0 114.421 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.09 131.85 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.569 0.223 . . . . 0.0 111.375 -178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 45.18 89.41 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.632 1.173 . . . . 0.0 113.503 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -87.02 1.04 54.15 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.378 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -92.7 -18.31 23.14 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.629 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -133.17 147.44 52.06 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.373 0.421 . . . . 0.0 111.441 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.601 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -113.34 151.01 18.44 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.149 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.404 ' CE2' ' SD ' ' A' ' 107' ' ' MET . 1.2 m-85 -86.66 151.33 23.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.951 -1.124 . . . . 0.0 110.829 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 3.6 t -127.76 107.99 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.087 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.898 HD11 HD13 ' A' ' 105' ' ' LEU . 13.8 tp -104.93 127.74 52.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.619 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.405 ' ND1' ' HB3' ' A' ' 123' ' ' PRO . 3.4 p80 -124.37 162.18 43.59 Favored Pre-proline 0 CA--C 1.552 1.022 0 O-C-N 123.653 0.596 . . . . 0.0 111.59 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 18.0 Cg_endo -97.42 28.89 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.802 2.334 . . . . 0.0 113.579 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.0 t -115.69 156.73 25.39 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.63 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.74 23.18 35.31 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.817 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.01 153.17 21.49 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.472 0.309 . . . . 0.0 110.523 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.7 p -121.55 153.25 38.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.664 ' CD2' HG12 ' A' ' 113' ' ' VAL . 28.5 m-85 -132.89 -151.13 0.44 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.834 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -61.02 -48.69 80.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.791 0.436 . . . . 0.0 111.267 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 108' ' ' SER . 38.3 m -134.01 79.05 1.79 Allowed 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.243 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 107' ' ' MET . 9.3 m -126.72 115.95 20.2 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.956 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.49 122.18 42.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.859 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.97 128.45 34.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.095 0.474 . . . . 0.0 111.15 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.449 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -123.63 46.76 2.15 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.482 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.93 -107.6 2.02 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 114.819 -1.082 . . . . 0.0 113.25 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.88 -10.28 3.83 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.898 HD13 HD11 ' A' ' 89' ' ' LEU . 1.8 pp -155.06 153.15 30.46 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.335 0.397 . . . . 0.0 111.167 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.558 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -117.17 158.05 24.92 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.884 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.594 ' O ' ' HA ' ' A' ' 99' ' ' THR . 16.0 ttm -122.52 135.17 54.58 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 98' ' ' SER . 15.9 m -136.18 134.35 38.11 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 81.1 p -125.42 21.36 7.89 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.64 0.587 . . . . 0.0 111.836 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.877 ' O ' HG22 ' A' ' 113' ' ' VAL . 51.6 m -91.12 131.63 36.56 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.944 0.878 . . . . 0.0 112.885 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.614 ' HA ' HD12 ' A' ' 114' ' ' LEU . 5.2 mt-30 -61.91 -26.16 68.0 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.419 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.39 -45.45 90.99 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.493 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 110' ' ' SER . 18.6 m -62.28 -43.46 98.04 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.614 HD12 ' HA ' ' A' ' 111' ' ' GLN . 29.3 mt -54.82 -51.48 65.7 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.864 0.727 . . . . 0.0 112.177 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.471 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 43.2 m-85 -65.63 -45.64 82.28 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 120.772 0.32 . . . . 0.0 111.475 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.4 -52.7 64.49 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.865 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.841 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.4 tp -64.22 -43.91 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.45 -31.18 65.67 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.793 0.683 . . . . 0.0 109.683 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.443 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -85.3 -20.43 30.03 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.156 176.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.26 18.01 22.96 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.731 -1.122 . . . . 0.0 114.581 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.2 p -109.42 7.83 25.11 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.25 -137.51 9.37 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.583 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.405 ' HB3' ' ND1' ' A' ' 90' ' ' HIS . 5.9 Cg_exo -79.82 168.11 19.63 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 123.251 2.634 . . . . 0.0 113.519 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.484 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -50.94 -57.79 7.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.31 1.044 . . . . 0.0 111.789 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.486 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.7 mmtt -138.48 157.27 46.52 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.619 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 40.8 m -149.99 162.89 39.48 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.9 tp -126.41 113.96 17.57 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.744 177.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.804 HD12 HD13 ' A' ' 75' ' ' ILE . 10.1 pt -98.81 104.59 16.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-O 121.492 0.663 . . . . 0.0 109.507 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.3 t -125.0 124.88 42.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.508 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.608 ' O ' HD12 ' A' ' 130' ' ' LEU . 2.1 pp -67.12 117.2 8.82 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.095 0.474 . . . . 0.0 111.738 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.99 174.69 4.4 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.259 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -128.47 -179.87 5.28 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.334 0.588 . . . . 0.0 111.027 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -116.31 130.63 56.87 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.227 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.55 153.01 19.75 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.488 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -134.17 137.87 44.76 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.84 0.377 . . . . 0.0 110.666 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -78.1 158.36 29.16 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.904 0.753 . . . . 0.0 110.822 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.79 92.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.28 7.72 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.134 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -56.01 -47.38 77.89 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.082 0.553 . . . . 0.0 112.125 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.58 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 16.3 tp -67.51 -46.45 72.85 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.31 -30.54 64.85 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 123.443 0.465 . . . . 0.0 110.693 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -71.06 -49.33 45.91 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.013 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -72.1 -26.76 62.26 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.749 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.1 tp -75.3 -38.73 60.16 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.84 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.6 m -78.03 -29.91 49.65 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.355 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.17 0.17 33.48 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.533 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 61.29 29.37 18.6 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.89 0.876 . . . . 0.0 111.712 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.94 -41.91 16.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.516 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.404 ' HE1' ' CE ' ' A' ' 20' ' ' MET . 13.2 m95 -122.9 109.62 14.38 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 123.328 0.393 . . . . 0.0 110.113 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.01 128.46 34.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.387 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.1 p -102.33 141.81 34.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.039 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 80.2 m -155.37 158.6 31.97 Favored Pre-proline 0 N--CA 1.471 0.593 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.315 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -57.44 153.93 38.45 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.215 1.943 . . . . 0.0 111.429 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.479 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.33 169.2 14.51 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -177.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -134.93 135.06 22.39 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 114.264 -1.334 . . . . 0.0 107.934 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.77 -26.59 13.37 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.64 2.226 . . . . 0.0 113.907 -177.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -51.95 -40.64 61.16 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.874 0.734 . . . . 0.0 112.284 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.573 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.6 mt -71.42 -34.49 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 121.378 0.609 . . . . 0.0 110.328 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -74.22 -38.47 63.54 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.253 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -84.25 -33.86 23.97 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -85.63 -72.67 0.48 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.026 0.375 . . . . 0.0 111.69 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.892 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.35 99.22 6.48 Favored Pre-proline 0 C--N 1.348 0.54 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.85 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.3 Cg_endo -92.02 -0.03 4.26 Favored 'Trans proline' 0 CA--C 1.57 2.301 0 C-N-CA 121.677 1.585 . . . . 0.0 114.26 175.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.644 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 88.0 Cg_endo -73.85 -52.55 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 122.63 2.22 . . . . 0.0 114.388 -178.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.518 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.61 -30.37 3.91 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.694 -178.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.892 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -69.73 -11.14 60.62 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.303 178.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.72 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.54 -42.95 41.22 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.255 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -69.18 -50.68 45.37 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.2 m -57.76 -50.7 72.35 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.734 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.646 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -62.85 -38.57 91.36 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.07 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.27 -45.43 80.11 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.664 0.602 . . . . 0.0 110.441 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.45 91.04 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.552 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 177' ' ' VAL . . . -64.36 -29.12 70.2 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.667 177.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.99 -40.19 39.95 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 122.865 0.466 . . . . 0.0 110.423 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -67.14 -34.02 76.67 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.485 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 130.37 40.71 0.25 Allowed Glycine 0 C--N 1.34 0.771 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.272 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 173' ' ' ALA . 5.0 t -129.45 133.42 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -88.32 82.85 6.95 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.651 0.739 . . . . 0.0 111.218 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -77.95 -26.39 48.81 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.31 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 51.9 m -57.95 -45.52 86.51 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.47 -26.89 51.8 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 21.6 mt -77.28 -29.1 53.67 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.338 0.399 . . . . 0.0 111.687 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 24.1 p -91.12 -48.66 6.83 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.544 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -131.69 120.27 22.53 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.28 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -100.92 140.08 35.71 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.95 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -102.14 -42.4 6.08 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.456 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -148.69 -147.53 4.55 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 123.484 0.49 . . . . 0.0 112.448 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -99.95 132.7 45.15 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.633 0.255 . . . . 0.0 111.019 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.421 -0.8 . . . . 0.0 111.172 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.51 0.195 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.5 tttt -100.11 -43.2 6.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.113 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 71.05 -49.35 0.68 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.379 1.072 . . . . 0.0 112.362 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.56 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 16.6 t -99.5 147.32 25.43 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.253 0.346 . . . . 0.0 110.653 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.5 m -105.13 90.31 3.64 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.993 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.4 Cg_endo -87.59 8.25 4.32 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.982 2.454 . . . . 0.0 112.127 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.5 t -91.66 -48.0 7.07 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.171 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -122.61 151.55 41.34 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.645 0.59 . . . . 0.0 111.291 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.668 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 7.0 mp -92.63 -3.3 55.19 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.749 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -41.98 9.45 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.612 ' N ' ' O ' ' A' ' 9' ' ' LEU . 13.0 p-80 177.02 52.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.144 0.978 . . . . 0.0 110.513 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -141.82 166.08 25.7 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.759 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 30' ' ' THR . 14.2 m-30 -104.54 138.54 40.74 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 6.4 mt -107.19 143.38 35.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.405 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 mp -123.47 137.71 55.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.462 0.476 . . . . 0.0 110.128 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.47 123.48 26.61 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.837 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.3 mmt -106.32 157.09 35.75 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.202 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.6 30.58 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.678 2.252 . . . . 0.0 113.248 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -87.32 -15.56 37.65 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.93 -168.35 1.41 Allowed 'General case' 0 CA--C 1.54 0.584 0 O-C-N 123.075 0.234 . . . . 0.0 110.703 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.541 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.82 41.87 1.28 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.082 0.468 . . . . 0.0 111.628 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -111.32 81.05 2.78 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.916 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.3 Cg_exo -75.49 -22.24 14.18 Favored 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 123.017 2.478 . . . . 0.0 113.312 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -84.62 -36.3 22.11 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.875 0.47 . . . . 0.0 111.867 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.8 3.72 53.64 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.021 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.42 163.77 20.16 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 48.75 32.15 3.47 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.2 p -116.68 154.27 30.87 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 122.367 -0.208 . . . . 0.0 110.573 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.739 HG11 ' HE ' ' A' ' 167' ' ' ARG . 60.3 t -129.05 132.69 67.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-O 121.515 0.674 . . . . 0.0 110.857 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.2 m -114.48 154.39 28.28 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.691 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.461 ' OH ' HD11 ' A' ' 105' ' ' LEU . 13.2 t80 -110.22 115.7 30.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.668 ' HB3' ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -81.08 110.63 16.79 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-O 121.684 0.754 . . . . 0.0 110.566 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.975 HG23 ' HA2' ' A' ' 42' ' ' GLY . 32.2 t -71.18 -63.93 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 112.819 -1.991 . . . . 0.0 110.614 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.426 ' OE1' HD11 ' A' ' 100' ' ' LEU . 12.3 tt0 -132.51 117.63 18.24 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.96 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -106.92 127.91 53.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.733 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -138.9 153.45 48.27 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.22 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -64.82 -15.63 62.04 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -104.88 5.41 32.93 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.687 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.6 164.72 12.64 Favored Glycine 0 C--N 1.344 1.015 0 C-N-CA 121.486 -0.388 . . . . 0.0 112.35 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.645 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -144.73 146.46 32.19 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.482 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -125.97 137.58 53.69 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.954 178.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.975 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.72 159.95 30.66 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.83 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.436 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.4 mt -114.62 130.66 56.81 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.703 0.252 . . . . 0.0 110.837 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 78' ' ' GLY . 20.7 t -65.96 125.39 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.541 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -128.44 55.18 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.542 0.686 . . . . 0.0 112.408 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.842 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.8 t-20 -147.63 -3.61 0.53 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.265 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -129.78 87.84 51.05 Favored Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.51 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 35.3 Cg_exo -59.09 141.91 98.73 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 121.578 1.518 . . . . 0.0 112.277 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 59.9 m -88.64 161.96 16.59 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.364 0.415 . . . . 0.0 111.561 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -103.96 44.69 1.43 Allowed Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.37 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.463 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -134.97 150.95 50.44 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.1 p-10 -100.52 161.4 13.62 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.268 0.355 . . . . 0.0 110.939 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.678 ' HA ' HD11 ' A' ' 75' ' ' ILE . 12.3 tp -58.7 -37.58 76.4 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.16 -37.14 53.64 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.96 -43.68 95.05 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.206 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.859 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 1.3 t -62.8 -45.77 98.02 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.742 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.5 mp -54.55 -36.51 64.4 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.702 0.626 . . . . 0.0 110.618 177.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.9 -27.86 49.65 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.466 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.16 -30.14 49.04 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.283 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.859 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.9 mt -77.75 -45.12 25.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.945 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -132.26 116.24 15.32 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.524 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.62 -32.64 2.71 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.604 2.869 . . . . 0.0 112.769 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.3 -14.15 55.84 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.361 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.86 149.68 24.65 Favored 'General case' 0 C--N 1.345 0.389 0 O-C-N 123.323 0.389 . . . . 0.0 111.754 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.65 123.88 29.98 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.02 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 55.4 Cg_endo -73.82 144.68 35.25 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.226 1.951 . . . . 0.0 112.408 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.458 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.6 Cg_endo -92.52 -170.98 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.566 2.177 . . . . 0.0 111.974 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -63.37 -24.89 68.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.297 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -66.15 -54.17 28.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.701 ' HA ' HD12 ' A' ' 73' ' ' ILE . 61.3 m -71.58 -25.05 62.03 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 50.4 mt-30 -66.91 -36.02 81.32 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.5 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 19.9 p80 -91.55 23.18 3.6 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.147 0.498 . . . . 0.0 111.65 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 70' ' ' CYS . 56.8 mt -119.47 140.04 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.517 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.56 154.91 22.08 Favored 'General case' 0 N--CA 1.462 0.167 0 O-C-N 123.692 0.62 . . . . 0.0 112.498 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.763 HD13 HD12 ' A' ' 128' ' ' ILE . 24.4 mm -103.53 153.66 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.093 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.709 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -117.31 155.95 28.65 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.57 118.92 26.3 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.844 0.293 . . . . 0.0 110.698 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.575 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.08 -23.62 8.46 Favored Glycine 0 C--N 1.348 1.242 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.976 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.76 -167.9 35.4 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.293 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -88.35 -11.38 4.31 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 123.313 2.675 . . . . 0.0 114.263 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -85.61 126.91 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 123.12 0.263 . . . . 0.0 110.893 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 48.81 82.16 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.309 1.043 . . . . 0.0 112.91 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.473 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.1 t -84.75 1.55 46.14 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -99.13 -0.66 41.22 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.603 ' NH2' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -133.09 153.27 51.66 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.586 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.83 133.34 11.6 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.434 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.75 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.8 OUTLIER -85.75 150.87 24.27 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.321 1.048 . . . . 0.0 110.288 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.1 t -127.11 104.81 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 123.429 0.455 . . . . 0.0 111.039 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.9 HD11 HD13 ' A' ' 105' ' ' LEU . 15.2 tp -106.67 127.66 53.54 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.821 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -129.14 169.44 13.1 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.38 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.654 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.6 Cg_endo -97.13 18.06 0.55 Allowed 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.65 2.233 . . . . 0.0 113.52 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.4 t -105.85 159.73 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.951 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.2 20.62 49.31 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.501 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -84.21 154.44 23.04 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.645 0.378 . . . . 0.0 110.438 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.0 p -126.78 157.22 39.75 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.579 ' CE2' HG23 ' A' ' 113' ' ' VAL . 53.0 m-85 -129.51 -150.9 0.45 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.418 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -60.2 -46.84 88.36 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.418 0.287 . . . . 0.0 111.25 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.8 m -135.63 83.05 1.99 Allowed 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.338 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 107' ' ' MET . 7.8 m -129.34 124.39 34.17 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.868 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.426 HD11 ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.93 123.94 46.7 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.902 178.627 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -88.74 130.56 35.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.103 0.478 . . . . 0.0 110.748 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.14 48.67 2.18 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.314 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.47 -106.76 1.64 Allowed Glycine 0 C--N 1.334 0.433 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.279 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.06 -10.18 4.0 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.9 HD13 HD11 ' A' ' 89' ' ' LEU . 2.5 pp -155.44 155.19 33.09 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.206 0.317 . . . . 0.0 111.561 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.593 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -125.14 157.73 35.66 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.875 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.598 ' SD ' ' HB2' ' A' ' 89' ' ' LEU . 27.0 tpp -125.33 141.25 52.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.52 ' CB ' HG11 ' A' ' 113' ' ' VAL . 1.9 m -134.15 133.53 41.12 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 120.916 0.388 . . . . 0.0 110.275 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 65.0 p -118.3 16.41 13.95 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.985 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.742 ' O ' HG12 ' A' ' 113' ' ' VAL . 32.9 p -91.51 126.93 36.76 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 121.681 0.753 . . . . 0.0 111.686 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.519 ' HA ' ' NH2' ' A' ' 85' ' ' ARG . 20.3 pt20 -60.87 -26.91 67.73 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.602 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -66.11 -41.06 91.08 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.585 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.744 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.2 p -69.85 -39.74 78.09 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.603 HD22 ' NH2' ' A' ' 85' ' ' ARG . 0.6 OUTLIER -58.03 -47.64 82.48 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 123.672 0.608 . . . . 0.0 110.457 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.478 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 25.9 m-85 -69.72 -38.39 76.89 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.924 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.94 -52.1 65.42 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.0 tp -64.66 -42.99 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.173 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.38 -31.04 65.39 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.83 0.706 . . . . 0.0 109.627 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.35 -20.26 30.2 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.167 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.59 15.17 30.22 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 114.626 -1.17 . . . . 0.0 114.735 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.2 p -105.34 7.66 33.43 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.58 -137.52 9.47 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-O 119.093 -0.837 . . . . 0.0 112.598 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.41 171.56 14.67 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.167 2.578 . . . . 0.0 113.615 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.82 -55.64 31.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.776 0.83 . . . . 0.0 112.159 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.654 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.2 mmtt -140.72 139.82 34.77 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.728 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.8 m -140.26 168.35 20.01 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 tp -127.9 119.3 25.3 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.794 -1.093 . . . . 0.0 108.734 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.763 HD12 HD13 ' A' ' 75' ' ' ILE . 15.8 pt -98.26 102.0 12.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.852 0.834 . . . . 0.0 109.814 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.1 t -117.88 122.75 44.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.37 -1.287 . . . . 0.0 110.925 -178.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.473 HD21 ' O ' ' A' ' 83' ' ' THR . 6.1 tp -66.64 114.94 5.95 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.327 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.29 178.16 6.95 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 114.442 -1.254 . . . . 0.0 114.562 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.6 176.81 7.48 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.367 0.603 . . . . 0.0 110.8 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -117.39 130.11 56.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.927 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.44 149.73 18.73 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.601 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.4 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 20.1 m-90 -126.46 135.96 52.02 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 124.022 0.483 . . . . 0.0 110.235 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.39 158.09 27.46 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.844 0.715 . . . . 0.0 110.766 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.57 90.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.92 -25.06 6.9 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.997 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -56.07 -45.63 79.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.984 0.514 . . . . 0.0 112.058 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.556 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 10.5 tp -66.97 -48.28 69.0 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.22 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.47 -30.26 64.91 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 123.451 0.469 . . . . 0.0 110.861 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.4 -50.7 35.88 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.903 178.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.5 pt-20 -71.65 -26.61 62.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.026 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 6.1 tp -76.05 -38.48 57.07 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.898 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.0 m -77.98 -30.85 50.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -80.9 0.5 35.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.571 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.45 29.16 18.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.853 0.861 . . . . 0.0 111.735 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.82 -42.52 24.2 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.051 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -123.02 113.0 18.47 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.46 0.475 . . . . 0.0 109.752 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.3 tp -82.76 142.14 31.82 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.408 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 25.3 p -105.0 135.77 45.72 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.088 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 79.5 m -149.22 148.68 27.42 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.24 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.55 153.7 64.83 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.325 2.016 . . . . 0.0 110.772 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -134.75 174.58 10.42 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -135.02 138.89 30.48 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.322 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.58 -26.66 16.33 Favored 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 122.686 2.257 . . . . 0.0 113.561 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -50.84 -41.02 57.37 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.967 0.792 . . . . 0.0 112.451 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.725 HD13 HH12 ' A' ' 167' ' ' ARG . 4.3 mt -69.94 -34.38 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.569 0.7 . . . . 0.0 110.395 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.5 tt -75.71 -36.82 59.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.462 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -84.8 -32.15 23.51 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -88.83 -72.88 0.52 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.982 0.356 . . . . 0.0 111.714 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.67 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -141.27 99.26 6.52 Favored Pre-proline 0 C--N 1.349 0.584 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.842 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 73.1 Cg_endo -91.74 -0.43 4.44 Favored 'Trans proline' 0 CA--C 1.571 2.331 0 C-N-CA 121.831 1.687 . . . . 0.0 114.421 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.647 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 69.2 Cg_endo -75.09 -50.01 0.14 Allowed 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.73 2.287 . . . . 0.0 114.532 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.502 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.5 mt-10 -122.22 -34.02 3.39 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.792 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 8.6 mt-10 -69.01 -10.99 60.31 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.219 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.739 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.03 -41.55 42.12 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -70.85 -49.58 44.56 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.9 t -58.29 -48.03 81.78 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.644 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.63 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.57 -40.37 92.7 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.578 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.62 82.77 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.409 0.443 . . . . 0.0 110.582 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.91 -37.29 85.7 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.795 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.45 -30.56 71.67 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.497 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.63 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 3.4 mmp_? -77.67 -40.33 41.93 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.802 0.441 . . . . 0.0 110.372 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.36 -33.94 76.85 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.526 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 119.06 45.4 0.45 Allowed Glycine 0 C--N 1.34 0.759 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.133 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 10.5 t -130.16 147.05 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -91.47 77.53 5.75 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.651 0.738 . . . . 0.0 110.45 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.79 -26.09 49.46 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.069 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 51.1 m -58.29 -43.69 88.15 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.38 -27.03 52.42 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.2 mt -77.23 -30.58 54.65 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.712 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.7 p -89.97 -47.57 7.77 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.373 0.421 . . . . 0.0 111.474 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -129.53 118.73 22.52 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.132 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -101.85 150.47 23.14 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.846 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -97.16 -42.13 7.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.55 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -107.25 122.34 6.84 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 123.431 0.457 . . . . 0.0 112.479 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -100.44 141.98 32.55 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.616 0.245 . . . . 0.0 110.845 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.449 -0.786 . . . . 0.0 111.143 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.568 0.223 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.57 122.99 44.17 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.847 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -132.69 -53.92 0.94 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.98 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -142.59 -50.2 0.36 Allowed 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.346 0.404 . . . . 0.0 111.145 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.6 t -136.44 97.69 11.58 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.889 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.72 7.1 5.24 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.741 2.294 . . . . 0.0 112.296 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 m -115.23 -55.6 2.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.315 -1.312 . . . . 0.0 110.565 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -99.82 157.58 16.41 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 123.53 0.519 . . . . 0.0 111.46 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.55 HD12 ' CE1' ' A' ' 35' ' ' HIS . 11.2 mt -94.3 46.97 1.17 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.081 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -92.68 23.01 4.31 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.964 0.412 . . . . 0.0 110.841 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 177.08 51.99 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.775 0.83 . . . . 0.0 110.0 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -136.87 160.22 39.52 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.455 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.1 m-30 -98.17 137.46 36.9 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.267 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.821 HD11 HD23 ' A' ' 32' ' ' LEU . 3.6 mt -108.63 137.03 47.25 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.033 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.434 HD13 HG13 ' A' ' 29' ' ' VAL . 2.4 mm -117.38 133.79 63.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 123.519 0.512 . . . . 0.0 109.713 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.09 123.03 23.63 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.598 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.9 mmt -114.46 155.12 46.32 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 123.463 0.477 . . . . 0.0 111.341 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -80.68 79.28 3.36 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.652 2.235 . . . . 0.0 112.935 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -136.38 -20.65 1.39 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.994 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -163.29 0.87 Allowed 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.182 0.301 . . . . 0.0 110.431 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.61 35.84 2.48 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.01 0.433 . . . . 0.0 111.9 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.32 82.87 3.69 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.36 -24.6 12.11 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.006 2.471 . . . . 0.0 113.316 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -85.2 -37.38 20.19 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.469 0.481 . . . . 0.0 111.619 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.58 -0.53 57.6 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.794 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -63.5 2.81 0.38 Allowed 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -141.22 40.12 1.76 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.172 0.51 . . . . 0.0 112.237 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 p -123.28 158.04 31.83 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.562 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.857 HG11 ' HE ' ' A' ' 167' ' ' ARG . 60.6 t -131.32 132.88 62.79 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.005 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -114.9 152.01 33.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.266 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.45 ' OH ' HD21 ' A' ' 105' ' ' LEU . 36.0 t80 -105.95 120.48 41.87 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.821 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -84.76 108.32 17.39 Favored 'General case' 0 C--O 1.247 0.97 0 CA-C-O 121.447 0.642 . . . . 0.0 111.304 -178.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.934 HG23 ' HA2' ' A' ' 42' ' ' GLY . 24.0 t -67.42 -59.92 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.786 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -144.68 112.64 6.35 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.31 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.55 ' CE1' HD12 ' A' ' 9' ' ' LEU . 15.6 t-80 -95.84 128.74 42.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.606 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -139.85 153.37 47.03 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.624 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.53 -18.39 65.28 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.725 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.33 2.22 42.3 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.418 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.88 167.2 15.21 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.455 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -144.82 136.43 25.49 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.97 134.37 55.24 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.399 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.934 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.9 155.01 26.05 Favored Glycine 0 N--CA 1.45 -0.425 0 O-C-N 124.195 0.935 . . . . 0.0 112.5 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.423 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.4 mt -110.95 133.32 53.48 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.022 0.411 . . . . 0.0 111.194 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 78' ' ' GLY . 20.5 t -69.34 124.61 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -128.24 56.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.47 0.653 . . . . 0.0 112.276 -177.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.86 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.7 t-20 -147.9 -3.5 0.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.491 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.73 87.75 51.48 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.512 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -59.63 142.51 98.93 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 121.695 1.596 . . . . 0.0 112.177 175.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.444 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 50.2 m -92.73 158.67 15.79 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.504 0.502 . . . . 0.0 111.572 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.44 50.15 1.29 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.67 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mt -133.34 159.14 41.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.226 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.622 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 7.4 p-10 -112.48 157.71 20.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.621 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.812 HD12 HD13 ' A' ' 128' ' ' ILE . 1.9 tt -58.5 -26.95 64.01 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.956 0.408 . . . . 0.0 111.765 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.622 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -65.12 -39.97 93.82 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.645 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.71 -46.66 84.45 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.289 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.867 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 19.2 m -62.12 -43.81 98.25 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.722 ' HA ' HD12 ' A' ' 60' ' ' LEU . 15.8 mt -56.13 -35.13 66.77 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.487 176.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.05 -27.75 48.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.425 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.417 HE22 ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -77.89 -30.57 50.79 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.339 179.765 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.867 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.94 -45.58 23.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.146 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -131.12 116.31 16.68 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.58 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.63 -32.97 2.54 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 123.677 2.918 . . . . 0.0 112.732 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.86 -14.62 56.0 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.334 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.36 149.94 24.16 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.445 0.466 . . . . 0.0 111.722 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.3 122.42 29.46 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.184 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.87 153.92 38.12 Favored 'Trans proline' 0 C--N 1.368 1.591 0 C-N-CA 122.25 1.966 . . . . 0.0 112.299 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -95.07 -166.0 0.12 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.67 2.247 . . . . 0.0 112.387 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.26 -24.58 62.2 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.311 0.644 . . . . 0.0 111.921 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.437 ' O ' HG13 ' A' ' 73' ' ' ILE . 10.5 ptp180 -67.39 -47.7 69.56 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.703 ' HA ' HD12 ' A' ' 73' ' ' ILE . 29.4 m -71.59 -26.02 62.43 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.451 ' HA ' HD22 ' A' ' 52' ' ' ASN . 40.8 mt-30 -72.83 -26.89 61.65 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.402 0.62 . . . . 0.0 111.511 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -92.87 15.84 13.88 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.257 -1.338 . . . . 0.0 111.057 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.703 HD12 ' HA ' ' A' ' 70' ' ' CYS . 44.6 mt -122.08 139.55 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.685 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.01 153.55 22.94 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.733 HD13 HD12 ' A' ' 128' ' ' ILE . 25.0 mm -99.78 153.07 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.88 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.703 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.4 t80 -119.98 155.67 32.38 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.16 120.36 27.45 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 117.733 0.242 . . . . 0.0 110.572 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.536 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.16 -23.74 8.91 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.949 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.24 -168.48 34.65 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.291 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -88.73 -11.52 3.93 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 123.546 2.831 . . . . 0.0 114.366 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.56 131.29 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.709 0.29 . . . . 0.0 111.418 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 48.2 86.25 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.532 1.133 . . . . 0.0 113.232 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.9 p -81.74 -18.87 42.77 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.151 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.417 ' HA ' HE22 ' A' ' 59' ' ' GLN . 3.4 p-10 -76.92 -18.1 58.5 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.601 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -132.97 147.83 52.28 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.0 0.428 . . . . 0.0 111.558 179.526 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.595 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -112.41 141.33 16.73 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.776 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.23 134.44 33.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.65 -1.275 . . . . 0.0 109.493 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 4.8 t -116.31 128.52 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 123.067 0.23 . . . . 0.0 111.376 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.878 HD11 HD13 ' A' ' 105' ' ' LEU . 13.4 tp -114.23 127.64 55.98 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.608 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.408 ' ND1' ' HB3' ' A' ' 123' ' ' PRO . 4.9 p80 -122.01 162.84 35.08 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.18 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -97.52 31.15 0.14 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.588 2.192 . . . . 0.0 113.403 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.5 t -118.33 156.74 28.37 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.651 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.49 22.13 42.48 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.71 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tp -87.71 153.5 21.31 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.526 0.33 . . . . 0.0 110.479 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.8 p -122.84 153.17 39.94 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.636 ' CD2' HG12 ' A' ' 113' ' ' VAL . 25.6 m-85 -132.99 -149.05 0.36 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.862 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -60.33 -48.91 79.71 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 122.834 0.453 . . . . 0.0 111.395 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 108' ' ' SER . 57.9 m -135.38 80.29 1.83 Allowed 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.434 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 107' ' ' MET . 7.9 m -126.6 116.85 21.67 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.867 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.96 122.16 40.75 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.098 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.35 130.36 34.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.128 0.489 . . . . 0.0 111.135 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.42 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -127.4 48.64 2.2 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.354 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.42 -109.82 3.12 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.169 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.44 -8.9 4.58 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.878 HD13 HD11 ' A' ' 89' ' ' LEU . 2.2 pp -153.34 150.23 28.67 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.285 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.495 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -120.81 160.61 23.04 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.812 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.573 ' O ' ' HA ' ' A' ' 99' ' ' THR . 17.1 tpp -126.46 142.22 51.61 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 98' ' ' SER . 54.3 m -137.32 136.62 38.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 120.73 0.3 . . . . 0.0 110.478 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.7 p -123.03 18.72 10.05 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.383 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.829 ' O ' HG22 ' A' ' 113' ' ' VAL . 14.5 t -92.31 130.11 38.08 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 122.044 0.926 . . . . 0.0 112.564 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.645 ' HA ' HD12 ' A' ' 114' ' ' LEU . 4.8 mt-30 -61.48 -26.27 67.79 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.725 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -62.54 -47.14 85.2 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.527 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.849 ' O ' HG22 ' A' ' 117' ' ' ILE . 21.0 m -62.2 -43.12 97.52 Favored 'Isoleucine or valine' 0 C--N 1.36 1.043 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 177.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 111' ' ' GLN . 22.0 mt -54.57 -50.58 67.63 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.718 0.636 . . . . 0.0 111.984 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.464 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 37.2 m-85 -65.6 -47.2 76.49 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.771 0.319 . . . . 0.0 111.23 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.08 -52.99 63.23 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.138 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.849 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.02 -43.3 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.75 -30.48 65.63 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 123.618 0.574 . . . . 0.0 109.662 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.401 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -86.21 -19.64 29.72 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.174 176.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.75 17.19 26.57 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 114.652 -1.158 . . . . 0.0 114.904 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.7 p -107.88 8.14 28.45 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -98.17 -136.51 9.26 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-O 119.195 -0.78 . . . . 0.0 112.527 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.408 ' HB3' ' ND1' ' A' ' 90' ' ' HIS . 3.2 Cg_exo -77.78 169.9 19.94 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.333 2.688 . . . . 0.0 113.161 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -51.5 -58.36 6.51 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.695 0.798 . . . . 0.0 110.863 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -133.66 168.41 18.73 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.452 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.4 ' HB2' ' CG1' ' A' ' 88' ' ' VAL . 31.6 p -152.52 156.9 40.28 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 4.8 tp -125.68 106.09 9.47 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.812 HD13 HD12 ' A' ' 53' ' ' LEU . 15.7 pt -92.82 102.62 13.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.812 0.815 . . . . 0.0 110.044 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.0 t -122.45 122.64 39.43 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.255 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.12 117.07 8.65 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.198 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.44 ' H ' ' HA2' ' A' ' 86' ' ' GLY . . . 66.38 172.94 4.95 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.366 -0.833 . . . . 0.0 114.307 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -128.11 -179.06 4.79 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.231 0.538 . . . . 0.0 110.824 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -116.81 128.98 55.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.246 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.25 148.83 18.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.379 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.455 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 22.3 m-90 -127.14 137.86 53.05 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.803 0.354 . . . . 0.0 110.435 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.85 158.02 26.86 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.818 0.699 . . . . 0.0 110.66 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.14 92.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 119.32 -24.72 8.05 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.401 -0.818 . . . . 0.0 113.177 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -57.57 -44.38 85.27 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.87 0.468 . . . . 0.0 112.15 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.9 tm? -68.07 -47.64 67.73 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.502 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.21 -30.12 67.99 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.013 0.435 . . . . 0.0 110.644 177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.17 -49.91 45.66 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.887 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.55 -26.63 63.64 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.84 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.6 tp -74.71 -38.91 62.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.593 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 71.0 m -77.88 -28.44 49.92 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.296 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -81.93 -0.92 46.07 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.553 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 61.19 29.55 18.83 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.801 0.841 . . . . 0.0 111.744 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 143' ' ' GLU . . . -83.53 -43.6 15.55 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.829 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -124.62 113.4 17.99 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.5 tp -84.67 140.43 31.32 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.442 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.4 p -104.61 137.42 42.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.17 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 73.2 m -152.46 155.87 33.12 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.629 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.21 157.66 29.33 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.319 2.013 . . . . 0.0 111.191 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.455 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.36 168.32 17.12 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -177.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -136.31 135.03 20.33 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 114.405 -1.27 . . . . 0.0 107.84 177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.27 -26.57 14.45 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.582 2.188 . . . . 0.0 113.695 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.68 -40.5 62.97 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.768 0.667 . . . . 0.0 112.329 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.576 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.8 mt -71.06 -35.37 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-O 121.375 0.607 . . . . 0.0 110.354 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 tt -73.88 -38.58 64.37 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.051 -1.431 . . . . 0.0 111.392 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -84.77 -33.44 23.02 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.35 -72.34 0.49 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.047 0.385 . . . . 0.0 111.532 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.883 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.3 99.52 6.46 Favored Pre-proline 0 C--N 1.348 0.517 0 CA-C-O 121.194 0.521 . . . . 0.0 112.349 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.86 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 73.0 Cg_endo -91.45 -0.68 4.63 Favored 'Trans proline' 0 CA--C 1.569 2.254 0 C-N-CA 121.721 1.614 . . . . 0.0 114.304 175.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.646 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 73.9 Cg_endo -74.37 -52.62 0.12 Allowed 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.643 2.229 . . . . 0.0 114.48 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.523 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.6 mt-10 -122.29 -30.33 4.01 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.75 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.883 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.0 tt0 -69.78 -11.59 60.97 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.367 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.857 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.63 -41.7 44.95 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.272 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.36 -50.28 40.54 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.349 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.8 m -58.09 -49.45 76.91 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.651 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.26 -39.95 94.99 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.209 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.09 -46.58 79.0 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 123.545 0.528 . . . . 0.0 110.587 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.67 88.33 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.51 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.24 -28.26 69.24 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.492 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.75 -40.14 42.0 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 122.835 0.454 . . . . 0.0 110.303 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -69.98 -32.03 70.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.489 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.64 53.68 0.48 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.94 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.3 t -128.03 147.3 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -89.5 78.12 7.15 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.684 0.754 . . . . 0.0 110.682 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.65 -26.17 50.23 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.088 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 53.3 m -58.69 -44.22 90.21 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.51 -26.86 51.52 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.2 mt -77.08 -30.26 55.38 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.358 0.411 . . . . 0.0 111.658 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 21.1 p -89.94 -47.68 7.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.38 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -130.63 119.21 22.12 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 123.514 0.508 . . . . 0.0 111.03 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -100.73 145.21 28.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.918 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.33 145.04 50.59 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 173.97 149.97 7.34 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.582 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -128.16 145.73 50.93 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.619 0.246 . . . . 0.0 110.854 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.07 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.499 0.19 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -100.33 143.45 30.5 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.107 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -98.62 -41.91 7.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.003 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.539 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.7 m -104.12 153.78 20.51 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.708 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.3 m -97.55 97.42 4.0 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.055 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 4' ' ' SER . 2.0 Cg_endo -87.93 7.57 4.52 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.909 2.406 . . . . 0.0 112.093 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.4 t -93.9 -46.9 6.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.979 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -104.22 157.92 16.8 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.396 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.09 45.36 1.21 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.143 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -91.23 20.21 5.28 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.846 0.355 . . . . 0.0 111.276 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.2 p80 176.71 52.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.99 0.916 . . . . 0.0 110.257 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -133.2 160.43 37.27 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.716 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.434 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 14.4 m-30 -95.59 135.01 37.81 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 150' ' ' LEU . 1.6 mm? -108.04 139.92 41.97 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.525 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 29' ' ' VAL . 3.0 mp -124.58 134.43 66.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 O-C-N 123.545 0.528 . . . . 0.0 109.936 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.33 133.21 35.39 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.479 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 24.5 mmt -123.2 157.36 61.28 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.03 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.22 78.01 3.61 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.563 2.175 . . . . 0.0 112.879 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -135.53 -21.79 1.52 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.875 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.53 -162.89 0.86 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 123.209 0.318 . . . . 0.0 110.493 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.545 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -103.39 30.89 4.64 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.1 m-20 -110.85 83.29 3.49 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.1 Cg_exo -75.37 -20.7 15.9 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.069 2.513 . . . . 0.0 113.417 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -84.93 -39.04 18.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 122.833 0.453 . . . . 0.0 111.649 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.27 -2.72 56.28 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.76 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -61.0 2.29 0.12 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -142.28 38.95 1.57 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.167 0.508 . . . . 0.0 112.03 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 p -123.22 158.45 30.83 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.625 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.78 HG11 ' HE ' ' A' ' 167' ' ' ARG . 99.4 t -130.57 131.45 64.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.896 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.464 HG21 ' HH2' ' A' ' 135' ' ' TRP . 2.3 m -113.15 154.55 26.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.363 -178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.429 ' OH ' HD11 ' A' ' 105' ' ' LEU . 43.3 t80 -106.66 119.93 40.62 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.659 HD11 ' HB1' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -82.34 106.86 14.56 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 123.595 0.559 . . . . 0.0 111.391 -178.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.94 HG23 ' HA2' ' A' ' 42' ' ' GLY . 34.3 t -67.69 -57.98 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.597 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -144.56 118.84 9.55 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.187 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -99.05 128.12 45.13 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.875 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -139.25 152.44 47.3 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.586 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -62.58 -24.19 67.42 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.644 0.378 . . . . 0.0 111.781 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -93.17 -3.72 53.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 123.492 0.495 . . . . 0.0 111.498 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.3 173.72 24.35 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 121.518 -0.373 . . . . 0.0 112.274 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.659 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -146.85 141.53 26.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -114.55 134.7 54.84 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.09 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.94 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.26 157.64 28.25 Favored Glycine 0 N--CA 1.443 -0.844 0 O-C-N 124.215 0.947 . . . . 0.0 112.618 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.4 HD23 ' C ' ' A' ' 42' ' ' GLY . 1.8 mt -112.32 128.72 56.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.925 0.363 . . . . 0.0 110.511 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.451 HG12 ' C ' ' A' ' 78' ' ' GLY . 11.1 p -68.29 125.97 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.544 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.5 pt -126.05 57.76 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.725 0.774 . . . . 0.0 112.059 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.829 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.6 t-20 -146.28 -1.7 0.72 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.032 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -130.2 88.26 48.56 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.508 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 40.9 Cg_exo -58.67 145.94 93.76 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 121.711 1.607 . . . . 0.0 112.48 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.447 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 73.1 m -96.38 160.23 14.52 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.554 0.534 . . . . 0.0 111.489 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.94 51.53 0.9 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.636 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.7 OUTLIER -133.35 154.02 51.09 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.929 0.429 . . . . 0.0 110.03 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.611 ' ND2' ' HB3' ' A' ' 54' ' ' ALA . 10.4 p-10 -112.45 157.7 20.76 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.822 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.537 HD12 HD13 ' A' ' 128' ' ' ILE . 2.4 tt -57.53 -26.74 61.82 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.611 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . . . -67.54 -40.87 84.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.419 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.1 -45.51 88.32 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.17 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.861 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.1 m -62.04 -44.96 99.66 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 60' ' ' LEU . 14.8 mt -56.16 -35.15 66.86 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.494 176.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.05 -27.25 48.68 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.313 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -30.46 51.42 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.334 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.861 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt -77.79 -45.91 23.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 113.655 -1.611 . . . . 0.0 111.099 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -131.22 116.75 16.68 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.52 -33.05 2.58 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.674 2.916 . . . . 0.0 112.78 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.71 -14.99 55.83 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.376 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.99 149.47 24.75 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 123.327 0.392 . . . . 0.0 111.636 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.71 123.21 29.26 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.303 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.61 153.48 38.99 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.298 1.999 . . . . 0.0 112.264 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 6.6 Cg_endo -94.01 -165.07 0.12 Allowed 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.596 2.198 . . . . 0.0 112.119 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.449 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -71.83 -24.74 61.76 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.134 0.574 . . . . 0.0 111.888 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 118' ' ' ALA . 12.0 ptp180 -67.33 -46.06 74.57 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.542 ' HA ' HD12 ' A' ' 73' ' ' ILE . 17.5 m -73.82 -25.54 60.15 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.468 ' HA ' HD22 ' A' ' 52' ' ' ASN . 46.8 mt-30 -70.63 -27.62 64.2 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.449 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 25.0 p80 -97.9 20.42 12.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.089 0.471 . . . . 0.0 111.606 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 70' ' ' CYS . 62.8 mt -118.72 136.76 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.255 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.83 163.94 12.14 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 51' ' ' LEU . 14.3 mm -115.23 152.69 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.022 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.744 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.5 t80 -116.49 155.1 29.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.895 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -83.72 125.03 31.48 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 131' ' ' GLY . . . -104.14 -23.53 8.06 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.741 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.86 -167.95 33.3 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.186 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -88.55 -10.38 4.52 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.434 2.756 . . . . 0.0 114.262 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.84 131.34 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 123.08 0.237 . . . . 0.0 111.206 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 45.06 82.98 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.537 1.135 . . . . 0.0 113.385 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.2 p -81.66 -14.6 56.44 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.198 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -76.91 -17.13 59.13 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.748 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.771 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -132.61 148.2 52.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.927 0.394 . . . . 0.0 111.882 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.603 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.71 148.48 17.68 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.404 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.5 m-85 -86.84 150.76 23.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.913 -1.144 . . . . 0.0 111.115 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 21.6 t -128.22 105.69 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.163 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.932 HD11 HD13 ' A' ' 105' ' ' LEU . 13.6 tp -106.26 127.95 53.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.456 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.404 ' ND1' ' HB3' ' A' ' 123' ' ' PRO . 3.7 p80 -128.43 166.34 25.04 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.421 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.684 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.34 25.22 0.25 Allowed 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.691 2.261 . . . . 0.0 113.691 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.0 t -112.98 158.83 19.77 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.624 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.27 22.94 34.13 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.653 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -89.27 150.51 22.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.502 0.321 . . . . 0.0 110.534 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.6 ' HA ' HG21 ' A' ' 99' ' ' THR . 24.7 m -128.47 157.09 42.1 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.146 0.498 . . . . 0.0 112.189 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.556 ' CE2' HG23 ' A' ' 113' ' ' VAL . 57.6 m-85 -126.81 -150.88 0.46 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.8 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -59.07 -46.87 87.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.595 0.358 . . . . 0.0 111.338 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.8 m -132.58 80.3 1.89 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.943 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.6 HG21 ' HA ' ' A' ' 95' ' ' SER . 47.2 m -128.7 121.15 27.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.153 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.5 123.57 46.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.861 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.58 127.82 34.04 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.027 0.441 . . . . 0.0 110.764 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.56 ' HB3' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -120.58 43.11 2.83 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.798 -179.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.61 -100.57 0.28 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.424 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -55.61 -14.83 2.36 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.932 HD13 HD11 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -160.0 159.87 32.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.907 0.483 . . . . 0.0 110.687 -179.318 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.574 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -118.73 156.98 28.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.846 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.49 ' CE ' HD13 ' A' ' 89' ' ' LEU . 16.1 ttm -123.91 134.64 53.49 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 m -136.68 133.72 36.47 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 82.7 p -127.97 19.7 6.52 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.007 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.755 ' O ' HG12 ' A' ' 113' ' ' VAL . 42.2 p -90.61 130.9 36.58 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.306 0.574 . . . . 0.0 112.021 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.489 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 7.9 mt-30 -57.95 -26.9 62.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.777 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -64.53 -40.02 94.84 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.119 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.77 ' O ' HG22 ' A' ' 117' ' ' ILE . 2.7 p -71.49 -38.5 68.39 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.77 -49.84 72.07 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.578 0.549 . . . . 0.0 110.495 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.489 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 39.2 m-85 -68.01 -40.79 82.93 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.405 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.64 -53.95 51.23 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.679 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.3 tp -64.56 -43.96 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.56 -32.31 65.05 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.665 0.603 . . . . 0.0 109.703 178.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.438 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.38 -20.55 31.75 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.365 176.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.35 17.23 25.02 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.8 -1.091 . . . . 0.0 114.472 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 p -108.26 8.39 27.79 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -93.84 -138.01 8.83 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-O 119.204 -0.776 . . . . 0.0 112.863 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.404 ' HB3' ' ND1' ' A' ' 90' ' ' HIS . 2.2 Cg_endo -82.37 165.76 16.34 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.146 2.564 . . . . 0.0 113.998 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.506 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -49.94 -60.14 3.2 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.482 1.113 . . . . 0.0 111.76 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.684 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -140.1 139.72 35.9 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 37.2 p -139.25 169.41 17.82 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.2 tp -125.61 115.81 20.73 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.45 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.537 HD13 HD12 ' A' ' 53' ' ' LEU . 8.6 pt -99.25 104.98 16.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.3 t -124.16 121.99 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.035 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.0 tp -67.21 113.06 4.84 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.379 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.502 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 72.75 170.51 17.06 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.158 -0.928 . . . . 0.0 114.283 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -128.66 177.77 6.8 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.206 0.526 . . . . 0.0 110.809 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -114.94 131.73 56.79 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.937 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.33 144.05 15.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.598 -178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.464 ' HH2' HG21 ' A' ' 30' ' ' THR . 16.8 m-90 -122.15 131.68 54.08 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.046 0.498 . . . . 0.0 110.597 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -78.94 159.19 27.83 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.53 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.16 124.05 10.77 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.671 0.388 . . . . 0.0 111.497 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.27 -28.02 8.64 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.017 -0.611 . . . . 0.0 114.128 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -56.71 -48.88 76.75 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.543 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.0 tp -67.8 -47.77 68.16 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.673 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.83 -31.57 64.88 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.456 0.472 . . . . 0.0 110.814 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.88 -50.35 43.29 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.044 178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -72.29 -26.64 62.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.097 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.4 tp -75.65 -38.49 58.81 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.738 0.815 . . . . 0.0 110.784 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.7 m -78.12 -31.09 49.75 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.444 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -80.8 0.4 35.03 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.649 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 60.13 28.68 18.27 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.908 0.883 . . . . 0.0 111.749 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.99 -43.16 22.49 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.831 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -126.29 116.48 21.31 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -84.72 150.34 25.17 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.487 ' H ' HD23 ' A' ' 150' ' ' LEU . 16.8 p -110.78 136.29 50.07 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.363 0.414 . . . . 0.0 110.915 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 74.9 m -151.83 154.87 33.42 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.54 159.04 25.12 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.284 1.989 . . . . 0.0 111.104 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.434 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.89 166.09 21.65 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -134.95 134.16 21.57 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-N 114.368 -1.287 . . . . 0.0 107.863 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.51 -26.43 16.79 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.596 2.198 . . . . 0.0 113.663 -177.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.8 -39.97 62.82 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 123.871 0.732 . . . . 0.0 112.056 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.565 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.2 mt -72.27 -35.66 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.363 0.602 . . . . 0.0 110.392 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.61 -37.41 65.43 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.412 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -86.67 -33.75 19.99 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -85.78 -72.33 0.49 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.052 0.387 . . . . 0.0 111.666 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.913 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.75 98.11 6.44 Favored Pre-proline 0 C--N 1.349 0.584 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.829 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 59.5 Cg_endo -92.76 1.2 3.77 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 C-N-CA 121.719 1.613 . . . . 0.0 114.258 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.636 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 80.4 Cg_endo -74.1 -52.14 0.13 Allowed 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.561 2.174 . . . . 0.0 114.224 -178.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.507 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.4 mt-10 -122.97 -29.79 3.88 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.658 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.913 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.5 tt0 -70.36 -10.13 58.18 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.247 178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.78 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.01 -38.2 53.52 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.135 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.7 tt -74.01 -49.58 23.7 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.3 m -58.41 -46.72 85.89 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.487 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -67.14 -40.66 86.78 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.397 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.15 -45.98 79.43 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 123.362 0.414 . . . . 0.0 110.446 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.99 -38.65 91.87 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.487 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.56 -27.87 69.25 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.595 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.69 -40.23 42.14 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 122.931 0.492 . . . . 0.0 110.26 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -71.0 -31.19 67.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.529 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.08 53.64 0.74 Allowed Glycine 0 C--N 1.34 0.776 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.884 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 6.8 t -127.71 149.48 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -87.7 79.46 8.21 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.665 0.745 . . . . 0.0 110.735 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -26.17 49.76 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.183 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.5 m -58.97 -42.15 89.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.51 -26.71 51.4 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.9 mt -77.02 -37.86 54.13 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.263 0.352 . . . . 0.0 111.944 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.8 p -93.99 -48.68 6.14 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.28 0.363 . . . . 0.0 111.424 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 57.8 120.27 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.114 0.966 . . . . 0.0 112.889 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -99.69 142.83 30.66 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.942 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -124.32 146.54 48.75 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.12 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -145.39 130.68 3.91 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.471 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -99.37 -40.5 7.87 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 122.284 0.234 . . . . 0.0 111.285 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.081 -0.961 . . . . 0.0 111.072 -179.948 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.554 0.216 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -97.98 152.31 19.4 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.816 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.595 ' NE2' ' H ' ' A' ' 104' ' ' GLU . 12.4 mm100 -123.55 -43.74 2.14 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.823 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.1 p -124.76 -57.57 1.53 Allowed 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.196 0.31 . . . . 0.0 111.629 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.4 p -139.18 145.04 43.07 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 119.405 -0.331 . . . . 0.0 111.278 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -86.27 7.52 4.93 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.907 2.405 . . . . 0.0 112.732 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -93.43 -38.3 11.51 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.224 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -90.58 153.32 20.42 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.862 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mt -107.75 51.46 0.74 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.744 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.539 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 14.2 ptmt -95.16 27.65 3.15 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.494 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 176.44 51.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.563 0.745 . . . . 0.0 110.91 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -134.04 159.39 40.95 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.452 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 30' ' ' THR . 12.3 m-30 -98.58 138.33 35.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.168 0.509 . . . . 0.0 112.15 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.672 HD11 HD23 ' A' ' 32' ' ' LEU . 1.9 mp -109.89 135.41 50.81 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.565 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.432 HG23 HG22 ' A' ' 29' ' ' VAL . 2.9 mp -120.04 130.72 73.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.53 127.63 33.19 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.012 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 19.6 mmt -112.28 154.62 44.37 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.171 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -79.96 72.57 6.45 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.561 2.174 . . . . 0.0 112.611 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -130.79 -16.4 3.32 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.54 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -164.69 0.94 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.303 0.377 . . . . 0.0 110.604 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.541 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.55 37.77 2.05 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 111.85 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -110.99 82.95 3.36 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.832 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.33 -21.88 14.8 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.973 2.449 . . . . 0.0 113.384 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -85.19 -38.52 18.89 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.909 0.484 . . . . 0.0 111.527 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.08 -5.53 55.06 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.842 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -57.3 -0.67 0.06 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -178.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -142.3 43.86 1.65 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.179 0.514 . . . . 0.0 111.839 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p -127.38 155.58 43.39 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.616 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.651 HG11 ' HE ' ' A' ' 167' ' ' ARG . 48.0 t -129.22 133.54 65.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.676 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 3.9 m -115.15 154.68 28.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.471 -178.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.408 ' OH ' HD11 ' A' ' 105' ' ' LEU . 17.7 t80 -109.14 116.26 31.59 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.672 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -78.61 108.47 12.03 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-O 121.04 0.448 . . . . 0.0 110.466 -179.33 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.891 HG23 ' HA2' ' A' ' 42' ' ' GLY . 56.4 t -64.78 -57.92 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 114.033 -1.439 . . . . 0.0 110.115 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.539 ' HA ' ' CB ' ' A' ' 10' ' ' LYS . 32.7 tt0 -151.11 119.67 6.48 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.793 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -95.8 129.24 43.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.629 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -139.48 152.89 47.35 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.475 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.8 -18.98 65.58 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.623 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 137' ' ' ALA . 46.5 mt-30 -95.68 -5.83 41.35 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.346 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.81 172.37 22.51 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -145.2 143.24 30.19 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.461 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -119.5 136.6 54.26 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.638 178.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.891 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -159.29 158.53 29.61 Favored Glycine 0 N--CA 1.452 -0.292 0 O-C-N 124.364 1.04 . . . . 0.0 112.529 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.428 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.8 mt -115.6 134.86 54.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.099 0.449 . . . . 0.0 111.438 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 78' ' ' GLY . 11.1 t -68.55 122.48 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.91 55.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.638 0.732 . . . . 0.0 112.074 -177.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.854 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.6 t-20 -148.32 -2.75 0.51 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.157 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -130.19 87.23 51.71 Favored Pre-proline 0 CA--C 1.554 1.106 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.53 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -59.7 143.15 99.7 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 121.559 1.506 . . . . 0.0 112.14 175.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 50.0 m -92.54 158.5 15.97 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 123.39 0.431 . . . . 0.0 111.368 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -97.89 50.29 1.37 Allowed Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.837 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 mt -133.57 158.96 41.85 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.979 0.458 . . . . 0.0 110.229 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.1 p-10 -112.23 157.54 20.77 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.102 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.642 HD13 HD13 ' A' ' 128' ' ' ILE . 13.4 tp -57.79 -37.07 73.08 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.07 -37.91 62.06 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -63.66 -43.03 97.93 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.21 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.864 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -62.63 -46.82 95.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.744 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.4 mp -53.56 -36.72 62.17 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 123.87 0.731 . . . . 0.0 110.784 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.93 -28.34 49.63 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.564 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -29.97 47.9 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.381 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.864 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.9 mt -77.83 -45.14 25.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.884 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -132.02 116.57 15.7 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.535 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -77.59 -32.73 2.69 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 123.615 2.876 . . . . 0.0 112.747 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.22 -14.38 55.63 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.364 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 149.7 24.52 Favored 'General case' 0 C--N 1.344 0.33 0 O-C-N 123.321 0.388 . . . . 0.0 111.792 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.32 123.75 29.68 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.99 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 57.5 Cg_endo -74.45 146.04 34.55 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.185 1.923 . . . . 0.0 112.351 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.502 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.4 Cg_endo -92.43 -170.62 0.3 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.491 2.127 . . . . 0.0 111.83 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.484 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -63.82 -24.89 67.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.142 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.504 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.6 ptp180 -66.18 -53.38 38.14 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -177.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.706 ' HA ' HD12 ' A' ' 73' ' ' ILE . 60.1 m -71.74 -25.02 61.88 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 47.7 mt-30 -68.12 -35.63 78.43 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.484 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 20.5 p80 -90.37 22.12 3.54 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.228 0.537 . . . . 0.0 111.667 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.706 HD12 ' HA ' ' A' ' 70' ' ' CYS . 55.1 mt -119.39 139.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.383 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.11 153.78 22.14 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.802 0.689 . . . . 0.0 112.728 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.689 HD13 HD12 ' A' ' 128' ' ' ILE . 25.9 mm -100.02 150.3 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.093 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.715 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -116.51 154.98 29.44 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.52 118.94 26.27 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.636 0.198 . . . . 0.0 110.552 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -101.46 -23.66 9.37 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.826 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.82 -167.77 35.4 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.123 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -88.39 -9.66 4.95 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 123.492 2.794 . . . . 0.0 114.264 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 t -87.07 131.18 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.003 0.19 . . . . 0.0 111.035 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 44.13 87.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.533 1.133 . . . . 0.0 113.316 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.428 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.0 t -88.09 1.51 54.11 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.428 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.87 -5.47 47.91 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.604 ' HD3' ' N ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.26 154.45 50.66 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.11 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.604 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -108.5 134.2 12.1 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.175 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.727 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.54 145.58 27.31 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.366 1.067 . . . . 0.0 110.231 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 t -123.97 103.42 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 123.366 0.416 . . . . 0.0 110.874 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.785 HD11 HD13 ' A' ' 105' ' ' LEU . 6.2 tp -105.71 129.21 53.97 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -125.6 168.23 14.37 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 118.985 -0.531 . . . . 0.0 112.146 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 16.5 Cg_endo -96.61 13.99 0.96 Allowed 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.862 2.375 . . . . 0.0 113.644 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 t -101.89 161.06 13.95 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.874 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.84 19.21 55.5 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.512 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -85.47 153.86 22.19 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.604 0.362 . . . . 0.0 110.403 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.0 p -127.03 157.89 38.39 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CE2' HG23 ' A' ' 113' ' ' VAL . 52.0 m-85 -129.34 -151.94 0.5 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.671 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -57.44 -46.26 83.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.776 0.431 . . . . 0.0 111.723 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 m -138.32 78.94 1.71 Allowed 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.642 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 107' ' ' MET . 25.1 m -126.29 120.96 31.3 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 107' ' ' MET . 3.3 tp -77.36 162.02 27.59 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.051 176.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -135.2 125.5 26.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.896 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.506 HD11 ' O ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -135.84 43.99 2.52 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.279 -179.383 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 61.13 -99.16 0.19 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.815 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.595 ' H ' ' NE2' ' A' ' 3' ' ' GLN . 10.6 pt-20 -57.4 -12.99 2.91 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.785 HD13 HD11 ' A' ' 89' ' ' LEU . 3.2 pp -158.44 148.11 19.55 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.265 0.555 . . . . 0.0 112.493 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.52 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -120.83 158.6 27.24 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.324 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' HE2' ' A' ' 87' ' ' PHE . 8.9 ttm -119.68 134.08 55.37 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.754 ' HB3' HG11 ' A' ' 113' ' ' VAL . 16.7 m -128.76 127.36 41.86 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.8 p -119.92 11.78 11.88 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.782 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.745 ' O ' HG12 ' A' ' 113' ' ' VAL . 49.2 m -85.59 130.38 34.59 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.617 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.497 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.7 pt20 -61.58 -29.52 70.08 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.382 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.45 -43.16 95.15 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.603 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.754 HG11 ' HB3' ' A' ' 108' ' ' SER . 4.0 p -68.14 -39.77 81.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 O-C-N 123.189 0.306 . . . . 0.0 110.38 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.53 HD22 ' NH2' ' A' ' 85' ' ' ARG . 1.5 tt -58.12 -48.34 80.51 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 123.571 0.544 . . . . 0.0 110.47 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.497 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 35.3 m-85 -69.98 -37.57 75.8 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.865 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.25 -51.94 65.72 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.0 tp -64.56 -43.14 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.156 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.02 -31.59 65.28 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 123.826 0.704 . . . . 0.0 109.546 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.504 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.71 -20.8 30.6 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.255 176.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.61 13.1 33.39 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.729 -1.123 . . . . 0.0 114.692 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 33.1 p -103.39 7.8 38.09 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.68 -137.7 9.6 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.239 -0.756 . . . . 0.0 112.635 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.72 173.72 12.59 Favored 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 123.228 2.619 . . . . 0.0 113.601 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.01 -54.37 47.53 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.757 0.823 . . . . 0.0 111.916 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.594 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.9 mmtt -139.05 151.14 46.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.775 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 74.0 m -148.05 165.38 30.97 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.7 tp -127.5 118.05 23.26 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.361 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.727 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 18.5 pt -98.63 102.7 13.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.989 0.9 . . . . 0.0 109.819 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 6.8 t -119.75 121.6 39.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.76 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.428 HD21 ' O ' ' A' ' 83' ' ' THR . 6.9 tp -66.84 115.06 6.2 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.01 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.71 174.61 4.11 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.352 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -128.44 -179.49 5.06 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.408 0.623 . . . . 0.0 111.092 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -117.34 130.47 56.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.179 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.46 152.24 19.48 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.354 -178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 27.4 m-90 -132.69 139.02 47.48 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.898 0.41 . . . . 0.0 110.537 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.25 158.17 27.63 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.851 0.719 . . . . 0.0 110.794 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 38' ' ' GLN . . . -50.92 91.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.82 -22.05 10.11 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.521 -0.763 . . . . 0.0 113.339 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -57.22 -46.35 83.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.866 0.466 . . . . 0.0 111.978 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 15.5 tp -66.73 -47.18 73.09 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -56.69 -30.84 63.86 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.453 0.471 . . . . 0.0 110.793 177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.43 -49.08 52.57 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.04 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.4 pt-20 -72.69 -26.75 61.73 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.0 tp -75.48 -38.23 59.68 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.744 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.1 t -78.19 -30.31 48.92 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.272 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.4 t70 -80.06 0.5 31.61 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.605 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 61.38 28.98 18.3 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.871 0.868 . . . . 0.0 111.797 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.45 -42.71 16.63 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.528 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -124.14 111.39 15.86 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 123.495 0.497 . . . . 0.0 109.856 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 7.3 tp -86.93 128.36 35.06 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.614 0.245 . . . . 0.0 111.506 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.5 p -100.33 142.3 31.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.758 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 78.2 m -154.95 155.83 30.66 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 123.446 0.466 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.51 148.46 92.94 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.325 2.016 . . . . 0.0 110.999 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 174' ' ' ARG . . . -135.06 177.42 7.82 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -134.29 141.11 38.02 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 113.88 -1.509 . . . . 0.0 108.584 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -74.85 -26.54 11.14 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 122.766 2.311 . . . . 0.0 114.007 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -48.89 -41.71 34.4 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.915 0.759 . . . . 0.0 112.631 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.704 HD13 HH12 ' A' ' 167' ' ' ARG . 4.9 mt -70.26 -32.63 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.467 0.651 . . . . 0.0 110.421 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.6 tt -76.65 -37.12 56.81 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.93 -1.486 . . . . 0.0 111.37 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -83.61 -33.45 25.32 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -86.84 -72.93 0.48 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.939 0.336 . . . . 0.0 111.657 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.89 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.47 99.93 6.3 Favored Pre-proline 0 C--N 1.349 0.578 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.854 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 70.3 Cg_endo -90.94 -0.91 4.97 Favored 'Trans proline' 0 CA--C 1.57 2.275 0 C-N-CA 121.742 1.628 . . . . 0.0 114.261 175.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.651 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 87.8 Cg_endo -74.28 -54.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 122.636 2.224 . . . . 0.0 114.502 -178.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.542 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.1 mt-10 -120.58 -29.84 4.64 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.729 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.89 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 30.0 tt0 -70.38 -11.38 60.88 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.422 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.704 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.28 -45.5 32.29 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.397 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.5 tp -68.06 -50.19 56.72 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.1 m -57.57 -51.16 70.6 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.922 178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.09 88.98 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.158 0.286 . . . . 0.0 110.987 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.28 83.92 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 123.657 0.598 . . . . 0.0 110.457 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.11 84.54 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.646 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 177' ' ' VAL . . . -62.76 -32.28 73.39 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.532 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.483 ' CZ ' ' HA ' ' A' ' 154' ' ' ALA . 10.9 mtm-85 -77.7 -41.57 37.47 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 122.682 0.393 . . . . 0.0 110.702 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.77 -35.47 79.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.634 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 132.29 36.71 0.29 Allowed Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.2 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 173' ' ' ALA . 4.9 t -128.44 127.71 67.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -83.86 83.66 7.85 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.568 0.699 . . . . 0.0 111.511 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -77.99 -26.42 48.61 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.814 -1.085 . . . . 0.0 112.157 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.0 m -58.39 -45.26 88.67 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.36 -26.85 52.32 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 21.3 mt -77.28 -30.02 54.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.618 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 23.0 p -90.22 -47.98 7.45 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.374 0.421 . . . . 0.0 111.435 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -131.22 120.2 22.92 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.48 0.488 . . . . 0.0 111.04 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -97.25 138.72 34.3 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.976 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -102.79 151.2 22.69 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.215 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -98.14 -103.7 2.33 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.595 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -99.1 -40.56 7.95 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.345 0.258 . . . . 0.0 111.332 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.094 -179.96 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.349 0.118 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -99.88 130.66 46.09 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.034 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -101.5 -40.89 6.84 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.096 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.432 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 16.1 t -98.56 153.21 18.81 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.369 0.418 . . . . 0.0 110.891 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 p -93.74 101.78 6.68 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.038 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 4' ' ' SER . 1.9 Cg_endo -87.65 7.67 4.56 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.769 2.312 . . . . 0.0 112.287 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 t -92.57 166.2 12.62 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.97 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 62.74 151.71 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.933 0.893 . . . . 0.0 112.581 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 32' ' ' LEU . 18.4 mt -93.84 46.57 1.18 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.323 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -93.0 19.36 7.89 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.068 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 175.55 55.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.268 1.027 . . . . 0.0 109.209 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -137.96 156.88 47.4 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.462 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 15.5 m-30 -96.46 135.43 38.34 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.928 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.762 HD11 HD23 ' A' ' 32' ' ' LEU . 6.2 mt -107.62 138.2 44.27 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.182 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.459 HG23 HG22 ' A' ' 29' ' ' VAL . 2.2 mm -116.69 132.63 65.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 O-C-N 123.623 0.577 . . . . 0.0 109.617 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.58 128.15 33.67 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.724 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 47.5 mtt -117.79 154.32 51.06 Favored Pre-proline 0 CA--C 1.538 0.509 0 O-C-N 123.383 0.427 . . . . 0.0 111.336 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.41 74.0 5.76 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.673 2.249 . . . . 0.0 112.661 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -131.63 -17.64 2.86 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.741 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.32 -163.26 0.84 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.272 0.357 . . . . 0.0 110.403 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.535 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -101.96 34.4 2.7 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 120.906 0.384 . . . . 0.0 111.979 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.0 m-20 -111.6 82.4 3.75 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.37 -22.3 14.32 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.033 2.488 . . . . 0.0 113.333 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -85.13 -39.13 18.25 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.93 0.492 . . . . 0.0 111.498 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -4.63 56.94 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.889 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -57.69 0.71 0.05 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -143.13 43.34 1.55 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.212 0.529 . . . . 0.0 111.866 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.6 p -126.49 158.28 36.5 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.674 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.794 HG11 ' HE ' ' A' ' 167' ' ' ARG . 58.4 t -130.72 133.07 63.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.816 0 CA-C-N 114.946 -1.024 . . . . 0.0 109.641 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.446 HG21 ' HH2' ' A' ' 135' ' ' TRP . 1.8 m -114.33 155.18 26.71 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.647 -178.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.479 ' OH ' HD21 ' A' ' 105' ' ' LEU . 34.1 t80 -107.71 115.58 30.4 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.762 HD23 HD11 ' A' ' 14' ' ' LEU . 0.1 OUTLIER -80.08 108.21 13.48 Favored 'General case' 0 C--O 1.249 1.056 0 CA-C-O 121.393 0.616 . . . . 0.0 111.236 -178.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.947 HG23 ' HA2' ' A' ' 42' ' ' GLY . 43.4 t -68.42 -63.32 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.267 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -136.82 122.65 19.99 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.492 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -104.66 128.79 52.82 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.9 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -139.81 153.14 47.02 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.627 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.61 -21.56 66.43 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.005 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -94.99 -4.66 46.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.398 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.54 176.23 27.48 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.405 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.649 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -148.99 148.95 30.36 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.21 136.17 54.62 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.289 177.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.947 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.11 160.39 30.4 Favored Glycine 0 N--CA 1.447 -0.624 0 O-C-N 124.603 1.189 . . . . 0.0 112.509 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.4 mt -112.69 131.19 55.77 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.939 0.37 . . . . 0.0 111.223 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 78' ' ' GLY . 15.7 t -67.05 122.12 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.49 56.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.648 0.737 . . . . 0.0 112.038 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.852 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.1 t-20 -147.15 -3.25 0.58 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.158 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -130.08 88.57 47.99 Favored Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.521 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 36.3 Cg_exo -59.6 143.68 99.61 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.712 1.608 . . . . 0.0 112.157 175.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.441 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 69.2 m -93.29 159.71 15.15 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 123.386 0.429 . . . . 0.0 111.639 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.06 50.69 1.18 Allowed Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.588 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 mt -133.6 158.44 43.19 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 122.848 0.459 . . . . 0.0 110.143 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 24.7 p-10 -112.61 157.61 20.99 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.808 HD12 HD13 ' A' ' 128' ' ' ILE . 1.6 tt -58.1 -26.51 62.68 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 120.947 0.403 . . . . 0.0 111.847 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.87 -41.68 95.47 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.173 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.56 -45.78 88.92 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.095 0.247 . . . . 0.0 111.457 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.867 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 7.8 m -62.12 -44.51 99.12 Favored 'Isoleucine or valine' 0 C--N 1.349 0.553 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 60' ' ' LEU . 14.4 mt -55.99 -35.14 66.43 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.853 0.721 . . . . 0.0 110.618 176.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -78.08 -27.41 48.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.391 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.84 -30.97 51.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.284 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.867 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.2 mt -77.69 -45.76 23.92 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 113.739 -1.573 . . . . 0.0 111.162 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -131.12 116.52 16.73 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.581 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.7 -32.94 2.51 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 123.554 2.836 . . . . 0.0 112.75 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.74 -14.77 56.05 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.313 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.18 149.66 24.48 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.42 0.45 . . . . 0.0 111.672 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.24 123.45 29.39 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.304 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.42 149.48 35.11 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.275 1.983 . . . . 0.0 112.279 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.428 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 7.6 Cg_endo -94.33 -167.86 0.16 Allowed 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.653 2.235 . . . . 0.0 112.432 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.43 -24.64 64.76 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.373 0.669 . . . . 0.0 112.095 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.514 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 9.1 ptp180 -67.91 -48.08 67.0 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.701 ' HA ' HD12 ' A' ' 73' ' ' ILE . 21.2 m -73.15 -26.19 61.11 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.087 0.555 . . . . 0.0 112.343 -178.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.442 ' HA ' HD22 ' A' ' 52' ' ' ASN . 44.1 mt-30 -70.34 -26.96 63.99 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.668 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -96.71 17.66 16.05 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.58 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 70' ' ' CYS . 52.1 mt -120.97 139.63 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.818 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -106.45 154.53 20.7 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.731 HD13 HD12 ' A' ' 128' ' ' ILE . 24.2 mm -102.02 153.12 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.805 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.711 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.3 t80 -117.97 155.21 30.64 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.64 121.23 28.87 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 117.684 0.22 . . . . 0.0 110.59 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -104.04 -23.6 8.07 Favored Glycine 0 C--N 1.346 1.137 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.888 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.7 -168.36 33.81 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.043 -0.598 . . . . 0.0 113.315 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -88.58 -13.09 3.48 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 123.545 2.83 . . . . 0.0 114.394 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 t -83.41 129.8 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.099 0.249 . . . . 0.0 111.162 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 44.25 86.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.635 1.174 . . . . 0.0 113.392 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.6 p -82.72 -13.88 55.56 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.085 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -77.05 -17.59 58.66 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.805 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -132.58 148.87 52.38 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.089 0.471 . . . . 0.0 111.908 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.614 ' N ' ' HD3' ' A' ' 85' ' ' ARG . . . -110.71 159.75 13.66 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.429 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 1.3 m-85 -96.14 151.71 19.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.721 -1.24 . . . . 0.0 110.854 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 t -128.35 102.91 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 126' ' ' SER . 0.3 OUTLIER -102.37 127.69 49.27 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.869 -179.216 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -130.07 164.42 40.78 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.499 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.681 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.5 Cg_endo -97.08 19.78 0.46 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.647 2.231 . . . . 0.0 113.78 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.8 t -106.4 158.52 16.83 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.59 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.85 22.82 33.92 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.717 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 95' ' ' SER . 2.8 tt -90.73 149.58 21.97 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.521 0.329 . . . . 0.0 110.435 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.592 ' HA ' HG21 ' A' ' 99' ' ' THR . 27.5 m -126.22 155.51 41.71 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.054 0.454 . . . . 0.0 112.093 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.538 ' CE2' HG23 ' A' ' 113' ' ' VAL . 53.6 m-85 -126.55 -150.4 0.44 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.846 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.417 ' HB2' ' OG ' ' A' ' 110' ' ' SER . 5.4 mm100 -58.4 -47.29 84.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.61 0.364 . . . . 0.0 111.491 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 63.2 m -133.05 81.05 1.92 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.964 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 107' ' ' MET . 44.7 m -127.98 120.06 26.78 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.04 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -103.06 122.42 44.62 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.911 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.24 125.47 30.35 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.773 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -121.47 55.29 1.09 Allowed 'General case' 0 C--O 1.24 0.57 0 CA-C-O 122.232 1.015 . . . . 0.0 110.626 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 69.87 -114.35 5.53 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.259 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.5 -3.44 6.25 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.479 HD21 ' OH ' ' A' ' 31' ' ' TYR . 3.5 pp -147.78 157.02 43.34 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.19 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -120.44 158.59 26.87 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.368 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.611 ' O ' ' HA ' ' A' ' 99' ' ' THR . 25.6 ttm -124.56 132.14 53.46 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.631 ' HB3' HG11 ' A' ' 113' ' ' VAL . 49.2 m -133.95 130.99 38.49 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.9 p -124.37 18.82 8.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.433 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.679 ' O ' HG12 ' A' ' 113' ' ' VAL . 19.0 t -90.66 133.97 34.74 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.92 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.467 ' O ' ' HD2' ' A' ' 115' ' ' PHE . 5.7 mt-30 -62.35 -26.37 68.41 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.473 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.28 -41.96 93.66 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.496 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.742 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.5 p -71.49 -37.58 64.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 tp -58.89 -47.12 86.09 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 123.511 0.507 . . . . 0.0 110.198 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.467 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 18.4 m-85 -68.5 -40.91 80.67 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.837 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.68 -52.6 64.44 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.385 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.742 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.4 tp -64.82 -44.23 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.718 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.447 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.54 -32.33 65.03 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 123.745 0.653 . . . . 0.0 109.679 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.514 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.56 -20.17 31.94 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.396 176.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.08 16.2 28.59 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.698 -1.137 . . . . 0.0 114.544 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.9 p -107.55 7.96 29.02 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.01 -138.28 9.04 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 119.213 -0.77 . . . . 0.0 112.747 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.75 168.46 15.87 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.191 2.594 . . . . 0.0 113.754 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.489 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 1.1 tt0 -50.76 -58.83 4.96 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.363 1.065 . . . . 0.0 111.748 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.681 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.4 mmtt -141.3 139.93 33.74 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.797 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 36.7 p -137.02 168.05 20.33 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 tp -128.27 117.07 20.84 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.81 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.808 HD13 HD12 ' A' ' 53' ' ' LEU . 11.5 pt -98.18 103.88 15.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-O 121.415 0.626 . . . . 0.0 109.639 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.0 t -121.37 120.09 34.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.014 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 tp -67.1 115.6 6.98 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.601 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.58 169.82 11.28 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.026 -0.988 . . . . 0.0 114.405 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -128.42 171.97 11.55 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.278 0.561 . . . . 0.0 110.803 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -108.86 130.89 55.42 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.05 178.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.5 142.67 13.83 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.387 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.446 ' HH2' HG21 ' A' ' 30' ' ' THR . 17.4 m-90 -120.53 133.6 55.38 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.967 0.451 . . . . 0.0 110.391 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -82.12 158.86 23.52 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.181 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.77 124.37 9.63 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.364 0.415 . . . . 0.0 111.705 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.57 -26.76 8.72 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.036 -0.602 . . . . 0.0 114.35 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -58.27 -49.03 78.58 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.58 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.7 tm? -66.23 -48.96 68.85 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.983 0.177 . . . . 0.0 110.772 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.86 -31.12 66.37 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 120.927 0.394 . . . . 0.0 110.827 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -69.18 -50.09 50.69 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.086 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.45 -26.62 62.8 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.966 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.1 tp -75.22 -38.48 60.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.427 0.691 . . . . 0.0 110.668 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.0 m -77.93 -29.65 50.09 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.34 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.8 t70 -81.43 -1.13 44.58 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.615 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 t30 60.5 30.31 19.67 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.879 0.872 . . . . 0.0 111.402 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.73 -42.17 18.35 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.984 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -126.71 115.86 20.06 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.7 tp -86.78 145.3 26.69 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.514 0.197 . . . . 0.0 111.225 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.4 p -105.31 137.0 43.81 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.964 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 71.1 m -152.12 149.76 24.03 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.598 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -57.5 158.47 19.27 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.39 2.06 . . . . 0.0 111.247 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.462 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.67 167.22 19.14 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -177.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -133.39 135.64 25.7 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 114.132 -1.395 . . . . 0.0 107.85 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.82 -26.76 13.09 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.61 2.207 . . . . 0.0 114.013 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.77 -40.55 63.25 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.759 0.662 . . . . 0.0 112.104 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.596 HG21 HH11 ' A' ' 167' ' ' ARG . 4.5 mt -70.95 -34.71 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.24 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.3 tt -74.0 -38.62 64.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.654 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.412 ' HE1' ' O ' ' A' ' 89' ' ' LEU . 44.7 m-85 -88.0 -31.1 19.51 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -85.57 -71.73 0.52 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.215 0.461 . . . . 0.0 111.451 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.892 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.43 98.59 5.94 Favored Pre-proline 0 C--N 1.35 0.609 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.852 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 59.3 Cg_endo -91.99 0.35 4.27 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 C-N-CA 121.602 1.535 . . . . 0.0 114.206 175.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.643 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 78.7 Cg_endo -74.19 -53.78 0.11 Allowed 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 122.546 2.164 . . . . 0.0 114.461 -178.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.546 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -121.09 -29.66 4.51 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.61 -178.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.892 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.8 tt0 -70.27 -11.49 60.94 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.382 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.794 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.04 -40.2 47.25 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.325 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.0 tp -72.02 -49.9 32.98 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.8 m -58.92 -47.36 85.31 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.55 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.673 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -65.79 -40.69 92.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.158 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.82 -46.28 78.12 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 123.488 0.492 . . . . 0.0 110.472 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.21 90.28 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.428 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.82 -27.29 68.14 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.66 177.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.76 -40.21 41.64 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 122.832 0.453 . . . . 0.0 110.306 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.84 -30.28 63.89 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.408 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 102.17 56.67 0.83 Allowed Glycine 0 C--N 1.339 0.745 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.817 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.5 t -126.06 151.52 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -86.77 78.68 9.04 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.73 0.776 . . . . 0.0 110.92 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 -26.23 49.11 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.892 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.7 t -59.64 -42.66 93.25 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.54 -26.54 51.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 15.9 mt -76.09 -37.69 57.88 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.318 0.386 . . . . 0.0 111.816 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 19.6 p -92.89 -47.74 6.88 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 123.281 0.363 . . . . 0.0 111.367 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 57.87 118.73 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.221 1.008 . . . . 0.0 112.824 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -112.0 148.25 34.2 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -99.62 132.67 44.8 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.135 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 152.8 77.54 0.02 OUTLIER Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -128.48 138.34 52.24 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.652 0.266 . . . . 0.0 110.89 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.501 -0.761 . . . . 0.0 111.094 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.462 0.173 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -100.19 130.28 46.3 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.764 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -128.8 -54.67 1.22 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.138 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.8 m -141.86 -53.68 0.44 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.252 0.345 . . . . 0.0 111.164 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.2 m -137.76 95.08 11.24 Favored Pre-proline 0 CA--C 1.544 0.722 0 O-C-N 123.269 0.356 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -88.83 7.27 4.36 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.835 2.357 . . . . 0.0 112.095 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -95.09 -47.48 6.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.145 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -107.63 156.2 19.31 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 123.7 0.625 . . . . 0.0 111.547 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.487 HD12 ' CE1' ' A' ' 35' ' ' HIS . 19.4 mt -91.92 47.27 1.33 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.655 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -89.22 17.3 6.14 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.529 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.41 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 19.0 p80 172.2 58.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.351 1.06 . . . . 0.0 110.108 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -137.19 161.61 35.71 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.465 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.485 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 18.9 m-30 -97.76 136.95 37.37 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.81 HD11 HD23 ' A' ' 32' ' ' LEU . 3.7 mt -108.28 140.18 41.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.949 177.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 150' ' ' LEU . 2.9 mp -120.62 135.73 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 123.462 0.476 . . . . 0.0 110.02 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.14 125.61 29.6 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.048 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 35.9 mtt -110.34 157.44 38.12 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.206 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.21 30.16 0.53 Allowed 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.63 2.22 . . . . 0.0 113.213 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -86.72 -17.02 34.69 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.29 -167.13 1.15 Allowed 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.094 0.246 . . . . 0.0 110.597 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.531 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.09 40.33 1.47 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.102 0.477 . . . . 0.0 111.764 -179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -112.19 80.33 3.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.915 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.4 Cg_exo -75.45 -23.12 13.38 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 123.036 2.491 . . . . 0.0 113.315 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -84.54 -34.93 23.15 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.825 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -90.94 3.92 53.34 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.048 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.16 163.87 19.3 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.815 0.341 . . . . 0.0 111.761 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 49.23 31.79 3.88 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.0 p -117.53 154.25 31.8 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.753 HG11 ' HE ' ' A' ' 167' ' ' ARG . 96.4 t -128.93 134.2 64.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 121.487 0.661 . . . . 0.0 110.857 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.2 m -114.66 153.67 29.79 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.914 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.466 ' OH ' HD21 ' A' ' 105' ' ' LEU . 43.3 t80 -106.82 118.54 36.94 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.81 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.44 109.97 17.15 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.255 0.55 . . . . 0.0 111.139 -178.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.918 HG23 ' HA2' ' A' ' 42' ' ' GLY . 38.1 t -71.35 -64.73 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 113.519 -1.673 . . . . 0.0 110.397 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -133.8 117.25 16.66 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.583 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.487 ' CE1' HD12 ' A' ' 9' ' ' LEU . 12.1 t-80 -102.46 126.8 49.62 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.466 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -139.25 152.01 46.96 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.08 -13.14 59.54 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.042 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -107.77 3.13 24.19 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.306 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.07 166.27 15.16 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.424 ' O ' ' HE3' ' A' ' 135' ' ' TRP . . . -148.5 145.29 27.85 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.86 138.0 53.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.17 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.918 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.43 158.94 29.72 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.451 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.439 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.1 mt -112.77 131.89 55.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.042 0.421 . . . . 0.0 111.196 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 78' ' ' GLY . 15.9 t -66.04 123.43 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.69 55.07 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.598 0.713 . . . . 0.0 112.224 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.851 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.4 t-20 -147.55 -3.24 0.55 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.116 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -129.72 87.03 53.64 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.537 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.0 Cg_exo -60.27 147.29 94.19 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 121.695 1.597 . . . . 0.0 112.721 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.414 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 66.1 m -92.39 160.13 15.24 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.85 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.02 -2.19 64.64 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 116.144 -0.48 . . . . 0.0 113.711 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.477 ' O ' HG12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -90.16 152.78 20.95 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.731 0.3 . . . . 0.0 111.28 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 71' ' ' GLN . 17.1 p-10 -101.33 164.85 11.58 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.155 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.64 ' HA ' HD11 ' A' ' 75' ' ' ILE . 13.4 tp -60.26 -28.19 67.85 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 120.802 0.334 . . . . 0.0 111.739 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.55 98.79 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -63.99 -46.52 84.19 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.082 0.239 . . . . 0.0 111.625 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.865 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.5 m -61.91 -44.96 99.61 Favored 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.739 ' HA ' HD12 ' A' ' 60' ' ' LEU . 11.6 mt -56.58 -34.5 67.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.598 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.18 -27.5 48.01 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.317 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.85 -30.7 51.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.248 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.865 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.8 mt -77.87 -46.1 22.33 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.81 -1.541 . . . . 0.0 110.987 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -130.26 115.9 17.54 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -77.6 -32.9 2.59 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 123.589 2.859 . . . . 0.0 112.757 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.63 -14.91 56.12 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.291 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.43 150.38 23.82 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.355 0.409 . . . . 0.0 111.709 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.79 122.82 28.87 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.175 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.67 149.0 42.71 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 122.409 2.073 . . . . 0.0 112.25 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.446 ' C ' HE21 ' A' ' 71' ' ' GLN . 9.1 Cg_endo -94.86 -171.79 0.24 Allowed 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.57 2.18 . . . . 0.0 112.6 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.74 -24.5 67.58 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.116 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 7.8 ptp180 -68.55 -49.15 61.71 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.713 ' HA ' HD12 ' A' ' 73' ' ' ILE . 19.0 m -74.17 -26.03 60.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.083 0.553 . . . . 0.0 112.425 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.451 ' HA ' HD22 ' A' ' 52' ' ' ASN . 45.0 mt-30 -68.53 -27.54 66.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.949 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -97.51 18.85 14.45 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.439 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.713 HD12 ' HA ' ' A' ' 70' ' ' CYS . 65.0 mt -119.64 140.07 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.941 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -107.18 154.34 21.34 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.819 0.7 . . . . 0.0 112.851 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.8 HD13 HD12 ' A' ' 128' ' ' ILE . 20.7 mm -102.98 156.74 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.168 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.712 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.2 t80 -121.58 155.23 35.5 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -85.63 121.06 27.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 117.763 0.256 . . . . 0.0 110.471 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.571 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.97 -23.67 8.06 Favored Glycine 0 C--N 1.348 1.213 0 C-N-CA 120.206 -0.997 . . . . 0.0 114.211 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.52 -167.88 34.15 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.431 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -88.46 -13.55 3.43 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.468 2.778 . . . . 0.0 114.376 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.61 127.03 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 123.086 0.241 . . . . 0.0 111.148 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 46.99 84.18 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.406 1.082 . . . . 0.0 113.203 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -85.86 1.23 50.66 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.415 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -92.86 -10.76 35.51 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.843 HH21 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -133.03 150.82 52.11 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.008 0.432 . . . . 0.0 112.108 -179.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.598 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -110.24 144.88 17.07 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.172 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.8 OUTLIER -86.75 146.12 26.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.923 -1.139 . . . . 0.0 110.525 179.248 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.46 103.71 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 123.601 0.563 . . . . 0.0 109.949 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.872 HD11 HD13 ' A' ' 105' ' ' LEU . 11.4 tp -107.65 127.98 54.14 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.127 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -126.67 168.72 13.66 Favored Pre-proline 0 CA--C 1.556 1.196 0 CA-C-O 118.879 -0.581 . . . . 0.0 111.663 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.684 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.11 17.44 0.6 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.75 2.3 . . . . 0.0 113.691 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 t -105.31 159.49 15.85 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.808 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.84 19.58 54.19 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.752 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.8 mp -85.24 154.59 21.85 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.585 0.354 . . . . 0.0 110.912 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.2 p -125.49 156.95 38.15 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.567 ' CE2' HG23 ' A' ' 113' ' ' VAL . 56.7 m-85 -130.0 -149.3 0.4 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.495 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -60.41 -45.69 92.68 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.406 0.283 . . . . 0.0 111.323 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.3 m -137.09 85.24 2.12 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.492 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 107' ' ' MET . 13.8 m -129.89 129.16 43.55 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.712 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -112.42 123.21 49.79 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.871 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.93 125.12 29.33 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.447 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -135.09 76.96 1.65 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.973 0.892 . . . . 0.0 112.041 -177.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.592 ' O ' ' HG2' ' A' ' 104' ' ' GLU . . . 43.25 104.88 0.01 OUTLIER Glycine 0 N--CA 1.475 1.279 0 CA-C-N 113.677 -1.601 . . . . 0.0 114.823 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 103' ' ' GLY . 10.4 pt-20 61.36 -15.86 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.777 1.231 . . . . 0.0 113.25 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.872 HD13 HD11 ' A' ' 89' ' ' LEU . 2.7 pp -132.88 145.56 51.04 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-O 120.806 0.336 . . . . 0.0 110.451 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.578 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -114.84 155.46 26.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.986 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 99' ' ' THR . 16.9 ttm -121.66 128.96 52.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.649 ' HB3' HG11 ' A' ' 113' ' ' VAL . 49.9 m -128.57 129.64 46.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 p -119.65 16.39 12.8 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.311 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.705 ' O ' HG12 ' A' ' 113' ' ' VAL . 45.0 p -91.17 131.0 36.99 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-O 121.737 0.78 . . . . 0.0 112.439 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.491 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 11.7 pt20 -61.43 -27.74 68.76 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.3 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.17 -43.42 95.19 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.484 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 117' ' ' ILE . 4.6 p -69.56 -36.4 70.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.46 HD13 HH12 ' A' ' 85' ' ' ARG . 5.4 tp -58.64 -49.43 77.56 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 123.472 0.482 . . . . 0.0 110.372 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.491 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 31.8 m-85 -68.19 -38.74 82.31 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.907 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.1 -52.74 63.64 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.269 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -65.48 -43.83 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.672 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -56.6 -32.59 65.4 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.714 0.634 . . . . 0.0 109.579 178.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.477 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.71 -19.53 32.61 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.316 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.62 14.99 33.13 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.748 -1.114 . . . . 0.0 114.739 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.9 p -104.88 6.53 33.84 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.52 -138.29 9.59 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.169 -0.795 . . . . 0.0 112.515 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.25 172.99 12.16 Favored 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 123.128 2.552 . . . . 0.0 113.611 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.61 -55.0 40.46 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.966 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.684 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 11.9 mmtt -141.63 139.93 33.16 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.843 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 67.3 m -137.67 166.83 22.99 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tp -125.38 116.46 21.91 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.601 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.8 HD12 HD13 ' A' ' 75' ' ' ILE . 9.8 pt -99.15 102.57 13.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 O-C-N 123.82 0.7 . . . . 0.0 109.45 178.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.9 t -120.26 120.78 37.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.031 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.08 112.86 4.63 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.488 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.66 171.54 19.13 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.88 -1.055 . . . . 0.0 114.405 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.38 176.12 7.96 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.099 -0.55 . . . . 0.0 110.397 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -115.36 131.01 57.06 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.161 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.94 150.26 18.72 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.549 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.424 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 26.4 m-90 -127.78 136.12 51.05 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 123.902 0.413 . . . . 0.0 110.408 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.08 158.07 26.52 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.922 0.764 . . . . 0.0 110.725 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.27 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.43 -24.84 7.15 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 115.408 -0.815 . . . . 0.0 113.042 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.71 -45.46 85.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.968 0.507 . . . . 0.0 112.28 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -68.04 -48.25 66.15 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.187 0.304 . . . . 0.0 110.594 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -59.63 -29.39 67.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 120.98 0.419 . . . . 0.0 110.715 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.4 -50.42 38.87 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.84 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -70.35 -26.67 63.85 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.847 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.1 tp -76.02 -37.87 57.91 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.745 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.5 t -77.78 -29.03 50.7 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.202 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.7 t70 -82.64 0.21 44.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.395 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 59.64 29.51 19.08 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.944 0.897 . . . . 0.0 111.507 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.76 -42.76 19.31 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.949 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -124.52 113.65 18.38 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.2 tp -85.04 139.49 31.71 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.634 0.254 . . . . 0.0 111.371 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.5 p -104.46 137.85 41.72 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.047 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 74.3 m -151.69 154.95 33.74 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.816 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.76 153.26 51.16 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.314 2.009 . . . . 0.0 111.074 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.485 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -128.42 166.37 18.85 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -133.66 135.9 25.78 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.207 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.433 ' HG3' ' OE1' ' A' ' 104' ' ' GLU . 72.6 Cg_endo -73.51 -26.44 14.08 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 122.553 2.168 . . . . 0.0 113.684 -178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.11 62.17 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.9 0.75 . . . . 0.0 112.157 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.589 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.7 mt -72.31 -34.87 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.328 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.35 -36.16 63.59 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.277 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -85.28 -36.87 20.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -83.65 -71.96 0.48 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 117.927 0.331 . . . . 0.0 111.786 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 166' ' ' GLU . 1.1 tp -142.29 98.97 5.97 Favored Pre-proline 0 C--N 1.349 0.544 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.851 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.2 Cg_endo -91.8 0.21 4.39 Favored 'Trans proline' 0 CA--C 1.571 2.349 0 C-N-CA 121.652 1.568 . . . . 0.0 114.319 175.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.641 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 66.2 Cg_endo -75.46 -50.67 0.12 Allowed 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.609 2.206 . . . . 0.0 114.607 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.516 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 11.4 mt-10 -121.44 -34.06 3.52 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.731 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 162' ' ' LEU . 9.0 mt-10 -69.04 -10.77 59.23 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.135 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.753 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.06 -41.57 41.86 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.8 tp -70.65 -49.98 41.6 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 43.8 m -58.5 -48.76 79.74 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.637 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.677 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.31 -40.19 95.41 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.148 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.87 -46.46 78.25 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 123.568 0.542 . . . . 0.0 110.435 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.45 91.22 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.423 177.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.55 -27.25 68.3 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.676 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.677 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.82 -39.93 42.09 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 122.823 0.449 . . . . 0.0 110.327 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.83 -31.85 68.71 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.376 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.68 54.81 0.56 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.834 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 12.5 t -127.57 147.36 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -86.81 77.75 9.21 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.676 0.751 . . . . 0.0 110.622 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -26.18 49.81 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.029 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.7 m -58.81 -41.95 87.99 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.59 -26.67 50.94 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 18.0 mt -77.14 -38.12 52.56 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.8 p -94.31 -48.35 6.2 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.277 0.361 . . . . 0.0 111.397 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 57.76 118.75 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.173 0.989 . . . . 0.0 112.74 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -100.81 147.08 26.48 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.04 140.23 34.57 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.078 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -150.92 -96.48 0.15 Allowed Glycine 0 C--N 1.337 0.595 0 O-C-N 123.691 0.619 . . . . 0.0 112.5 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -99.47 -40.46 7.84 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.602 0.237 . . . . 0.0 111.279 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.167 -0.92 . . . . 0.0 111.081 -179.94 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.262 0.077 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -100.34 131.33 46.33 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.425 0.453 . . . . 0.0 111.041 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -99.59 -41.41 7.35 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.188 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 m -99.14 153.0 19.24 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.99 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.9 m -93.35 104.25 11.82 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.047 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -86.36 6.79 5.27 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.821 2.347 . . . . 0.0 112.249 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.8 m -109.14 -53.65 2.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.606 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -114.75 151.39 33.81 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.389 0.431 . . . . 0.0 111.427 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mt -104.1 55.07 0.73 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.552 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -91.89 17.21 9.5 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.765 0.317 . . . . 0.0 111.396 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 175.99 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.845 0.858 . . . . 0.0 110.474 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -136.95 158.97 43.25 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.305 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 30' ' ' THR . 13.7 m-30 -98.42 136.15 38.97 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.679 HD11 HD23 ' A' ' 32' ' ' LEU . 6.2 mt -105.39 139.2 40.38 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.936 177.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -120.15 132.53 69.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 123.572 0.545 . . . . 0.0 109.636 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.23 120.57 18.01 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.926 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.8 mmt -103.22 155.24 36.96 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.166 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -82.9 32.92 0.52 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.669 2.246 . . . . 0.0 112.965 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -87.01 -13.28 44.91 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.254 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -169.52 1.83 Allowed 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.984 0.178 . . . . 0.0 110.876 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.543 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -105.09 42.19 1.25 Allowed 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.079 0.466 . . . . 0.0 111.583 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -111.58 80.72 2.88 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.88 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 5.1 Cg_exo -75.49 -16.99 18.87 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.081 2.521 . . . . 0.0 113.404 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -84.56 -38.41 20.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.845 0.458 . . . . 0.0 111.875 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.23 3.88 53.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.175 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.97 162.77 21.25 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.803 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 49.39 33.36 5.38 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.9 p -119.96 154.0 35.12 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 120.562 0.22 . . . . 0.0 110.445 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.621 HG11 ' HE ' ' A' ' 167' ' ' ARG . 99.8 t -129.41 134.95 62.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.503 0.668 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.3 m -116.91 155.26 29.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.875 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.422 ' OH ' HD11 ' A' ' 105' ' ' LEU . 22.6 t80 -109.67 117.34 33.65 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.749 HD11 ' HB1' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -77.46 108.14 10.4 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 123.499 0.5 . . . . 0.0 110.943 -179.17 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.945 HG23 ' HA2' ' A' ' 42' ' ' GLY . 51.8 t -66.29 -58.74 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 113.967 -1.47 . . . . 0.0 110.409 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -144.39 122.5 12.15 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.235 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -100.52 129.12 46.43 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.987 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -139.6 152.07 46.53 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.591 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.03 -22.63 66.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.657 0.383 . . . . 0.0 112.0 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -94.12 -5.35 47.46 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.346 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.94 176.16 27.76 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 121.579 -0.343 . . . . 0.0 112.333 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.749 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -148.57 148.29 30.0 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.416 ' O ' HD13 ' A' ' 32' ' ' LEU . 1.1 tpp -121.67 136.45 54.94 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.105 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.945 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -156.4 159.56 29.54 Favored Glycine 0 N--CA 1.447 -0.614 0 O-C-N 124.409 1.068 . . . . 0.0 112.446 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.451 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.2 mt -113.71 131.34 56.21 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.118 0.459 . . . . 0.0 111.365 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 78' ' ' GLY . 7.9 t -66.62 121.77 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.526 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.2 pt -125.87 54.82 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.561 0.696 . . . . 0.0 112.377 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.855 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.6 t-20 -147.96 -2.31 0.55 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.09 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -130.21 88.03 49.23 Favored Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.529 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 42.9 Cg_exo -59.08 145.04 99.02 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 121.648 1.565 . . . . 0.0 112.412 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.433 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 71.5 m -94.57 161.06 14.36 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.41 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -100.89 51.34 0.97 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.806 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' C ' HG12 ' A' ' 75' ' ' ILE . 1.1 mt -133.48 156.33 47.94 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 123.86 0.388 . . . . 0.0 110.044 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.509 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 20.3 p-10 -112.7 159.67 18.68 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.836 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.474 HD13 HD13 ' A' ' 128' ' ' ILE . 14.3 tp -59.15 -28.28 66.44 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.08 96.77 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.39 -45.47 87.54 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.068 0.23 . . . . 0.0 111.559 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.874 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 16.7 m -62.45 -44.5 99.33 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.712 ' HA ' HD12 ' A' ' 60' ' ' LEU . 13.3 mt -57.48 -33.85 68.43 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.552 177.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -78.25 -27.92 47.64 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.27 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -77.87 -30.96 51.09 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.297 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.874 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 13.1 mt -77.85 -45.62 23.8 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 113.851 -1.522 . . . . 0.0 111.113 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -130.34 115.83 17.44 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.623 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.7 -32.91 2.53 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.664 2.91 . . . . 0.0 112.759 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -81.66 -14.91 56.05 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.423 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.63 149.91 23.99 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.401 0.438 . . . . 0.0 111.679 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -119.14 123.0 29.13 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.232 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.03 149.7 36.94 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.318 2.012 . . . . 0.0 112.389 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.409 ' HD2' ' SG ' ' A' ' 70' ' ' CYS . 9.5 Cg_endo -95.1 -171.61 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.576 2.184 . . . . 0.0 112.532 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.29 -24.52 67.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.294 0.638 . . . . 0.0 112.007 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 73' ' ' ILE . 9.8 ptp180 -68.72 -47.93 65.11 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.709 ' HA ' HD12 ' A' ' 73' ' ' ILE . 25.5 m -74.51 -25.91 59.65 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.555 0.535 . . . . 0.0 112.38 -178.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.446 ' HA ' HD22 ' A' ' 52' ' ' ASN . 44.8 mt-30 -69.5 -26.97 64.8 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.797 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -97.36 20.46 11.54 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.497 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 70' ' ' CYS . 59.4 mt -122.16 138.97 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.737 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -104.34 164.17 11.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.471 HG12 ' C ' ' A' ' 51' ' ' LEU . 13.6 mm -114.17 152.45 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.822 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.728 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -115.81 156.09 26.69 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.482 0.313 . . . . 0.0 110.429 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.36 119.92 27.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.615 0.189 . . . . 0.0 110.623 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.566 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.78 -23.45 8.72 Favored Glycine 0 C--N 1.346 1.1 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.884 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.99 -168.29 32.92 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.371 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -88.42 -13.9 3.35 Favored 'Trans proline' 0 C--N 1.359 1.129 0 C-N-CA 123.513 2.809 . . . . 0.0 114.356 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.73 131.04 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 123.119 0.262 . . . . 0.0 111.29 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 47.79 83.14 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.366 1.066 . . . . 0.0 113.09 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.1 t -84.07 1.03 45.95 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.348 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -93.77 -18.4 22.11 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.634 ' CZ ' ' H ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -133.2 147.37 52.02 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.968 0.413 . . . . 0.0 111.562 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.634 ' H ' ' CZ ' ' A' ' 85' ' ' ARG . . . -112.65 152.69 17.82 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.646 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.45 ' HE2' ' SD ' ' A' ' 107' ' ' MET . 1.2 m-85 -86.33 153.86 21.64 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.352 1.061 . . . . 0.0 111.174 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 127' ' ' LEU . 3.7 t -127.85 103.65 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.666 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.648 ' O ' ' HA ' ' A' ' 126' ' ' SER . 0.3 OUTLIER -98.28 127.39 44.19 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.652 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -129.1 160.76 62.08 Favored Pre-proline 0 CA--C 1.552 1.03 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.614 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 27.2 Cg_endo -99.58 33.83 0.1 OUTLIER 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.916 2.41 . . . . 0.0 113.468 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.3 t -118.13 159.08 23.88 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.749 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.58 21.15 47.65 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.646 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.28 153.62 21.07 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.556 0.342 . . . . 0.0 110.58 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.0 p -122.94 153.58 39.52 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.653 ' CD2' HG12 ' A' ' 113' ' ' VAL . 27.8 m-85 -131.93 -150.98 0.44 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.733 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -62.4 -48.62 78.89 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 122.507 0.323 . . . . 0.0 111.103 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.7 m -132.68 78.41 1.8 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.324 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 107' ' ' MET . 11.1 m -126.49 115.44 19.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.616 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.01 123.45 44.26 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.803 178.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -83.47 127.48 33.74 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.318 0.58 . . . . 0.0 110.859 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.496 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -120.33 50.01 1.36 Allowed 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.521 -1.218 . . . . 0.0 110.567 -179.422 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.29 -109.62 3.01 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 114.579 -1.191 . . . . 0.0 113.41 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' OE1' ' HD3' ' A' ' 156' ' ' PRO . 10.8 pt-20 -63.1 -6.85 4.56 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.422 HD11 ' OH ' ' A' ' 31' ' ' TYR . 3.3 pp -152.08 160.01 43.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -122.58 158.84 29.04 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' ' 99' ' ' THR . 19.1 ttm -124.48 134.76 52.94 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.7 m -135.65 133.24 37.97 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 67.1 p -126.37 21.83 7.19 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.316 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.871 ' O ' HG22 ' A' ' 113' ' ' VAL . 10.7 t -89.26 130.31 35.68 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.13 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.492 ' HA ' HD12 ' A' ' 114' ' ' LEU . 21.2 pt20 -60.33 -28.3 68.03 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.554 0.692 . . . . 0.0 109.608 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -63.63 -44.7 93.12 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.925 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.871 HG22 ' O ' ' A' ' 110' ' ' SER . 18.7 m -62.01 -42.64 95.65 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 111' ' ' GLN . 31.4 mt -54.66 -52.19 63.09 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.795 0.685 . . . . 0.0 111.992 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.461 ' HD2' ' O ' ' A' ' 111' ' ' GLN . 50.2 m-85 -64.86 -46.05 83.47 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.329 0.393 . . . . 0.0 111.585 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.83 63.89 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.029 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.839 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.5 tp -63.84 -43.92 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.92 -30.68 66.12 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.797 0.685 . . . . 0.0 109.762 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.63 -19.99 30.16 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.023 176.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.63 19.04 21.47 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.68 -1.145 . . . . 0.0 114.636 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.8 p -111.03 9.09 22.11 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -95.91 -137.78 9.42 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-O 119.256 -0.747 . . . . 0.0 112.756 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.72 167.65 22.13 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.284 2.656 . . . . 0.0 113.509 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.488 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -49.65 -58.19 5.74 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.378 1.071 . . . . 0.0 111.754 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.519 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.6 mmtt -138.76 154.61 48.53 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 66.3 m -149.63 163.96 36.47 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 2.3 tp -130.31 115.08 16.43 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.883 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 73' ' ' ILE . 11.1 pt -98.03 107.86 20.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.399 0.618 . . . . 0.0 109.508 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 60.1 p -125.4 122.13 35.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.762 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.1 tp -67.5 117.51 9.55 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.604 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.444 ' O ' ' HA3' ' A' ' 78' ' ' GLY . . . 70.05 167.69 6.43 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.183 -0.917 . . . . 0.0 114.271 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -128.5 174.16 9.6 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.157 0.503 . . . . 0.0 110.958 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -109.98 132.23 54.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.497 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.58 144.34 15.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.496 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -122.49 133.63 54.59 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.961 0.448 . . . . 0.0 110.585 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.77 158.95 23.95 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.321 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.57 125.42 11.36 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.746 0.418 . . . . 0.0 111.81 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.01 -26.45 7.64 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.119 -0.562 . . . . 0.0 114.475 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -58.3 -49.1 78.38 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.574 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.6 tm? -66.34 -49.36 67.2 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.0 0.188 . . . . 0.0 110.807 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.45 -31.59 66.07 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.472 0.482 . . . . 0.0 110.567 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -68.83 -50.12 52.69 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.157 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.8 pt-20 -71.86 -26.73 62.47 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.059 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.8 tp -75.34 -38.19 60.29 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.673 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.5 m -77.95 -29.99 50.16 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.291 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -81.46 -1.02 44.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.577 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 60.29 30.1 19.55 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.779 0.832 . . . . 0.0 111.658 -179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.22 -43.04 18.15 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.93 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -125.36 114.76 19.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.7 tp -86.24 138.53 31.79 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.588 0.218 . . . . 0.0 111.588 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.0 p -101.75 137.52 39.94 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.488 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 77.6 m -149.95 146.19 20.01 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-O 119.192 -0.433 . . . . 0.0 111.4 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.27 148.18 91.0 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 122.286 1.991 . . . . 0.0 110.584 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.487 ' HA ' ' CZ ' ' A' ' 174' ' ' ARG . . . -134.11 176.32 8.69 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 115.327 1.602 . . . . 0.0 115.327 -176.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -132.26 142.17 44.04 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 113.549 -1.66 . . . . 0.0 108.671 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.418 ' HD3' ' OE1' ' A' ' 104' ' ' GLU . 92.3 Cg_endo -76.11 -26.51 9.14 Favored 'Trans proline' 0 C--N 1.364 1.392 0 C-N-CA 122.692 2.262 . . . . 0.0 114.177 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -49.77 -42.11 45.75 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.774 0.671 . . . . 0.0 112.448 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.73 HD13 HH12 ' A' ' 167' ' ' ARG . 4.6 mt -69.52 -32.65 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-O 121.492 0.663 . . . . 0.0 110.229 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.0 tt -75.81 -38.87 57.76 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.687 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.425 ' HE1' ' O ' ' A' ' 89' ' ' LEU . 42.8 m-85 -86.51 -29.7 22.52 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -87.02 -72.56 0.5 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.106 0.412 . . . . 0.0 111.378 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.897 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -142.18 98.73 6.07 Favored Pre-proline 0 C--N 1.348 0.514 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.855 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 60.4 Cg_endo -91.55 0.08 4.55 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 C-N-CA 121.657 1.571 . . . . 0.0 114.28 175.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.649 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 87.5 Cg_endo -74.11 -54.16 0.1 Allowed 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.655 2.237 . . . . 0.0 114.445 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.549 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.1 mt-10 -121.05 -29.55 4.54 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.7 -177.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.897 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.6 tt0 -70.56 -11.24 60.8 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.417 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.73 HH12 HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -76.66 -43.99 35.73 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -69.37 -50.21 48.28 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 m -57.65 -49.57 76.01 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.769 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.33 96.77 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.096 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.54 -46.61 80.56 Favored 'General case' 0 C--N 1.352 0.681 0 O-C-N 123.637 0.586 . . . . 0.0 110.729 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.94 -36.12 82.47 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.7 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.45 -31.44 72.61 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.446 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.487 ' CZ ' ' HA ' ' A' ' 154' ' ' ALA . 11.3 mtm-85 -77.55 -41.5 38.81 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.793 0.437 . . . . 0.0 110.548 178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 tp -64.48 -34.1 77.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.676 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 123.47 44.78 0.3 Allowed Glycine 0 C--N 1.339 0.747 0 C-N-CA 121.041 -0.599 . . . . 0.0 113.017 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 6.9 t -128.58 138.71 53.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -89.56 80.81 6.6 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.653 0.74 . . . . 0.0 110.836 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -77.94 -26.3 48.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.252 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.8 m -59.12 -44.1 91.99 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.53 -26.56 51.14 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.9 mt -76.97 -36.36 56.55 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.334 0.396 . . . . 0.0 111.922 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 24.1 p -94.21 -48.82 6.02 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.319 0.387 . . . . 0.0 111.247 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 57.33 118.27 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.211 1.004 . . . . 0.0 112.771 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -107.11 13.37 27.46 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.479 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.32 145.69 50.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.118 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -160.31 69.74 0.24 Allowed Glycine 0 C--N 1.338 0.681 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.558 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -128.36 141.55 51.39 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 123.625 0.25 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.117 179.966 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.565 0.221 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -108.83 130.4 55.4 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.015 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -100.87 -42.0 6.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.099 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.8 m -100.37 153.07 19.63 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 123.511 0.507 . . . . 0.0 110.944 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.8 t -92.23 106.53 18.26 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -85.41 7.91 4.86 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.722 2.281 . . . . 0.0 112.263 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.2 m -116.11 -53.52 2.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.776 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -110.94 152.22 27.02 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.654 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.454 ' O ' HD12 ' A' ' 32' ' ' LEU . 17.5 mt -97.22 50.64 1.08 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.988 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.422 ' NZ ' ' HG3' ' A' ' 34' ' ' GLU . 27.6 tttm -92.88 19.29 7.84 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.113 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.6 t60 173.79 56.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.039 0.936 . . . . 0.0 109.641 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 153' ' ' PRO . 30.2 m80 -139.28 160.96 38.59 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.461 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 17.1 m-30 -99.09 137.44 37.6 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.057 0.456 . . . . 0.0 111.914 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.839 HD11 HD23 ' A' ' 32' ' ' LEU . 2.0 mt -108.16 140.97 40.59 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.202 177.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.55 137.21 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 123.352 0.407 . . . . 0.0 110.139 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.77 119.22 17.69 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.699 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 14.6 mmt -99.44 159.82 29.07 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.617 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.91 5.24 5.07 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.716 2.277 . . . . 0.0 113.652 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -77.34 -14.22 59.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.506 0.322 . . . . 0.0 111.856 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.724 ' SD ' ' HB2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -104.4 154.98 19.18 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.264 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.44 48.67 1.41 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.253 0.549 . . . . 0.0 112.021 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.724 ' HB2' ' SD ' ' A' ' 20' ' ' MET . 8.2 m-20 -125.05 89.66 52.27 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.626 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.54 -16.83 21.25 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.905 2.404 . . . . 0.0 113.388 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -84.47 -35.23 23.12 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 122.826 0.45 . . . . 0.0 111.772 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -93.41 3.96 54.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.045 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.49 163.21 21.52 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.847 0.356 . . . . 0.0 111.835 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 49.1 32.41 4.03 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.3 p -118.0 154.51 31.87 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 120.541 0.21 . . . . 0.0 110.694 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.784 HG11 ' HE ' ' A' ' 167' ' ' ARG . 60.7 t -129.76 133.15 65.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.773 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.2 m -113.74 153.57 28.79 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.759 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.429 ' OH ' HD21 ' A' ' 105' ' ' LEU . 33.4 t80 -107.66 116.82 32.63 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.839 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -82.38 109.52 16.7 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 121.457 0.646 . . . . 0.0 111.03 -178.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.938 HG23 ' HA2' ' A' ' 42' ' ' GLY . 29.6 t -70.22 -66.21 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 113.161 -1.836 . . . . 0.0 110.132 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' HG3' ' NZ ' ' A' ' 10' ' ' LYS . 6.6 tt0 -132.55 119.83 21.05 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.726 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -102.97 126.59 50.21 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.428 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -139.51 152.11 46.68 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.504 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.2 -19.56 65.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.832 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -97.73 -3.73 38.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.428 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.26 171.14 22.24 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 112.277 -0.329 . . . . 0.0 112.277 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.526 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -148.26 146.9 28.82 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.1 mpp? -122.81 136.34 54.84 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.615 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.938 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -158.12 158.79 29.48 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.334 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 42' ' ' GLY . 2.3 mt -114.75 133.72 55.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.055 0.427 . . . . 0.0 111.367 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 78' ' ' GLY . 14.9 t -67.69 123.21 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.6 54.55 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.57 0.7 . . . . 0.0 112.126 -178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.852 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 22.4 t-20 -147.66 -3.21 0.54 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.156 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -129.67 87.24 53.17 Favored Pre-proline 0 CA--C 1.554 1.133 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.515 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 32.6 Cg_exo -59.39 142.77 99.52 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 121.702 1.602 . . . . 0.0 112.252 175.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.432 ' H ' ' HA ' ' A' ' 76' ' ' TYR . 62.4 m -91.72 158.27 16.47 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.479 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -98.29 50.52 1.3 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.842 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 mt -133.55 158.04 44.15 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.743 0.417 . . . . 0.0 110.046 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.517 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 17.7 p-10 -112.07 158.98 18.93 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.204 0.315 . . . . 0.0 110.423 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 128' ' ' ILE . 12.7 tp -59.21 -36.16 74.9 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.08 -38.4 65.28 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -64.76 -40.2 94.88 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.36 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.847 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.0 t -61.8 -50.82 78.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.65 ' HA ' HD12 ' A' ' 60' ' ' LEU . 4.8 mp -52.31 -36.38 53.01 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.978 0.799 . . . . 0.0 111.099 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.94 -29.18 49.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.451 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -31.72 46.55 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.713 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.847 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 11.5 mt -77.56 -44.63 27.9 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.833 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -131.93 116.8 15.87 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.479 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.49 -33.11 2.57 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.585 2.857 . . . . 0.0 112.844 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -82.2 -13.79 56.58 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.388 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.42 149.62 24.33 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.291 0.37 . . . . 0.0 111.721 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.68 123.72 29.5 Favored Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.972 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.97 143.84 29.66 Favored 'Trans proline' 0 C--N 1.369 1.619 0 C-N-CA 122.271 1.981 . . . . 0.0 112.414 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.511 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 5.1 Cg_endo -91.93 -169.65 0.28 Allowed 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.576 2.184 . . . . 0.0 111.85 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.487 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -64.23 -24.92 67.84 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.224 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.515 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 8.8 ptp180 -66.91 -51.61 53.29 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.711 ' HA ' HD12 ' A' ' 73' ' ' ILE . 58.2 m -72.46 -25.07 61.3 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 47.4 mt-30 -68.21 -34.84 77.01 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.487 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 21.8 p80 -91.12 22.53 3.7 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.115 0.484 . . . . 0.0 111.649 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 70' ' ' CYS . 58.9 mt -119.22 139.44 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.312 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.59 157.05 17.97 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.625 HD13 HD12 ' A' ' 128' ' ' ILE . 22.5 mm -103.7 152.69 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.853 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.713 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.1 t80 -118.68 154.71 32.27 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -85.82 120.48 27.28 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.623 0.192 . . . . 0.0 110.649 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -103.33 -23.64 8.35 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 120.082 -1.056 . . . . 0.0 114.006 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.98 -167.62 34.34 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.324 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -88.16 -12.17 4.16 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 123.364 2.71 . . . . 0.0 114.136 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.47 126.35 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 123.094 0.246 . . . . 0.0 110.596 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 50.26 79.02 0.09 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.099 0.96 . . . . 0.0 112.46 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.466 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.5 t -83.01 1.57 39.3 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.554 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -102.63 2.74 36.39 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.477 HH21 ' HB3' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -133.07 154.62 50.38 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -179.386 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.47 128.58 9.02 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.778 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -85.64 144.82 27.63 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.436 1.095 . . . . 0.0 109.936 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.87 105.86 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.142 0.276 . . . . 0.0 110.963 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.82 HD11 HD13 ' A' ' 105' ' ' LEU . 10.9 tp -107.57 127.82 53.98 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -123.35 164.35 28.55 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-O 118.998 -0.525 . . . . 0.0 111.762 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 12.4 Cg_endo -94.86 14.62 1.25 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.659 2.239 . . . . 0.0 113.615 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.1 t -101.81 157.52 16.79 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.73 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.12 20.98 48.38 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.631 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 tp -85.66 154.7 21.49 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 122.611 0.364 . . . . 0.0 110.321 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.6 p -118.89 151.89 37.3 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.668 ' CD2' HG12 ' A' ' 113' ' ' VAL . 18.2 m-85 -130.68 -150.59 0.43 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.469 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -62.05 -47.6 83.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.775 0.321 . . . . 0.0 111.065 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 108' ' ' SER . 66.7 m -135.12 81.22 1.88 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.136 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 107' ' ' MET . 19.2 m -127.48 119.45 26.1 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.412 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -105.0 122.11 45.18 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.96 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -79.3 124.24 28.21 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.462 HD21 ' O ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -136.43 77.85 1.67 Allowed 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.862 0.839 . . . . 0.0 111.829 -177.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.578 ' O ' ' HG2' ' A' ' 104' ' ' GLU . . . 44.33 103.0 0.01 OUTLIER Glycine 0 N--CA 1.474 1.223 0 CA-C-N 113.679 -1.6 . . . . 0.0 114.676 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 103' ' ' GLY . 10.7 pt-20 60.75 -14.72 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.85 1.26 . . . . 0.0 113.426 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.82 HD13 HD11 ' A' ' 89' ' ' LEU . 2.8 pp -132.68 145.51 51.11 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-O 120.705 0.288 . . . . 0.0 110.486 178.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.614 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -114.8 155.61 26.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.056 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.584 ' O ' ' HA ' ' A' ' 99' ' ' THR . 15.2 ttm -120.33 122.15 40.2 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 98' ' ' SER . 51.0 m -121.25 129.59 53.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.209 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.1 p -119.43 22.12 11.86 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.886 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.815 ' O ' HG22 ' A' ' 113' ' ' VAL . 61.7 m -92.29 126.19 37.27 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.215 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.502 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 10.8 pt20 -59.9 -28.08 67.27 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.394 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.29 -49.15 76.82 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.872 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.843 ' O ' HG22 ' A' ' 117' ' ' ILE . 16.6 m -59.43 -40.44 81.71 Favored 'Isoleucine or valine' 0 C--N 1.361 1.068 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.6 tp -56.86 -54.06 50.8 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.684 0.615 . . . . 0.0 111.534 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.502 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 61.4 m-85 -67.02 -42.5 84.8 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.341 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.38 -51.7 68.79 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.542 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.843 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.2 tp -64.15 -43.3 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.378 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.49 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -57.88 -30.26 65.7 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.893 0.745 . . . . 0.0 109.79 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.515 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -86.16 -19.92 29.37 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.09 176.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.15 15.65 29.96 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 114.558 -1.201 . . . . 0.0 114.696 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.4 p -107.22 8.42 29.95 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -96.95 -138.02 9.84 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.261 -0.744 . . . . 0.0 112.641 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.56 171.19 16.14 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 123.332 2.688 . . . . 0.0 113.557 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.481 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 0.8 OUTLIER -51.11 -57.16 9.43 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.211 1.004 . . . . 0.0 111.604 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 13.5 mmtt -140.03 156.59 46.54 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.533 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 73.5 m -149.26 161.83 41.24 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.6 tp -126.61 115.7 19.88 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.326 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.648 HD13 HD13 ' A' ' 53' ' ' LEU . 13.3 pt -97.4 102.12 13.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.781 0.801 . . . . 0.0 109.685 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.5 t -119.36 121.86 40.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.606 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 83' ' ' THR . 8.9 tp -67.32 113.7 5.43 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.111 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.24 173.17 6.08 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-N 114.714 -1.13 . . . . 0.0 114.314 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -128.49 178.23 6.44 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.314 0.578 . . . . 0.0 110.73 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -114.23 129.54 56.63 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.151 178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.61 147.56 17.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.37 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.413 ' HE3' ' O ' ' A' ' 40' ' ' ALA . 29.6 m-90 -125.33 136.31 53.34 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 123.886 0.403 . . . . 0.0 110.35 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -80.19 158.27 26.32 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.901 0.751 . . . . 0.0 110.66 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.76 89.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.16 -23.79 7.57 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.161 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -56.58 -46.31 80.85 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.949 0.5 . . . . 0.0 112.231 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.573 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 14.4 tp -67.22 -47.88 69.51 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -57.35 -30.55 64.93 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.467 0.479 . . . . 0.0 110.77 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.19 -50.3 41.56 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.914 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.6 pt-20 -71.85 -26.7 62.47 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.924 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 5.0 tp -75.06 -39.23 61.02 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.833 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.5 m -78.14 -30.37 49.27 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.507 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.5 t70 -80.24 0.49 32.39 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.674 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 59.72 29.85 19.43 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.826 0.85 . . . . 0.0 111.645 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.32 -41.75 19.66 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.794 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -123.47 112.21 17.24 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 5.9 tp -84.13 138.37 33.06 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.533 0.206 . . . . 0.0 111.148 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 19.9 p -105.19 138.89 40.68 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.311 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.2 m -152.57 155.47 32.7 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.725 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.413 ' HA ' ' CD2' ' A' ' 12' ' ' HIS . 31.7 Cg_exo -59.06 153.52 51.35 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.332 2.021 . . . . 0.0 111.12 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.461 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -129.09 168.36 16.21 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.75 135.76 24.01 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.138 177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.414 ' HG3' ' OE1' ' A' ' 104' ' ' GLU . 72.9 Cg_endo -73.48 -26.48 14.12 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 122.591 2.194 . . . . 0.0 113.687 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.43 -40.44 62.2 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.885 0.74 . . . . 0.0 112.132 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.604 HD13 HH12 ' A' ' 167' ' ' ARG . 4.8 mt -71.68 -34.8 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.385 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.33 -36.96 63.69 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.279 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -84.92 -35.32 22.18 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -84.13 -72.45 0.46 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.006 0.367 . . . . 0.0 111.624 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.886 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.67 99.61 6.23 Favored Pre-proline 0 C--N 1.348 0.539 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.852 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 64.7 Cg_endo -91.24 -0.84 4.78 Favored 'Trans proline' 0 CA--C 1.569 2.266 0 C-N-CA 121.637 1.558 . . . . 0.0 114.271 175.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.648 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 74.6 Cg_endo -74.18 -52.95 0.12 Allowed 'Trans proline' 0 C--N 1.392 2.861 0 C-N-CA 122.656 2.238 . . . . 0.0 114.519 -178.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.53 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.5 mt-10 -122.17 -30.35 4.04 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.746 -177.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.886 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 5.0 tp10 -69.8 -11.42 60.84 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.364 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.784 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.96 -41.71 41.99 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.296 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.38 -50.04 42.92 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -58.29 -49.0 78.68 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.717 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.672 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.34 -39.96 94.94 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.122 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.13 -46.72 79.1 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.626 0.579 . . . . 0.0 110.461 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.02 -38.45 91.24 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.398 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.6 -27.81 68.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.705 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.672 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.8 mmp_? -77.7 -40.01 42.77 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 122.876 0.47 . . . . 0.0 110.4 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -72.82 -30.37 64.0 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.44 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.67 57.37 0.93 Allowed Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.284 -0.484 . . . . 0.0 112.841 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.09 150.91 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -83.38 78.69 9.6 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.701 0.762 . . . . 0.0 110.868 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.7 -26.2 49.96 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.003 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.1 m -56.29 -38.68 71.55 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.16 -26.54 53.15 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 11.0 mt -76.62 -34.84 58.34 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.307 0.379 . . . . 0.0 111.507 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.9 p -85.92 -48.1 9.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.562 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -128.75 117.94 21.97 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.566 0.541 . . . . 0.0 111.308 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -99.73 140.86 33.32 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.853 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.43 141.69 32.93 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 150.14 97.89 0.18 Allowed Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.53 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -99.56 -40.31 7.88 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.661 0.271 . . . . 0.0 111.32 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.443 -0.789 . . . . 0.0 111.161 179.961 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.517 0.199 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -129.33 149.89 50.93 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -128.55 -50.4 1.27 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.346 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.0 p -138.61 -51.27 0.56 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.313 0.383 . . . . 0.0 111.48 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 54.2 m -134.78 122.97 15.78 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.293 -0.384 . . . . 0.0 111.042 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 5' ' ' SER . 7.1 Cg_endo -90.93 5.0 4.18 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.653 2.235 . . . . 0.0 112.594 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -99.83 162.33 13.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.153 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 60.8 149.0 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.341 1.056 . . . . 0.0 113.162 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 32' ' ' LEU . 20.7 mt -98.69 47.78 0.98 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.88 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -89.79 16.37 8.15 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.642 -177.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 173.06 56.75 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.141 0.976 . . . . 0.0 110.161 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -135.82 161.67 34.96 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.654 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.465 ' CZ ' ' HB1' ' A' ' 154' ' ' ALA . 16.4 m-30 -97.68 136.29 38.25 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.853 HD11 HD23 ' A' ' 32' ' ' LEU . 2.8 mt -108.49 136.6 47.83 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.703 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.426 HG23 HG22 ' A' ' 29' ' ' VAL . 2.7 mp -120.85 131.4 73.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.44 126.61 30.26 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.588 0.555 . . . . 0.0 111.92 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.2 mmt -114.29 155.26 45.94 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.22 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -79.47 75.82 4.86 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.662 2.241 . . . . 0.0 112.593 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -132.32 -20.35 2.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.779 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.34 -163.54 0.86 Allowed 'General case' 0 CA--C 1.542 0.636 0 O-C-N 123.324 0.39 . . . . 0.0 110.46 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . -104.51 36.31 2.45 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.925 0.393 . . . . 0.0 111.861 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.1 m-20 -111.1 82.97 3.49 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.798 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 6.2 Cg_exo -75.38 -22.78 13.82 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.969 2.446 . . . . 0.0 113.417 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -85.13 -37.78 19.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.94 0.496 . . . . 0.0 111.713 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.6 -3.22 56.66 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.823 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 22' ' ' ASP . . . -61.17 1.99 0.15 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -141.77 40.33 1.68 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.187 0.518 . . . . 0.0 112.005 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 p -123.71 156.09 36.6 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.535 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.702 HG11 ' HE ' ' A' ' 167' ' ' ARG . 48.9 t -130.41 132.03 64.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.89 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -114.59 154.01 29.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.341 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.412 ' OH ' HD21 ' A' ' 105' ' ' LEU . 42.9 t80 -107.21 119.24 38.86 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.853 HD23 HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -83.52 109.95 17.81 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.32 0.581 . . . . 0.0 111.098 -178.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.941 HG23 ' HA2' ' A' ' 42' ' ' GLY . 30.3 t -71.85 -63.73 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 113.461 -1.699 . . . . 0.0 110.685 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -133.91 117.96 17.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.537 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -103.0 126.61 50.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.491 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -139.46 152.1 46.74 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.514 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -65.63 -14.86 62.04 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.046 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -103.79 -0.36 29.38 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.302 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.01 169.2 19.32 Favored Glycine 0 C--N 1.345 1.058 0 N-CA-C 112.064 -0.414 . . . . 0.0 112.064 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.504 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -149.49 149.22 30.41 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.82 137.85 53.25 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.047 178.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.941 ' HA2' HG23 ' A' ' 33' ' ' VAL . . . -157.41 159.46 29.79 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.461 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.441 HD23 ' C ' ' A' ' 42' ' ' GLY . 3.3 mt -114.58 131.44 56.68 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.794 0.297 . . . . 0.0 111.111 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 78' ' ' GLY . 14.0 t -66.19 123.74 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.531 ' O ' ' HB2' ' A' ' 163' ' ' PRO . 1.4 pt -126.8 55.45 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 121.773 0.797 . . . . 0.0 112.064 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.857 ' HA ' ' O ' ' A' ' 163' ' ' PRO . 23.1 t-20 -146.82 -4.0 0.58 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.131 178.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -130.17 89.5 44.89 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' CG ' ' HB3' ' A' ' 164' ' ' PRO . 41.0 Cg_exo -59.39 139.38 89.4 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 121.483 1.456 . . . . 0.0 111.19 174.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.5 m -76.63 -53.32 8.18 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.1 -9.14 20.87 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.173 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 3.1 mp -82.43 169.64 16.18 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.633 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 12.0 p-10 -112.47 156.94 21.72 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.689 0.281 . . . . 0.0 111.7 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.822 HD12 HD13 ' A' ' 128' ' ' ILE . 4.5 tt -58.41 -31.71 67.96 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.347 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.46 74.55 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' ' OD1' ' A' ' 52' ' ' ASN . 39.4 mt-10 -65.28 -42.56 93.02 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.735 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.853 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.9 t -61.42 -50.09 81.79 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.657 ' HA ' HD12 ' A' ' 60' ' ' LEU . 22.1 mt -53.5 -35.23 60.4 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.062 0.851 . . . . 0.0 111.568 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -78.34 -29.46 47.58 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.254 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -31.29 47.85 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.66 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.853 ' HG ' ' O ' ' A' ' 56' ' ' VAL . 12.3 mt -77.6 -44.93 26.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.83 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -131.35 116.47 16.45 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.583 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.24 -32.82 2.88 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.725 2.95 . . . . 0.0 112.812 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.79 -15.03 55.53 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.293 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.75 149.28 25.39 Favored 'General case' 0 C--N 1.345 0.38 0 O-C-N 123.402 0.439 . . . . 0.0 111.609 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -118.21 123.04 29.73 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.114 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.94 147.77 34.63 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.231 1.954 . . . . 0.0 112.246 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.472 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 8.2 Cg_endo -94.45 -169.83 0.2 Allowed 'Trans proline' 0 C--N 1.368 1.56 0 C-N-CA 122.608 2.206 . . . . 0.0 112.172 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.473 ' O ' ' HD2' ' A' ' 72' ' ' HIS . . . -66.75 -24.84 66.27 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.089 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' NH1' ' HA ' ' A' ' 119' ' ' ALA . 6.5 ptp180 -67.88 -47.02 70.02 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.707 ' HA ' HD12 ' A' ' 73' ' ' ILE . 13.1 m -75.24 -25.34 58.01 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 67' ' ' PRO . 51.1 mt-30 -69.57 -30.4 68.17 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.473 ' HD2' ' O ' ' A' ' 68' ' ' ALA . 22.9 p80 -94.9 22.33 6.6 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.144 0.497 . . . . 0.0 111.461 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 70' ' ' CYS . 62.8 mt -118.3 136.17 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.318 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 1.7 m-20 -103.49 158.39 16.39 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.787 HD13 HD12 ' A' ' 128' ' ' ILE . 22.4 mm -108.23 149.1 11.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.991 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.736 ' CE2' ' HG2' ' A' ' 163' ' ' PRO . 3.0 t80 -115.54 156.62 25.4 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.82 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -86.4 120.32 27.62 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 44' ' ' VAL . . . -102.0 -23.42 9.21 Favored Glycine 0 C--N 1.345 1.044 0 C-N-CA 120.322 -0.942 . . . . 0.0 114.134 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.23 -167.59 35.01 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.261 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -88.15 -11.39 4.47 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.521 2.814 . . . . 0.0 114.173 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.2 t -86.84 127.16 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.088 0.242 . . . . 0.0 110.563 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 49.68 76.88 0.12 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.127 0.971 . . . . 0.0 112.518 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.463 ' O ' HD21 ' A' ' 130' ' ' LEU . 9.8 t -80.87 1.96 28.54 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.687 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -103.78 3.95 34.61 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -132.91 155.18 49.53 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.211 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.42 127.4 8.47 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.982 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 128' ' ' ILE . 0.3 OUTLIER -85.91 144.24 27.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.482 1.113 . . . . 0.0 110.383 179.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.6 t -121.82 104.71 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 123.231 0.332 . . . . 0.0 110.852 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.862 HD11 HD13 ' A' ' 105' ' ' LEU . 9.9 tp -106.98 129.03 54.84 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.946 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -127.8 168.77 14.17 Favored Pre-proline 0 CA--C 1.555 1.136 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.54 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.677 ' HD3' ' O ' ' A' ' 125' ' ' LYS . 19.7 Cg_endo -97.03 13.77 0.89 Allowed 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.784 2.322 . . . . 0.0 113.857 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.0 t -101.82 160.38 14.52 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.726 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.14 21.35 44.59 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.617 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -88.81 152.7 21.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.616 0.366 . . . . 0.0 110.511 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.526 ' HA ' HG21 ' A' ' 99' ' ' THR . 10.0 m -131.02 156.9 44.35 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.569 ' CE2' HG23 ' A' ' 113' ' ' VAL . 40.1 m-85 -123.87 -150.86 0.46 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.753 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -58.27 -46.68 85.58 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.604 0.362 . . . . 0.0 111.488 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.9 m -132.77 80.81 1.91 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.097 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.526 HG21 ' HA ' ' A' ' 95' ' ' SER . 31.7 m -130.45 130.04 43.75 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.756 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -110.16 123.6 50.04 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.791 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.36 125.41 30.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.271 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.578 ' HB3' HD12 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -119.39 44.63 2.31 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.609 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 62.41 -101.6 0.4 Allowed Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.354 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -56.29 -14.27 2.75 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.862 HD13 HD11 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -160.81 160.95 31.8 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.844 0.458 . . . . 0.0 110.821 -179.31 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.571 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -119.49 158.23 26.69 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.76 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.508 ' CE ' HD13 ' A' ' 89' ' ' LEU . 15.8 ttm -123.23 130.07 52.25 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.67 ' HB3' HG11 ' A' ' 113' ' ' VAL . 70.2 m -124.83 129.27 50.09 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.871 0.367 . . . . 0.0 110.257 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.7 p -120.87 21.0 11.55 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.335 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.755 ' O ' HG12 ' A' ' 113' ' ' VAL . 35.5 p -93.48 127.81 39.3 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.517 ' O ' ' HD1' ' A' ' 115' ' ' PHE . 20.8 pt20 -60.99 -28.67 69.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.926 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.31 -39.68 94.39 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.497 -1.228 . . . . 0.0 110.198 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 110' ' ' SER . 2.9 p -70.11 -37.7 72.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mt -56.82 -47.96 79.09 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.532 0.52 . . . . 0.0 110.239 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.517 ' HD1' ' O ' ' A' ' 111' ' ' GLN . 32.1 m-85 -66.54 -42.61 86.91 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.017 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.72 -53.88 52.07 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.888 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 113' ' ' VAL . 4.1 tp -64.69 -43.2 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.549 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 69' ' ' ARG . . . -57.34 -31.73 66.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.716 0.635 . . . . 0.0 109.602 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.417 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . . . -84.98 -19.44 32.08 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.331 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.97 17.06 28.78 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.697 -1.138 . . . . 0.0 114.575 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.8 p -107.39 7.7 29.21 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.08 -137.34 8.58 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-O 119.168 -0.795 . . . . 0.0 112.628 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -80.78 172.1 13.62 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 123.13 2.554 . . . . 0.0 113.545 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.01 -55.34 33.99 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.86 0.864 . . . . 0.0 111.994 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.677 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 12.0 mmtt -141.16 139.82 33.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.667 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 73.1 m -139.51 166.39 24.7 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 tp -127.19 117.79 23.02 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.273 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.822 HD13 HD12 ' A' ' 53' ' ' LEU . 10.9 pt -97.49 102.31 13.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 CA-C-O 121.724 0.774 . . . . 0.0 109.778 178.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 87' ' ' PHE . 8.2 t -118.98 121.08 39.09 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.907 -177.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 10.9 tp -67.51 112.73 4.84 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.355 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.65 172.44 11.82 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 115.012 -0.994 . . . . 0.0 114.376 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -128.68 176.36 7.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.333 0.587 . . . . 0.0 110.908 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 42' ' ' GLY . . . -115.82 130.71 56.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.029 178.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.52 149.11 18.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.447 -178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 21.1 m-90 -127.26 135.89 51.23 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 122.579 0.351 . . . . 0.0 110.381 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.34 158.15 27.52 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.863 0.727 . . . . 0.0 110.876 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.95 91.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.8 -24.47 7.51 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.478 -0.783 . . . . 0.0 113.11 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -57.88 -45.35 86.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 2.8 tm? -67.97 -48.05 66.9 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.136 0.273 . . . . 0.0 110.516 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.01 -29.11 68.26 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.008 0.432 . . . . 0.0 110.667 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 146' ' ' ASP . . . -70.38 -50.48 38.29 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.938 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 4.7 pt-20 -70.09 -26.5 64.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.773 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.8 tp -75.79 -38.91 57.79 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.804 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.0 m -77.8 -28.37 50.38 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.572 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 142' ' ' ALA . 2.6 t70 -82.66 0.96 40.78 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.496 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.88 29.54 19.1 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.874 0.87 . . . . 0.0 111.622 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.66 -43.11 17.32 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.94 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -123.52 113.4 18.68 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.348 0.405 . . . . 0.0 110.043 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 6.4 tp -83.61 139.81 32.6 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.245 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.4 p -105.81 138.09 42.58 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.513 0.508 . . . . 0.0 111.335 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 72.6 m -152.73 155.35 32.39 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.713 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.75 157.24 28.89 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.298 1.998 . . . . 0.0 111.182 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.465 ' HB1' ' CZ ' ' A' ' 13' ' ' PHE . . . -130.69 166.97 19.58 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -177.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -134.22 135.35 23.98 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.997 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.39 -26.46 14.33 Favored 'Trans proline' 0 C--N 1.364 1.363 0 C-N-CA 122.54 2.16 . . . . 0.0 113.785 -177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -52.85 -40.6 63.51 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.818 0.699 . . . . 0.0 112.158 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.567 HG21 ' NH1' ' A' ' 167' ' ' ARG . 4.6 mt -71.18 -35.24 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.408 0.623 . . . . 0.0 110.388 178.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.5 tt -73.98 -38.2 64.23 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.011 -1.449 . . . . 0.0 111.437 -177.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -85.57 -32.76 21.94 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -86.69 -72.58 0.5 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.054 0.388 . . . . 0.0 111.636 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.917 ' O ' ' HB3' ' A' ' 166' ' ' GLU . 1.1 tp -141.72 98.84 6.32 Favored Pre-proline 0 C--N 1.349 0.56 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.857 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 61.5 Cg_endo -92.68 0.2 3.83 Favored 'Trans proline' 0 CA--C 1.57 2.281 0 C-N-CA 121.737 1.625 . . . . 0.0 114.256 175.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.642 ' HD2' ' C ' ' A' ' 162' ' ' LEU . 94.8 Cg_endo -73.28 -52.39 0.15 Allowed 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 122.656 2.237 . . . . 0.0 114.195 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.516 ' H ' ' HG2' ' A' ' 164' ' ' PRO . 5.2 mt-10 -122.79 -29.93 3.92 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.664 -178.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.917 ' HB3' ' O ' ' A' ' 162' ' ' LEU . 29.7 tt0 -70.07 -10.91 60.28 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.407 178.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.702 ' HE ' HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -77.03 -41.21 43.54 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.151 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.1 tp -70.47 -50.21 40.47 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.5 m -58.38 -49.25 77.93 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.689 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.669 ' O ' ' HG2' ' A' ' 174' ' ' ARG . . . -64.05 -39.81 94.91 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.228 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.42 79.63 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 123.536 0.523 . . . . 0.0 110.424 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.4 90.99 Favored 'General case' 0 C--N 1.349 0.584 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.448 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.29 -27.87 68.93 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.673 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 170' ' ' ALA . 2.9 mmp_? -77.66 -40.01 43.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 122.908 0.483 . . . . 0.0 110.412 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.53 -31.96 69.24 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.413 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 109.66 54.65 0.56 Allowed Glycine 0 C--N 1.34 0.784 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.81 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.7 t -127.55 147.58 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -87.07 77.79 9.06 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.738 0.78 . . . . 0.0 110.616 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.79 -26.1 49.45 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.059 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 53.5 m -58.93 -41.96 88.59 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.64 -26.7 50.68 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 17.8 mt -77.08 -38.13 53.05 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.7 p -94.26 -48.32 6.23 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.242 0.339 . . . . 0.0 111.355 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 57.42 117.66 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.192 0.997 . . . . 0.0 112.786 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -103.74 145.25 30.36 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -122.31 -42.66 2.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.457 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 100.1 -70.53 0.48 Allowed Glycine 0 C--N 1.339 0.72 0 O-C-N 123.46 0.475 . . . . 0.0 112.555 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -100.85 135.37 42.41 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.63 0.253 . . . . 0.0 110.843 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.115 179.991 . . . . . . . . 0 0 . 1 stop_ save_